"","language_a","language_b","a_text","b_text","sentence_length_b","sentence_length_a"
"1","de","en","Abacavir zeigt in vitro in Kombination mit Nevirapin und Zidovudin synergistische Effekte.","Abacavir shows synergy in vitro in combination with nevirapine and zidovudine.",11,12
"2","de","en","Abbott Laboratories Limited Queenborough Kent ME11 5EL United Kingdom","Abbott Laboratories Limited Queenborough Kent ME11 5EL United Kingdom",9,9
"3","de","en","Abdominalschmerzen, Diarrhoe, Dyspepsie, Nausea, Erbrechen Erfahrungen aus der Zeit seit der Zulassung:","Common: abdominal pain, diarrhoea, dyspepsia, nausea, vomiting.",7,12
"4","de","en","Abfallmaterialien sind sicher zu entsorgen.","Waste material should be disposed of safely.",7,5
"5","de","en","Abgeschlossen im September 1998","Finalised in September 1998",4,4
"6","de","en","Abgesehen von einem Laktam Metaboliten ist die Identität anderer Metaboliten bei Katzen oder Hunden nicht bekannt.","Apart from one lactam metabolite, the identity of other metabolites is not known in cats or dogs.",17,16
"7","de","en","ABILIFY 10 mg Tabletten","ABILIFY 10 mg tablets",4,4
"8","de","en","Abilify ist ein Arzneimittel, das den Wirkstoff Aripiprazol enthält.","Abilify is a medicine containing the active substance aripiprazole.",9,9
"9","de","en","Abnahme der Leukozytenzahl (< 3.000/mm3) † ‡ * ○","White blood cell count decreased (< 3000/ mm³) × Λ *°",11,9
"10","de","en","Abraxane wird alleine, d. h. als Monotherapie, angewendet.","Abraxane is used on its own.",6,8
"11","de","en","Abschluss in Biochemie und Pharmakologie an der Universität Leeds.","Graduate in biochemistry and pharmacology from Leeds University.",8,9
"12","de","en","Abschluss in Medizin und Promotion in Entwicklungskardiologie an der Universität Leiden.","Qualified medical doctor from",4,11
"13","de","en","Abschnitt 4.8 und 5.1).","Co-administration of sildenafil and intravenous epoprostenol has been evaluated (see section 4.8 and 5.1).",14,4
"14","de","en","Abseamed 3000 I.E./0,3 ml Injektionszubereitung","Abseamed 3000 IU/ 0.3 ml injection",6,5
"15","de","en","Abseamed 8000 I.E./0,8 ml Injektionslösung in einer Fertigspritze","Abseamed 8000 IU/ 0.8 ml solution for injection in a pre-filled syringe",12,8
"16","de","en","Absetzen der Behandlung Abruptes Absetzen muss vermieden werden.","36 Discontinuation of treatment Abrupt discontinuation should be avoided.",9,8
"17","de","en","Absetzen der VELCADE-Behandlung bis die Toxizitätssymptome abgeklungen sind.","Withhold VELCADE treatment until symptoms of toxicity have resolved.",9,8
"18","de","en","Absetzen von MAO-Hemmern angewendet werden.","weeks after discontinuation of MAO inhibitor therapy.",7,5
"19","de","en","Abszesse und Wundinfektionen der Haut bei der Katze:","Skin and soft tissue abscesses and wounds in cats:",9,8
"20","de","en","ac-Pharma Vertriebs AG Frundsbergstr.","ac-Pharma Vertriebs AG Frundsbergstr.",4,4
"21","de","en","Achten Sie besonders darauf, einen erniedrigten Blutzuckerspiegel zu vermeiden.","Take special care to avoid low blood sugar.",8,9
"22","de","en","Achten Sie darauf, dass Sie während der Behandlung mit Ciprofloxacin Bayer ausreichend Flüssigkeit zu sich nehmen.","Remember to drink plenty of fluids while you are taking Ciprofloxacin Bayer.",12,16
"23","de","en","Achten Sie darauf, dass weder Alkohol noch andere Desinfektionsmittel oder sonstige Substanzen das Insulin verunreinigen.","Make sure that neither alcohol nor other disinfectants or other substances contaminate the insulin.",14,15
"24","de","en","Achten Sie darauf, nur während der Injektion auf den Druckknopf zu drücken.","Be careful only to push the push-button when injecting.",9,12
"25","de","en","Achtzehn Patienten haben die Studie abgeschlossen.","Eighteen patients completed the study.",5,6
"26","de","en","Aclar/Aluminiumblister mit 14 Hartkapseln pro Blisterstreifen und 4 Blisterstreifen (56 Hartkapseln) pro Packung.","aclar/ aluminum blisters with 14 hard capsules per card and 4 cards (56 hard capsules) per carton.",17,13
"27","de","en","Acticam sollte nicht zusammen mit anderen nicht-steroidalen Antiphlogistika oder Glukokortikoiden verabreicht werden.","Acticam must not be administered in conjunction with other NSAIDs or glucocorticosteroids.",12,12
"28","de","en","Actos wird einmal täglich mit oder ohne Nahrung eingenommen.","Actos is taken once daily with or without food.",9,9
"29","de","en","Actraphane 30 40 I.E./ml Injektionssuspension in einer Durchstechflasche Insulin human (r-DNS)","Actraphane 30 40 IU/ ml suspension for injection in a vial Insulin human (rDNA),",14,11
"30","de","en","Actraphane 30 Penfill darf nicht wieder aufgefüllt werden.","Do not refill Actraphane 30 Penfill.",6,8
"31","de","en","Actraphane 40 NovoLet ist ein einfacher, kompakter vorgefüllter Fertigpen.","Actraphane 40 NovoLet is a simple, compact pre-filled pen.",9,9
"32","de","en","Actraphane Penfill darf nur von einer Person benutzt werden.","Actraphane Penfill is for single person use only.",8,9
"33","de","en","Actrapid Penfill 100 I.E./ml Injektionslösung in einer Patrone Insulin human (r-DNS)","Actrapid Penfill 100 IU/ ml solution for injection in a cartridge Insulin human (rDNA)",14,11
"34","de","en","ADENURIC 120 mg Filmtabletten","ADENURIC 120 mg film-coated tablets",5,4
"35","de","en","Adjuvanzien werden eingesetzt, um die Immunantwort des Körpers auf den Impfstoff zu verbessern.","Adjuvants are used to improve the body’ s response to the vaccine.",12,13
"36","de","en","ADROVANCE vermindert das Risiko für Wirbel- und Hüftfrakturen.","ADROVANCE reduces the risk of vertebral and hip fractures.",9,8
"37","de","en","adsorbiert an Aluminiumhydroxid ln","adsorbed on aluminium hydroxide, hydrated t",6,4
"38","de","en","Advagraf 0,5 mg Hartkapseln, retardiert (30, 50 Aluminiumbeutel)","Advagraf 0.5 mg Prolonged-Release Capsules (30, 50 Aluminium Wrapper)",9,8
"39","de","en","Advagraf ist einmal täglich am Morgen einzunehmen.","Advagraf is taken orally once daily in the morning.",9,7
"40","de","en","Advocate für Hunde enthält 100 mg/ml Imidacloprid und 25 mg/ml Moxidectin.","Advocate for dogs contains 100 mg/ ml imidacloprid and 25 mg/ ml moxidectin.",13,11
"41","de","en","Advocate Lösung zum Auftropfen für mittelgroße Hunde","Advocate spot-on solution for large dogs",6,7
"42","de","en","Aerinaze linderte die Symptome wirksamer als die beiden Wirkstoffe jeweils allein.","Aerinaze was more effective in reducing symptoms than either of the two active substances taken alone.",16,11
"43","de","en","Aerius 5 mg Schmelztabletten Desloratadin","Aerius 5 mg orodispersible tablets desloratadine",6,5
"44","de","en","against Hepatitis A/B in children","against Hepatitis A/B in children",5,5
"45","de","en","Agenerase 15 mg/ml Lösung zum Einnehmen","Agenerase 15 mg/ ml oral solution.",6,6
"46","de","en","Agenerase wird zur Behandlung von HIV-1-infizierten, mit Proteasehemmern vorbehandelten Erwachsenen und Kindern ab 4 Jahren angewendet.","Agenerase is used in protease inhibitor experienced HIV-1 infected adults and children above the age of 4 years.",18,16
"47","de","en","AGEPS-EPHP Agence Générale des Équipements et Produits de Santé","AGEPS-EPHP Agence Générale des Équipements et Produits",7,9
"48","de","en","Agnès SAINT RAYMOND John PURVES Isabelle MOULON Marisa PAPALUCA AMATI","Agnès SAINT RAYMOND John PURVES Isabelle MOULON Marisa PAPALUCA AMATI",10,10
"49","de","en","Agopton schmeckt nach Erdbeeren und sollte auf die Zunge gelegt und behutsam gelutscht werden.","Agopton is strawberry flavoured and should be placed on the tongue and gently sucked.",14,14
"50","de","en","Ähnliche Nebenwirkungen sind bei Kindern zu beobachten.","Similar side effects are seen in children.",7,7
"51","de","en","Aivlosin 8,5 mg/g Arzneimittel-Vormischung zur Herstellung von Fütterungsarzneimitteln für Schweine","Aivlosin 8.5 mg/g Premix for medicated feeding stuff for pigs.",10,10
"52","de","en","Alcon Laboratories (UK) Ltd.","Alcon Laboratories (UK) Ltd.",4,4
"53","de","en","Aldara 5% Creme Imiquimod Anwendung auf der Haut","Aldara 5% cream Imiquimod For cutaneous use",7,8
"54","de","en","Aldara Creme darf nicht angewendet werden:","Do not use Aldara cream:",5,6
"55","de","en","Alerlisin, Virdos, Zyrtec gotas orales en solución Schweden:","Alerlisin, Virlix, Reactine, Zyrtec comprimidos recubiertos con pelicula, Alerrid 10 mg comprimidos recubiertos con pelicula Sweden:",16,8
"56","de","en","Aliud Pharma GmbH & Co.KG Gottlieb-Daimler-Str.","Aliud Pharma GmbH & Co. KG Gottlieb-Daimler-Str.",7,6
"57","de","en","Alkalische Phosphatase, LDH und Serumharnsäure erhöht (vorübergehend), Blutzucker erniedrigt (vorübergehend, leicht)","Blood alkaline phosphatase, LDH and blood uric acid increased (transient), blood glucose decreased (transient, moderate)",15,11
"58","de","en","Alkohol führt zu einem Anstieg der Abacavirkonzentration in Ihrem Blut.","Alcohol does increase the amount of abacavir in your blood.",10,10
"59","de","en","Alle 24 Stunden, mindestens 1 Tag, bis die Wundheilung erfolgt ist.","Every 24 hours, at least 1 day, until healing is achieved.",11,11
"60","de","en","Alle anderen Bedenken bleiben jedoch bestehen.","However, all other concerns remain.",5,6
"61","de","en","Alle Bereiche 0 1 2 ≥3","ranges 0 1 2 ≥3",5,6
"62","de","en","Alle diese Patienten hatten zusätzlich Arzneimittel erhalten, die als Azathioprin oder 6- Mercaptopurin bekannt sind.","All of these patients had also received drugs known as azathioprine or 6-mercaptopurine.",13,15
"63","de","en","Alle für den Lösungsvorgang und für die Anwendung verwendeten Materialien sollten üblichen Standards entsprechend entsorgt werden.","All materials that have been utilised for dilution and administration should be disposed of according to standard procedures.",18,16
"64","de","en","alle Grade Grad 3 Grad 4 alle Grade Grad 3 Grad 4 klasse Stoffwechsel-","all grades grade 3 grade 4 all grades grade 3 grade 4",12,14
"65","de","en","Alle Nebenwirkungen, die bei Patienten in mehreren klinischen Studien berichtet wurden","All adverse reactions reported in patients in multiple clinical trials",10,11
"66","de","en","Alle operativen Maßnahmen an der Eingriffsstelle sollten, sofern möglich, vor der Implantation des Produkts abgeschlossen werden.","Where practical, surgical manipulations to the site should be completed prior to product implantation.",14,16
"67","de","en","Alle Tabletten können in gleiche Hälften geteilt werden (mit Ausnahme von MIRAPEXIN 0,088/0,125 mg Tabletten).","All tablets can be divided into equal halves (with the exception of the 0.088/ 0.125 mg tablet).",17,15
"68","de","en","Alle Unterschiede waren entsprechend begründet, und der in der Zusammenfassung der Merkmale des Arzneimittels vorgeschlagene Wortlaut ist annehmbar.","All differences were accordingly justified and the proposed wording in the SPC is acceptable.",14,18
"69","de","en","Alle zur Lebensmittelerzeugung genutzten Arten","All food producing species",4,5
"70","de","en","allein oder der Kombination mit Ribavirin kann das Risiko in dieser Patienten-Untergruppe erhöhen.","increase the risk in this patient subset.",7,13
"71","de","en","Allein oder in Kombination mit anderen Diabetesmedikamenten war Januvia wirksamer als das Placebo.","Januvia was more effective than placebo when it was taken alone or in combination with other antidiabetes medicines.",18,13
"72","de","en","Allen Patienten wurde 1 mg Folsäure zweimal täglich verabreicht.","All patients received folate 1 mg bid.",7,9
"73","de","en","Allenopar 20 mg – Filmtabletten","Allenopar 20 mg – Filmtabletten",5,5
"74","de","en","Allerdings wurden im Rahmen von Studien zur allgemeinen Toxizität nach Einmal- und Mehrfachgabe keine Nebenwirkungen im Injektionsbereich berichtet.","However, in single and repeat-dose general toxicity studies no adverse reactions at the injection sites were reported.",17,18
"75","de","en","Allerdings zeigen die Daten erhebliche Unterschiede zwischen den Tieren, lagen aber innerhalb der bekannten Bandbreite dieser Spezies.","ra inter-animal variation and were within the historical control range for this species.",13,17
"76","de","en","Allergieartige Überempfindlichkeitsreaktionen Wie bei allen intravenös angewendeten proteinhaltigen Arzneimitteln sind allergieartige Hypersensitivitätsreaktionen möglich.","Allergic-type hypersensitivity reactions As with any intravenous protein product, allergic-type hypersensitivity reactions are possible.",14,13
"77","de","en","Allergische Reaktionen vom Sofort-Typ auf Insulin oder einen der sonstigen Bestandteile können lebensbedrohlich sein.","Immediate type allergic reactions to insulin or to the excipients may be life-threatening.",13,14
"78","de","en","Allergische Reaktionen* einschließlich Anaphylaxie, Hautrötung, Urtikaria, Angioödem, Dyspnoe und Hypotonie Gefäßerkrankungen Gelegentlich:","Adverse reactions in clinical trials in cancer patients Immune system disorders",11,12
"79","de","en","Allgemeine Erkrankungen und Beschwerden am","General disorders and administration site conditions",6,5
"80","de","en","Allgemeine Erkrankungen und Beschwerden am Verabreichungs-","sweats, +skin disorder hypertonia, myalgia, arthralgia, back pain, neck pain, pain",11,6
"81","de","en","Allgemeine Erkrankungen und Beschwerden am Verabreichungsort","18 General disorders and administration site conditions",7,6
"82","de","en","Allgemeine Erkrankungen und Beschwerden am Verabreichungsort Häufig","Reproductive system and breast disorders Uncommon",6,7
"83","de","en","Allgemeine Erkrankungen und Beschwerden am Verabreichungsort Häufig:","General disorders and administration site conditions common:",7,7
"84","de","en","Allgemeine Erkrankungen und Beschwerden am Verabreichungsort Verletzung, Vergiftung und durch Eingriffe bedingte Komplikationen","General disorders and administration site conditions Injury, poisoning and procedural complications",11,13
"85","de","en","Allgemeine Erkrankungen und Beschwerden am Verabreichungsort:","General disorders and administration site conditions:",6,6
"86","de","en","Allgemeine Erkrankungen und eim","Amenorrhea, breast pain, dysmenorrhea, menorrhagia,",5,4
"87","de","en","Allgemeine pharmakokinetische Eigenschaften Die Pharmakokinetik von Anidulafungin wurde bei gesunden Probanden, besonderen Populationen und Patienten untersucht.","General pharmacokinetic characteristics The pharmacokinetics of anidulafungin have been characterised in healthy subjects, special populations and patients.",17,16
"88","de","en","Allgemeine Störungen und Beschwerden am Ort der Anwendung Gelegentlich:","General disorders and administration site conditions Uncommon: local inflammatory reactions at the site of subcutaneous or intramuscular injection",18,9
"89","de","en","ALLGEMEINE TÄTIGKEIT DER EMEA","GENERAL ACTIVITIES OF THE EMEA",5,4
"90","de","en","Allgemeines Die im Folgenden empfohlenen Initialdosen sind nur als Richtlinien gedacht.","General considerations The recommended initial doses presented below are intended to act solely as a guideline.",16,11
"91","de","en","Almac Pharma Service Seagoe Industrial Estate Craigavon BT63 5QD Vereinigtes Königreich","Almac Pharma Service Seagoe Industrial Estate Craigavon BT63 5QD United Kingdom",11,11
"92","de","en","Alpha-, Beta- und Gamma-Interferone.","Three major classes of interferons have been identified: alpha, beta, and gamma.",12,4
"93","de","en","Alpharma-ISIS GmbH & Co.KG Elisabeth-Selbert-Str.","Alpharma-ISIS GmbH & Co. KG Elisabeth-Selbert-Str.",6,5
"94","de","en","Als calcitropes Hormon hemmt Calcitonin die Knochenresorption aufgrund einer direkten Wirkung auf die Osteoklasten.","Calcitonin is a calciotropic hormone, which inhibits bone resorption by a direct action on osteoclasts.",15,14
"95","de","en","Als das Unternehmen seinen Antrag zurücknahm, war in dem Antragsverfahren Tag 180 erreicht.","The application was at day 180 when the company withdrew.",10,13
"96","de","en","Als Einzeldosis oder 2-mal täglich","600 300 150 75",4,5
"97","de","en","Als übliche Startdosis von Trazec wird 60 mg vor den drei Hauptmahlzeiten empfohlen.","The usual dose of Trazec to start with is 60 mg before the three main meals.",16,13
"98","de","en","Als Vorsichtsmassnahme sollte die Behandlung mit PROTELOS während der Einnahme von Tetrazyklin- oder Chinolon-Antibiotika ausgesetzt werden.","As a precautionary measure, PROTELOS treatment should be suspended during treatment with oral tetracycline or quinolone antibiotics.",17,16
"99","de","en","Altargo ist ein Antibiotikum.","Altargo is an antibiotic medicine.",5,4
"100","de","en","Alter von 11 Jahren und 6,75 Mikrogramm/kg alle drei Wochen bei Krebspatienten.","11 years or older, to 6.75 micrograms/ kg every three weeks in cancer patients.",14,12
"101","de","en","Ältere Patienten (≥ 65 Jahre alt) Eine Dosisanpassung nach Alter ist nicht erforderlich.","Elderly patients (≥ 65 years old) Dose modification based upon age is not required.",14,13
"102","de","en","Ältere Patienten ≥ 65 Jahre:","Elderly patients ≥ 65 years of age:",7,5
"103","de","en","Ältere Patienten Die Pharmakokinetik im Steady-state ist bei Patienten über 65 Jahre und älter und jungen Patienten vergleichbar.","Steady state pharmacokinetics are similar in patients age 65 and over and young subjects.",14,18
"104","de","en","Ältere Patienten Für ältere Patienten ist keine Dosisanpassung erforderlich.","Elderly No dosage adjustment is necessary for elderly patients.",9,9
"105","de","en","Ältere Patienten mit Demenz Bei älteren Patienten mit Demenz besteht ein erhöhtes Risiko für einen Schlaganfall.","Elderly people with dementia In elderly patients with dementia, there is an increased risk of stroke.",16,16
"106","de","en","Alternativ kann eine Therapie mit Loxicom 5 mg/ml Injektionslösung eingeleitet werden.","Alternatively therapy may be initiated with Loxicom 5 mg/ ml solution for injection.",13,11
"107","de","en","Alternativ kann Epoetin alfa auch einmal wöchentlich subkutan mit einer Initialdosis von 450 I.E./kg angewendet werden.","Alternatively, epoetin alfa can be administered at an initial dose of 450 IU/ kg subcutaneously once weekly.",17,16
"108","de","en","Alternativ kann Silapo auch mit einer Initialdosis von 450 I.E. pro kg 1-mal wöchentlich subkutan gegeben werden.","Alternatively, Silapo can be administered at an initial dose of 450 IU/ kg subcutaneously once weekly.",16,17
"109","de","en","Aluminium/PVC-Blisterpackung in Faltschachteln aus Karton (Kalenderpackung).","Aluminium/ PVC blister packed in cardboard boxes (calendar).",8,6
"110","de","en","Aluminiumhydroxid Saponin (**) Hämolytische Einheiten","Aluminium hydroxide 2.7 mg.",4,5
"111","de","en","Alzheimer-Demenz wird mit Depression, Suizidgedanken und Suizid in Verbindung gebracht.","Alzheimer's disease has been associated with depression, suicidal ideation and suicide.",11,10
"112","de","en","Am häufigsten werden Blutungen an der Injektionsstelle, gelegentlich Blutungen im Urogenitaltrakt und Zahnfleischbluten beobachtet.","Most frequently haemorrhage at the injection site, and occasionally genitourinary and gingival bleeding were observed.",15,14
"113","de","en","Ambrisentan ist ein oral wirksamer, zur Klasse der Propionsäuren gehörender ERA mit Selektivität für den Endothelin-A-(ETA-)Rezeptor.","Ambrisentan is an orally active, propanoic acid-class, ERA selective for the endothelin A (ETA) receptor.",15,16
"114","de","en","Amitriptylin) • einige Klassen von Antibiotika (z.","quinidine, amiodarone, sotalol, dofetilide)",4,7
"115","de","en","Amlodipin Wörwag Tabletten können in Kombination mit Beta-Blockern, Saluretika, ACE-Hemmern oder in der Monotherapie angewendet werden.","Amlodipin Wörwag tablets can be used in combination with beta-blockers, saluretics, ACE inhibitors, or as monotherapy.",16,16
"116","de","en","Amlovita 10 mg Tabletten:","Amlovita 10 mg tablet:",4,4
"117","de","en","Amnesie, Parästhesie, Benommenheit, Ataxie / Koordinationsstörung, Schwindelgefühl, herabgesetzte Konzentrationsfähigkeit, Geruchstäuschung, Sprechstörung (Dysarthrie, verwaschene Sprache), Sensibilitätsstörung","amnesia, paraesthesia, somnolence ataxia/ coordination abnormal, dizziness, disturbance in attention, parosmia, speech disorder (dysarthria, slurred speech), hypoaesthesia",17,15
"118","de","en","An den Knochen wurden keine histopathologischen Veränderungen beobachtet.","No histopathological effects on bone were observed.",7,8
"119","de","en","An eine mögliche Sensibilisierung ist zu denken.","The possibility of sensitisation should be borne in mind.",9,7
"120","de","en","Analyse der zu 30% und zu 50% ansprechenden Patienten nach 10 und 15 Minuten für die Studie EN3267-005,","Analysis of the 30% and 50% responder rates at 10 and 15 minutes for the study EN-3267- 005,",18,18
"121","de","en","Anämie (erniedrigter Hämoglobinwert, erniedrigter Hämatokrit)","Anaemia (decreased haemoglobin, decreased haematocrit)",5,5
"122","de","en","Anämiesymptome und Folgeerscheinungen können mit Alter, Geschlecht und der gesamten m","Anaemia symptoms and sequelae may vary with age, gender, and overall burden of disease; a a",16,11
"123","de","en","Anaphylaktische Reaktionen können sich bis zum lebensbedrohlichen Schock entwickeln, auch bereits nach der Erstanwendung.","Anaphylactic reactions can progress to a life-threatening shock, even after the first administration.",13,14
"124","de","en","Anaphylaxie, Angioödem, Urtikaria, Ausschlag Erkrankungen des Blutes und des Lymphsystems Sehr häufig:","Severe allergic reaction: anaphylaxis, angioedema, urticaria, rash Blood and the lymphatic system disorders Very common:",15,12
"125","de","en","Anaphylaxie, Gewebsentzündung, Phlebitis und neutralisierende Antikörper.","Of these the most significant include: anaphylaxis, cellulitis, phlebitis, and neutralising antibodies.",12,6
"126","de","en","Anaphylaxie, systemischer Lupus erythematodes, rheumatoide Arthritis","Anaphylaxis, systemic lupus erythematosus rheumatoid arthritis",6,6
"127","de","en","Andere Antimykotika zur systemischen Anwendung; ATC-Code:","Other antimycotics for systemic use, ATC code:",7,6
"128","de","en","Andere Berichte über Leberreaktionen betrafen Erhöhungen der Leberenzyme, Hyperbilirubinämie und Hepatitis.","Other reported hepatic reactions include increases in liver enzymes, hyperbilirubinaemia, and hepatitis.",12,11
"129","de","en","Andere berichtete Symptome waren extrapyramidale Symptome, Sprachstörungen, Ataxie, Aggression, Schwindel, Schwäche, Hypertension und Krampfanfälle.","Other symptoms noted include extrapyramidal symptoms, dysarthria, ataxia, aggression, dizziness, weakness, hypertension and convulsion.",14,14
"130","de","en","Andere Lösungsmittel zur Rekonstitution sollten vermieden werden.","Use of other reconstitution solvents should be avoided.",8,7
"131","de","en","Andere Mechanismen könnten ebenfalls zur zytotoxischen Wirkung von Nelarabin beitragen.","Other mechanisms may contribute to the cytotoxic effects of nelarabine.",10,10
"132","de","en","Andere Mittel bei obstruktiven Atemwegserkrankungen zur systemischen Anwendung, ATC-Code:","Pharmacotherapeutic group: other systemic drugs for obstructive airway diseases, ATC code:",11,9
"133","de","en","Andere phänotypische und genotypische Testmethoden werden derzeit geprüft.","Other phenotypic and genotypic assays are currently being evaluated.",9,8
"134","de","en","Andere, normalerweise sterile Lokalisationen b","Peritoneal fluid/ IA abscess Other",5,5
"135","de","en","anderen drei Studien betrug die Zi elhämoglobinkonzentration 12-14 g/dl.","with recombinant human erythropoietin and controls.",6,9
"136","de","en","Ändern Sie die Dosierung bitte nicht, ohne Ihren Arzt zu Rate zu ziehen.","Please do not change the dosage without consulting your doctor.",10,13
"137","de","en","Andernfalls könnte Flüssigkeit austreten und dies zu Dosierungsungenauigkeiten führen.","Otherwise, the liquid may leak out which can cause inaccurate dosing.",11,9
"138","de","en","Andernfalls wird Ihnen Cetrotide 0,25 mg nicht den bestmöglichen Nutzen bringen.","Please observe these instructions for use, otherwise you will not fully benefit from Cetrotide 0.25 mg.",16,11
"139","de","en","Anfänglich kommt es zu einem Blutdruckanstieg, der sich dann wieder normalisiert oder in eine leichte Hypotonie übergeht.","Blood pressure will increase initially and then return to normal or below normal.",13,17
"140","de","en","ANGABE DER RÜCKSTANDSHÖCHSTMENGEN (MRLs)","STATEMENT OF THE MRLs",4,4
"141","de","en","Angemessene Vorsichtsmaßnahmen sollten weiterhin eingehalten werden.","Appropriate precautions should continue to be employed.",7,6
"142","de","en","angewendet werden, um die bei der bipolaren Störung auftretenden depressiven Phasen zu verhindern.","It is not yet known how Lamictal works in the brain to have this effect.",15,13
"143","de","en","Angioödem, Bluterguss, Urtikaria, Juckreiz, Exanthem, Erythema nodosum Sklelettmuskulatur-, Bindegewebs- und Knochenerkrankungen:","Skin and subcutaneous tissue disorders: angiooedema, bruising, urticaria, pruritus, rash, erythema nodosum.",12,11
"144","de","en","Angioödem, Urtikaria Enzephalopathische Symptome** Selbstmordversuch Retinaerkrankungen (wie periphere Atrophie der Retina)","Retinal disorder (such as peripheral retinal atrophy)",7,11
"145","de","en","Angiotensin II stimuliert ebenfalls die Aldosteronsekretion durch die Nebennierenrinde.","Angiotensin II also stimulates aldosterone secretion by the adrenal cortex.",10,9
"146","de","en","Angiox 250 mg Pulver zur Herstellung eines Konzentrates für eine Injektions- oder Infusionslösung Intravenöse Anwendung Bivalirudin","Angiox 250 mg powder for concentrate for solution for injection or infusion Intravenous use bivalirudin",15,16
"147","de","en","Anhang 1 - Mitglieder des Verwaltungsrates","Annex 3 Membership of the Committee for Veterinary Medicinal Products",10,6
"148","de","en","Anhang III stellt daher nicht notwendigerweise den aktuellen Text dar.","Therefore, Annex III may not necessarily represent the current text.",10,10
"149","de","en","Anhängig Clobenzorex; Fenbutrazate; Fenproporex; Mazindol; Mefenorex; Norpseudoephedrine; Phenmetrazine; Phendimetrazine; Propylhexedrine","Norpseudoephedrine; Phenmetrazine; Phendimetrazine; Propylhexedrine",4,10
"150","de","en","Ankylosierende Spondylitis Die ankylosierende Spondylitis ist eine entzündliche Erkrankung der Wirbelsäule.","Ankylosing spondylitis Ankylosing spondylitis is an inflammatory disease of the spine.",11,11
"151","de","en","Anleitung für alternative Injektionsstellen","Instructions for alternate injection sites",5,4
"152","de","en","annähernd 1,2 pro 1000 Patientenjahre.","lymphomas is approximately 1.2 per 1000 patient years.",8,5
"153","de","en","Annähernd 12% der Kinder, die mit Rebetol und Interferon alfa- 2b behandelt wurden, entwickelten erhöhte TSH-Werte.","Approximately 12% of children treated with Rebetol and interferon alfa-2b developed increase in TSH.",14,16
"154","de","en","Annex II (E422) Alle zur Lebensmittelerzeugung genutzten Arten","Annex II (E422): producing species",5,8
"155","de","en","Annopol 6B – 03-236 Warszawa, Polen","Wicklow, Ireland Przedsiebiorstwo Farmaceutyczne ANPHARM S. A., ul. Annopol 6B – 03-236 Warszawa, Poland",14,6
"156","de","en","Anorexie Hyperglykämie, Hyperurikämie, Hypocalcämie, Dehydratation, gesteigerter Appetit, Durst","Hyperglycaemia, hyperuricaemia, hypocalcaemia, dehydration, increased appetite, thirst",7,8
"157","de","en","Ansonsten können Ihre Symptome wieder auftreten.","Your symptoms may return.",4,6
"158","de","en","ANSPRECHRATEN BEI PATIENTEN MIT MORBUS BECHTEREW IN EINER PLAZEBO-KONTROLLIERTEN STUDIE Proze ntsatz der Patienten","48 RESPONSES OF PATIENTS WITH ANKYLOSING SPONDYLITIS IN A PLACEBO-CONTROLLED TRIAL Percent of Patients",14,14
"159","de","en","ANSPRECHRATEN BEI PATIENTEN MIT MORBUS BECHTEREW IN EINER PLAZEBO-KONTROLLIERTEN STUDIE Prozentsatz der Patienten","175 RESPONSES OF PATIENTS WITH ANKYLOSING SPONDYLITIS IN A PLACEBO-CONTROLLED TRIAL Percent of Patients",14,13
"160","de","en","Anti-Polio-Typ 1 (1/8 Verdünnung) †","Anti-Polio type 1 (1/ 8 dilution) †",7,5
"161","de","en","Antibakterielle Substanzen zur systemischen Anwendung, Sonstige antibakterielle Substanzen, ATC-Code:","Antibacterials for systemic use, Other antibacterials, ATC code:",8,9
"162","de","en","Antiepileptika In Interaktionsstudien beeinflusste Lacosamid den Plasmaspiegel von Carbamazepin und Valproinsäure nicht signifikant.","Antiepileptic drugs In interaction trials lacosamide did not significantly affect the plasma concentrations of carbamazepine",15,13
"163","de","en","Antihistaminika – H1-Antagonisten, ATC-Code:","Pharmacotherapeutic group: antihistamines – H1 antagonist, ATC code:",8,4
"164","de","en","Antikoagulationsparameter sollten überwacht werden bei gleichzeitiger Gabe von Warfarin mit Indinavir/Ritonavir.","Anticoagulation parameters should be monitored when warfarin is coadministered with indinavir/ ritonavir.",12,11
"165","de","en","Antikörper gegen Diphtherie (0,1 IU/ml) †","Anti-diphtheria (0.1 IU/ ml) †",5,6
"166","de","en","Antineoplastische Mittel, monoklonale Antikörper, ATC-Code:","Antineoplastic agents, monoclonal antibodies, ATC code:",6,5
"167","de","en","Antithrombotikum – direkter Thrombin-Inhibitor (ATC Code:","Antithrombotic agent - direct thrombin inhibitor, ATC Code:",8,6
"168","de","en","Anträge auf Erstbeurteilung (Tierarzneimittel)","Applications for initial evaluation (veterinary medicines)",6,4
"169","de","en","Anträge auf Erstbeurteilung 2000 - 2002","12 EMEA Annual Report 2002",5,6
"170","de","en","Anträge auf Folgeverfahren für zentral zugelassene Arzneimittel 2000-2002","Post-authorisation applications for centrally authorised medicinal product 2000-2002",8,8
"171","de","en","Anweisungen zum Verdünnen von Xyrem","Instructions on how to dilute Xyrem",6,5
"172","de","en","ANWEISUNGEN ZUR ZUBEREITUNG VON RADIOAKTIVEN ARZNEIMITTELN","INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS",5,6
"173","de","en","Anwendung bei älteren Patienten (über 65 Jahre)","25 Use in the elderly (over 65 years of age)",10,7
"174","de","en","Anwendung bei gestörter Nierenfunktion:","Use in renal impairment:",4,4
"175","de","en","Anwendung bei Kindern und Jugendlichen (unter 18 Jahren):","Use in children and adolescents (under the age of 18):",10,8
"176","de","en","Anwendung bei Kindern und Jugendlichen:","24 Use in children and adolescents:",6,5
"177","de","en","Anwendung bei Kindern VIRAMUNE Tabletten sind geeignet für Kinder, die 16 Jahre oder älter sind.","Use in children VIRAMUNE tablets can be taken by children 16 years of age or older.",16,15
"178","de","en","Anwendung bei Männern mit Diabetes Bei Diabetikern sind Dosisanpassungen nicht erforderlich.","Use in men with diabetes Dose adjustments are not required in diabetic patients.",13,11
"179","de","en","Anwendung bei pädiatrischen Patienten (< 18 Jahren)","2 Use in paediatric patients (< 18 years of age)",10,7
"180","de","en","Anwendung fast so groß wie das Gesamtblutvolumen und liegt zwischen 0,063 und 0,097 l/kg.","in both healthy volunteers and patients with chronic renal failure.",10,14
"181","de","en","Anwendung in der Schwangerschaft siehe Abschnitt 4.6.","For pregnant women, see section 4.6.",6,7
"182","de","en","Anwendung mit anderen Therapien zur Raucherentwöhnung:","Use with other therapies for smoking cessation:",7,6
"183","de","en","Anwendung von Apidra mit anderen Arzneimitteln "").","Warning symptoms of hyperglycaemia",4,7
"184","de","en","Anwendung von Humalog • Säubern Sie Ihre Haut, wie es Ihnen gelehrt wurde, bevor Sie injizieren.","Injecting Humalog • Before you make an injection, clean your skin as you have been instructed.",16,16
"185","de","en","Anwendung Zur subkutanen Anwendung.","30 Administration For subcutaneous use.",5,4
"186","de","en","Anwendungsfehler, einschließlich unachtsamer, unbeabsichtigter oder unbeaufsichtigter Umstellung zwischen Tacrolimus-Formulierungen mit unmittelbarer oder retardierter Freisetzung, sind beobachtet worden.","Medication errors, including inadvertent, unintentional or unsupervised substitution of immediate- or prolonged-release tacrolimus formulations, have been observed.",17,17
"187","de","en","Anwendungsgebiete Der CHMP bestätigte die Anwendung von Diovan zur “ Behandlung der essenziellen Hypertonie”.","Therapeutic indications The CHMP endorsed the use of Diovan in the “ treatment of essential hypertension”.",16,14
"188","de","en","Anzahl (%) Patienten mit dauerhaftem Thrombozyten- ansprechen bei stabiler Dosise","(%) patients with durable",4,10
"189","de","en","Anzahl der 200 mg Kapseln 3 Kapselna 4 Kapselnb","Number of 200 mg capsules 3 capsulesa 4 capsulesb",9,9
"190","de","en","Anzahl der Patienten ohne Ereignis Fernmetastasenfreies Überleben","- No. patients with event - No. patients without event Distant disease-free survival",13,7
"191","de","en","Anzahl der Tabletten Körpergewicht","Number of tablets Body weight (kg)",6,4
"192","de","en","Anzeichen einer akuten Toxizität bei Tieren beinhalteten Ataxie, erschwerte Atmung, Ptose, Hypoaktivität oder Erregung.","Signs of acute toxicity in animals included ataxia, laboured breathing, ptosis, hypoactivity, or excitation.",14,14
"193","de","en","Anzeichen und Symptome einer Tuberkulose untersuchen, bevor er die Behandlung mit RoActemra beginnt.","of tuberculosis before starting RoActemra.",5,13
"194","de","en","Apotheke zur Verfügung stellt), damit Sie die Spritzen sicher entsorgen können.","dispose of used syringes safely.",5,11
"195","de","en","Apotheker wie das Arzneimittel zu entsorgen ist, wenn Sie es nicht mehr benötigen.","Medicines should not be disposed of via wastewater or household waste.",11,13
"196","de","en","Appetitlosigkeit, Obstipation Dyspepsie, Übelkeit, Abdominalschmerzen, Gastroenteritis, Stuhlveränderungen","Anorexia, constipation Dyspepsia, nausea, abdominal pain, gastroenteritis, stool abnormal",9,7
"197","de","en","April 2002 erteilte die Europäische Kommission eine Genehmigung für das Inverkehrbringen von PritorPlus in der gesamten Europäischen Union.","The European Commission granted a marketing authorisation valid throughout the European Union for PritorPlus on 22 April 2002.",18,18
"198","de","en","April 2007 in eine Entscheidung umgewandelt.","1 Article 29(4) of Directive 2001/ 83/ EC, as amended.",10,6
"199","de","en","Aprovel 75 mg Tabletten.","Aprovel 75 mg tablets.",4,4
"200","de","en","Aprovel verlangsamt die Verschlechterung der Nierenfunktion bei Patienten mit hohem Blutdruck und Typ-2-Diabetes.","Irbesartan Krka slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.",18,13
"201","de","en","APTIVUS ist ein antivirales (gegen Viren gerichtetes) Arzneimittel.","APTIVUS is an antiviral medicine.",5,8
"202","de","en","Aranesp 130 µg Darbepoetin alfa IV/SC","Aranesp 130 µg Darbepoetin alfa IV/ SC",7,6
"203","de","en","Aranesp 20 µg Injektionszubereitung Darbepoetin alfa","Aranesp 20 µg injection Darbepoetin alfa",6,6
"204","de","en","Aranesp 40 µg Injektionszubereitung Darbepoetin alfa SC","Aranesp 40 µg injection Darbepoetin alfa SC",7,7
"205","de","en","Aranesp 80 Mikrogramm Injektionslösung in einem vorgefüllten Injektor.","Aranesp 80 micrograms solution for injection in a pre-filled pen.",10,8
"206","de","en","Arava 10 mg Filmtabletten Leflunomid","Arava 10 mg film-coated tablets Leflunomide",6,5
"207","de","en","Arbeitsgruppe Impfstoffe Die neu geschaffene CPMP-Arbeitsgruppe Impfstoffe trate 2002 fünfmal zusammen.","The working party contributed to the review of variation regulation and Annex 1 of Directive 2001/83/EC.",16,11
"208","de","en","ARCOXIAist sowohl bei älteren als auch bei jüngeren erwachsenen Patienten gleich gut wirksam und verträglich.","< ARCOXIA > works equally well in older and younger adult patients.",12,15
"209","de","en","ARICLAIM erhöht die Spiegel von Serotonin und Noradrenalin im Nervensystem.","ARICLAIM increases the levels of serotonin and norepinephrine in the nervous system.",12,10
"210","de","en","Arixtra enthält eine synthetische Substanz mit der Bezeichnung Fondaparinux-Natrium.","Arixtra contains a synthetic substance called fondaparinux sodium.",8,9
"211","de","en","Arsenverbindungen induzieren in vitro und in vivo Chromosomenaberrationen und morphologische Veränderungen der Säugerzelle.","Arsenic compounds induce chromosomal aberrations and morphological transformations of mammalian cells in vitro and in vivo.",16,13
"212","de","en","Art der Anwendung Fondaparinux wird durch tiefe subkutane Injektion am liegenden Patienten angewendet.","Method of administration Fondaparinux is administered by deep subcutaneous injection while the patient is lying down.",16,13
"213","de","en","Art der Anwendung Lansoprazol AbZ 15 mg werden als Ganzes mit ausreichend Flüssigkeit (z.","Lansoprazol AbZ capsules are swallowed whole with sufficient liquid (e. g. a glass of water).",15,14
"214","de","en","Art der Anwendung Zum Einnehmen Zum Einnehmen Zum Einnehmen Zum Einnehmen","Route of administration Oral use Oral use Oral use Oral use",11,11
"215","de","en","Art und Inhalt des Behältnisses","6.5 Nature and contents of container",6,5
"216","de","en","Arthralgie, Arthrose, Myalgie, Rückenschmerzen, Gelenkschmerzen","Arthralgia, arthosis, myalgia, back pain, joint disorder",7,5
"217","de","en","Artikel 2 2 1 — Insgesamt","Article 2 2 1 — Total",6,6
"218","de","en","Artikel 8 - Vertraulichkeit","Article 8 - Confidentiality",4,4
"219","de","en","ARZNEILICH WIRKSAME(R) BESTANDTEIL(E) NACH ART UND MENGE","QUANTITY OF THE ACTIVE SUBSTANCE(S)",5,7
"220","de","en","ARZNEILICH WIRKSAME(R) BESTANDTEIL(E) UND SONSTIGE BESTANDTEILE","STATEMENT OF ACTIVE AND OTHER SUBSTANCES",6,6
"221","de","en","Arzneimittel auf eingeschränkte ärztliche Verschreibung (siehe Anhang I:","Medicinal product subject to restricted medical prescription (see Annex I:",10,8
"222","de","en","Arzneimittel außer Reich- und Sichtweite von Kindern aufbewahren.","Keep out of the reach and sight of children Do not store above 25° C.",15,8
"223","de","en","Arzneimittel direkt aus Messlöffel durch Herunterschlucken einnehmen.","Swallow the medicine directly from the measuring spoon.",8,7
"224","de","en","Arzneimittel dürfen nicht im Abwasser oder Haushaltsabfall entsorgt werden.","106 Medicines should not be disposed of via wastewater or household waste.",12,9
"225","de","en","Arzneimittel für kinder unzugänglich aufbewahren","Keep out of the reach and sight of children",9,5
"226","de","en","Arzneimittel für Kinder unzugänglich aufbewahren!","Keep out of the reach and sight of children.",9,5
"227","de","en","Arzneimittel für Kinder unzugänglich aufbewahren.","12 Keep out of the reach and sight of children.",10,5
"228","de","en","Arzneimittel für Kinder unzugänglich aufbewahren. eim","Keep out of the reach and sight of children. ici",10,6
"229","de","en","Arzneimittel unzugänglich für Kinder aufbewahren, da die versehentliche Einnahme schwerwiegende Folgen haben kann.","Keep out of reach and sight of children as accidental ingestion should be regarded as serious.",16,13
"230","de","en","Arzneimittel, das der Verschreibungspflicht unterliegt.","Medicinal product subject to medical prescription.",6,5
"231","de","en","Ärzten wird geraten, das Wachstum von Kindern, die Ribavirin in Kombination mit Interferon alfa-2b erhalten, zu überwachen.","Physicians are advised to monitor the growth of children taking ribavirin in combination with interferon alfa-2b.",16,17
"232","de","en","as Anwendung von Tacrolimussalbe gering ist, wird das Stillen während der Behandlung mit Protopy Salbe nicht empfohlen.","4.7 Effects on ability to drive and use machines",9,17
"233","de","en","as Maßnahme hilft die Umwelt zu schützen.","These measures will help to protect the environment.",8,7
"234","de","en","AS03 als Adjuvans, bestehend aus Squalen (10,68 Milligramm), DL-α -Tocopherol (11,86 Milligramm) und Polysorbat 80 (4,85 Milligramm)","AS03 adjuvant composed of squalene (10.68 milligrams), DL-α -tocopherol (11.86 milligrams) and polysorbate 80 (4.85 milligrams)",16,17
"235","de","en","Aspartam (E951) Sorbitol (Ph.Eur.), Sprühgetrockneter Glucose-Sirup, 0,22 g Natrium pro Beutel","Aspartame (E951) Sorbitol Glucose liquid spray dried 0.22 mg sodium per sachet",12,11
"236","de","en","Aspartat- und Alanin- Aminotransferasewerte, assoziiert.","Bosentan has been associated with dose-related elevations in liver aminotransferases, i.e., aspartate and alanine aminotransferases.",15,5
"237","de","en","Aspergillus spp.1 A. fumigatus A. flavus A. terreus A. niger","Aspergillus spp.1 A. fumigatus A. flavus A. terreus A. niger",10,10
"238","de","en","Astellas Pharma Europe B.V.","Astellas Pharma Europe B. V.",5,4
"239","de","en","Asthenie (extreme Müdigkeit), Unwohlsein Selten:","uncommon: asthenia (extreme fatigue), malaise rare: oedema (swelling)",8,5
"240","de","en","Asthenie, Irritationen an der Applikationsstelle","Asthenia, application site irritation",4,5
"241","de","en","AstraZenca BV Postbus 599","AstraZenca BV Postbus 599",4,4
"242","de","en","AstraZeneca Österreich GmbH Schwarzenbergplatz 7","AstraZeneca Österreich GmbH Schwarzenbergplatz 7",5,5
"243","de","en","AstraZeneca UK Ltd 600 Capability Green Luton LU1 3LU","AstraZeneca UK Ltd 600 Capability Green Luton LU1 3LU",9,9
"244","de","en","Ataxie Schwindel Gedächtnis- beein- trächtigung Schläfrigkeit","Ataxia Dizziness Memory impairment Somnolence Diplopia",6,6
"245","de","en","Atazanavir/Ritonavir 300/100 mg 1 x täglich 400/100 mg 1 x täglich","30 PIs Atazanavir/ ritonavir 300/ 100 mg QD 400/ 100 mg QD",12,11
"246","de","en","atmadisc forte 50µg/500µg Diskus","atmadisc forte 50µg/ 500µg Diskus",5,4
"247","de","en","Atorvastatin wird von Cytochrom P450 Isoenzym 3A4 zu ortho- und parahydroxylierten Derivaten und verschiedenen Beta-Oxidationsprodukten metabolisiert.","Atorvastatin is metabolized by cytochrome P450 3A4 to ortho- and parahydroxylated derivatives and various beta-oxidation products.",16,16
"248","de","en","Atripla ist ein antivirales Arzneimittel.","Atripla is an antiviral medicine.",5,5
"249","de","en","ATryn wird für gewöhnlich in Verbindung mit Heparin oder niedermolekularem Heparin gegeben.","ATryn is normally given in association with heparin or low molecular weight heparin.",13,12
"250","de","en","AUC: ↓ 13% Cmin: ↓ 31% (CYP3A4-Induktion) Efavirenz:","AUC: ↓ 13% Cmin: ↓ 31% (CYP3A4 induction)",8,8
"251","de","en","AUC: ↔ Cmax: ↑ 11% (↑ 6 bis ↑ 16) Cmin: ↔ (CYP3A4-Induktion)","AUC: ↔ Cmax: ↑ 11% (↑ 6 to ↑ 16) Cmin: ↔ (CYP3A4 induction)",14,13
"252","de","en","Auch eine gut geführte Organisation wie die EMEA bedarf der ständigen Weiterentwicklung und Orientierung.","I am pleased to present my first work programme as EMEA",11,14
"253","de","en","Auch Kreuzresistenzen mit anderen Cephalosporinen und sonstigen Beta-Laktam- Antibiotika können auftreten.","Cross resistance with other cephalosporins and other beta- lactam antibacterials can be observed.",13,11
"254","de","en","Auch über Eiweißbindung vermittelte Wechselwirkungen sind unwahrscheinlich.","Interactions mediated by protein binding are also unlikely.",8,7
"255","de","en","auf das weiße Pulver am Boden der Durchstechflasche.","Do not aim the stream at the white powder at the bottom of the vial.",15,8
"256","de","en","Auf der Rückseite finden Sie Informationen zur Bedienung Ihres NovoLet.","Now turn over for information on how to use your NovoLet.",11,10
"257","de","en","auf die Leber wirken (siehe „ Bei Einnahme von Tasigna mit anderen Arzneimitteln“).","(see Taking other medicines).",4,13
"258","de","en","Auf diese Weise „verschlafen” Sie die Nebenwirkungen.","This may allow you to sleep through the effects.",9,7
"259","de","en","Auf diese Weise werden die Auswirkungen der Zyanidvergiftung vermindert.","This helps to reduce the effects of cyanide poisoning.",9,9
"260","de","en","Auf diese Weise wird die Krankheit auf andere Tiere übertragen.","This contributes to the spread of the disease to other animals.",11,10
"261","de","en","Auf eine geeignete sterile Spritze eine passende Kanüle aufsetzen.","Take an appropriate sterile syringe and attach a suitable needle.",10,9
"262","de","en","Aufgrund der Ähnlichkeit mit Emtricitabin sind gleichzeitig mit Atripla keine anderen Cytidin-","Due to similarities with emtricitabine, Atripla should not be administered concomitantly with other cytidine analogues, such as lamivudine.",18,12
"263","de","en","Aufgrund der intraindivuellen Variabilitäten werden gelegentlich Hämoglobinwerte beobachtet, die ei","Due to intra-patient variability, occasional individual haemoglobin values for a patient above and ed",14,10
"264","de","en","Aufgrund des großen zu verabreichenden Volumens (3 ml) sollte die Injektion langsam erfolgen.","Injection should be given slowly due to the large volume to be administered (3 ml).",15,13
"265","de","en","Aufgrund des Potenzials, die Wirksamkeit von Mycophenolatmofetil Teva zu reduzieren, ist bei gleichzeitiger Verabreichung Vorsicht geboten.","Caution should be used during concomitant administration because of the potential to reduce efficacy of mycophenolate mofetil.",17,16
"266","de","en","Aufgrund des Stoffwechselweges werden keine klinisch signifikanten pharmakokinetischen Wechselwirkungen zwischen Enfurvitid und Nevirapin erwartet.","Due to the metabolic pathway no clinically significant pharmacokinetic interactions are expected between enfuvirtide and nevirapine.",16,14
"267","de","en","Aufgrund fehlender Daten ist VELCADE bei Patienten mit schwerer Einschränkung der Leberfunktion kontraindiziert (siehe Abschnitt 4.3).","In the absence of data VELCADE is contraindicated in patients with severe liver impairment (see section 4.3).",17,16
"268","de","en","Aufgrund spärlicher klinischer Daten wurden Sicherheit und Wirksamkeit bei weiblichen Patienten nicht nachgewiesen.","Safety and effectiveness in women have not been established because of the paucity of clinical data.",16,13
"269","de","en","Aufgrund unzureichender klinischer Erfahrung soll Amlovita bei Kindern nicht angewendet werden.","Paediatric patients Amlovita tablets should not be given to children due to insufficient clinical experience.",15,11
"270","de","en","Aufrecht im Kühlschrank lagern (2°C-8°C).","Store upright in a refrigerator (2°C -8°C).",7,5
"271","de","en","Aufstoßen, Verstopfung, Blähungen. akute Pankreatitis (siehe Abschnitt 4.4).","Gastrointestinal disorders: eructation, constipation, flatulence, acute pancreatitis (see section 4.4).",10,8
"272","de","en","Aufziehen von Fuzeon in die 1-ml-Spritze","Drawing Up Fuzeon into the 1 ml syringe",8,6
"273","de","en","Augenerkrankungen (siehe Abschnitt 4.4)","Eye disorders (see section 4.4)",5,4
"274","de","en","Augenerkrankungen Gelegentlich: verschwommenes Sehen, Sehstörung.","Eye disorders Uncommon: blurred vision, visual disturbance.",7,5
"275","de","en","Augenkontakt und orale Aufnahme bei der Katze vermeiden.","Avoid contact with the eyes of the cat and avoid oral ingestion by the animal.",15,8
"276","de","en","Augentropfensuspension Anwendung am Auge","Eye drops, suspension Ocular use",5,4
"277","de","en","August 1997 Datum der letzten Verlängerung:","27 August 1997 Date of latest renewal:",7,6
"278","de","en","August 2005 die EMEA mit den Gründen für die unterschiedlichen Auffassungen.","The United Kingdom referred the reasons for disagreement to the EMEA on 16 August 2005.",15,11
"279","de","en","Aus den begrenzten Daten geht hervor, dass die Dosis bei Patienten mit mäßig eingeschränkter Nierenfunktion verringert werden sollte.","Limited data indicate that the dose should be reduced in patients with moderate renal impairment.",15,18
"280","de","en","Aus diesem Grund kann das Risiko einer Lipodystrophie nicht ausgeschlossen werden.","Tenofovir is structurally related to nucleoside analogues hence the risk of lipodystrophy cannot be excluded.",15,11
"281","de","en","Aus diesem Grund sollte vor dem Schlafengehen ein Multivitaminpräparat eingenommen werden.","For this reason, a multivitamin supplement should be taken at bedtime.",11,11
"282","de","en","Aus diesem Grund sollten während der Behandlung mit Somatropin Anzeichen einer Skoliose überwacht werden.","Therefore, signs of scoliosis should be monitored during treatment with somatropin.",11,14
"283","de","en","Aus diesem Grund wird Ihr Blut regelmäßig kontrolliert, um sicherzustellen, dass sich Ihre HIV-Infektion nicht verschlechtert.","Therefore, your blood will be checked regularly to be sure that the HIV infection is not getting worse.",18,16
"284","de","en","Aus diesem Grunde besteht ein erhöhtes Risiko für die Entwicklung von Hautkrebs.","Because of this, there is an increased risk of skin cancer.",11,12
"285","de","en","Aus mikrobiologischer Sicht muss das Arzneimittel sofort verwendet werden.","From a microbiological point of view, the product must be used immediately.",12,9
"286","de","en","Aus mikrobiologischer Sicht soll die gebrauchsfertige Zubereitung sofort verwendet werden.","From a microbiological point of view, the product should be used immediately.",12,10
"287","de","en","Aus welchen Gründen hat das Unternehmen den Antrag zurückgenommen?","What were the reasons given by the company to withdraw the application?",12,9
"288","de","en","Ausführliche Erläuterungen sind der Zusammenfassung der Merkmale des Arzneimittels zu entnehmen, die ebenfalls Teil des EPAR ist.","See the Summary of Product Characteristics, also part of the EPAR, for full details.",14,17
"289","de","en","Ausführliche Informationen zu diesem Arzneimittel sind auf der Webseite der Europäischen Arzneimittel-Agentur (EMEA) http://www.emea.europa.eu/ verfügbar.","Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/.",16,15
"290","de","en","Ausführliche Informationen zu diesem Arzneimittel sind auf der Website der Europäischen Arzneimittel-Agentur (EMEA) http://www.emea.europa.eu / verfügbar.","Detailed information on this medicine is available on the European Medicines Agency (EMEA) web site: http://www.emea.europa.eu/",16,16
"291","de","en","Ausgangswert Veränderung gegenüber Baseline","Baseline Change from baseline",4,4
"292","de","en","Ausgeprägtere Gelenkblutung, Muskelblutung oder Hämatom.","More extensive haemarthrosis, muscle bleeding or haematoma.",7,5
"293","de","en","Ausmaß und Rate der topischen Resorption nehmen jedoch mit Fortschreiten des Heilungsprozesses ab.","However, both the extent and the rate of topical absorption of tacrolimus decrease as the skin heals.",17,13
"294","de","en","Ausschlag (11,6%), Schwindel (8,5%), Übelkeit (8,0%), Kopfschmerzen (5,7%) und Müdigkeit (5,5%).","The most notable adverse reactions associated with efavirenz are rash and nervous system symptoms.",14,11
"295","de","en","Ausschlag und allergische Reaktionen:","Rash and allergic reactions:",4,4
"296","de","en","Ausschlag, Lichtempfindlichkeitsreaktion, Alopezie, Hyperhidrose","rash, photosensitivity reaction, alopecia, hyperhidrosis",5,4
"297","de","en","AUSSCHUSS FÜR HUMANARZNEIMITTEL (CHMP)","COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)",8,4
"298","de","en","AUSSCHUSS FÜR HUMANARZNEIMITTEL GUTACHTEN IM NACHGANG ZU EINEM VERFAHREN GEMÄSS ARTIKEL 31","COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE OPINION FOLLOWING AN ARTICLE 31 REFERRAL",13,12
"299","de","en","außer außer bei dem Patienten ist bei dem Patienten ist","experienced a experienced a",4,10
"300","de","en","Außerdem erarbeitete die Arbeitsgruppe Leitlinien über:","In addition, the Working Party has provided guidance on",9,6
"301","de","en","Außerdem hemmt das rekombinante Interferon alfa-2b sowohl in vitro als auch in vivo die Virusreplikation.","s ori Recombinant interferon alfa-2b also inhibits viral replication in vitro and in vivo.",14,15
"302","de","en","Außerdem wurde sehr häufig über Laborwertveränderungen (z.B. bei Blut- oder Harnuntersuchungen) berichtet.","Also, changes in laboratory markers (e.g., blood or urine tests) have been reported very commonly.",15,12
"303","de","en","Auswählen und Vorbereiten einer Injektionsstelle","Choosing and preparing an injection site",6,5
"304","de","en","AUSWIRKUNGEN AUF DIE FAHRTÜCHTIGKEIT UND DAS BEDIENEN VON MASCHINEN","EFFECTS ON ABILITY TO DRIVE AND USE MACHINES",8,9
"305","de","en","Auswirkungen auf die Fertilität:","ori Effect on fertility:",4,4
"306","de","en","Auswirkungen von anderen Arzneimittel auf Thelin","Effects of other medicinal products on Thelin",7,6
"307","de","en","Avaglim Avaglim Avaglim Avaglim Avaglim Avaglim Avaglim Avaglim Avaglim Avaglim","blister (PVC/ PVdC/ alu)",4,10
"308","de","en","Avaglim wird einmal täglich kurz vor oder während einer Mahlzeit eingenommen, üblicherweise zum Frühstück.","Avaglim is taken once a day, just before or during a meal, generally breakfast.",14,14
"309","de","en","AVAMYS ist ein Nasenspray, das den Wirkstoff Fluticasonfuroat enthält.","AVAMYS is a nasal spray that contains the active substance fluticasone furoate.",12,9
"310","de","en","AVANDAMET ist angezeigt zur Behandlung des Typ-2-Diabetes mellitus bei Patienten, insbesondere übergewichtigen Patienten:","AVANDAMET is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:",15,13
"311","de","en","Avansor Pharma Oy Tekniikantie 14 02150 Espoo","Avansor Pharma Oy Tekniikantie 14 02150 Espoo",7,7
"312","de","en","Avda Barcelona 69 Sant Joan Despi ES-08970 Barcelona, Spanien","Avda Barcelona 69 Sant Joan Despi ES-08970 Barcelona, Spain",9,9
"313","de","en","Avenida de Barcelona 239 E-08750 Molins de Rei","Avenida de Barcelona 239 E-08750 Molins de Rei",8,8
"314","de","en","AVENTIS PHARMA LTD 50 Kings Hill Avenue Kings Hill West Malling Kent ME19 4AH","AVENTIS PHARMA LTD 50 Kings Hill Avenue Kings Hill West Malling Kent ME19 4AH",14,14
"315","de","en","Avenue Molière 225 B-1050 Bruxelles/Brussel Tél: +32 2 340 2828","Avenue Molière 225 B-1050 Bruxelles/Brussel Tél: +32 2 340 2828",10,10
"316","de","en","Avonex wurde in drei Hauptstudien untersucht.","Avonex has been studied in three main studies.",8,6
"317","de","en","Axura Axura Axura Axura Axura Axura Axura","Axura Axura Axura Axura Axura Axura Axura",7,7
"318","de","en","AZARGA 10 mg/ml + 5 mg/ml Augentropfensuspension Brinzolamid/Timolol Anwendung am Auge","AZARGA 10 mg/ml + 5 mg/ml eye drops Brinzolamide/Timolol Ocular use",11,11
"319","de","en","Azithromycin, Clarithromycin, Erythromycin) sind.","macrolide antibiotics (e. g. azithromycin, clarithromycin, erythromycin).",7,4
"320","de","en","AZOPT 10 mg/ml Augentropfensuspension","AZOPT 10 mg/ ml eye drops, suspension",7,4
"321","de","en","B Stellen Sie Ihre benötigte Dosis ein, indem Sie den Dosierring vorwärts drehen.","Select y our required d ose by turning the dose selector forward.",12,13
"322","de","en","B-CLL-Patienten, bei denen nach Behandlung mit herkömmlichen","B-CLL pts who had B-CLL pts who had",8,7
"323","de","en","B. bei Hämodialyse-Patienten über die arteriovenöse Fistel im Anschluss an die Dialyse.","2 minutes, e. g. in haemodialysis patients via the arterio-venous fistula at the end of dialysis.",16,12
"324","de","en","B. bei Patienten mit niedrigem Körpergewicht).","IU) adjustments of insulin are necessary (for example in patient with low body weight). ed",15,6
"325","de","en","B. ein Unterschenkelgeschwür), ziehen Sie Ihren Arzt zu Rate, bevor Sie mit der Trudexa-Behandlung beginnen.","It is important to tell your doctor if you get symptoms such as fever, wounds, na",16,15
"326","de","en","B. eine Erkältung, dürfte zwar unproblematisch sein, Sie sollten aber zuerst mit Ihrem Arzt darüber sprechen.","A minor infection such as a cold should not be a problem, but talk to the doctor first.",18,16
"327","de","en","B. eine Flüssigkeitstherapie) sollte durchgeführt werden.","Symptomatic treatment, e. g., fluid therapy, should be provided.",9,6
"328","de","en","B. in einem feuchten Badezimmer) ausgesetzt war.","ho HOW TO STORE YOUR INSULIN INHALER",7,7
"329","de","en","B. über die Stelle im Körper, an der sich ein Tumor befindet.","This can give the doctor valuable information such as the location of a tumour.",14,12
"330","de","en","B. unterschiedliche Behandlungsdauer, Vorerkrankungen oder Ausgangsmerkmale der Patienten nicht berücksichtigt.","Frequency categories do not account for other factors including varying study duration, pre-existing conditions and baseline patient characteristics.",18,10
"331","de","en","B. virale Infektionen, sollten ausgeschlossen werden.","Other special precautions Causes of transient neutropenia such as viral infections should be excluded.",14,6
"332","de","en","B. von Blut, Desinfektionsmitteln und anderen Flüssigkeiten.","Prior to application the wound area should be cleansed, e. g. from blood, disinfectants and other fluids.",17,7
"333","de","en","b) Verteilung des arzneilich wirksamen Bestandteils im Patienten:","b) Characteristics in patients:",4,8
"334","de","en","B/Malaysia/2506/2004 – entsprechender Stamm (B/Malaysia/2506/2004) 15 Mikrogramm HA**","B/ Malaysia/ 2506/ 2004 like strain (B/ Malaysia/ 2506/ 2004) 15 micrograms HA**",13,8
"335","de","en","Baix Llobregat, 3-5 E-08970 Sant Joan Despí (Barcelona)na Tel: +34 93 4956500","Baix Llobregat, 3-5 E-08970 Sant Joan Despí (Barcelona) Tel: +34 93 4956500",12,12
"336","de","en","Baraclude Lösung zum Einnehmen enthält Maltitol (13 g Maltitol (flüssig) pro 20 ml Dosis).","Baraclude oral solution contains maltitol (13 g maltitol liquid per 20 ml dose).",13,14
"337","de","en","Basierend auf den Erfahrungen mit Glimepirid und mit anderen Sulfonylharnstoffen müssen folgende Interaktionen hervorgehoben werden.","Based on the experience with glimepiride and with other sulphonylurea the following interactions have to be mentioned.",17,15
"338","de","en","Basierend auf der individuellen Verträglichkeit kann die Dosis auf einmal täglich 2,5 mg herabgesetzt werden.","The appropriateness of continued use of the daily regimen should be reassessed periodically.",13,15
"339","de","en","Bass geleiteten Referat fort.","as Deputy Heads of Sector.",5,4
"340","de","en","Bauchschmerzen c / aufgeblähter Bauch","Abdominal pain c / distension",5,5
"341","de","en","Bauchschmerzen, Durchfall, Dyspepsie, Übelkeit.","Abdominal pain, diarrhoea, dyspepsia, nausea.",5,4
"342","de","en","Baxter AG Industriestrasse 67 A-1221 Wien Österreich","Baxter AG Industriestrasse 67 A-1221 Vienna Austria",7,7
"343","de","en","Baxter AG Latvijas filiāle Dzelzavas iela 117 LV 1021 RĪGA Tel.: +371 67784784","LatvijaBaxter AG Latvijas filiā le Dzelzavas iela 117 LV 1021 RĪ GA Tel.: +371 67784784",15,13
"344","de","en","Bayer AG 51368 Leverkusen Deutschland","Bayer AG 51368 Leverkusen Germany",5,5
"345","de","en","Bayer Austria Gesellschaft Lipobay G.m.b.H.","Bayer Austria Gesellschaft G. m. b. H.",7,5
"346","de","en","Bayer Health Care AG 51368 Leverkusen Deutschland","Estonia Bayer Health Care AG 51368 Leverkusen Germany",8,7
"347","de","en","Bayer HealthCare AG 51368 Leverkusen Deutschland","Austria Bayer HealthCare AG 51368 Leverkusen Germany",7,6
"348","de","en","Bayer HealthCare AG D-51368 Leverkusen Deutschland","63 Marketing Authorisation Holder Bayer HealthCare AG Bayer HealthCare AG D-51368 Leverkusen D-51368 Leverkusen Germany Germany",16,6
"349","de","en","Bayer Plc Bayer House.","Bayer Plc Bayer House.",4,4
"350","de","en","Bayer Schering Pharma AG D-13342 Berlin Germany","Bayer Schering Pharma AG D-13342 Berlin Germany",7,7
"351","de","en","Bayer, spol. s r.o.","Bayer, spol. s r.o.",4,4
"352","de","en","Beachten Sie die Empfehlungen unter 4 Verhalten im Notfall.","See the advice in 4 What to do in an emergency.",11,9
"353","de","en","Beclometason), in Erwägung gezogen werden.","9 performed over a longer period.",6,5
"354","de","en","Bedienungsanleitung Der BYETTA Pen darf nur von einer Person angewendet werden.","Instructions for use BYETTA is for use by one person only.",11,11
"355","de","en","bedingt durch die Anstiege der Triglyceride und des Cholesterins, sind zur Zeit nicht bekannt.","Talk to you pharmacist if you have difficulty opening the bottle.",11,14
"356","de","en","BEDINGUNGEN DER GENEHMIGUNG FÜR DAS INVERKEHRBRINGEN","B CONDITIONS OF THE MARKETING AUTHORISATION",6,6
"357","de","en","BEDINGUNGEN DER GENEHMIGUNG FÜR DAS INVERKEHRBRINGEN, EINSCHLIESSLICH DER EINSCHRÄNKUNGEN FÜR LIEFERUNG UND VERWENDUNG","CONDITIONS OF THE MARKETING AUTHORISATION INCLUDING RESTRICTIONS REGARDING SUPPLY AND USE",11,13
"358","de","en","BEDINGUNGEN ODER BESCHRÄNKUNGEN DER GENEHMIGUNG FÜR DAS INVERKEHRBRINGEN, IN BEZUG AUF ABGABE UND ANWENDUNG","CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY AND USE",11,14
"359","de","en","BEDINGUNGEN ODER BESCHRÄNKUNGEN IN BEZUG AUF ABGABE UND ANWENDUNG","CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE",7,9
"360","de","en","BEDINGUNGEN ODER EINSCHRÄNKUNGEN HINSICHTLICH DER SICHEREN UND WIRKSAMEN ANWENDUNG DES ARZNEIMITTELS","• CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT",16,11
"361","de","en","Beenden Sie die Anwendung von Betaferon und informieren Sie Ihren Arzt unverzüglich, wenn irgendetwas davon eintritt.","► Stop using Betaferon and tell your doctor immediately if any of these happens to you.",16,16
"362","de","en","Beenden Sie die Therapie mit CYMBALTA nicht ohne Rücksprache mit Ihrem Arzt.","Do not stop taking CYMBALTA without talking to your doctor.",10,12
"363","de","en","Beendigung der Behandlung Neupro sollte ausschleichend abgesetzt werden.","41 Treatment discontinuation Neupro should be discontinued gradually.",8,8
"364","de","en","Befolgen Sie die Anweisungen Ihres Arztes oder Ihrer Diabetesberaterin, wie das Mischen korrekt durchzuführen ist. el itt","Follow the instructions of your doctor or diabetes nurse concerning the correct mixing procedure.",14,17
"365","de","en","Befolgen Sie genau die Anweisungen Ihres Arztes und beachten Sie die folgenden Hinweise:","Follow the directions given by your doctor closely and use the instructions below as a guide:",16,13
"366","de","en","Befolgen Sie sorgfältig die Anweisungen Ihres Arztes, welche Arzneimittel miteinander kombiniert werden können.","Follow your doctor’s instruction carefully on which medicines can be combined.",11,13
"367","de","en","Befragen Sie hierzu Ihren Arzt.","Ask your doctor about this.",5,5
"368","de","en","Begleiterkrankungen, insbesondere Infektionen, erhöhen in der Regel den Insulinbedarf des Patienten.","Concomitant illness, especially infections, usually increases the patient’ s insulin requirements.",11,11
"369","de","en","Begleittherapie Acetylsalicylsäure führt zu keiner weiteren Flushreduktion über die von Pelzont hinaus.","Concomitant therapy Acetylsalicylic acid provides no additional reduction of flushing beyond that achieved by Pelzont.",15,12
"370","de","en","Begrenzte aber relevante Mutagenitätstests wurden durchgeführt.","Limited but relevant mutagenesis tests have been carried out.",9,6
"371","de","en","BEGRÜNDUND DER ÄNDERUNG DER ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS","- The MAH must undertake not to provide any free sample of the product.",14,9
"372","de","en","Behandlung der proliferativen Enteropathie (Ileitis)","Treatment of PPE (ileitis)",4,5
"373","de","en","Behandlung der symptomatischen, chemotherapieinduzierten Anämie bei Tumorpatienten","Treatment of symptomatic chemotherapy induced anaemia in cancer patients",9,7
"374","de","en","Behandlung Die wirksamste Methode zur Entfernung von Metformin ist die Hämodialyse.","Management The most effective method of removing metformin is haemodialysis.",10,11
"375","de","en","Behandlung mit Trudexa nicht weitergeführt werden (siehe Abschnitt 4.8). itte","ed given (see section 4.8).",5,10
"376","de","en","Behandlung unterbrechen, bis eine Rückbildung auf Grad 0 - 1 erreicht","Interrupt until resolved to grade 0-1",6,11
"377","de","en","Behandlung von Angiostrongylus vasorum","Treatment of Angiostrongylus vasorum",4,4
"378","de","en","Behandlung von Fluconazol-resistenten, schweren invasiven Candida-Infektionen (einschließlich durch C. krusei).","Treatment of fluconazole-resistant serious invasive Candida infections (including C. krusei).",10,10
"379","de","en","Behandlung von invasiver Candidose Behandlung der ösophagealen Candidose Prophylaxe von Candida-Infektionen","Treatment of invasive candidiasis Treatment of oesophageal candidiasis Prophylaxis of Candida infection",12,11
"380","de","en","Behandlung von Spulwürmern und Hakenwürmern","Roundworm and hookworm treatment",4,5
"381","de","en","Behandlungsschemata in der Studie NO16966","Treatment Regimens in Study N016966 (mCRC)",6,5
"382","de","en","Bei +2 °C bis +8 °C und lichtgeschützt aufbewahren.","Store between 2°C and 8°C, protected from light.",8,9
"383","de","en","Bei +2 bis +8 °C lagern.","Store at 2 - 8°C.",5,6
"384","de","en","Bei 1 von 10 Personen, die wegen Multipler Sklerose behandelt werden, kann eine Depression auftreten.","93 Depression may occur in 1 patient out of 10 treated for multiple sclerosis.",14,15
"385","de","en","Bei 2 Patienten mit hämodynamischem Gefährdungsfaktor war der Perikarderguss jedoch klinisch signifikant.","However, the pericardial effusion was clinically significant in 2 patients with some associated haemodynamic compromise.",15,12
"386","de","en","Bei 2°C - 8°C lagern (im Kühlschrank).","Store at 2°C to 8°C (in a refrigerator).",8,7
"387","de","en","Bei 42 Schwangerschaften wurde über 5 Fehlgeburten und 2 Fehlbildungen (Mikrozephalie und korrigierbarer Herzfehler) berichtet.","Five miscarriages and 2 birth defects (microcephaly and correctable heart defect) were reported in 42 pregnancies.",16,15
"388","de","en","Bei 43 Patienten wurde über einen stabilen Krankheitszustand berichtet.","In 43 patients stable disease was reported.",7,9
"389","de","en","Bei 5 Patienten wurde eine Zunahme der Viruslast beobachtet (siehe auch Abschnitt 4.4).","An increase in HIV viral load was observed in 5 patients (see also Section 4.4).",15,13
"390","de","en","Bei 80% der untersuchten Kaninchen wirksame Dosis (RED = Rabbit Effective Dose) (Serologie).","Rabbit effective dose in 80% of the animals (serology).",9,13
"391","de","en","Bei A nwendung von Viraferon mit anderen Arzneimitteln Ar","Be sure to tell your doctor if you are taking the Chinese herbal medication Shosaikoto. uc",16,9
"392","de","en","Bei Affen, die oral 50, 150 oder 450 mg/kg für 14 Tage erhielten, wurde dosisabhängiges Erbrechen festgestellt.","In monkeys dosed orally (50, 150 or 450 mg/ kg) for 14 days there was dose-related emesis.",17,17
"393","de","en","Bei allen Patienten trat eine ausgeprägte Myelosuppression auf.","All patients experienced a profound myelosuppression.",6,8
"394","de","en","Bei älteren Patienten ist das Risiko möglicherweise erhöht.","Renal/ hepatic impairment Caution is recommended in patients with severe renal impairment or in those with hepatic impairment.",18,8
"395","de","en","Bei älteren Patienten ist keine Dosisanpassung erforderlich.","No dosage adjustment is necessary in elderly patients.",8,7
"396","de","en","Bei älteren Patienten ist keine Dosisanpassung von Karvezide erforderlich.","15 Elderly patients: no dosage adjustment of Karvezide is necessary in elderly patients.",13,9
"397","de","en","Bei älteren Patienten kann eine fortschreitende Verschlechterung der Nierenfunktion zu einer stetigen Abnahme des Insulinbedarfs führen.","In the elderly, progressive deterioration of renal function may lead to a steady decrease in insulin requirements.",17,16
"398","de","en","Bei älteren Patienten, die Icandra einnehmen, sollte die Nierenfunktion regelmäßig überwacht werden.","Elderly patients taking Icandra should have their kidney function monitored regularly.",11,12
"399","de","en","Bei älteren Personen (> 65 Jahre) ist die AUC im Vergleich zu jüngeren um 50% erhöht.","The AUC is 50% higher in elderly (> 65 years) than in young subjects.",14,16
"400","de","en","Bei Analyse der Sicherheitsdaten nach Alter, ethnischer Zugehörigkeit oder Geschlecht wurden keine klinisch bedeutsamen Unterschiede festgestellt.","No clinically significant differences were seen when the safety data were analysed by age, race, or gender.",17,16
"401","de","en","Bei Anwendung von 16 mg/kg Bridion zur schnellen Erholung der Patienten, trat diese nach 4,2 Minuten ein.","When used for rapid recovery, patients receiving 16 mg/ kg Bridion recovered after 4.2 minutes.",15,17
"402","de","en","Bei Anwendung von Hycamtin zusammen mit Nahrungsmitteln und Getränken Eine Wechselwirkung zwischen Hycamtin und Alkohol ist nicht bekannt.","Using Hycamtin with food and drink There is no known interaction between Hycamtin and alcohol.",15,18
"403","de","en","Bei Anwendung von IVEMEND bei diesen Patienten wird zur Vorsicht geraten (siehe Abschnitt 5.2).","IVEMEND should be used with caution in these patients (see section 5.2).",12,14
"404","de","en","Bei Anwendung von Panretin ist folgendes besonders zu beachten","Take special care with Panretin",5,9
"405","de","en","Bei Anwendung von Soliris mit anderen Arzneimitteln:","Using Soliris with other medicines:",5,7
"406","de","en","Bei aufeinanderfolgenden Impfungen sollte jeweils eine andere Injektionsstelle gewählt werden.","The site of injection should be alternated for subsequent injections.",10,10
"407","de","en","Bei Auftreten dieser Symptome muss die Anwendung sofort abgesetzt werden.","If these symptoms occur, the administration has to be discontinued immediately.",11,10
"408","de","en","Bei Auftreten von Nebenwirkungen sollte die Behandlung abgebrochen werden.","If side effects occur, treatment should be discontinued.",8,9
"409","de","en","Bei Bedarf wird Verbindung mit anderen Arbeitsgruppen des Ausschusses für Arzneispezialitäten aufgenommen.","When appropriate, it liaises with other CPMP Working Parties.",9,12
"410","de","en","Bei beiden CABG– Studien erhielten die Patienten vor der Randomisierung und während der gesamten Studiendauer niedrig dosierte Acetylsalicylsäure.","Patients received low-dose acetylsalicylic acid prior to randomization and throughout the two CABG surgery studies.",15,18
"411","de","en","Bei beiden Vorgehensweisen wird im Anschluss die Plasmakonzentration von A771726 zum ersten Mal gemessen.","In either case the A771726 plasma concentration is then measured for the first time.",14,14
"412","de","en","Bei bestehender Nieren- Leberinsuffizienz sollte eine Dosisanpassung nicht erforderlich sein.","The presence of renal and hepatic impairment should not require a change in dosage.",14,10
"413","de","en","Bei den Frauen mit dem höchsten Ausgangscholesterinspiegel war die Senkung am ausgeprägtesten.","Women with the highest baseline cholesterol levels had the greatest decreases.",11,12
"414","de","en","Bei den meisten Patienten gingen die Beschwerden nach dem Absetzen der Therapie zurück.","Most patients had relief of symptoms after stopping treatment.",9,13
"415","de","en","Bei den mit Risperidon Behandelten betrug die Mortalität 4%, verglichen mit 3,1% unter Plazebo.","Among those treated with risperidone, the mortality was 4% compared with 3.1% for placebo.",14,14
"416","de","en","Bei den Patienten, die Placebo einnahmen, verringerte sich die Gehstrecke dagegen nach 12 Wochen um 9,0 m.","Patients taking placebo showed a reduction of 9.0 m after 12 weeks.",12,17
"417","de","en","Bei den Patienten, die Placebo erhielten, sank dieser Wert im Vergleich dazu von 99,3 mmHg um 5,8 mmHg.","This was compared with a fall of 5.8 mmHg from 99.3 mmHg in those taking placebo.",16,18
"418","de","en","Bei den pharmakokinetischen Eigenschaften wurden keine klinisch relevanten Unterschiede festgestellt.","There was no clinically relevant difference in pharmacokinetic properties.",9,10
"419","de","en","Bei den üblichen klinischen Konzentrationen werden MPA und MPAG nicht durch Dialyse entfernt.","At clinically encountered concentrations, MPA and MPAG are not removed by haemodialysis.",12,13
"420","de","en","Bei der Anwendung von Flebogammadif ist besondere Vorsicht erforderlich","Take special care with Flebogammadif",5,9
"421","de","en","Bei der Ausübung ihrer Tätigkeit handeln die Ausschußmitglieder und Sachverständigen für die Agentur und in ihrem Auftrag.","In fulfilling their tasks, Committee members and experts shall act for and on behalf of the Agency.",17,17
"422","de","en","Bei der Bewertung von Nebenwirkungen werden folgende Häufigkeitsangaben zugrunde gelegt:","The frequency of the side effects listed below is defined using the following convention:",14,10
"423","de","en","Bei der bipolaren Störung ist Lamictal ebenfalls wirksam.","Lamictal also treats bipolar disorder.",5,8
"424","de","en","Bei der Einnahme von < Phantasiebezeichnung > ist besondere Vorsicht erforderlich.","Take special care with< Invented name >",7,11
"425","de","en","Bei der externen Ganzkörper- Gammaszintigraphie fand sich die höchste Radioaktivität im Abdomen.","External whole-body gamma scintigraphy showed highest location of radioactivity in the abdomen.",12,12
"426","de","en","Bei der Kombination von Aliskiren mit anderen Antihypertensiva wurden ähnliche Reduktionen gefunden.","Similar reductions were found when aliskiren was combined with other antihypertensive agents.",12,12
"427","de","en","Bei der Niemann-Pick-Krankheit Typ C beträgt die 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.","7 Westferry Circus, Canary Wharf, London E14 4HB, UK Tel.",10,17
"428","de","en","Bei der Nutzen-Risiko-Abwägung sollte das individuelle Blutungsrisiko berücksichtigt werden.","Bleeding risk should be taken into account when considering the risk benefit for individual patients.",15,9
"429","de","en","Bei der Parkinson-Krankeit kommen Symptome wie Halluzinationen und Verwirrtheitszustände vor.","Parkinson's disease is associated with symptoms of hallucinations and confusion.",10,10
"430","de","en","Bei der Planung von operativen Eingriffen sollte die lange Halbwertszeit von Adalimumab berücksichtigt werden.","The long half-life of adalimumab should be taken into consideration if a surgical procedure is planned.",16,14
"431","de","en","Bei der Verabreichung eines Pneumokokkenimpfstoffs 6 Wochen nach Absetzen von Raptiva wurden normale Ergebnisse erzielt.","A pneumococcal vaccine administered 6 weeks after discontinuation of Raptiva yielded normal results.",13,15
"432","de","en","Bei der Vorbereitung der Infusion ist auf aseptische Bedingungen zu achten.","Care must be taken to ensure aseptic handling when preparing the infusion.",12,11
"433","de","en","Bei der Wiederaufnahme der Behandlung mit Tyverb ist gegebenenfalls eine niedrigere Dosis anzuwenden.","If patients start to take Tyverb again, they may need to use a lower dose.",15,13
"434","de","en","Bei der Wirbelfusion war InductOs genauso wirksam wie die Knochentransplantate.","In spinal fusion, InductOs was as effective as bone grafts.",10,10
"435","de","en","BEI DEREN FEHLEN AUF DEM BEHÄLTNIS","109 PARTICULARS TO APPEAR ON THE OUTER PACKAGING",8,6
"436","de","en","Bei diesen Patienten darf die Behandlung mit VIRAMUNE nicht wieder aufgenommen werden.","In these patients VIRAMUNE must not be restarted.",8,12
"437","de","en","Bei diesen Patienten wurde darüber hinaus ein um 25% erhöhtes Risiko des Auftretens klinisch signifikanter kardiovaskulärer Erkrankungen verzeichnet.","Furthermore, they had 25% higher risk of developing clinically significant cardiovascular disorders.",12,18
"438","de","en","Bei diesen Patientinnen besteht die Möglichkeit einer Schwangerschaft.","These patients may be at risk of pregnancy.",8,8
"439","de","en","Bei dieser Art von Radioaktivität erfolgt keine direkte Strahlenwirkung außerhalb Ihres Körpers.","With this type of radioactivity, there is no direct effect of radiation outside the body.",15,12
"440","de","en","Bei Druckaufbau kann Entlüftung erforderlich sein. • Gut schütteln.","Pressure build-up may require venting. • Shake well.",8,9
"441","de","en","Bei einem vorpubertären Mädchen wurde das Einsetzen der Pubertät aufgrund ovarialer Insuffizienz verhindert.","Busulfan treatment in a pre-adolescent girl prevented the onset of puberty due to ovarian failure.",15,13
"442","de","en","Bei einer Dosis von 140 mg Docetaxel benötigen Sie beispielsweise 14 ml Docetaxel-Basislösung.","For example, a dose of 140 mg docetaxel would require 14 ml docetaxel premix solution.",15,13
"443","de","en","Bei einer Verordnung für solche Patienten ist Vorsicht angezeigt.","Caution must be exercised when prescribing to such patients.",9,9
"444","de","en","Bei einigen Patienten, die mit Arzneimitteln behandelt wurden, welche Faktor VIII enthalten, wurde Überempfindlichkeit (allergische Reaktion) beobachtet.","Hypersensitivity (allergic reactions) has sometimes been seen in patients treated with factor VIII-containing products.",14,17
"445","de","en","Bei Einnahme von Azomyr zusammen mit Nahrungsmitteln und Getränken Azomyr kann unabhängig von den Mahlzeiten eingenommen werden.","93 Taking Azomyr with food and drink Azomyr may be taken with or without a meal.",16,17
"446","de","en","Bei Einnahme von CoAprovel zusammen mit Nahrungsmitteln und Getränken CoAprovel kann unabhängig von den Mahlzeiten eingenommen werden.","Taking CoAprovel with food and drink CoAprovel can be taken with or without food.",14,17
"447","de","en","Bei Einnahme von Galvus zusammen mit Nahrungsmitteln und Getränken Sie können Galvus mit oder ohne Nahrung einnehmen.","Taking Galvus with food and drink You can take Galvus with or without food.",14,17
"448","de","en","Bei Einnahme von Kinzalmono zusammen mit Nahrungsmitteln und Getränken","Taking Kinzalmono with food and drink",6,9
"449","de","en","Bei Einnahme von Kuvan mit anderen Arzneimitteln Halten Sie Rücksprache mit Ihrem Arzt, wenn Sie Folgendes anwenden:","Taking other medicines You should consult your doctor if you are taking:",12,17
"450","de","en","Bei Einnahme von Nexavar mit anderen Arzneimitteln Einige Arzneimittel können Nexavar beeinflussen oder durch Nexavar beeinflusst werden.","Taking other medicines Some medicines may affect Nexavar, or be affected by it.",13,17
"451","de","en","Bei Einnahme von NovoNorm zusammen mit Nahrungsmitteln und Getränken","Using NovoNorm with food and drink",6,9
"452","de","en","Bei Einnahme von Sonata zusammen mit Nahrungsmitteln und Getränken:","Taking Sonata with food and drink",6,9
"453","de","en","Bei Einnahme von Tandemact mit anderen Arzneimitteln:","63 Taking other medicines:",4,7
"454","de","en","Bei Einsatz von Carbamazepin sollte die Dosis von INVEGA neu beurteilt und, falls erforderlich, erhöht werden.","On initiation of carbamazepine, the dose of INVEGA should 5 be re-evaluated and increased if necessary.",16,16
"455","de","en","Bei Erwachsenen und Kindern ab einem Alter von 2 Jahren ist Zyrtec angezeigt zur:","In adults and children aged 6 year and above, Zyrtec is indicated",12,14
"456","de","en","Bei Erwachsenen: leichte Ödeme","In adults: mild oedema",4,4
"457","de","en","Bei etwa 80% der betroffenen Patienten geschieht dies innerhalb der ersten 3 Monate. ng","ra so within 1 month of starting treatment, approximately 80% appear to do so within 3 months.",17,14
"458","de","en","Bei Fortbestehen der Symptome sollte die Behandlung mit DepoCyte abgebrochen werden.","If it persists, treatment with DepoCyte should be discontinued.",9,11
"459","de","en","Bei GIST wurde die Gabe der Studienmedikation bei 4% der Patienten auf Grund von Arzneimittel-bedingten Nebenwirkungen unterbrochen.","In GIST the study drug was discontinued for drug-related adverse reactions in 4% of patients.",15,17
"460","de","en","Bei gleichzeitigem Vorliegen einer renovaskulären Hypertonie besteht ein erhöhtes Risiko für starken Blutdruckabfall und Niereninsuffizienz.","If renovascular hypertension is also present there is an increased risk of severe hypotension and renal insufficiency.",17,15
"461","de","en","Bei gleichzeitiger Anwendung von EMEND und CYP3A4-Substraten ist Vorsicht geboten.","Caution is advised during concomitant administration of EMEND and CYP3A4 substrates.",11,10
"462","de","en","Bei gleichzeitiger Anwendung von Rifampicin und Atripla wird die zusätzliche Gabe von 200 mg Efavirenz","An additional 200 mg/ day (800 mg total) of efavirenz is recommended when rifampicin is co-administered with",17,15
"463","de","en","Bei gleichzeitiger Anwendung von Ritonavir kann eine stärkere Erhöhung der Clarithromycin- spiegel auftreten.","When ritonavir is co-administered an increase in clarithromycin concentrations may occur.",11,13
"464","de","en","Bei gleichzeitiger Anwendung von Verapamil und REYATAZ mit Ritonavir ist Vorsicht geboten.","Caution should be exercised when verapamil is co-administered with REYATAZ/ ritonavir",11,12
"465","de","en","Bei Hämophilie A- oder B-Patienten wurde keine Antikörperentwicklung gegen Faktor VII berichtet.","33 There have been no reports of antibodies against factor VII in haemophilia A or B patients.",17,12
"466","de","en","Bei heissem Wetter kann bei Patienten mit Ödemen eine Verdünnungshyponatriämie auftreten.","Dilutional hyponatraemia may occur in oedematous patients in hot weather.",10,11
"467","de","en","Bei Hunden, die bis zu 2 Wochen behandelt wurden, wurde kein Anstieg von Leberenzym-aktivitäten beobachtet.","In dogs treated up to 2 weeks no increases in liver enzyme activities were observed.",15,15
"468","de","en","Bei In-vitro-Untersuchungen konnte kein durch Cytochrom P 450 katalysierter Metabolismus festgestellt werden.","No cytochrome P 450 catalysed metabolism has been detected in vitro.",11,12
"469","de","en","Bei jedem Mastzelltumor, der chirurgisch behandelbar ist, sollte die Resektion die Behandlung der Wahl sein.","For any mast cell tumour treatable by surgery, surgery should be the first choice of treatment.",16,15
"470","de","en","Bei juvenilen Ratten, die Darunavir bis zum 23.-26.","In juvenile rats receiving darunavir up to days 23-26, increased mortality was observed with convulsions in some animals.",18,8
"471","de","en","Bei Kindern bis 20 kg sollte die Behandlung vorzugsweise mit Keppra 100 mg/ml Lösung zum Einnehmen begonnen werden.","Children 20 kg or less should preferably start the treatment with Keppra 100 mg/ ml oral solution.",17,18
"472","de","en","Bei Kindern war die am häufigsten gemeldete Nebenwirkung Erbrechen.","In children, the most commonly reported adverse drug reaction was vomiting.",11,9
"473","de","en","Bei Kindern wurden Wirksamkeit und Verträglichkeit von Optisulin nur für die Verabreichung am Abend nachgewiesen.","In children efficacy and safety of Optisulin have only been demonstrated when given in the evening.",16,15
"474","de","en","Bei Kleinkindern steigt bei versehentlicher Einnahme das Risiko einer NSAID-Nebenwirkung.","In small children, accidental ingestion increases the risk for NSAID adverse effects.",12,10
"475","de","en","Bei Kombination von Telbivudin mit diesen Arzneimitteln ist Vorsicht geboten.","The combination of telbivudine with these medicinal products should be used with caution.",13,10
"476","de","en","Bei Lagerung der Fertigspritze kann sich eine feine, weiße Ablagerung mit einem klaren, farblosen Überstand bilden.","24 A fine white deposit with a clear colourless supernatant may be observed upon storage of the syringe.",18,16
"477","de","en","Bei laktierenden Ratten treten Oseltamivir und sein aktiver Metabolit in die Milch über.","In lactating rats, oseltamivir and the active metabolite are excreted in the milk.",13,13
"478","de","en","Bei massiver Überdosierung kann Atropin verabreicht werden.","In massive overdose, atropine can be used.",7,7
"479","de","en","Bei Menschen wurden keine Auswirkungen auf die Nebennierenrindenachse festgestellt.","No effect on the adreno-cortical axis was noted in humans.",10,9
"480","de","en","Bei mit Aclasta behandelten Patienten wurde keine Osteomalazie, Knochenmarksfibrose oder Geflechtknochenbildung festgestellt.","In patients treated with Aclasta, no osteomalacia, marrow fibrosis or woven bone formation was detected.",15,12
"481","de","en","Bei mit Efavirenz behandelten Frauen ist eine Schwangerschaft zu vermeiden.","39 Women of childbearing potential: pregnancy should be avoided in women treated with efavirenz.",14,10
"482","de","en","Bei Netvax handelt es sich um einen Impfstoff.","Netvax is a vaccine.",4,8
"483","de","en","Bei Neugeborenen und Kleinkindern wird empfohlen, in den anterolateralen Bereich des Oberschenkels zu impfen.","The anterolateral thigh is the preferred site for injection in neonates and infants.",13,14
"484","de","en","Bei Neugeborenen und Kleinkindern wird empfohlen, in den vorderen seitlichen Bereich des Oberschenkels zu impfen.","The upper side of the thigh is the preferred site for injection in neonates and infants.",16,15
"485","de","en","Bei Neugeborenen, Kindern und Jugendlichen wird Busilvex in Kombination mit Cyclophosphamid oder Melphalan eingesetzt.","In new-born infants, children and adolescents, Busilvex is used in combination with cyclophosphamide or melphalan.",15,14
"486","de","en","Bei nicht vollständig geheilten Patienten kann die Behandlung für weitere vier Wochen fortgeführt werden.","In patients not fully healed the treatment may be continued for another four weeks.",14,14
"487","de","en","Bei Nicht-Ansprechen auf die Aranesp-Therapie, sollten unverzüglich die Ursachen hierfür gesucht werden.","Non-response to therapy with Aranesp should prompt a search for causative factors.",12,12
"488","de","en","Bei nierentransplantierten Patienten mit schweren Leberparenchymschäden sind Dosisanpassungen nicht erforderlich.","No dose adjustments are needed for renal transplant patients with severe hepatic parenchymal disease.",14,10
"489","de","en","Bei Patienten mit anderen schweren Grunderkrankungen wurde Voriconazol in seltenen Fällen mit schwerer Lebertoxizität in Zusammenhang gebracht.","Voriconazole has been infrequently associated with cases of serious hepatic toxicity in patients with other serious underlying conditions.",18,17
"490","de","en","Bei Patienten mit bestätigten signifikanten hämatologischen Abnormalitäten sollte eine Unterbrechung der Humira-Therapie in Betracht gezogen werden.","7 Humira therapy should be considered in patients with confirmed significant haematologic abnormalities.",13,16
"491","de","en","Bei Patienten mit einer Nierenfunktionsstörung sollte die Nierenfunktion engmaschig überwacht werden (siehe Abschnitt 4.4).","Patients with renal impairment may require close monitoring of renal function (see section 4.4).",14,14
"492","de","en","Bei Patienten mit eingeschränkter Leberfunktion wird eine engmaschige Überwachung der Sirolimus- Talspiegel im Vollblut empfohlen.","In hepatically impaired patients, it is recommended that sirolimus whole blood trough levels be closely monitored.",16,15
"493","de","en","Bei Patienten mit eingeschränkter Nierenfunktion ist keine Dosisanpassung erforderlich.","There is no need to change the dose in patients with impaired renal function.",14,9
"494","de","en","Bei Patienten mit eingeschränkter Nierenfunktion korrelieren Veränderungen der Plasmakonzentrationen von Amlodipin nicht mit dem Grad der Niereninsuffizienz.","In patients with renal impairment, changes in amlodipine plasma concentrations are not correlated with degree of renal impairment.",18,17
"495","de","en","Bei Patienten mit eingeschränkter Nierenfunktion korrelierte die renale Clearance von Zonisamid- Einzeldosen positiv mit der Kreatinin-Clearance.","In subjects with renal impairment, renal clearance of single doses of zonisamide was positively correlated with creatinine clearance.",18,16
"496","de","en","Bei Patienten mit Hämophilie A (angeborener Mangel an Faktor VIII) fehlt er oder funktioniert nicht richtig.","In patients with haemophilia A (inborn factor VIII deficiency), it is missing or not working properly.",16,16
"497","de","en","Bei Patienten mit leicht bis mäßig eingeschränkter Leberfunktion ist eine Dosisanpassung nicht erforderlich.","No dose adjustment is needed in patients with mild to moderate hepatic impairment.",13,13
"498","de","en","Bei Patienten mit leicht bis mäßig eingeschränkter Leberfunktion sollte Pritor mit Vorsicht angewandt werden.","Pritor should be used only with caution in patients with mild to moderate hepatic impairment.",15,14
"499","de","en","Bei Patienten mit leicht eingeschränkter Nierenfunktion (Kreatinin-Clearance (CLCr) 50 bis 80 ml/Minute) ist keine Dosisanpassung erforderlich.","No dosage adjustment is needed for patients with mild renal impairment (CLcr 50 to 80 ml/ minute).",17,16
"500","de","en","Bei Patienten mit mäßiger Beeinträchtigung der Leberfunktion ist Vorsicht geboten","Caution should be exercised if patients have moderate hepatic disease",10,10
"501","de","en","Bei Patienten mit mäßiger bis schwerer Leberfunktionsstörung ist Vorsicht bei der Anwendung von SPRYCEL geboten (siehe Abschnitt 4.4).","SPRYCEL should be used with caution in patients with moderate to severe hepatic impairment (see section 4.4).",17,18
"502","de","en","Bei Patienten mit mittelschwerer Niereninsuffizienz muss FORSTEO mit Vorsicht angewendet werden.","In patients with moderate renal impairment, FORSTEO should be used with caution.",12,11
"503","de","en","Bei Patienten mit Nierenfunktionsstörungen ist keine Dosisanpassung erforderlich.","Renal impairment: no dosage adjustment is necessary in patients with impaired renal function.",13,8
"504","de","en","Bei Patienten mit Nierenproblemen muss Pramipexol Teva weniger häufig verabreicht werden.","Pramipexole Teva must be given less frequently in patients who have problems with their kidneys.",15,11
"505","de","en","Bei Patienten mit schwerer akuter Arsenüberdosis ist eine Dialyse zu erwägen.","For patients with severe, acute arsenic overdose, dialysis should be considered",11,11
"506","de","en","Bei Patienten mit schwerer Leberinsuffizienz darf AZILECT nicht angewendet werden.","AZILECT should not be used in patients who have severe problems with their liver.",14,10
"507","de","en","Bei Patienten mit stark eingeschränkter Leberfunktion liegt keine klinische Erfahrung vor.","There is no clinical experience in patients with severe hepatic impairment.",11,11
"508","de","en","Bei Patienten mit unkontrolliertem Bluthochdruck darf eine Behandlung mit Duloxetin nicht begonnen werden (siehe Abschnitt 4.3).","In patients with uncontrolled hypertension duloxetine should not be initiated (see section 4.3).",13,16
"509","de","en","Bei Patienten mit Zyanidvergiftung wurde ein Abfall des Blutdrucks beobachtet.","A decrease in blood pressure was observed in cyanide-poisoned patients.",10,10
"510","de","en","Bei Patienten unter Hämodialyse sollte eine niedrigere Anfangsdosis (75 mg) in Erwägung gezogen werden.","A lower starting dose (75 mg) should be considered for patients undergoing haemodialysis.",13,14
"511","de","en","Bei Patienten, deren IgE-Spiegel unter 76 IE/ml liegt, ist es weniger wahrscheinlich, dass das Medikament hilft.","Patients whose IgE level is below 76 IU/ ml are less likely to benefit from the medicine.",17,16
"512","de","en","Bei Patienten, die einen anderweitig nicht erklärbaren Hautausschlag entwickeln, muss das Absetzen von Zonegran erwogen werden.","Consideration must be given to discontinuing Zonegran in patients who develop an otherwise unexplained rash.",15,16
"513","de","en","Bei Patienten, die Methotrexat nicht erhalten dürfen, kann RoActemra auch allein angewendet werden.","RoActemra can be used on its own in patients who cannot take methotrexate.",13,13
"514","de","en","Bei Patienten, die mit P-gp-Inhibitoren behandelt werden, wird eine sorgfältige Titrierung der Ranexa-Dosis empfohlen.","Careful dose titration of Ranexa is recommended in patients treated with P-gp inhibitors.",13,14
"515","de","en","Bei Patienten, die nach einem Jahr nicht auf die Behandlung ansprechen, sollten andere Behandlungen in Betracht gezogen werden.","Treatment should be reconsidered if after a year patients remain non-responsive.",11,18
"516","de","en","Bei Patienten, die nicht mit Kortikosterioden vorbehandelt wurden, wurden Hautreaktionen berichtet.","Skin reactions have been reported in patients not pre-treated with a corticosteroid.",12,11
"517","de","en","Bei Patienten, die Probleme mit ihren Nieren haben, muss die Dosis verringert und die orale Lösung angewendet werden.","The dose needs to be lowered for patients who have problems with their kidneys, using the oral solution.",18,18
"518","de","en","Bei Patienten, für die eine antidiabetische Behandlung angezeigt ist, sollte ein alternatives Antidiabetikum angewendet werden.","An alternative antidiabetic medicinal product should be used in patients in whom an antidiabetic treatment is indicated.",17,15
"519","de","en","Bei Patientinnen mit leicht oder mäßig ausgeprägter Nierenfunktionsstörung ist keine Anpassung der FABLYN-Dosis erforderlich (siehe Abschnitt 4.4).","No dose adjustment for FABLYN is necessary for patients with mild or moderate renal insufficiency (see section 4.4).",18,17
"520","de","en","Bei Patientinnen mit mäßig eingeschränkter Nierenfunktion ist daher keine Dosisanpassung nötig.","No dosage adjustment is therefore required in patients with mild-to-moderate renal impairment.",12,11
"521","de","en","Bei Personen mit normaler Nierenfunktion lag der Anteil der renalen Exkretion an der Gesamt-Clearance bei 65 – 85%.","The contribution of renal excretion to total clearance in subjects with normal renal function was 65-85%.",16,18
"522","de","en","Bei Psoriasis-Arthritis wurde Trudexa in zwei Studien mit 413 Patienten mit einem Scheinmedikament (Placebo) verglichen.","tho For psoriatic arthritis, Trudexa was compared to placebo in two studies including 413 patients.",15,15
"523","de","en","Bei Ratten und Hunden wurden darüber hinaus Schädigungen der Magenschleimhaut (Erosion, Ulcus oder Entzündung) beschrieben.","Gastric mucosal injury (erosion, ulcers or inflammation) also was noted in rats and dogs.",14,15
"524","de","en","Bei Ratten war die Konzentration des radioaktiv markierten Wirkstoffes in der Milch höher als im Plasma.","In rats, the concentration of active substance-related radioactivity was higher in breast milk than in plasma.",16,16
"525","de","en","Bei Ratten war Raltegravir leicht plazentagängig, passierte die Blut-Hirn-Schranke jedoch nicht in nennenswertem Umfang.","Raltegravir readily crossed the placenta in rats, but did not penetrate the brain to any appreciable extent.",17,14
"526","de","en","Bei Rindern und Schweinen zur Therapie und Metaphylaxe von bakteriellen und durch Mycoplasmen verursachte Infektionen.","Treatment and prevention of bacterial and mycoplasmal infections in cattle and pigs.",12,15
"527","de","en","Bei Risikopatienten wird eine entsprechende Überwachung der Serumkaliumspiegel empfohlen.","Adequate monitoring of serum potassium in patients at risk is recommended.",11,9
"528","de","en","Bei Schweinen liegt die Halbwertszeit für beide Substanzen bei etwa 2,5 Stunden.","In pigs, elimination half-life for both substances is approximately 2.5 hours.",11,12
"529","de","en","Bei schwerer Niereninsuffizienz sollte Azomyr nur mit Vorsicht angewendet werden (siehe unter Abschnitt 5.2).","In the case of severe renal insufficiency, Azomyr should be used with caution (see section 5.2).",16,14
"530","de","en","Bei sichtbaren Ausfällungen sollte die rekonstituierte Suspension verworfen werden.","Discard the reconstituted suspension if precipitates are observed.",8,9
"531","de","en","Bei solchen Patienten muss eine Unterbrechung oder ein Abbruch der Therapie erwogen werden (siehe Abschnitt 4.8).","In such patients, interruption or discontinuation of treatment must be considered (see section 4.8).",14,16
"532","de","en","Bei stark überhöhten Hämoglobinwerten sollte die Behandlung mit MIRCERA vorübergehend unterbrochen werden (siehe Abschnitt 4.2).","In case of excessive haemoglobin levels, treatment with MIRCERA should be temporarily discontinued (see section 4.2).",16,15
"533","de","en","Bei stillenden Frauen kann eine Anpassung von Insulindosis und Diät notwendig werden.","Lactating women may require adjustments in insulin dose and diet.",10,12
"534","de","en","Bei Tageslicht ist die vollständige Wirksamkeit der Lösung für 3 Tage gewährleistet.","In daylight conditions complete efficacy is guaranteed for a period of three days.",13,12
"535","de","en","Bei Therapieabbruch wird ein ausschleichendes Absetzen empfohlen.","Upon discontinuation, gradual withdrawal is advised.",6,7
"536","de","en","Bei Therapieversagen sind alternative Behandlungsmethoden in Betracht zu ziehen.","In cases of non-response, alternative therapies should be considered.",9,9
"537","de","en","Bei Tieren geht Glimepirid in die Muttermilch über.","In animals, glimepiride is excreted in milk.",7,8
"538","de","en","Bei Tieren wird Rivastigmin mit der Muttermilch ausgeschieden.","It is not known if rivastigmine is excreted into human",10,8
"539","de","en","Bei Überdosierung kann Gadograf durch extrakorporale Dialyse aus dem Körper entfernt werden.","In case of an overdose, Gadograf can be removed from the body by extracorporeal dialysis.",15,12
"540","de","en","Bei Überdosierung können Übelkeit und Erbrechen auftreten.","Overdose may be manifested by nausea and vomiting.",8,7
"541","de","en","Bei Überdosierungen, die von Blutungskomplikationen begleitet sind, muss die Behandlung abgebrochen werden und die Blutungsursache ermittelt werden.","Overdose associated with bleeding complications should lead to treatment discontinuation and search for the primary cause.",16,17
"542","de","en","Bei unkastrierten männlichen Hunden wird häufig eine reversible Prostataatrophie (Reduktion der Größe) beobachtet.","A reversible prostatic atrophy (reduction in size) is often observed in entire male dogs.",14,13
"543","de","en","Bei Unklarheiten fragen Sie bitte Ihren Arzt.","If you are not sure please consult your doctor.",9,7
"544","de","en","Bei Verabreichung mit der Fütterung des Tieres kann die Resorption etwas verzögert sein.","If the animal is fed at the time of dosing, the absorption may be slightly delayed.",16,13
"545","de","en","Bei Verfärbungen oder Vorliegen von Partikeln darf die Lösung nicht verwendet werden.","Do not use if discolouration or particulate matter is present.",10,12
"546","de","en","Bei versehentlichem Haut- oder Augenkontakt sollten diese gründlich mit Wasser ab- bzw. ausgespült werden.","In case of accidental contact (skin, eye), wash thoroughly with water.",11,14
"547","de","en","Bei versehentlicher Überdosierung sollte eine symptomatische Therapie erfolgen.","In case of accidental overdosing, symptomatic therapy should be administered.",10,8
"548","de","en","Bei Vorhandensein von Antikörpern erfolgt die Impfung ab einem Alter von drei Monaten.","If there are antibodies, the vaccine should be given from the age of 3 months.",15,13
"549","de","en","Bei zuvor behandelten Patienten erhöhte die zusätzliche Gabe von Avastin die Überlebenszeit von 10,8 auf 13 Monate.","In previously-treated patients, adding Avastin increased survival time from 10.8 to 13.0 months.",13,17
"550","de","en","Bei zwei Studie n betrug die Zielhämoglobinkonzentration > 13 g/dl, bei den zn","In the open-label study there was no difference in overall survival between patients treated a",15,13
"551","de","en","Beide Dosierungen wurden von diesen Patienten gut vertragen.","Both regimens were well- tolerated by these patients.",8,8
"552","de","en","Beide Komponenten müssen miteinander vermischt werden, bevor Ihr Kind den Impfstoff erhält.","Both components must be mixed together before your child receives the vaccine.",12,12
"553","de","en","Beide Kontrastmittel waren mit einer ähnlichen Verbesserung des Scores für die Aufnahmen verbunden.","Both medicines were associated with similar improvements in the score given to the scans.",14,13
"554","de","en","Beide Spritzen sollten mit den gleichen Volumen gefüllt sein und dürfen keine Luftblasen enthalten.","Both syringes should be filled with equal volumes, and should not contain air bubbles.",14,14
"555","de","en","Beim Menschen besitzt Metformin unabhängig von seiner Wirkung auf den Blutzuckerspiegel eine günstige Wirkung auf den Fettstoffwechsel.","In humans, independently of its action on glycaemia, metformin has favourable effects on lipid metabolism.",15,17
"556","de","en","Beim Neugeborenen wurden keine Nebenwirkungen festgestellt.","No side effects have been noted in the newborn baby.",10,6
"557","de","en","Beispiel Tetrazykline, Makrolide, Chloramphenicol und Aminoglykoside;","tetracyclines, macrolides, chloramphenicol, aminoglycosids;",4,6
"558","de","en","Bekannte oder vermutete Immundefizienz.","Infants who have known or suspected immunodeficiency.",7,4
"559","de","en","Bekannte oder vermutete Überempfindlichkeit gegen Retapamulin oder die sonstigen Bestandteile.","Known or suspected hypersensitivity to retapamulin or to the excipient.",10,10
"560","de","en","Belastungsdys- pnoe, Epistaxis, Nasopharyngitis, Sinus- Sekretstauungen, Nasen- Sekretstauungen, Rhinitis, rauer Hals","Vomiting, dyspepsia, dysphagia, mouth ulceration, gingival bleeding, glossitis, stomatitis, flatulence, dry mouth",12,11
"561","de","en","Belivon 2 mg 2 mg Filmtabletten","Belivon 2 mg Filmtabletten",4,6
"562","de","en","BeneFIX kann zur Langzeitprophylaxe von Blutungen bei Patienten mit schwerer Hämophilie B verabreicht werden.","For long term prophylaxis against bleeding in patients with severe haemophilia B, BeneFIX may be administered.",16,14
"563","de","en","benötigen und Abweichungen davon entsprechend Ihren Ernährungsgewohnheiten und Ihrer körperlichen Aktivität verordnen. ni","ho recommend any changes after that based on your diet and amount of exercise.",14,13
"564","de","en","Benötigtes Volumen von VFEND-Konzentrat (10 mg / ml) für:","Volume of VFEND Concentrate (10 mg/ ml) required for:",9,9
"565","de","en","Benzalkoniumchlorid 0,15 mg (siehe Abschnitt 4.4).","Excipients: benzalkonium chloride 0.15 mg, (see section 4.4).",8,6
"566","de","en","Beratung nach Thema 2002 7% 1%","16 EMEA Annual Report 2002",5,6
"567","de","en","Berechnen Sie die Dosis und die Anzahl der notwendigen Durchstechflaschen.","Calculate the dose and the number of Xigris vials needed.",10,10
"568","de","en","Bereich Klinischer Aspekt 1","Area Description Clinical 1",4,4
"569","de","en","Bereiten Sie die Gegend für eine aseptische Technik vor.","Prepare the site for an aseptic technique.",7,9
"570","de","en","Berlin-Chemie/A.Menarini Ceska republika s.r.o.","Berlin-Chemie/A.Menarini Ceska republika s.r.o.",4,4
"571","de","en","Bernsteinfarben e Glasflasche (Typ III) Polypropylen- Dosierspritze","amber glass bottle (type III), polypropylene dosing syringe.",8,7
"572","de","en","Berühren Sie die Nadel nicht.","Do not touch the needle.",5,5
"573","de","en","BESCHRÄNKUNGEN FÜR EINE SICHERE UND WIRKSAME ANWENDUNG DES TIERARZNEIMITTELS, sofern erforderlich","THE WORDS “FOR ANIMAL TREATMENT ONLY“ AND CONDITIONS OR RESTRICTIONS REGARDING SALE AND SUPPLY, if any",16,11
"574","de","en","BESCHRIFTUNG DER ÄUSSEREN UMHÜLLUNG UND ETIKETT FÜR DIE FLASCHE","OUTER CARTON AND LABEL TEXT FOR BOTTLE PACK",8,9
"575","de","en","Besondere Vorsicht bei der Anwendung von Aclasta ist erforderlich Sagen Sie Ihrem Arzt vor der Anwendung von Aclasta:","26 Take special care with Aclasta Tell your doctor before you are given Aclasta:",14,18
"576","de","en","Besondere Vorsicht bei der Anwendung von Docetaxel Winthrop ist erforderlich","99 Take special care with Docetaxel Winthrop",7,10
"577","de","en","Besondere Vorsicht bei der Anwendung von Infanrix Penta ist erforderlich","Take special care with Infanrix Penta",6,10
"578","de","en","Besondere Vorsicht bei der Anwendung von IONSYS ist erforderlich Informieren Sie Ihren Arzt oder Ihre Pflegekraft,","Take special care with IONSYS Tell your doctor or nurse",10,16
"579","de","en","Besondere Vorsicht bei der Anwendung von Neupopeg ist erforderlich","Take special care with Neupopeg",5,9
"580","de","en","Besondere Vorsicht bei der Anwendung von Puregon ist erforderlich:","Take special care with Puregon",5,9
"581","de","en","Besondere Vorsicht bei der Anwendung von RotaTeq","20 Take special care with RotaTeq:",6,7
"582","de","en","Besondere Vorsicht bei der Anwendung von ViraferonPeg ist erforderlich,","278 Take special care with ViraferonPeg",6,9
"583","de","en","Besondere Vorsicht bei der Einnahme von APTIVUS ist erforderlich,","Take special care with APTIVUS",5,9
"584","de","en","Besondere Vorsicht bei der Einnahme von Carbaglu ist erforderlich:","Take special care with Carbaglu:",5,9
"585","de","en","Besondere Vorsicht bei der Einnahme von Lisonorm ist erforderlich,","Take special care with LISONORM You should check with your doctor before taking this medicine if you:",17,9
"586","de","en","Besondere Vorsicht bei der Injektion","Special care before injection",4,5
"587","de","en","Besondere Vorsicht ist angebracht bei","Caution should be used with coadministration",6,5
"588","de","en","Besondere Vorsicht ist angezeigt im Hinblick auf eine Depletion des Knochenmarks.","Special caution is required with respect to bone marrow depletion.",10,11
"589","de","en","Besondere Vorsichtsmaßnahmen bei Patienten mit Sichelzellanämie","Special precautions in sickle cell disease",6,6
"590","de","en","Besondere Vorsichtsmaßnahmen für den Anwender","Special precautions to be taken by the person administering the veterinary medicinal product to animals",15,5
"591","de","en","Besondere Vorsichtsmaßnahmen für die Anwendung bei Tieren","Special precautions for use in animals",6,7
"592","de","en","BESONDERE VORSICHTSMASSNAHMEN FÜR DIE ENTSORGUNG VON NICHT VERWENDETEM ARZNEIMITTEL ODER VON ABFALLMATERIALIEN, SOFERN ERFORDERLICH","SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY",13,14
"593","de","en","BESONDERE VORSICHTSMASSNAHMEN FÜR DIE ENTSORGUNG VON NICHT VERWENDETEN ARZNEIMITTELN ODER ABFALLMATERIALIEN, SOFERN ERFORDERLICH","12 SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY",14,13
"594","de","en","Besondere Warnhinweise und Vorsichtsmaßnahmen bei der Anwendung bei akuten Tibia-Frakturen","Special warnings and precautions for use specific to acute tibia fractures",11,10
"595","de","en","BESONDERE WARNHINWEISE, SOWEIT ERFORDERLICH","SPECIAL WARNING(S), IF NECESSARY",4,4
"596","de","en","Besprechen Sie mit Ihrem Arzt, wie lange Sie die DULOXETINE BOEHRINGER INGELHEIM Behandlung durchführen sollen.","Talk with your doctor about how long you should keep taking DULOXETINE BOEHRINGER INGELHEIM.",14,15
"597","de","en","Bestandteile von {(Name (Phantasiebezeichnung)} Creme sind.","< Invented Name > cream.",5,6
"598","de","en","Bestes Ansprechen gemäß ACTG Kriterien für die Phasen mit Placebo-Kontrolle","Best response according to ACTG criteria for vehicle controlled phase",10,10
"599","de","en","Bestimmte Arzneimittel können die Wirkung von Glivec beeinflussen, wenn sie zusammen eingenommen werden.","Certain medicines may interfere with the effect of Glivec when taken together.",12,13
"600","de","en","Bestimmung der ungefähren Anzahl der bereits abgegebenen Dosen","Determining Approximate Number of Doses Delivered",6,8
"601","de","en","Betaferon kann auch mit einem Autoinjektor injiziert werden.","Betaferon can also be administered with an auto-injector.",8,8
"602","de","en","Betain wirkt bei Patienten mit Homocysteinurie als Methylgruppendonator bei der Remethylierung von Homocystein zu Methionin.","Betaine acts as a methyl group donor in the remethylation of homocysteine to methionine in patients with homocystinuria.",18,15
"603","de","en","Betäubungsmittel, Schlafmittel oder Sedativa dürfen nur mit Vorsicht gleichzeitig mit Viraferon verabreicht werden.","201 Narcotics, hypnotics or sedatives must be administered with caution when used concomitantly with Viraferon.",15,13
"604","de","en","Betroffene Patienten dürfen nicht am Straßenverkehr teilnehmen und keine Maschinen bedienen.","May cause drowsiness, if affected do not drive or operate machines.",11,11
"605","de","en","Betropfen Sie immer nur einen Streifen und bearbeiten Sie insgesamt drei ITLC-Streifen.","Spot one strip at a time and run three ITLC strips.",11,12
"606","de","en","betrugen die Hazard-Ratios für das Gesamtüberleben zwischen 1,25 und 2,47 zugunsten des Kontrollarms.","ratios for overall survival ranged between 1.25 and 2.47 in favour of controls.",13,13
"607","de","en","Bevor Sie fortfahren, wie- derholen Sie die Schritte zur Entlüftung des Pens.","Before continuing, repeat the priming steps.",6,12
"608","de","en","Bevor Sie mit der Avandamet-Behandlung beginnen, wird Ihnen eine Blutprobe abgenommen, um Ihre Leberfunktion zu untersuchen.","Before you start taking Avandamet you will have a blood sample taken to check your liver function.",17,16
"609","de","en","bevorsteht, da Sie möglicherweise Janumet für einige Tage vor und nach dem Eingriff absetzen müssen","need to stop taking Janumet for a couple of days before and after the procedure",15,15
"610","de","en","Bewahren Sie die Patrone vor dem Einsetzen in den Pen 1 bis 2 Stunden bei Raumtemperatur auf.","Keep the cartridge at room temperature for 1 or 2 hours before inserting it into the pen.",17,17
"611","de","en","Bewegen Sie die Durchstechflasche vorsichtig, bis sich das gesamte Pulver gelöst hat und die Lösung klar ist.","Gently agitate the vial until the solution is clear and without residue.",12,17
"612","de","en","BEZEICHNUNG DES ARZNEIMITTELS SOWIE ART DER ANWENDUNG","NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION",9,7
"613","de","en","BEZEICHNUNG DES ARZNEIMITTELS SOWIE ART(EN) DER ANWENDUNG","NAME OF THE MEDICINAL PRODUCT",5,7
"614","de","en","Bezüglich der Morphologie des Endometriums sind keine Daten verfügbar.","No data are available regarding endometrial morphology.",7,9
"615","de","en","Bezüglich der Todesfälle gab es einen positiven Trend (82 Todesfälle in der Plazebo-Gruppe vs.","A favourable trend was observed regarding the mortality rate (82 deaths in the placebo group vs.",16,14
"616","de","en","Bezüglich Informationen zur Inkompatibilität des Produktes siehe Abschnitt 4.2.","For information on product incompatibilities see section 4.2.",8,9
"617","de","en","Bezüglich Wirkstoffkonzentrationen in der Muttermilch liegen keine Daten vor.","There are no data available for human breast milk.",9,9
"618","de","en","Bindegewebs- und Knochen- erkrankungen einschließlich diesbezüglicher Untersuchungs- parameter","Blood creatine phosphokinase increased Myalgia Back Pain",7,8
"619","de","en","Binocrit 4000 I.E./0,4 ml","Binocrit 4000 IU/ 0.4 ml",5,4
"620","de","en","Binocrit 9000 I.E./0,9 ml Injektionszubereitung","Binocrit 9000 IU/ 0.9 ml injection",6,5
"621","de","en","Biogaran 15, Boulevard Charles De Gaulle 92707 Colombes Cedex Frankreich","Biogaran 15, Boulevard Charles De Gaulle 92707 Colombes Cedex France",10,10
"622","de","en","Biograstim ist ein „ biologisch ähnliches“ Arzneimittel.","Biograstim is a ‘ biosimilar’ medicine.",6,7
"623","de","en","Biosearch Ireland, National Cell & Tissue Culture Centre, Glasnevin, Dublin 9, Irland.","Biosearch Ireland National Cell & Tissue Culture Centre Glasnevin Dublin 9 Ireland",12,12
"624","de","en","Biovitrum AB (publ) SE-112 76 Stockholm Schweden","Biovitrum AB (publ) SE-112 76 Stockholm Sweden",7,7
"625","de","en","bis bis bis bis bis bis","9 to 8 to 7 to 6 to w.2 w.3 w.3 w.4 w.57 w.6 w.7",15,6
"626","de","en","bis er in der Ausgangsstellung einrastet. zn Ar","Inhale your insulin dose Perform the following steps in immediate sequence.",11,8
"627","de","en","Bis zum Ende des Jahres verringerte sich diese Zahl auf 3%.","This fell to 3 per cent by the end of the year.",12,11
"628","de","en","Bisher sind keine anderen einschlägigen epidemiologischen Daten verfügbar.","To date, no other relevant epidemiological data are available.",9,8
"629","de","en","Bisher wurde diese Nebenwirkung jedoch bei keinem mit ATryn behandelten Patienten festgestellt.","However, until now this has not been seen in patients treated with ATryn.",13,12
"630","de","en","Bitte beachten Sie auch die Gebrauchsinformationen der entsprechenden Antibiotika.","Please read the package leaflet of the antibacterial agents for further information.",12,9
"631","de","en","Bitte die Bedienungsanleitung des Lasers und der Mikrolinsenfaser beachten","Please refer to the laser user manual, and to the microlens fibre-optic user leaflet.",14,9
"632","de","en","Bitte fragen Sie bei Ihrem Arzt oder Apotheker nach, wenn Sie sich nicht ganz sicher sind.","Check with your doctor or pharmacist if you are unsure.",10,16
"633","de","en","Bitte fragen Sie Ihren Arzt um Rat","Pregnancy and breast-feeding If you are pregnant, planning a pregnancy or breast-feeding: please contact your doctor for advice.",18,7
"634","de","en","Bitte fragen Sie Ihren Arzt um Rat, wenn Sie weiterhin Verhütungsmittel zum Einnehmen oder eine Hormonersatztherapie erhalten möchten.","You should check with your doctor if you do wish to continue taking oral contraceptives or HRT.",17,18
"635","de","en","Bitte informieren Sie Ihren Arzt, wenn bei Ihnen eine der folgenden Nebenwirkungen auftritt:","Tell your doctor about any of the following side effects:",10,13
"636","de","en","Bitte informieren Sie Ihren Arzt, wenn einer dieser Punkte auf Sie zutrifft.","Tell your doctor if any of the above applies to you.",11,12
"637","de","en","Bitte informieren Sie Ihren Arzt, wenn Sie bereits Cimetidin, Glucokorticoide, Beta-2-Agonisten, Diuretika oder ACE-Hemmer einnehmen.","Please let your doctor know if you already take cimetidine, glucocorticoids, beta-2-agonists, diuretics or ACE inhibitors.",16,15
"638","de","en","Bitte informieren Sie Ihren Arzt, wenn Sie irgendeines dieser Symptome bemerken.","If you notice any of these symptoms please inform your doctor.",11,11
"639","de","en","Bitte lesen Sie die folgende Bedienungsanleitung vor der Benutzung Ihres Insulatard FlexPen sorgfältig durch.","Please read the following instructions carefully before using your Insulatard FlexPen.",11,14
"640","de","en","Bitte lesen Sie die Hinweise sorgfältig durch und folgen Sie ihnen Schritt für Schritt.","Please read the instructions carefully and follow them step by step.",11,14
"641","de","en","Bitte reiben Sie die Injektionsstelle nicht.","Do not ng rub the injection site.",7,6
"642","de","en","Bitte wenden Sie sich zur Fortsetzung der Behandlung an Ihren Arzt.","For continuation of the treatment please consult your doctor.",9,11
"643","de","en","Bitte ziehen Sie die Suspension mit dem oralen Dispenser wie folgt auf:","85 To withdraw the suspension with the oral dispenser proceed as follows:",12,12
"644","de","en","Blasen Sie nicht in das Mundstück hinein.","Do not blow into the mouthpiece. ic",7,7
"645","de","en","Blassrosa farbene Filmtabletten, auf der einen Seite mit „ gsk“ und auf der anderen mit „ 2/500“ gekennzeichnet.","Pale pink film-coated tablets marked ""gsk"" on one side and ""2/ 500"" on the other.",15,18
"646","de","en","Blepharospasmus, hemifazialem Spasmus und koexistierenden fokalen Dystonien.","Blepharospasm, hemifacial spasm and associated focal dystonias.",7,7
"647","de","en","Blister (Aclar/PVC/Alu) in einer Karte","1.0 mg 1.0 mg 0.5 mg 0.5 mg 0.5 mg and 1.0 mg",13,5
"648","de","en","Blisterkennzeichnung – Woche 2","Blister label – week 2",5,4
"649","de","en","Blisterpackung für < Cozaar Comp > 100 mg/25 mg Filmtabletten","Blister for Cozaar Comp 100 mg/ 25 mg film-coated tablets",10,10
"650","de","en","Blisterpackung mit 14 x 1 mg Vareniclin-Filmtabletten, hitzeversiegelte Blisterkarte","Blister Pack of 14 x 1 mg varenicline film-coated tablets, Heat Sealed Card",13,9
"651","de","en","Blutdruck überwachen und Ihnen gegebenenfalls ein Arzneimittel zur Behandlung Ihres Bluthochdrucks verordnen.","monitor your blood pressure and may give you a medicine to treat your high blood pressure.",16,12
"652","de","en","Bluthochdruck, Hämorrhagie, Hitzewallungen, Hypotension, orthostatische Hypotension","Hypertension, haemorrhage, hot flushes, hypotension, orthostatic hypotension",7,6
"653","de","en","Blutkörperchen) und zur Verminderung des Vorkommens neutropenischen Fiebers (niedrige Anzahl ch","use of cytotoxic chemotherapy (medicines that destroy rapidly growing cells).",10,11
"654","de","en","Blutplättchenzahl) leiden oder wenn Sie blutgerinnungshemmende Mittel einnehmen.","any medicines that stop the blood clotting normally.",8,8
"655","de","en","Blutuntersuchungen), siehe „Besondere Vorsicht bei der Anwendung von Extavia“,","(this will show up in blood tests),",7,9
"656","de","en","Boehringer Ingelheim International GmbH, Binger Str.","Boehringer Ingelheim International GmbH, Binger Str.",6,6
"657","de","en","Boehringer Ingelheim spol. s r.o.","Nederland Boehringer Ingelheim b. v.",5,5
"658","de","en","Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/Rhein Deutschland","Boehringer Ingelheim Vetmedica GmbH 55216 Ingelheim/ Rhein Germany",8,7
"659","de","en","Bondenza kann helfen, das Risiko von Knochenbrüchen (Frakturen) zu senken.","Bondenza may help lower the chances of breaking bones (fractures).",10,10
"660","de","en","Boniscontro & Gazzone s.r.l.","Boniscontro & Gazzone s. r. l.",6,4
"661","de","en","Bonviva 150 mg einmal monatlich","8 Bonviva 150 mg once monthly",6,5
"662","de","en","Bonviva darf während der Schwangerschaft nicht angewendet werden.","Bonviva should not be used during pregnancy.",7,8
"663","de","en","Bovilis BVD wurde erstmals in Deutschland als Bovilis BVD-MD zugelassen.","Bovilis BVD was first authorised in Germany as Bovilis BVD-MD.",10,10
"664","de","en","Box 205, N-1372 Asker 0010 Oslo Norwegen","Box 205, N-1372 Asker 0010 Oslo Norway",7,7
"665","de","en","Box 24, FIN-02231 Espoo, Finnland","Box 24 FIN-02231 Espoo Finland",5,5
"666","de","en","Box 55 FIN-00301 Helsinki Tel: +358 9 473 341 Fax: +358 9 714 46","Box 55 FIN-00301 Helsinki Tel: +358.9.473.341 Fax: +358.9.714.469",8,14
"667","de","en","Branch Office Seimyniskiu str.","Branch Office Seimyniskiu str.",4,4
"668","de","en","Brennen an der Applikationsstelle.","- very common: application site burning.",6,4
"669","de","en","Bridion kann die Wirkung anderer Arzneimittel beeinflussen oder durch andere Arzneimittel in seiner Wirkung beeinflusst werden.","Bridion may affect other medicines or be affected by them.",10,16
"670","de","en","Bringen Sie die Hündin in die seitliche Rückenlage.","Position the bitch on her back.",6,8
"671","de","en","Bringen Sie die Lösung vor der Anwendung auf Raumtemperatur.","Allow the solution to return to room temperature before using.",10,9
"672","de","en","Bringen Sie es zu Ihrem Apotheker zurück.","Return it to your pharmacist.",5,7
"673","de","en","Bristol-Myers Squibb Belgium SPRL/BVBA Chaussée de La Hulpe,185","Bristol-Myers Squibb Belgium sa/ nv Chaussée de La Hulpe,185 B-1170 Bruxelles",11,8
"674","de","en","BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH Vereinigtes Königreich","BRISTOL-MYERS SQUIBB PHARMA EEIG Uxbridge Business Park Sanderson Road Uxbridge UB8 1DH United Kingdom",14,14
"675","de","en","Brnč ič eva 1 SI - 1000 Ljubljana Tel: +386 158969 00","Brnč ič eva 1 SI - 1000 Ljubljana Tel: +386 158969 00",12,12
"676","de","en","bronchospasmusähnliche Symptome, Serumkrankheit, Thrombozytopenie","symptoms, serum sickness, thrombocytopenia",4,4
"677","de","en","Brustschmerzen Grippeähnliche Symptome Mukositis Mundödeme Ödeme","Chest pain Influenza-like symptoms",4,6
"678","de","en","Bucharest Business Park Ş os.","Bucharest Business Park Şos.",4,5
"679","de","en","Bündelpackungen enthalten 140 Filmtabletten in Form von 2 Packungen à 70 Tabletten in einem großen Umkarton.","Multipacks contain 140 film-coated tablets consisting of 2 x 70 tablet packs in a large outer carton.",17,16
"680","de","en","Buprenorphin ↑ 1.67 ↑ 1.37 ↑ 1.69","buprenorphine ↑ 1.67 ↑ 1.37 ↑ 1.69",7,7
"681","de","en","Busilvex wurde hauptsächlich an Patienten mit Blutkrebs untersucht, die auf eine Transplantation von hämatopoetischen Stammzellen angewiesen waren.","Busilvex has been studied in patients, mainly with blood cancer, who needed transplantation of haematopoietic progenitor cells.",17,17
"682","de","en","BYETTA sollte während der Schwangerschaft nicht angewendet werden, hier ist die Anwendung von Insulin zu empfehlen.","BYETTA should not be used during pregnancy and the use of insulin is recommended.",14,16
"683","de","en","C Apidra ist eine klare Insulinlösung.","Apidra is a clear insulin.",5,6
"684","de","en","Č eská republika Cephalon Sp. zo.o.","Č eská republika Cephalon Sp. zo. o.",7,6
"685","de","en","Č eská republika Mundipharma Ges.m.b.H.","Č eská republika Mundipharma Ges. m. b. H.",8,5
"686","de","en","Č eská republika sanofi-aventis, s.r.o.","Č eská republika sanofi -aventis, s. r. o.",8,5
"687","de","en","C Schrauben Sie die Spritze fest auf den Durchstechflaschen-Adapter an der Durchstechflasche mit dem Lösungsmittel.","C Screw the syringe tightly onto the vial adapter on the solvent vial.",13,15
"688","de","en","C) Behandlung oder Vorbeugung von Infektionen nach einer Knochenmarktransplantation (allogene Knochenmarktransplantation).","C) Treatment or prevention of infections after a bone marrow transplantation (allogeneic bone marrow transplantation).",15,11
"689","de","en","C09DA Treatment of essential hypertension in patients whose blood pressure is not adequately controlled on telmisartan alone","controlled on telmisartan alone",4,17
"690","de","en","Cabergolin, Lisurid oder Pergolid (bei Parkinson) anwenden.","cabergoline, lisuride and pergolide (for Parkinson’ s disease).",8,7
"691","de","en","Caelyx wird als Einzelpackung oder Zehnerpackung angeboten.","Caelyx is supplied as a single pack or packs of ten vials.",12,7
"692","de","en","Calcium Sandoz 500 mg enthält 2,976 mmol (entsprechend 68,45 mg) Natrium pro Tablette.","Calcium Sandoz 500 mg contains 2.976 mmol (corresponding to 68.45 mg) of sodium per tablet.",15,13
"693","de","en","Calciumfolinat darf nur intravenös oder intramuskulär angewendet werden.","For intravenous and intramuscular administration only.",6,8
"694","de","en","Cambridge Antibody Technology Ltd","Cambridge Antibody Technology Ltd",4,4
"695","de","en","Campo de las Naciones E-28042 Madrid Tel: +34 91 722 81 00","Paseo de las Doce Estrellas, 5-7 Campo de las Naciones E-28042 Madrid Tel: +34 91 722 81 00",18,12
"696","de","en","Can Guasch, 2 - Parets del Vallès E-08150, Barcelona Tel: +34 93 571 01 00","Can Guasch, 2 - Parets del Vallès E-08150, Barcelona Tel: +34 93 571 01 00",15,15
"697","de","en","Cancidas ist ein Antimykotikum (Arzneimittel gegen Pilze).","Cancidas is an antifungal medicine.",5,7
"698","de","en","Canyon Pharmaceuticals Limited 20-22 Bedford Row London WC1R 4JS United Kindom","Canyon Pharmaceuticals Limited 20-22 Bedford Row London WC1R 4JS United Kingdom.",11,11
"699","de","en","Carbamazepin Bei gleichzeitiger Verabreichung von Carbamazepin (einem CYP3A-Substrat) und Lansoprazol ist Vorsicht geboten.","9 Carbamazepine Caution is adviced during cotreatment with carbamazepin (a CYP3A substrate) and lansoprazole.",14,13
"700","de","en","Carbamazepin kann möglicherweise die Wirkung von SUSTIVA beeinträchtigen.","Carbamazepine may make SUSTIVA less likely to work.",8,8
"701","de","en","Catalent UK Packaging Ltd.","Catalent UK Packaging Ltd.",4,4
"702","de","en","CD4+-Zellzahl Mittlere Verände- rung gegenüber Baseline (x 106/l)c a Bewertungen nach dem TLOVR-Algorithmus b","median CD4+ cell count change from baseline (x 106/l)c a",10,14
"703","de","en","Cedarwood, Chineham Business Park Crockford Lane Basingstoke Hampshire, RG24 8WD","Cedarwood, Chineham Business Park Crockford Lane Basingstoke Hampshire, RG24 8WD",10,10
"704","de","en","Ceftriaxon Tyrol Pharma und damit verbundenen Bezeichnungen Internationaler Freiname (INN):","OPINION FOLLOWING AN ARTICLE 29(2)1 REFERRAL FOR Ceftriaxone Tyrol Pharma and associated names International Non-Proprietary Name (INN):",17,10
"705","de","en","Cefuroxim Sandoz 250 mg comprimés pelliculés","Cefuroxim Sandoz 250 mg comprimés pelliculés",6,6
"706","de","en","Cefuroximaxetil 500 enthält 601,44 mg Cefuroximaxetil, entsprechend 500 mg Cefuroxim pro Tablette","Cefuroximaxetil 500 contain 601.44 mg cefuroxime axetil which is equivalent to 500 mg cefuroxime per tablet",16,12
"707","de","en","Cefuroximaxetil sollte nicht während der Schwangerschaft verwendet werden, es sei denn, dies ist eindeutig erforderlich.","Cefuroxime axetil should not be used during pregnancy unless considered essential by the physician.",14,15
"708","de","en","CellCept 250 mg Kapseln:","CellCept 250 mg capsules:",4,4
"709","de","en","CellCept Mycophenolate mofetil Part B","CellCept Mycophenol ate mofetil Part B",6,5
"710","de","en","Celvapan ist ein Impfstoff, der als Injektion verabreicht wird.","Celvapan is a vaccine that is given by injection.",9,9
"711","de","en","Centro Direzionale Milano Due Palazzo Borromini I-20090 Segrate (Milano)","ge Palazzo Borromini I-20090 Segrate (Mila no) Tel: + 39-02 21018.1",11,9
"712","de","en","Cephalosporin- und Penicillin-Antibiotika können beim Menschen Allergien auslösen, die manchmal sehr schwerwiegend sein können.","Cephalosporin and penicillin antibiotics can cause allergies in humans, and sometimes these allergies can be very serious.",17,14
"713","de","en","Cerepro enthält das im Herpes-Virus vorhandene Gen für das Enzym Thymidinkinase.","Cerepro contains the gene for the enzyme ‘ thymidine kinase’ from the herpes virus.",14,11
"714","de","en","Cervarix ist in Packungsgrößen zu 1, 10 und 100 Glasfläschchen für 1 Dosis (0,5 ml) erhältlich.","Cervarix is available in vials for 1 dose (0.5 ml) in packs of 1, 10 and 100.",17,16
"715","de","en","Česká republika Actelion Pharmaceuticals Ltd Tel: +420 2 3413 8150","Česká republika Actelion Pharmaceuticals Ltd Tel: +420 2 3413 8150",10,10
"716","de","en","Česká republika Amgen s.r.o Tel :+420 2 21 773 500","Č eská republika Amgen s. r. o Tel: +420 2 21 773 500",13,10
"717","de","en","Česká republika KRKA Č s.r.o.","Česká republika KRKA Č s.r.o.",5,5
"718","de","en","Česká republika Na Příkopě 25","Na Příkopě 25 CZ-110 00 Praha 1 Tel: + 420 221771250",11,5
"719","de","en","Ceská republika Pharma Avalanche s.r.o.","Ceská republika Pharma Avalanche s. r. o.",7,5
"720","de","en","Cetirizin wird durch eine Dialyse nur unvollständig entfernt.","Cetirizine is not effectively removed by dialysis.",7,8
"721","de","en","Cetrotide 3 mg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung","Cetrotide 3 mg powder and solvent for solution for injection",10,10
"722","de","en","CEVA SANTE ANIMALE Z.I.","CEVA SANTE ANIMALE Z. I.",5,4
"723","de","en","Charakteristisch bei Patienten mit Wachstumshormonmangel ist ein extrazelluläres Volumendefizit.","Patients with growth hormone deficiency are characterised by extracellular volume deficit.",11,9
"724","de","en","Cheadlw Royal Business Park Highfield, Cheadle SK8 3GY Vereinigtes Königreich","Cheadlw Royal Business Park Highfield, Cheadle SK8 3GY United Kingdom",10,10
"725","de","en","Chł odna 51 00-867 Warszawa Poland","Chł odna 51 00-867 Warszawa Poland",6,6
"726","de","en","Cholestagel Cholestagel Cholestagel Cholestagel","Cholestagel Cholestagel Cholestagel Cholestagel",4,4
"727","de","en","Chronisch obstruktive Atemwegserkrankung (COPD)","Chronic Obstructive Pulmonary Disease (COPD)",5,4
"728","de","en","CIALIS 2,5 mg ist in Blisterpackungen zu 28 Tabletten erhältlich.","CIALIS 2.5 mg is available in blister packs containing 28 tablets.",11,10
"729","de","en","CIALIS war in allen Studien deutlich wirksamer als Placebo.","CIALIS was significantly more effective than placebo in all studies.",10,9
"730","de","en","CIMZIA ist ein Pulver und Lösungsmittel zur Herstellung einer Injektionslösung, die unter die Haut gespritzt wird.","CIMZIA is a powder and solvent that is made up into a solution for injection under the skin.",18,16
"731","de","en","Ciprofloxacin Bayer kann Ihre Aufmerksamkeit beeinträchtigen.","Ciprofloxacin Bayer may make you feel less alert.",8,6
"732","de","en","Ciprofloxacin Hikma hat nur leichte oder mittelschwere Auswirkungen auf die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen.","Ciprofloxacin Hikma has minor or moderate influence on the ability to drive and use machines.",15,18
"733","de","en","Ciprofloxacin sollte zusammen mit einer anderen geeigneten antibakteriellen Substanz kombiniert werden, es sei denn, Ciprofloxacin resistente","Ciprofloxacin should be co-administered with another appropriate antibacterial agent unless ciprofloxacin-resistant Neisseria gonorrhoeae can be excluded.",16,16
"734","de","en","Ciprofloxacin wird im Wesentlichen unverändert sowohl renal als auch in geringerem Umfang fäkal ausgeschieden.","90 Ciprofloxacin is largely excreted unchanged both renally and, to a smaller extent, faecally.",14,14
"735","de","en","Ciprofloxacin wird nach oraler Gabe schnell und wirksam resorbiert.","Ciprofloxacin is rapidly and effectively absorbed after oral administration.",9,9
"736","de","en","Circa 50 bis 60% einer oralen Dosis werden im Urin ausgeschieden, der Rest wird mit dem Stuhl ausgeschieden.","Approximately 50-60% of an oral dose is excreted in the urine with the remainder eliminated in the faeces.",18,18
"737","de","en","Circadin wird vorwiegend an Albumin, Alpha-1-saures Glycoprotein und High-Density-Lipoprotein gebunden.","Circadin is mainly bound to albumin, alpha1-acid glycoprotein and high density lipoprotein.",12,10
"738","de","en","CIS bio international B.P.","CIS bio international B. P.",5,4
"739","de","en","Citrobacter koseri Francisella tularensis Haemophilus ducreyi Haemophilus influenzae* Legionella spp.","Citrobacter koseri Francisella tularensis Haemophilus ducreyi Haemophilus influenzae* Legionella spp.",10,10
"740","de","en","Clarithromycin erhöht die Cmin von Tipranavir um mehr als 100%.","Clarithromycin increases the Cmin of tipranavir by more than 100%.",10,10
"741","de","en","CLcr (ml/min) CLcr (ml/min/1,73 m2) = ----------------------------- x 1,73 KO des Patienten (m2)","CLcr (ml/ min) CLcr (ml/ min/ 1.73 m2) = ---------------------------- x 1.73 BSA subject (m2)",15,13
"742","de","en","Clopidogrel ist nicht für Kinder oder Jugendliche vorgesehen.","Clopidogrel is not intended for use in children or adolescents.",10,8
"743","de","en","Cmax (mg/l) – 0,39 (31%) Tmax (h) – 2,8 (18%) und Cmin (mg/l) – 0,14 (56%).","Cmax (mg/ l) - 0.39 (31%), Tmax (h) - 2.8 (18%) and Cmin (mg/ l) -0.14 (56%).",17,16
"744","de","en","Cmax, maximale Serumkonzentration; Cmin, minimale Serumkonzentration (Talspiegel); t½, Eliminationshalbwertzeit","Cmax, maximum serum concentration; Cmin, trough (minimum level) serum concentration; t½, elimination half-life",13,9
"745","de","en","CoAprovel 300 mg/12,5 mg Tabletten stehen in Blisterpackungen zu 14, 28, 56 oder 98 Stück zur Verfügung.","CoAprovel 300 mg/ 12.5 mg tablets are supplied in blister packs of 14, 28, 56 or 98 tablets.",18,17
"746","de","en","Competact enthält zwei arzneilich wirksame Bestandteile mit unterschiedlicher Wirkungsweise.","Competact contains two active substances which each have a different mode of action.",13,9
"747","de","en","Computerweg 10 3542 DR Utrecht Niederlande","Teva Pharma BV, Computerweg 10, 3542 DR Utrecht; The Netherlands",10,6
"748","de","en","Comtan darf nur zusammen mit den gängigen Levodopa-Kombinationen angewendet werden.","Comtan can only be used with conventional combinations of levodopa.",10,10
"749","de","en","Comtess wird zusammen mit Levodopa zur Behandlung der Parkinson-Krankheit angewendet.","Comtess is used together with levodopa to treat Parkinson’ s disease.",11,10
"750","de","en","Copalia 5 mg/80 mg Filmtabletten","Copalia 5 mg/ 80 mg film-coated tablets",7,5
"751","de","en","COX ist ein Schlüsselenzym des Arachidonsäuremetabolismus.","COX is a key enzyme in pathways of arachidonic acid metabolism.",11,6
"752","de","en","Cozaar’ Comp 100mg/25mg film-coated tablets","‘ Cozaar’ Comp 50mg/ 12.5mg film-coated tablets",7,5
"753","de","en","CPMP/1327/03 5.3 Präklinische Daten zur Sicherheit","5.3 Preclinical safety data",4,6
"754","de","en","Creatinin-Clearance (CLcr) (ml / min)","Creatinine clearance (CLcr) (ml/ min)",5,5
"755","de","en","CRIXIVAN 100 mg Hartkapseln","CRIXIVAN 100 mg hard capsules",5,4
"756","de","en","CRIXIVAN soll von Ärzten verordnet werden, die auf die Behandlung von HIV-Infektionen spezialisiert sind.","CRIXIVAN should be administered by physicians who are experienced in the treatment of HIV infection.",15,14
"757","de","en","ct-Arzneimittel Chemische Tempelhof GmbH Lengeder Str.","ct-Arzneimittel Chemische Tempelhof GmbH Lengeder Str.",6,6
"758","de","en","Cubicin ist mit glucosehaltigen Lösungen weder physikalisch noch chemisch kompatibel.","Cubicin is not physically or chemically compatible with glucose-containing solutions.",10,10
"759","de","en","CY-1055 Λευκωσία Τηλ: +357-22 757188","Latvija Bauskas 58a -401",4,5
"760","de","en","Cyathostomum spp, Cylicocyclus spp., Cylicodontophorus spp., Cylicostephanus spp., Gyalocephalus spp., Askariden:","Cyathostomum spp, Cylicocyclus spp., Cylicodontophorus spp., Cylicostephanus spp., Gyalocephalus spp., Ascarids:",11,11
"761","de","en","CYMBALTA 30 mg ist in Packungen mit 7, 28 und 98 Hartkapseln erhältlich.","CYMBALTA 30 mg is available in packs of 7, 28 and 98 capsules.",13,13
"762","de","en","CYP3A4 scheint in vivo zur Metabolisierung von Etoricoxib beizutragen.","CYP3A4 appears to contribute to the metabolism of etoricoxib in vivo.",11,9
"763","de","en","CYSTAGON 150 mg Hartkapseln","CYSTAGON 150 mg hard capsules",5,4
"764","de","en","D Halten Sie den Injektionsknopf vollständig eingedrückt.","Keep the injection button pressed all the way in.",9,7
"765","de","en","D) Aufziehen der Injektionslösung","D) Drawing up the injection",5,4
"766","de","en","Da Agenerase Lösung zum Einnehmen Vitamin E enthält, sollten Sie kein Vitamin E zusätzlich einnehmen.","Because Agenerase oral solution contains vitamin E, you should not take additional vitamin E supplements.",15,15
"767","de","en","Da Busulfan durch Konjugation mit Glutathion metabolisiert wird, könnte auch die Gabe von Glutathion in Betracht gezogen werden.","Since, busulfan is metabolized through conjugation with glutathione, administration of glutathione might be considered.",14,18
"768","de","en","Da CoAprovel Hydrochlorothiazid enthält, wird eine Anwendung während des ersten Schwangerschaftstrimesters nicht empfohlen.","Since CoAprovel contains hydrochlorothiazide, it is not recommended during the first trimester of pregnancy.",14,13
"769","de","en","Da die Inzidenz für Purpura haemorrhagica sehr gering ist, kann ein Auftreten nicht vollständig ausgeschlossen werden.","As the incidence of purpura haemorrhagica is very low, its occurrence cannot be ruled out completely.",16,16
"770","de","en","Da es sich um einen flüchtigen Spray handelt, muss das Arzneimittel nicht eingerieben werden.","Presented as a volatile spray, this veterinary medicinal product does not require any massage.",14,14
"771","de","en","Da keine Kompatibilitätsstudien durchgeführt wurden, darf dieses Arzneimittel nicht mit anderen Arzneimitteln gemischt werden.","In the absence of compatibility studies this medicinal product must not be mixed with other medicinal products.",17,14
"772","de","en","Da Lansoprazol in den Belegzellen aktiviert wird, besteht kein Zusammenhang zwischen Plasmakonzentration und Hemmung der Magensäuresekretion.","Since lansoprazole is activated in the parietal cells, its plasma concentration is not related to gastric acid inhibition.",18,16
"773","de","en","Da Patienten mit schweren Lebererkrankungen nicht untersucht wurden, ist Nateglinid in dieser Patientengruppe kontraindiziert.","As patients with severe liver disease were not studied, nateglinide is contraindicated in this group.",15,14
"774","de","en","Da Practic die Eiproduktion unterdrückt, wird der Lebenszyklus der Flöhe unterbrochen.","Since Prac-tic completely eliminates egg production, it breaks the flea life cycle.",12,11
"775","de","en","Da Zaleplon über die Muttermilch ausgeschieden wird, sollte Zerene nicht von stillenden Müttern angewendet werden.","Because zaleplon is excreted in the breast milk, Zerene should not be administered to breast-feeding mothers.",16,15
"776","de","en","Dabei hatte die Gabe von 10 mg Enbrel durchgehend weniger Wirkung auf die Gelenkschäden als die 25 mg-Dosis.","The 10 mg Enbrel dose had consistently less effect on structural damage than the 25 mg dose.",17,18
"777","de","en","Dabei sind im Rahmen der Präventionsstrategie auch entsprechende Anstrengungen zu unternehmen, die Infektion in der Elterntiergeneration zu eliminieren.","The prevention strategy should include efforts to eliminate the infection from the parent generation.",14,18
"778","de","en","Dabei sollte beachtet werden, dass Nebenwirkungen hierdurch verstärkt werden können.","It should be noted that the adverse reactions may be intensified.",11,10
"779","de","en","Dabei sollte eine Dosistitration durchgeführt werden.","A titration of the dose should be performed.",8,6
"780","de","en","Dadurch kann der Mechanismus beschädigt werden.","This may damage the mechanism.",5,6
"781","de","en","Dadurch können eventuell mögliche allergische Reaktionen (Hypersensitivität) verhindert werden.","This will help avoid a possible allergic reaction (hypersensitivity).",9,9
"782","de","en","Dadurch verringert sich das Risiko für Magenprobleme.","This will lower the risk of an upset stomach.",9,7
"783","de","en","Dadurch wird die Produktion von DNA unterbunden und werden das Wachstum sowie die Vermehrung der Tumorzellen verlangsamt.","This stops the production of DNA and thus slows down the growth and multiplication of tumour cells.",17,17
"784","de","en","Dafiro 5 mg/160 mg Filmtabletten Amlodipin/Valsartan","Dafiro 5 mg/ 160 mg film-coated tablets amlodipine/ valsartan",9,6
"785","de","en","Daher darf Fluoxetin nicht zusammen mit einem nicht-selektiven MAOI angewendet werden.","Therefore, fluoxetine is contra-indicated in combination with a non-selective MAOI.",10,11
"786","de","en","Daher darf intranasales Calcitonin bei diesen Patienten nicht angewendet werden.","Therefore, intranasal calcitonin is not to be administered to such patients.",11,10
"787","de","en","Daher führen diese Komponenten zur Ausbildung einer Immunität gegen Infektionen mit equinem Influenzavirus (H3N8).","As a consequence, these components induce immunity against equine influenza virus (H3N8).",12,14
"788","de","en","Daher ist für Raucher keine Dosisanpassung erforderlich.","Thus, no dosage adjustment is required for smokers.",8,7
"789","de","en","Daher ist in diesen Situationen Vorsicht geboten.","Caution should be exercised in such situations.",7,7
"790","de","en","Daher ist Vorsicht ratsam, wenn die Therapie eines Patienten gleichzeitig Venlafaxin und einen CYP3A4-Inhibitor umfasst.","Therefore, caution is advised if a patient’ s therapy includes a CYP3A4 inhibitor and venlafaxine concomitantly.",16,15
"791","de","en","Daher kann seine klinische Anwendung während der Stillzeit nicht empfohlen werden.","Its clinical use, therefore, cannot be recommended in breast-feeding women.",10,11
"792","de","en","Daher müssen die Patienten während dieser Zeit sorgfältig hinsichtlich des Auftretens von Hautausschlägen überwacht werden.","Therefore, patients should be monitored carefully for the appearance of rash during this period.",14,15
"793","de","en","Daher müssen TNF-Antagonisten Ar","Therefore, caution should be exercised when using any no",9,4
"794","de","en","Daher sind bei diesen Patienten keine speziellen Vorsichtsmaßnahmen oder Dosisanpassungen erforderlich (siehe Abschnitt 4.2 und 5.2).","Therefore, no special precautions or dose adjustments are required in these patients (see sections 4.2 and 5.2).",17,16
"795","de","en","Daher sind die konventionellen Daten zur präklinischen Sicherheit von Infliximab beschränkt.","Therefore, conventional preclinical safety data with infliximab are limited.",9,11
"796","de","en","Daher sind diese Empfehlungen nur vorläufig.","Therefore, these recommendations are only tentative.",6,6
"797","de","en","Daher sollen weiterhin entsprechende Vorsichtsmaßnahmen angewendet werden.","You should continue to use appropriate precautions to prevent this.",10,7
"798","de","en","Daher sollte die gemeinsame Gabe von Lenalidomid mit anderen myelosuppressiven Substanzen mit Vorsicht vorgenommen werden.","Therefore, co-administration of lenalidomide with other myelosuppressive agents should be undertaken with caution.",13,15
"799","de","en","Daher sollte die Prasugrel Anwendung bei diesen Patienten nur mit Vorsicht erfolgen.","Therefore, prasugrel should be used with caution in these patients.",10,12
"800","de","en","Daher sollte dieser regelmäßig","- This medicine may affect your blood pressure, so it should be measured regularly, especially at",16,4
"801","de","en","Daher sollte ein potenter CYP3A4-Inhibitor bei Patienten, die Dasatinib erhalten, nicht gleichzeitig angewendet werden (siehe Abschnitt 4.5).","Therefore, in patients receiving dasatinib, coadministration of a potent CYP3A4 inhibitor is not recommended (see section 4.5).",17,17
"802","de","en","Daher sollte eine gerinnungshemmende Therapie nicht abgesetzt werden (siehe 4.5 und 5.l).","Therefore antiplatelet therapies should not be discontinued (see sections 4.5 and 5.1).",12,12
"803","de","en","Daher sollte es bei diesen Patienten mit Vorsicht angewandt werden.","Therefore, it should be used with caution in these patients.",10,10
"804","de","en","Daher sollte nach Anwendung solcher Arzneimittel eine behandlungsfreie Zeit eingehalten werden.","The treatment- free period should take into account the pharmacological properties of the products used previously.",16,11
"805","de","en","Daher sollten Patienten, die zu diesem Zwecke Cysteamin- haltige Augenlösungen erhalten, diese weiterverwenden.","Therefore, where cysteamine ophthalmic solution is used for that purpose, its usage should continue.",14,13
"806","de","en","Daher wird die Anwendung von Azomyr während der Schwangerschaft nicht empfohlen.","The use of Azomyr during pregnancy is therefore not recommended.",10,11
"807","de","en","Daher wird die Anwendung von Circadin bei Patienten mit Autoimmunerkrankungen nicht empfohlen.","Therefore Circadin is not recommended for use in patients with autoimmune diseases.",12,12
"808","de","en","Daher wird die Anwendung von Enbrel bei schwangeren Frauen nicht empfohlen.","189 reproductive performance are not available.",6,11
"809","de","en","Daher wird die Anwendung von Kinzalkomb nicht empfohlen.","Therefore, the use of Kinzalkomb is not recommended.",8,8
"810","de","en","Daher wird die Anwendung von TOVIAZ während der Schwangerschaft nicht empfohlen.","TOVIAZ is not recommended during pregnancy.",6,11
"811","de","en","Daher wird die Behandlung für diese Altersgruppe nicht empfohlen.","Therefore, treatment is not recommended in this age group.",9,9
"812","de","en","Daher wird die Kombination von Crestor und Gemfibrozil nicht empfohlen.","Therefore, the combination of Crestor and gemfibrozil is not recommended.",10,10
"813","de","en","Daher wird für Neugeborene eine Dosis von 4 mg/kg/Tag empfohlen, um eine der Erwachsenen-Exposition ähnliche Exposition zu erreichen.","Therefore to achieve similar adult and paediatric exposure, the recommended dose for neonates is 4 mg/ kg/ day.",18,18
"814","de","en","Daher wird nicht empfohlen, DUKORAL an Kinder unter 2 Jahren zu verabreichen.","Therefore, DUKORAL is not recommended to be used in children less than 2 years of age.",16,12
"815","de","en","Damit Sie in den vollen Genuss des Nutzens einer Behandlung mit FORCALTONIN kommen, wird","Please ask him to explain the reasons for any changes in your",12,14
"816","de","en","Damit verbunden ist ein erhöhtes Risiko von Knochenkomplikationen, einer Verstärkung der Zytopenie, Blutungen und eines erhöhten Bluttransfusionsbedarfs.","This includes an increased risk of skeletal manifestations, exacerbation of cytopenia, haemorrhage, and an increased need for transfusion.",18,17
"817","de","en","Damit verbunden ist oft ein Anstieg bestimmter Blutfette (Triglyzeride).","This is often associated with an increase of certain blood fats (triglycerides).",12,9
"818","de","en","Danach ist es eventuell schwieriger, das Virus zu behandeln.","The virus may then become harder to treat.",8,9
"819","de","en","Danach sollte die Dosierung auf der Grundlage der Reaktion des Blutdrucks angepasst werden.","Thereafter, the dosage should be adjusted according to the blood pressure response.",12,13
"820","de","en","Danach wird die Dosis der ovariellen Reaktion angepasst.","The dose is then adjusted according to the ovarian response.",10,8
"821","de","en","Dank der Airless-Pumpe kann das Mittel unabhängig von der Flaschenposition verabreicht werden.","The airless pump allows the product to be administered whatever the position of the bottle is.",16,12
"822","de","en","Danmark Alcon Danmark A/S + 45 3636 3434","Danmark Alcon Danmark A/ S + 45 3636 3434",9,8
"823","de","en","Danmark BioMarin Europe Limited Tlf:","Danmark BioMarin Europe Limited Tlf:",5,5
"824","de","en","Danmark GE Healthcare A/S Huginsvej 8 DK-3400 Hillerød Tlf: + 45 70 22 22 03","Danmark GE Healthcare A/ S Huginsvej 8 DK-3400 Hillerød Tlf: + 45 70 22 22 03",16,15
"825","de","en","Danmark GlaxoSmithKline Pharma A/S Tlf: + 45 36 35 91 00 info@glaxosmithkline.dk zn","r ge Danmark GlaxoSmithKline Pharma A/ S Tlf: + 45 36 35 91 00",14,13
"826","de","en","Danmark Lautrupbjerg 2 DK-2750 Ballerup","Danmark Lautrupbjerg 2 DK-2750 Ballerup",5,5
"827","de","en","Danmark Lautrupbjerg 2 DK-2750 Ballerup Tlf: + 45-44 39 50 00","70 Danmark Lautrupbjerg 2 DK-2750 Ballerup Tlf: + 45-44 39 50 00",12,11
"828","de","en","Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 janumet@msd.dk","Danmark Merck Sharp & Dohme Tlf: +45 43 28 77 66 janumet@msd.dk",12,12
"829","de","en","Danmark Nycomed Danmark ApS Langebjerg 1 DK-4000 Roskilde Tlf: +45 46 77 11 11 info@nycomed.com","21 Danmark Nycomed Danmark ApS Langebjerg 1 DK-4000 Roskilde Tlf: +45 46 77 11 11 info@nycomed. com",17,15
"830","de","en","Danmark Orphan Europe Nordic AB Banérgatan 37 S- 11522 Stockholm Sverige Tel: +46 8 545 80 230","Danmark Orphan Europe Nordic AB Banérgatan 37 S- 11522 Stockholm Sverige Tel: +46 8 545 80 230",17,17
"831","de","en","Danmark Swedish Orphan A/S, Wilders Plads 5, DK – 1403 København K Tlf: +45 32 96 68 69","Danmark Swedish Orphan A/S, Wilders Plads 5, DK – 1403 København K Tlf: +45 32 96 68 69",18,18
"832","de","en","Danmark/Norge/Sverige/Suomi/Finland/ Ísland Genzyme A/S, (Danmark/Tanska/Danmörk), Tlf/Puh./Sími: + 45 32712600","Danmark/Norge/Sverige/Suomi/Finland/ Ísland Genzyme A/S, (Danmark/Tanska/Danmörk), Tlf/Puh./Sími: + 45 32712600",9,9
"833","de","en","Dann wird der Injektionsknopf vollständig eingedrückt.","Then the injection button should be pressed all the way in.",11,6
"834","de","en","Daraufhin prüfte der CHMP die zu dieser Sicherheitsfrage verfügbaren Daten, einschließlich Berichte nach der Markteinführung,","Following this request, the CHMP",5,15
"835","de","en","Darf nur Trockenfutter beigemischt werden.","Only to be added to dry food.",7,5
"836","de","en","Darmverstimmungen, angioneurotische Ödeme, Schwierigkeiten bei der Atmung, Herzklopfen und niedriger Blutdruck.","Generalised hypersensitivity reactions are potentially life threatening.",7,11
"837","de","en","Darüber hinaus ist eine Dosisreduktion oder eine Beendigung der Therapie zu erwägen.","Furthermore a reduction of dosage or termination of therapy may be considered.",12,12
"838","de","en","Darüber hinaus kann es auch zu synergistischen/additiven nephrotoxischen Effekten kommen.","In addition, synergistic/ additive nephrotoxic effects can occur.",8,10
"839","de","en","Darüber hinaus soll eine aktualisierte Version des RMP eingereicht werden:","In addition, an updated RMP should be submitted:",8,10
"840","de","en","Darüber hinaus wurde Quixidar in zwei Hauptstudien an Patienten mit instabiler Angina pectoris oder itte","In all studies, the main measure of effectiveness was the",10,15
"841","de","en","Darüber hinaus wurden bei Patienten unter Trudexa-Therapie in sehr Ar","In addition very rare cases of non-melanoma skin cancer have been observed in patients taking Trudexa. no",17,10
"842","de","en","Darüber hinaus wurden die Prometax-Kapseln an 541 Patienten mit Parkinson-Demenz untersucht.","Prometax capsules have also been studied in 541 patients with dementia due to Parkinson’ s disease.",16,11
"843","de","en","Darüberhinaus sind selten auch spät auftretende Fälle von Hepatitis ungefähr 18 Monate nach Behandlungsbeginn beobachtet worden.","Additionally late onset hepatitis after approximately 18 months of treatment has been reported rarely.",14,16
"844","de","en","Darunavir, Indinavir, Lopinavir/Ritonavir, Ritonavir, Ritonavir- geboostetes Atazanavir, Saquinavir oder Fosamprenavir/Saquinavir.","protease inhibitors: darunavir, indinavir, lopinavir/ritonavir, ritonavir, ritonavir boosted atazanavir, saquinavir or fosamprenavir/saquinavir.",12,10
"845","de","en","Darunavir/Ritonavir erhöht die Plasmakonzentration von Digoxin.","50 Darunavir/ritonavir increases the plasma concentrations of digoxin.",8,6
"846","de","en","Darwinweg 20 2333 CR Leiden Niederlande","Darwinweg 20 2333 CR Leiden Netherlands",6,6
"847","de","en","Das Abbrechen der Behandlung mit Viread kann zu einer verringerten Wirksamkeit der von Ihrem Arzt verordneten Therapie führen.","Stopping treatment with Viread may reduce the effectiveness of the treatment recommended by your doctor.",15,18
"848","de","en","Das Absetzen der Behandlung führt zu keinem Rebound-Effekt.","Discontinuation of treatment does not lead to a rebound effect.",10,8
"849","de","en","Das Absinken der Knochenmineraldichte der Hüfte war in dieser Gruppe bis zur Woche 96 signifikant größer.","Decreases in bone mineral density of hip were significantly greater in this group until 96 weeks.",16,16
"850","de","en","Das Ansprechen auf die Behandlung in beiden Studien ist in Tabelle 9 dargestellt.","The response to treatment in both of these trials is presented in Table 9.",14,13
"851","de","en","Das Arzneimittel (in Gebrauch befindiche Patrone in der Pumpe) kann maximal 2 Wochen lang aufbewahrt werden.","The product (cartridges in-use in the pump) may be stored for a maximum of 2 weeks.",16,16
"852","de","en","Das Arzneimittel bedarf einer ärztlichen Verschreibung.","The medicine can only be obtained with a prescription.",9,6
"853","de","en","Das Arzneimittel darf nicht im Abwasser oder Haushaltsabfall entsorgt werden.","Medicines should not be disposed of via via wastewater or household waste.",12,10
"854","de","en","Das Arzneimittel darf, außer mit den unter Abschnitt 12 aufgeführten, nicht mit anderen Arzneimitteln gemischt werden.","This medicinal product must not be mixed with other medicinal products except those mentioned in section 12.",17,16
"855","de","en","Das Arzneimittel enthält Metacresol, das allergische Reaktionen hervorrufen kann.","This medicinal product contains metacresol, which may cause allergic reactions.",10,9
"856","de","en","Das Arzneimittel ist indiziert bei schweren chronischen Schmerzen, die nur mit Opioid-Analgetika ausreichend behandelt werden können.","The product is indicated in severe chronic pain which can be adequately managed only with opioid analgesics.",17,16
"857","de","en","Das Arzneimittel muss intravenös angewendet werden (siehe Abschnitt 4.4 - Patienten mit chronischer Niereninsuffizienz).","The intravenous route has to be used (please see section 4.4 - chronic renal failure patients).",16,14
"858","de","en","Das Arzneimittel nach dem auf dem Behältnis und der äußeren Umhüllung angegebenen Verfalldatum nicht mehr anwenden.","Do not use after the expiry date stated on the label.",11,16
"859","de","en","Das Arzneimittel nicht mehr nach dem auf dem Etikett angegebenen Verfalldatum anwenden.","Do not use Avamys after the expiry date which is stated on the label and carton.",16,12
"860","de","en","Das Arzneimittel wird einmalig verabreicht.","A single dose of the product should be administered.",9,5
"861","de","en","Das Auftreten von 3 Mutationen oder mehr war mit einem verringerten Ansprechen auf Saquinavir/Ritonavir verbunden.","The presence of 3 or more mutations was associated with reduced response to saquinavir/ritonavir.",14,15
"862","de","en","Das Auftreten von Husten wurde in Zusammenhang mit ACE-Hemmern beobachtet.","Cough has been reported with the use of ACE inhibitors.",10,10
"863","de","en","Das Behältnis darf nicht nachgefüllt werden.","The container must not be refilled.",6,6
"864","de","en","Das Behältnis fest verschlossen halten, um den Inhalt vor Feuchtigkeit zu schützen.","Keep container tightly closed in order to protect from moisture.",10,12
"865","de","en","Das Behältnis im Umkarton aufbewahren, um den Inhalt vor Licht zu schützen.","Keep the container in the outer carton, in order to protect from light.",13,12
"866","de","en","Das Behandlungsschema wird in Tabelle 4 zusammengefasst.","The treatment regimen is summarized in Table 4.",8,7
"867","de","en","das biotechnologisch aus E. coli-Bakterien hergestellt wird.","Pegfilgrastim is a protein produced by biotechnology in bacteria called E. coli.",12,7
"868","de","en","Das Brechen der Tabletten in zwei Hälften ermöglicht die meisten der erforderlichen Dosierungsanpassungen.","The breaking of the tablets in halves allows most of the required posology adjustments.",14,13
"869","de","en","Das Diät- und Bewegungsprogramm sollte nach Beenden der Behandlung mit alli weitergeführt werden.","The diet and exercise programme should continue to be followed when treatment with alli is stopped.",16,13
"870","de","en","Das Einhalten des intravenösen Verabreichungsweges ist zwingend erforderlich (siehe Abschnitt 4.4).","Strict adherence to the intravenous administration route is required (see section 4.4).",12,11
"871","de","en","Das endgültige Verdünnungsvolumen kann jedoch je nach klinischem Status des Patienten und Ermessen des Arztes variieren.","However, the final dilution volume may vary depending on the patient’ s clinical status and physician discretion.",17,16
"872","de","en","Das Enzym findet sich nur in Bakterienzellen und hat in tierischen Zellen keine solche Funktion.","This enzyme is only found in bacterial cells, and does not have a similar function in animal cells.",18,15
"873","de","en","Das für den Betrieb erforderliche technische Personal wird später eingestellt.","Operational technical staff would be recruited thereafter.",7,10
"874","de","en","Das gebrauchsfertige Produkt ist eine farblose, klare bis schwach opaleszente Lösung.","The reconstituted product is a colourless, clear to slightly opalescent solution.",11,11
"875","de","en","Das Gel zum Eingeben kann bis spätestens 3 Stunden vor einem chirurgischen Eingriff verabreicht werden.","For details, please see the Package Leaflet.",7,15
"876","de","en","Das Gen, welches das Virus in Advexin trägt, ist das normale (nicht defekte) p53-Gen.","The gene carried by the virus in Advexin is the normal (non-defective) p53 gene.",14,14
"877","de","en","Das Glas mit mindestens 120 ml Wasser oder Orangensaft nochmals auffüllen, gut umrühren und sofort trinken.","Refill the glass with at least 120 ml of water or orange juice, stir well, and drink immediately.",18,16
"878","de","en","Das Gutachten des wissenschaftlichen Ausschusses wird der Europäischen Kommission übermittelt.","Contents Introduction by the Executive Director",6,10
"879","de","en","Das Hauptwirksamkeitsmaß war in diesen Studien das Hinauszögern des Fortschreitens der Behinderung.","The main measure of effectiveness was the delay to progression of disability.",12,12
"880","de","en","Das Humalog im vorliegenden KwikPen entspricht dem Humalog, das in separaten Humalog Patronen im Handel ist.","The Humalog in your pre-filled pen is the same as the Humalog, which comes in separate Humalog cartridges.",18,16
"881","de","en","Das Implantat ist biologisch verträglich und muss deshalb nicht entfernt werden.","The biocompatible implant does not require removal.",7,11
"882","de","en","Das inaktive D-Isomer liegt in höheren Konzentrationen vor als L-5-Formyl-tetrahydrofolat.","The inactive D-isomer is present in higher concentration than L-5-formyl- tetrahydrofolate.",11,10
"883","de","en","Das ist ausreichend für einen Bedarf von 4 Wochen.","This is enough for 4 weeks’ usage.",7,9
"884","de","en","Das ist die Tageshöchstdosis für Doxazosin Retard Arrow [und andere Bezeichnungen] 4 mg Retardtabletten.","This is the maximum daily dose of Doxazosin Retard Arrow 4 mg prolonged release tablets and associated names.",18,14
"885","de","en","Das kanzerogene Potenzial für Nagetiere wurde nur bei oral angewandtem Aprepitant untersucht.","Carcinogenic potential in rodents was only investigated with orally administered aprepitant.",11,12
"886","de","en","Das Kind sollte eine zurückgelehnte sitzende Position einnehmen.","The child should be seated in a reclining position.",9,8
"887","de","en","Das klare bis leicht trübe und farblose bis blassgelbe Konzentrat darf keine sichtbaren Partikel enthalten.","The clear to slightly opalescent and colourless to pale yellow concentrate must be free of visible particles.",17,15
"888","de","en","Das Langzeitsicherheitsprofil von Tacrolimus ist nicht systematisch untersucht worden.","The long-term safety profile of tacrolimus has not been systematically studied.",11,9
"889","de","en","Das Lösungsmittel enthält Benzylalkohol und Benzalkoniumchlorid in Wasser für Injektionszwecke.","The solvent contains benzyl alcohol and benzalkonium chloride in water for injections.",12,10
"890","de","en","Das Lösungsmittel ist eine klare farblose Lösung.","The solvent is a clear colourless solution.",7,7
"891","de","en","Das Lösungsmittel langsam in die Durchstechflasche mit dem Pulver injizieren.","Inject the solvent slowly into the vial with powder.",9,10
"892","de","en","Das Medikament wird el","Medicine will be automatically lp",5,4
"893","de","en","Das Mix2Vial Set mit der Packung greifen und mit der blauen Seite auf die Lösungsmittelflasche fest aufstecken.","Take the Mix2Vial together with the package and snap the blue end onto the diluent stopper.",16,17
"894","de","en","Das Multivitaminpräparat sollte die Vitamine A, D, E und K enthalten.","The multivitamin should contain vitamins A, D, E and K.",10,11
"895","de","en","Das Nutzen- Risiko-Verhältnis ist in Modul 6 dieses EPAR zu finden.","The benefit-risk balance may be found in module 6 of this EPAR.",12,11
"896","de","en","Das Oberteil ist mit „ Temodal“ bedruckt.","The cap is imprinted with “ Temodal”.",7,7
"897","de","en","Das optimale Dosierungsschema von Refludan unter diesen Umständen ist nicht bekannt. − Anwendung bei Kindern:","The optimal dose regimen of Refludan in these circumstances is not known. – Paediatric Use:",15,15
"898","de","en","Das Patientenkollektiv der Studie umfasste PI-naive, NNRTI- erfahrene Patienten mit nachgewiesener NNRTI-Resistenz.","The trial population included PI-naïve, NNRTI-experienced patients with evidence of NNRTI resistance.",12,12
"899","de","en","Das potentielle Risiko einer einmaligen Anwendung am Menschen ist nicht bekannt.","The potential risk of single administration for humans is unknown.",10,11
"900","de","en","Das potentielle Risiko für den Menschen ist nicht bekannt.","The potential risk for humans is unknown.",7,9
"901","de","en","Das potentielle Risiko für den Menschen ist nicht bekannt.Revasc ist während der Schwangerschaft kontraindiziert (siehe Abschnitt 4.3).","Revasc is contraindicated in pregnancy (see section 4.3).",8,17
"902","de","en","Das Präparat wird nicht für Patienten mit schweren Nierenproblemen empfohlen.","It is not recommended for patients with severe kidney problems.",10,10
"903","de","en","Das primäre Ziel dieser Studie war, Daten zur Sicherheit und Unbedenklichkeit von FORSTEO zu erheben.","The primary objective of the study was to collect safety data of FORSTEO.",13,15
"904","de","en","Das Produkt darf nicht wieder in den Kühlschrank zurückgestellt werden, nachdem es bei Raumtemperatur gelagert wurde.","The product may not be returned to refrigerated storage after storage at room temperature.",14,16
"905","de","en","Das Produkt ergänzt die schützenden Eigenschaften des normalen Kolostrums gegen E. coli F5 (K99) Adhäsine.","The product supplements the protective properties of normal colostrum against E. coli F5 (K99) adhesin.",15,15
"906","de","en","Das Produkt ist 50 Jahre alt und wird hauptsächlich unter Überwachung durch onkologische Ärzte verwendet.","It is a 50 year old product, mainly used under the supervision of medical oncologists.",15,15
"907","de","en","Das Produkt wie unter 6.6 beschrieben auflösen.","Dissolve the product as described at 6.6.",7,7
"908","de","en","Das Programm zu Probenahme und Prüfung von zentral zugelassenen Arzneimitteln wird 2003 fortgesetzt.","• Additional work will need to be undertaken with inspection services of candidate countries prior to accession.",17,13
"909","de","en","Das Pulver ist unmittelbar vor der Anwendung im beigefügten Lösungsmittel aufzulösen.","The powder should be reconstituted immediately prior to use with the solvent provided.",13,11
"910","de","en","Das Pulver wird im Wasser aufgelöst, bevor es von einem Arzt injiziert wird.","The powder is reconstituted in the water before it is injected by a health professional.",15,13
"911","de","en","Das Pulver zur Herstellung einer Injektionslösung muss mit Wasser für Injektionszwecke aufgelöst werden.","The powder for solution for injection has to be reconstituted with water for injection.",14,13
"912","de","en","Das Referat Verwaltung besteht aus zwei Arbeitsbereichen:","The Administration Unit comprises two operational sectors:",7,7
"913","de","en","Das Referenzarzneimittel für Filgrastim ratiopharm ist Neupogen.","The reference medicine for Filgrastim ratiopharm is Neupogen.",8,7
"914","de","en","Das rekonstituierte Volumen erlaubt die exakte Entnahme von 10,0 ml (entsprechend 50 mg) pro Durchstechflasche.","The reconstituted volume allows accurate withdrawal of 10.0 ml (equal to 50 mg) from each vial.",16,15
"915","de","en","Das Risiko für venöse Thromboembolien bei Anwenderinnen kombinierter Kontrazeptiva steigt mit:","The risk of venous thromboembolism in combined contraceptives users increases with:",11,11
"916","de","en","Das Risiko hierfür kann mit ansteigendem Sirolimus- Talspiegel zunehmen.","The risk may increase as the trough sirolimus level increases.",10,9
"917","de","en","Das Risiko, eine fruchtbare Läufigkeit zu induzieren ist im Metöstrus gering (5%).","The risk of inducing a fertile heat is low in metoestrus (5%).",12,12
"918","de","en","Das scheinbare Verteilungsvolumen von Telmisartan beträgt etwa 500 Liter, was auf eine zusätzliche Bindung im Gewebe hinweist.","The apparent volume of distribution for telmisartan is approximately 500 litres indicating additional tissue binding.",15,17
"919","de","en","Das Schreiben, in dem das Unternehmen die EMEA über die Rücknahme des Antrags informiert, kann hier aufgerufen werden.","The letter from the company notifying the EMEA of the withdrawal of the application is available here.",17,18
"920","de","en","Das System sollte aus dem Beutel entnommen und sofort angewendet werden.","The system should be removed from the sachet and used immediately.",11,11
"921","de","en","Das Therapieergebnis des mit Imiquimod-Creme behandelten Tumors sollte 12 Wochen nach Ende der Behandlung beurteilt werden.","Response of the treated tumour to imiquimod cream should be assessed 12 weeks after the end of treatment.",18,16
"922","de","en","Das Tierarzneimittel ist in durchsichtigen Kunststoffpipetten mit je einer Einzeldosis verpackt, deren Umhüllung aus Aluminiumfolie besteht.","The veterinary medicinal product is packaged in individual-dose transparent plastic pipettes over packed in an aluminium foil package.",18,16
"923","de","en","Das Tierarzneimittel nicht auf die Oberfläche des Katzenfelles auftragen.","Do not apply the veterinary medicinal product to the surface of the cat’ s hair coat.",16,9
"924","de","en","Das Tierarzneimittel sollte unmittelbar nach dem Auflösen verwendet werden.","The product should be used immediately after reconstitution.",8,9
"925","de","en","Das Tierarzneimittel wird in den folgenden Fällen eingesetzt:","It is used in the following ways:",7,8
"926","de","en","Das Tragen undurchlässiger Schutzhandschuhe wird empfohlen.","The use of waterproof gloves is advisable.",7,6
"927","de","en","Das Trocknungsmittel darf nicht geschluckt werden.","Do not swallow the desiccant.",5,6
"928","de","en","Das Unternehmen hat den CHMP unterrichtet, dass die laufenden Studien mit SCINTIMUN zu Ende geführt werden.","The Company has informed the CHMP that the ongoing clinical studies of SCINTIMUN will continue until completion.",17,16
"929","de","en","Das Unternehmen wird ferner Daten darüber erheben, ob das Arzneimittel außerhalb der zugelassenen Indikation angewendet wird.","The company will also collect information on whether the medicine is used outside its approved indication.",16,16
"930","de","en","Das Verdünnungsmittel ist eine klare bis leicht getrübte, leicht gelbliche bis gelbe Lösung.","The diluent is a clear to slightly turbid, light-yellow to yellow solution.",12,13
"931","de","en","Das Verfahren wurde am 20.","The referral procedure was then started on 20 September 2007.",10,5
"932","de","en","Das Verfahren zur gegenseitigen Anerkennung wurde am 25.","The Mutual Recognition Procedure started on 25 May 2005.",9,8
"933","de","en","Das Verfalldatum bezieht sich auf den letzten Tag des Monats.","The expiry date refers to the last day of that month.",11,10
"934","de","en","Das Verfallsdatum bezieht sich auf den letzten Tag des Monats.","37 Store in the original package in order to protect from moisture.",12,10
"935","de","en","Das Verteilungsvolumen beträgt 53-93 Liter.","The volume of distribution is 53-93 litres.",7,5
"936","de","en","Das Verteilungsvolumen im Steady-State beträgt ungefähr 16,8 l, ähnlich dem extrazellulären Flüssigkeitsvolumen beim Menschen.","The volume of distribution at steady state is approximately 16.8 L, similar to extracellular fluid volume in man.",18,14
"937","de","en","Das Verzeichnis der betroffenen Bezeichnungen des Arzneimittels ist in Anhang I enthalten.","The information given in this document and Annexes reflect only the CHMP Opinion dated 23 March 2006.",17,12
"938","de","en","Das Ziel dieser Behandlung muss darin bestehen, unter engmaschiger ärztlicher Beobachtung die anticholinergen Symptome zu beseitigen.","Therapy should be aimed at reversing the anticholinergic symptoms under careful medical supervision.",13,16
"939","de","en","Dass die Behandlung mit Volibris periphere Ödeme und eine Flüssigkeitsretention verursachen kann","That treatment with Volibris causes peripheral oedema and fluid retention",10,12
"940","de","en","Daten über eine mögliche Wechselwirkung von Levetiracetam mit Alkohol liegen nicht vor.","No data on the interaction of levetiracetam with alcohol are available.",11,12
"941","de","en","Daten zu pharmakokinetischen Eigenschaften sind für Impfstoffe nicht erforderlich.","Evaluation of pharmacokinetic properties is not required for vaccines.",9,9
"942","de","en","Daten zur Milchsäure im Serum wurden nicht erhoben.","Data on lactic acid in serum were not collected.",9,8
"943","de","en","Datenblatt für die Patientendokumentation Packungsbeilage Barcode Etiketten und Aufkleber","Data sheet for patient documentation Package leaflet Page of Barcode labels and sticker",13,9
"944","de","en","DaTSCAN darf nicht angewendet werden,","Do not use DaTSCAN if:",5,5
"945","de","en","DATUM DER ERTEILUNG DER ERSTZULASSUNG / VERLÄNGERUNG DER ZULASSUNG","DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION",8,9
"946","de","en","DATUM DER ERTEILUNG DER ERSTZULASSUNG/VERLÄNGERUNG DER ZULASSUNG","DATE OF FIRST AUTHORISATION",4,7
"947","de","en","Datum der Erteilung der Zulassung:","Date of first authorisation:",4,5
"948","de","en","DATUM DER ERTEILUNG DER ZULASSUNG/VERLÄNGERUNG DER","DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION ct",9,6
"949","de","en","DATUM DER ERTEILUNG DER ZULASSUNG/VERLÄNGERUNG DER ZULAS- SUNG","DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION",7,8
"950","de","en","Datum der letzten Verlängerung:","DATE OF REVISION OF THE TEXT",6,4
"951","de","en","DATUM DER VERLÄNGERUNG DER ZULASSUNG","DATE OF RENEWAL OF THE AUTHORISATION",6,5
"952","de","en","DATUM DER ZULASSUNG / VERLÄNGERUNG DER ZULASSUNG","DATE OF FIRST AUTHORISATION/ RENEWAL OF AUTHORISATION",7,7
"953","de","en","Dauer der Behandlung Die Behandlung mit Herceptin sollte bis zur Progression der Erkrankung fortgesetzt werden.","Duration of treatment Herceptin should be administered until progression of disease.",11,15
"954","de","en","Dauer der Haltbarkeit nach der ersten Verwendung der Patrone:","Shelf life after first use of the cartridge:",8,9
"955","de","en","David Drakeford arbeitete bei Telecom Eireann, wo er die Einrichtung eines nationalen Datenkommunikationsnetzes leitete.","David Drakeford worked with",4,14
"956","de","en","Dazu gehören Rötung, Schmerz, Schwellung, Jucken, Wärmegefühl und Bluterguss an der Einstichstelle.","These side effects included redness, pain, swelling, itching, warmth, and bruising at the injection site.",15,12
"957","de","en","De Burgos 16 D - 5ª Planta 28036 Madrid Spanien","De Burgos 16 D - 5ª Planta 28036 Madrid Spain",10,10
"958","de","en","Dem ging die vorheriger Einführung einer EMEA-Firewall und neuen Internet-Service-Provider im Juli 2002 voraus.","The Head of Sector",4,14
"959","de","en","Demnach leisten die Metabolite keinen Beitrag zur pharmakologischen Wirkung von Tacrolimus.","Therefore, metabolites do not contribute to the pharmacological activity of tacrolimus.",11,11
"960","de","en","DEMO ABEE 21st Km National Road Athens-Lamia Post Code:","DEMO ABEE 21st Km National Road Athens-Lamia Post Code:",9,9
"961","de","en","Demyelinisierende Erkrankung (Multiple Sklerose-artige Erkrankungen) des Zentralnervensystems Selten:","Central nervous system demyelinating disorders (multiple sclerosis-like disease) Rare:",9,8
"962","de","en","Den Fertigpen im Umkarton aufbewahren, um den Inhalt vor Licht zu schützen.","Keep the pen in the outer carton in order to protect from light.",13,12
"963","de","en","Den Hauptmetaboliten im Stuhl stellte 6 alpha-Hydroxypaclitaxel dar.","6 alpha-hydroxypaclitaxel is the major component excreted in faeces.",9,8
"964","de","en","Den Kopf leicht nach vorne neigen.","Tilt your head forward a little bit.",7,6
"965","de","en","Den Patienten ist zu raten, Vorsichtsmaßnahmen zu treffen, um Hypoglykämien beim Führen von Kraftfahrzeugen zu vermeiden.","244 Patients should be advised to take precautions to avoid hypoglycaemia whilst driving.",13,16
"966","de","en","Den Strohhalm und die beiden Probenröhrchen mit der Aufschrift ""Probenzeit:","Take the straw and the two sample tubes with the label “Sampling time:",13,10
"967","de","en","Den vollständigen Wortlaut des EPAR finden Sie hier. ich","The full EPAR for Monotard is available here. t uc",10,9
"968","de","en","Den vollständigen Wortlaut des EPAR für Advagraf finden Sie hier.","The full EPAR for Advagraf can be found here.",9,10
"969","de","en","Den vollständigen Wortlaut des EPAR für Avastin finden Sie hier.","The full EPAR for Avastin is available here.",8,10
"970","de","en","Den vollständigen Wortlaut des EPAR für CEPROTIN finden Sie hier.","The full EPAR for CEPROTIN is available here.",8,10
"971","de","en","Den vollständigen Wortlaut des EPAR für Diacomit finden Sie hier.","The full EPAR for Diacomit can be found here.",9,10
"972","de","en","Den vollständigen Wortlaut des EPAR für Extavia finden Sie hier.","The full EPAR for Extavia can be found here.",9,10
"973","de","en","Den vollständigen Wortlaut des EPAR für Glubrava finden Sie hier.","The full EPAR for Glubrava is available here.",8,10
"974","de","en","Den vollständigen Wortlaut des EPAR für KOGENATE Bayer finden Sie hier.","The full EPAR for KOGENATE Bayer is available here.",9,11
"975","de","en","Den vollständigen Wortlaut des EPAR für Olanzapin Neopharma finden Sie hier.","The full EPAR for Olanzapine Neopharma can be found here.",10,11
"976","de","en","Den vollständigen Wortlaut des EPAR für Plavix finden Sie hier.","The full EPAR for Plavix is available here.",8,10
"977","de","en","Den vollständigen Wortlaut des EPAR für Raptiva finden Sie hier.","The full EPAR for Raptiva can be found here.",9,10
"978","de","en","Den vollständigen Wortlaut des EPAR für Siklos finden Sie hier.","The full EPAR for Siklos can be found here.",9,10
"979","de","en","Den vollständigen Wortlaut des EPAR für TAXOTERE finden Sie hier.","The full EPAR for TAXOTERE is available here.",8,10
"980","de","en","Den vollständigen Wortlaut des EPAR für TRISENOX finden Sie hier.","The full EPAR for TRISENOX is available here.",8,10
"981","de","en","Den vollständigen Wortlaut des EPAR für Visudyne finden Sie hier.","The full EPAR for Visudyne is available here.",8,10
"982","de","en","Den vollständigen Wortlaut des EPAR für Zomarist finden Sie hier.","The full EPAR for Zomarist can be found here.",9,10
"983","de","en","Den Vorgang abbrechen und Spritze und Nadel verwerfen (eine neue Dosis für den Patienten vorbereiten).","Discontinue the procedure and discard the syringe and the needle (reconstitute a new dose for the patient).",17,15
"984","de","en","Den vorgefüllten Pen im Umkarton aufbewahren.","Keep the pre-filled pen in the outer carton.",8,6
"985","de","en","Den weißen Dorn des BAXJECTs II durch den Gummistopfen der ADVATE-Flasche drücken.","Insert the white plastic spike through the ADVATE stopper.",9,12
"986","de","en","Dennoch bewältigten alle davon betroffenen Arbeitsgruppen ein beachtliches Leistungspensum.","Nevertheless a significant amount was achieved by all the working parties concerned.",12,9
"987","de","en","Dennoch ist es unwahrscheinlich, dass diese Metabolite zu den klinischen Effekten beitragen.","However, a contribution of these metabolites to clinical effects is unlikely.",11,12
"988","de","en","Dennoch sollte bei jeder verabreichten Infusion das Risiko einer Überempfindlichkeitsreaktion in Betracht gezogen werden.","However, the risk of hypersensitivity reactions should be considered for every infusion administered.",13,14
"989","de","en","DepoCyte ist eine Cytarabin-Formulierung mit verzögerter Wirkstofffreisetzung, die für die direkte Anwendung in die Zerebrospinalflüssigkeit vorgesehen ist.","DepoCyte is a sustained-release formulation of cytarabine, designed for direct administration into the cerebrospinal fluid (CSF).",16,17
"990","de","en","Depression, Halluzination, Verwirrtheit, Schlafstörungen, Schläfrigkeit, Benommenheit, Drehschwindel, Tremor, Parästhesien, Unruhe","Depression, hallucination, confusion, insomnia, somnolence, drowsiness, vertigo, tremor and paresthesia, restlessness.",11,10
"991","de","en","Depressionen (siehe unter Abschnitt 4.4), Schlaflosigkeit","depression (see section 4.4), insomnia",5,6
"992","de","en","Der Abschnitt über Gegenanzeigen ist unverändert geblieben.","Section on contraindications remained unchanged.",5,7
"993","de","en","Der Alkoholgehalt in diesem Arzneimittel kann die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen beeinflussen.","The amount of alcohol in this medicinal product may impair the ability to drive or use machines.",17,16
"994","de","en","Der Anstieg korrelierte mit der Gesamt-Bilirubin-Konzentration.","The increase correlated with total bilirubin concentrations.",7,6
"995","de","en","Der Anteil von Raloxifen an der Gesamtkonzentration aus Raloxifen und seinen Glucuronidmetaboliten beträgt weniger als 1%.","Raloxifene comprises less than 1% of the combined concentrations of raloxifene and the glucuronide metabolites.",15,16
"996","de","en","Der Antikörper wird in einer Suspensionskultur aus Säugetierzellen (Ovarialzellen des chinesischen Hamsters) in einem Nährmedium hergestellt.","The antibody is produced in mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium.",16,16
"997","de","en","Der Antragsteller legte bibliographische Daten aus mehreren Studien vor.","The applicant provided bibliographical data from a number of studies.",10,9
"998","de","en","Der arzneilich wirksame Bestandteil von Nespo ist Darbepoetin alfa, das m","The active substance of Nespo is darbepoetin alfa produced by gene-technology in Chinese Hamster Ovary a",16,11
"999","de","en","Der Arzt Ihres Kindes wird Ihnen die neue Dosis des/der anderen antiepileptischen Arzneimittel mitteilen.","Your child’ s doctor will tell you the new dose of the other antiepileptic medicine(s).",15,14
"1000","de","en","Der Arzt sollte auf die jeweiligen Fachinformationen für diese Präparate zurückgreifen.","Physicians should refer to the individual summary of product characteristics of these medicinal products.",14,11
"1001","de","en","Der Ausschlag ist gewöhnlich schwach bis mäßig.","The rash is usually mild to moderate.",7,7
"1002","de","en","Der Ausschuss empfahl die Genehmigung für das Inverkehrbringen von Helicobacter Test INFAI zu erteilen.","The Committee recommended that Helicobacter Test INFAI be given marketing authorisation.",11,14
"1003","de","en","Der Ausschuss empfahl, die Genehmigung für das Inverkehrbringen von SOMAVERT zu erteilen.","The Committee recommended that SOMAVERT be given marketing authorisation.",9,12
"1004","de","en","Der Ausschuss empfahl, die Genehmigung für das Inverkehrbringen von Ziagen zu erteilen.","The Committee recommended that Ziagen be given marketing authorisation.",9,12
"1005","de","en","Der Ausschuss stellte fest, dass Cystadane kein Ersatz für andere Behandlungen ist.","The committee noted that Cystadane is not a substitute for other treatments.",12,12
"1006","de","en","Der Begründung für das Nicht-Aufnehmen der Braille-Schrift wird zugestimmt","Justification for not including Braille accepted",6,9
"1007","de","en","Der behandelnde Arzt wird TachoSil während der Operation anwenden.","The doctor treating you will administer TachoSil during surgery.",9,9
"1008","de","en","Der Behandlungseffekt von Icatibant wurde durch die sekundären Wirksamkeitsendpunkte bestätigt.","The treatment effect of icatibant was confirmed by secondary efficacy endpoints.",11,10
"1009","de","en","Der Betätiger wird am Luer-Lock-Anschluss des Implantatinjektors befestigt.","The actuator is attached to the implanter using the Luer Lock connection.",12,8
"1010","de","en","Der CHMP ernannte Dr.","The CHMP appointed Dr.",4,4
"1011","de","en","Der CPMP forderte außerdem, dass:","- Prescriptions of isotretinoin for women of childbearing potential should be limited to 30 days of",16,5
"1012","de","en","Der CVMP kam zu dem Schluss, dass die Nutzen-Risiko-Bewertung für Bovilis BVD günstig ist.","The CVMP concluded that the benefit - risk assessment for Bovilis BVD was favourable.",14,14
"1013","de","en","Der Dosierring kann nur in eine Richtung gedreht werden.","The dosage selector will only turn in one direction.",9,9
"1014","de","en","Der Dosierring kann nur vorwärts gedreht werden.","The d osage selector can only be turned forward.",9,7
"1015","de","en","Der Dosierungs- und Anwendungsplan für NutropinAq sollte für jeden Patienten individuell erstellt werden.","The NutropinAq dosage and administration schedule should be individualised for each patient.",12,13
"1016","de","en","Der Einfluss einer Langzeitbehandlung mit Humira auf die Entwicklung von Autoimmunerkrankungen ist nicht bekannt.","The impact of long- term treatment with Humira on the development of autoimmune diseases is unknown.",16,14
"1017","de","en","Der Entwurf des Anfangshaushalts für 1997 über 28,2 Millionen ECU wurde am 4.","The initial draft budget for 1997 of ECU 28.2 million was adopted on 4 December 1996.",16,13
"1018","de","en","Der Fertigpen darf nicht geschüttelt werden.","Do not shake the pre-filled pen. lo",7,6
"1019","de","en","Der Filmüberzug der VIAGRA-Tablette enthält Lactose.","The film coating of the VIAGRA tablet contains lactose.",9,6
"1020","de","en","Der Filter kann gelegentlich während der Infusion verstopfen und muss dann durch einen neuen ersetzt werden.","If there is evidence of filter clogging, the filter must be replaced.",12,16
"1021","de","en","Der Gebrauch von Lebendimpfstoffen sollte deshalb während einer Behandlung mit Rapamune vermieden werden.","The use of live vaccines should be avoided during treatment with Rapamune.",12,13
"1022","de","en","Der gesamte Inhalt der Durchstechflasche sollte für eine einmalige Anwendung aufgezogen werden.","The entire contents of the vial should be withdrawn for a single administration.",13,12
"1023","de","en","Der gesamte Inhalt der Fertigspritze wird in das Fläschchen mit dem Pulver injiziert.","Inject the entire content of the pre-filled syringe into the vial containing the powder.",14,13
"1024","de","en","Der getränkte Schwamm kann dann da eingesetzt werden, wo Knochenwachstum erwünscht ist.","The soaked sponge may then be placed where bone growth is desired.",12,12
"1025","de","en","Der Gichtanfall sollte mit einer individuell auf den Patienten zugeschnittenen Begleittherapie behandelt werden.","The gout flare should be managed concurrently as appropriate for the individual patient.",13,13
"1026","de","en","Der größte Anstieg trat bei der absoluten Anzahl der zirkulierenden Lymphozyten auf.","The largest increase occurred in the absolute count of circulating lymphocytes.",11,12
"1027","de","en","Der Grund für diese längere Halbwertszeit ist unbekannt.","The reason for this longer half-life is unknown.",8,8
"1028","de","en","Der Hämoglobinwert ist jede Woche oder alle zwei Wochen zu überprüfen, bis er stabil ist.","er The haemoglobin should be measured every one or two weeks until it is stable.",15,15
"1029","de","en","Der Hauptindikator für die Wirksamkeit war die Bildung von schutzwirksamen Antikörpern bei den Kindern.","The main measure of effectiveness was the production of protective antibodies in the infants.",14,14
"1030","de","en","Der Hauptmetabolit Desloratadin (DL) ist pharmakologisch wirksam und zum großen Teil für die klinische Wirkung verantwortlich.","The major metabolite-desloratadine (DL) is pharmacologically active and responsible for a large part of the clinical effect.",17,16
"1031","de","en","Der Hauptmetabolit ist das 10-N-Glukuronid, das die Bluthirnschranke nicht passiert.","The major circulating metabolite is the 1 0-N-glucuronide, which does not pass the blood brain barrier.",16,10
"1032","de","en","Der Hauptvorteil lag in der Wirkung auf den Blutkreatininspiegel.","The main benefit was on the effect on blood creatinine levels.",11,9
"1033","de","en","Der Hersteller von FOSAVANCE hat zugestimmt, dass die wissenschaftlichen Daten dieses Produkts auch für ADROVANCE verwendet werden können.","The company that makes FOSAVANCE has agreed that its scientific data can be used for ADROVANCE.",16,18
"1034","de","en","Der ideale Abstand zwischen der Düse und der Gewebeoberfläche beträgt 10 bis 15 cm.","The distance between the nozzle and the tissue surface should ideally be 10 to 15 cm.",16,14
"1035","de","en","Der IgA-Gehalt beträgt maximal 0,025 mg/ml (durchschnittlich 0,0027 mg/ml).","The maximum IgA content is 0.025 mg/ ml (average of 0.0027 mg/ ml).",13,9
"1036","de","en","Der Impfstoff darf Kindern vor Vollendung des 6.","The vaccine must not be given to children less than 6 months old (see section 4.3).",16,8
"1037","de","en","Der Impfstoff darf nicht mit anderen Impfstoffen oder Lösungen in derselben Spritze gemischt werden.","The vaccine should not be mixed in the same syringe with any other vaccines and solutions.",16,14
"1038","de","en","Der Impfstoff IDflu kann stillenden Frauen verabreicht werden.","The vaccine IDflu may be used during breast-feeding.",8,8
"1039","de","en","Der Impfstoff ist nur auf ärztliche Verschreibung erhältlich.","The vaccine can only be obtained with a prescription.",9,8
"1040","de","en","Der Impfstoff kann bei Tieren während der Legeperiode und bei Zuchttieren sicher angewendet werden.","The vaccine is safe for use in laying and breeding birds.",11,14
"1041","de","en","Der Impfstoff wird gemäß den offiziellen Empfehlungen verabreicht.","The vaccine is given according to official recommendations.",8,8
"1042","de","en","Der individuelle Wert der scheinbaren oralen Clearance lag bei Kindern im gleichen Bereich wie bei Erwachsenen.","Individual CL/ F in the paediatric population was in the same range as individual adult data.",16,16
"1043","de","en","Der Inhaber der Genehmigung für das Inverkehrbringen ist das Unternehmen Pfizer Limited.","The marketing authorisation holder is Pfizer Limited.",7,12
"1044","de","en","Der Inhaber der Genehmigung für das Inverkehrbringen legte am 16.","The Marketing Authorisation Holder provided supplementary information on 16 October 2007.",11,10
"1045","de","en","Der Inhaber der Genehmigung für das Inverkehrbringen legte am 25.","The Marketing Authorisation Holder provided written explanations on 25 May 2007.",11,10
"1046","de","en","Der Inhaber der Genehmigung für das Inverkehrbringen wurde aufgefordert, die folgenden Fragen zu beantworten:","The MAH was requested to reply to the following Questions:",10,14
"1047","de","en","Der Inhaber der Zulassung verpflichtet sich, die im Pharmakovigilanzplan angeführten Studien und zusätzliche Pharmakovigilanz-Aktivitäten durchzuführen.","The MAH commits to performing the studies and additional pharmacovigilance activities detailed in the Pharmacovigilance Plan.",16,15
"1048","de","en","Der Inhalt der Durchstechflasche wird einem Infusionsbeutel mit Natriumchlorid oder Glukoselösung zugesetzt.","The vial contents are added to a sodium chloride or glucose solution contained in a drip bag.",17,12
"1049","de","en","Der Injektionsknopf sollte vor Wiederverwendung des Fertigpens vollständig heruntergedrückt sein.","The injection button should be fully depressed before using the pen again.",12,10
"1050","de","en","Der Insulinbedarf kann sich während einer Krankheit oder bei seelischer Belastung verändern.","Insulin requirements may be altered during illness or emotional disturbances.",10,12
"1051","de","en","Der Karton enthält eine oder 4 Durchstechflasche(n) mit entweder 250 Mikrogramm oder 500 Mikrogramm Romiplostim.","Carton containing 1 or 4 vials of either 250 micrograms or 500 micrograms of romiplostim.",15,15
"1052","de","en","Der Konsum von Alkohol ist vor, während und nach der Einnahme von Circadin zu vermeiden.","Patients should avoid alcohol before, during and after taking Circadin.",10,15
"1053","de","en","Der Kontakt mit dem Fentanyl-Hydrogel kann für Menschen schädlich sein.","Contact with the fentanyl hydrogel can be harmful to humans.",10,10
"1054","de","en","Der Körper kann dieses Nahrungsfett weder zur Energiegewinnung nutzen noch in Fettgewebe umwandeln.","The body cannot use this dietary fat for energy or convert it into fat tissue.",15,13
"1055","de","en","Der KwikPen ist gemäß den Vorschriften der Bedie- nungsanleitung zu benutzen.","The KwikPen has to be used as recommended in the user manual.",12,11
"1056","de","en","Der letzte Wortlaut in Abschnitt 4.8.","The final wording of section 4.8.",6,6
"1057","de","en","Der Mechanismus dieser Wechselwirkung ist nicht vollständig geklärt.","The mechanism of the interaction has not been completely clarified.",10,8
"1058","de","en","Der Messbecher ist mit einer Stricheinteilung versehen, und jeder Strich entspricht einem ml Lösung.","The cup has lines to indicate each ml of solution.",10,14
"1059","de","en","Der Metabolismus von Celecoxib wird hauptsächlich durch Cytochrom P 450 CYP 2C9 katalysiert.","Celecoxib metabolism is primarily mediated via cytochrome P450 2C9.",9,13
"1060","de","en","Der Name Ihrer Tablette ist Velmetia.","The name of your tablet is Velmetia.",7,6
"1061","de","en","Der Nutzen einer erneuten Enbrel-Behandlung bei Patienten, die ursprünglich auf die Behandlung angesprochen hatten, konnte belegt werden.","There was some evidence to support a benefit of re-treatment with Enbrel in patients initially responding to treatment.",18,17
"1062","de","en","Der Nutzen war in erster Linie durch eine signifikante Herabsetzung der nicht tödlichen MI gegeben (siehe Tabelle 3).","The benefit was primarily due to a significant decrease in non-fatal MI (see table 3).",15,18
"1063","de","en","Der Patient bleibt gewöhnlich bei Bewusstsein und es kommt nicht zur Atemdepression.","The patient usually remains conscious and breathing is not depressed.",10,12
"1064","de","en","Der Patient sollte zu Beginn der Behandlung hierüber informiert werden.","The patient should be informed about this at the start of the treatment.",13,10
"1065","de","en","Der pH-Wert wird, sofern erforderlich, mit Natriumhydroxid und/oder Salzsäure eingestellt.","The pH may have been adjusted with sodium hydroxide and/ or hydrochloric acid.",13,10
"1066","de","en","Der Plasmaspiegel von Efavirenz kann durch die gleichzeitige Anwendung von Johanniskraut verringert werden.","Plasma levels of efavirenz can be reduced by concomitant use of St.",12,13
"1067","de","en","Der potentielle negative Einfluss einer Dosisreduktion von Ribavirin auf die Wirksamkeit konnte nicht ausgeschlossen werden.","The potential negative impact of ribavirin dose reduction on efficacy results could not be ruled out.",16,15
"1068","de","en","Der primäre Endpunkt war das progressionsfreie Überleben (PFS = Progression Free Survival).","The primary endpoint was progression-free survival (PFS).",7,12
"1069","de","en","Der primäre Wirksamkeitsendpunkt war die Änderungsrate der Urinalbuminexkretionsrate (AER) nach 24 Monaten.","The primary efficacy endpoint was the rate of change in urinary albumin excretion rate (AER) at 24 months.",18,12
"1070","de","en","Der Progesteronspiegel wurde bei gleichzeitiger Anwendung der Arzneimittel nicht beeinflusst.","Progesterone concentrations were not affected when the medicinal products were co-administered.",11,10
"1071","de","en","Der ra- sche Wirkeintritt von Liprolog im Vergleich mit Normalinsulin ist unabhängig vom Injektionsort.","The faster onset of action compared to soluble human insulin is maintained regardless of injection site.",16,14
"1072","de","en","Der Rückgang bei Patienten unter Tolterodin betrug 1,69.","The decrease seen in patients who received tolterodine was 1.69.",10,8
"1073","de","en","Der Säuremetabolit ist ein stark wirksamer Cyclooxygenase-Hemmer und verlängert die Wirksamkeit der Muttersubstanz.","The acid metabolite is a potent, active cyclooxygenase inhibitor and prolongs the activity of the parent compound.",17,13
"1074","de","en","Der Steady-State wird im Allgemeinen nach 4-tägiger wiederholter Einnahme erreicht.","Steady-state is generally achieved following 4 days of repeat dosing.",10,10
"1075","de","en","Der Tod tritt als Folge von Anoxie durch erhöhte Methämoglobinkonzentrationen auf.","Deaths are secondary to anoxia resulting from elevated methaemoglobin levels.",10,11
"1076","de","en","Der Toxizitätsgrad in diesen Tabellen basiert auf den allgemeinen Toxizitätskriterien des National Cancer Institute (NCI-CTC).","The toxicity grading in these tables is based on the National Cancer Institute Common Toxicity Criteria (NCI-CTC).",17,15
"1077","de","en","Der Wirkmechanismus ist unklar.","The mode of action is unclear.",6,4
"1078","de","en","Der wirksame Bestandteil von Amlovita Tabletten, das Dihydropyridin-Derivat Amlodipin, ist eine chirale Substanz und liegt als Razemat vor.","No metabolic effects, e. g. on plasma lipids or glucose metabolism, have been seen during treatment with amlodipine.",18,18
"1079","de","en","Der Wirkstoff in Abilify, Aripiprazol, ist ein sogenanntes Antipsychotikum.","The active substance in Abilify, aripiprazole, is an antipsychotic medicine.",10,9
"1080","de","en","Der Wirkstoff in Bondronat, Ibandronsäure, ist ein Bisphosphonat.","The active substance in Bondronat, ibandronic acid, is a bisphosphonate.",10,8
"1081","de","en","Der Wirkstoff ist Ciprofloxacin.","The active substance is ciprofloxacin.",5,4
"1082","de","en","Der Wirkstoff ist Interferon beta-1b, 2 50 Mikrogramm je Milliliter, nach Zubereitung der Lösung.","The active substance is Interferon beta-1b, 250 microgram per millilitre when reconstituted.",12,14
"1083","de","en","Der Wirkstoff ist Pramipexol.","What SIFROL contains The active substance is pramipexole.",8,4
"1084","de","en","Der Wirkstoff ist Risperidon.","The active substance is risperidone",5,4
"1085","de","en","Der Wirkstoff von Lucentis ist Ranibizumab.","The active substance in Lucentis is ranibizumab.",7,6
"1086","de","en","Der Wirkstoff von ZIMULTI ist Rimonabant.","The active ingredient of ZIMULTI is rimonabant.",7,6
"1087","de","en","Der Wirkungsmechanismus von Glucosamin beim Menschen ist nicht bekannt.","The mechanism of action of glucosamine in humans is unknown.",10,9
"1088","de","en","der Xeloda Anfangsdosis auf 800 mg/m2 zweimal täglich empfohlen.","Xeloda to 800 mg/ m2 twice daily is recommended.",9,9
"1089","de","en","Der Zeitraum zwischen zwei Behandlungsintervallen soll mindestens 10 Wochen betragen.","The period between each treatment session should be at least 10 weeks.",12,10
"1090","de","en","Derartige Veränderungen können nach Abbruch der Bortezomib-Gabe reversibel sein (siehe Abschnitt 4.8).","Such changes may be reversible upon discontinuation of bortezomib (see section 4.8).",12,12
"1091","de","en","Dermatitis (einschließlich Kontaktdermatitis, atopischer Dermatitis und Windeldermatitis), Miliaria, rötelnartiger Ausschlag*, Urtikaria, virales Exanthem, Ekzema, Erythem Selten:","Uncommon: dermatitis (including contact, atopic, and diaper rash), heat rash, rubella-like rash ‡, urticaria, viral exanthema, eczema, erythema.",18,16
"1092","de","en","derselben mit jeder Durchstechflasche mitgelieferten Silikon-freien Einmalspritze dem Infusionsbeutel bzw. der Infusionsflasche zu.","the same silicone-free disposable syringe provided with each vial.",9,13
"1093","de","en","Derzeit verfügbare Daten von Schwangeren zeigen keine zu Missbildungen führende oder den Fetus / das Neugeborene betreffende Toxizität.","Currently available data on pregnant women indicate no malformative or foeto/ neonatal toxicity.",13,18
"1094","de","en","Des Weiteren wurden re-transplantierte Empfänger eingeschlossen, deren vorheriges Transplantat mindestens 6 Monate nach der Transplantation überlebt hatte.","In addition, re-transplant recipients whose previous grafts survived for at least 6 months after transplantation were included.",17,17
"1095","de","en","Deshalb ist Lisonorm in der Schwangerschaft kontraindiziert (siehe Abschnitt 4.3).","Consequently, Lisonorm is contraindicated in pregnancy (see section 4.3).",9,10
"1096","de","en","Deshalb kann die Erfahrung mit diesem Impfstoff zugrunde gelegt werden.","5 and rubella vaccine manufactured by Merck & Co., Inc., experience with this vaccine can be considered.",17,10
"1097","de","en","Deshalb kann die Relevanz der bibliografischen Daten von Eqvalan für das Prüfarzneimittel nicht bestätigt werden.","Therefore, the relevance of the bibliographical data regarding Eqvalan to the test product cannot be confirmed.",16,15
"1098","de","en","Deshalb müssen die oben genannten Studien sowohl an Jungtieren als auch an ausgewachsenen Tieren durchgeführt werden.","Therefore, the above-mentioned studies must be performed in both young and adult animals.",13,16
"1099","de","en","Deshalb sollte vor der Anwendung von Advocate der Hinweis unter Abschnitt 4.5 beachtet werden.","Therefore prior to treatment with Advocate, the advice provided in section 4.5. should be considered.",15,14
"1100","de","en","Deshalb weist das Kombinationspräparat Terfenadin-Pseudoephedrin ein unannehmbares Nutzen- Risiko-Verhältnis auf.","Therefore the combination product of terfenadine-pseudoephedrine has an unacceptable risk/ benefit balance.",12,10
"1101","de","en","Deshalb wird das zeitliche Wirkprofil eines Insulinpräparats ausschließlich von seinen Resorptionseigenschaften bestimmt.","Consequently, the time-action profile of an insulin preparation is determined solely by its absorption characteristics. rod",16,12
"1102","de","en","Deshalb wird empfohlen, während der Behandlung nicht zu stillen (siehe 4.4).","Therefore, breast-feeding is not recommended during treatment.",7,11
"1103","de","en","Deshalb wurde die Niere als das bestimmende Gewebe für die Wartezeit betrachtet.","Therefore kidney was considered the tissue determining the withdrawal period.",10,12
"1104","de","en","Desirudin ist ein rekombinantes DNS-Produkt, das aus Hefezellen hergestellt wird.","Desirudin is a recombinant DNA product derived from yeast cells.",10,10
"1105","de","en","Desoypyridinolin-Werte im Harn, überwacht werden.","The dose may be reduced after the condition of the patient has improved.",13,5
"1106","de","en","Detaillierte Angaben zu diesem Tierarzneimittel finden Sie auf der Website der Europäischen Arzneimittel-Agentur (EMEA) unter http://www.emea.europa.eu.","Detailed information on this product is available on the website of the European Medicines Agency (EMEA) http://www.emea.europa.eu.",17,16
"1107","de","en","Deutschland ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64","Deutschland ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64",13,13
"1108","de","en","Deutschland MSD SHARP & DOHME GMBH Tel: +49 (0) 89 4561 2612 Infocenter@msd.de","112 Deutschland MSD SHARP & DOHME GMBH Tel: +49 (0) 89 4561 2612 Infocenter@msd. de",15,13
"1109","de","en","Deutschland Mylan dura GmbH Tel: + 49-(0) 6151 9512 0","Deutschland Mylan dura GmbH Tel: + 49-(0) 6151 9512 0",10,10
"1110","de","en","Deutschland Pfizer Pharma GmbH Tel: +49 (0)30 550055-51000","Deutschland Pfizer Pharma GmbH Tel: +49 30 550055-51000.",8,8
"1111","de","en","Deutschland UCB GmbH Tel: + 49 / (0) 2173 48 4847","Deutschland UCB GmbH Tel: + 49 / (0) 2173 48 4847",11,11
"1112","de","en","Dexamethason wurde 30 Minuten vor Beginn der Chemotherapie an Tag 1 gegeben.","Dexamethasone was administered 30 minutes prior to chemotherapy treatment on Day 1.",12,12
"1113","de","en","DHT = Dihydrotestosteron, SHBG = Sexualhormon-bindendes Globulin SEM = Standardfehler des Mittelwerts","DHT = dihydrotestosterone, SHBG = sex hormone binding globulin SEM = Standard Error of the Mean",16,12
"1114","de","en","Diabetes mellitus mit oder ohne Beteiligung der Gefäße","Diabetes mellitus with or without vascular involvement",7,8
"1115","de","en","Diabetiker REYATAZ Pulver zum Einnehmen enthält 7,3 g Saccharose pro 300 mg Tagesdosis.","Diabetics REYATAZ oral powder contains 7.3 g sucrose per 300 mg daily dose.",13,13
"1116","de","en","Diagnose einer Laktatazidose Die Laktatazidose ist gekennzeichnet durch eine azidotische Dyspnoe, Abdominalbeschwerden und Hypothermie, gefolgt von Koma.","Diagnosis of lactic acidosis Lactic acidosis is characterised by acidotic dyspnoea, abdominal pain and hypothermia followed by coma.",18,17
"1117","de","en","Diarrhö, Erbrechen, Bauchschmerzen, Übelkeit, Bauchaufblähungen, Flatulenz","Common: diarrhoea, vomiting, abdominal pain, nausea, abdominal distension, flatulence",9,6
"1118","de","en","Diazepine, Oxazepine und Thiazepine, ATC Code:","Diazepines, oxazepines and thiazepines, ATC code:",6,6
"1119","de","en","Dicural überzogene Tabletten bestehen aus einem Kern, der Difloxacinhydrochlorid enthält, und einem sehr schmackhaften Überzug.","Dicural Coated Tablets consist of a core tablet containing difloxacin hydrochloride and a highly palatable coating.",16,15
"1120","de","en","Didier TABUTEAU Jacques BOISSEAU","Didier TABUTEAU Jacques BOISSEAU",4,4
"1121","de","en","Die „Post-Marketing Surveillance“ läuft so lange bis 40 Patienten eingeschlossen wurden.","This post-marketing surveillance will run up until such time as 40 patients are enrolled.",14,11
"1122","de","en","Die < Cozaar > 50 mg Tabletten können auch Carnaubawachs (E903), Titandioxid (E 171) enthalten.","The Cozaar 50 mg tablets also may contain Carnauba wax (E903), Titanium dioxide (E171).",14,15
"1123","de","en","Die 125 mg Kapsel enthält außerdem rotes Eisen(III)-oxid (E 172) und gelbes Eisenoxydhydrat x H2O (E 172).","The capsule shell may also contain sodium laurilsulfate and silica colloidal anhydrous.",12,17
"1124","de","en","Die 2001 von der EMEA begonnene Initiative zur Durchführung von Schulungen für Gutachter","Sessions were organised on IT aspects including preparation for the electronic submission of applications using the new",17,13
"1125","de","en","Die 3 ml Patrone darf nur mit einem 3 ml Pen verwendet werden.","The 3 ml cartridge is only for use in 3ml pens.",11,13
"1126","de","en","Die 5 mg Azomyr Schmelztablette ist hellrot, gesprenkelt, rund und auf einer Seite gekennzeichnet mit „ A“.","Azomyr 5 mg orodispersible tablet is light red, speckled, and round with “ A” branded on one side.",18,17
"1127","de","en","Die 50 mg und 150 mg Weichkapseln haben Bioäquivalenz gezeigt.","The 50 mg and 150 mg capsules have been shown to be bioequivalent.",13,10
"1128","de","en","Die absolute Bioverfügbarkeit beträgt 85%.","The absolute bioavailability is 85%.",5,5
"1129","de","en","Die absolute Bioverfügbarkeit von Raltegravir wurde nicht bestimmt.","The absolute bioavailability of raltegravir has not been established.",9,8
"1130","de","en","Die absolute orale Bioverfügbarkeit im Vergleich zu einer i.v.-Applikation wurde nicht untersucht.","Absolute oral bioavailability relative to intravenous",6,12
"1131","de","en","Die Absorption von Mycophenolat- mofetil ging bei gleichzeitiger Verabreichung mit Antazida zurück.","Antacids with magnesium and aluminium hydroxides: absorption of mycophenolate mofetil was decreased when administered with antacids.",16,12
"1132","de","en","Die Ad-hoc-Gruppe der GMP-Inspektionsdienste tritt im Jahr 2003 viermal zusammen.","Chapter 1 EMEA in the European system",7,10
"1133","de","en","Die Adalimumab-Konzentrationen in der Synovialflüssigkeit mehrerer Ar","Adalimumab concentrations in the synovial fluid from several lP",9,7
"1134","de","en","Die Aktivität der Osteoklasten wird gehemmt, Rekrutierung und Anbindung der Osteoklasten sind jedoch nicht betroffen.","Activity of osteoclasts is inhibited, but recruitment or attachment of osteoclasts is not affected.",14,15
"1135","de","en","Die Albuminbindung ist von der Konzentration der Substanz unabhängig (10 – 100 µg/ml).","Binding to albumin is independent of micafungin concentration (10-100 µg/ml).",10,13
"1136","de","en","Die am häufigsten gemeldeten invasiven Pilzinfektionen waren","The most commonly reported invasive fungal infections were Pneumocystis and Aspergillus.",11,7
"1137","de","en","Die am häufigsten gemeldeten Nebenwirkungen unter der Lacosamid-Therapie waren Schwindelgefühl, Kopfschmerzen, Übelkeit und Diplopie.","The most frequently reported adverse reactions with lacosamide treatment were dizziness, headache, nausea and diplopia.",15,14
"1138","de","en","Die Analyse zur Populationspharmakokinetik zeigte keine Auswirkung der Zugehörigkeit zu einer ethnischen Gruppe auf die Pharmakokinetik von Entecavir.","Race: the population pharmacokinetic analysis did not identify race as significantly influencing entecavir pharmacokinetics.",14,18
"1139","de","en","Die anderen Schichten der Retina waren nicht betroffen.","The other layers of retina were not affected.",8,8
"1140","de","en","Die Anfangs- und Erhaltungsdosis muss konservativ und sorgfältig eingestellt werden (siehe Abschnitt 4.2).","The initial and maintenance dosages should be conservative (see section 4.2).",11,13
"1141","de","en","Die Anfangsdosis beträgt 3 x 20 I.E./kg Körpergewicht und Woche.","The dosage may be increased every 4",7,10
"1142","de","en","Die Anfragen sind entweder schriftlich an die EMEA zu richten oder an folgende E-Mail-Adressen zu senden:","Requests may be made either in writing to the EMEA or sent to the following e-mail addresses:",17,16
"1143","de","en","Die angewendeten Maßnahmen sind bei nicht behüllten Viren, wie dem Parvovirus B19, möglicherweise von begrenzter Wirksamkeit.","The measures taken may be of limited value against non-enveloped viruses such as parvovirus B19.",15,16
"1144","de","en","Die Anleitung erfolgt im Folgenden separat für erwachsene und pädiatrische Patienten.","Guidance is given separately for adult and paediatric patients.",9,11
"1145","de","en","Die Anleitung ist in folgende wesentliche Schritte gegliedert:","The instructions include the following main steps:",7,8
"1146","de","en","Die antimikrobielle Wirksamkeit von Tylvalosin gegen krankheitserregende Bakterien bei Schweinen wurde in mikrobiologischen Laboratorien untersucht.","The antimicrobial effectiveness of tylvalosin against bacteria causing diseases was investigated in microbiological laboratories.",14,15
"1147","de","en","Die antiretrovirale Kombinationstherapie wurde mit Stoffwechselstörungen assoziiert, wie Hypertriglyzeridämie, Hypercholesterinämie, Insulinresistenz, Hyperglykämie und Hyperlaktazidämie (siehe Abschnitt 4.4).","The frequency of this is unknown (see section 4.4).",9,17
"1148","de","en","Die Anwendung anderer Azole war assoziiert mit einer Erhöhung der Digoxinwerte.","Administration of other azoles has been associated with increases in digoxin levels.",12,11
"1149","de","en","Die Anwendung bei dehydrierten, hypovolämischen oder hypotensiven Tieren sollte aufgrund des nierentoxischen Potenzials vermieden werden.","Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity.",18,15
"1150","de","en","Die Anwendung höherer Dosen als 1,95 g/m2/Tag wird nicht empfohlen (vergl.","The maximum dose of CYSTAGON used in clinical trials was 1.95 g/ m2/ day.",14,11
"1151","de","en","Die Anwendung von {(Name (Phantasiebezeichnung)} unter Okklusion wurde an Patienten nicht untersucht.","The use of < Invented Name > under occlusion has not been studied in patients.",15,12
"1152","de","en","Die Anwendung von Arzneimitteln zur Thromboseprophylaxe, wie niedermolekulare Heparine oder Warfarin, sollte empfohlen werden.","Prophylactic antithrombotic medicinal products, such as low molecular weight heparins or warfarin, should be recommended.",15,14
"1153","de","en","Die Anwendung von Cyanokit kann die Beurteilung von Verbrennungen erschweren und die Ergebnisse von Labortests verfälschen.","The use of Cyanokit can interfere with the assessment of burns and with laboratory test results.",16,16
"1154","de","en","Die Anwendung von Galvus bei Kindern und Jugendlichen wird nicht empfohlen.","The use of Galvus in children and adolescents is not recommended.",11,11
"1155","de","en","Die Anwendung von Interferonen kann zu Abweichungen in den Laborparametern führen.","Laboratory abnormalities are associated with the use of interferons.",9,11
"1156","de","en","Die Anwendung von Luminity bei diesen Patienten darf nur nach sorgfältiger Nutzen- Risiko-Abwägung erfolgen.","Caution should be exercised when considering the administration of Luminity to these patients.",13,14
"1157","de","en","Die Anwendung von Orlistat kann bei Patienten, die an einer chronischen Nierenerkrankung leiden, mit Nierensteinen verbunden sein.","The use of orlistat may be associated with renal stones in patients suffering from chronic kidney disease.",17,17
"1158","de","en","Die Anwendung von Pradaxa bei dieser Patientengruppe wird daher nicht empfohlen (siehe Abschnitte 4.4 und 5.2).","Therefore the use of Pradaxa is not recommended in this population (see sections 4.4 and 5.2).",16,16
"1159","de","en","Die Anwendung von Pramipexol kann mit einer Störung der Libido (Zunahme [0,1%] oder Abnahme [0,4%]) verbunden sein.","Pramipexole may be associated with libido disorders (increased (0.1%) or decreased (0.4%)).",12,17
"1160","de","en","Die Anwendung von Rasagilin bei Patienten mit mittelschwerer Leberinsuffizienz sollte vermieden werden.","Rasagiline use in patients with moderate hepatic impairment should be avoided.",11,12
"1161","de","en","Die Anwendung von Rasilez bei Kindern und Jugendlichen wird nicht empfohlen.","The use of Rasilez in children and adolescents is not recommended.",11,11
"1162","de","en","Die Anwendung von Simulect sollte unter qualifizierter medizinischer Aufsicht erfolgen.","It should be given under qualified medical supervision.",8,10
"1163","de","en","Die Anwendung von Viani Diskus sollte währenddessen fortgeführt werden.","Symptomatic candidiasis can be treated with topical anti- fungal therapy whilst still continuing with the Viani Diskus.",17,9
"1164","de","en","Die Anzeichen und Symptome dauerten im Allgemeinen bis zu 7 Tage an.","The signs and symptoms generally lasted equal to or less than 7 days.",13,12
"1165","de","en","Die Arbeitsgruppe Wirksamkeit erarbeitete","The EWP initiated or is revising existing guidance concerning the treatment of obesity, hypertension, Safety Working Party (SWP)",18,4
"1166","de","en","Die Arzneimitteltherapie kann gleichzeitig mit einer Diät und körperlichem Training eingeleitet werden.","Drug therapy can be initiated simultaneously with diet and exercise.",10,12
"1167","de","en","Die Ätiologie ist nicht definiert worden.","The  132 aetiology has not been defined.",8,6
"1168","de","en","Die AUC 0-12h betrug 2349±850 ng·h/ml im steady state.","The steady-state AUC0-12h was 2349±850 ng• h/ ml.",8,9
"1169","de","en","Die aus der therapeutischen Exposition resultierende Strahlendosis kann eine höhere Inzidenz von Krebserkrankungen und Mutationen zur Folge haben.","The radiation dose resulting from therapeutic exposure may result in higher incidence of cancer and mutations.",16,18
"1170","de","en","Die Ausscheidung von Daptomycin in die Milch laktierender Tiere wurde nicht untersucht.","Excretion of daptomycin into milk of lactating animals has not been studied.",12,12
"1171","de","en","Die Außenseite der Trägerschicht ist beige und trägt den Aufdruck Neupro 8 mg/24 h.","The outside is tan-coloured and is imprinted with Neupro 8 mg/24 h.",12,14
"1172","de","en","Die Auswirkungen auf den Blutdruck und den peripheren Gefäßwiderstand waren gering und klinisch nicht signifikant.","The effects on blood pressure and peripheral vascular resistance were minor and not clinically significant.",15,15
"1173","de","en","Die Auswirkungen von Volibris auf die Hodenfunktion beim Menschen und auf die männliche Fertilität sind nicht bekannt.","The effect of Volibris on human testicular function and male fertility is not known.",14,17
"1174","de","en","Die Bedeutung dieser Befunde für den Menschen ist wahrscheinlich begrenzt.","The relevance of the findings to humans is likely limited.",10,10
"1175","de","en","Die Beeinflussung der Pharmakokinetik von Methotrexat im Menschen durch Enbrel wurde nicht untersucht.","The effect of Enbrel on the human pharmacokinetics of methotrexate has not been investigated.",14,13
"1176","de","en","Die befallenen Gliedmaßen können schmerzhaft missgebildet sein.","The limbs affected by the disease may be painfully deformed.",10,7
"1177","de","en","Die behandelten Bereiche dürfen nicht mit Verbänden oder Umschlägen abgedeckt werden.","If the ointment gets on any of ic",8,11
"1178","de","en","Die Behandlung ist bei Auftreten arterieller thromboembolischer Ereignisse dauerhaft abzusetzen.","Therapy should be permanently discontinued in patients who develop arterial thromboembolic events.",12,10
"1179","de","en","Die Behandlung ist so lange fortzusetzen, wie es zur Aufrechterhaltung des therapeutischen Erfolges erforderlich ist.","Continue treatment as needed to maintain a therapeutic response.",9,15
"1180","de","en","Die Behandlung mit Bosentan war mit dosisabhängigen Erniedrigungen der Hämoglobinkonzentration assoziiert(siehe Abschnitt 4.8).","Treatment with bosentan has been associated with dose-related decreases in haemoglobin concentration (see section 4.8).",15,13
"1181","de","en","Die Behandlung mit Lucentis darf ausschließlich als intravitreale Injektion erfolgen.","Treatment with Lucentis is for intravitreal injection only.",8,10
"1182","de","en","Die Behandlung mit Nespo besteht aus zwei Pha sen, der Korrekturphase und der Erhaltungsphase.","Treatment with Nespo is divided into two stages – correction and maintenance phase.",13,14
"1183","de","en","Die Behandlung mit Nespo sollte ungefähr 4 Wochen nach Beendigung der Chemotherapie abge setzt werden.","Once the therapeutic objective for an individual patient has been achieved, the dose should be reduced ro",17,15
"1184","de","en","Die Behandlung mit Rimonabant führte zur signifikanten Reduktion des Taillenumfanges, eines charakteristischen Kennzeichens für intraabdominales Fett.","Treatment with rimonabant was associated with significant reductions in waist circumference, a known marker of intra-abdominal fat. ct",18,16
"1185","de","en","Die Behandlung mit Trudexa kann zur Bildung von Autoantikörpern führen.","Treatment with Trudexa may result in the formation of autoimmune antibodies.",11,10
"1186","de","en","Die Behandlung sollte fortgesetzt werden, bis der Patient wieder vollständig mobilisiert ist.","The treatment should be maintained until patients are fully mobilized.",10,12
"1187","de","en","Die Behandlung sollte intermittierend, kurzzeitig und nicht kontinuierlich erfolgen.","The patient or caregiver should stop using < Invented Name > when signs and symptoms resolve.",16,9
"1188","de","en","Die Behandlung sollte unbedingt mit Dicural überzogene Tabletten fortgesetzt werden (siehe Fachinformation zu diesem Produkt).","Treatment must then be continued with Dicural Coated Tablets (see that SPC).",12,15
"1189","de","en","Die Behandlung von Katzen ist auf sechs Tage begrenzt.","Treatment in cats is limited to six days.",8,9
"1190","de","en","Die Behandlung wurde in der akuten Phase nach Klinikeinweisung begonnen und über 16 Wochen durchgeführt.","Treatment was initiated during the acute phase after hospital admission and lasted for a period of 16 weeks.",18,15
"1191","de","en","Die Behandlungsdauer betrug 12 Monate.","Treatment duration was 12 months.",5,5
"1192","de","en","Die beiden arzneilich wirksamen Bestandteile in Advocate greifen an bestimmten Rezeptoren in den Parasiten an.","The two active substances in Advocate interact with receptors in the parasites.",12,15
"1193","de","en","Die beobachtete Rate von nicht-melanomartigen Hauttumoren ich","The observed rate of non- i dic",7,7
"1194","de","en","Die beobachteten Erhöhungen der Cholesterinwerte entsprachen etwa Grad 3 bis 4.","Elevations in cholesterol were of grade 3-4 intensity.",8,11
"1195","de","en","Die berichteten Nebenwirkungen sind gewöhnlich leicht und von kurzer Dauer:","The reported side effects are usually mild and of short duration:",11,10
"1196","de","en","Die beste Art, Viraferon bei dieser Indikation anzuwenden, ist die Kombination mit Ribavirin. itte","The best way to use Viraferon in this indication is in combination with ribavirin. lp",15,14
"1197","de","en","Die betroffene Körperoberfläche variierte zwischen 10-92%.","The affected BSA ranged from 10-92%.",6,6
"1198","de","en","Die Beutel unter leichtem Druck auf die Wände schütteln.","Shake the sachet applying slight pressure to the walls.",9,9
"1199","de","en","Die Bildung von Antikörpern war bei gleichzeitiger Anwendung von Humira und Methotrexat niedriger als unter Monotherapie.","Antibody formation was lower when Humira was given together with methotrexate in comparison with use as",16,16
"1200","de","en","Die Bildung von Ösophagusstenosen konnte durch die Anwendung von Steroiden weder reduziert noch eleminiert werden.","The formation of oesophageal stenosis cannot be reduced or eliminated by the use of steroids.",15,15
"1201","de","en","Die biliäre Exkretion scheint auch zur Elimination beizutragen.","Biliary excretion may also contribute to the elimination.",8,8
"1202","de","en","Die Bioverfügbarkeit einer Einzelgabe von 800 mg Indinavir betrug ungefähr 65% (90% CI, 58- 72%).","The bioavailability of a single 800– mg dose of indinavir was approximately 65% (90% CI, 58 – 72%).",18,15
"1203","de","en","Die Bioverfügbarkeit ist 65 bis 70%.","Bioavailability is 65 to 70%.",5,6
"1204","de","en","Die Blisterpackung im Umkarton aufbewahren.","Keep the blister in the outer carton.",7,5
"1205","de","en","Die calciumkanalhemmende Wirkung löst beispielsweise eine direkte Arteriendilatation mit Natrium- und Wasserretention aus.","Calcium channel blocking activity, for example elicits direct arterial dilation accompanied by sodium and water retention.",16,13
"1206","de","en","Die chemische und physikalische Stabilität der gebrauchsfertigen Zubereitung wurde für 24 Stunden bei 2 bis 8°C nachgewiesen.","Chemical and physical in-use stability has been demonstrated for 24 hours at 2 to 8°C.",15,17
"1207","de","en","Die chemische und physikalische Stabilität der rekonstituierten Lösung wurde für 4 Stunden bei einer Temperatur von 25°C nachgewiesen.","Chemical and physical in-use stability has been demonstrated for 4 hours at 25°C.",13,18
"1208","de","en","Die Cinacalcet-Plasmaspiegel können bei Rauchern aufgrund der Induktion eines durch CYP1A2 vermittelten Metabolismus erniedrigt sein.","4 Plasma levels of cinacalcet may be lower in smokers due to induction of CYP1A2-mediated metabolism.",16,15
"1209","de","en","Die Clearance kann bei Patienten mit geringer Kreatinin-Clearance herabgesetzt sein.","Clearance may be reduced in patients with low creatinine clearance.",10,10
"1210","de","en","Die co- primären Endpunkte waren Tod jeglicher Ursache bzw. das erste Auftreten eines Reinfarktes, eines Schlaganfalls oder Todes.","The co-primary endpoints were death from any cause and the first occurrence of re-infarction, stroke or death.",17,18
"1211","de","en","Die dann einsetzende Fibrinogen-Thrombin-Reaktion initiiert die letzte Phase der physiologischen Blutgerinnung.","This is followed by the fibrinogen- thrombin reaction which initiates the last phase of physiological blood coagulation.",17,11
"1212","de","en","Die Datenlage zur Wirksamkeit einer Kombination mit anderen Kortikosteroiden und 5-HT3-Antagonisten ist begrenzt.","Efficacy data on combination with other corticosteroids and 5-HT3 antagonists are limited.",12,13
"1213","de","en","Die Dauer der Behandlung hängt vom Komplikationsrisiko ab und sollte sich an den offiziellen Empfehlungen orientieren.","The duration of treatment depends on the risk of complications and official recommendations.",13,16
"1214","de","en","Die Dauer der Behandlung mit {HANDELSNAME} 80 mg wird von Ihrem Arzt bestimmt.","The duration of treatment with {PRODUCT NAME} 80 mg is determined by your doctor.",14,13
"1215","de","en","Die Dauer der Schutzwirkung betrug 5 Monate nach der Grundimmunisierung und ein Jahr nach der dritten Impfung.","The duration of protection was 5 months after primary vaccination and one year after the third vaccination.",17,17
"1216","de","en","Die Dauer von Fieber war bei Patienten nach myeloablativer Therapie mit anschließender Knochenmarktransplantation nicht reduziert.","The duration of fever was not reduced in patients undergoing myeloablative therapy followed by bone marrow transplantation.",17,15
"1217","de","en","Die Deferipron-Therapie muss von einem Arzt eingeleitet und durchgeführt werden, der Erfahrung in der Behandlung von Thalassämie-Patienten hat.","Deferiprone therapy should be initiated and maintained by a physician experienced in the treatment of patients with thalassaemia.",18,18
"1218","de","en","Die Dialysemodalitäten müssen daher möglicherweise periodisch angepasst werden, um Harnstoff, Kreatinin und Kalium im gewünschten Bereich zu behalten.","Dialysis prescriptions may have to be adjusted periodically to maintain urea, creatinine and potassium in the desired range.",18,18
"1219","de","en","die Dopamin-Agonisten und andere dopaminerge Arzneimittel einschließlich Stalevo zur Behandlung der Parkinson-Erkrankung angewendet haben, berichtet.","disease patients treated with dopamine agonists and other dopaminergic treatments such as Stalevo.",13,15
"1220","de","en","Die Dosen werden von Ihrem Arzt genau überprüft, eine Überdosierung ist daher sehr unwahrscheinlich.","These doses are carefully checked by the doctor, so an overdose is very unlikely.",14,14
"1221","de","en","Die Dosierung für Kinder und Jugendliche wird vom Arzt individuell bestimmt.","The dose for children and adolescents will be determined by the doctor.",12,11
"1222","de","en","Die Dosierung kann, wenn nötig, während der Behandlung geändert werden.","If necessary, the dose may be changed during treatment.",9,10
"1223","de","en","Die Dosierung sollte je nach Ansprechen des Blutdrucks angepasst werden.","Dosage should be adjusted according to blood pressure response.",9,10
"1224","de","en","Die Dosierung und der schützende Schwellenwert entsprachen denen in der aktuellen zentralen Zusammenfassung der Merkmale des Arzneimittels.","The dose regimen and protective threshold were consistent with the current core SPC.",13,17
"1225","de","en","Die Dosierung von BeneFIX kann sich von der von aus Plasma hergestellten Faktor IX-Produkten unterscheiden.","Dosing of BeneFIX may differ from that of plasma-derived factor IX products.",12,15
"1226","de","en","Die Dosierung von Levemir muss individuell angepasst werden.","Dosage of Levemir should be adjusted individually.",7,8
"1227","de","en","Die Dosierung von Metformin ist unverändert fortzuführen und Repaglinid gleichzeitig zu verabreichen.","In this case, the dosage of metformin should be maintained and repaglinide administered concomitantly.",14,12
"1228","de","en","Die Dosierung wird gemäß dem Ansprechen des Patienten angepasst. m","Doses are adjusted depending on the response. a",8,10
"1229","de","en","Die Dosierungsempfehlungen für GONAL-f entsprechen den für urinäres FSH gebräuchlichen Dosierungen.","72 The dosage recommendations given for GONAL-f are those in use for urinary FSH.",14,11
"1230","de","en","Die Dosis kann bei Unverträglichkeit reduziert werden (siehe Abschnitte 4.2 und 5.2).","The dose can be reduced if not tolerated (see section 4.2 and 5.2).",13,12
"1231","de","en","Die Dosis kann gegebenenfalls je nach den individuellen Erfordernissen auf maximal 90 mg einmal täglich erhöht werden.","If necessary the dosage can be increased according to individual requirements up to a maximum of 90mg once-daily.",18,17
"1232","de","en","Die Dosis sollte je nach Ansprechen des Patienten angepasst und individualisiert werden.","Dosing should be individualised and adjusted according to the patient’ s clinical response.",13,12
"1233","de","en","Die Dosis sollte über mindestens 15 Minuten infundiert werden.","The dose should be infused over at least 15 minutes.",10,9
"1234","de","en","Die Dosis von Januvia beträgt 100 mg einmal täglich.","The dose of Januvia is 100 mg once daily.",9,9
"1235","de","en","Die Dosis von TESAVEL beträgt 100 mg einmal täglich.","The dose of TESAVEL is 100 mg once daily.",9,9
"1236","de","en","Die Dosis wird je nach Ansprechen des Patienten auf die Behandlung oder auftretenden Nebenwirkungen angepasst.","The dose is adjusted depending on the patient ’ s response to treatment or side effects.",16,15
"1237","de","en","Die dritte Gruppe erhielt jede zweite Woche 40 mg Trudexa mit Placebo-Injektionen in den dazwischen liegenden Wochen.","The third group received 40 mg of Trudexa every other week with placebo injections on alternate weeks.",17,17
"1238","de","en","Die Durchführung dieser Tests sollte in Ihrem Patientenpass dokumentiert werden.","The conduct of these tests should be recorded on your Patient Alert Card.",13,10
"1239","de","en","Die durchschnittliche Exposition des aktiven 4'-Hydroxy-Lumiracoxib- Metaboliten blieb weitgehend unbeeinflusst.","Mean exposure to the active 4'-hydroxy-lumiracoxib metabolite was largely unaffected.",10,10
"1240","de","en","Die Durchstechflasche im Umkarton aufbewah- ren, um den Inhalt vor Licht zu schützen.","Keep the vial in the outer carton in order to protect from light.",13,13
"1241","de","en","Die Durchstechflasche im Umkarton aufbewahren, um den Inhalt vor Licht zu schützen.","is Protect from excessive heat and sunlight.",7,12
"1242","de","en","Die Durchstechflasche im Umkarton aufbewahren.","Keep the vial in the outer carton.",7,5
"1243","de","en","Die Durchstechflasche ist zusätzlich mit einer Schutzkappe aus Polypropylen verschlossen, die Manipulationen sofort erkennen lässt.","17 The closed vials are equipped with a tamper-evident snap-off cap which is made of polypropylene.",16,15
"1244","de","en","die Durchstechflasche mit einer vorsichtigen Drehbewegung schwenken, bis der Inhalt vollständig gelöst ist.","swirling until the contents are completely dissolved.",7,13
"1245","de","en","Die Durchstechflaschen enthalten 20 ml Clofarabin und sind in einer Schachtel verpackt.","The vials contain 20 mg of clofarabine and are packaged in a box.",13,12
"1246","de","en","Die Durchstechflaschen sind zum einmaligen Gebrauch bestimmt.","6 Vials are intended for single use only.",8,7
"1247","de","en","Die Effekte könnten aus einer Komplementaktivierung resultieren.","The effects may result from complement activation.",7,7
"1248","de","en","Die einbezogenen Patienten sollten gegenüber der Thalidomid-Historie möglichst unbefangen sein.","Patients involved should be preferably naïve to the history of thalidomide.",11,10
"1249","de","en","Die Einhaltung der Spezifikationen wird durch Tests zur Linearität, Stabilität (Referenzgas-Präzision) und zur Präzision der Messung überprüft.","The principle tests to verify the specifications are linearity, stability (reference gas precision), and precision of measurement.",17,17
"1250","de","en","Die Einleitung der Behandlung erfolgt mit Prometax 4,6 mg/24 Stunden.","Treatment is started with 4.6 mg/ 24 h.",8,10
"1251","de","en","Die einmal tägliche Anwendung von Tadalafil wurde bei Patienten mit Leberfunktionsstörung nicht untersucht.","There are no available data about the administration of once-a-day dosing of tadalafil to patients with hepatic impairment.",18,13
"1252","de","en","Die einmal tägliche Gabe von Kinzalkomb führt zu einer wirksamen und gleichmäßigen Blutdrucksenkung über den therapeutischen Dosisbereich.","Kinzalkomb once daily produces effective and smooth reductions in blood pressure across the therapeutic dose range.",16,17
"1253","de","en","Die Einnahme von Mimpara wurde bei schwangeren Frauen nicht untersucht.","Mimpara has not been tested in pregnant women.",8,10
"1254","de","en","Die Einstichstelle sollte gewechselt werden, um Beschwerden an der Injektionsstelle zu vermeiden.","Rotate the injection sites to avoid discomfort at the site of injection.",12,12
"1255","de","en","Die Eizellen werden 34 bis 35 Stunden später gewonnen.","Oocyte retrieval is performed 34-35 hours later.",7,9
"1256","de","en","Die Elimination aus dem Blut ist in 24 Stunden weitgehend abgeschlossen.","Elimination from blood is largely complete within 24 hours.",9,11
"1257","de","en","Die Eliminationshalbwertszeit des unveränderten Wirkstoffs beträgt etwa 13 Stunden.","The elimination half-life of the unchanged drug is approximately 13 hours.",11,9
"1258","de","en","Die Eliminationshalbwertszeit nimmt bei höheren Dosen nicht zu.","The elimination half-life does not increase at higher doses.",9,8
"1259","de","en","Die Eliminationshalbwertzeit (t1/2) betrug 2,75 Stunden in beiden Dosierungsgruppen..","Mean plasma elimination half-life (t1/ 2) was 2.75 hours for the two dose groups.",14,9
"1260","de","en","Die EMEA wird auch 2002 eng mit der Europäischen Arzneibuchkommission zusammenarbeiten.","The EMEA will continue to work closely with the European Pharmacopoeia in 2002.",13,11
"1261","de","en","Die Empfindlichkeit des Impfstammes gegenüber Antibiotika ist oben beschrieben.","The sensitivity of the vaccine strain to antibiotics is listed above.",11,9
"1262","de","en","Die empfohlene Anfangsdosis beträgt 100 mg, gefolgt von 50 mg alle 12 Stunden.","The recommended dose is 100 mg given initially, followed by 50 mg every 12 hours.",15,13
"1263","de","en","Die empfohlene Anfangsdosis beträgt 25 mg Risperdal Consta alle zwei Wochen.","The recommended starting dose is 25 mg Risperdal Consta every two weeks.",12,11
"1264","de","en","Die empfohlene Anfangsdosis von TOVIAZ ist eine 4 mg Tablette täglich.","The recommended starting dose of TOVIAZ is one 4 mg tablet a day.",13,11
"1265","de","en","Die empfohlene Dosis beträgt 25 mg, die einmal täglich beim Zubettgehen einzunehmen ist.","The recommended dose is 25 mg once daily taken orally at bedtime.",12,13
"1266","de","en","Die empfohlene Dosis beträgt 8 mg pro Kilogramm Körpergewicht.","The recommended dose is 8 mg per kilogram body weight.",10,9
"1267","de","en","Die empfohlene Dosis beträgt zwei Kapseln zweimal täglich.","The recommended dose is two capsules twice a day, for as long as the patient continues to benefit.",18,8
"1268","de","en","Die empfohlene Dosis von Pradaxa ist 220 mg einmal täglich, eingenommen als 2 Kapseln zu 110 mg.","The recommended dose of Pradaxa is 220 mg once daily taken as 2 capsules of 110 mg.",17,17
"1269","de","en","Die empfohlene Dosis von Valdoxan beträgt eine Tablette einmal täglich beim Zubettgehen unabhängig von den Mahlzeiten.","The recommended dose of Valdoxan is one tablet once a day, taken at bedtime with or without food.",18,16
"1270","de","en","Die empfohlene Epivir-Dosis für Patienten über 12 Jahren beträgt 300 mg täglich.","The recommended dose of Epivir for patients over 12 years of age is 300 mg daily.",16,12
"1271","de","en","Die empfohlene Erhaltungsdosis beträgt einmal täglich 20 mg.","The recommended daily dose is 20 mg once a day.",10,8
"1272","de","en","Die empfohlene Höchstdosis beträgt 10 g.","The maximum recommended dose is 10 g.",7,6
"1273","de","en","Die empfohlene Stelle für die Injektion mit dem vorgefüllten Injektor ist der obere Oberschenkelbereich. ni","The preferred injection site for using the Nespo pre-filled pen is the front of the thigh.",16,15
"1274","de","en","Die empfohlenen Dosierungen und Häufigkeiten der Dosierung sind nicht zu überschreiten.","The recommended dosages and frequencies of administration of BOTOX should not be exceeded.",13,11
"1275","de","en","Die enterohepatische Zirkulation könnte eine wichtige Rolle in der Pharmakokinetik von Isotretinoin beim Menschen spielen.","Enterohepatic circulation may play a significant role in the pharmacokinetics of isotretinoin in man.",14,15
"1276","de","en","Die Entscheidung über eine Fortsetzung des Stillens bzw.","The excretion of Botulinum Toxin Type B in milk has not been studied in animals.",15,8
"1277","de","en","Die entsprechenden Eliminationshalbwertszeiten sind 29 Stunden bei Patienten mit mittelgradiger und 72 Stunden bei Patienten mit schwerer Nierenfunktionsstörung.","Associated terminal half-life values were 29 h in moderate and 72 h in patients with severe renal impairment.",18,18
"1278","de","en","Die Entwicklung von Inhibitoren ist eine bekannte Komplikation der Hämophilie A Behandlung.","Development of inhibitors is a known complication in the treatment of haemophilia A.",13,12
"1279","de","en","Die Erbitux 5 mg/ml Infusionslösung ist wie folgt vorzubereiten:","Erbitux 5 mg/ ml must be prepared as follows:",9,9
"1280","de","en","Die Erfahrung bei akuten Herzerkrankungen ist jedoch begrenzt, daher ist Vorsicht geboten.","However, clinical experience in acute cardiac disease is limited, therefore caution is advisable.",13,12
"1281","de","en","Die Erfahrung mit Wiederholungsbehandlungen mit ATryn ist sehr eingeschränkt.","The experience from repeated treatment with ATryn is very limited.",10,9
"1282","de","en","Die Erfahrungen mit Efavirenz bei Patienten, die andere antiretrovirale Wirkstoffe der NNRTI-Klasse abgesetzt haben, sind begrenzt.","161 Experience with efavirenz in patients who discontinued other antiretroviral agents of the NNRTI class is limited.",17,16
"1283","de","en","Die Ergebnisse der bis zu 24 Monate dauernden FORSTEO- Behandlung (Median:","Results from up to 24 months (median:",7,11
"1284","de","en","Die Ergebnisse der CAPRIE- Studie zeigen, dass Phenytoin und Tolbutamid zusammen mit Clopidogrel unbedenklich gegeben werden können.","Data from the CAPRIE study indicate that phenytoin and tolbutamide can be safely co-administered with clopidogrel.",16,17
"1285","de","en","Die Ergebnisse sind in Tabelle 2 zusammengestellt.","The results are given in Table 2.",7,7
"1286","de","en","Die Ergebnisse zur Wirksamkeit aus den Studien ACTG 364 und 020 sind in Tabelle 4 dargestellt.","Efficacy results for studies ACTG 364 and 020 are found in Table 4.",13,16
"1287","de","en","Die erhöhten Insulinspiegel normalisierten sich nach Einnahme der Mahlzeit.","This resulted in a blood glucose-lowering effect throughout the meal period.",11,9
"1288","de","en","Die erste Dosis Filgrastim sollte frühestens 24 Stunden nach der zytotoxischen Chemotherapie verabreicht werden.","The first dose of filgrastim should not be administered less than 24 hours following cytotoxic chemotherapy.",16,14
"1289","de","en","Die erste Fondaparinux-Injektion darf nicht vor Ablauf von 6 Stunden nach Beendigung des chirurgischen Eingriffs gegeben werden.","The first fondaparinux administration should be given not earlier than 6 hours following surgical closure.",15,17
"1290","de","en","Die erste Gruppe erhielt über einen Zeitraum von 52 Wochen wöchentlich eine Placebo-Injektion.","The first received placebo injections every week for 52 weeks.",10,13
"1291","de","en","Die ersten Symptome eines niedrigen Blutzuckers kommen üblicherweise schnell und bestehen in: •","227 The first symptoms of low blood sugar usually come on quickly and include the following: •",17,13
"1292","de","en","Die Erwachsenendosis von 150 mg zweimal täglich sollte eingenommen werden.","For children weighing at least 30 kg: the adult dosage of 150 mg twice daily should be taken.",18,10
"1293","de","en","Die Ethinylöstradiolspiegel wurden bei gleichzeitiger Einnahme von östrogenhaltigen oralen Kontrazeptiva zusammen mit Kaletra erniedrigt.","Contraceptives: levels of ethinyl oestradiol were decreased when oestrogen-based oral contraceptives were co-administered with Kaletra.",15,14
"1294","de","en","Die fäkale Ausscheidung von Gesamt-Topotecan betrug 33%, während die fäkale Ausscheidung von N-Desmethyl-Topotecan bei 1,5% lag.","Faecal elimination of total topotecan accounted for 33% while faecal elimination of N-desmethyl topotecan was 1.5%.",16,16
"1295","de","en","Die Fertigspritzen sind applikationsfertig (siehe Abschnitt 4.2 - Hinweise zur Anwendung).","The pre-filled syringes are ready to use (see section 4.2 – Method of administration).",14,11
"1296","de","en","Die Flasche enthält 240 ml Lösung zum Einnehmen (5 mg Lamivudin/ml).","The bottle contains 240 ml of lamivudine solution (5 mg/ml).",10,11
"1297","de","en","Die Flasche fest verschlossen halten.","Keep the bottle tightly closed.",5,5
"1298","de","en","Die Flasche im Umkarton aufbewahren.","Store in a refrigerator (2 °C - 8 °C) Keep the bottle in the outer carton.",16,5
"1299","de","en","Die Flasche kann mit dem am Adapter befestigten Deckel verschlossen und so aufbewahrt werden.","VIRAMUNE oral suspension should",4,14
"1300","de","en","Die Flasche nicht länger als 6 Wochen nach dem Öffnen verwenden.","Do not use the bottle more than 6 weeks after opening.",11,11
"1301","de","en","Die folgende Tabelle enthält Richtwerte für minimale Faktor VIII-Blutspiegel.","The following table provides a guide for factor VIII minimum blood levels.",12,9
"1302","de","en","Die folgende Tabelle veranschaulicht dies:","This is seen in the following table:",7,5
"1303","de","en","Die folgenden Angaben entsprechen dem Stand der Informationen zu den einzelnen Wirkstoffen (Pioglitazon und Metformin).","The following statements reflect the information available on the individual active substances (pioglitazone and metformin).",15,15
"1304","de","en","Die folgenden Anweisungen erklären Ihnen, wie Sie Viraferon selbst injizieren.","The following instructions explain how to inject Viraferon yourself.",9,10
"1305","de","en","Die folgenden Arzneimittel können ebenfalls mit Efexor wechselwirken und sollten mit Vorsicht an- gewendet werden.","The following medicines may also interact with Efexor and should be used with caution.",14,15
"1306","de","en","Die folgenden Ausführungen betreffen die zu impfende Person, unabhängig vom Alter:","The following questions apply to the person who is to receive the vaccine regardless of age:",16,11
"1307","de","en","Die folgenden Dokumente wurden vom CPMP 1998 verabschiedet bzw. zur Stellungnahme herausgegeben:","The following documents were adopted or released by the CPMP for consultation in 1998:",14,12
"1308","de","en","Die folgenden Informationen sind nur für Ärzte bzw. medizinisches Fachpersonal bestimmt:","The following information is intended for medical or healthcare professionals only",11,11
"1309","de","en","Die folgenden Nebenwirkungen sind in placebokontrollierten Studien mitgeteilt worden:","The following side effects have been reported in placebo controlled clinical trials:",12,9
"1310","de","en","Die folgenden Nebenwirkungen wurden bei der Therapie der HIV-Erkrankung mit Epivir berichtet.","The following adverse reactions have been reported during therapy for HIV disease with Epivir.",14,12
"1311","de","en","Die folgenden Nebenwirkungen wurden nach breiter Anwendung der früheren Formulierung berichtet.","The following undesirable effects have been reported following the widespread use of the former formulation.",15,11
"1312","de","en","Die folgenden Substanzen können den Insulinbedarf des Patienten senken:","The following substances may reduce the patient’ s insulin requirements:",10,9
"1313","de","en","Die folgenden Wirkstoffe sollten nicht gleichzeitig über dasselbe Infusionsbesteck wie Tygacil verabreicht werden:","The following active substances should not be administered simultaneously through the same Y-site as Tygacil:",15,13
"1314","de","en","Die Gabe hoher Dosen führte bei Hunden und Kaninchen zum Exitus.","High rates of administration caused death in dogs and rabbits.",10,11
"1315","de","en","Die Gabe muss unter Aufsicht eines in der Anwendung von zytotoxischen Wirkstoffen erfahrenen Arztes erfolgen.","To be administered under the supervision of a physician experienced in the use of cytotoxic agents",16,15
"1316","de","en","Die gebrauchsfertige Lösung muss unverzüglich nach der Zubereitung verwendet werden.","19 The reconstituted solution should be used immediately after preparation.",10,10
"1317","de","en","Die gebrauchsfertige Lösung sollte vor der Anwendung visuell auf Partikel und Verfärbung inspiziert werden.","The reconstituted solution should be inspected visually for particulate matter and discoloration prior to administration.",15,14
"1318","de","en","Die Gebrauchsinformation wurde zuletzt genehmigt im.","This leaflet was last approv ed in.",7,6
"1319","de","en","Die Genehmigung für das Inverkehrbringen wurde am 11-2006 verlängert","The marketing authorisation was renewed on 11-2006.",7,9
"1320","de","en","Die Genehmigung für das Inverkehrbringen wurde am 2.","The marketing authorisation was renewed on 2 February 2006.",9,8
"1321","de","en","Die Genehmigung für das Inverkehrbringen wurde am 25.","The marketing authorisation was renewed on 25 May 2005.",9,8
"1322","de","en","Die Genehmigung wurde am 5.","The marketing authorisation was renewed on 5 February 2003.",9,5
"1323","de","en","Die Gesamtdosis sollte 8,7 ml pro Patient nicht überschreiten.","The total dose should not exceed 8.7 ml per patient.",10,9
"1324","de","en","Die gesamte Menge Soliris aus der(den) Durchstechflasche(n) in eine sterile Spritze aufziehen.","Withdraw the total amount of Soliris from the vial(s) using a sterile syringe.",13,12
"1325","de","en","Die Gesamtmenge des rekonstituierten Impfstoffes in eine sterile Spritze aufziehen und subkutan verabreichen.","Withdraw the entire contents of the reconstituted vaccine into a sterile syringe and administer the whole contents subcutaneously.",18,13
"1326","de","en","Die geschätzte Clearance von Anakinra nahm mit steigender Kreatinin-Clearance und zunehmendem Körpergewicht zu.","The estimated anakinra clearance increased with increasing creatinine clearance and body weight.",12,13
"1327","de","en","Die gleichzeitige Anwendung von Chinidin ist kontraindiziert (siehe Abschnitt 4.3).","The concomitant use of quinidine is contraindicated (see section 4.3).",10,10
"1328","de","en","Die gleichzeitige Anwendung von Efavirenz mit Atazanavir/Ritonavir wird nicht empfohlen.","with atazanavir/ ritonavir is not recommended.",6,10
"1329","de","en","Die gleichzeitige Anwendung von Efavirenz und Johanniskraut oder einer pflanzlichen Zubereitung von Johanniskraut ist kontraindiziert.","John’ s wort is contraindicated.",5,15
"1330","de","en","Die gleichzeitige Anwendung von Levviax und einem der folgenden Arzneistoffe ist kontraindiziert: itte","Concomitant administration of Levviax and any of the following substances is contraindicated: t uc",14,13
"1331","de","en","Die gleichzeitige Anwendung von Neulasta mit einem Chemotherapeutikum wurde bei Patienten nicht untersucht.","Concomitant use of Neulasta with any chemotherapy agent has not been evaluated in patients.",14,13
"1332","de","en","Die gleichzeitige Anwendung von NSAID und Kortikosteroiden, kann die Heilung zusätzlich verzögern.","Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems.",15,12
"1333","de","en","Die gleichzeitige Anwendung von REYATAZ /Ritonavir und Indinavir wird nicht empfohlen (siehe Abschnitt 4.4).","Coadministration of REYATAZ/ ritonavir and indinavir is not recommended (see section 4.4).",12,14
"1334","de","en","Die gleichzeitige Anwendung von Telzir mit Halofantrin oder (systemisch gegebenem) Lidocain wird nicht empfohlen (siehe Abschnitt 4.5).","The use of Telzir concomitantly with halofantrine or lidocaine (systemic) is not recommended (see section 4.5).",16,17
"1335","de","en","Die gleichzeitige Gabe von EXJADE und aluminiumhaltigen Antazida wurde nicht systematisch untersucht.","The concomitant administration of EXJADE and aluminium-containing antacid preparations has not been formally studied.",14,12
"1336","de","en","Die gleichzeitige Gabe von Rasilez hatte keinen signifikanten Einfluss auf die Pharmakokinetik von Atorvastatin, Valsartan, Metformin oder Amlodipin.","Co- administration of Rasilez had no significant impact on atorvastatin, valsartan, metformin or amlodipine pharmacokinetics.",15,18
"1337","de","en","Die gleichzeitige Verabreichung von Probenecid und Mycophenolatmofetil an Affen bewirkt einen dreifachen Anstieg der AUC von MPAG.","Other interactions: co-administration of probenecid with mycophenolate mofetil in monkeys raises plasma AUC of MPAG by 3-fold.",17,17
"1338","de","en","Die Halbwertszeit von Lapatinib nach Einmalgabe steigt mit steigender Dosis an.","The half-life of lapatinib measured after single doses increases with increasing dose.",12,11
"1339","de","en","Die Haltbarkeit von Bondronat 2 mg beträgt 5 Jahre.","The shelf-life of Bondronat 2 mg is 5 years.",9,9
"1340","de","en","Die Häufigkeit basiert auf Daten aus klinischen Studien.","The frequencies are based on clinical trial data.",8,8
"1341","de","en","Die Häufigkeit der infusionsbedingten Reaktionen war im Laufe der Zeit rückläufig.","The frequency of IARs decreased over time.",7,11
"1342","de","en","Die Häufigkeit kann aus den verfügbaren Daten nicht abgeschätzt werden ● allergische Reaktion (z.B.","Rare side effects: affect 1 to 10 users in 10,000 • Male or female breast enlargement.",16,14
"1343","de","en","Die Häufigkeit proximaler TVTs wurde ebenfalls signifikant reduziert.","ut but the incidence of proximal DVT was also significantly reduced.",11,8
"1344","de","en","Die Häufigkeit solcher Ereignisse kann jedoch durch die Anwendung der empfohlenen Dosierung und des empfohlenen Behandlungsschemas verringert werden.","However, this can be minimised by using the recommended dose and schedule of administration.",14,18
"1345","de","en","Die Häufigkeit von Hypoglykämien war in allen Behandlungsgruppen ähnlich.","The incidence of hypoglycaemia was similar across treatment groups.",9,9
"1346","de","en","Die Häufigkeiten sind wie folgt definiert: sehr häufig (≥ 1/10) und häufig (≥ 1/100 bis < 1/10).","Very common (≥ 1/ 10) and Common (≥ 1/ 100 to < 1/ 10).",14,17
"1347","de","en","Die Häufigkeiten von Ödemen,","22 concerns regarding use of pioglitazone.",6,4
"1348","de","en","Die Häufigkeitsangaben sind wie folgt definiert:","The frequency is defined as follows:",6,6
"1349","de","en","Die häufigste Nebenwirkung ist ein niedriger Blutzucker (Hypoglykämie).","The most common side effect is low blood sugar (hypoglycaemia).",10,8
"1350","de","en","Die häufigste Nebenwirkung von Pelzont (beobachtet bei mehr als 1 von 10 Patienten) ist Hautrötung (Flush).","The most common side effect with Pelzont (seen in more than 1 patient in 10) is flushing.",17,16
"1351","de","en","Die häufigsten Anzeichen und Symptome einer Überdosierung sind Übelkeit und Schläfrigkeit.","The most common signs and symptoms of overdose are nausea and somnolence.",12,11
"1352","de","en","Die häufigsten Nebenwirkungen waren Blutungskomplikationen (siehe Abschnitt 4.4).","The most common adverse",4,8
"1353","de","en","Die häufigsten Nebenwirkungen, die häufiger als unter Placebo verzeichnet wurden, waren Somnolenz, Kopfschmerzen, gesteigerter Appetit und Schlaflosigkeit.","The most frequent adverse reactions reported in excess of placebo were somnolence, headache, increased appetite and insomnia.",17,17
"1354","de","en","Die Hauptmetabolite beim Menschen sind N-3,5-Dimethyl- Gludantan, ein Isomerengemisch von 4- und 6-Hydroxy-Memantin, sowie 1-Nitroso-3,5- Dimethyl-Adamantan.","Main human metabolites are N-3,5-dimethyl-gludantan, the isomeric mixture of 4- and 6-hydroxy-memantine, and 1-nitroso-3,5-dimethyl-adamantane.",14,16
"1355","de","en","Die Hauptmetaboliten sind hydrolysierbare Konjugate des Difloxacins, die sonstigen Metaboliten sind größenordnungsmäßig unbedeutend.","The main metabolites are hydrolysable conjugates of difloxacin, the other metabolites are proportionally minor ones.",15,13
"1356","de","en","Die hergestellte Lösung hat eine Konzentration von 80 Mikrogramm/0,5 ml.","The reconstituted solution has a concentration of 80 micrograms in 0.5 ml.",12,10
"1357","de","en","Die Histamin-H1-antagonistische Wirkung von Mirtazapin steht im Zusammenhang mit seinen sedierenden Eigenschaften.","The average plasma concentration of mirtazapine was about 55% and 115 %increased respectively.",13,12
"1358","de","en","Die histopathologischen Ergebnisse von Knochenmarkuntersuchungen zeigten keine nennenswerten Veränderungen, die auf die Behandlung zurückzuführen gewesen wären.","Histopathology results from bone marrow samples revealed no remarkable changes attributable to treatment.",13,16
"1359","de","en","Die Höchstdosis von 600 mg täglich kann nach einer weiteren Woche erreicht werden.","The maximum dosage of 600 mg per day may be achieved after an additional week.",15,13
"1360","de","en","Die höchste untersuchte Dosierung lag bei intravenösen Mehrfachdosen von 10 mg/kg. eim","The highest dose level evaluated has been multiple intravenous doses of 10 mg/ kg. na",15,12
"1361","de","en","Die Hypomagnesiämie ist nach Absetzen von Cetuximab reversibel.","Hypomagnesaemia is reversible following discontinuation of cetuximab.",7,8
"1362","de","en","Die Ihnen verordnete Dosis muss möglicherweise angepasst werden.","- a liver problem, because your dose may need to be adjusted",12,8
"1363","de","en","Die Impfserie besteht aus zwei Dosen.","The vaccination course consists of two doses.",7,6
"1364","de","en","Die Impfung ist kein Ersatz für Routineuntersuchungen zur Gebärmutterhalskrebs-Früherkennung.","Vaccination is not a substitute for routine cervical screening.",9,9
"1365","de","en","Die in Tabelle 2 aufgelisteten Nebenwirkungen, wurden in klinischen Studien mit Kindern berichtet.","The adverse reactions listed in Table 2 are based on experience from paediatric clinical trials.",15,13
"1366","de","en","Die Infusion alle 8 - 24 Stunden bis zur Wundheilung wiederholen","Repeat infusion every 8 to 24 hours until threat is resolved.",11,11
"1367","de","en","Die Infusion ist unmittelbar vor Anwendung herzustellen.","The infusion must be prepared immediately prior to use.",9,7
"1368","de","en","Die Infusion wird alle zwei Wochen gegeben.","The infusion will be given every two weeks.",8,7
"1369","de","en","Die Infusionsleitung anschließen und vor dem Start der Infusion mit dem verdünnten Erbitux spülen.","Connect the infusion line and prime it with the diluted Erbitux before starting the infusion.",15,14
"1370","de","en","Die Infusionslösung ist auf sichtbare Partikel oder Verfärbung zu prüfen.","Visually inspect the infusion solution for particulate matter or discolouration.",10,10
"1371","de","en","Die Injektion mit der Luftblase ist unbedenklich.","Injecting the solution with the air bubble is harmless.",9,7
"1372","de","en","Die Injektionen sind bei Bedarf zu wiederholen, um eine gute Funktion aufrechtzuerhalten und die Schmerzen zu minimieren.","Injections should be repeated as required to maintain good function and minimise pain.",13,17
"1373","de","en","Die Injektionslösung darf nicht angewendet werden, wenn sie Schwebstoffe enthält oder nicht klar ist.","The solution should not be administered if it contains particles or is not clear.",14,14
"1374","de","en","Die Injektionsstelle mit einem Alkoholtupfer reinigen.","Clean the site of injection with an alcohol swab.",9,6
"1375","de","en","Die Injektionsstelle muss regelmäßig gewechselt werden.","The injection site must be changed regularly.",7,6
"1376","de","en","Die Injektionsstelle nicht massieren.","Do not massage the injection site.",6,4
"1377","de","en","Die Injektionsstelle sollte daher nur innerhalb der gewählten Körperregion gewechselt werden.","Injection sites should therefore be alternated within the same region.",10,11
"1378","de","en","Die Inkretine sind Teil eines endogenen Systems, das bei der physiologischen Regulation der Glukosehomöostase eine Rolle spielt.","The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis.",16,17
"1379","de","en","Die INR-Werte erhöhten sich im Mittel um 13% (90% Konfidenzintervall 6 %-19%).","The INR values increased on average by 13% [CI90 6-19%].",10,12
"1380","de","en","Die Interferone bilden eine Gruppe kleiner Proteinmoleküle mit einem Molekulargewicht von etwa 15.000 bis 21.000 Dalton.","The interferons are a family of small protein molecules with molecular weights of approximately 15,000 to 21,000 daltons.",18,16
"1381","de","en","Die interindividu- elle Variabilität der Clearance ist mit 19,3% gering.","Between patient variability in clearance is moderate at 19.3%.",9,10
"1382","de","en","Die Kaplan-Meier-Analyse zeigte unter Gliclazid eine kürzere Zeitperiode bis zum Nachlassen der Wirksamkeit als unter Pioglitazon.","Kaplan-Meier analysis showed shorter time to treatment failure in patients treated with gliclazide, compared with pioglitazone.",16,16
"1383","de","en","Die Kapseln müssen unzerkaut, vorzugsweise mit Wasser geschluckt werden.","The active substance in Revlimid, lenalidomide, is an immunomodulating agent.",10,9
"1384","de","en","Die Kapseln sind halbdurchscheinend weiß und in grün mit CRIXIVAN™ 100 mg beschriftet.","The capsules are semi– translucent white and coded CRIXIVAN™ 100 mg in green.",13,13
"1385","de","en","Die Kapseln sind unzerkaut mit einem Glas Wasser zu schlucken.","The capsules should be swallowed whole with a glass of water.",11,10
"1386","de","en","Die Kapseln sollten unzerkaut mit einem Glas Wasser geschluckt werden.","You should swallow the whole capsule with a glass of water.",11,10
"1387","de","en","Die Kapseln wirken ausschließlich in Ihrem Verdauungstrakt.","1.50m 1.55m 1.60m 1.65m 1.70m 1.75m 1.80m 1.85m 1.90m",9,7
"1388","de","en","die keine Hämodialyse erhalten, ist die subkutane Verabreichnung vorzuziehen, um Punktionen peripherer Venen zu vermeiden. m","haemodialysis to avoid puncture of peripheral veins. a",8,16
"1389","de","en","Die Kenntnisse über den Mechanismus sind unvollständig.","Knowledge about the mechanism is incomplete.",6,7
"1390","de","en","Die klinisch bedeutsamsten unerwünschten Reaktionen sind Lebertoxizität und Myopathien.","incidence of rhabdomyolysis with cerivastatin 0.4mg is 2 fold greater than with other statins.",14,9
"1391","de","en","Die klinische Anwendung von TESLASCAN ist bei Feldstärken von 0,5 bis 2,0 Tesla untersucht worden.","The clinical use of TESLASCAN has been investigated at field strengths from 0.5 to 2.0 Tesla.",16,15
"1392","de","en","Die klinische Bedeutung dieser Abnahme ist nicht bekannt.","The clinical significance of this decrease is unknown.",8,8
"1393","de","en","Die klinische Einstufung in die entsprechende Demenzgruppe basierte auf einer umfassenden standardisierten klinischen und neuropsychiatrischen Beurteilung.","Clinical categorisation into the respective dementia group was based on a standardised and comprehensive clinical and neuropsychiatric evaluation.",18,16
"1394","de","en","Die klinische Erfahrung mit NocoMix 70 während einer Schwangerschaft ist gering.","There is limited clinical experience with NovoMix 70 in pregnancy.",10,11
"1395","de","en","Die klinische Relevanz der Ergebnisse dieser Einzeldosisstudie ist nicht bekannt.","The clinical relevance of results from this single dose study is unknown.",12,10
"1396","de","en","Die klinische Relevanz dieser Beobachtung ist noch nicht völlig aufgeklärt.","The clinical relevance of this observation has not been fully elucidated.",11,10
"1397","de","en","Die klinische Relevanz dieser Ergebnisse ist noch nicht bekannt.","The clinical relevance of these findings is still unknown.",9,9
"1398","de","en","Die klinische Relevanz dieser Verringerung ist nicht bekannt.","The clinical relevance of this decrease is unknown.",8,8
"1399","de","en","Die klinische Relevanz dieses Befundes ist jedoch nicht bekannt.","However, the clinical relevance of this finding is not known.",10,9
"1400","de","en","Die klinische Wirksamkeit wurde in einer großen Zahl von Milchviehbeständen in 8 europäischen Ländern untersucht.","The clinical effectiveness was studied in a large number of dairy herds in 8 European countries.",16,15
"1401","de","en","Die klinischen Daten zur Verträglichkeit von Abacavir bei Patienten mit eingeschränkter Leberfunktion sind sehr begrenzt.","The clinical safety data available with abacavir in hepatically impaired patients is very limited.",14,15
"1402","de","en","Die klinischen Erfahrungen bei schwangeren Frauen sind begrenzt, jedoch wurden kongenitale Anomalien und Aborte berichtet.","Clinical experience in pregnant women is limited, but congenital anomalies and abortions have been reported.",15,15
"1403","de","en","Die Knochenmarksuppres- sion ist üblicherweise die dosislimitierende Toxizität.","Myelosuppression is usually the dose-limiting toxicity.",6,8
"1404","de","en","Die Köder werden von Hand oder aus der Luft im Rahmen von Impfprogrammenn gegen Tollwut verteilt.","The baits are distributed by land or by air within the framework of vaccination campaigns against rabies.",17,16
"1405","de","en","Die Kombination aus Aliskiren und Hydrochlorothiazid neutralisierte den durch Hydrochlorothiazid verursachten reaktiven Anstieg der PRA.","The combination of aliskiren and hydrochlorothiazide neutralised the reactive increase of PRA caused by hydrochlorothiazide.",15,15
"1406","de","en","Die Kombination von Lithium und Irbesartan Winthrop wird nicht empfohlen (siehe Abschnitt 4.5).","Lithium: the combination of lithium and Irbesartan Winthrop is not recommended (see section 4.5).",14,13
"1407","de","en","Die Kombination von Rifampicin und REYATAZ zusammen mit niedrig dosiertem Ritonavir ist kontraindiziert (siehe Abschnitt 4.5).","Combination of rifampicin and REYATAZ with concomitant low-dose ritonavir is contraindicated (see section 4.5).",14,16
"1408","de","en","Die Kombination war bis zu zwei Jahre wirksam.","The combination was effective for up to two years.",9,8
"1409","de","en","Die Kombinationsbehandlung mit Metformin führt zu einem erhöhten Risiko für Hypoglykämien.","Combination treatment with metformin is associated with an increased risk of hypoglycaemia.",12,11
"1410","de","en","Die komplette Resuspension sollte durch leichtes Schütteln der Durchstechflasche vor dem Gebrauch sichergestellt werden.","Complete resuspension should be ensured by mild agitation of the vial before use.",13,14
"1411","de","en","Die Konzentration beträgt 30 Mikrogramm pro 0,5 ml.","The concentration is 30 micrograms per 0.5 ml.",8,8
"1412","de","en","Die Konzentrationen dieser Immunsuppressiva können bei gleichzeitiger Anwendung von REYATAZ mit Ritonavir aufgrund Hemmung von CYP3A4 erhöht sein.","Concentrations of these immunosuppressants may be increased when co-administered with REYATAZ/ ritonavir due to CYP3A4 inhibition.",16,18
"1413","de","en","Die Konzentrationen liegen etwa 5mal höher als im mütterlichen Plasma.","Telithromycin is excreted in the milk of lactating animals, at concentrations about 5 times those of maternal plasma.",18,10
"1414","de","en","Die Konzentrationen von HDL- Cholesterin und Triglyceriden änderten sich nicht signifikant.","HDL cholesterol and triglyceride concentrations did not change significantly.",9,11
"1415","de","en","Die Krankheit wird meist bei Kleinkindern im Alter von einem bis fünf Jahren diagnostiziert.","The disease is usually diagnosed in infants between one and five years of age.",14,14
"1416","de","en","Die Lagerung sollte in Übereinstimmung mit den nationalen Vorschriften für radioaktive Stoffe erfolgen.","Storage should be in accordance with national regulations for radioactive materials.",11,13
"1417","de","en","Die Lebensqualität wurde mit Hilfe des Asthma-bezogenen Lebensqualitäts-Fragebogens nach Juniper ermittelt.","Quality of life scores were measured using the Juniper Asthma-related Quality of Life Questionnaire.",14,11
"1418","de","en","Die Leber ist ein potenzielles Zielorgan für Toxizität.","Clofarabine is predominately excreted via the kidneys and the liver is a potential target organ for toxicity.",17,8
"1419","de","en","Die Leberfunktion sollte bei allen Patienten vor Behandlungsbeginn und danach monatlich bestimmt werden (siehe Abschnitt 4.4).","Hepatic function in all patients should be monitored before treatment then every month (see section 4.4).",16,16
"1420","de","en","Die letzte Dosis muss innerhalb eines Monats nach der letzten Mückenexposition gegeben werden.","The final dose must be given within one month after the last exposure to mosquitoes.",15,13
"1421","de","en","Die Lösung ist klar und farblos.","The solution is clear and colourless.",6,6
"1422","de","en","Die Lösung ist nicht klar.","The solution is not clear.",5,5
"1423","de","en","Die Lösung kann durchsichtige bis weißliche Eiweiß-Partikel enthalten.","There may be some translucent-to-white particles of protein in the solution.",11,8
"1424","de","en","Die Lösung muss klar, farblos oder blassgelb, ohne Klumpen, Flocken oder Partikel sein.","The solution should be clear, colourless or pale yellow, with no lumps or flakes or particles.",16,13
"1425","de","en","Die Maximaldosis bei intramuskulärer Verabreichung darf 2 g nicht überschreiten.","The maximum daily dose by intramuscular administration should not exceed 2 g.",12,10
"1426","de","en","Die maximale blutdrucksenkende Wirkung wird etwa 3-6 Wochen nach Behandlungsbeginn erreicht.","The maximal blood pressure lowering effect should be reached 3-6 weeks after beginning treatment.",14,11
"1427","de","en","Die maximale Einzeldosis beträgt 200 mg.","The maximum single dose is 200 mg.",7,6
"1428","de","en","Die maximale Plasmakonzentration von Irbesartan ist 1,5-2 Stunden nach oraler Anwendung erreicht, die von Hydrochlorothiazid nach 1-2,5 Stunden.","Peak plasma concentration occurs at 1.5-2 hours after oral administration for irbesartan and 1-2.5 hours for hydrochlorothiazide.",17,18
"1429","de","en","Die maximalen Plasmaspiegel wurden im Allgemeinen 2 bis 3 Stunden nach der Verabreichung erreicht.","Peak plasma levels were generally achieved at 2 to 3 hours after administration.",13,14
"1430","de","en","Die maximalen Steady-state-Konzentrationen schwanken interindividuell beträchtlich, intraindividuell jedoch nur selten.","There is considerable inter-individual variation in steady state maximum concentrations but within an individual, concentrations rarely vary.",17,10
"1431","de","en","Die mediane Überlebensdauer aller aufgenommener Patienten betrug 17 Monate (Bereich < 1","The median survival of all patients enrolled was 17 months (range < 1 to 36+ months).",16,12
"1432","de","en","Die medizinische Bezeichnung für diesen Zustand lautet: ‘ persistierender Ductus arteriosus’, d.h. offener Ductus arteriosus.","The medical term for this condition is ‘ patent ductus arteriosus’, i. e. an open ductus arteriosus.",17,15
"1433","de","en","Die Mehrzahl der Nebenwirkungen erforderte im allgemeinen keine Beendigung der Therapie.","The majority of adverse reactions have not usually required cessation of therapy.",12,11
"1434","de","en","Die meisten Blutungen waren typischerweise mit schwerer Thrombozytopenie assoziiert.","Most bleeding related events were typically associated with severe thrombocytopenia.",10,9
"1435","de","en","Die meisten der Patienten mit perimetrisch bestätigten Störungen zeigten keine klinischen Symptome.","Most of the patients with perimetry-confirmed defects have been asymptomatic.",10,12
"1436","de","en","Die meisten dieser Patienten nahmen das Medikament unmittelbar vor dem Zubettgehen ein.","Most of these patients took medication just prior to going to bed.",12,12
"1437","de","en","Die meisten Hautreaktionen entwickeln sich innerhalb der ersten drei Behandlungswochen.","The majority of skin reactions develop within the first three weeks of therapy.",13,10
"1438","de","en","Die meisten Nebenwirkungen waren von leichter bis mäßiger Ausprägung.","Most reactions were of mild-to-moderate grade.",6,9
"1439","de","en","Die meisten Reaktionen klangen nach 1 bis 3 Tagen spontan ab.","11 Most reactions resolved spontaneously within 1 to 3 days after onset.",12,11
"1440","de","en","Die meisten Zecken werden innerhalb von 48 Stunden getötet.","Kills most ticks within 48 hours.",6,9
"1441","de","en","Die Messung der Serumlipide im Nüchternzustand und des Blutzuckers sollte erwogen werden.","Consideration should be given to the measurement of fasting serum lipids and blood glucose.",14,12
"1442","de","en","Die Metabolisierung von Ribavirin erfolgt über zwei Wege:","Ribavirin has two pathways of metabolism:",6,8
"1443","de","en","Die Metaboliten weisen in vitro eine antimikrobielle Aktivität auf, die allerdings deutlich niedriger als die der Muttersubstanz ist.","The metabolites display in-vitro antimicrobial activity but to a lower degree than the parent compound.",15,18
"1444","de","en","Die Milzgröße sollte regelmäßig kontrolliert werden.","Spleen size should be evaluated regularly.",6,6
"1445","de","en","Die Mischung muss sofort nach der Zubereitung eingenommen werden.","This mixture must be swallowed immediately after its preparation.",9,9
"1446","de","en","Die mit Crestor beobachteten Nebenwirkungen sind gewöhnlich leicht und vorübergehend.","The adverse events seen with Crestor are generally mild and transient.",11,10
"1447","de","en","Die mit dem Arzneimittel mitgelieferten Dosierpipetten sind entsprechend des Körpergewichts des Hundes abgestuft.","The dosing pipettes provided with the product show graduations corresponding to the correct body weight of the dog.",18,13
"1448","de","en","Die mit Paxene erzielten Ergebnisse sind denjenigen aus veröffentlichten Paclitaxel-Phase III-Studien sehr ähnlich.","The results obtained with Paxene are closely similar to those of published paclitaxel Phase III trials.",16,13
"1449","de","en","Die mittlere Behandlungsdauer betrug 3,4 Jahre.","42 metabolites were not altered.",5,6
"1450","de","en","Die mittlere Halbwertzeit betrug 71,5 Stunden (Bereich 45,2 bis 98,5 Stunden).","The mean apparent half-life was 71.5 hours (range 45.2 - 98.5 hours).",12,11
"1451","de","en","Die mittlere Spitzenkonzentration von Telithromycin in weißen Blutkörperchen betrug 83±25 mg/l. eim","The mean maximum white blood cell concentration of telithromycin was 83±25 mg/ l.",13,12
"1452","de","en","Die mittlere Therapiedauer betrug 29 Tage für Posaconazol und 25 Tage für Fluconazol/Itraconazol.","The mean duration of therapy was 29 days for posaconazole and 25 days for fluconazole/ itraconazole.",16,13
"1453","de","en","Die mittleren Plasmakonzentrationen bei den männlichen Ratten betrugen etwa 200 nMol.","In contrast to these findings in rats,",7,11
"1454","de","en","Die Molekulargewichte von Interferonen liegen im Bereich von 15.000 bis 21.000 Dalton.","Interferons have molecular weights ranging from 15,000 to 21,000 Daltons.",10,12
"1455","de","en","Die MS ruft eine Entzündung im Gehirn hervor, durch die die Nervenzellen geschädigt werden.","MS causes inflammation in the brain that damages the nerve cells.",11,14
"1456","de","en","Die nach Vorschrift zubereitete Injektionslösung enthält eine Konzentration von 100 mg/ml.","When reconstituted as recommended the final concentration is 100 mg/ml.",10,11
"1457","de","en","Die nachfolgend angegebenen Nebenwirkungen werden sehr häufig (> 1/10) unter METALYSE beobachtet:","59 The following side effects are very common (> 1/ 10) with METALYSE:",13,12
"1458","de","en","Die nachfolgende Dosis Zestril sollte nach der Reaktion des Blutdruckes angepasst werden.","The subsequent dosage of Zestril should be adjusted according to blood pressure response.",13,12
"1459","de","en","Die Narkoseeinleitung verläuft entsprechend schnell und die Narkosetiefe kann sich je nach Konzentration des Anästhetikums rasch ändern.","Anaesthetic induction is correspondingly rapid and the depth of anaesthesia changes rapidly with changes in anaesthetic concentration.",17,17
"1460","de","en","Die Nebenwirkungen entsprachen der pharmakologischen Wirkung von Kepivance auf die Haut und die Mundschleimhaut (siehe Tabelle 1).","Adverse reactions were consistent with the pharmacologic action of Kepivance on skin and oral epithelium (see Table 1).",18,17
"1461","de","en","Die Nebenwirkungen sind nach Systemorganklassen in Tabelle 4 aufgeführt.","Adverse event reactions are listed by system organ class in Table 4.",12,9
"1462","de","en","Die Nebenwirkungen unter CYSTAGON treten hauptsächlich im Zusammenhang mit dem Verdauungssystems auf.","The side effects of CYSTAGON are mainly connected with the digestive system.",12,12
"1463","de","en","Die Nebenwirkungsrate war bei gleichzeitiger Verabreichung von Natriumoxybat mit trizyklischen Antidepressiva erhöht.","The rate of adverse events have increased when sodium oxybate is co-administered with tricyclic antidepressants.",15,12
"1464","de","en","Die NeoRecormon Fertigspritze ist gebrauchsfertig.","The NeoRecormon pre-filled syringe is ready for use.",8,5
"1465","de","en","Die niedrigste Konzentration von Tacrolimus im Blut, bei der systemische Wirkungen zu beobachten sind, ist nicht bekannt.","The lowest tacrolimus blood concentration at which systemic effects can be observed is not known.",15,17
"1466","de","en","Die niedrigstmögliche Dosis von Atorvastatin","Use the lowest possible dose of atorvastatin with careful monitoring.",10,5
"1467","de","en","Die NNT in dieser Studie betrug 28 (95% Konfidenzintervall 24 – 50).","The NNT in this study was 28 (95% CI 24 – 50).",12,12
"1468","de","en","Die Notwendigkeit für eine Fortsetzung der Behandlung sollte alle 6 Monate überprüft werden.","The need for treatment continuation should be reconsidered every 6 months.",11,13
"1469","de","en","Die obere Spitze wird zur Pipette hin umgebogen.","The top of the tip will fold back against the pipette.",11,8
"1470","de","en","Die offiziellen Richtlinien für den angemessenen Gebrauch von Antibiotika sollten beachtet werden.","Consideration should be given to official guidance on the appropriate use of antibacterial agents.",14,12
"1471","de","en","Die orale Absorptionsrate von Lenalidomid änderte sich jedoch bei eingeschränkter Nierenfunktion nicht.","However, renal impairment did not alter the oral absorption of lenalidomide.",11,12
"1472","de","en","Die orale Aufnahme durch Collies, Bobtails und mit diesen verwandten Hunderassen oder -kreuzungen sollte vermieden werden.","Oral uptake by Collies, Old English Sheepdogs and related breeds or crossbreeds should be prevented.",15,16
"1473","de","en","Die orale Therapie sollte in den ersten 24 Stunden nach der Transplantation beginnen.","Administration should commence within 24 hours after the completion of surgery.",11,13
"1474","de","en","Die Packung muss dann zur Analyse zu einem qualifizierten Labor geschickt werden.","The package must be sent to a qualified laboratory for analysis.",11,12
"1475","de","en","Die Packungen enthalten 7, 14, 28, 30, 50, 56, 84, 90, 98 oder 280 Tabletten.","Packs containing 7, 14, 28, 30, 50, 56, 84, 90, 98 or 280 tablets.",14,15
"1476","de","en","Die Paste befindet sich in einer Kunststoffspritze mit einer Dosis zur Behandlung von 50 kg beim Pferd.","The paste is presented in a syringe of plastic with the dose to treat 50 kg of horse.",18,17
"1477","de","en","Die Patien- ten sollten angewiesen werden bei Auftreten dieser Symptome unverzüglich den Arzt zu kontaktieren (siehe Abschnitt 4.4).","Patients should be advised to immediately contact their physician if these symptoms occur (see section 4.4).",16,18
"1478","de","en","Die Patienten können sich Betaferon selbst spritzen, sofern sie entsprechend geschult worden sind.","The patients can inject Betaferon themselves, provided that they have been trained.",12,13
"1479","de","en","Die Patienten leiden für gewöhnlich unter Kurzatmigkeit und Husten.","Patients usually present with shortness of breath and cough.",9,9
"1480","de","en","Die Patienten müssen engmaschig auf dosisabhängige Nebenwirkungen, 91 besonders aber hinsichtlich ZNS-Symptomen überwacht werden.","Patients should be monitored carefully for dose-related adverse reactions, especially nervous system symptoms.",13,14
"1481","de","en","Die Patienten müssen vor dem Genuss jeglicher alkoholischer Getränke zusammen mit Natriumoxybat gewarnt werden.","Patients should be warned against the use of any alcoholic beverages in conjunction with sodium oxybate.",16,14
"1482","de","en","Die Patienten sollen während der Therapie sorgfältig überwacht werden.","Patients should be carefully monitored during therapy.",7,9
"1483","de","en","Die Patienten sollten auf jegliche Anzeichen oder Symptome von psychiatrischen Störungen eng überwacht werden.","Patients should be closely monitored for any signs or symptoms of psychiatric disorders.",13,14
"1484","de","en","Die Patienten sollten darauf hingewiesen werden, dass Schwindel und Schläfrigkeit unter INVANZ berichtet wurden (siehe Abschnitt 4.8).","Patients should be informed that dizziness and somnolence have been reported with INVANZ (see section 4.8).",16,17
"1485","de","en","Die Patienten sollten einem einmaligen dynamischen Test unterzogen werden, um einen Wachstumshormonmangel zu diagnostizieren oder auszuschließen.","These patients should undergo a single dynamic test in order to diagnose or exclude a growth hormone deficiency.",18,16
"1486","de","en","Die Patienten waren bei Beginn der Behandlung 6 Monate alt oder jünger.","Subjects were aged 6 months or less at the onset of treatment.",12,12
"1487","de","en","Die Patienten wurden bis zum Fortschreiten ihrer Erkrankung oder bis zum Auftreten nicht tolerabler toxischer Wirkungen behandelt.","Patients were treated until disease progression or unacceptable toxicity occurred.",10,17
"1488","de","en","Die Patientencharakteristi- ka waren in beiden Studienarmen ähnlich.","The patient characteristics were similar across the study arms.",9,8
"1489","de","en","Die Patientinnen sollten zusätzlich Vitamin D oder Kalzium einnehmen, falls sie mit der Nahrung nicht genügend davon aufnehmen.","Patients should receive calcium or vitamin D supplements if they are not getting enough from their diet.",17,18
"1490","de","en","Die Patrone darf nicht wieder aufgefüllt werden.","The cartridge must not be refilled.",6,7
"1491","de","en","Die Patrone im Umkarton aufbewahren.","Keep the cartridge in the outer carton.",7,5
"1492","de","en","Die Patronen eignen sich nicht zum Mischen unterschiedlicher Insuline.","Insuman Comb 15 cartridges are not designed to allow any other insulin to be mixed in the cartridge.",18,9
"1493","de","en","Die Patronen enthalten ein kleines Kügelchen, um das Mischen zu erleich- tern.","Cartridges contain a small glass bead to assist mixing.",9,12
"1494","de","en","Die Pharmakokinetik und Pharmakodynamik von Prasugrel wurde in der pädiatrischen Bevölkerungsgruppe nicht bewertet (siehe Abschnitt 4.2).","Pharmacokinetics and pharmacodynamics of prasugrel have not been evaluated in a paediatric population (see section 4.2).",16,16
"1495","de","en","Die Pharmakokinetik von Aliskiren und Hydrochlorothiazid war bei Patienten mit leichter bis mäßiger Leberinsuffizienz nicht signifikant beeinflusst.","The pharmacokinetics of aliskiren and hydrochlorothiazide are not significantly affected in patients with mild to moderate liver disease.",18,17
"1496","de","en","Die Pharmakokinetik von Digoxin wurde durch die gemeinsame Anwendung mit Irbesartan nicht verändert.","The pharmacokinetic of digoxin was not altered by co-administration of irbesartan.",11,13
"1497","de","en","Die Pharmakokinetik von Efavirenz bei pädiatrischen Patienten war ähnlich der von Erwachsenen.","The pharmacokinetics of efavirenz in paediatric patients were similar to adults.",11,12
"1498","de","en","Die Pharmakokinetik von Rimonabant ist bei weiblichen und männlichen Patienten vergleichbar.","The pharmacokinetics of rimonabant are similar in female and male patients.",11,11
"1499","de","en","Die Pharmakokinetik von Viraferon und Ribavirin (Dosis- normalisiert) ist bei Erwachsenen und Kindern oder Jugendlichen ähnlich.","The pharmacokinetics of Viraferon and ribavirin (dose-normalized) are similar in adults and children or adolescents. t",16,16
"1500","de","en","Die Pharmakokinetik war bei Männern und Frauen sowie bei jüngeren und älteren (über 65 Jahre) Patienten ähnlich.","Pharmacokinetics were similar in males and females, as well as in young and elderly (above 65 years) patients.",18,17
"1501","de","en","Die pharmakokinetischen Eigenschaften von Humalog Mix50 spie- geln die individuellen pharmakokinetischen Eigenschaften der beiden Bestandteile wieder.","The pharmacokinetics of Humalog Mix50 are representative of the individual pharmacokinetic properties of the two components.",16,16
"1502","de","en","Die pharmakokinetischen Eigenschaften von Lepirudin nach intravenöser Gabe sind durch ein Zwei- Kompartiment-Modell gut beschrieben.","The pharmacokinetic properties of lepirudin following intravenous administration are well described by a two-compartment model.",15,15
"1503","de","en","Die pharmakokinetischen Eigenschaften von Liprolog Mix50 spie- geln die individuellen pharmakokinetischen Eigenschaften der beiden Bestandteile wieder.","The pharmacokinetics of Liprolog Mix50 are representative of the individual pharmacokinetic properties of the two components.",16,16
"1504","de","en","Die Phase 2-Studie (Studie 001/007) schloss nur Frauen ein, die","The phase II trial (study 001/ 007) enrolled only women who:",11,10
"1505","de","en","Die Phenytoin-Spiegel sollten bei gleichzeitiger Einnahme von Lopinavir/Ritonavir kontrolliert werden.","Phenytoin levels should be monitored when co-administering with lopinavir/ ritonavir.",10,10
"1506","de","en","Die Plasmakonzentration bei Erreichen von Cmax entspricht lediglich 1-2% der angewendeten Dosis.","At the Cmax, the plasma concentration represented only 1-2% of the applied dose.",13,12
"1507","de","en","Die Plasmakonzentration von Duloxetin zeigt eine große interindividuelle Variabilität (siehe Abschnitt","The plasma concentration of duloxetine displays large inter-individual variability (see 5.2).",11,11
"1508","de","en","Die Plasmaproteinbindung ist zu vernachlässigen.","Distribution Plasma protein binding is negligible.",6,5
"1509","de","en","Die Plasmaproteinbindung von Risperidon beträgt 90%, die des aktiven Metaboliten 9-Hydroxy-Risperidon 77%.","The plasma protein binding of risperidone is 90%, that of 9-hydroxy- risperidone is 77%.",14,12
"1510","de","en","Die Prasugrel-Pharmakokinetik ist bei gesunden Probanden, Patienten mit stabiler Atherosklerose und Patienten mit perkutaner Koronarintervention ähnlich.","Prasugrel’ s pharmacokinetics are similar in healthy subjects, patients with stable atherosclerosis, and patients undergoing percutaneous coronary intervention.",18,16
"1511","de","en","Die progressive atrophische Rhinitis wird durch Toxine (Giftstoffe) des Bakteriums Pasteurella multocida verursacht.","Progressive atrophic rhinitis is caused by toxins from the bacteria Pasteurella multocida.",12,13
"1512","de","en","Die Proteinbindung von Ciprofloxacin ist gering (20-30%).","Protein binding of ciprofloxacin is low (20-30%).",7,7
"1513","de","en","Die Protopic-Behandlung darf nur von Ärzten mit Erfahrung in der Diagnose und Behandlung des atopischen Ekzems begonnen werden.","Protopic should be initiated by physicians with experience in the diagnosis and treatment of atopic dermatitis.",16,18
"1514","de","en","Die rekonstituierte Lösung enthält 150 I.E./ml.","The reconstituted solution contains 150 IU/ ml.",7,6
"1515","de","en","Die rekonstituierte Lösung inspizieren.","Inspect the reconstituted product:",4,4
"1516","de","en","Die rekonstituierte Lösung muss innerhalb von 1 Stunde weiter verdünnt und innerhalb von 24 Stunden appliziert werden.","The reconstituted solution must be further diluted within an hour and administered within 24 hours.",15,17
"1517","de","en","Die Relevanz für den Menschen ist nicht bekannt.","The relevance to humans is unknown.",6,8
"1518","de","en","Die renale Clearance von Fluticason-17-propionat ist vernachlässigbar.","The renal clearance of fluticasone propionate is negligible.",8,7
"1519","de","en","Die Resistenz gegen eine Influenza- und Streptokokkeninfektion war in Ratten lediglich leicht geschwächt.","The resistance to influenza and streptococcal infection in rats was only weakly compromised.",13,13
"1520","de","en","Die Resorption von Entacapon wird durch Nahrungsaufnahme nicht wesentlich beeinflusst.","Food does not significantly affect the absorption of entacapone.",9,10
"1521","de","en","Die Resorption von fettlöslichen Arzneimitteln bei gleichzeitiger Anwendung mit Mitratapid wurde nicht untersucht.","The absorption of lipid soluble drugs used concomitantly with mitratapide has not been investigated.",14,13
"1522","de","en","Die Resultate klinisch-chemischer Harnuntersuchungen (z.B. mit Teststreifen auf pH, Glukose, Ketonkörper, Protein) sind bei deutlicher Urinverfärbung unzuverlässig.","Dipstick measurements (i. e., pH, glucose, ketones, protein) are inaccurate while gross discolouration of the urine is present.",18,17
"1523","de","en","Die resuspendierte Flüssigkeit muss gleichmäßig milchig weiß aussehen.","The resuspended liquid must appear uniformly white and cloudy.",9,8
"1524","de","en","Die Rezeptoren sind ebenfalls in den Adipozyten (den Fettzellen im Fettgewebe) zu finden.","also found in adipocytes (fat tissue).",6,13
"1525","de","en","Die Rückbildung einer Hypoglykämie kann sich verzögern, da Lantus lange wirkt.","The recovery of hypoglycaemia may be delayed because Lantus has a long action.",13,11
"1526","de","en","Die Rückstände in Muskeln, Fett und Leber lagen zu sämtlichen Zeitpunkten unterhalb der Rückstandshöchstmenge.","Residues in muscle, fat and liver were below the MRL at all time points.",14,14
"1527","de","en","Die Schachtel beinhaltet einen Beipackzettel mit einer vollständigen Anleitung zur Benutzung und Handhabung des vorgefüllten Injektors.","241 The carton contains a package leaflet with the full instructions for use and handling.",15,16
"1528","de","en","Die Schachtel beinhaltet einen Beipackzettel mit einer vollständigen Anleitung zur Benutzung und tl","312 6.6 Special precautions for disposal",6,13
"1529","de","en","Die Schale ist in einer Folienlaminathülle mit Trockenmittel eingesiegelt.","The tray is sealed in a foil laminate pouch with a desiccant.",12,9
"1530","de","en","Die Schmerzen wurden von den Patienten auf einer 11-Punkte-Skala gemessen.","Pain was measured by the patients on an 11-point scale.",10,10
"1531","de","en","Die Sedierung beeinflusste das Paarungsverhalten männlicher Ratten.","Sedation affected mating performance of male rats.",7,7
"1532","de","en","Die selektive Hemmung der COX-2 durch Lumiracoxib führt zur antiinflammatorischen und analgetischen Wirkung.","Selective inhibition of COX-2 by lumiracoxib provides anti-inflammatory and analgesic effects.",11,13
"1533","de","en","Die Serum-Elektrolyte (insbesondere Kalium) müssen kontrolliert werden.","au Blood electrolytes (especially potassium) must be controlled.",8,7
"1534","de","en","Die Serumelektrolyte, Nierenfunktion und Diurese müssen überwacht werden.","Serum electrolytes, renal function and diuresis must be monitored.",9,8
"1535","de","en","Die Sicherheit der Anwendung von VASOVIST während der Schwangerschaft wurde nicht nachgewiesen.","It has not been proven that VASOVIST is safe to use during pregnancy.",13,12
"1536","de","en","Die Sicherheit und Wirksamkeit dieser Vorgaben für die Anpassung der Dosis wurden nicht klinisch evaluiert.","The safety and effectiveness of these dosing adjustment guidelines have not been clinically evaluated.",14,15
"1537","de","en","Die Sicherheit und Wirksamkeit von Soliris wurde bei Patienten mit Nierenfunktionsstörung nicht untersucht.","The safety and efficacy of Soliris have not been studied in patients with renal impairment.",15,13
"1538","de","en","Die Sicherheitsdatenbank für Tacrolimus ist fragmentiert und unklar.","The safety database for tacrolimus is fragmented and uncertain.",9,8
"1539","de","en","Die Sicherheitsgrenzen aus toxikologischen Studien sind - aufgrund der dosislimitierenden Hypokalzämie, die im Tiermodell beobachtet wurde - eng.","Safety margins from the toxicology studies are small due to the dose-limiting hypocalcaemia observed in the animal models.",18,18
"1540","de","en","Die sonstigen Bestandteile sind","- The active substance is lansoprazole",6,4
"1541","de","en","Die sonstigen Bestandteile sind Benzoesäure, Sucrose (Saccharose), Glycerol, Pfefferminzaroma (enthält 0,23% Alkohol), gereinigtes Wasser","Benzoic Acid, Sucrose, Glycerin, Mint flavour (containing 0.23% alcohol) and Purified Water.",12,14
"1542","de","en","Die sonstigen Bestandteile sind Povidon (K25), Meglumin, Natriumhydroxid, Sorbitol (Ph.Eur.) und Magnesiumstearat (Ph.Eur.).","The other ingredients are povidone, meglumine, sodium hydroxide, sorbitol (E420) and magnesium stearate.",13,13
"1543","de","en","Die sonstigen Bestandteile sind:","21 The other ingredients are:",5,4
"1544","de","en","Die sonstigen Bestandteile sind: hochdisperses Siliciumdioxid und Stearinsäure.","The tablet coating contains",4,8
"1545","de","en","Die speziellen Maßnahmen, die im Falle dieser Reaktionen zu treffen sind, werden im Abschnitt 4.5 beschrieben.","Specific measures to be taken in case of the above reactions are described in section 4.5.",16,16
"1546","de","en","Die Spezifität von Eculizumab für C5 in Humanserum wurde in zwei In-vitro-Studien beurteilt.","The specificity of eculizumab for C5 in human serum was evaluated in two in vitro studies.",16,13
"1547","de","en","Die Spitze ist jetzt gebrauchsfertig.","The syringe is now ready for use.",7,5
"1548","de","en","Die Spritze darf nicht schräg in die Vorrichtung gedrückt werden, da der Inhalt der Spritze sonst danebenlaufen könnte.","If the syringe is at an angle to the Bio-Set, it will leak.",13,18
"1549","de","en","Die Spritze sollte nach jeder Entnahme der Dosis aus der Flasche herausgenommen werden.","After each dose, the syringe should be removed from the bottle.",11,13
"1550","de","en","Die Spritzen bestehen aus Glas (Glastyp I) mit Edelstahlkanülen.","The syringes are type I glass-fitted with stainless steel needles.",10,9
"1551","de","en","Die Studie verglich die Wirksamkeit der Weiterbehandlung mit Entacapon mit der Umstellung auf Tasmar.","The study compared the effectiveness of continuing with entacapone or switching to Tasmar.",13,14
"1552","de","en","Die Studie verglich mit Netvax geimpfte Hühner mit Vögeln, die den Impfstoff nicht erhalten haben.","The vaccine was well tolerated by the chickens, with no effect on the production of eggs or chicks.",18,15
"1553","de","en","Die Studien fanden mit jungen und adulten Katzen verschiedener Rassen statt, jedoch nicht mit jungen Kitten.","They included young and adult cats of various breeds, but not young kittens.",13,16
"1554","de","en","Die Studien wurden mit Katzen und Hunden verschiedener Altersgruppen, verschiedenen Geschlechts und unterschiedlicher Rasse durchgeführt.","The studies involved cats and dogs of different age groups, genders and breeds.",13,15
"1555","de","en","Die Studienergebnisse sind in Tabelle 11 zusammengefasst.","Study results are summarized in Table 11.",7,7
"1556","de","en","Die Studienpopulation bestand hauptsächlich aus Kindern mit leicht- bis mittelgradiger Hepatitis C.","The population enrolled mainly consisted in children with mild to moderate hepatitis C.",13,12
"1557","de","en","Die subkutane Anwendung ist bei Patienten, die keine Hämodialyse erhalten, zur Vermeidung der Punktion peripherer Venen vorzuziehen.","Subcutaneous use is preferable in patients who are not receiving haemodialysis to avoid the puncture of peripheral veins.",18,17
"1558","de","en","Die subkutane Injektion wird in gleicher Weise durchgeführt wie mit einer herkömmlichen Spritze.","The subcutaneous injection is administered in the same way as with a classical syringe.",14,13
"1559","de","en","Die Suspension kann für 45 Minuten bei 25°C oder für 8 Stunden bei 2°C bis 8°C gelagert werden.","The suspension may be stored at 25°C for 45 minutes or at 2°C to 8°C for 8 hours.",18,18
"1560","de","en","Die Suspension zum Einnehmen muss vor der Anwendung kräftig geschüttelt werden.","The oral suspension must be shaken well before use.",9,11
"1561","de","en","Die Symptome Fieber und Abgeschlagenheit bildeten sich meist innerhalb von 72 Stunden nach Unterbrechung oder","Fever and fatigue were often reversible within 72 hours of interruption or cessation of treatment.",15,15
"1562","de","en","Die Symptome können beinhalten:","The symptoms of MS vary from patient to patient, and you may experience some or none of them.",18,4
"1563","de","en","Die systemische Clearance war geringfügig niedriger; dies war jedoch klinisch nicht signifikant.","Systemic clearance was slightly lower, but this was not clinically significant.",11,12
"1564","de","en","Die Tablette soll vorzugsweise am selben Datum eines jeden Monats eingenommen werden.","The tablet should preferably be taken on the same date each month.",12,12
"1565","de","en","Die Tabletten können mit oder ohne Nahrung eingenommen werden.","The tablets can be taken with or without food.",9,9
"1566","de","en","Die Tabletten müssen ganz mit einer ausreichenden Menge Flüssigkeit geschluckt werden.","The tablets must be swallowed whole with a sufficient amount of liquid.",12,11
"1567","de","en","Die Tabletten sind erhältlich in Durchdrückpackungen.","The tablets are packed in blisters.",6,6
"1568","de","en","Die Tabletten sind runde, leicht bikonvexe, hellgelbe Tabletten mit einzelnen gelben Flecken.","Tablets are round, slightly biconvex, slightly yellow tablets with possible individual yellow spots.",13,12
"1569","de","en","Die Tabletten sollten in Abständen von etwa 6 bis 8 Stunden mit oder ohne Mahlzeit eingenommen werden.","Tablets should be taken approximately 6 to 8 hours apart with or without food.",14,17
"1570","de","en","Die Tabletten sollten mit einem Glas Wasser geschluckt werden.","The tablets should be swallowed with a glass of water.",10,9
"1571","de","en","Die Tabletten sollten nicht geteilt oder durchgebrochen werden.","The tablets should not be divided or broken.",8,8
"1572","de","en","Die Tagesdosis sollte zwei Tabletten (100 mg) nicht überschreiten.","The daily dose should not exceed two tablets (100 mg).",10,9
"1573","de","en","Die Talspiegel nach 24 Stunden sind jedoch bei beiden Formulierungen vergleichbar.","Trough levels at 24 hours are, however, similar for both formulations.",11,11
"1574","de","en","Die terminale Eliminationshalbwertzeit (t 1/2) beträgt 10 Stunden.","The terminal elimination half-life (t½) is 10 hours.",8,8
"1575","de","en","Die terminale Halbwertszeit liegt in Abhängigkeit von der Dosis zwischen 5 und 7 Stunden.","The terminal half-life is between 5 and 7 hours depending on dose.",12,14
"1576","de","en","Die Therapie mit Riluzol ist abzubrechen, wenn die ALT-Spiegel den oberen Normwert um mehr als das 5fache überschreiten.","Riluzole should be discontinued if the ALT levels increase to 5 times the ULN.",14,18
"1577","de","en","Die Thrombozytenzahl und der Hämoglobinwert sollten in regelmäßigen Abständen ch","Platelet counts and haemoglobin level should also be monitored at regular intervals.",12,10
"1578","de","en","Die Tropfen zum Einnehmen enthalten Sorbitol.","The oral drops contain sorbitol.",5,6
"1579","de","en","Die Überlebensdauer betrug im Median 10,5 Monate (Xeloda + Cisplatin) gegenüber 9,3 Monate (5-FU + Cisplatin).","The median duration of survival was 10.5 months (Xeloda + cisplatin) versus 9.3 months (5-FU + cisplatin).",17,16
"1580","de","en","Die Überwachung der Kaliumwerte und von Kreatinin ist bei mittelschwerer Nierenfunktionsstörung angezeigt.","Monitoring of potassium levels and creatinine is advised in moderate renal impairment.",12,12
"1581","de","en","Die übliche Anfangsdosis beträgt 50 I.E./kg.","The usual starting dose is 50 IU/kg.",7,6
"1582","de","en","Die übliche Dosis beträgt 0,5 Millionen Einheiten (Mio.E.) pro kg Körpergewicht pro Tag.","The usual dose is 0.5 million units (MU) per kg bodyweight each day.",13,13
"1583","de","en","Die übliche Dosis ist eine Infusion von 0,5 mg (einem halben Milligramm) je Kilogramm Körpergewicht.","The usual dose is an infusion of 0.5 mg (half a milligramme) for every kg you weigh.",17,15
"1584","de","en","Die übliche empfohlene Anfangs- und Erhaltungsdosis ist 150 mg ein Mal täglich, unabhängig von den Mahlzeiten.","The usual recommended initial and maintenance dose is 150 mg once daily, with or without food.",16,16
"1585","de","en","Die übliche Tagesdosis an Epivir beträgt für Erwachsene und Jugendliche über 12 Jahren 300 mg.","The usual daily dose of Epivir in adults and adolescents over 12 years of age is 300 mg.",18,15
"1586","de","en","Die Unbedenklichkeit des Impfstoffes während der Trächtigkeit und Laktation wurde nicht untersucht.","The safety of the vaccine in pregnant and lactating animals has not been investigated.",14,12
"1587","de","en","Die Unbedenklichkeit des Tierarzneimittels während der Trächtigkeit und der Laktation ist nicht belegt.","The safety of the veterinary medicinal product has not been established during pregnancy or lactation.",15,13
"1588","de","en","Die Unbedenklichkeit von Fluoxetin bei einer Langzeitanwendung über 19 Wochen hinaus wurde nicht systematisch untersucht.","The safety of fluoxetine has not been systematically assessed for chronic treatment longer than 19 weeks.",16,15
"1589","de","en","Die unerwünschten Ereignisse waren denen vergleichbar, die bei niedrigeren Dosen gesehen werden.","Adverse events were similar to those seen at lower doses.",10,12
"1590","de","en","Die ungeraden Zahlen erschei- nen als Linien zwischen den geraden Zahlen.","The odd numbers are shown as full lines between the even numbers.",12,11
"1591","de","en","Die unter Abschnitt 4.2 „ Dosierung, Art und Dauer der Anwendung“ empfohlene Infusionsgeschwindigkeit ist unbedingt einzuhalten.","The recommended infusion rate given under “ 4.2.",8,16
"1592","de","en","Die untersuchten P-450-Enzyme waren:","The P450 enzymes tested for inhibition were:",7,4
"1593","de","en","Die Ursachen und die langfristigen Auswirkungen dieser Fettumverteilung sind noch nicht geklärt.","The cause and the long-term effects of these changes are not yet known.",13,12
"1594","de","en","Die Vene punktieren, wie vom Arzt angewiesen.","Perform venipuncture as instructed by your physician.",7,7
"1595","de","en","Die verabreichte Dosis hängt davon ab, ob es in Kombination mit Ribavirin oder als Monotherapie angewendet wird.","The dose administered depends on whether it is used in combination with ribavirin or as monotherapy.",16,17
"1596","de","en","Die Verabreichung muss an 5 aufeinanderfolgenden Tagen erfolgen.","The administration must be continued for 5 days.",8,8
"1597","de","en","Die Verabreichung von Aktivkohle kann bei der Behandlung einer Überdosierung von Nutzen sein.","Activated charcoal may be useful in the treatment of overdose.",10,13
"1598","de","en","Die Verabreichung von Gardasil sollte verschoben werden, wenn die zu impfende Person an einer schweren fieberhaften Erkrankung leidet.","Vaccination should be postponed in patients who are ill with a high fever.",13,18
"1599","de","en","Die Verabreichung von Tigecyclin als intravenöse Bolusinjektion wurde in Tierstudien mit einer Histaminreaktion in Zusammenhang gebracht.","Bolus intravenous administration of tigecycline has been associated with a histamine response in animal studies.",15,16
"1600","de","en","Die Veränderung der Irisfarbe geschieht langsam und kann über Monate bis Jahre hinweg unbemerkt bleiben.","The change in iris colour occurs slowly and may not be noticeable for months to years.",16,15
"1601","de","en","Die Verbesserung wurde bis Woche 28 aufrechterhalten.","The improvement was sustained through Week 28.",7,7
"1602","de","en","Die Veröffentlichung von EPARs wurde 1996 ein Bestandteil der festen Praxis, und inzwischen liegen 28 EPARs vor.","The publishing of EPARs became an established practice in 1996, with 28 EPARs now available.",15,17
"1603","de","en","Die verwendete Zylinderam- pulle darf zwischen den Injektionen nicht aus dem Pen entfernt werden.","Do not remove cartridge between injections.",6,14
"1604","de","en","Die Verwendung von InductOs bei gebohrter Nagelung zur Versorgung offener Tibia-Frakturen wird nicht empfohlen.","The use of InductOs with reamed nails in open tibial fracture repair is not recommended.",15,14
"1605","de","en","Die verzögerte Elimination von Mitotan aus dem Körper nach dem Absetzen von Lysodren muss berücksichtigt werden.","The prolonged elimination of mitotane from the body after discontinuation of Lysodren should be considered.",15,16
"1606","de","en","Die vollständige Anleitung zur Dosisberechnung und -anpassung ist der Packungsbeilage zu entnehmen.","See the Package Leaflet for the full instructions on calculating and adjusting the doses.",14,12
"1607","de","en","Die vollständige Auflistung der Einschränkungen ist der Packungsbeilage zu entnehmen.","For the full list of restrictions, see the Package Leaflet.",10,10
"1608","de","en","Die vollständige Auflistung der im Zusammenhang mit Agenerase berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Agenerase, see the Package Leaflet.",15,15
"1609","de","en","Die vollständige Auflistung der im Zusammenhang mit Azarga berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Azarga, see the Package Leaflet.",15,15
"1610","de","en","Die vollständige Auflistung der im Zusammenhang mit Clopidogrel Winthrop berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Clopidogrel Winthrop, see the Package Leaflet.",16,16
"1611","de","en","Die vollständige Auflistung der im Zusammenhang mit Emadine berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Emadine, see the Package Leaflet.",15,15
"1612","de","en","Die vollständige Auflistung der im Zusammenhang mit Flebogammadif berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Flebogammadif, see the Package Leaflet.",15,15
"1613","de","en","Die vollständige Auflistung der im Zusammenhang mit Insulatard berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Insulatard, see the Package Leaflet.",15,15
"1614","de","en","Die vollständige Auflistung der im Zusammenhang mit Kineret berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Kineret, see the Package Leaflet.",15,15
"1615","de","en","Die vollständige Auflistung der im Zusammenhang mit Mixtard berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Mixtard, see the Package Leaflet.",15,15
"1616","de","en","Die vollständige Auflistung der im Zusammenhang mit Optisulin berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Optisulin, see the Package Leaflet.",15,15
"1617","de","en","Die vollständige Auflistung der im Zusammenhang mit Ranexa berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Ranexa, see the Package Leaflet.",15,15
"1618","de","en","Die vollständige Auflistung der im Zusammenhang mit TESLASCAN berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with TESLASCAN, see the Package Leaflet.",15,15
"1619","de","en","Die vollständige Auflistung der im Zusammenhang mit Velcade berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Velcade, see the Package Leaflet.",15,15
"1620","de","en","Die vollständige Auflistung der im Zusammenhang mit Zerene berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen.","For the full list of all side effects reported with Zerene, see the Package Leaflet.",15,15
"1621","de","en","Die vollständige Auflistung der sonstigen Bestandteile siehe Abschnitt 6.1.","For a full list of excipients, see section 6.1.",9,9
"1622","de","en","Die vollständige Auflistung dieser Arzneimittel ist der Packungsbeilage zu entnehmen.","A list of these medicines is given in the Package Leaflet.",11,10
"1623","de","en","Die vollständige Beschreibung der Dosierungen ist der Packungsbeilage zu entnehmen.","For a full description of the dosages, please see the Package Leaflet.",12,10
"1624","de","en","Die vollständige Liste der im Zusammenhang mit Exubera berichteten Nebenwirkungen ist der Packungsbeilage zu entnehmen. tl","For the full description of the side effects reported with",10,16
"1625","de","en","Die vollständigen und durch erklärende Bilder ergänzten Handhabungshinweise sind im Anhang der Gebrauchsinformation dargestellt.","A complete and illustrated set of instructions is provided in the Annex to the Package Leaflet.",16,14
"1626","de","en","Die vom Patienten erhaltene kumulative Strahlendosis muss dabei ebenfalls berücksichtigt werden.","The overall radiation dose received by the patient over time should also be taken into account.",16,11
"1627","de","en","Die Vorschläge sind mit einigen Verbesserungen akzeptabel.","The proposals are acceptable with some improvements.",7,7
"1628","de","en","Die Warnzeichen treten allmählich auf.","The warning signs appear gradually.",5,5
"1629","de","en","Die Wartezeit für Milch betrug 2,5 Tage.","The withdrawal period for milk was 2.5 days.",8,7
"1630","de","en","Die weitere katalytische Aktivierung von 5‘-DFUR erfolgt dann durch die Thymidin-Phosphorylase (ThyPase).","Further catalytic activation of 5'-DFUR then occurs by thymidine phosphorylase (ThyPase).",11,12
"1631","de","en","Die Werte für die renale Clearance liegen bei etwa 74 ml/min (Losartan) und 26 ml/min (aktiver Metabolit).","Renal clearance of losartan and its active metabolite is about 74 mL/ min and 26 mL/ min, respectively.",18,17
"1632","de","en","Die wichtigste Nebenwirkung von Rapilysin sind Blutungen (z.","The main side effect of Rapilysin is bleeding (such as a bruise at the site of injection).",17,8
"1633","de","en","Die Wirkmechanismen sind nur unvollständig bekannt.","The mechanisms are incompletely known.",5,6
"1634","de","en","Die Wirksamkeit hormonaler Kontrazeptiva kann während und 28 Tage nach der Anwendung von EMEND vermindert werden.","The efficacy of hormonal contraceptives may be reduced during and for 28 days after administration of EMEND.",17,16
"1635","de","en","Die Wirksamkeit und Unbedenklichkeit von Filgrastim ist bei Erwachsenen und bei Kindern, die eine zytotoxische Chemotherapie erhalten, vergleichbar.","The safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.",15,18
"1636","de","en","Die Wirksamkeit und Unbedenklichkeit von Renagel bei Kindern oder bei Prädialysepatienten ist nicht untersucht worden.","Efficacy and safety of Renagel has not been studied in children or in predialysis patients.",15,15
"1637","de","en","Die Wirksamkeit von Aerius Lösung zum Einnehmen wurde nicht in speziellen Studien an Kindern untersucht.","Efficacy of Aerius oral solution has not been investigated in separate paediatric trials.",13,15
"1638","de","en","Die Wirksamkeit von RISPERDAL CONSTA blieb über die Zeit erhalten (Abbildung 1).","Over time efficacy was maintained with RISPERDAL CONSTA (Figure 1).",10,12
"1639","de","en","Die Wirksamkeit von Telbivudin gegen HBV mit einer M204V-Mutation wurde nicht in klinischen Studien nachgewiesen.","The efficacy of telbivudine against HBV harbouring the M204V mutation has not been established in clinical trials.",17,15
"1640","de","en","Die Wirksamkeit war definiert als virologisches Langzeitansprechen","Efficacy was defined as sustained virologic response, 6 months after the end of treatment.",14,7
"1641","de","en","Die Wirksamkeitsdaten der Studien zur Monotherapie und zur Kombinationstherapie sind in der folgenden Tabelle zusammengefasst:","The efficacy results from the monotherapy and combination therapy studies are summarised in the following table:",16,15
"1642","de","en","Die Wirkstoffe in Janumet, Sitagliptin und Metforminhydrochlorid, haben eine jeweils unterschiedliche Wirkungsweise.","These hormones are released after a meal and stimulate the pancreas to produce insulin.",14,12
"1643","de","en","Die Wirkstoffe und sonstigen Bestandteile von Infanrix Penta sind am Ende der vorliegenden Packungsbeilage aufgezählt.","The active substances and other ingredients in Infanrix Penta are listed at the end of the leaflet.",17,15
"1644","de","en","Die Wirkung hielt über einen Zeitraum von 6 Monaten an.","The effect was maintained over a 6 months period.",9,10
"1645","de","en","Die Wirkung ist bei Herzpatienten ausgeprägter.","The effect is more marked in cardiac patients.",8,6
"1646","de","en","Die Wirkung von Rebif ist möglicherweise nicht sofort bemerkbar.","The effects of Rebif may not be noticed immediately.",9,9
"1647","de","en","Die Wirkung von wiederholten Dosen ist jedoch nicht bekannt.","However the effect of multiple doses is not known.",9,9
"1648","de","en","Die Wirkung von Xiliarx beruht darauf, dass es die Bauchspeicheldrüse veranlasst, mehr Insulin und weniger Glucagon zu produzieren.","Xiliarx works by making the pancreas produce more insulin and less glucagon.",12,18
"1649","de","en","Die Wirkungen des Arzneimittels wurden in zwei der Studien über bis zu 52 Wochen aufrechterhalten.","The medicine’ s effects were maintained for up to 52 weeks in two of the studies.",16,15
"1650","de","en","Die Wirkungen des Impfstoffs wurden zunächst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.","The effects of the vaccine were first tested in experimental models before being studied in humans.",16,15
"1651","de","en","Die Wirkungen von CELSENTRI wurden zunächst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.","The effects of CELSENTRI were first tested in experimental models before being studied in humans.",15,15
"1652","de","en","Die Wirkungen von EXULETT wurden zunächst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.","The effects of EXULETT were first tested in experimental models before being studied in humans.",15,15
"1653","de","en","Die Wirkungen von IDflu wurden zunächst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.","The effects of IDflu were first tested in experimental models before being studied in humans.",15,15
"1654","de","en","Die Wirkungen von Nplate wurden zunächst in Versuchsmodellen getestet, bevor sie an Menschen untersucht wurden.","The effects of Nplate were first tested in experimental models before being studied in humans.",15,15
"1655","de","en","Die Zahl der Dokumente, die über die Internet-Homepage der Agentur abrufbar sind, stieg 1997 auf über 550.","The number of documents contained on the EMEA Website increased to over 550 in 1997.",15,17
"1656","de","en","Die Zeitspanne bis zum Erreichen der maximalen Konzentration Tmax beträgt 11 Stunden.","The time necessary to obtain the maximum concentration Tmax is 11 hours.",12,12
"1657","de","en","Die zubereitete Lösung nicht im Kühlschrank lagern oder einfrieren.","Do not refrigerate or freeze reconstituted solutions.",7,9
"1658","de","en","Die zur parenteralen Applikation zubereiteten Lösungen sind isotonisch.","The reconstituted solutions are isotonic for parenteral administration.",8,8
"1659","de","en","Die Zusammenfassung des Gutachtens des Ausschusses für Arzneimittel für seltene Leiden über Gliolan finden Sie hier.","The summary of opinion of the Committee for Orphan Medicinal Products for Gliolan is available here.",16,16
"1660","de","en","Die zuständigen Behörden der Mitgliedstaaten werden das Produkt regelmäßig überprüfen.","The Member States competent authorities will continue to keep the product under regular review.",14,10
"1661","de","en","Die zweite Studie lieferte daher keinen Beweis, das Zidovudin als ein transplazentales Karzinogen wirkt.","The second study thus provided no evidence that zidovudine acts as a transplacental carcinogen.",14,14
"1662","de","en","Dies bedeutet, dass Remicade, bevor Sie es erhalten, zunächst in Wasser für Injektionszwecke aufgelöst wird.","This means that before Remicade is given to you, it is first dissolved in water for injections.",17,15
"1663","de","en","Dies betrifft auch unbekannte oder neuartige Viren und andere Infektionsarten.","This also applies to any unknown or emerging viruses or other types of infections. lp",15,10
"1664","de","en","Dies bezeichnet man als intravenöse Infusion.","This is known as intravenous infusion.",6,6
"1665","de","en","Dies dauert üblicherweise 15 bis 30 Minuten.","This usually takes between 15 and 30 minutes.",8,7
"1666","de","en","Dies deutet darauf hin, dass der Vorteil mit der Zeit hin kleiner werden könnte.","This indicates that clinical benefit may diminish over time.",9,14
"1667","de","en","Dies dient der Kontrolle einer normalen Leberfunktion.","This is to check that your liver is working normally.",10,7
"1668","de","en","Dies führt zur Umwandlung von Prothrombin in Thrombin, das dann Fibrinogen in","This results ultimately in the conversion of prothrombin to thrombin.",10,12
"1669","de","en","Dies gilt auch für Krankheitserreger von bisher ungeklärter Herkunft.","This applies also to pathogens of hitherto unknown origin.",9,9
"1670","de","en","Dies gilt ebenfalls für Arzneimittel, die die Muskeln lähmen.","This is also relevant for medicinal products that weaken the muscle.",11,9
"1671","de","en","Dies gilt für Männer bei: • primärer testikulärer Insuffizienz","34 In men: • primary testicular insufficiency",7,9
"1672","de","en","Dies hilft Ihnen dabei, nur die erforderliche Dosis zu injizieren.","This will help you to inject the required dose only.",10,10
"1673","de","en","Dies ist aber wahrscheinlich klinisch nicht relevant, da die Probandenzahl sehr klein war.","6, 10, 14 weeks schedule",5,13
"1674","de","en","Dies ist bei der Zubereitung und Verabreichung von BeneFIX zu beachten.","This should be considered during the preparation and administration of BeneFIX.",11,11
"1675","de","en","Dies ist eine so genannte ""Patientensicherheitskarte"".","This card is named: “Patient Safety Card”..",7,6
"1676","de","en","Dies ist häufig und kein Grund zur Besorgnis.","This is common, and nothing to worry about.",8,8
"1677","de","en","Dies ist normal und die Wirksamkeit des Impfstoffes wird dadurch nicht beeinflusst.","This is normal and does not impair the performance of the vaccine.",12,12
"1678","de","en","Dies ist zu berücksichtigen bei Patienten unter Natrium kontrollierter (natriumarmer/-kochsalzarmer) Diät.","This should be taken into consideration by patients on a controlled sodium diet.",13,11
"1679","de","en","Dies ist zu berücksichtigen bei Patienten unter Natrium kontrollierter Diät.","To be taken into consideration by patients on a controlled sodium diet.",12,10
"1680","de","en","Dies kann daran liegen, dass das Insulin an Wirksamkeit verloren hat.","This is because the insulin may have lost some of its effectiveness.",12,11
"1681","de","en","Dies kann das Einleiten einer Behandlung mit oder das Erhöhen der Dosierung von fettsenkenden Wirkstoffen notwendig machen.","This may require initiation, or increase, in the dose of lipid-lowering agents.",12,17
"1682","de","en","Dies kann sich als Schmerz im Unterleib bemerkbar machen.","This may be noticed as pain in the abdomen.",9,9
"1683","de","en","Dies kann zum Schock (Kollaps) und sogar zum Tod führen.","This can lead to shock (collapse) and even be fatal.",10,10
"1684","de","en","Dies könnte darauf hindeuten, dass Prometax transdermale Pflaster bei den Patienten ein leichtes Erythem induzieren können.","This may indicate a potential for Prometax transdermal patches to induce mild erythema in patients.",15,16
"1685","de","en","Dies sollte mit Ihrem Arzt besprochen werden.","This can be discussed with your doctor.",7,7
"1686","de","en","Dies vergeht üblicherweise von selbst, falls nicht, sagen Sie es bitte Ihrem Arzt.","This will usually pass on its own but if it does not, tell your doctor.",15,13
"1687","de","en","dies verhindern kann, dass VIRAMUNE wie vorgesehen wirkt.","Take special care with VIRAMUNE",5,8
"1688","de","en","Dies war jedoch statistisch nicht signifikant.","1.9% for placebo) of serum potassium concentration (≥ 6.0 mmol/ l), although this was not statistically significant.",17,6
"1689","de","en","Dies wird als „ Demyelinisation“ bezeichnet.","This is called ‘ demyelination’.",5,6
"1690","de","en","Dies wurde als Maß für die körperliche Leistungsfähigkeit der Patienten herangezogen.","This measures the patients’ exercise capacity.",6,11
"1691","de","en","Dies wurde bei Dosierungen, die über dem 17fachen der systemischen Exposition der klinischen Dosis lagen, beobachtet.","These occurred at dosages which provided > 17-fold the systemic exposure seen at the clinical dosage.",16,16
"1692","de","en","Dies zeigte, dass Clopidogrel Winthrop das Risiko eines Ereignisses senkt.","This showed that Clopidogrel Winthrop reduces the risk of an event.",11,10
"1693","de","en","Diese Abfrage beeinflusst nicht die Dosisabgabe.","This query will not influence dose delivery.",7,6
"1694","de","en","Diese Aktualisierung könnte freilich durch eine Typ-II-Änderung auf nationaler Ebene erfolgen.","This could indeed be done through a type II variation at national level.",13,11
"1695","de","en","Diese Ansprechraten waren bei den Patienten vergleichbar, unabhängig davon, ob sie zum Zeitpunkt der Baseline-Visite eine Begleitbehandlung erhielten.","Responses were similar in patients who were or were not receiving concomitant therapies at baseline.",15,18
"1696","de","en","Diese Antikörper schützen vor Erkrankungen, die diese Rotavirus-Typen verursachen.","These antibodies protect against disease caused by these types of rotavirus.",11,9
"1697","de","en","Diese Arzneimittel werden zur Vorbeugung und Behandlung einer Vielzahl von Pilzinfektionen verwendet.","These medicines are used to prevent and treat a wide variety of fungal infections.",14,12
"1698","de","en","Diese Arzneimittelkombination könnte zu einem Anstieg der Carbamazepin- Konzentrationen und zu einer Verringerung der Lansoprazol-Konzentrationen führen.","The drug combination may result in increased carbamazepine concentrations as well as reduced lansoprazole concentrations.",15,16
"1699","de","en","Diese Arzneimittelkombination könnte zu einem Anstieg der Carbamazepin-Konzentrationen und zu einer Verringerung der Lansoprazol-Konzentrationen führen.","This combination of medicines could cause a rise in carbamazepine concentrations and a decrease in lansoprazole concentrations.",17,15
"1700","de","en","Diese Auswaschmaßnahmen können, falls klinisch erforderlich, wiederholt werden.","These washout procedures may be repeated if clinically necessary.",9,8
"1701","de","en","Diese Befunde deuten auf eine rasche Hornhautpenetration hin.","These findings indicate rapid corneal penetration.",6,8
"1702","de","en","Diese Beschwerden beginnen gewöhnlich während der ersten 24 Stunden nach der Geburt des Kindes.","These symptoms usually begin during the first 24 hours after the baby is born.",14,14
"1703","de","en","Diese Beschwerden waren Schmerzen, Schwellungen, Wundinfektion und Fieber.","These effects were pain, swelling, wound infection, and fever.",9,8
"1704","de","en","Diese Bestandteile können Überempfindlichkeitsreaktionen, auch Spätreaktionen, hervorrufen.","These ingredients may cause allergic reactions (sometimes delayed).",8,7
"1705","de","en","Diese Bindung führt zu einer differenzierten Expression verschiedenartiger östrogenregulierter Gene in unterschiedlichen Geweben.","This binding results in differential expression of multiple oestrogen-regulated genes in different tissues.",13,13
"1706","de","en","Diese CD4-Zellen spielen eine wichtige Rolle für die Aufrechterhaltung eines intakten Immunsystems zur Bekämpfung von Infektionen.","These CD4 cells play an important role in maintaining a healthy immune system to help fight infection.",17,16
"1707","de","en","Diese Daten weisen darauf hin, dass der Großteil der Substanz nicht über die Nieren ausgeschieden wird.","These data indicate that elimination of micafungin is primarily non-renal.",10,16
"1708","de","en","Diese Dosis muss möglicherweise nach ein oder zwei Wochen erhöht werden.","This dose may need to be increased after one or two weeks.",12,11
"1709","de","en","Diese Ereignisse können daher auch im Falle einer Überdosierung von intranasalem Calcitonin erwartet werden.","Such events might therefore also be expected to occur in association with an overdose of intranasal calcitonin.",17,14
"1710","de","en","Diese Ereignisse können im frühen Verlauf der Behandlung auftreten.","These effects may occur early on in treatment.",8,9
"1711","de","en","Diese Ergebnisse zeigen, dass IONSYS zur Schmerzkontrolle nach einer Operation von Nutzen ist.","These results show that IONSYS has a benefit in controlling pain after an operation.",14,13
"1712","de","en","Diese erhöhte Häufigkeit wurde nach einem Jahr der Behandlung festgestellt und blieb während des weiteren Studienverlaufs bestehen.","38 noted after the first year of treatment and remained during the course of the study.",16,17
"1713","de","en","Diese Erhöhung war jedoch in den entsprechenden Tests statistisch nicht signifikant im Vergleich zu männlichen Mäusen der Kontrollgruppe.","However, this increase was not statistically significantly different from male control mice by appropriate tests.",15,18
"1714","de","en","Diese Flüssigkeit wird ständig aus dem Auge abgeleitet und durch neue Flüssigkeit ersetzt.","Liquid is constantly being drained out of the eye and new liquid is made to replace this.",17,13
"1715","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt am","This leaflet was last approved on",6,6
"1716","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt am {MM/YYYY}","This leaflet was last approved in {MM/ YYYY}",8,7
"1717","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im","56 This leaflet was last approved in {MM/ YYYY}.",9,6
"1718","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im {MM/JJJJ}","This leaflet was last approved in {date}",7,7
"1719","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im {MM/JJJJ} [ist national auszufüllen]","[To be completed nationally]",4,10
"1720","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im {MM/JJJJ}.","This leaflet was last approved in {MM/ YYYY}.",8,7
"1721","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im {MM/YYYY}","This leaflet was last approved in {MM/YYYY}.",7,7
"1722","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im MM/JJJJ","This leaflet was last approved in MM/YYYY.",7,7
"1723","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt im.","This leaflet was last approved in.",6,6
"1724","de","en","Diese Gebrauchsinformation wurde zuletzt genehmigt in","This leaflet was last approved in",6,6
"1725","de","en","Diese Gruppe wird sich erstmals 2003 treffen.","1.4 Revision of EMEA fees",5,7
"1726","de","en","Diese Infektion wird durch als Candida bezeichnete Pilz(Hefe)-Zellen verursacht.","The infection is caused by fungal (yeast) cells called Candida.",10,9
"1727","de","en","Diese Interaktionen sind in den unten stehenden Tabellen beschrieben.","These interactions are described in the interaction tables below.",9,9
"1728","de","en","Diese Kombinationen wurden gut vertragen.","These combinations were well tolerated.",5,5
"1729","de","en","Diese ließen sich durch konventionelle Therapiemaßnahmen zur Behandlung von Schilddrüsenfehlfunktionen beheben.","The abnormalities were controlled by conventional therapy for thyroid dysfunction.",10,11
"1730","de","en","Diese LVEF-Verringerungen scheinen nicht progressiv verlaufen zu sein und verbesserten sich oft unter fortgesetzter Therapie.","These LVEF declines do not appear to have been progressive and often improved as treatment continued.",16,15
"1731","de","en","Diese Metaboliten sind im Wesentlichen gegen HIV-1 inaktiv.","These metabolites are essentially inactive against HIV-1.",7,8
"1732","de","en","Diese Nebenwirkung war jedoch bei Absetzen von Pregabalin reversibel.","Cases of renal failure have been reported and discontinuation of pregabalin did show reversibility of this adverse effect.",18,9
"1733","de","en","Diese Nebenwirkungen klangen innerhalb von ein bis zwei Tagen ab und erforderten keine zusätzliche Behandlung.","These adverse reactions were self-limiting within one or two days and did not require additional treatment.",16,15
"1734","de","en","Diese Nebenwirkungen schlossen Suizidabsichten und Suizidversuche ein (siehe Abschnitt 4.4).","These events included suicidal ideation and attempted suicide (see section 4.4).",11,10
"1735","de","en","Diese Nebenwirkungen sind normalerweise leicht bis mittelschwer ausgeprägt und verschwinden oft nach wenigen Wochen.","These effects are normally mild to moderate and often disappear after a few weeks.",14,14
"1736","de","en","Diese Nebenwirkungen treten gewöhnlich in der ersten Behandlungswoche auf und sind im Allgemeinen vorübergehend.","They disappear once treatment has stopped.",6,14
"1737","de","en","Diese Nebenwirkungen wurden auch bei Viraferon alleine beobachtet.","These undesirable effects have also been reported with Viraferon alone.",10,8
"1738","de","en","Diese Packung wird mit dem verbliebenen Aufkleber versiegelt.","This packaging should be sealed with the remaining sticker.",9,8
"1739","de","en","Diese Reaktion konnte generell auf einen unzureichenden Wechsel der Injektionsstelle zurückgeführt werden.","This reaction was generally associated with lack of proper rotation of injections.",12,12
"1740","de","en","Diese Reaktionen klangen durchschnittlich innerhalb von vier Tagen ab.","These reactions resolve over an average of 4 days.",9,9
"1741","de","en","Diese Reaktionen können vermieden werden, indem man die ACE-Hemmer-Therapie vor jeder Apherese zeitweise unterbricht.","(See 4.5 Interaction with other medicinal products and other forms of interaction, Antidiabetics.)",13,14
"1742","de","en","Diese Reaktionen sind normalerweise leicht und dauern nur kurze Zeit an.","These reactions are usually mild and last only for a short time.",12,11
"1743","de","en","Diese Reaktionen verliefen zumeist leicht bis mäßig schwer.","The majority of these reactions were mild or moderate in intensity.",11,8
"1744","de","en","Diese Reaktionen waren vorwiegend vorübergehender Natur.","These reactions were primarily transient in nature.",7,6
"1745","de","en","Diese Studie zeigte, dass ViraferonPeg gegenüber Interferon alfa-2b überlegen war (Tabelle 5).","This study showed that ViraferonPeg was superior to interferon alfa-2b (Table 5).",12,12
"1746","de","en","Diese Substanzen können eine Überempfindlichkeitsreaktion hervorrufen.","These products may cause an allergic reaction in some individuals.",10,6
"1747","de","en","Diese Symptome beinhalten Niesen, laufende oder juckende Nase, Juckreiz am Gaumen und juckende, gerötete oder tränende Augen.","These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.",16,17
"1748","de","en","Diese Symptome klangen nach Absetzen von Ferriprox ab.","They recovered from these symptoms after Ferriprox discontinuation.",8,8
"1749","de","en","Diese Symptome lassen sich durch Ausdehnung der Infusionszeit vermeiden.","These can be avoided by increasing the length of time the infusion is given over.",15,9
"1750","de","en","Diese Symptome verschwinden ohne weitere Behandlung.","These signs disappear without further treatment.",6,6
"1751","de","en","Diese Testlösung sollten Sie sofort trinken.","The patient should drink this test solution immediately.",8,6
"1752","de","en","Diese Veränderung ist möglicherweise dauerhaft.","This change may be permanent.",5,5
"1753","de","en","Diese vorübergehenden Veränderungen begannen im gleichen Konzentrationsbereich wie er nach Gabe der maximal empfohlenen klinischen Dosis erreicht wird.","These transient changes started in the same concentration range as after maximum recommended clinical dosing.",15,18
"1754","de","en","Diese war nach zweiwöchiger Applikationsdauer nicht reversibel.","Bone discolouring was observed in rats which was not reversible after two weeks of dosing.",15,7
"1755","de","en","Diese waren größtenteils vom Schweregrad 1/2 und ließen sich ohne Intervention handhaben.","Most were Grade 1/2 in severity and manageable without intervention.",10,12
"1756","de","en","Diese werden für die Behandlung von Infektionen mit dem humanen Immundefizienzvirus (HIV) angewendet.","These are used to treat Human Immunodeficiency Virus (HIV) infection.",10,13
"1757","de","en","Diese Wirkung ist von anderen Wirkstoffen, die kationisch-amphiphile Eigenschaften besitzen, bekannt.","This effect is known from other active substances with cationic amphiphilic properties.",12,11
"1758","de","en","Diese wurden im Vergleich zur r- HuEPO-Anwendung häufiger beobachtet.","This was seen more frequently than with r-HuEPO.",8,9
"1759","de","en","Diese Zusammenfassung wurde zuletzt am 25.","This summary was last updated on 25 September 2007.",9,6
"1760","de","en","Diese Zusammenfassung wurde zuletzt im Dezember 2006 aktualisiert.","This summary was last updated in December 2006.",8,8
"1761","de","en","Diesen Vorgang wiederholen, bis das errechnete Volumen erreicht ist.","Repeat this procedure until the calculated volume has been reached.",10,9
"1762","de","en","Dieser Abschnitt enthält Informationen dazu, wie Sie sich selbst eine Injektion mit Filgrastim ratiopharm geben.","This section contains information on how to give yourself an injection of Filgrastim ratiopharm.",14,15
"1763","de","en","Dieser Effekt ist auf die pharmakologische Wirkung zurückzuführen.","Skin flushes (facial or upper body).",6,8
"1764","de","en","Dieser Effekt war abgeschwächt, wenn die Antacida-Dosis 2 Stunden nach Crestor verabreicht wurde.","This effect was mitigated when the antacid was dosed 2 hours after Crestor.",13,13
"1765","de","en","Dieser Hauptmetabolit hat keine bekannte pharmakologische Aktivität.","This major metabolite has no known pharmacological activity.",8,7
"1766","de","en","Dieser Hinweis ist für alle Indikationen und für alle speziellen Patientenpopulationen gültig.","This advice is applicable to all indications and to all special populations.",12,12
"1767","de","en","Dieser Impfstoff ist ausschließlich zur oralen Verabreichung bestimmt.","This vaccine is for oral administration only.",7,8
"1768","de","en","Dieser Posten ist bestimmt zur Deckung der Vergütungen, der Dienstreisekosten sowie anderer Kosten für Sonderberater.","This item is intended to cover the remuneration of special advisors, their mission expenses and other expenses.",17,15
"1769","de","en","Dieser Prozess wird von mehreren Faktoren beeinflusst (z.","insulin preparation is determined solely by its absorption characteristics.",9,8
"1770","de","en","Dieser Test soll gewährleisten, dass die Patientin nicht schwanger ist, wenn sie die Behandlung mit Isotretinoin beginnt.","This test should ensure the patient is not pregnant when she starts treatment with isotretinoin.",15,17
"1771","de","en","Dieser Tremor wurde bei der Gaucher-Krankheit des Typs 1 als ein gesteigerter physiologischer Tremor der Hände beschrieben.","In type 1 Gaucher disease, these tremors were described as an exaggerated physiological tremor of the hands.",17,17
"1772","de","en","Dieser Unterschied war jedoch weniger als der 2-fache Bereich der AUC(0-∞), der für pädiatrische Patienten beobachtet wurde.","AUC(0-∞) was similar between adult and paediatric patients with CRF following subcutaneous administration.",13,17
"1773","de","en","Dieser Unterschied zwischen den Behandlungsarmen war statistisch signifikant.","This difference between treatment arms was statistically significant.",8,8
"1774","de","en","Dieses Arzneimittel darf nicht mit anderen Arzneimitteln oder Lösungsmitteln gemischt werden.","This medicinal product must not be mixed with other medicinal products or solvents.",13,11
"1775","de","en","Dieses Arzneimittel darf nur unter ärztlicher Aufsicht eingenommen werden.","This product should only be taken under the supervision of a doctor.",12,9
"1776","de","en","Dieses Arzneimittel enthält 75 mmol/l Natriumchlorid pro Dosis.","This medicinal product contains 75mmol/ l sodium chloride per dose.",10,8
"1777","de","en","Dieses Arzneimittel enthält Lactose.","Lactose: this product contains lactose.",5,4
"1778","de","en","Dieses Arzneimittel ist identisch mit Coaprovel, das bereits in der Europäischen Union (EU) zugelassen ist.","This medicine is the same as Coaprovel, which is already authorised in the European Union (EU).",16,15
"1779","de","en","Dieses Arzneimittel ist in den Mitgliedsstaaten des Europäischen Wirtschaftsraumes (EWR) unter den folgenden Bezeichnungen zugelassen:","This medicinal product is authorised in the Member States of the EEA under the following names:",16,15
"1780","de","en","Dieses Arzneimittel ist ohne Verschreibung erhältlich.","This medicine is available without prescription.",6,6
"1781","de","en","Dieses Arzneimittel kann durch andere Arzneimittel, die über die Nieren abgebaut werden, beeinflusst werden.","This medicine can be affected by other medicines that are removed by the kidneys.",14,14
"1782","de","en","Dieses Arzneimittel wurde unter besonderen Bedingungen zugelassen.","This medicinal product has been authorised under a so-called “ conditional approval” scheme.",13,7
"1783","de","en","Dieses Dokument kann das persönliche Gespräch mit dem Tierarzt nicht ersetzen.","This document cannot replace a face- to-face discussion with your veterinarian.",11,11
"1784","de","en","Dieses Produkt enthält Saccharose und Sorbitol.","This product contains sucrose and sorbitol.",6,6
"1785","de","en","Dieses setzt dann Fibrin aus Fibrinogen frei und die Gerinnselbildung kann erfolgen.","Thrombin then converts fibrinogen into fibrin and a clot can be formed.",12,12
"1786","de","en","Dieses Tierarzneimittel ist ausschließlich zum Auftropfen auf die Haut.","This veterinary medicinal product is for spot-on application only.",9,9
"1787","de","en","Dieses Verfahren nennt man Infusion.","This procedure is referred to as an infusion.",8,5
"1788","de","en","Dieses Verfahren verdeutlichte die","• Management of Type I Variations in the Centralised Procedure",10,4
"1789","de","en","Dieses wird nicht weiter verstoffwechselt und wird durch den Urin ausgeschieden.","It is not further metabolised and is eliminated in the urine.",11,11
"1790","de","en","Diffuses großzelliges B-Zell-Non-Hodgkin-Lymphom MabThera sollte in Kombination mit einer CHOP-Chemotherapie angewendet werden.","Diffuse large B cell non-Hodgkin's lymphoma MabThera should be used in combination with CHOP chemotherapy.",15,12
"1791","de","en","Digoxin (Herzwirksames Glykosid) Die gemeinsame Anwendung von Lansoprazol und Digoxin kann zu einem Anstieg der Digoxin- Plasmakonzentrationen führen.","34 Simultaneous administration of lansoprazole and digoxin can cause a rise in plasma digoxin concentrations.",15,18
"1792","de","en","Digoxin AUC0-72 ↑ 49% Digoxin Cmax ↑ 27% Die Digoxin-Spiegel können sich im Laufe der Zeit verändern.","Digoxin AUC0-72 ↑ 49% Digoxin Cmax ↑ 27% Digoxin levels may differ over time.",14,17
"1793","de","en","Dihydroergotamin, Ergotamin, Methylergometrin, (dopaminerge Vasokonstriktoren):","Dihydroergotamine, ergotamine, methylergometrine (dopaminergic vasoconstricteurs): risk of vasoconstriction and increase in blood pressure.",13,5
"1794","de","en","Dinatriumhydrogenphosphat, Natriumdihydrogenphosphat 1 H 2 O, Natriumedetat (Ph.Eur.), Natriumchlorid, Metacresol (Ph.Eur.), Polysorbat 80 und Wasser für Injektionszwecke.","monohydrate, edetate disodium, sodium chloride, m-cresol, polysorbate 80 and water for injections.",12,17
"1795","de","en","Dinatriumhydrogenphosphat, Natriumdihydrogenphosphat 1 H 2 O, Natriumedetat (Ph.Eur.), Natriumchlorid, Metacresol (Ph.Eur.), Polysorbat 80, Wasser für Injektionszwecke.","Disodium phosphate anhydrous, Sodium dihydrogen phosphate monohydrate, Edetate disodium,",9,16
"1796","de","en","Diovan kann allein oder in Kombination mit ACE-Hemmern angewendet werden.","It can be used on its own and in combination with ACE inhibitors.",13,10
"1797","de","en","Diovan kann auch zusammen mit anderen Antihypertensiva gegeben werden.","Diovan may also be administered with other antihypertensive agents.",9,9
"1798","de","en","Distribution, Metabolismus und Exkretion Aufgrund der Hautselektivität sind die Blutspiegel von Pimecrolimus nach topischer Anwendung sehr niedrig.","Distribution, Metabolism, and Excretion Consistent with its skin selectivity, after topical application, pimecrolimus blood levels are very low.",18,17
"1799","de","en","Divalproex, Lamotrigin, Phenytoin ANTIDEPRESSIVA","Divalproex, lamotrigine, phenytoin ANTIDEPRESSANTS",4,4
"1800","de","en","DK Desitin Pharma AS Havnegade 55, st. tv.","DK Desitin Pharma AS Havnegade 55, st. tv.",8,8
"1801","de","en","Doc Generici Srl Via Manuzio, 7 20124 Milano Italien","Doc Generici Srl Via Manuzio, 7 20124 Milano Italy",9,9
"1802","de","en","Docetaxel darf nicht angewandt werden bei Patienten mit einer Neutrophilenzahl < 1500 Zellen/mm3.","Docetaxel must not be used in patients with baseline neutrophil count of < 1,500 cells/ mm3.",16,13
"1803","de","en","DOCETAXEL WINTHROP 20 MG KONZENTRAT UND LÖSUNGSMITTEL ZUR HERSTELLUNG EINER INFUSIONSLÖSUNG Docetaxel","INFORMATION FOR THE USER Docetaxel Winthrop 20 mg concentrate and solvent for solution for infusion docetaxel",16,12
"1804","de","en","Docetaxel Winthrop 75 mg/m2 in Kombination mit Cisplatin und 5-Fluorouracil zur Behandlung von Adenokarzinomen des Magens","56 Docetaxel Winthrop 75 mg/ m² in combination with cisplatin and 5-fluorouracil for gastric adenocarcinoma cancer",16,16
"1805","de","en","Docetaxel Winthrop wird als Durchstechflasche zur Einmalentnahme geliefert.","Docetaxel Winthrop is supplied as single-dose vials.",7,8
"1806","de","en","Doktortitel in klinischer Pharmakologie.","Doctorate in clinical pharmacology.",4,4
"1807","de","en","Domaniewska 50 C PL – 02.672 Warszawa Tel: + 48-22 549 15 00","Domaniewska 50 C PL – 02 672 Warszawa Tel.: + 48-22 549 15 00",14,13
"1808","de","en","Doribax 500 mg Pulver zur Infusion Doripenem Zur intravenösen Anwendung","Doribax 500 mg powder for infusion doripenem Intravenous use",9,10
"1809","de","en","Dorzolamid führte zu einer Senkung zwischen 4,3 und 4,9 mmHg.","Dorzolamide led to decreases of between 4.3 and 4.9 mmHg.",10,10
"1810","de","en","Dosen von mehr als 100 mg Vildagliptin werden nicht empfohlen.","Doses of vildagliptin above 100 mg are not recommended.",9,10
"1811","de","en","Dosenschema erfolgte N = 350","dose primary course N = 350",6,5
"1812","de","en","Dosierbeispiele Einstellen von 8 Einheiten:","Dosage examples To set 8 units:",6,5
"1813","de","en","Dosiertube senkrecht halten und durch leichtes Klopfen gegen den Twist-off- Verschluss die in der Dosierspitze befindliche Lösung entfernen.","Clear the fluid from the dispensing tip by holding tube vertically and tapping the twist-off cap.",16,18
"1814","de","en","Dosierung bei Patienten mit eingeschränkter Nierenfunktion","Dosage in patients with impaired kidney function",7,6
"1815","de","en","Dosierung Einen Tropfen EMADINE zweimal täglich in das betroffene Auge oder die betroffenen Augen eintropfen.","Posology The dose is one drop of EMADINE to be applied to the affected eye(s) twice daily.",17,15
"1816","de","en","DOSIERUNG FÜR JEDE TIERART, ART UND DAUER DER ANWENDUNG","DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION",9,9
"1817","de","en","Dosierungen über 1 200 mg sind nicht untersucht worden.","The minimum dose is 480 mg, and doses above 1,200 mg have not been tested.",15,9
"1818","de","en","Dosis 2x täglich (Dosis in mg)","Daily Oral Solution Dose (dose in mg)",7,6
"1819","de","en","Dosis von 5 g","interference after a 5 g dose",6,4
"1820","de","en","Dosisänderungen waren bei 30% der Ar","In addition, injection site disorders, fever, anorexia, vomiting, and emotional lability occurred more frequently in children and na",18,6
"1821","de","en","Dosisänderungen waren bei 30% der Patienten nötig, hauptsächlich wegen Anämie und Neutropenie.","Dose modifications were required in 30% of patients, most commonly for anaemia and neutropaenia.",14,12
"1822","de","en","Dosisanpassung Bei älteren Patienten kann eine Dosisverringerung erforderlich sein.","Dosage adjustment In elderly patients a dose reduction may be necessary.",11,9
"1823","de","en","Dosisanpassung mit dem Ziel, den Hämoglobinwert zwischen 10 g/dl und 12 g/dl zu halten:","Dosage adjustment to maintain haemoglobin concentration between 10 g/ dl - 12 g/ dl:",14,14
"1824","de","en","Dosisanpassung zur Stabilisierung der Hämoglobinwerte (Hb) auf dem","Dose adjustment in order to maintain haemoglobin (Hb) values at the desired level:",13,8
"1825","de","en","Dosisanpassungen müssen auf Serumspiegeln von Insulin-like-Growth-Factor-I (IGF-I) beruhen.","Dose adjustments should be based on serum IGF-I levels.",9,8
"1826","de","en","Dosisanpassungen müssen unter Berücksichtigung der Nierenfunktion, des Gewichtes und der aPTT (siehe Abschnitt 4.2) erfolgen.","Dosing adjustments are based on renal function, weight, and aPTT (see section 4.2).",13,15
"1827","de","en","Dosisreduktion auf 400 mg einmal täglich erforderlich.","If blood counts remain low, a dose reduction to 400 mg once daily may be required.",16,7
"1828","de","en","Dosisreduktion von CRIXIVAN auf 400-600 mg alle 8 Stunden sollte in Erwägung gezogen werden.","Dose reduction of CRIXIVAN to 400-600 mg every 8 hours should be considered.",13,14
"1829","de","en","Dosisreduktion von Diltiazem um 50% mit nachfolgender Titration nach Bedarf und EKG-","reduction of diltiazem by 50% is recommended, with subsequent titration as",11,12
"1830","de","en","Down, BT35 6JP United Kingdom","Down, BT35 6JP United Kingdom",5,5
"1831","de","en","Doxazosin Winthrop 4 mg Retardtabletten","Doxazosin Winthrop 4 mg Retardtabletten",5,5
"1832","de","en","Doxazosin wird größtenteils abgebaut; weniger als 5% der Substanz werden unverändert ausgeschieden.","Doxazosin is extensively metabolised with < 5% excreted as unchanged product.",11,12
"1833","de","en","Doxyprex 100 mg/g Vormischung","Doxyprex 100 mg/ g Premix",5,4
"1834","de","en","Dr Reddy's Laboratories (Uk) Limited 6 Riverview Road Beverley, E Yorks HU17 0LD Vereinigtes Königreich","Dr Reddy's Laboratories (Uk) Limited 6 Riverview Road Beverley, E Yorks HU17 0LD United Kingdom",15,15
"1835","de","en","Drehen Sie den Verschluss um und öffnen Sie damit die Versiegelung der Pipette (siehe Abbildung).","Reverse the cap and use it to twist and remove the seal from the pipette, as shown.",17,15
"1836","de","en","Drehen Sie die Flasche auf den Kopf.","Turn bottle upside down.",4,7
"1837","de","en","Drücken Sie den Injektionsknopf vollständig durch, wenn möglich mit dem Daumen.","Using your thumb, if possible, push in the injection button completely.",11,11
"1838","de","en","Drücken Sie hierzu den Kolben vorsichtig nach unten, bis die Spritze leer ist.","Slowly (over a few seconds) inject the solution by gently depressing the plunger until the syringe is empty.",18,13
"1839","de","en","Drynam Road, Swords, Co.","Drynam Road, Swords, Co.",4,4
"1840","de","en","Dukoral ist ein Impfstoff, der als Suspension in einer Durchstechflasche erhältlich ist.","Dukoral is a vaccine, which is available as a suspension in a vial.",13,12
"1841","de","en","Duloxetin wird beim Menschen zu etwa 96% an Plasmaproteine gebunden.","Duloxetine is approximately 96% bound to human plasma proteins.",9,10
"1842","de","en","DULOXETINE BOEHRINGER INGELHEIM 30 mg ist in Packungen mit 7, 28 und 98 Hartkapseln erhältlich.","DULOXETINE BOEHRINGER INGELHEIM 30 mg is available in packs of 7, 28 and 98 capsules.",15,15
"1843","de","en","DULOXETINE BOEHRINGER INGELHEIM 60 mg ist in Packungen mit 28 und 98 Hartkapseln erhältlich.","60 DULOXETINE BOEHRINGER INGELHEIM 60 mg is available in packs of 28 and 98 capsules.",15,14
"1844","de","en","Dunkelgrünes bis schwarzes Pulver.","Dark green to black powder.",5,4
"1845","de","en","DuoTrav bedarf einer ärztlichen Verschreibung.","DuoTrav can only be obtained with a prescription.",8,5
"1846","de","en","Duration of chronic toxicity testing in animals (rodent and non-rodent toxicity testing) Safety studies for gene therapy products.","Duration of chronic toxicity testing in animals (rodent and non-rodent toxicity testing)",12,18
"1847","de","en","Durch Cytochrom P450 verstoffwechselte Produkte:","22/28 or four hours after cholestyramine or one hour",9,5
"1848","de","en","Durch die antiretrovirale Kombinationstherapie kann auch der Fettgehalt des Blutes (Hyperlipidämie) zunehmen sowie das Ansprechen auf Insulin abnehmen.","Combination antiretroviral therapy may also cause increased fat levels in the blood (hyperlipaemia) and resistance to insulin.",17,18
"1849","de","en","Durch die Aufnahme von Nahrung wird die Resorption von Metformin verringert und leicht verzögert.","24 Food slightly delays and decreases the extent of the absorption of metformin.",13,14
"1850","de","en","Durch die Blockade des TNF verringert Etanercept die Entzündung und andere Symptome der Erkrankungen.","By blocking TNF, etanercept improves the inflammation and other symptoms of the diseases.",13,14
"1851","de","en","Durch die Hemmung der Osteoklastenaktivität über spezifische Rezeptoren verringert Lachs-Calcitonin die Knochenresorption.","By inhibiting osteoclast activity via its specific receptors, salmon calcitonin decreases bone resorption.",13,12
"1852","de","en","Durch Punktion des Stöpsels mit einer Nadel kann Osigraft durch Partikel des Stöpselmaterials verunreinigt werden.","Puncture of the stopper with a needle may result in particles of stopper material contaminating Osigraft.",16,15
"1853","de","en","Durchfall Oberbauchschmerzen Übelkeit Erbrechen","MedDRA Standard System Organ Class",5,4
"1854","de","en","Durchfall Übelkeit Erbrechen Stomatitis Oberbauch- beschwerden","Diarrhoea Nausea Vomiting Stomatitis Dyspepsia Abdominal pain C / distension",10,6
"1855","de","en","Durchschnittliche (% CV) pharmakokinetische Parameter der Mehrfachdosierung für eim","Mean (% CV) multiple-dose pharmacokinetic parameters for Viraferon and ribavirin uc",11,9
"1856","de","en","Durchstech- flasche (Glas) Lösungsmittel:","Powder: vial (glass); Solvent: vial (glass)",6,4
"1857","de","en","Durchstechflasche (mit Pulver für Injektionslösung):","Vial (with powder for solution and injection):",7,5
"1858","de","en","Durchstechflasche 0,5 ml (Glas) (1 Dosis = 0,5ml)","0.5 ml (1 dose = 0.5ml)",6,8
"1859","de","en","Durchstechflasche 100 ml (Glas)","Cardboard box with one vial",5,4
"1860","de","en","Durchstechflasche aufrecht auf einer flachen Oberfläche (wie z.","Look for the needle tip inside the stopper window.",9,8
"1861","de","en","Durchstechflasche mit je 50, 100 und 250 ml","50, 100 and 250 ml vials.",6,8
"1862","de","en","Durchstechflasche mit Pulver zur Herstellung einer Injektionssuspension (alle Packungen)","Vial for powder for suspension for injection (all packs)",9,9
"1863","de","en","DURCHSTECHFLASCHE/Docetaxel Winthrop 20 mg","VIAL/ Docetaxel Winthrop 20 mg",5,4
"1864","de","en","Durchstechflaschen 250 ml (Glastyp II) verschlossen mit einem Gummi- stopfen und einer Aluminiumkappe","Intramuscular Glass bottles 250ml or (hydrolytical subcutaneous Type II) with rubber stopper and aluminium cap",15,13
"1865","de","en","Durchstechflaschen des Glastyps I verschlossen mit Halogenobutylgummistopfen und versiegelt mit einer Aluminiumbördelkappe.","Type I glass vial closed with a halogenobutyl rubber stopper and sealed with an aluminium cap.",16,12
"1866","de","en","Duvaxyn WNV – Emulsion zur Injektion für Pferde","Duvaxyn WNV emulsion for injection for horses",7,8
"1867","de","en","Dynastat darf nicht bei stillenden Frauen angewendet werden (siehe Abschnitte 4.3 und 5.3).","Dynastat should not be administered to women who breast-feed (see sections 4.3 and 5.3).",14,13
"1868","de","en","Dynastat hat keine Wirkung auf die durch Acetylsalicylsäure vermittelte Hemmung der Thrombozytenaggregation oder die Blutungszeiten.","Dynastat had no effect on acetylsalicylic acid-mediated inhibition of platelet aggregation or bleeding times.",14,15
"1869","de","en","Dysgeusie/Parosmie; periphere sensorische Neuropathie (G3/4:","Dysgeusia/ Parosmia; Dizziness Peripheral sensory neuropathy (G3/ 4:",8,5
"1870","de","en","Dyslipidämie Durch Hypertriglyceridämie und / oder niedriges HDL-Cholesterin charakterisierte gemischte Dyslipidämie.","Treatment of dyslipidemia Mixed dyslipidaemia characterised by hypertriglyceridaemia and/ or low HDL-cholesterol.",12,11
"1871","de","en","Dyspnoe, Husten, Heiserkeit, Pharyngolaryngealschmerzen, Rachenreizungen, Atemwegkongestion, Kongestion der Nasennebenhöhlen, retronasaler Schleimfluss, Rhinorrhoe, Schnarchen","Dyspnoea, cough, hoarseness, pharyngolaryngeal pain, throat irritation, respiratory tract congestion, sinus congestion, post nasal drip, rhinorrhoea, snoring",17,13
"1872","de","en","Dyspnoe, Tachypnoe, Epistaxis, Husten, verstopfte Nase, Reizung der Nasenschleimhaut, Rhinorrhoe, Niesen","Dyspnoea, tachypnea, epistaxis, coughing, nasal congestion, nasal irritation, rhinorrhea, sneezing",10,11
"1873","de","en","e Daten über die Auswirkung von Calcitonin zur Injektion auf die Fahrtüchtigkeit und auf das Bedienen","tho No data exist on the effects of injectable calcitonin on the ability to drive and use machines.",18,16
"1874","de","en","E2, E1, Erns, gp 54 und gp 80.","E2, E1, Erns, gp54, gp80.",5,8
"1875","de","en","Easotic, Ohrentropfen, Suspension für Hunde","Easotic, ear drops suspension for dogs",6,5
"1876","de","en","Ebixa 10 mg/g Tropfen zum Einnehmen, Lösung Memantinhydrochlorid","Ebixa 10 mg/ g oral drops, solution Memantine hydrochloride",9,8
"1877","de","en","Econor 0,5% Arzneimittel-Vormischung enthält Valnemulin in Form von Valnemulinhydrochlorid.","Econor 0.5% premix contains valnemulin in the form of valnemulin hydrochloride.",11,9
"1878","de","en","Econor 50% Arzneimittel-Vormischung zur Herstellung von Fütterungsarzneimitteln für Schweine","Econor 50% premix for medicated feed for pigs",8,9
"1879","de","en","Econor Valnemulin Part B extension","G03GA01 Assisted reproductive techniques sus as in vitro fertilisation (IVF)",10,5
"1880","de","en","Eesti Alcon Eesti + 372 6 313 214","Eesti Alcon Eesti + 372 6 313 214",8,8
"1881","de","en","Eesti Eli Lilly Holdings Limited Eesti filiaal Tel: + 3726817280","Eesti Eli Lilly Holdings Limited Eesti filiaal Tel: + 3726817280",10,10
"1882","de","en","Eesti Generics [UK] Ltd Tel: +44 1707 853000 (United Kingdom)","Eesti Generics [UK] Ltd Tel: +44 1707 853000 (United Kingdom)",10,10
"1883","de","en","Eesti GlaxoSmithKline Eesti OÜ Tel: + 372 6676 900 estonia@gsk.com","Eesti Österreich GlaxoSmithKline Eesti OÜ Tel: + 372 6676 900 estonia@gsk.com",11,10
"1884","de","en","Eesti Norge Boehringer Ingelheim Pharma GmbH Eesti filiaal Weizenbergi 20 EE-10150 Tallinn Tel: + 372 60 80 940","Eesti Norge Boehringer Ingelheim Pharma GmbH Eesti filiaal Weizenbergi 20 EE-10150 Tallinn Tel: + 372 60 80 940",18,18
"1885","de","en","Eesti Österreich Järvevana tee 9 EE-11314 Tallinn Tel: + 372 654 96 86","Eesti Järvevana tee 9 EE-11314 Tallinn Tel: + 372 654 96 86",12,13
"1886","de","en","Eesti Österreich sanofi-aventis Estonia OÜ Tel: +372 627 34 88","Eesti sanofi-aventis Estonia OÜ Tel: +372 627 34 88",9,10
"1887","de","en","Eesti Österreich Takeda Global Research and Development Centre (Europe) Ltd., Ühendkuningriik Tel: + 44 (0)203 116 8000","27 Eesti Österreich Takeda Global Research and Development Centre (Europe) Ltd., Ühendkuningriik Tel: + 44 (0)203 116 8000",18,17
"1888","de","en","Eesti Pfizer Luxembourg SARL Eesti filiaal Tel: +372 6 405 328","Eesti Pfizer Luxembourg SARL Eesti filiaal Tel: +372 6 405 328",11,11
"1889","de","en","Eesti ratiopharm Eesti büroo Tel: +372 6838 006","Eesti Österreich ratiopharm Eesti büroo Tel: +372 6838 006",9,8
"1890","de","en","Efalizumab ist ein monoklonaler Antikörper.","Efalizumab is a monoclonal antibody.",5,5
"1891","de","en","Efavirenz soll nicht gleichzeitig mit einer fixen Dosiskombination aus Efavirenz, Emtricitabin und Tenofovirdisoproxilfumarat angewandt werden.","Co-administration of efavirenz with the fixed combination tablet containing efavirenz, emtricitabine, and tenofovir disoproxil fumarate is not recommended.",18,15
"1892","de","en","Efexor depot und zugehörige Namen (siehe Annex I) 150 mg Hartkapseln, retardiert","Efexor depot and associated names (see Annex I) 150 mg prolonged-release capsules, hard",13,12
"1893","de","en","Effentora 400 Mikrogramm Buccaltabletten Fentanyl","Effentora 400 micrograms buccal tablets Fentanyl",6,5
"1894","de","en","Efficib 50 mg/850 mg Tabletten Sitagliptin/Metformin-HCl","Efficib 50 mg/ 850 mg tablets sitagliptin/ metformin HCl",9,6
"1895","de","en","Efficib darf nicht eingenommen werden,","Do not take Efficib:",4,5
"1896","de","en","Effkete auf die Körpergröße In der 3-Jahres-Osteoporosestudie wurde jährlich die Körpergröße im Stehen mit einem Stadiometer gemessen.","Effect on height In the three-year osteoporosis study standing height was measured annually using a stadiometer.",16,17
"1897","de","en","Efient verringerte die Gesamtzahl kardiovaskulärer Todesfälle, Herzinfarkte oder Schlaganfälle wirksamer als Clopidogrel.","Efient was more effective than clopidogrel at reducing the total number of cardiovascular deaths, heart attacks or strokes.",18,12
"1898","de","en","Ein abtrennbarer Abschnitt am Ende dieser Gebrauchsinformation enthält Informationen zur Zubereitung und Anwendung.","Information on reconstitution and administration is provided in a detachable section at the end of this leaflet.",17,13
"1899","de","en","Ein ähnlicher Trend wurde auch bei den Therapieabbruchraten beobachtet.","A similar trend is also seen for the discontinuation rates.",10,9
"1900","de","en","Ein Antidot zur Behandlung einer Überdosierung von Dopaminagonisten ist nicht bekannt.","There is no established antidote for overdose 38 of a dopamine agonist.",12,11
"1901","de","en","Ein Behältnis ist ausreichend für die Behandlung beider Augen.","For single use only; one container is sufficient to treat both eyes.",12,9
"1902","de","en","Ein Diabetiker sollte deshalb immer einige zuckerhaltige Lebensmittel bei sich haben.","It is therefore recommended that the diabetic patient always carries sugar containing products.",13,11
"1903","de","en","Ein einzelner Endpunkt aus mehreren Komponenten, bekannt als „ Overall Success“ (Gesamterfolg), war die primäre Variable der Studie.","A single, multi-component endpoint, known as overall success was the primary variable of the study.",15,18
"1904","de","en","Ein im Umgang mit Krebsmedikamenten erfahrener Arzt wird die Behandlung mit Erbitux bei Ihnen überwachen.","A doctor experienced in the use of anticancer medicines will supervise your Erbitux therapy.",14,15
"1905","de","en","Ein Karton mit Entfällt 25 Fertigspritzen","25 pre-filled Not applicable syringes per cardboard box",8,6
"1906","de","en","Ein maximales klinisches Ansprechen wurde in der Regel innerhalb von 12 Wochen nach Beginn der Behandlung beobachtet.","Maximal clinical response was generally seen within 12 weeks after starting treatment.",12,17
"1907","de","en","Ein ml enthält 1,11 mg Hydrocortisonaceponat, 15,1 mg Miconazolnitrat und 1.505 IE Gentamicinsulfat.","One ml contains 1.11 mg hydrocortisone aceponate, 15.1 mg miconazole (as nitrate) and 1505 IU gentamicin (as sulphate).",18,13
"1908","de","en","Ein nicht-hormonelles Verfahren zur Empfängnisverhütung ist daher vorzuziehen.","Male patients with sexual partners who are pregnant, possibly pregnant, or may",12,8
"1909","de","en","Ein plötzliches Absetzen von Dafiro war nicht mit einem schnellen Anstieg des Blutdrucks verbunden.","Abrupt withdrawal of Dafiro has not been associated with a rapid increase in blood pressure.",15,14
"1910","de","en","Ein positiver Vorhersagewert der Fluoreszenz des Gewebes von 84,8% (90% KI:","A positive predictive value of tissue fluorescence of 84.8% (90% CI:",11,11
"1911","de","en","Ein Problem bei der Indikation der Nierentransplantation bei Kindern ist jedoch der Mangel an Langzeitdaten.","One pitfall for the renal paediatric indication is, however, the lack of long- term data.",15,15
"1912","de","en","Ein realistisches Ziel ist eine Gewichtsabnahme von 5% bis 10% Ihres Ausgangsgewichtes.","A realistic goal is to lose between 5% to 10% of your starting weight.",14,12
"1913","de","en","Ein Sprühstoß enthält 25 Mikrogramm Salmeterol (als Xinafoat) und 250 Mikrogramm Fluticasonpropionat","25 micrograms of salmeterol (as xinafoate) and 250 micrograms of fluticasone propionate per actuation",14,12
"1914","de","en","Ein statistisch signifikanter Anstieg von fötalen Missbildungen (Fehlstellung der Sternebrae) wurde in den Würfen der OP-1-immunisierten Gruppe festgestellt.","A statistically significant increase in foetal malformations (misaligned sternabrae) was seen in litters of the OP-1 immunized group.",18,18
"1915","de","en","Ein Umkarton enthält 4 Durchstechflaschen mit Enbrel, 4 Fertigspritzen mit Lösungsmittel und 8 Alkoholtupfer.","Cartons contain 4 vials of Enbrel with 4 pre-filled solvent syringes and 8 alcohol swabs.",15,14
"1916","de","en","Ein ursächlicher Zusammenhang mit der Impfung konnte nicht festgestellt werden.","The causal relationship to the vaccine has not been established.",10,10
"1917","de","en","Ein Vitamin-D-Mangel entsteht, wenn Sonnenbestrahlung und Aufnahme aus der Nahrung unzureichend sind.","Vitamin D insufficiency develops when both sunlight exposure and dietary intake are inadequate.",13,12
"1918","de","en","Ein wichtiger sekundärer Endpunkt war das Auftreten bewiesener/wahrscheinlicher IFIs 100 Tage nach Randomisierung.","A key secondary endpoint was the incidence of proven/ probable IFIs at 100 days post-randomization.",15,13
"1919","de","en","Ein zentraler Venenkatheter ist nicht erforderlich.","A central venous catheter is not required.",7,6
"1920","de","en","Eine 0,8 ml-Fertigspritze mit Stichschutz-System enthält 40 mg Adalimumab","One 0.8 ml pre-filled syringe with needleguard contains 40 mg adalimumab",11,9
"1921","de","en","Eine Abnahme der Levetiracetam-Plasma-Konzentration wurde während der Schwangerschaft beobachtet.","Decrease in levetiracetam plasma concentrations has been observed during pregnancy.",10,9
"1922","de","en","Eine akute Überdosierung kann Hypoglykämie zur Folge haben.","Acute overdose could lead to hypoglycaemia.",6,8
"1923","de","en","Eine akute, lebensbedrohliche Toxizität wurde bei Gabapentin-Überdosierung bis zu einer Dosis von 49 g nicht beobachtet.","Acute, life-threatening toxicity has not been observed with gabapentin overdoses of up to 49 g.",15,16
"1924","de","en","Eine andere Injektionsstelle wählen und ebenfalls 3,0 ml spritzen.","Choose a different injection site and inject 3.0 ml.",9,9
"1925","de","en","Eine Änderung der Dosierung ist nicht","- Hepatic impairement without cholestasis: no dosage modification is required (see",11,6
"1926","de","en","Eine angemessene Dosistitration sollte erfolgen.","Appropriate dose titration should be considered.",6,5
"1927","de","en","Eine Angiotensin-II-Rezeptor-Antagonisten-Therapie darf nicht während einer Schwangerschaft begonnen werden.","Pregnancy Angiotensin II receptor antagonists should not be initiated during pregnancy.",11,9
"1928","de","en","Eine Anwendung im ersten Schwangerschaftsdrittel sowie bei Frauen, die beabsichtigen, schwanger zu werden, wird nicht empfohlen.","Its use during the first trimester of pregnancy and in women planning to become pregnant is not recommended.",18,16
"1929","de","en","Eine ärztliche Bewertung des klinischen Verlaufs und des Zustandes eines jeden Patienten ist daher erforderlich.","NeoRecormon should be administered either subcutaneously or intravenously in order to increase",12,15
"1930","de","en","Eine Atemdepression in Folge einer Überdosierung kann die Wirkungsdauer des Opioid-Antagonisten überdauern.","Respiratory depression following an overdose may outlast the duration of action of the opioid antagonist.",15,12
"1931","de","en","Eine Ausnahme ist möglich, falls der Arzt ausdrücklich Fentanyl-ratiopharm verordnet hat.","An exception can be made if the doctor has expressly prescribed Fentanyl-ratiopharm.",12,11
"1932","de","en","Eine Behandlung der Kreislaufüberladung ist gegebenenfalls erforderlich.","Treatment of circulatory overload may be necessary.",7,7
"1933","de","en","Eine Behandlung sollte normalerweise nicht begonnen werden, wenn die GPT-Spiegel über dem 10-Fachen des oberen Normwertes liegen.","Treatment should normally not be initiated if ALT is > 10 times the upper limit of normal.",17,17
"1934","de","en","Eine Besserung der Symptome wird normalerweise innerhalb von 3 - 4 Tagen beobachtet.","A clinical response is normally seen within 3- 4 days.",10,13
"1935","de","en","Eine Blisterpackung enthält 7, 10 oder 14 Filmtabletten.","One blister contains 7, 10 or 14 film-coated tablets.",9,8
"1936","de","en","Eine Dauerbehandlung kann zu einer weiteren Besserung führen und ist für einen dauerhaften Therapieerfolg notwendig.","Continued treatment may give further improvement and is necessary to maintain beneficial effects.",13,15
"1937","de","en","Eine Dosis (0,5 ml) des aufgelösten Impfstoffs enthält:","After reconstitution, one dose (0.5 ml) contains:",7,8
"1938","de","en","Eine Dosis (0,5 ml) des rekonstituierten Impfstoffs enthält:","After reconstitution, 1 dose (0.5 ml) contains:",7,8
"1939","de","en","Eine Dosis (40 µg) von 1 ml pro Injektion.","1 dose (40 µg) of 1 ml at each injection is intended for use.",14,9
"1940","de","en","Eine Dosis von 0,5 ml enthält:","One dose of 0.5 ml contains:",6,6
"1941","de","en","Eine Dosis von mehr als 80 Einheiten muss durch zwei oder mehr Injektionen verabreicht werden.","If you need a dose greater than 80 units, you should give it as two or more injections.",18,15
"1942","de","en","Eine Dosisabhängigkeit der EPS war bei den beiden höheren Dosierungen von INVEGA (9 und 12 mg) zu beobachten.","Dose dependence for EPS was seen with the two higher doses of INVEGA (9 and 12 mg).",17,18
"1943","de","en","Eine Dosisanpassung ist bei dieser Bevölkerungsgruppe nicht erforderlich (siehe Abschnitt 5.2).","No dose adjustment is required in this population (see section 5.2).",11,11
"1944","de","en","Eine Dosisanpassung ist für keines dieser Arzneimittel erforderlich.","No dosage adjustment is necessary for either medicinal product.",9,8
"1945","de","en","Eine Dosisanpassung kann notwendig sein, wenn Patienten von einem Insulinpräparat zu einem anderen wechseln (siehe Abschnitt 4.4).","30 Dosage adjustment may be necessary when transferring patients from one insulin preparation to another (see section 4.4).",18,17
"1946","de","en","Eine Dosisanpassung von VIRAMUNE ist bei gleichzeitiger Anwendung mit Lopinavir nicht erforderlich.","Dose adjustment of VIRAMUNE is not required when co-administered with lopinavir.",11,12
"1947","de","en","Eine Durchstechflasche – 5 ml.","One vial – 5 ml.",5,5
"1948","de","en","Eine Durchstechflasche enthält 2000 I.E.","One vial contains 2000 IU moroctocog alfa.",7,5
"1949","de","en","Eine Durchstechflasche enthält 217,6 mg Natrium.","Excipient: each vial contains 217.6 mg sodium For a full list of excipients, see section 6.1.",16,6
"1950","de","en","Eine Durchstechflasche enthält 500 mg Daptomycin.","Each vial contains 500 mg daptomycin.",6,6
"1951","de","en","Eine Durchstechflasche enthält 75 I.E.","One vial contains 75 IU of lutropin alfa (recombinant human luteinising hormone {LH}).",13,5
"1952","de","en","Eine Durchstechflasche Ovitrelle ist vor der Anwendung in 1 ml Lösungsmittel zu rekonstituieren.","One vial of Ovitrelle can be reconstituted with 1 ml of the solvent before use.",15,13
"1953","de","en","Eine EKG-Überwachung sollte eingeleitet und der Patient genau auf eine mögliche Entwicklung von Arrhythmien hin überwacht werden.","ECG monitoring should be started and the patient carefully monitored for the possible development of arrhythmias.",16,17
"1954","de","en","Eine Elimination durch Dialyse ist daher nicht zu erwarten.","Valsartan is highly bound to plasma protein and is unlikely to be removed by dialysis.",15,9
"1955","de","en","Eine engmaschige Blutzuckerkontrolle sollte erwogen werden (siehe Abschnitt 4.4).","Close monitoring of glycaemic control should be considered (see section 4.4).",11,9
"1956","de","en","Eine erhöhte Inzidenz an hepatozellulären Karzinomen wurde bei allen männlichen Mäusen in den mit Amprenavir behandelten Gruppen beobachtet.","A higher incidence of hepatocellular carcinoma was seen in all amprenavir male mouse treatment groups.",15,18
"1957","de","en","Eine Erhöhung der Dosis von Probenecid oder Sulfinpyrazon kann notwendig sein.","Increase in dosage of probenecid or sulfinpyrazone may be necessary.",10,11
"1958","de","en","Eine Erhöhung der Pioglitazondosierung bei gleichzeitiger Gabe mit Rifampicin kann erforderlich sein.","The pioglitazone dose may need to be increased when rifampicin is concomitantly administered.",13,12
"1959","de","en","Eine erneute intravenöse Anwendung ist nur dann kontraindiziert, wenn die Reaktionen wieder auftreten oder sich verschlechtern.","Subsequent intravenous administration is not contraindicated unless the reactions recur or worsen.",12,16
"1960","de","en","Eine Exelon 4,5 mg Hartkapsel enthält 4,5 mg Rivastigmin.","Each Exelon 4.5 mg capsule contains 4.5 mg of rivastigmine.",10,9
"1961","de","en","Eine Fertigspritze enthält 50 Mikrogramm Methoxy-Polyethylenglycol-Epoetin beta* in einer Konzentration von 167 Mikrogramm/ml.","One pre-filled syringe contains 50 micrograms of methoxy polyethylene glycol-epoetin beta* at a concentration of 167 micrograms/ ml.",18,13
"1962","de","en","Eine Filmtablette enthält 400 mg Telithromycin.","Each film-coated tablet contains 400 mg of telithromycin.",8,6
"1963","de","en","Eine Filmtablette enthält entweder 150 mg oder 300 mg Maraviroc.","Each film-coated tablet contains either 150 mg or 300 mg of maraviroc.",12,10
"1964","de","en","Eine Flasche enthält 240 ml Suspension zum Einnehmen.","Each bottle contains 240 ml of oral suspension.",8,8
"1965","de","en","Eine forcierte Diurese, Hämodialyse, Hämoperfusion oder Austauschtransfusion haben wahrscheinlich keinen Nutzen.","Forced diuresis, dialysis, haemoperfusion, and exchange transfusion are unlikely to be of benefit.",13,11
"1966","de","en","Eine generelle Umkehr dieser Entwicklungen wurde während der 6 Folgemonate nach Behandlungsende beobachtet.","A general reversal of these trends was noted during the 6 months follow-up post treatment.",15,13
"1967","de","en","Eine gleichzeitige Anwendung wird daher nicht empfohlen.","Concomitant use is not recommended.",5,7
"1968","de","en","Eine gleichzeitige Anwendung wird nicht empfohlen.","Erectile dysfunction medicinal products: concomitant use is not recommended.",9,6
"1969","de","en","Eine gleichzeitige Einnahme von EMEND mit pflanzlichen Präparaten, die Johanniskraut (Hypericum perforatum) enthalten, wird nicht empfohlen.","John’ s Wort (Hypericum perforatum) is not recommended.",8,16
"1970","de","en","Eine Hartkapsel enthält 200 mg Pregabalin.","Each hard capsule contains 200 mg pregabalin",7,6
"1971","de","en","Eine Hartkapsel enthält 40 mg Aprepitant.","Each capsule contains 40 mg of aprepitant.",7,6
"1972","de","en","Eine Hib-Infektion verursacht am häufigsten eine Hirnhautentzündung.","HIB infection most frequently causes brain inflammation na",8,7
"1973","de","en","Eine Hyperhydratation ist bei Patienten mit einem Risiko für eine Herzinsuffizienz zu vermeiden.","Overhydration should be avoided in patients at risk of cardiac failure.",11,13
"1974","de","en","Eine Hypoglykämie kann im Allgemeinen durch sofortige Aufnahme von Kohlenhydraten korrigiert werden.","Hypoglycaemia can generally be corrected by immediate carbohydrate intake.",9,12
"1975","de","en","Eine Hypoglykämie kann sich jedoch stufenweise entwickeln:","A specific overdose of insulin cannot be defined.",8,7
"1976","de","en","Eine Hypotonie, die auf einen derartigen Mechanismus zurückgeführt wird, kann durch Plasmaexpansion behoben werden.","NOT MARKETED YET -30 tablets",5,14
"1977","de","en","Eine Keimreduktion von Helicobacter pylori kann zu falsch-negativen Ergebnissen führen.","The suppression of Helicobacter pylori might give false negative results.",10,10
"1978","de","en","Eine klinisch signifikante Hypotonie wurde nach Markteinführung bei gleichzeitiger Anwendung von Risperidon und einer blutdrucksenkenden Behandlung beobachtet.","Clinically significant hypotension has been observed postmarketing with concomitant use of risperidone and antihypertensive treatment.",15,17
"1979","de","en","Eine Kombination von CHAMPIX mit anderen Arzneimitteln zur Raucherentwöhnung wird daher nicht empfohlen.","CHAMPIX in combination with other smoking cessation therapies is therefore not recommended.",12,13
"1980","de","en","Eine Kombination von Venlafaxin mit Wirkstoffen zur Gewichtsabnahme wird nicht empfohlen.","Co-administration of venlafaxine and weight loss agents is not recommended.",10,11
"1981","de","en","Eine Kontamination während der Entnahme ist zu vermeiden.","Avoid introduction of contamination during use.",6,8
"1982","de","en","Eine Laktatazidose, wenn sie auftritt, entwickelt sich meist nach einigen Monaten Behandlung.","Lactic acidosis, if it occurs, usually develops after a few months of treatment.",13,12
"1983","de","en","Eine Langzeitanwendung von Fentanyl-ratiopharm kann zu einer physischen Gewöhnung führen.","Prolonged use of Fentanyl-ratiopharm can cause physical dependence.",8,10
"1984","de","en","Eine Langzeittherapie bei Patienten mit Wachstumshormonmangel erhöht die Knochendichte.","Long-term therapy in growth hormone-deficient patients increases bone mineral density.",10,9
"1985","de","en","Eine Lebererkrankung, die zu einer Leberfunktionseinschränkung führt (siehe Abschnitt 5.2).","Liver disease resulting in hepatic impairment (see section 5.2).",9,10
"1986","de","en","Eine Liste dieser Mittel finden Sie zu Beginn von Abschnitt 2 unter STOCRIN darf nicht eingenommen werden.","These are listed under Do not take STOCRIN, at the start of Section 2.",14,17
"1987","de","en","Eine Minute lang gut umrühren und sofort trinken.","Stir well for one minute and drink immediately.",8,8
"1988","de","en","Eine Nieren- oder Leberfunktionsstörung kann den Insulinbedarf verringern.","Renal or hepatic impairment may reduce insulin requirement.",8,8
"1989","de","en","Eine normale altersabhängige Einschränkung der Nierenfunktion erfordert keine Dosisanpassung für Terfenadin.","Normal age-related decrease of renal function does not require dosage adjustment for terfenadine.",13,11
"1990","de","en","Eine orale Aufnahme des Fentanyl-haltigen Gels kann zu lebensbedrohlicher Hypoventilation oder zum Tode führen.","Oral ingestion of the fentanyl-containing gel may cause life-threatening hypoventilation or death.",12,14
"1991","de","en","Eine Ösophagitis und ösophageale Ulzerationen wurden meist bei Patienten berichtet, die das Doxycyclinhyclat in Kapselform erhalten hatten.","Oesophagitis and oesophageal ulceration have been reported most often in patients administered the hyclate salt in capsule form.",18,17
"1992","de","en","Eine Packung enthält 1 Fertigspritze.","One pack contains 1 pre-filled syringe.",6,5
"1993","de","en","Eine Pandemie kann sich in fast alle Länder und Regionen der Welt ausbreiten.","A pandemic can affect most countries and regions around the world.",11,13
"1994","de","en","Eine pulmonale arterielle Hypertonie ist eine schwere und oft tödlich verlaufende Erkrankung.","Pulmonary artery hypertension is a severe and often fatal disease.",10,12
"1995","de","en","eine Radiotherapie oder einen chirurgischen Eingriff erfordern) bei Patienten mit Brustkrebs und Knochenmetastasen.","or surgery) in patients with breast cancer and bone metastases.",10,13
"1996","de","en","Eine Reduktion der Kortikosteroide war nach Woche 8 erlaubt.","Corticosteroid taper was permitted after week 8.",7,9
"1997","de","en","Eine Reduktion der Tagesdosis für ältere Patienten ist nicht erforderlich (siehe unter Abschnitt 5.2).","Elderly: in elderly patients there is no need to reduce the daily dosage (see section 5.2).",16,14
"1998","de","en","Eine Resorption nach oraler Aufnahme von Fondaparinux durch den Säugling ist jedoch unwahrscheinlich.","Oral absorption by the child is however unlikely.",8,13
"1999","de","en","Eine Schritt-für-Schritt Gebrauchsanweisung ist auf der nächsten Seite enthalten.","For step-by-step instructions please see over the page.",8,9
"2000","de","en","Eine schwere Hyperglykämie oder Ketoazidose muss stets von einem Arzt, normalerweise im Krankenhaus, behandelt werden.","treated by a doctor, normally in a hospital. pr",9,15
"2001","de","en","Eine Seite hat einen abgeschrägten Rand und ist mit ""LTG"" über der Ziffer 2 gekennzeichnet.","One side has a bevelled edge and is marked “ LTG” above the number 2.",15,15
"2002","de","en","Eine sekundäre Generalisierung tritt auf, wenn die Überaktivität im weiteren Verlauf das ganze Gehirn erfasst.","Secondary generalisation occurs when the overactivity later reaches the whole brain.",11,15
"2003","de","en","Eine solche Reaktion kann noch, bevor Sie die Arztpraxis verlassen, auftreten.","Such reactions may occur before leaving the doctor’s surgery.",9,11
"2004","de","en","Eine sorgfältige Nutzen-Risiko-Bewertung muss vor der Entscheidung für eine Therapie mit Herceptin durchgeführt werden.","A careful risk-benefit assessment should be made before deciding to treat with Herceptin.",13,14
"2005","de","en","Eine Stomatitis Grad 3 wurde bei 2% der Patienten in der Kombinationstherapiegruppe beobachtet.","Grade 3 stomatitis was reported in 2% of patients in the combination therapy group.",14,13
"2006","de","en","Eine Tablette enthält 30 mg Pioglitazon (als Hydrochlorid).","Each tablet contains 30 mg pioglitazone (as hydrochloride).",8,8
"2007","de","en","Eine Tablette enthält 5 mg Amlodipin (als Amlodipinmaleat).","Each tablet contains 5 mg of amlodipine (as amlodipine maleate).",10,8
"2008","de","en","Eine Tablette enthält eine Behandlungsdosis und darf nur als ganze Tablette angewendet werden.","One tablet contains one treatment dose and the tablet may only be administered as whole tablets.",16,13
"2009","de","en","Eine trübe Infusionslösung darf nicht verwendet werden.","It must not be used if cloudy.",7,7
"2010","de","en","Eine über einen längeren Zeitraum verbesserte Blutzuckereinstellung mindert das Risiko des Fortschreitens einer diabetischen Retinopathie.","Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.",12,15
"2011","de","en","Eine Überdosierung von Darifenacin kann jedoch theoretisch zu schweren anticholinergen Wirkungen führen und muss daher entsprechend behandelt werden.","However, overdose with darifenacin can potentially lead to severe anticholinergic effects and should be treated accordingly.",16,18
"2012","de","en","Eine Überwachung der Herzfunktion wird jedoch nur bei Patienten mit schweren Überleitungsstörungen oder Arrhythmien empfohlen.","Cardiac monitoring is not recommended except in patients with serious conduction abnormalities or arrhythmias.",14,15
"2013","de","en","Eine Überwachung dieser Nebenwirkungen wird empfohlen.","Clinical monitoring is recommended for these adverse reactions.",8,6
"2014","de","en","Eine Umstellung auf eine geeignete andere Behandlung sollte vor einer geplanten Schwangerschaft erfolgen.","A switch to a suitable alternative treatment should be carried out in advance of a planned pregnancy.",17,13
"2015","de","en","Eine Umverteilung, Ansammlung oder Verlust von Körperfett kann bei Patienten auftreten, die eine antiretrovirale Kombinationsbehandlung erhalten.","Redistribution, accumulation or loss of body fat may occur in patients receiving combination antiretroviral therapy.",15,16
"2016","de","en","Eine unachtsame, versehentliche oder unbeaufsichtigte Umstellung zwischen Tacrolimus-Formulierungen mit unmittelbarer oder retardierter Freisetzung ist gefährlich.","Inadvertent, unintentional or unsupervised switching of immediate- or prolonged-release formulations of tacrolimus is unsafe.",14,15
"2017","de","en","Eine Untersuchung zur Massenbilanz wurde anhand von 3H-Iloprost bei gesunden Probanden durchgeführt.","A mass-balance study was done using 3H-iloprost in healthy subjects.",10,12
"2018","de","en","Eine Unterzuckerung (Hypoglykämie) kann besonders auch dann auftreten, wenn","770 Hypoglycaemia is also more likely to occur if:",9,9
"2019","de","en","Eine Verlängerung des QT-Intervalls kann zu einem erhöhten Risiko für ventrikuläre Arrhythmien, einschließlich Torsade de pointes, führen.","QT interval prolongation may lead to an increased risk of ventricular arrhythmias including Torsade de pointes.",16,17
"2020","de","en","Eine Verminderung der antihypertensiven Wirkung von TRITACE ist zu erwarten.","Reduction of the antihypertensive effect of TRITACE is to be anticipated.",11,10
"2021","de","en","Eine Verordnung für Schwangere sollte mit Vorsicht erfolgen.","Caution should be exercised when prescribing to pregnant women.",9,8
"2022","de","en","Eine versehentliche Exposition mit Temperaturen im Gefrierbereich hat keinen nachteiligen Auswirkungen auf die Stabilität von Tevagrastim.","Accidental exposure to freezing temperatures does not adversely affect the stability of Tevagrastim.",13,16
"2023","de","en","Eine versehentliche Injektion ist gefährlich.","Accidental self-injection is dangerous",4,5
"2024","de","en","Eine vollständige Auflistung der sonstigen Bestandteile finden Sie unter Abschnitt 6.1.","For a full list of excipients see section 6.1.",9,11
"2025","de","en","Eine Wachstumshor- montherapie kann die Insulin-Sensitivität senken und die Glukosetoleranz beeinträchtigen.","Growth hormone therapy may decrease insulin sensitivity and impair glucose tolerance.",11,11
"2026","de","en","Eine Wundinfektion sollte vor der Anwendung von REGRANEX behandelt werden.","Infection should be treated prior to the use of REGRANEX.",10,10
"2027","de","en","Eine zufriedenstellend markierte Zubereitung soll mindestens 90% aufweisen.","A value of at least 90% should be obtained in a satisfactory preparation.",13,8
"2028","de","en","Eine zweite Dosis zu 0,5 ml sollte vier bis 10 Wochen nach der ersten Impfung verabreicht werden.","A second dose of 0.5 ml should be administered 4 to 10 weeks after the first vaccination.",17,17
"2029","de","en","Einen Monat nach der vierten Dosis wurden bei 98,6% der Impflinge protektive Antikörperspiegel erzielt.","One month after the fourth dose 98.6% of vaccinees achieved seroprotective levels of antibody.",14,14
"2030","de","en","Einfluss der Nahrung auf die Resorption bei oraler Anwendung:","Effects of food on oral absorption:",6,9
"2031","de","en","Einfluss von EVRA auf andere Arzneimittel","Influence of EVRA on other medications",6,6
"2032","de","en","Eingegange regelmäßig aktualisierte Sicherheitsberichte (Input)","reporting of adverse reactions as part of the implementation of the EudraVigilance pharmacovigilance reporting system for veterinary medicines",18,5
"2033","de","en","eingereichten Anträge zu erleichtern, wurden Standardarbeitsanweisungen zur Verbesserung der Bearbeitungsverfahren anhand der bisherigen Erfahrungen erarbeitet.","processing of applications submitted the EMEA, standard operational procedures have been developed to",13,15
"2034","de","en","Eingeschränkte Leber- oder Nierenfunktion:","Impaired hepatic or renal function:",5,4
"2035","de","en","Eingeschränkte Nierenfunktion Lenalidomid wird hauptsächlich über die Nieren ausgeschieden.","Renal impairment Lenalidomide is substantially excreted by the kidney.",9,9
"2036","de","en","Eingeschränkte Nierenfunktion Pharmakokinetische Daten weisen auf eine erhöhte Plasmakonzentration von Miglustat bei Patienten mit Nierenfunktionsstörungen hin.","Pharmacokinetic data indicate increased systemic exposure to miglustat in patients with renal impairment.",13,16
"2037","de","en","Einige dieser Fälle waren schwerwiegend und rasch fortschreitend.","Acute haemolytic anaemia Acute haemolytic anaemia has been reported which in some cases was severe and progressed rapidly.",18,8
"2038","de","en","Einige dieser Nebenwirkungen können jedoch schwerwiegend sein und ärztliche Behandlung erfordern.","Some of these effects may be serious and may require medical attention.",12,11
"2039","de","en","Einige dieser Nebenwirkungen werden von BEROMUN hervorgerufen, andere von Melphalan und wieder andere entstehen durch die ILP-Technik.","Some of these side-effects will be caused by BEROMUN, some by melphalan and some by the ILP technique.",18,17
"2040","de","en","Einige Kinder zeigten eine Abnahme ihrer Wachstumsrate (Körpergröße und Körpergewicht).","Some children have had a decrease in their rate of growth (height and weight).",14,10
"2041","de","en","Einige Nebenwirkungen könnten schwerwiegend sein Schwere allergische Reaktionen einschließlich Schwellungen, vor allem des Gesichtes und des Halses.","Some side effects could be serious Serious allergic reactions including swelling, mainly of the face and throat.",17,17
"2042","de","en","Einige Patienten erhielten zusätzlich Faktor VIII.","In some patients additional factor VIII was given.",8,6
"2043","de","en","Einige Patienten hatten die folgenden Nebenwirkungen, während sie Jalra allein einnahmen:  Häufig:","Some patients have had the following side effects while taking Jalra alone:  Common:",14,13
"2044","de","en","Einige Patienten zeigten Reaktionen an vorhergehenden Injektionsstellen.","Some patients have developed a reaction at an injection site that was used before.",14,7
"2045","de","en","Einige Produkte umfassen die Empfehlung, die Behandlung auf eine Testung der Suszeptibilität zu gründen.","Some products include the recommendation to base treatment on susceptibility testing.",11,14
"2046","de","en","Einige sind hautfarben, andere gräulich, rosa, rot oder braun.","Some are skin coloured, others are greyish, pink, red or brown.",11,9
"2047","de","en","Einleitung von Fernand Sauer Verwaltungsdirektor","Introduction by Fernand Sauer Executive Director",6,5
"2048","de","en","Einmal täglich 15 mg.","15 mg once daily.",4,4
"2049","de","en","Einmal tägliche (600 mg) Gabe:","Once daily (600 mg) administration:",5,5
"2050","de","en","Einnahme von Actos 30 mg Tabletten mit Nahrungsmitteln und Getränken:","Taking Actos 30mg tablets with food and drink:",8,10
"2051","de","en","einschließlich Änderungen, für Arzneimittel, die Paroxetin enthalten.","for paroxetine containing medicinal products.",5,7
"2052","de","en","Einschränkung der Nierenfunktion Die Elimination von Paliperidon nahm mit abnehmender Nierenfunktion ab.","11 Renal Impairment Elimination of paliperidone decreased with decreasing renal function.",11,12
"2053","de","en","Einzeldosen von bis zu 20 mg/kg wurden ohne toxische Wirkungen verabreicht.","Single doses up to 20 mg/ kg have been administered without toxic effects.",13,11
"2054","de","en","Einzeldosen-Blisterpackung (Packung mit 28 x 1 Tablette) oder andere als Blisterpackung mit 7 Tabletten","Unit dose blister (28x1 tablets pack) or any non 7 count blister",12,14
"2055","de","en","Einzeldosen) oder aufgeteilt in zwei Einzeldosen).","(given as 25 mg (once a day) (once a day or dose on alternate two divided days) doses)",18,6
"2056","de","en","Einzelheiten zu diesen Dokumenten sind dem Anhang 10 zu entnehmen.","3% 68% 6% s Marketing authorisation applications",7,10
"2057","de","en","Einzelne Fälle von entweder versehentlicher oder absichtlicher Überdosierung von Tolcapon Tabletten wurden berichtet.","Isolated cases of either accidental or intentional overdose with tolcapone tablets have been reported.",14,13
"2058","de","en","Einzunehmende Dosis für Erwachsene und Kinder über 13 Jahre","Dose to be taken by adults and children older than 13 years",12,9
"2059","de","en","Eisen(III)-oxid (E 172) Schellack Phospholipide aus Sojabohnen","Iron oxide, red (E172) Shellac Soya lecithin",7,7
"2060","de","en","Ekzem, vermehrtes Schwitzen, Rosazea Arthritis","Eczema, increased sweating, rosacea Arthritis",5,5
"2061","de","en","el EU/1/02/202/002 60 g","th EU/ 1/ 02/ 202/ 001 30 g EU/ 1/ 02/ 202/ 002 60 g",15,4
"2062","de","en","el Tragen Sie stets eine Information bei sich, aus der hervorgeht, dass Sie Diabetiker sind.","Carry some information with you to show you are diabetic. al",11,15
"2063","de","en","el ug Wie bei anderen Insulinprodukten ist die Hypoglykämie im Allgemeinen die am häufigsten auftretende Nebenwirkung.","As for other insulin products, in general, hypoglycaemia is the most frequently occurring undesirable effect.",15,16
"2064","de","en","el Wegen individueller Schwankungsmöglichkeiten muss die Einstellung der optimalen therapeutischen Dosis bei jedem Patienten individuell erfolgen.","39 individual variability, titration to optimal therapeutic doses is expected for individual patients.",13,16
"2065","de","en","Elaprase darf nicht angewendet werden:","Is there any reason for not being given Elaprase?",9,5
"2066","de","en","Eli Lilly and Company Limited","Eli Lilly and Company Limited Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL United Kingdom",15,5
"2067","de","en","Eli Lilly Holdings Limited Gemzar Kingsclere Road, Basingstoke, Hampshire RG21 6XA Vereinigtes Königreich","Eli Lilly Holdings Limited Kingsclere Road, Basingstoke, Hampshire RG21 6XA United Kingdom",12,13
"2068","de","en","Eli Lilly Nederland B.V., Grootslag 1-5, NL-3991 RA Houten, Niederlande","Eli Lilly Nederland B. V., Grootslag 1-5, NL-3991 RA, Houten, The Netherlands",12,10
"2069","de","en","Eli Lilly Netherlands BV Grootslag 1-5 3991 RA Houten Niederlande","Eli Lilly Netherlands BV Grootslag 1-5 3991 RA Houten The Netherlands",11,10
"2070","de","en","Elimination Die Eliminationshalbwertszeit von Fluoxetin beträgt 4-6 Tage und die von Norfluoxetin 4 bis 16 Tage.","Elimination The elimination half-life of fluoxetine is 4 to 6 days and for norfluoxetine 4 to16 days.",17,16
"2071","de","en","Elimination Die terminale Halbwertszeit wird durch die Resorptionsrate aus dem subkutanen Gewebe bestimmt.","20 Elimination The terminal half-life is determined by the rate of absorption from the subcutaneous tissue.",16,13
"2072","de","en","Elisabethhof 19 NL-2353 EW Leiderdorp Holland Tel: +31 (0)71 5455745","Elisabethhof 19 NL-2353 EW Leiderdorp Holland Tel: +31 (0)71 5455745",10,10
"2073","de","en","EMADINE darf nach dem erstmaligen Öffnen nicht länger als 4 Wochen verwendet werden.","EMADINE should not be used for longer than 4 weeks after first opening.",13,13
"2074","de","en","EMEA Arbeitsprogramm 2003 EMEA/MB/057/02/de/endgültig (2) Abschließend für den Haushalt 2002 bereitgestellte Mittel.","(2) Final appropriations for the 2002 budget.",7,12
"2075","de","en","EMEA Arbeitsprogramm 2003 EMEA/MB/057/02/de/endgültig 4.","EMEA Work Programme 2003",4,5
"2076","de","en","EMEA-Jahresbericht 2002 EMEA/MB/055/02/de/Endgültig Dokumentennummer Titel des Dokuments","Release for consultation July 2002",5,7
"2077","de","en","EMEA/CHMP/123464/2006/DE ANGABEN AUF DER ÄUSSEREN UMHÜLLUNG","EMEA/ CHMP/ 123464/ 2006/ΕΝ PARTICULARS TO APPEAR ON THE OUTER PACKAGING",11,6
"2078","de","en","EMEA/COMP Einreichung Beginn Gutachten","EMEA/COMP • Submission • Start Date • Opinion • Active Time",11,4
"2079","de","en","EMEA/CPMP Validierung Gutachten Bearbeitungszeit Anhalten der Uhr","• 25.2.2002 • 22.4.2002 • 23.4.2002",6,7
"2080","de","en","EMEA/CPMP/3736/03 21/21  EMEA 2003","EMEA/ CPMP/ 3736/ 03 20/ 21  EMEA 2003 EMEA/ CPMP/ 3736/ 03 21/ 21  EMEA 2003",18,5
"2081","de","en","EMEND 80 mg Kapsel","EMEND 80 mg capsule",4,4
"2082","de","en","EMEND muss bei Kombination mit einigen anderen Arzneimitteln mit Vorsicht angewendet werden.","EMEND should be used with caution when taken with some medicines.",11,12
"2083","de","en","Empfehlung bei gleichzeitiger Gabe","Recommendations concerning co - administration",5,4
"2084","de","en","Empfohlene Dosis Jede Spritze enthält eine Tagesdosis für ein Pferd mit 500 kg.","Each syringe provides one daily dose for a 500 kg horse.",11,13
"2085","de","en","Empfohlene und Maximaldosis 1 mg/kg KG zweimal täglich.","Recommended and maximum dose 1 mg per kg twice daily.",10,8
"2086","de","en","Emselex 7,5 mg Retardtabletten Darifenacin","Emselex 7.5 mg prolonged-release tablets Darifenacin",6,5
"2087","de","en","Emtricitabin wird primär durch glomeruläre Filtration und aktive tubuläre Sekretion ausgeschieden.","Emtricitabine is primarily excreted via glomerular filtration and active tubular secretion.",11,11
"2088","de","en","Emtriva ist ein antivirales Arzneimittel.","Emtriva is an antiviral medicine.",5,5
"2089","de","en","en • Glaukom; • Hautkrebs; • Störungen der Schilddrüsenfunktion;","ris • glaucoma; • skin cancer;",6,9
"2090","de","en","en a Methotrexat b 95% Konfidenzintervalle für die Unterschiede der Veränderungen der Scores zwischen Methotrexat","methotrexate b 95% confidence intervals for the differences in change scores between methotrexate and Trudexa. i",16,15
"2091","de","en","en Arzneimittel außer Reich- und Sichtweite von Kindern aufbewahren.","Store out of reach and sight of children.",8,9
"2092","de","en","en Monotherapie, als auch in der Kombination mit Methotrexat untersucht.","monotherapy and those taking concomitant methotrexate.",6,10
"2093","de","en","en unter strenger ärztlicher Kontrolle erfolgen.","Usual warning symptoms may disappear in patients with longstanding diabetes.",10,6
"2094","de","en","Enbrel 25 mg Injektionslösung Etanercept Subkutane Anwendung","Enbrel 25 mg injection etanercept Subcutaneous use",7,7
"2095","de","en","Enbrel 50 mg Pulver zur Herstellung einer Injektionslösung.","Enbrel 50 mg powder for solution for injection.",8,8
"2096","de","en","Enbrel darf nicht angewendet werden bei","Do not use Enbrel",4,6
"2097","de","en","Enbrel wird ebenfalls zur Behandlung folgender Erkrankungen bei Kindern und Jugendlichen verordnet:","341 Enbrel is also prescribed for the treatment of the following diseases in children and adolescents:",16,12
"2098","de","en","Enbrel wird vor der Anwendung in 1 ml bakteriostatischem Wasser für Injektionszwecke aufgelöst und subkutan injiziert.","Enbrel is reconstituted with 1 ml bacteriostatic water for injections before use, and administered by subcutaneous injection.",17,16
"2099","de","en","Endokrine Erkrankungen Stoffwechsel- und Ernährungsstörungen","Emotional disorders, mood alteration Aggression, nervousness, libido decreased",8,5
"2100","de","en","Endometriale Störungen, Endometriumhypertrophie* (sonographische Untersuchung der Endometriumdicke), Gebärmutterpolyp, Vaginalausfluss, vaginale Störungen, Zystozele","Cystocele, endometrial disorder, endometrial hypertrophy* (sonographic endometrial thickness), uterine polyp, vaginal discharge, vaginal disorder",14,12
"2101","de","en","Engelenkampstraat 72 NL-6131JJ Sittard Niederlande","Engelenkampstraat 72 NL-6131JJ Sittard The Netherlands",6,5
"2102","de","en","Entacapon wird oral und gleichzeitig mit jeder Dosis Levodopa/Carbidopa oder Levodopa/Benserazid angewendet.","Entacapone is administered orally and simultaneously with each levodopa/ carbidopa or levodopa/ benserazide dose.",14,12
"2103","de","en","Entfernen Sie den Nadelschutz, ohne dabei die Nadel zu berühren.","Remove the needle guard without touching the needle.",8,10
"2104","de","en","Entfernen Sie die Nadel, indem Sie die mit der Schutzkappe versehe - ne Nadel gegen den Uhrzeigersinn drehen.","Remove the capped needle by turning it anticlockwise.",8,18
"2105","de","en","Entfernen Sie die Schutzkappe von der Durchstechflasche mit GONAL-f und von der Fertigspritze mit Lösungsmittel.","Remove the protective caps from the GONAL-f vial and from the solvent pre-filled syringe.",14,15
"2106","de","en","Entfernen Sie die Schutzkappe von der Nadel, wenn Sie diese vorher wieder aufgesteckt haben.","Uncap the needle if previously recapped.",6,14
"2107","de","en","Entfernen Sie nicht die graue Nadelschutzkappe des Fertigpens, bevor Sie zu Ihrer Selbstinjektion bereit sind.","Do not remove the grey needle shield from the pre-filled pen until you are ready to inject.",17,15
"2108","de","en","Entfernen Sie vor dem Spritzen alle Luftblasen (siehe Bedienungsanleitung des Pens).","Before injection remove any air bubbles (see instructions for using the pen).",12,11
"2109","de","en","Enthält 1 transdermales Pflaster.","Contains 1 transdermal patch.",4,4
"2110","de","en","Enthält 10 mg Maropitant pro ml als Maropitant-Citrat-Monohydrat.","10 mg maropitant per ml as maropitant citrate monohydrate.",9,8
"2111","de","en","Enthält Lactose und entölte Phospholipide aus Sojabohnen: weitere Informationen siehe Packungsbeilage.","Contains lactose and soya lecithin: see the package leaflet for further information.",12,11
"2112","de","en","Enthält unter anderem Sucrose - Packungsbeilage beachten.","Also contains sucrose – see leaflet for further information.",9,7
"2113","de","en","Entlüften des Fertigpens (Überprüfung des Insulinflusses).","Priming the Pen (check Insulin Flow).",6,6
"2114","de","en","Entnehmen Sie 10 ml aus einem 100 ml Infusionsbeutel und verwerfen Sie diese.","Withdraw 10 ml solution from a 100 ml infusion bag and discard.",12,13
"2115","de","en","Entnehmen Sie die Spritze aus der Faltschachtel und überprüfen Sie, dass: • das Verfalldatum nicht abgelaufen ist ich","Remove the syringe from the carton and check that: • the expiry date has not passed ct",17,18
"2116","de","en","Entsorgen Sie den verbrauchten Mixtard 50 NovoLet sorgfältig ohne die abgeschraubte Injektionsnadel.","Dispose of your used Mixtard 50 NovoLet carefully without the needle attached.",12,12
"2117","de","en","Entsorgen Sie Kanüle und Spritze entsprechend der Anweisung Ihres Arztes, der medizinischen Fachkraft oder Ihres Apothekers.","Dispose of the needle and syringe as instructed by your doctor, nurse or pharmacist.",14,16
"2118","de","en","Entsorgungsmaßnahme Entsorgen Sie die benutzte Spritze unmittelbar in einem Behälter für spitze Gegenstände.","Disposal instructions Dispose of the used syringe immediately in a sharps container.",12,13
"2119","de","en","Entsprechend der Prävalenz von HSDD liegen nur begrenzte Daten zu Patientinnen über 60 Jahre vor.","Consistent with the prevalence of HSDD, there are limited data above the age of 60.",15,15
"2120","de","en","Entsprechend der Verträglichkeit und Wirksamkeit kann die Dosis anschließend erhöht werden.","Based on tolerability and efficacy, the dose may subsequently be increased.",11,11
"2121","de","en","Entsprechende Dosis (Million I.E.), die mit einer IntronA 25 Millionen I.E./2,5 ml Injektions- oder Infusionslösung aufgezogen wird","Corresponding dose 25 million IU/2.5",5,17
"2122","de","en","Entsteht ein Ungleichgewicht zwischen Bildung und Abfluss des Kammerwassers, kommt es zu einem Anstieg des Augeninnendrucks.","If the eye fills up faster than it empties, the pressure inside the eye builds up.",16,16
"2123","de","en","Entzündung an der Injektionsstelle, Veränderung an der Injektionsstelle, Müdigkeit, Schüttelfrost, Fieber, grippeartige Symptome, Asthenie, Reizbarkeit","conditions Injection site inflammation, injection site reaction, fatigue, rigors, fever, flu-like symptoms, asthenia, irritability",14,15
"2124","de","en","Entzündung, Schwellung, Schmerz, Juckreiz, Rötung an der Injektionsstelle","101 Not known: injection site inflammation, injection site swelling, injection site pain, injection site pruritus, injection site erythema.",18,8
"2125","de","en","Enviage wird in die Milch von stillenden Ratten abgegeben.","Enviage was secreted in the milk of lactating rats.",9,9
"2126","de","en","eosinophilen Granulozyten hemmt. itt","or mediators from skin mast cells, basophils and eosinophils.",9,4
"2127","de","en","Epivir kann mit oder ohne Mahlzeiten eingenommen werden.","Epivir can be taken with or without food.",8,8
"2128","de","en","Epoetin alfa HEXAL 1000 I.E./0,5 ml Injektionslösung in einer Fertigspritze","Epoetin alfa HEXAL 1000 IU/ 0.5 ml solution for injection in a pre-filled syringe",14,10
"2129","de","en","Epoetin alfa HEXAL 6000 I.E./0,6 ml Injektionslösung in einer Fertigspritze","Epoetin alfa HEXAL 6000 IU/ 0.6 ml solution for injection in a pre-filled syringe",14,10
"2130","de","en","Epoetin alfa HEXAL darf nicht angewendet werden,","Epoetin alfa HEXAL must not be used",7,7
"2131","de","en","Epoetin alfa HEXAL ist ein steriles, jedoch nicht konserviertes Produkt und nur zur einmaligen Anwendung bestimmt.","Administer the amount required.",4,16
"2132","de","en","Epoetin zeta pro ml.","The solution contains 3333 IU Epoetin zeta per ml.",9,4
"2133","de","en","Epstein-Barr-Virus (EBV)-assoziierte lymphoproliferative Krankheit ist berichtet worden.","EBV-associated lymphoproliferative disorder has been reported.",6,7
"2134","de","en","Eptotermin alfa, der Wirkstoff in Opgenra, wirkt auf die Knochenstruktur.","The active substance in Opgenra, eptotermin alfa, acts on the bone.",11,10
"2135","de","en","Equilis Prequenza ist ein Impfstoff zur Anwendung bei Pferden.","Equilis Prequenza is a vaccine for use in horses.",9,9
"2136","de","en","Equilis Te, Injektionssuspension, für Pferde","Equilis Te, suspension for injection, for horses",7,5
"2137","de","en","Er enthält inaktivierte (abgetötete) Hepatitis-A-Viren und Teile des Hepatitis-B-Virus als Wirkstoffe.","It contains inactivated (killed) hepatitis A viruses and parts of the hepatitis B virus as active substances.",17,11
"2138","de","en","Er muss mit der entsprechenden Sorgfalt behandelt werden.","It must be handled with care.",6,8
"2139","de","en","Er vertrat das Vereinigte Königreich in der Arbeitsgruppe Biotechnologie und wirkte","He joined the EMEA in August 1996.",7,11
"2140","de","en","Er wird eine Blutuntersuchung durchführen, um festzustellen, ob eine Verminderung der weißen Blutkörperchen (Agranulozytose) vorliegt.","A blood test will be taken to check possible reduction of white blood cells (agranulocytosis).",15,15
"2141","de","en","Er wird entscheiden, ob vorbeugende Maßnahmen erforderlich sind.","Your doctor will determine if preventive treatment for chickenpox is appropriate.",11,8
"2142","de","en","Er wirkt nur in Kombination mit Levodopa, einer Kopie des Neurotransmitters Dopamin, die oral eingenommen werden kann.","As a result, levodopa remains active for longer.",8,17
"2143","de","en","er zu ge las se n ANGABEN AUF DER ÄUSSEREN UMHÜLLUNG","LABELLING lon ge ra uth ori sed PARTICULARS TO APPEAR ON THE OUTER PACKAGING",14,11
"2144","de","en","Erbrechen, Bauchschmerzen, Durchfall Hepatobiliäre Störungen:","Uncommon: vomiting, abdominal pain, diarrhoea.",5,5
"2145","de","en","Erbrechen), Verschlechterung einer Magen- oder Darmentzündung","inflammation (indigestion, stomach ache or vomiting), worsening of inflammation of the stomach or intestine.",14,6
"2146","de","en","Ereignisse (%) bei Casodex-Patienten","Events (%) in Casodex patients",5,4
"2147","de","en","Ereignisse (RR 1,67, 95% CI:","An increased relative risk of thromboembolic events (RR 1.67, 95% CI:",11,5
"2148","de","en","Erfahrungen bei SGA-Patienten mit einem Behandlungsbeginn nahe dem Pubertätsbeginn sind begrenzt.","Experience in initiating treatment in SGA patients near onset of puberty is limited.",13,11
"2149","de","en","Erfahrungen mit Kindern liegen nicht vor.","There is no experience in children.",6,6
"2150","de","en","Erfahrungen nach der Markteinführung (Spontanberichte), Häufigkeit unbekannt (kann aus den vorliegenden Daten nicht bestimmt werden)","Postmarketing experience (spontaneous reports) frequency not known (can’t be estimated from the available data)",14,15
"2151","de","en","Erfahrungen nach der Markteinführung Die folgenden schwerwiegenden Nebenwirkungen wurden nach der Markteinführung beobachtet:","Post-Marketing Experience The following additional serious adverse reactions have been identified during post-marketing exposure:",14,13
"2152","de","en","erfasst und bestand überwiegend aus distalen TVTs.","e evaluated up to day 11 after surgery, irrespective of the type of surgery performed.",15,7
"2153","de","en","Ergänzende Vorgaben des jeweiligen Geräteherstellers sind unbedingt zu beachten.","Any additional instructions from the respective equipment manufacturer must also be strictly adhered to.",14,9
"2154","de","en","Ergebnisse zur Wirksamkeit (Patienten mit Prostatakarzinom unter hormoneller Therapie)","Efficacy results (prostate cancer patients receiving hormonal therapy)",8,9
"2155","de","en","Erhaltungsdosis Die übliche wirksame Erhaltungsdosis beträgt 20 mg einmal täglich.","Maintenance dose The usual effective maintenance dosage is 20 mg administered in a single daily dose.",16,10
"2156","de","en","Erhöhte Choleste- rinwerte, Ge- wichtsabnahme","Serum cholesterol increased, Weight loss",5,5
"2157","de","en","Erhöhte Leberenzyme, Gelbsucht, Hepatitis.","Elevated liver enzymes, jaundice, hepatitis",5,4
"2158","de","en","erhöhte Leberfunktionstests (ALT erhöht, AST erhöht, Bilirubin erhöht, alkalische Phosphatase erhöht, GGT erhöht)","liver function tests raised (ALT increased, AST increased, bilirubin increased, alkaline phosphatase increased, GGT increased)",15,13
"2159","de","en","erhöhte Plasmakonzentrationen von Amiodaron, Bepridil, Encainid, Flecainid, Propafenon, Chinidin.","Increased plasma concentrations of amiodarone, bepridil, encainide, flecanide, propafenone, quinidine.",10,9
"2160","de","en","Erhöhte Pulsfrequenz, Herzgeräusche, niedriger Blutdruck und geringere Blutversorgung des Herzmuskels.","Increased heart rate, heart murmur, low blood pressure, decreased blood supply to the heart muscle.",15,10
"2161","de","en","Erhöhte Schmerzempfindlichkeit Verengung der oberen Atemwege Roter Ausschlag","• ear swelling • incr",5,8
"2162","de","en","Erhöhte Transaminasen Hepatitis, Cholelithiasis","Transaminases increased Hepatitis, cholelithiasis Hepatic failure 1 P P",9,4
"2163","de","en","Erhöhungen des Gesamtcholesterins von 10 - 20% wurden bei einigen nicht infizierten Probanden unter Efavirenz beobachtet.","Lipids: increases in total cholesterol of 10 - 20% have been observed in some uninfected volunteers receiving efavirenz.",18,16
"2164","de","en","Erkankungen der Haut und des Unterhautzellgewebes Gelegentlich:","Skin and subcutaneous tissue disorders Uncommon:",6,7
"2165","de","en","Erkrankungen der Atemwege, des Brustraums und Mediastinums","Respiratory, thoracic and mediastinal disorders",5,7
"2166","de","en","Erkrankungen der Atemwege, des Brustraums und Mediastinums:","Respiratory, thoracic and mediastinal disorders:",5,7
"2167","de","en","Erkrankungen der Geschlechtsorgane und der Brustdrüse","Reproductive system and breast disorders",5,6
"2168","de","en","Erkrankungen der Geschlechtsorgane und der Brustdrüse:","Reproductive system and breast disorders: - Uncommon:",7,6
"2169","de","en","Erkrankungen der Haut und des Unterhautgewebes","Skin and subcutaneous tissue disorders 30",6,6
"2170","de","en","Erkrankungen der Haut und des Unterhautzell- gewebes","Skin and subcutaneous tissue disorders",5,7
"2171","de","en","Erkrankungen der Haut und des Unterhautzellgewebes","121 Skin and subcutaneous tissue disorders",6,6
"2172","de","en","Erkrankungen der Niere und des Harntraktes:","bronchospasm dyspnoea, cough, throat irritation, postnasal drip asthma",8,6
"2173","de","en","Erkrankungen der Niere und Harnwege","Musculoskeletal, connective tissue and bone disorders",6,5
"2174","de","en","Erkrankungen der Nieren und der Harnwege Gelegentlich:","Renal and urinary disorders Uncommon:",5,7
"2175","de","en","Erkrankungen der Nieren und Harnwege","6 Renal and urinary disorders",5,5
"2176","de","en","Erkrankungen der Nieren und Harnwege:","Blood and lymphatic system disorders: increases in MCV, decreases in neutrophils.",11,5
"2177","de","en","Erkrankungen des Blutes und des","Blood and lymphatic system disorders",5,5
"2178","de","en","Erkrankungen des Blutes und des Lymphsystems Häufig","Blood and Lymphatic system disorders Common",6,7
"2179","de","en","Erkrankungen des Blutes und des Lymphsystems: erhöhte Blutungsneigung Erkrankungen des Immunsystems:","21 Immune system disorders: hypersensitivity reactions including anaphylaxis, hepatic eosinophilic infiltration.",11,11
"2180","de","en","Erkrankungen des Gastrointestinaltraktes Übelkeit (0,5%).","Gastrointestinal disorders Nausea (0.5%).",4,5
"2181","de","en","Erkrankungen des Gastrointestinaltrakts Sehr häufig Gelegentlich","Gastrointestinal disorders Very common Uncommon",5,6
"2182","de","en","Erkrankungen des Immunsystems Leber- und Gallenerkrankungen","Immune system disorders Hepato-biliary disorders",5,6
"2183","de","en","Erkrankungen des Nervensystems Augenerkrankungen","Adverse Drug Reaction System Organ Class (Preferred Term) Nervous system disorders Eye disorders",13,4
"2184","de","en","Erkrankungen des Nervensystems Gelegentlich:","Nervous system disorders Uncommon:",4,4
"2185","de","en","Erkrankungen des Nervensystems Schläfrigkeit Herzerkrankungen","Nervous system disorders 7 Somnolence Cardiac disorders",7,5
"2186","de","en","Erkrankungen des Nervensystems§ Sehr häufig:","disorder, abnormal dreaming, apathy Nervous system disorders§ i",8,5
"2187","de","en","Erkrankungen des Ohrs und des Labyrinths","Ear and labyrinth disorders",4,6
"2188","de","en","Erkrankungen des Ohrs und des Labyrinths Häufig:","Ear and labyrinth disorders Common: vertigo",6,7
"2189","de","en","Erkrankungen des Ohrs und des Labyrinths:","Ear and labyrinth disorders:",4,6
"2190","de","en","Erlotinib ist ein starker Inhibitor der intrazellulären Phosphorylierung von EGFR.","Erlotinib potently inhibits the intracellular phosphorylation of EGFR.",8,10
"2191","de","en","Erwachsene Olanzapin ist für die Behandlung der Schizophrenie angezeigt.","Adults Olanzapine is indicated for the treatment of schizophrenia.",9,9
"2192","de","en","Erwachsene Patienten In klinischen Studien wurden 1.440 erwachsene Personen mit Einzel- oder Mehrfachdosen von CANCIDAS behandelt:","Adult patients In clinical studies, 1440 adult individuals received single or multiple doses of CANCIDAS:",15,16
"2193","de","en","Erwachsene Patienten mit Plaque-Psoriasis","149 Adult patients with plaque psoriasis",6,4
"2194","de","en","Erwachsene Patienten sollten die Fosamprenavir Suspension zum Einnehmen ohne Mahlzeit und auf nüchternem Magen einnehmen.","For adult patients the fosamprenavir oral suspension should be taken without food and on an empty stomach.",17,15
"2195","de","en","Erwachsene und Jugendliche ab 16 Jahre:","Adults and adolescents ≥ 16 years:",6,6
"2196","de","en","Erwachsene: ≥ 12 g/dl (weiblich); ≥ 13 g/dl (männlich) Kinder: ≥ 11 g/dl (weiblich); ≥ 12 g/dl (männlich)","Adult: ≥ 12 g/dl (females); ≥ 13 g/dl (males) Paediatric: ≥ 11 g/dl (females); ≥ 12 g/dl (males)",18,18
"2197","de","en","Erwarteter Faktor VIII-Anstieg (% d.","Expected factor VIII rise (% of normal) =",8,5
"2198","de","en","Es besteht die Gefahr von schweren allergie-ähnlichen Reaktionen bis hin zum anaphylaktischen Schock.","There is a risk of severe allergy-like reactions, including anaphylactic shock.",11,13
"2199","de","en","Es bindet primär an α 1-saures Glykoprotein und Albumin.","It binds primarily to α 1-acid glycoprotein and albumin.",9,9
"2200","de","en","Es bleibt aber selbstverständlich noch viel zu tun, und neue Herausforderungen müssen bewältigt werden.","But there remains of course much to do and fresh challenges to meet.",13,14
"2201","de","en","Es darf auf keinen Fall in eine Vene injiziert werden.","It should never be injected into a vein.",8,10
"2202","de","en","Es darf nicht in andere Behälter umgefüllt werden.","Don't transfer it to any other container.",7,8
"2203","de","en","Es darf nur in Insulinpumpen eingesetzt werden, die für dieses Insulin geeignet sind.","It must only be used in insulin pumps suitable for this insulin.",12,13
"2204","de","en","Es darf nur klare, partikelfreie Lösung verwendet werden.","Do not use if the solution contains particles or if the solution is not clear.",15,8
"2205","de","en","Es dürfen nur Injektionsspritzen verwendet werden, die für diese Insulinkonzentration (100 I.E. pro ml) bestimmt sind.","Only injection syringes designed for this strength of insulin (100 IU per ml) are to be used.",17,16
"2206","de","en","Es empfiehlt sich, das Datum der Entnahme aus dem Kühlschrank auf der Verpackung zu vermerken.","It is advised to write the date of removal from the refrigerator on the package.",15,15
"2207","de","en","Es enthält den arzneilich wirksamen Bestandteil Trabectedin.","It contains the active substance trabectedin.",6,7
"2208","de","en","Es enthält den Wirkstoff Bivalirudin.","It contains the active substance bivalirudin.",6,5
"2209","de","en","Es enthält keine Hormone.","It does not contain hormones.",5,4
"2210","de","en","Es findet keine tubuläre Sekretion statt.","No tubular secretion takes place.",5,6
"2211","de","en","Es gab ebenso keinen Hinweis auf Missbrauch des Systems während der klinischen Studien.","There was also no evidence of abuse of the system during the clinical trials.",14,13
"2212","de","en","Es gab in dieser Studie drei Behandlungsgruppen.","96 been intolerant to 10 mg of methotrexate every week.",10,7
"2213","de","en","Es gab keine Anzeichen für eine Atemdepression.","There was no indication of respiratory depression.",7,7
"2214","de","en","Es gab keine Anzeichen für eine kumulative hämatologische oder nicht-hämatologische Toxizität.","There were no signs of cumulative haematological or non-haematological toxicity.",10,11
"2215","de","en","Es gab seltene Berichte von Hypokaliämie und Nierenversagen (einschließlich Todesfälle).","There have been rare reports of hypokalaemia and renal failure (including fatalities).",12,10
"2216","de","en","Es gibt auch Links zu anderen Websites über seltene Erkrankungen und Behandlungen.","There are also links to other websites about rare diseases and treatments.",12,12
"2217","de","en","Es gibt eine Reihe von Herausforderungen, die wir analysieren und deren Folgen wir in unseren Planungen berücksichtigen müssen.","There are a number of challenges that we will need to analyse and plan for their consequences.",17,18
"2218","de","en","Es gibt kein spezielles Antidot für Extravasate von Pemetrexed.","There is not a specific antidote for extravasation of pemetrexed.",10,9
"2219","de","en","Es gibt keine Anzeichen dafür, dass eine dieser Substanzen den pharmakodynamischen Wirkungen von Tasonermin entgegenwirkt.","There is no evidence that any of these agents counteracts the pharmacodynamic effects of tasonermin.",15,15
"2220","de","en","Es gibt keine Daten für die Anwendung von Dexrazoxan bei schwangeren Frauen.","There are no data from the use of dexrazoxane in pregnant women.",12,12
"2221","de","en","Es gibt keine Erfahrungen bezüglich der Anwendung von Dafiro bei schwangeren Frauen.","There is no experience on the use of Dafiro in pregnant women.",12,12
"2222","de","en","Es gibt keine Erfahrungen hinsichtlich der Dosisreduzierung/-erhöhung sowie der Änderung des Plans zur Behandlung der Extravasation.","There is no experience with dose reduction/ increase or modification of the schedule in the treatment of extravasation.",18,16
"2223","de","en","Es gibt keine festen Regeln für die Insulindosierung.","There are no fixed rules for insulin dosage.",8,8
"2224","de","en","Es gibt keine Hinweise für Auswirkungen einer Erythropoetin-Therapie auf die Verstoffwechselung anderer Arzneimittel.","There is no evidence to indicate that treatment with erythropoietin alters the metabolism of other medicinal products.",17,13
"2225","de","en","Es gibt Packungen mit 1, 3, 4, 5, 6, 8, 9 und 10 Patronen.","Packs of 1, 3, 4, 5, 6, 8, 9 and 10 cartridges are available.",14,14
"2226","de","en","Es gibt Packungen mit 5 Patronen zu je 3,15 ml.","Pack of 5 cartridges of 3.15 ml is available.",9,10
"2227","de","en","Es ist sehr selten über Hyperglykämie berichtet worden (siehe 4.4 Besondere Warnhinweise und Vorsichtsmaßnahmen für die Anwendung).","There have been very rare reports of hyperglycaemia (see 4.4 Special Warnings and Precautions for Use).",16,17
"2228","de","en","Es ist Vorsicht geboten und eine klinische Überwachung der Patienten wird empfohlen.","Caution is warranted and clinical monitoring of patients is recommended.",10,12
"2229","de","en","Es ist Vorsicht geboten, da bei diesen Patienten ein Volumen- und/oder Salzmangel vorliegen kann.","Caution is recommended therefore, since these patients may be volume and/or salt depleted.",13,14
"2230","de","en","Es ist wichtig, dass Ihre Hände und die verwendeten Gegenstände so sauber wie möglich sind.","It is important that your hands and the items you use are as clean as possible.",16,15
"2231","de","en","Es ist wichtig, dass Sie diesen Patientenpass mit sich führen und ihn Ihrem Partner oder Ihren Pflegern zeigen.","It is important that you keep this Alert Card and show it to your partner or caregivers.",17,18
"2232","de","en","Es ist wichtig, dass Sie keine Einnahme von Truvada auslassen.","It is important not to miss a dose of Truvada.",10,10
"2233","de","en","Es ist wichtig, dass Sie Tarceva täglich einnehmen und so lange, wie Ihr Arzt es Ihnen verordnet hat.","It is important to keep taking Tarceva every day, as long as your doctor prescribes it for you.",18,18
"2234","de","en","Es ist wichtig, dass Sie Zalasta Tabletten so lange einnehmen, wie Ihr Arzt es Ihnen empfiehlt.","It is important that you carry on taking Zalasta for as long as your doctor tells you.",17,16
"2235","de","en","Es ist zu erwarten, dass die Plasmakonzentrationen von Abacavir bei diesen Patienten stark ansteigen.","Plasma concentrations of abacavir are expected to substantially increase in these patients.",12,14
"2236","de","en","Es ist zu erwarten, dass eine Langzeit-Testosteronsuppression bei Männern Auswirkungen auf die Knochendichte hat.","It can be anticipated that long periods of testosterone suppression in men will have effects on bone density.",18,14
"2237","de","en","Es ist zu erwarten, dass Etravirin die Plasmakonzentrationen von Diazepam erhöht.","Not studied, etravirine is expected to increase plasma concentrations of diazepam.",11,11
"2238","de","en","Es kann anderen Menschen schaden, auch wenn diese dieselben Beschwerden haben wie Sie.","them, even if their symptoms are the same as yours.",10,13
"2239","de","en","Es kann anderen Menschen schaden, auch wenn diese dieselben Symptome haben wie Sie.","It may harm them, even",5,13
"2240","de","en","Es kann bei Säuglingen und Kindern bis zu 3 Jahren toxische und anaphylaktoide Reaktionen hervorrufen.","It may cause toxic reactions and anaphylactoid reactions in infants and children up to 3 years old.",17,15
"2241","de","en","Es kann bis zu 2 Monate dauern, bis Sie eine Wirkung sehen.","It may take up to 2 months before you see results.",11,12
"2242","de","en","Es kann eine kleine Blutung auftreten.","A small amount of bleeding may occur.",7,6
"2243","de","en","Es kann jedoch erforderlich werden, die Dosierung von Actrapid anzupassen.","However, the Actrapid dosage may need to be adjusted.",9,10
"2244","de","en","Es kann nicht ausgeschlossen werden, dass dies bei längerer Ventavis-Therapie beim Menschen ebenfalls der Fall ist.","It cannot be excluded that this is also relevant to man on prolonged Ventavis therapy.",15,16
"2245","de","en","Es kann sein, dass die Anwendung von Fluoxetin beendet werden muss.","Treatment with fluoxetine should only be started 2 weeks after discontinuation of an irreversible MAOI (for instance tranylcypromine).",18,11
"2246","de","en","Es kann sein, dass Sie t lä","If you have them, you may have had a serious allergic reaction to i dic",15,7
"2247","de","en","Es kann zu einigen Nebenwirkungen am Nervensystem kommen.","Some neurological adverse events can occur.",6,8
"2248","de","en","Es können nicht mehr Insulineinheiten eingestellt werden, als in der Patrone vorrätig sind.","The Pen will not allow you to dial more than the number of units left in the Pen.",18,13
"2249","de","en","Es können zwei Programme verwendet werden:","Two programs can be operated:",5,6
"2250","de","en","Es konnte gezeigt werden, dass Efavirenz durch die Induktion der P450-Enzyme seinen eigenen Metabolismus induziert.","Efavirenz has been shown to induce P450 enzymes, resulting in the induction of its own metabolism.",16,15
"2251","de","en","Es konnte gezeigt werden, dass Tacrolimus den Phenytoinspiegel im Blut erhöht.","Tacrolimus has been shown to increase the blood level of phenytoin.",11,11
"2252","de","en","Es konnte kein zusätzlicher Nutzen bei Verabreichung einer höheren Dosis (60 Mikrogramm) einmal wöchentlich belegt werden.","No additional benefit has been shown by administering a higher dose (60 micrograms) once a week.",16,16
"2253","de","en","Es könnte sich um Warnzeichen eines plötzlichen Blutdruckanstiegs handeln, der dringend behandelt werden muss.","These may be the warning signs of a sudden rise in blood pressure, which requires urgent treatment.",17,14
"2254","de","en","Es liegen begrenzte Daten zur Salvage-Therapie von Patienten vor, bei denen die Behandlung mit Kaletra versagte.","There are limited data on salvage therapy on patients who have failed therapy with Kaletra.",15,16
"2255","de","en","Es liegen Berichte über verschwommenes Sehen aufgrund einer Schwellung (oder Flüssigkeitsansammlung) im Augenhintergrund vor.","Blurred vision due to swelling (or fluid) at the back of the eye has been reported.",16,14
"2256","de","en","Es liegen Hinweise auf eine mögliche geänderte Pharmakokinetik von Efavirenz bei sehr jungen Kindern vor.","Evidence exists indicating that efavirenz may have altered pharmacokinetics in very young children.",13,15
"2257","de","en","Es liegen keine abgeschlossenen Studien zu kardiovaskulären Langzeitergebnissen bei Patienten vor, die Rosiglitazon erhalten haben.","There are no studies completed assessing long-term cardiovascular outcome in patients receiving rosiglitazone.",13,15
"2258","de","en","Es liegen keine ausreichenden Daten über die Verwendung von Cysteaminbitartrat bei Schwangeren vor.","There are no adequate data from the use of cysteamine bitartrate in pregnant women.",14,13
"2259","de","en","Es liegen keine Daten von Labortieren oder Menschen darüber vor, ob Saquinavir in die Muttermilch übertritt.","The re are no laboratory animal or human data available on secretion of saquinavir in breast milk.",17,16
"2260","de","en","Es liegen keine Daten zu Überdosierungen mit Zomarist vor.","No data are available with regard to overdose of Zomarist.",10,9
"2261","de","en","Es liegen keine Daten zur Anwendung unter 18 Jahren vor.","There is no information on the use of Daronrix below 18 years of age.",14,10
"2262","de","en","Es liegen keine Daten zur gleichzeitigen Gabe von ZOSTAVAX und antiviralen Arzneimitteln gegen VZV vor.","Concurrent administration of ZOSTAVAX and anti-viral medications known to be effective against VZV has not been evaluated.",17,15
"2263","de","en","Es liegen keine hinreichenden Daten für die Anwendung von Vildagliptin bei Schwangeren vor.","There are no adequate data from the use of vildagliptin in pregnant women.",13,13
"2264","de","en","Es liegen keine hinreichenden Daten für die Verwendung von AVONEX bei Schwangeren vor.","There is limited information on the use of AVONEX in pregnancy.",11,13
"2265","de","en","Es liegen keine hinreichenden und kontrollierten Studien bei schwangeren Frauen vor.","There are no adequate and well-controlled studies in pregnant women.",10,11
"2266","de","en","Es liegen keine Informationen zu Wechselwirkungen mit anderen veterinärmedizinischen Produkten vor.","No information on interactions with other veterinary medicinal products is available.",11,11
"2267","de","en","Es liegen keine Informationen zur gegenseitigen Verträglichkeit (Kompatibilität) dieses Impfstoffes mit anderen Impfstoffen vor.","No information is available on the compatibility of this vaccine with any other.",13,14
"2268","de","en","Es liegen keine klinischen Daten über die Anwendung von Memantin während der Schwangerschaft vor.","For memantine, no clinical data on exposed pregnancies are available.",10,14
"2269","de","en","Es liegen keine klinischen Daten zu einer Exposition mit Rasburicase während der Schwangerschaft vor.","For rasburicase no clinical data on exposed pregnancies are available.",10,14
"2270","de","en","Es liegen keine Studien mit NovoMix 70 bei Kindern und Jugendlichen unter 18 Jahren vor.","No studies have been performed with NovoMix 70 in children and adolescents under the age of 18 years.",18,15
"2271","de","en","Es liegen neuropharmakologische Hinweise auf eine primäre Einbeziehung des dopaminergen Systems vor.","Neuropharmacological evidence suggests primary dopaminergic system involvement.",7,12
"2272","de","en","Es liegen noch keine Studien zu Sicherheit und Wirksamkeit von Dasatinib bei pädiatrischen Patienten vor.","Safety and efficacy of dasatinib have not yet been studied in paediatric patients.",13,15
"2273","de","en","Es muss eine klare, farblose oder","It must be a clear, colourless or lo",8,6
"2274","de","en","Es reduziert die Leukozyten-Infiltration in das entzündete Gewebe.","It reduces leukocyte infiltration into the inflamed tissue.",8,8
"2275","de","en","Es sind 16 400 IE* pro kg Körpergewicht anzuwenden.","You should use 16400 IU* per kg bodyweight.",8,9
"2276","de","en","Es sind keine Auswirkungen auf das gestillte Neugeborene/Kind zu erwarten.","No effects on the breastfed newborn/ infant are anticipated.",9,10
"2277","de","en","Es sind keine wesentlichen Nebenwirkungen mit Locatim zu beobachten.","There are no major side effects with Locatim.",8,9
"2278","de","en","Es sollte immer in Verbindung mit anderen verordneten Antiepileptika nach Anweisungen Ihres Arztes eingenommen werden.","It should always be taken in combination with other prescribed antiepileptic medicines under the direction of a doctor.",18,15
"2279","de","en","Es sollten etwa 12 Stunden zwischen jeder Einzeldosis Combivir liegen.","Each dose of Combivir should be taken approximately 12 hours apart.",11,10
"2280","de","en","Es sollten strenge aseptische Vorsichtsmassnahmen getroffen werden.","In case of the occurrence of allergic reaction, the treatment should be immediately withdrawn.",14,7
"2281","de","en","Es stehen nur begrenzt pharmakokinetische Informationen bei Kindern und Jugendlichen zur Verfügung (siehe Abschnitt 5.2).","Limited pharmacokinetic information is available in children and adolescents (see section 5.2).",12,15
"2282","de","en","Es verhindert ebenso ein Eindringen von Luft in den Fertigpen und ein Verstopfen der","It also stops air entering the pen and your needle clogging.",11,14
"2283","de","en","Es verhindert ebenso ein Eindringen von Luft in den Pen und ein Verstopfen der Nadel.","It will also stop air going back into the pen and the needle clogging up.",15,15
"2284","de","en","Es war genauso wirksam wie die Chemotherapie-Standardkombination.","It was as effective as the standard combination chemotherapy.",9,7
"2285","de","en","Es werden möglicherweise nicht alle Pa- ckungsgrößen in den Verkehr gebracht.","Not all pack sizes may be marketed.",7,11
"2286","de","en","Es werden möglicherweise nicht alle Packungsgrößen in den Verkehr gebracht.","16 Not all pack sizes may be marketed.",8,10
"2287","de","en","Es werden möglicherweise nicht alle Packungsgrößen in Ihrem Land angeboten.","Not all pack sizes may be available in your country.",10,10
"2288","de","en","Es werden möglicherweise nicht alle Packungsgrößen in Verkehr gebracht.","5/ 33 Not all pack sizes may be marketed.",9,9
"2289","de","en","Es werden möglicherweise nicht alle Packungsgrößen und Handelsformen in den Verkehr gebracht.","Not all pack sizes or presentations may be marketed.",9,12
"2290","de","en","Es wird als Infusion verabreicht.","Ceftriaxone is normally given by a doctor or nurse It is given as an infusion.",15,5
"2291","de","en","Es wird angenommen, dass diese Symptome auf die Erholung des körpereigenen Immunsystems zurückzuführen sind.","It is believed that these symptoms are due to a recovery of the body’ s immune system.",17,14
"2292","de","en","Es wird angenommen, dass Pseudoephedrin die Plazentaschranke und die Blut-Hirn-Schranke passiert.","Pseudoephedrine is presumed to cross the placenta and the haematoencephalic barrier.",11,11
"2293","de","en","Es wird angewendet, wenn der Patient ein hohes Risiko für die Entwicklung einer MS hat.","It is used when the patient is considered to be at high risk of developing MS.",16,15
"2294","de","en","Es wird durch die Hornhaut absorbiert, wo der Isopropylester zur aktiven freien Säure hydrolysiert wird.","It is absorbed through the cornea where the isopropyl ester is hydrolysed to the active free acid.",17,15
"2295","de","en","Es wird eine Initialdosis von 90 µg pro kg Körpergewicht als intravenöse Bolusinjektion empfohlen.","The recommended initial dose, administered by intravenous bolus injection, is 90 µg per kg body weight.",16,14
"2296","de","en","Es wird eine Tablette ACOMPLIA einmal pro Tag vor dem Frühstück eingenommen.","ACOMPLIA is taken as one tablet once a day, before breakfast.",11,12
"2297","de","en","Es wird empfohlen, die Behandlung mit Mirtazapin schrittweise abzusetzen, um Absetzsymptome zu vermeiden (siehe Abschnitt 4.4).","It is recommended to discontinue treatment with mirtazapine gradually to avoid withdrawal symptoms (see section 4.4).",16,16
"2298","de","en","Es wird empfohlen, die Durchführung dieser Tests auf dem Patientenpass zu dokumentieren.","It is recommended that the conduct of these tests should be recorded in the patient alert card.",17,12
"2299","de","en","Es wird empfohlen, die retardierten Venlafaxin-Kapseln mit einer Mahlzeit täglich etwa zur gleichen Zeit einzunehmen.","It is recommended that venlafaxine prolonged-release capsules be taken with food, at approximately the same time each day.",18,15
"2300","de","en","Es wird empfohlen, die Thrombozytenzahl während der ersten 8 Wochen der Behandlung regelmäßig zu überwachen.","It is recommended that the platelet count is regularly monitored during the first 8 weeks of therapy.",17,15
"2301","de","en","Es wird empfohlen, ein geschlossenes Mehrdosen-Impfpistolensystem zu verwenden.","It is recommended to use a closed multiject vaccination system.",10,8
"2302","de","en","Es wird empfohlen, Myozyme unmittelbar nach dem Vermischen mit sterilem Wasser zu verwenden.","It is recommended that Myozyme is used immediately after it has been mixed with sterile water.",16,13
"2303","de","en","Es wird empfohlen, nach der Behandlung nicht mehr zu Stillen.","It is recommended that breast-feeding be discontinued following treatment.",9,10
"2304","de","en","Es wird in Patronen für die Anwendung mit einem OptiPen angeboten.","It comes in cartridges designed for use in an injection device of the OptiPen series.",15,11
"2305","de","en","Es wird keine wesentliche Veränderung der MPA-Pharmakokinetik erwartet, demzufolge ist eine Dosisanpassung von CellCept nicht erforderlich.","No substantial alteration of MPA pharmacokinetics is anticipated and CellCept dose adjustment is not required.",15,16
"2306","de","en","Es wird nicht empfohlen, Combivir während des Stillens einzunehmen.","Combivir is not recommended if you are breast-feeding.",8,9
"2307","de","en","Es wird so lange vorsichtig gemischt, bis die Lösung klar ist.","Mix gently until a clear solution is obtained.",8,11
"2308","de","en","Es wirkt durch Hemmung des Enzyms Phosphodiesterase, das gewöhnlich eine Substanz, das so genannte zyklische GMP (cGMP), abbaut.","It works by blocking the phosphodiesterase enzyme which normally breaks down a substance known as cyclic GMP (cGMP).",18,18
"2309","de","en","Es wurde ein Fall einer allergischen Reaktion beobachtet, die wahrscheinlich in einem Zusammenhang mit der Atosiban-Behandlung stand.","One case of allergic reaction was reported, which was considered to be probably related to atosiban.",16,17
"2310","de","en","Es wurde gezeigt, dass Venlafaxin die durch Ethanol verursachte Beeinträchtigung geistiger und mo- torischer Fähigkeiten nicht verstärkt.","Venlafaxine has been shown not to increase the impairment of mental and motor skills caused by ethanol.",17,17
"2311","de","en","Es wurde kein Anstieg der Tumorinzidenz beobachtet, der auf Vildagliptin zurückzuführen war.","No increases in tumour incidence attributable to vildagliptin were observed.",10,12
"2312","de","en","Es wurde kein direkter Vergleich von GONAL-f/LH mit humanem Menopausengonadotropin (hMG) durchgeführt.","No direct comparison of GONAL-f/ LH versus human menopausal gonadotrophin (hMG) has been performed.",14,12
"2313","de","en","Es wurde keine wesentliche Veränderung der pharmakokinetischen Parameter von Agomelatin bei Patienten mit schwerer Niereninsuffizienz beobachtet.","No relevant modification in agomelatine pharmacokinetic parameters in patients with severe renal impairment has been observed.",16,16
"2314","de","en","Es wurde nach Markteinführung über einige Fälle von stark erhöhtem Blutdruck berichtet, der eine sofortige Behandlung erforderte.","In some cases, severely elevated blood pressure requiring immediate treatment has been reported in postmarketing experience.",16,17
"2315","de","en","Es wurde nachgewiesen, dass Optruma vertebrale Frakturen (Wirbelsäulenbrüche) erheblich reduziert, Hüftfrakturen jedoch nicht.","Optruma has been shown to significantly reduce vertebral fractures (breaks in the spine), but not hip fractures.",17,13
"2316","de","en","Es wurde somit nachgewiesen, dass Ratiograstim die gleiche Wirkung wie Neupogen hat.","Therefore, the effectiveness of Ratiograstim was shown to be equivalent to that of Neupogen.",14,12
"2317","de","en","Es wurde über die Inkompatibilität einiger Fertigspritzen aus Glas (einschließlich Rapilysin) mit bestimmten Verbindungsstücken ohne Injektionsnadeln berichtet.","Incompatibility of some prefilled glass syringes (including Rapilysin) with certain needle free connectors has been reported.",16,17
"2318","de","en","Es wurde über Dosierungen berichtet, die dem 10,5fachen der beabsichtigten Dosierung entsprachen.","37 Doses up to 10.5 times the intended dose have been reported.",12,12
"2319","de","en","Es wurde über seltene Fälle von erhöhten Leberenzymwerten und hepatozellulären Funktionsstörungen berichtet.","Rare cases of elevated liver enzymes and hepatocellular dysfunction have been reported.",12,12
"2320","de","en","Es wurde untersucht, wie wirksam das Arzneimittel GL-3 aus den Nieren entfernte.","The study looked at the effect of the medicines on clearing GL-3 from the kidney.",15,12
"2321","de","en","Es wurde von allergischen Reaktionen berichtet, die in seltenen Fällen zum Schock führten.","Allergic reactions, in rare cases leading to shock, have been reported.",11,13
"2322","de","en","Es wurden Brustvergrößerungen sowie Eierstockzysten beobachtet.","Breast enlargement, as well as cysts in the ovaries, have been observed.",12,6
"2323","de","en","Es wurden drei Studien ermittelt, in denen der Ausgang von Loratadin-exponierten Schwangerschaften mit Kontrollen verglichen wurde.","Hence, the data presented show that hypospadias have not been spontaneously reported as an adverse drug reaction.",17,16
"2324","de","en","Es wurden jedoch keine Daten für das Pferd erhoben.","However, no data have been generated in horses.",8,9
"2325","de","en","Es wurden keine Fälle von Raloxifen-Überdosierungen in den klinischen Studien berichtet.","No cases of raloxifene overdose were reported during clinical trials.",10,11
"2326","de","en","Es wurden keine Fälle von Überdosierung berichtet.","No case of overdose has been reported.",7,7
"2327","de","en","Es wurden keine gezielten Wechselwirkungsstudien mit Prometax transdermalen Pflastern durchgeführt.","No specific interaction studies have been conducted with Prometax transdermal patches.",11,10
"2328","de","en","Es wurden keine Hinweise auf toxische Wirkungen gefunden.","No evidence of toxic effects was found.",7,8
"2329","de","en","Es wurden keine klinischen oder pharmakokinetischen Studien bei Kindern oder Jugendlichen durchgeführt.","No formal clinical trials or pharmacokinetic studies have been conducted in children or adolescents.",14,12
"2330","de","en","Es wurden keine Langzeitstudien zur Kanzerogenität von Nepafenac durchgeführt.","Nepafenac has not been evaluated in long-term carcinogenicity studies.",9,9
"2331","de","en","Es wurden keine nicht-klinischen Studien mit der Kombination von Alendronat und Colecalciferol durchgeführt.","Non-clinical studies with the combination of alendronate and colecalciferol have not been conducted.",13,13
"2332","de","en","Es wurden keine physikalisch-biochemischen Kompatibilitätsstudien zur Evaluierung der gleichzeitigen Verabreichung von Remicade mit anderen Mitteln durchgeführt.","No physical biochemical compatibility studies have been conducted to evaluate the co- administration of Remicade with other agents.",18,16
"2333","de","en","Es wurden keine Reproduktionsstudien an Tieren durchgeführt.","Studies on reproduction were not performed in animals.",8,7
"2334","de","en","Es wurden keine signifikanten Qualitätsaspekte festgestellt.","No significant issues relating to Quality were identified.",8,6
"2335","de","en","Es wurden keine Spätfolgen nach ILP-Behandlung von Tieren mit Tasonermin beobachtet.","No late detrimental effects of tasonermin were seen.",8,11
"2336","de","en","Es wurden keine speziellen Studien an Patienten mit verminderter Nierenfunktion durchgeführt.","No formal studies have been conducted in patients with decreased renal function.",12,11
"2337","de","en","Es wurden keine Studien zu den Auswirkungen auf die Verkehrstüchtigkeit und das Bedienen von Maschinen durchgeführt.","No studies on the effects on the ability to drive and use machines have been performed.",16,16
"2338","de","en","Es wurden keine Studien zu den Auswirkungen auf die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen durchgeführt.","18 No studies on the effects on the ability to drive and use machines have been performed.",17,18
"2339","de","en","Es wurden keine Studien zu den Auswirkungen von Tracleer auf die Verkehrstüchtigkeit und das Bedienen von Maschinen durchgeführt.","No studies on the effect of Tracleer on the ability to drive and use machines have been performed.",18,18
"2340","de","en","Es wurden keine Studien zu Wechselwirkungen durchgeführt, auch keine Studien zu Wechselwirkungen mit Immunsuppressiva.","This includes studies with immunosuppressive drugs.",6,14
"2341","de","en","Es wurden keine Studien zu Wechselwirkungen von AZARGA durchgeführt.","No interaction studies have been performed with AZARGA.",8,9
"2342","de","en","Es wurden keine ungünstigen Anwendungsgebietes festgestellt.","• no untoward safety findings related to the extension of the indication have been identified.",15,6
"2343","de","en","Es wurden keine Untersuchungen an Patienten mit Nierenfunktionsstörung durchgeführt.","Studies have not been conducted in patients with impaired renal function.",11,9
"2344","de","en","Es wurden keine Untersuchungen zu Wechselwirkungen bei Dialysepatienten durchgeführt.","Interaction studies have not been conducted in patients on dialysis.",10,9
"2345","de","en","Es wurden keine Wechselwirkungen beobachtet, wenn Ibandronsäure gleichzeitig mit Tamoxifen oder Melphalan/Prednisolon verabreicht wurde.","No interaction was observed when ibandronic acid was administered concomitantly with tamoxifen, or melphalan/ prednisolone.",15,14
"2346","de","en","Es wurden keine Wechselwirkungsstudien durchgeführt.","No interaction studies have been performed.",6,5
"2347","de","en","Es zeigte sich eine Abnahme an Lendenwirbelbrüchen nicht aber für Oberschenkelhalsbrüche.","This reduction in fractures was shown for the spine but not for the hip.",14,11
"2348","de","en","Es zeigte sich eine zusätzliche Schmerzlinderung im Vergleich zur Monotherapie mit Opioiden.","Added pain relief compared to opioids alone was shown.",9,12
"2349","de","en","Es zeigte sich, d ass diese Antikörper mit allen erythropoetischen Proteinen kreuzreagieren.","Nespo should also be used with caution in those patients with sickle cell anaemia or epilepsy. ct",17,12
"2350","de","en","Es zeigten sich keine vom Geschlecht abhängigen signifikanten Unterschiede in den pharmakokinetischen Eigenschaften.","No significant differences in pharmacokinetics based on gender were identified.",10,13
"2351","de","en","ES-8950 Esplugues de Llobregat (Barcelona).","ES-8950 Esplugues de Llobregat (Barcelona).",5,5
"2352","de","en","España Abbott Laboratories, S.A.","España Abbott Laboratories, S.A.",4,4
"2353","de","en","España Bristol-Myers Squibb, S.A.","España Bristol-Myers Squibb, S. A.",5,4
"2354","de","en","España Laboratorios Menarini S.A.","España Laboratorios Menarini S. A.",5,4
"2355","de","en","España Mylan Pharmaceuticals, S.L tel: + 34 94 565 55 00","España Mylan Pharmaceuticals, S. L tel: + 34 94 565 55 00",12,11
"2356","de","en","España Wyeth Farma S.A.","España Wyeth Farma S.A.",4,4
"2357","de","en","Essbare Drucktinte weiß enthält:","Edible White Ink contains:",4,4
"2358","de","en","Essbare Drucktinte: synthetisches Eisen(II,III)-oxid (E 172) Propylenglycol Schellack","Black Iron Oxide-Synthetic (E172) Propylene glycol Shellac",7,8
"2359","de","en","Essigsäure 99% Natriumhydroxid Sorbitol (Ph.Eur.) Polysorbat 80 Wasser für Injektionszwecke","Acetic acid, glacial Sodium hydroxide Sorbitol (E420) Polysorbate 80 Water for injections",12,10
"2360","de","en","Estrada do Rio da Mó n.º 8, 8A e 8B – Fervença 2705-906 Terrugem SNT Portugal","Estrada do Rio da Mó, nº8, 8A & 8B, Fervença, 2705-906 Terrugem SNT, PORTUGAL",14,16
"2361","de","en","Estradiol 0,5 mg als Estradiol- Hemihydrat und 0,1 mg Norethisteronacetat","Activelle Estradiol (as hemihydrate) 0.5 mg Film-coated tablets Oral use + Norethisterone acetate 0.1 mg",15,10
"2362","de","en","Estriol 1 mg/Tablette Eine vollständige Aufzählung der sonstigen Bestandteile finden Sie unter Abschnitt 6.1.","Active substance: estriol 1 mg/ tablet For a full list of excipients, see section 6.1",15,14
"2363","de","en","Ethnic factors in the acceptability of foreign clinical data","Ethnic factors in the acceptability of foreign clinical data",9,9
"2364","de","en","ETIKETT - FLASCHE MIT 180 TABLETTEN à 800 mg (MIT ÄUSSERER UMVERPACKUNG)","LABEL - BOTTLE OF 180 TABLETS 800 mg WITH OUTER CARTON",11,12
"2365","de","en","ETIKETT VORGEFÜLLTER INJEKTOR ch","MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS PRE-FILLED PEN LABEL ct",13,4
"2366","de","en","Etoricoxib ist nicht mittels Hämodialyse zu entfernen; es ist nicht bekannt, ob Etoricoxib mittels Peritonealdialyse eliminierbar ist.","Etoricoxib is not dialysable by haemodialysis; it is not known whether etoricoxib is dialysable by peritoneal dialysis.",17,17
"2367","de","en","Etwa 75% des verabreichten [14C]-Nateglinids wurde innerhalb von sechs Stunden nach der Verabreichung im Urin gefunden.","Approximately 75% of the administered [14C] nateglinide is recovered in the urine within six hours post-dose.",16,16
"2368","de","en","Etwa ein Viertel der weiblichen Patienten ist durch die häufigsten Nebenwirkungen betroffen.","About a quarter of female patients will be affected by the most common side effects.",15,12
"2369","de","en","Eurican Herpes 205 enthält kleine Mengen der Caninen Herpesvirus-Antigene.","Eurican Herpes 205 contains small amounts of canine herpes virus antigens.",11,9
"2370","de","en","Europäische Kommission Gutachten erhalten am","European Commission • Opinion received • Date of decision",9,5
"2371","de","en","Europäische Kommission wird 1997 einen Vorschlag für eine neue Gebührenverordnung des Rates vorlegen.","The European Commission will bring forward a proposal in 1997 for a new Council Fee Regulation.",16,13
"2372","de","en","EUROPÄISCHER ÖFFENTLICHER BEURTEILUNGSBERICHT (EPAR)","EUROPEAN PUBLIC ASSESSMENT REPORT (EPAR)",5,4
"2373","de","en","European Knowledge Centre Mosquito Way Hatfield Hertfordshire AL10 9SN Vereinigtes Königreich","European Knowledge Centre Mosquito Way Hatfield Hertfordshire AL10 9SN United Kingdom",11,11
"2374","de","en","European Medicines Agency Evaluation of Medicines for Human Use","European Medicines Agency Evaluation of Medicines for Human Use",9,9
"2375","de","en","European Medicines Agency Veterinary Medicines","European Medicines Agency Veterinary Medicines",5,5
"2376","de","en","European Medicines Agency Veterinary Medicines and Inspections","European Medicines Agency Veterinary Medicines and Inspections",7,7
"2377","de","en","Eurovet Animal Health B.V.","Eurovet Animal Health B. V.",5,4
"2378","de","en","Eventuell gibt Ihnen Ihr Arzt auch ein anderes krampflösendes Mittel.","Your doctor may give you a different anticonvulsant.",8,10
"2379","de","en","Evista raloxifene Te il B","Evista raloxifene Part B",4,5
"2380","de","en","EVRA hat keinen oder vernachlässigbaren Einfluss auf die Verkehrstüchtigkeit und die Fähigkeit zum Bedienen von Maschinen.","EVRA has no or negligible influence on the ability to drive and use machines.",14,16
"2381","de","en","Exazerbationen der chronisch-obstruktiven Lungenerkrankung (COPD) bronchopulmonale Infektionen bei zystischer Fibrose oder bei Bronchiektasen Pneumonie","exacerbations of chronic obstructive pulmonary disease broncho-pulmonary infections in cystic fibrosis or in bronchiectasis pneumonia",15,14
"2382","de","en","Exelon 4,5 mg [nur Faltschachtel]","Exelon 4.5 mg [folding box only]",6,5
"2383","de","en","Exelon wird zur Behandlung von Gedächtnisstörungen bei Patienten mit Alzheimer-Krankheit verwendet.","Exelon is used for the treatment of memory disorders in patients with Alzheimer’ s disease.",15,11
"2384","de","en","Exforge 10 mg/160 mg Filmtabletten Amlodipin/Valsartan","Exforge 10 mg/ 160 mg film-coated tablets amlodipine/ valsartan",9,6
"2385","de","en","EXJADE 250 mg Tabletten zur Herstellung einer Suspension zum Einnehmen","EXJADE 250 mg dispersible tablets",5,10
"2386","de","en","Extavia selbst hat keine direkte Auswirkung auf das Herz.","Extavia itself does not affect the heart directly.",8,9
"2387","de","en","Extremitäten, Rücken- schmerzen, Brust- schmerzen) Gelenk- schmerzen","Arthritis Increased muscle tone and cramping",6,7
"2388","de","en","EXUBERA 1 mg einzeldosiertes Pulver zur Inhalation","EXUBERA 1 mg inhalation powder pre-dispensed.",6,7
"2389","de","en","Eλλάδα BIANEΞ Α .Ε Τηλ: +3 0210 80091 11 Mailbox@vianex.gr","Eλλάδα BIANEΞ Α.Ε Τηλ: +3 0210 80091 11 Mailbox@vianex.gr.",9,10
"2390","de","en","F lasch e gu t schü tteln.","Shake bottle w ell.",4,7
"2391","de","en","Fabbroni, 6 - 00191 Roma Italien","Fabbroni, 6 - 00191 Roma Italy",6,6
"2392","de","en","FABLYN kann zu jeder Tageszeit unabhängig von Mahlzeiten oder Getränken eingenommen werden.","FABLYN may be administered any time of day without regard to food or beverage intake.",15,12
"2393","de","en","Fähigkeit, zu schlucken oder Nahrung durch normale Darmbewegungen weiterzutransportieren, beeinträchtigt ist.","foods by normal bowel movements.",5,11
"2394","de","en","Faktor IX-Präparate müssen nur selten mehrmals täglich verabreicht werden.","Factor IX products rarely require to be administered more than once daily.",12,9
"2395","de","en","Faktor VIII ist eine der Substanzen (Faktoren) im Körper, die an der Blutgerinnung beteiligt sind.","In the body, factor VIII is one of the substances (factors) involved in blood coagulation (clotting).",16,15
"2396","de","en","Falls dasselbe Pflaster sich nicht mehr aufbringen lässt, sollte an einer anderen Stelle ein neues Pflaster aufgebracht werden.","If the same patch cannot be reapplied, a new patch should be applied to another location.",16,18
"2397","de","en","Falls die Hautreaktionen nach mehrmaliger Dosisreduzierung wieder auftreten, wird Ihr Arzt entscheiden, ob die Behandlung abgebrochen werden muss.","Your doctor will decide whether treatment has to be stopped if skin reactions reappear after several dose reductions.",18,18
"2398","de","en","Falls es bei einem Patienten zu Symptomen kommt, die auf eine hepatische Dysfunktion hinweisen, sollten Leberfunktionstests durchgeführt werden.","If any patient develops symptoms suggesting hepatic dysfunction liver function tests should be performed.",14,18
"2399","de","en","Falls kein zufrieden stellendes Ansprechen erreicht wird, ist eine Zusatz- oder Alternativtherapie in Erwägung zu ziehen .”","If satisfactory response is not achieved, an additional or different therapy should be considered .”",15,17
"2400","de","en","Falls Nebenwirkungen auftreten, sollte die Behandlung abgebrochen werden und der Rat des Tierarztes eingeholt werden.","19 If side effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.",18,15
"2401","de","en","Falls nicht, wechseln Sie die Injektionsnadel und wiederholen Sie den Vorgang, aber nicht mehr als 6 Mal.","If not, change the needle and repeat the procedure no more than 6 times.",14,17
"2402","de","en","Falls noch feste Partikel zu erkennen sind oder die Dispersion nicht homogen ist, wird das Produkt entsorgt.","If solid parts are seen or the dispersion is not homogeneous, the product will be discarded.",16,17
"2403","de","en","Falls notwendig, kann NovoMix 30 kurz nach einer Mahlzeit verabreicht werden.","When necessary, NovoMix 30 can be given soon after a meal.",11,11
"2404","de","en","Falls Sie älter sind und Ihr Arzt Ihnen Emtriva verordnet hat, wird er Sie sorgfältig beobachten.","If you are older than this and are prescribed Emtriva, your doctor will monitor you carefully.",16,16
"2405","de","en","Falls Sie in irgendeinem Punkt nicht sicher sind, fragen Sie Ihren Arzt oder Apotheker.","If there’s anything you’re not sure about, check with your doctor or pharmacist.",13,14
"2406","de","en","Falls Sie schwanger sind oder schwanger werden wollen, sollten Sie Ihren Arzt informieren.","You should consult your doctor if you are pregnant or wish to become pregnant.",14,13
"2407","de","en","Falls Sie schwanger sind, dürfen Sie CRIXIVAN nur dann einnehmen, wenn Ihr Arzt dies für unbedingt erforderlich hält.","If you are pregnant, you should take CRIXIVAN only if your doctor decides it is clearly needed.",17,18
"2408","de","en","Falls verfügbar, sollte ein Vergleich mit einer früheren Knochenmarkbiopsie durchgeführt werden.","If available, comparison to a prior bone marrow biopsy should be made.",12,11
"2409","de","en","Falls vom Arzt nicht anders verordnet, ist die übliche Dosis von Bondenza eine Tablette einmal im Monat.","The usual dose of Bondenza is one tablet once a month.",11,17
"2410","de","en","Falsche Anwendung von Antibiotika vermehrt Resistenzentwicklungen.","Misuse of antibiotics increases resistance.",5,6
"2411","de","en","FALTSCHACHTEL - 100 Mikrogramm DURCHSTECHFLASCHE","OUTER CARTON – 100 micrograms VIAL",6,5
"2412","de","en","FALTSCHACHTEL (PACKUNG MIT 5 DURCHSTECHFLASCHEN)","OUTER CARTON (5-VIAL PACK)",4,5
"2413","de","en","Faltschachtel 10 ml, 20 ml und 100 ml Flasche","Carton box 10 ml, 20 ml and 100 ml bottle",10,9
"2414","de","en","FALTSCHACHTEL FÜR BLISTERPACKUNG (7 Filmtabletten)","CARTON FOR BLISTER PACK (7 film-coated tablets)",7,5
"2415","de","en","Faltschachtel mit 14 Filmtabletten; 1 Blisterstreifen mit 14 Filmtabletten in PVC/PVDC/Aluminium- Blistern.","Cartons of 14 film-coated tablets; 1 blister card of 14 film-coated tablets in PVC/ PVDC/ Aluminium blisters.",17,12
"2416","de","en","Faltschachtel mit 84 Filmtabletten; 6 Blisterstreifen zu je 14 Filmtabletten in PVC/PVDC/Aluminium- Blistern.","Cartons of 84 film-coated tablets; 6 blister cards of 14 film-coated tablets in PVC/ PVDC/ Aluminium blisters.",17,13
"2417","de","en","FALTSCHACHTEL MIT DURCHSTECHFLASCHE MIT PULVER","CARTON OF VIAL OF POWDER",5,5
"2418","de","en","FALTSCHACHTEL MIT Zalasta 20 mg TABLETTEN","CARTON FOR ZALASTA 20 mg TABLETS",6,6
"2419","de","en","Fara 35 I-20124 Milan Tel: +39 02 677 4171","Fara 35 I-20124 Milan Tel: +39 02 677 4171",9,9
"2420","de","en","Farblose bis gelbliche, klare Lösung zum Auftropfen auf die Haut","Colourless to yellow, clear spot-on solution",6,10
"2421","de","en","FARMASERVE LILLY S.A.Cl 15 Km National Road Athens-Lamia Kifissia, 14564 Griechenland","FARMASERVE LILLY S. A. Cl 15 Km National Road Athens-Lamia Kifissia, 14564 Greece",13,11
"2422","de","en","Fax (34) 915 38 21 21 (libros), Fax (34) 913 84 17 14 (suscripción)","Core SPC for Human plasma derived antithrombin Released for consultation December 2000",12,14
"2423","de","en","FBAL ist ein Metabolit ohne antiproliferative Aktivität.","FBAL is a metabolite without antiproliferative activity.",7,7
"2424","de","en","Feldene Gel 0.5% W/W","Feldene Gel 0.5% W/ W",5,4
"2425","de","en","Fentanilo Matrix ratiomed 25 microgramos/h parches transdérmicos EFG","Fentanilo Matrix ratiomed 25 microgramos/ h parches transdérmicos EFG",9,8
"2426","de","en","Fentanyl kann eine Bradykardie verursachen.","Fentanyl may produce bradycardia.",4,5
"2427","de","en","Fentanyl- ratiopharm 75 µg/h Matrixpflaster","Fentanyl- ratiopharm 75 µg/ h Matrixpflaster",6,5
"2428","de","en","Fentanyl, ein Wirkstoff mit hoher Clearance, wird hauptsächlich von CYP3A4 rasch und extensiv metabolisiert.","Fentanyl, a high clearance active substance, is rapidly and extensively metabolised mainly by CYP3A4.",14,14
"2429","de","en","Ferner liegen aus der Zeit nach Markteinführung Spontanberichte über hohe Inhibitortiter vor, die auch zuvor behandelte Patienten betreffen.","Also, there have been spontaneous post-marketing reports of high-titre inhibitors involving previously treated patients.",14,18
"2430","de","en","Ferriprox 100 mg/ml Lösung zum Einnehmen Deferipron","Ferriprox 100 mg/ ml oral solution Deferiprone",7,7
"2431","de","en","Fertavid 150 IE/0,5 ml Injektionslösung Follitropin beta","Fertavid 150 IU/ 0.5 ml solution for injection follitropin beta",10,7
"2432","de","en","Fertavid 900 IE/1,08 ml Injektionslösung Follitropin beta","Fertavid 900 IU/ 1.08 ml solution for injection follitropin beta",10,7
"2433","de","en","Fertigpen (Mehrdosen-Einwegspritze), bestehend aus einem Injektionspen mit einer Patrone (3 ml).","Pre-filled pen (multidose disposable pen) comprising a pen injector with a cartridge (3 ml).",14,11
"2434","de","en","Fertigspritze (Glas) 0.6 ml (500 µg/ml)","0.6 ml (500 µg/ ml)",5,6
"2435","de","en","Fertigspritze 10 x 1 Dosis 1 Dosis (0,5 ml)","Pre-filled syringe 10 x 1 dose 1 dose (0.5 ml)",10,9
"2436","de","en","Fertilität In Fertilitätsstudien verursachte Gemcitabin bei männlichen Mäusen eine reversible Hypospermatogenese (siehe Abschnitt 5.3).","Fertility In fertility studies gemcitabine caused hypospermatogenesis in male mice (see section 5.3).",13,14
"2437","de","en","Fett Leber Niere Milch","Fat Liver Kidney Milk",4,4
"2438","de","en","Fibrinkleber/Hämostatika werden auf die gleiche Weise wie endogenes Fibrin durch Fibrinolyse und Phagozytose metabolisiert.","Fibrin sealants/ haemostatics are metabolised in the same way as endogenous fibrin, by fibrinolysis and phagocytosis.",16,14
"2439","de","en","Fieber und Schüttelfrost, Anschwellen des Gesichts, Schwindelgefühl,","breathlessness, • tightness in the chest and throat, • fever and chills, • facial swelling, • dizziness, •",18,7
"2440","de","en","Fieber, bedingt durch eine zugrunde liegende bakterielle Infektion, kann durch NSAR maskiert werden.","If the combination cannot be avoided, anticoagulant activity should be monitored closely.",12,13
"2441","de","en","Filgrastim HEXAL darf nicht mit Natriumchlorid-Lösungen verdünnt werden.","Filgrastim HEXAL must not be diluted with sodium chloride solutions.",10,8
"2442","de","en","Filgrastim sollte in diesen Fällen abgesetzt und eine angemessene Therapie eingeleitet werden.","Filgrastim should be discontinued and appropriate treatment given in these cases.",11,12
"2443","de","en","Filmtabletten Filmtabletten Filmtabletten Filmtabletten","Film-coated tablet Film-coated tablet Film-coated tablet Film-coated tablet",8,4
"2444","de","en","Filmtabletten Filmtabletten Filmtabletten Schmelztabletten Schmelztabletten","Film-coated tablets Film-coated tablets Film-coated tablets Orodispersible tablets Orodispersible tablets",10,5
"2445","de","en","Filmtabletten in einer Blisterkarte","coated tablets in card packaging.",5,4
"2446","de","en","Filmüberzug (Opadry rosa OY-L-24802):","Film coating (Opadry pink OY-L-24802):",5,4
"2447","de","en","Finanziert wird das ETOMEP über das von der GD III verwaltete IDA-Programm.","The IDA programme, which is managed by DG III, funds the work of ETOMEP.",14,12
"2448","de","en","Firazyr ist nicht zur Selbstverabreichung bestimmt.","Firazyr is not for self-administration.",5,6
"2449","de","en","Firocoxib blockiert das Enzym Cyclooxygenase, das an der Produktion von Prostaglandinen beteiligt ist.","Firocoxib blocks the enzyme (cyclo-oxygenase) that is involved in the production of prostaglandins.",13,13
"2450","de","en","Flasche fest verschlossen halten, um den Inhalt vor Feuchtigkeit zu schützen.","Keep the bottle tightly closed in order to protect from moisture.",11,11
"2451","de","en","FLASCHE MIT 500 IE PULVER FLASCHE MIT 1000 IE PULVER","VIAL OF POWDER 500 IU VIAL OF POWDER 1000 IU",10,10
"2452","de","en","Flasche mit der Verschlusskappe fest verschließen (über dem Flaschenadapter).","Close the bottle tightly with the cap (on the top of the bottle adapter).",14,9
"2453","de","en","Flasche zusammen mit der Applikationsspritze umdrehen.","223 • Turn the bottle upside down with the syringe still in place.",13,6
"2454","de","en","Flaschen aus Polyethylen hoher Dichte mit Polypropylendeckel mit äußere Umverpackung.","High density polyethylene bottles with a polypropylene cap.",8,10
"2455","de","en","Flaschen enthalten 100 Tabletten.","Bottles contain 100 tablets.",4,4
"2456","de","en","Flaschenetikett für < Cozaar Comp > 100 mg/25 mg Filmtabletten HDPE Flasche","Outer carton for Cozaar Comp 100 mg/ 25 mg film-coated tablets HDPE bottle",13,12
"2457","de","en","FLASCHENETIKETT FÜR DIE SUSPENSION ZUM EINNEHMEN","BOTTLE LABEL FOR ORAL SUSPENSION",5,6
"2458","de","en","Flebogammadif 50 mg/ml Infusionslösung Normales Immunglobulin von Menschen","Flebogammadif 50 mg/ ml solution for infusion Human normal immunoglobulin (IVIg)",11,8
"2459","de","en","Flebogammdif nicht verwenden, wenn die Lösung trüb ist oder einen Bodensatz aufweist.","Do not use Flebogammadif if you notice that the solution is cloudy or has deposits.",15,12
"2460","de","en","Flexicam enthält Meloxicam, das zu der Gruppe der nichtsteroidalen Antiphlogistika (NSAID) gehört.","Flexicam contains meloxicam, which belongs to a class of medicines called non-steroidal anti- inflammatory drugs (NSAIDs).",16,12
"2461","de","en","Fluoxetin wird weitgehend in der Leber metabolisiert und über die Nieren ausgeschieden.","Fluoxetine is extensively metabolised by the liver and excreted by the kidneys.",12,12
"2462","de","en","Flush-Symptomatik Erkrankungen der Atemwege, des Brustraums und Mediastinums","Flushing Respiratory, thoracic and mediastinal disorders",6,8
"2463","de","en","Fluticasone furoate GSK nur innerhalb von 2 Monaten nach erstmaligem Öffnen anwenden.","Fluticasone furoate GSK nasal spray should be used within 2 months after first opening.",14,12
"2464","de","en","Folgendes kann Abhilfe schaffen:","To clear the jam:",4,4
"2465","de","en","Follikel sind kleine runde Bläschen, die die Eizellen enthalten.","Follicles are small round sacs that contain the egg cells.",10,9
"2466","de","en","Follitropin alfa 75 I.E.","One ampoule of powder contains: follitropin alfa 75 IU.",9,4
"2467","de","en","Fondaparinux beeinflusst in vitro nicht das CYP450-Enzymsystem (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 oder CYP3A4).","Fondaparinux does not inhibit CYP450s (CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1 or CYP3A4) in vitro.",15,15
"2468","de","en","Fondaparinux ist nur zur subkutanen Anwendung vorgesehen.","Fondaparinux is intended for subcutaneous use only.",7,7
"2469","de","en","Formale Karzinogenitätsstudien wurden mit Omalizumab nicht durchgeführt","Formal carcinogenicity studies have not been conducted with omalizumab.",9,7
"2470","de","en","FORSTEO kann unabhängig von den Mahlzeiten injiziert werden.","FORSTEO can be injected at meal times.",7,8
"2471","de","en","Fort Dodge Animal Health (Charles City) 2000 Rockford Road Charles City, Iowa 50616 USA","Fort Dodge Animal Health (Charles City) 2000 Rockford Road Charles City, Iowa 50616 USA",14,14
"2472","de","en","Fort Dodge Animal Health, Flanders Road, Hedge End, Southampton, UK SO30 4QH","Fort Dodge Animal Health Ltd Flanders Road Hedge End Southampton UK SO30 4QH",13,12
"2473","de","en","Fort Dodge Santé Animale, S.A.","Santé Animale, S. A.",4,5
"2474","de","en","Fortsetzung der MabCampath-Behandlung mit 30 mg bei Rückkehr zu Ausgangswerten.","Resume MabCampath at 30 mg upon return to baseline value(s).",10,10
"2475","de","en","Fosamprenavir 700 mg bid (Saquinavir/Ritonavir 1000/100 mg bid)","Fosamprenavir 700 mg bid (saquinavir/ritonavir 1000/100 mg bid)",8,8
"2476","de","en","FOSAVANCE 70 mg/5.600 I.E.","FOSAVANCE 70 mg/ 5600 IU tablets Alendronic acid as alendronate sodium trihydrate/ colecalciferol",13,4
"2477","de","en","Foscan ist ein photosensibilisierendes Arzneimittel aus der Gruppe der Porphyrine.","Foscan is a porphyrin photosensitising medicine.",6,10
"2478","de","en","Frage 2 - Die Begründung des Antragstellers für die ausgewählte Gruppierung von Stufen ist nicht akzeptabel.","4 Question 2 - The Applicant´s justification of the selected pooling of stages is not acceptable.",16,16
"2479","de","en","Fragen Sie bei der Einnahme von allen Arzneimitteln Ihren Arzt oder Apotheker um Rat.","Ask your doctor or pharmacist for advice before taking any medicine.",11,14
"2480","de","en","Fragen Sie Ihren Apotheker wie das Arzneimittel zu entsorgen ist, wenn Sie es nicht mehr benötigen.","Ask your pharmacist how to dispose of medicines no longer required.",11,16
"2481","de","en","Fragen Sie Ihren Arzt oder Apotheker um Rat.","Contact your doctor or pharmacist for advice.",7,8
"2482","de","en","Fragen Sie Ihren Arzt oder Apotheker, wenn Sie sich nicht sicher sind.","You should check with your doctor or pharmacist if you are unsure.",12,12
"2483","de","en","Fragen Sie Ihren Arzt um Rat, wenn Sie stillen.","Ask your doctor for advice if you are breast- feeding.",10,9
"2484","de","en","Fragen Sie Ihren Arzt um Rat.","Please contact your doctor for medical advice.",7,6
"2485","de","en","Fragen Sie Ihren Arzt, in Ihrem Krankenhaus oder Ihren Apotheker nach einem geeigneten Behältnis.","Ask your doctor, hospital or pharmacist for an appropriate container.",10,14
"2486","de","en","Fragen Sie Ihren Arzt, ob Sie bereits ein anderes Arzneimittel, das Duloxetin enthält, einnehmen.","Check with your doctor if you are already taking other medicines containing duloxetine.",13,14
"2487","de","en","Fragen Sie vor der Anwendung von Macugen Ihren Arzt um Rat.","Ask your doctor or pharmacist for advice before Macugen treatment.",10,11
"2488","de","en","Fragen Sie vor der Einnahme von allen Arzneimitteln Ihren Arzt oder Apotheker um Rat.","65 Ask your doctor or pharmacist for advice before taking any medicine.",12,14
"2489","de","en","Fragen Sie vor der Einnahme/Anwendung jeglicher Arzneimittel Ihren Arzt oder Apotheker um Rat.","Ask your doctor or pharmacist for advice before using any medicine.",11,13
"2490","de","en","Fragen und Antworten zur Rücknahme des Antrags auf Genehmigung für das Inverkehrbringen von Diractin","Questions and answers on the withdrawal of the marketing application for Diractin",12,14
"2491","de","en","France 92 rue Baudin F-92300 Levallois-Perret Tél: + 33-(0)1 41 06 35 00","France 92 rue Baudin F-92300 Levallois-Perret Tél: + 33-(0)1 41 06 35 00",13,13
"2492","de","en","France Biogen Idec France +33 (0)1 41 37 9595","France Biogen Idec France +33 (0)1 41 37 9595",9,9
"2493","de","en","France Eisai SAS Tél: + (33) 1 47 67 00 05","France Eisai SAS Tél: + (33) 1 47 67 00 05",11,11
"2494","de","en","France Ireland Italia Luxembourg Nederland Österreich Portugal Suomi/Finland Sverige United Kingdom","Room 3C – meeting room and video- conference suite (35 people)",11,11
"2495","de","en","France Laboratoires Merck Sharp & Dohme – Chibret Tél: +33 (0) 1 47 54 87 00 contact@msd-france.com","France Laboratoires Merck Sharp & Dohme – Chibret Tél: +33 (0) 1 47 54 87 00 contact@msd-france. com",18,17
"2496","de","en","France Pfizer Tél: +33 (0)1 58 07 34 40","France Pfizer Tél: +33 (0)1 58 07 34 40",9,9
"2497","de","en","France sanofi-aventis France Tél:","France sanofi-aventis France Tél:",4,4
"2498","de","en","Frankenschmidt A., Naber K.G., Bischoff W., Kullmann K.","Frankenschmidt A., Naber K. G., Bischoff W., Kullmann K.",9,8
"2499","de","en","Frankreich Laboratoire GlaxoSmithKline 100 route de Versailles 78163 Marly-le-roi Cedex, Frank- reich","France Laboratoire GlaxoSmithKline 100 route de Versailles 78163 Marly-le-roi Cedex France",11,12
"2500","de","en","Frau Mariette BACKES-LIES Inspecteur Chef de Division Laboratoire National de Santé 10, rue C.M.","Mme Mariette BACKES-LIES Inspecteur Chef de Division Laboratoire Nationale de Santé 10 rue C.M.",14,14
"2501","de","en","Frauen im gebährfähigen Alter sollten vermeiden, während der Behandlung mit Rivaroxaban schwanger zu werden.","Women of child-bearing potential should avoid becoming pregnant during treatment with rivaroxaban.",12,14
"2502","de","en","Frauen im gebärfähigen Alter müssen angewiesen werden, während der Behandlung mit Tarceva eine Schwangerschaft zu vermeiden.","Women of childbearing potential must be advised to avoid pregnancy while on Tarceva.",13,16
"2503","de","en","Frauen, die langfristig mit Leberenzyminduktoren behandelt werden, müssen eine andere Methode der Kontrazeption in Betracht ziehen.","9 For women on long-term therapy with hepatic enzyme inducers, another method of contraception should be considered.",17,16
"2504","de","en","Frauen, die stillen oder stillen wollen, sollten den Arzt informieren.","Persons who are breast-feeding or intend to breast-feed should tell the doctor.",12,10
"2505","de","en","FSH wird bei Frauen für Wachstum und Entwicklung der Follikel in den Eierstöcken eingesetzt.","FSH is needed in women for the growth and development of follicles in the ovaries.",15,14
"2506","de","en","Führen Sie immer die Notfallmedikation Ihres Kindes zur Inhalation für Asthmaanfälle mit sich.","Always have your child’ s inhaled rescue medicine for asthma attacks with you.",13,13
"2507","de","en","Führen Sie vor jeder Injektion den Sicherheitstest durch.","Always perform the safety test before each injection.",8,8
"2508","de","en","Fulvestrant geht bei laktierenden Ratten in die Muttermilch über.","Fulvestrant is excreted in milk in lactating rats.",8,9
"2509","de","en","Fulvestrant unterliegt einer extensiven und schnellen Verteilung.","Distribution Fulvestrant is subject to extensive and rapid distribution.",9,7
"2510","de","en","Fünfundvierzig Prozent der Patienten hatten vor der Behandlung mit Clofarabin eine oder mehrere andauernde Infektionen.","Forty five percent of patients had one or more ongoing infections prior to receiving treatment with clofarabine.",17,15
"2511","de","en","Für 150 Patienten liegen Ergebnisse vor:","Results are available for 150 patients:",6,6
"2512","de","en","Für ältere Patienten sind die Dosierungsempfehlungen dieselben wie für Erwachsene – ohne Einschränkungen.","For elderly patients the dosage recommendations are the same as for adults - without modification.",15,13
"2513","de","en","Für Anweisungen zur Rekonstitution und Verdünnung des Arzneimittels vor der Gabe siehe Abschnitt 6.6.","For instructions on reconstitution and dilution of the medicinal product before administration, see section 6.6.",15,14
"2514","de","en","Für Arzneimittel aus menschlichem Blut oder Plasma werden bestimmte Vorkehrungen getroffen, um Patienten vor übertragbaren Infektionen zu schützen.","and the testing of each donation and pools of plasma for signs of virus/infections.",14,18
"2515","de","en","Für Babys, deren Mütter während der Schwangerschaft Lamictal einnahmen, besteht jedoch ein erhöhtes Risiko für Geburtsfehler.","However, there is an increased risk of birth defects in babies whose mothers took Lamictal during pregnancy.",17,16
"2516","de","en","Für bereits vorbehandelte Patienten beträgt die empfohlene Dosis zweimal täglich 600 mg.","For patients who have been treated before, it is 600 mg twice a day.",14,12
"2517","de","en","Für das Varicella-Virus waren die Serokonversionsraten durchweg hoch (97,9% bis 99,8% in allen Studien).","While the seroconversion rate for varicella was",7,14
"2518","de","en","Für den ersten Tag wird also die zweifache Menge des Erhaltungsvolumens benötigt.","Thus for the first day, twice the maintenance volume will be required.",12,12
"2519","de","en","Für den Vergleich mit Diclofenac (150 mg pro Tag) ergaben sich keine einheitlichen Daten.","The data were inconsistent in comparison with diclofenac (150 mg per day).",12,14
"2520","de","en","Für den zeitlichen Verlauf des Wiederanstiegs zum Ausgangsblutdruckwert besteht beim systolischen Blutdruck ein deutlicher Trend zu einer Dosisabhängigkeit.","28 recovery of baseline systolic blood pressure (SBP).",8,18
"2521","de","en","Für die Anweisungen zur Zubereitung siehe Abschnitt 6.6.","For instructions for preparation see section 6.6.",7,8
"2522","de","en","FÜR DIE CHARGENFREIGABE VERANTWORTLICHER HERSTELLER","MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE",7,5
"2523","de","en","FÜR DIE CHARGENFREIGABE VERANTWORTLICHER HERSTELLER MERIAL Laboratoire Porte des Alpes Rue de l'Aviation F-69800 Saint Priest FRANKREICH","MANUFACTURER FOR THE BATCH RELEASE MERIAL Laboratoire Porte des Alpes Rue de l’ Aviation F-69800 SAINT PRIEST FRANCE",18,17
"2524","de","en","Für die Chargenfreigabe verantwortlicher Hersteller:","Manufacturer for the batch release:",5,5
"2525","de","en","Für die Dauer der Behandlung und während mindestens 2 Wochen nach deren Beendigung ist eine wirksame Empfängnisverhütung durchzuführen.","Adequate contraceptive methods should be used during therapy, and for at least 2 weeks after completing therapy.",17,18
"2526","de","en","Für die Ergebnisse beider Studien siehe Tabellen 5 und 6.","See Table 5 and 6 for results from both studies.",10,10
"2527","de","en","Für die gleichzeitige Gabe sind deshalb andere Therapeutika zu erwägen, die CYP3A4 nicht oder nur geringfügig hemmen.","Alternative concomitant medications with no or minimal CYP3A4 inhibition should be considered.",12,17
"2528","de","en","Für die Injektion von Dosen bis zu 25 mg ist Enbrel in einer Stärke von 25 mg verfügbar.","A 25 mg strength of Enbrel is available for doses of 25 mg (or less).",15,18
"2529","de","en","Für die Packungsgröße mit einer Flasche, braucht nur ein Datum eingetragen zu werden.","For a pack containing a single bottle, write only one date.",11,13
"2530","de","en","Für die Patienten können periodisch zusätzliche, schnell wirkende Analgetika erforderlich sein, um Schmerzdurchbrüche zu verhindern.","Patients may require periodic supplemental doses of a short-acting analgesic for breakthrough pain.",13,15
"2531","de","en","Für die Reinigung wischen Sie das Mundstück des Diskus mit einem trockenen Tuch ab.","Wipe the mouthpiece of the Diskus with a dry tissue to clean it.",13,14
"2532","de","en","Für die zubereitete Suspension:","For the constituted oral suspension:",5,4
"2533","de","en","Für dieses Arzneimittel sind keine besonderen Lagerungsbedingungen erforderlich.","51 This medicinal product does not require any special storage conditions.",11,8
"2534","de","en","Für dieses Tierarzneimittel sind keine besonderen Lagerungsbedingungen erforderlich.","This veterinary medicinal product does not require any special storage conditions.",11,8
"2535","de","en","Für Dosierungen, die ganzen Umdrehungen entsprechen, sollte die Dosierungsanzeige mit der entsprechenden Markierung der Druckknopfskala übereinstimmen.","For doses corresponding to full turns, the scale should line up with the correct dose marking.",16,16
"2536","de","en","Für Efavirenz ist keine Dosisanpassung erforderlich","No dosage adjustment is necessary for efavirenz.",7,6
"2537","de","en","Für erwachsenePatienten mit mäßiger Leberinsuffizienz wird eine Reduktion der Tagesdosis auf 35 mg empfohlen.","A reduction of the daily dose to 35 mg is recommended for adults with moderate hepatic impairment.",17,14
"2538","de","en","Für Etoricoxib liegen keine klinischen Daten über exponierte Schwangerschaften vor.","No clinical data on exposed pregnancies are available for etoricoxib.",10,10
"2539","de","en","Für höhere oder niedrigere Dosen kann die Kombination von verschiedenen Tablettenstärken notwendig sein.","For higher or lower doses use of combinations of the different tablet strengths may be necessary.",16,13
"2540","de","en","Für INTANZA gibt es bisher keine Daten aus der Post-Marketing-Beobachtung.","There is no safety data from post-marketing experience with INTANZA.",10,10
"2541","de","en","Für Interferon beta-1a liegen keine Daten zur Karzinogenität bei Menschen oder Tieren vor.","No carcinogenicity data for interferon beta-1a are available in animals or humans.",12,13
"2542","de","en","Für Irbesartan wurden ähnliche Wirkungen bisher sehr selten berichtet.","Similar effects have been very rarely reported with irbesartan so far.",11,9
"2543","de","en","Für jede Injektion ist eine neue Injektionsnadel zu verwenden.","A new needle should be used for every injection.",9,9
"2544","de","en","Für Jugendliche von 12–16 Jahren liegen jedoch in begrenztem Umfang Daten vor.","There have been no formal clinical trials undertaken in children or adolescents.",12,12
"2545","de","en","Für Katzen sollte Metacam 0,5 mg/ml Suspension zum Eingeben verwendet werden.","In cats, Metacam 0.5 mg/ ml oral suspension for cats should be used.",13,11
"2546","de","en","Für Nespo sind keine klinischen Daten zur Anwendung in der Schwangerschaft verfügbar. zn","For Nespo no clinical data on exposed pregnancies are available.",10,13
"2547","de","en","Für Patienten mit einem hohen Rückfallrisiko kann ein Ausschleichen der Dosierung erwogen werden (siehe Abschnitt 4.4).","In patients with a high risk of relapse, dose tapering may be considered (see section 4.4).",16,16
"2548","de","en","Für Patienten mit eingeschränkter Leberfunktion ist eine Dosisanpassung nicht erforderlich.","In patients with impaired liver function no dose adjustment is required.",11,10
"2549","de","en","Für Patienten mit schwerer Leberfunktionsstörung liegen keine Daten vor.","No data are available in patients with severe hepatic impairment.",10,9
"2550","de","en","Für Patienten mit Schwierigkeiten beim Schlucken steht eine Lösung zum Einnehmen zur Verfügung.","Oral solution is available to patients who have difficulty swallowing.",10,13
"2551","de","en","Für Patienten unter 6 Jahren liegen keine Daten zur Sicherheit aus klinischen Prüfungen vor.","No clinical study safety data are available in patients below 6 years of age.",14,14
"2552","de","en","Für Patienten, die keine Hämodialyse erhalten und eine Kreatinin-Clearance < 10 ml/min aufweisen, konnten keine Dosisempfehlungen aufgestellt werden.","No dosing recommendations can be given for non-haemodialysis patients with creatinine clearance < 10 ml/ min.",16,18
"2553","de","en","Für Patienten, für die eine Tabletteneinnahme nicht möglich ist, steht Telzir auch als Suspension zum Einnehmen zur Verfügung.","Telzir is also available as an oral suspension for those patients unable to swallow the tablets.",16,18
"2554","de","en","Für selektive, reversible MAO-Hemmer, wie Moclobemid, ist das Risiko eines Serotonin-Syndroms geringer.","For selective, reversible MAOIs, like moclobemide, the risk of serotonin syndrome is lower.",13,12
"2555","de","en","Für Tadalafil liegen keine klinischen Daten über exponierte Schwangere vor.","For tadalafil no clinical data on exposed pregnancies are available.",10,10
"2556","de","en","Für Tiere - Verschreibungspflichtig","To be supplied only on veterinary prescription.",7,4
"2557","de","en","Für Tiere - Verschreibungspflichtig.","For animal treatment only - to be supplied only on veterinary prescription.",12,4
"2558","de","en","Für weitere Informationen siehe Packungsbeilage","See package leaflet for further information.",6,5
"2559","de","en","Für zusätzliche Hinweise für die Handhabung und die Entsorgung siehe Abschnitt 6.6.","For additional instructions for use and handling and disposal see section 6.6.",12,12
"2560","de","en","Fütterungsarzneimittels als einzige tägliche Ration","Application period of medicated feed as the sole daily ration",10,5
"2561","de","en","Gabapentin geht in die Muttermilch stillender Frauen über.","Gabapentin is present in the breast milk of breast-feeding women.",10,8
"2562","de","en","Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist","Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist Gadovist",16,14
"2563","de","en","Gallows Green Services Limited Cod Beck Blenders, Cod Beck Mill Dalton, Thirsk, North Yorkshire YO7 3HR Großbritannien","Gallows Green Services Limited Cod Beck Blenders, Cod Beck Mill Dalton, Thirsk, North Yorkshire YO7 3HR United Kingdom",18,17
"2564","de","en","GANFORT 300 Mikrogramm/ml + 5 mg/ml Augentropfen Bimatoprost und Timololmaleat","GANFORT 300 micrograms/ ml + 5 mg/ ml eye drops, solution bimatoprost and timolol maleate",15,10
"2565","de","en","Ganganomalie, Dysphonie, Schlaflosigkeit, Somnolenz.","Nervous System Disorders: abnormal gait, dysphonia, insomnia, somnolence",8,4
"2566","de","en","Gardasil ist ein Impfstoff.","Gardasil is a vaccine.",4,4
"2567","de","en","Gardasil kann daher stillenden Frauen verabreicht werden.","Therefore Gardasil can be given to breastfeeding women.",8,7
"2568","de","en","Gastrointestinaltrakts Übelkeit Bluterbrechen, Erbrechen, Obstipation.","Nausea Haematemesis, vomiting, constipation",4,5
"2569","de","en","ge (soweit vorhanden) abgesehen.","A number of cleavage (hydrolysis) sites on the human insulin",10,4
"2570","de","en","ge Biologicals s.a. eine Genehmigung für das Inverkehrbringen von Quintanrix in der gesamten Europäischen Union.","2/ 3 The full EPAR for Quintanrix can be found here.",11,15
"2571","de","en","ge Diese Injektion sollte nicht in derselben Spritze oder Durchstechflasche mit einem anderen Arzneimittel gemischt werden.","This injection should not be mixed in the same syringe or vial with any other medicine. na",17,16
"2572","de","en","GE Healthcare AS, Nycoveien 1-2, 0401 Oslo, Norwegen","GE Healthcare AS, Nycoveien 1-2, 0401 Oslo, Norway",8,8
"2573","de","en","ge Kinder Quixidar wurde nicht bei Kindern und Jugendlichen unter 17 Jahren untersucht.","Children Quixidar has not been tested in children and adolescents under the age of 17 years.",16,13
"2574","de","en","Geben Sie es nicht an","Do not pass it on to others.",7,5
"2575","de","en","gebrauchsfertigen Injektionslösung in die Patrone (siehe Pen- Gebrauchsanleitung).","back into the cartridge (see Instructions for Use of the pen injector).",12,8
"2576","de","en","Gefäßerkrankung en Allgemeine Erkrankungen und Beschwerden am Verabreichungsor t","Vascular disorders General disorders and administration site conditions",8,9
"2577","de","en","GEGEBENENFALLS BESONDERE VORSICHTSMASSNAHMEN FÜR DIE 33 BESEITIGUNG VON NICHT VERWENDETEM ARZNEIMITTEL ODER DAVON STAMMENDEN ABFALLMATERIALIEN","SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE",18,15
"2578","de","en","GEGEBENENFALLS BESONDERE VORSICHTSMASSNAHMEN FÜR DIE BESEITIGUNG VON NICHT VERWENDETEM ARZNEIMITTEL ODER DAVON STAMMENDEN ABFALLMATERIALIEN Ar","SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS M",9,15
"2579","de","en","GEGEBENENFALLS WARNHINWEISE, FALLS ERFORDERLICH","7 OTHER SPECIAL WARNINGS, IF NECESSARY",6,4
"2580","de","en","Gegebenenfalls wird Ihr Arzt Ihnen die Einnahme eines Eisenpräparates empfehlen.","In some cases, your doctor may recommend that you take iron supplements.",12,10
"2581","de","en","gegen Hydroxyzin oder andere Piperazin-Derivate (eng verwandte Wirkstoffe anderer Arzneimittel) sind.","(other constituents), to hydroxyzine or to any piperazine derivatives (closely related active substances of other medicines).",16,11
"2582","de","en","Gegenstand des Verfahrens war die Harmonisierung der Zusammenfassungen der Merkmale des Arzneimittels,","undesirable effects sections on psychiatric disorders within 2 months after the CPMP opinion, as a follow-up measure.",17,12
"2583","de","en","Gegenwärtig ist die Sicherheit bei dieser Patientengruppe noch nicht ausreichend evaluiert.","At present the safety in this patient population has not been thoroughly evaluated.",13,11
"2584","de","en","Gehen Sie nicht ohne Begleitung zum Arzt.","Do not go unaccompanied to seek medical help.",8,7
"2585","de","en","Gelatine, Titandioxid (E171), Natriumdodecylsulfat und Siliciumdioxid.","Ingredients of the capsule shell: gelatin, titanium dioxide (E171), sodium lauryl sulphate and silicon dioxide.",15,6
"2586","de","en","Gelbfärbung oder Zunahme einer bestehenden Gelbfärbung Ihrer Haut oder Augen und dunklen Harn bemerken (Anzeichen für Leberprobleme).","- if you experience a combination of drowsiness, upper right abdominal pain, yellowing or",14,17
"2587","de","en","Gelegentlich - Diabetische Retinopathie Eine langfristige Verbesserung der glykämischen Kontrolle verringert das Risiko des Fortschreitens einer diabetischen Retinopathie.","Uncommon - Diabetic retinopathy Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy.",16,18
"2588","de","en","Gelegentlich (> 1/1.000, < 1/100) Psychische Erkrankungen:","10 Uncommon (> 1/ 1,000, < 1/ 100) Psychiatric disorders:",10,7
"2589","de","en","Gelegentlich (≥ 1/1.000 und < 1/100)*","Uncommon (≥ 1/ 1,000 and < 1/ 100)*",8,6
"2590","de","en","Gelegentlich (betrifft 1 bis 10 Patienten von 1.000) können von schwerwiegenderer Natur sein.","Uncommon (affects 1 to 10 patients in 1,000) may be more serious in nature and include:",16,13
"2591","de","en","Gelegentlich auftretende Nebenwirkungen Atemnot, verringerte Blutsauerstoffwerte, Erstickungsanfälle, Schwellungen der Atemwege, Flüssigkeitsansammlungen in den Atemwegen, Atemnot bei körperlicher Aktivität,","- difficulty breathing, decrease in level of oxygen, choking, swelling of the airways, fluid in",15,18
"2592","de","en","Gelegentlich Gelegentlich Gelegentlich Gelegentlich","Uncommon Uncommon Uncommon Uncommon",4,4
"2593","de","en","Gelegentlich können nach der Lagerung im Kühlschrank kleine farblose Teilchen in der NutropinAq-Lösung sein.","Occasionally, after refrigeration, you may notice that small colourless particles are present in the NutropinAq solution.",16,14
"2594","de","en","Gelegentlich Nephrolithiasis, Hämaturie, Pollakisurie Selten Niereninsuffizienz","Uncommon Nephrolithiasis, haematuria, pollakiuria Rare Renal insufficiency",7,6
"2595","de","en","Gelegentlich traten bei Patienten unter Valtropin-Therapie Antikörper gegen Wirtszell- (S. cerevisiae) Protein auf.","Anti-host cell protein (anti-S. cerevisiae) antibodies were uncommon in patients treated with Valtropin.",13,13
"2596","de","en","Gelegentlich: erhöhter Herzschlag, Hitzegefühl, Husten, Durchfall, Verdauungsstörungen/Sodbrennen, sexuelle Dysfunktion (Probleme mit der sexuellen Leistungsfähigkeit), Brustschmerzen.","Uncommon: heart rate increased, flushing, cough, diarrhoea, indigestion/ heartburn, sexual dysfunction (problems with sexual performance), chest pain.",17,15
"2597","de","en","Gelegentliche Nebenwirkungen (weniger als 1 von 100 Patienten betroffen):","Uncommon side effects (affecting less than 1 in every 100 patients):",11,9
"2598","de","en","Gemeinsame Forschungsstelle Anglo-Irish Desk, Gemeinsamer","Anglo-Irish Desk, Joint Interpretation",4,5
"2599","de","en","Gemfibrozil war weder bei der Ratte noch beim Kaninchen teratogen.","Gemfibrozil was not teratogenic in either rats or rabbits.",9,10
"2600","de","en","Gemzar® gehört zu einer Gruppe von Arzneimitteln, die „Zytostatika“ genannt werden.","Gemzar belongs to a group of medicines called “cytotoxics”.",9,11
"2601","de","en","Genehmigt für 2 2006","Authorised for 2 2006",4,4
"2602","de","en","Generell muss MicardisPlus vor Beginn einer Schwangerschaft durch geeignete blutdrucksenkende Arzneimittel ersetzt werden.","Appropriate antihypertensive drug must usually replace MicardisPlus before starting a pregnancy.",11,13
"2603","de","en","Generika und Erzeugnisse, die einander im Wesentlichen gleichen Biogenerika Wissenschaftliche Gutachten für Märkte in Drittländern","New medicinal products (non-orphan) Scientific opinions for non-EU markets",9,15
"2604","de","en","Genotyp 1 (n = 569)","Genotype 1 (N= 569)",4,5
"2605","de","en","Genotyp 2/3/4 (n=26) * Anzahl (%) der Patienten","Genotype 2/3/4 (n=26) *Number (%) of patients",7,8
"2606","de","en","genphosphat 7 H2O, Zinkoxid und Wasser für Injektionszwecke.","phosphate 7H2O, zinc oxide and water for injection.",8,8
"2607","de","en","Genzyme Europe B.V., Gooimeer 10, NL-1411 DD Naarden, Niederlande.","Genzyme Europe B. V., Gooimeer 10, NL-1411 DD Naarden, The Netherlands.",11,9
"2608","de","en","Gerard O’Malley, Leiter des Bereichs Rechnungsführung, geboren am 4.","Gerard O’Malley, Head of Sector, Accounting, b.",7,9
"2609","de","en","Gesamt-Scored (modifizierter van der Heijde Sharp-Score) Änderung vom Ausgangswert","Total scored (van der Heijde-modified Sharp score)",7,9
"2610","de","en","Gesamtbilirubin > 3– 10 ULN ASAT: beliebig","Total bilirubin: > 3– 10 ULN AST: any",8,7
"2611","de","en","Gesamte extrahierbare Aktivität, die zum Anwendungszeitpunkt zur Verfügung steht","Total extractable activity to deliver at time of use",9,9
"2612","de","en","Gesamtremission (VR + VRp) VR","Overall remission (CR + CRp) CR",6,5
"2613","de","en","Gesäß, Oberschenkel, Bauch oder Oberarme.","Sites for self-injection include the buttocks, thigh, abdomen or upper arm.",11,5
"2614","de","en","Geschlecht Anfangsdosis und Dosierungsbereich müssen üblicherweise bei Frauen im Vergleich zu Männern nicht verändert werden.","The starting dose and dose range need not be routinely altered for female patients relative to male patients.",18,15
"2615","de","en","Geschlecht Die Pharmakokinetik der Ibandronsäure ist bei Männern und Frauen ähnlich.","Gender Pharmacokinetics of ibandronic acid are similar in men and women.",11,11
"2616","de","en","Geschlecht, Rasse und ältere Patienten:","23 Gender, race, elderly:",4,5
"2617","de","en","Gesellschaftliche Beziehungen zwischen den Bediensteten","Social contacts between staff",4,5
"2618","de","en","gesteigerter Appetit, Hyperaktivität, erhöhte Konzentration von Triglyzeriden (bestimmte Fette) im Blut","appetite, hyperactive, excess of triglycerides (a type of fat) in the blood",12,11
"2619","de","en","Gewichtszu- nahme Kreatinin- phosphokinase -Anstieg","Weight increase Creatinine phosphokinase increase",5,5
"2620","de","en","Gewichtszunahme, Anstieg der Kreatininphosphokinase im Blut","Investigations Common: weight increased, blood creatinine phosphokinase increased",8,6
"2621","de","en","Gilead Sciences Intl Ltd Cambridge CB21 6GT Vereinigtes Königreich","Gilead Sciences Intl Ltd Cambridge CB21 6GT United Kingdom",9,9
"2622","de","en","Glas, verschlossen mit einer teflonbeschichteten Scheibe aus Bromobutylgummi und durch eine Verschlusskappe aus Aluminium gesichert.","Glass closed with a bromobutyl rubber disc with teflon, covered with an aluminium cap.",14,15
"2623","de","en","Glaxo Group Ltd Greenford Middlesex UB6 0NN Vereinigtes Königreich","Greenford Middlesex UB6 0NN United Kingdom",6,9
"2624","de","en","Glaxo Group Ltd Greenford Road Greenford Middlesex UB6 0NN Vereinigtes Königreich","45 Greenford Middlesex UB6 0NN United Kingdom",7,11
"2625","de","en","Glaxo Group Ltd, Greenford, Middlesex, UB6 0NN, Vereinigtes Königreich","Glaxo Group Ltd, Greenford, Middlesex, UB6 0NN, United Kingdom",9,9
"2626","de","en","Glaxo Wellcome GmbH & Co.","Glaxo Wellcome GmbH & Co.",5,5
"2627","de","en","Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN Vereinigtes Königreich","Glaxo Group Ltd Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 ONN United Kingdom",14,11
"2628","de","en","GlaxoSmithKline (Ireland) Limited (trading as:","GlaxoSmithKline (Ireland) Limited (trading as:",5,5
"2629","de","en","GlaxoSmithKline (Ireland) Ltd Tel: + 353 (0)1 4955000","44 Tel: + 353 (0)1 4955000",6,8
"2630","de","en","GlaxoSmithKline Biologicals Niederlassung von SmithKline Beecham Pharma GmbH & Co.","GlaxoSmithKline Biologicals Branch of SmithKline Beecham Pharma GmbH & Co.",10,10
"2631","de","en","GlaxoSmithKline Pharma A/S Nykaer 68 DK-2605 Broendby Dänemark","GlaxoSmithKline Pharma A/ S Nykaer 68 DK-2605 Broendby Denmark",9,8
"2632","de","en","GlaxoSmithKline s.a./n.v., Rue du Tilleul 13, B-1332 Genval, Belgien","GlaxoSmithKline s. a. / n. v., Rue du Tilleul 13 B-1332 Genval Belgium",13,9
"2633","de","en","Gleichzeitige Anwendung mit anderen Arzneimitteln:","Co-administration of other medicinal products:",5,5
"2634","de","en","gleichzeitiger Anwendung von Neupopeg mit 5-Fluorouracil (5-FU) oder anderen Antimetaboliten ch","or concomitant administration of Neupopeg and 5-fluorouracil (5-FU) or other antimetabolites has been shown to potentiate myelosuppression.",17,11
"2635","de","en","Glimepirid wird in die Milch von säugenden Ratten abgegeben.","Glimepiride is excreted into the milk of lactating rats.",9,9
"2636","de","en","Glivec 400 mg Filmtabletten Imatinib","Glivec 400 mg film-coated tablets Imatinib",6,5
"2637","de","en","Glucomed wird zur Linderung von Symptomen leichter bis mittelschwerer Arthrose des Kniegelenks angewendet.","Glucomed is used for the relief of symptoms in mild to moderate osteoarthritis of the knee.",16,13
"2638","de","en","Glustin 30 mg Tabletten können auch in Kombination mit Insulin angewendet werden.","Glustin 30 mg tablets may also be used in combination with insulin.",12,12
"2639","de","en","GONAL-f 1050 I.E./1,75 ml Pulver zur Herstellung einer Injektionslösung Follitropin alfa Subkutane Anwendung","GONAL-f 1050 IU/ 1.75 ml powder for solution for injection Follitropin alfa Subcutaneous use.",14,13
"2640","de","en","Gonazon 18,5 mg Implantat für Hunde","Gonazon 18.5 mg implant for dogs",6,6
"2641","de","en","Gooimeer 10 1411 DD Naarden Niederlande","Gooimeer 10 1411 DD Naarden The Netherlands",7,6
"2642","de","en","Grad 2 (funktions- aber nicht die Alltagsaktivität beeinträchtigend)","Grade 2 (interfering with function but not with activities of daily living)",12,8
"2643","de","en","gram-negative Bakterien; im Fall von Infektionen mit Streptococus pneumoniae ist Ciprofloxacin Kabi nicht das Mittel der ersten Wahl.","bacteria, in case of Streptococcus pneumoniae infections ciprofloxacin is not the substance of first choice.",15,18
"2644","de","en","Grampositive Erreger mit einem MHK-Wert > 2 µg/ml werden als resistent betrachtet.","3 Gram-positive isolates with an MIC > 2 µg/ ml are to be considered resistant.",15,12
"2645","de","en","Gramsci 731-733, 50019 Sesto Fiorentino, Florenz, Italien","Gramsci 731-733, 50019 Sesto Fiorentino, Florence, Italy.",7,7
"2646","de","en","Grand-Duché du Luxembourg Dr Jean-Louis ROBERT Pharm.","Grand-Duché du Luxembourg Dr Jean-Louis ROBERT Pharm.",7,7
"2647","de","en","Grapefruitsaft und andere Lebensmittel, die nachweislich CYP3A4-hemmend wirken, sind zu vermeiden.","Grapefruit juice and other foods that are known to inhibit CYP3A4 should be avoided.",14,11
"2648","de","en","Grippeähnliche Symptome lassen sich außerdem durch Verabreichung eines nicht-steroidalen Entzündungshemmers verringern.","Flu-like symptoms may also be reduced by administration of non- steroidal anti-inflammatory drugs.",13,11
"2649","de","en","GRÜNDE FÜR EINE WEITERE VERLÄNGERUNG","GROUNDS FOR ONE ADDITIONAL RENEWAL",5,5
"2650","de","en","Grundsätzlich ist die Bolusdosis auf 0,2 mg/kg Körpergewicht zu reduzieren.","In any case, the bolus dose must be reduced to 0.2 mg / kg body weight.",16,10
"2651","de","en","GUTACHTEN IM NACHGANG ZU EINEM VERFAHREN GEMÄSS ARTIKEL 33 ABSATZ 4 BEZÜGLICH EQUIBACTIN VET.","OPINION FOLLOWING AN ARTICLE 33 (4) REFERRAL FOR EQUIBACTIN VET.",10,14
"2652","de","en","Gutachten zu neuen MRL","Maximum residue limit (MRL) procedures",5,4
"2653","de","en","H- 1149 Budapest Tel.: + 36 - 1 – 555-59-30","H- 1149 Budapest Tel.: + 36 - 1 – 555-59-30",10,10
"2654","de","en","H-2045 Törökbálint, Tó Park Tel: +36 23 513-800","H-2045 Törökbálint, Tó Park Tel: +36 23 513-800",8,8
"2655","de","en","Ha ndhabung des vorgefüllten Injektors. ch","The carton contains a package leaflet with the full instructions for use and handling.",14,6
"2656","de","en","Hadovka Office Park Evropská 2590/33d CZ-160 00 Praha 6 Tel: + 420 267 292 111","Hadovka Office Park Evropská 2590/33d CZ-160 00 Praha 6 Tel: + 420 267 292 111",15,15
"2657","de","en","Halluzinationen oder Müdigkeit können auftreten.","Hallucinations or somnolence can occur.",5,5
"2658","de","en","Halofuginonlaktat, der Wirkstoff in Halocur, verhindert das Wachstum von Cryptosporidium parvum.","The active substance in Halocur, halofuginone lactate, prevents the growth of Cryptosporidium parvum.",13,11
"2659","de","en","Haltbarkeit des Tierarzneimittels im unversehrten Behältnis:","Shelf life of the veterinary medicinal product as packaged for sale:",11,6
"2660","de","en","Haltbarkeit des Tierarzneimittels laut Verkaufsverpackung (Pulver):","Shelf-life of the veterinary medicinal product as packaged for sale (powder):",11,6
"2661","de","en","Haltbarkeit nach dem ersten Öffnen der Applikationsspritze:","3 years Shelf life after first opening the syringe:",9,7
"2662","de","en","Haltbarkeit nach Einmischen in Futtermittel:","Shelf life after incorporation into feed:",6,5
"2663","de","en","Haltbarkeit nach erstmaligem Öffnen / nach Anbruch des Behältnisses:","Shelf-life after first opening the immediate packaging:",7,9
"2664","de","en","Halten die Schmerzen nach der ärztlichen Untersuchung länger als 12 Stunden an, ist der Arzt erneut aufzusuchen.","If pain persists for more than 12 hours after medical examination, the doctor should be contacted again.",17,17
"2665","de","en","Halten Sie die Flasche aufrecht und setzen Sie den Flaschenadapter zum Eindrücken in den Flaschenhals ein.","While holding the bottle in its upright position, insert the press-in-bottle-adaptor into the neck of the bottle.",17,16
"2666","de","en","Halten Sie die Spritze leicht schräg, die Durchstechflasche nach unten gerichtet.","Hold the syringe slightly tilted with the vial facing downwards.",10,11
"2667","de","en","Hämoglobin ist das Protein in den roten Blutkörperchen, das den Sauerstoff im Körper transportiert.","Haemoglobin is the protein in red blood cells that carries oxygen around the body.",14,14
"2668","de","en","Handelsweg 25 P.O.Box 179 NL- 5530 AD Bladel Niederlande","Handelsweg 25, P. O. Box 179, 5530 AD Bladel, The Netherlands",11,9
"2669","de","en","Händen und Füßen), Erkrankung des Herzens und anderen Störungen.","This helps SOMAVERT prevent the unwanted growth and other disorders seen in acromegaly.",13,9
"2670","de","en","Harmire Road Barnard Castle Durham, DL12 8DT Vereinigtes Königreich","Harmire Road Barnard Castle Durham, DL12 8DT United Kingdom",9,9
"2671","de","en","Harninkontinenz tritt bekanntlich bei Hündinnen am häufigsten nach einer Ovarektomie (operativen Entfernung der Eierstöcke) auf.","It is known to occur in bitches, with the incidence being highest after ovariectomy.",14,15
"2672","de","en","Harninkontinenz, Dysurie Nierenversagen, Oligurie Harnretention","Urinary incontinence, dysuria Renal failure, oliguria Urinary retention",8,5
"2673","de","en","Harnwegsstörungen (wie etwa Blaseninfektionen, unregelmäßiges","- Common adverse events: urinary tract disorders (such as bladder infections, irregular urination,",13,5
"2674","de","en","Hartkapseln Hartkapseln Hartkapseln Hartkapseln Hartkapseln Hartkapseln","Pharmaceutical Form Capsule, hard Capsule, hard Capsule, hard Capsule, hard Capsule, hard Capsule, hard Capsule, hard Capsule, hard",18,6
"2675","de","en","hat die EMEA den Widerruf der Genehmigungen für das Inverkehrbringen von Terfenadin 120 mg Tabletten befürwortet.","the EMEA has recommended the withdrawal of the Marketing Authorisations for terfenadine 120 mg tablet formulation.",16,16
"2676","de","en","Hat sie kein klares homogenes Aussehen oder enthält sie irgendwelche Partikel, wenden Sie sie nicht an.","If it does not have a clear uniform appearance or if it contains any particles, do not use.",18,16
"2677","de","en","hat, innerhalb der gesetzten Fristen bewältigen.","There is much work yet to do - to be achieved together.",12,6
"2678","de","en","Häufig (> 1/100, < 1/10)","Common (> 1/ 100, < 1/ 10)",7,5
"2679","de","en","Häufig (≥ 1/100, < 1/10), gelegentlich (≥ 1/1000, < 1/100).","Frequencies are defined as: common (≥ 1/ 100, < 1/ 10), uncommon (≥ 1/ 1,000, < 1/ 100).",18,10
"2680","de","en","Häufig (Schweregrad 3 oder 4)","Common (Grade 3 or 4)",5,5
"2681","de","en","Häufig gibt es andere Arzneimittel, die Sie stattdessen einnehmen können.","Often, there are other medicines you can take instead.",9,10
"2682","de","en","Häufig Häufig Häufig Häufig Häufig","Common Common Common Common Common",5,5
"2683","de","en","Häufig Selten Erkrankungen des Gastrointestinaltraktes","Respiratory, thoracic and mediastinal disorders Common Rare Gastrointestinal disorders",9,5
"2684","de","en","Häufig Stoffwechsel- und Ernährungsstörungen","Common Metabolism and Nutrition disorders",5,4
"2685","de","en","Häufig: erniedrigter Blutzucker, Kopfschmerzen Gelegentlich:","Common: low blood sugar, headache Uncommon: dizziness, constipation",8,5
"2686","de","en","Häufige Nebenwirkungen (bei 1 bis 10 von 100 Patienten berichtet)","Common side effects (reported in 1 to 10 out of 100 patients)",12,10
"2687","de","en","Häufige Nebenwirkungen (diese können bei bis zu 9 von 100 Patienten auftreten)","25 Less common side effects (these may affect up to 9 in every 100 people)",15,12
"2688","de","en","Häufige Nebenwirkungen (treten bei 1 bis 10 Patienten von 100 auf):","Common side effects (affects 1 to 10 patients in 100):",10,11
"2689","de","en","häufige Nebenwirkungen ≥ 1 bis < 10% der Patienten Dermatitis; erythematöse Rötung (G3/4: < 1%); Nagelverfärbung; Onycholysis (G3/4:","Dermatitis; Rash erythematous (G3/ 4: < 1%); Nail discolouration; Onycholysis (G3/ 4:",12,18
"2690","de","en","Häufige Nebenwirkungen, die bei mehr als 1 von 100 Personen auftreten können, sind","Common side-effects which may affect more than 1 person in 100 are listed below:",14,13
"2691","de","en","Häufigkeit von Nebenwirkungen ermittelt aus Daten aus der Literatur Nebenwirkung","Frequency of adverse reactions identified from literature data Adverse reaction",10,10
"2692","de","en","Hauptindikator für die Wirksamkeit bei Patienten mit Nierenversagen war die Erhöhung des Hämoglobin.","The main measure of effectiveness in patients with kidney disease was the increase in haemoglobin.",15,13
"2693","de","en","Hautausschlag, erythematöser Hautausschlag, Ekzem, Erythem, Hautveränderungen Sehr selten:","erythematous, eczema, erythema, skin disorder Very rarely:",7,8
"2694","de","en","Hazard Ratio (95% KI) p-Wert","Hazard Ratio (95% CI) p-value",5,5
"2695","de","en","HbA1c Ergebnisse in der plazebo-kontrollierten Studie mit Sitagliptin und Metformin*","HbA1c results in placebo-controlled combination therapy studies of sitagliptin and metformin*",11,10
"2696","de","en","HbA1c-Wertes (%) nach 24 Wochen (95-%-KI)","change in HbA1c (%) at week 24 (95%CI)",8,6
"2697","de","en","HBVAXPRO 10 Mikrogramm/ml, Injektionssuspension Hepatitis B-Impfstoff (rDNS)","HBVAXPRO 10 micrograms/ ml, suspension for injection Hepatitis B vaccine (rDNA)",11,7
"2698","de","en","HCV 2 ≤ 600.000 I.E./ml > 600.000 I.E./ml HCV 3","HCV 2 ≤ 600,000 IU/ml",5,10
"2699","de","en","HDPE-Flaschen mit kindergesichertem Polypropylenverschluss mit 180 ml Lösung zum Einnehmen.","HDPE bottles with a child-resistant polypropylene closure containing 180 ml of oral solution.",13,10
"2700","de","en","Helicobacter Test INFAI für Kinder im Alter von 3-11 ist ausschließlich zum diagnostischen Ge- brauch bestimmt.","Helicobacter Test INFAI for children of the age 3-11 is for diagnostic use only.",14,16
"2701","de","en","Hepatitis B-Virus-Oberflächenantigen, rekombinant (HBsAg)* ...........................10 Mikrogramm Adsorbiert an amorphes Aluminiumhydroxyphosphat-Sulfat (0,50 Milligramm Al3+).","10.00 micrograms Adsorbed on amorphous aluminium hydroxyphosphate sulfate (0.50 milligram Al+)",11,13
"2702","de","en","Hepatitis-A-Virus (inaktiviert)1,2 Hepatitis-B-Oberflächenantigen3,4 1 Hergestellt in humanen, diploiden (MRC-5) Zellen 2","Hepatitis A virus (inactivated)1,2 Hepatitis B surface antigen3,4 1 Produced on human diploid (MRC-5) cells 2",16,11
"2703","de","en","Hepsera 10 mg Tabletten Adefovirdipivoxil","Hepsera 10 mg tablets Adefovir dipivoxil",6,5
"2704","de","en","Heptakis-O-(4-sulfobutyl)cyclomaltoheptaose, Heptanatriumalz (SBECD) Weinsäure (Ph.Eur.) Natriumhydroxid Wasser für Injektionszwecke","Sulfobutylether β -cyclodextrin (SBECD) Tartaric acid Sodium hydroxide Water for injection",11,9
"2705","de","en","Herabhängen des Oberlids (Ptosis), trockene Augen","drooping eyelid (ptosis), dry eyes",5,6
"2706","de","en","Herbststraße 6-10 1160 Wien Österreich","Herbststraße 6-10 1160 Wien Austria",5,5
"2707","de","en","Hergestellt in Hefezellen (Saccharomyces cerevisiae) durch rekombinante DNA-Technologie 4","Produced in yeast cells (Saccharomyces cerevisiae) by recombinant DNA technology 4",11,9
"2708","de","en","Hermal Kurt Herrmann GmbH & Co OHG Scholtzstrasse 3 D-21465 Reinbek Deutschland","Hermal Kurt Herrmann GmbH & Co OHG Scholtzstrasse 3 D-21465 Reinbek Germany",12,12
"2709","de","en","Herpes genitalis†, Folliculits, Herpes simplex, Herpes Virus Infektion, Herpes zoster, Influenza, Molluscum contagiosum","genital herpes†, folliculitis, herpes simplex, herpes virus infection, herpes zoster, influenza, molluscum contagiosum",13,13
"2710","de","en","Hersteller • Lilly S.A., Avda. de la Industria 30, 28108 Alcobendas (Madrid), Spanien.","- Lilly S. A., Avda. de la Industria 30, 28108 Alcobendas (Madrid), Spain.",13,13
"2711","de","en","Hersteller Almac Pharma Services Limited, 20 Seagoe Industrial Estate, Craigavon, Co Armagh, BT63 5QD, Großbritannien.","Manufacturer Almac Pharma Services Limited, 20 Seagoe Industrial Estate, Craigavon, Co Armagh, BT63 5QD, United Kingdom.",16,15
"2712","de","en","Hersteller Bayer HealthCare Manufacturing S.r.l.","Bayer HealthCare Manufacturing S. r. l.",6,5
"2713","de","en","Hersteller Bristol-Myers Squibb Champ ""Lachaud"", La Goualle 19250 Meymac Frankreich","Manufacturer Bristol-Myers Squibb Champ ""Lachaud"", La Goualle F- 19250 Meymac France",11,10
"2714","de","en","HERSTELLER DER BIOLOGISCH AKTIVEN SUBSTANZ INHABER DER HERSTELLUNGSERLAUBNIS, DER FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST","MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE",14,14
"2715","de","en","HERSTELLER DES (DER) ARZNEILICH WIRKSAMEN BESTANDTEILS (BESTANDTEILE) BIOLOGISCHEN URSPRUNGS UND INHABER DER","MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE",14,12
"2716","de","en","HERSTELLER DES (DER) WIRKSTOFFS (WIRKSTOFFE) BIOLOGISCHEN URSPRUNGS UND INHABER DER HERSTELLUNGSERLAUBNIS, DER FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST","MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE",5,17
"2717","de","en","HERSTELLER DES (DER) WIRKSTOFFS (WIRKSTOFFE) BIOLOGISCHEN URSPRUNGS UND INHABER DER HERSTELLUNGSERLAUBNIS, DER/DIE FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST/SIND","MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE",7,17
"2718","de","en","HERSTELLER DES ARZNEILICH WIRKSAMEN BESTANDTEILS BIOLOGISCHEN URSPRUNGS UND INHABER DER HERSTELLUNGSERLAUBNIS, DER FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST","MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE",14,17
"2719","de","en","HERSTELLER DES ARZNEILICH WIRKSAMEN BESTANDTEILS BIOLOGISCHEN URSPRUNGS UND INHABER DER HERSTELLUNGSERLAUBNIS, DIE FÜR DIE CHARGENFREIGABE VERANTWORTLICH SIND","16 A MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE",16,17
"2720","de","en","HERSTELLER DES WIRKSTOFFS BIOLOGISCHEN URSPRUNGS UND INHABER DER HERSTELLUNGSERLAUBNIS, DER FÜR DIE CHARGENFREIGABE VERANTWORTLICH IST","10 A MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE",16,15
"2721","de","en","Hersteller Merck Serono S.p.A.","Manufacturer Merck Serono S. p. A.",6,4
"2722","de","en","Hersteller Novartis Pharma S.A.S.","Manufacturer Novartis Pharma S. A. S.",6,4
"2723","de","en","Hersteller Procter & Gamble Pharmaceuticals – Germany GmbH Dr.-Otto-Röhm-Strasse 2-4 D-64331 Weiterstadt Deutschland","Manufacturer Procter & Gamble Pharmaceuticals – Germany GmbH Dr. -Otto-Röhm-Strasse 2-4 D-64331 Weiterstadt Germany",14,13
"2724","de","en","Hersteller SANOFI WINTHROP INDUSTRIE 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc Cedex - Frankreich","Manufacturer SANOFI WINTHROP INDUSTRIE 1, rue de la Vierge Ambarès & Lagrave F-33565 Carbon Blanc Cedex - France",18,18
"2725","de","en","Herstellung der Lösung wie in Abschnitt 6.6 beschrieben.","Reconstitute the lyophilisate as described in section 6.6.",8,8
"2726","de","en","Herzinsuffizienz Behandlung der symptomatischen Herzinsuffizienz.","Heart Failure Treatment of symptomatic heart failure.",7,5
"2727","de","en","Herzklopfen Erkrankungen des Nervensystems","Palpitations Nervous System Disorders",4,4
"2728","de","en","Herzrhythmusstörungen, Angina pectoris, Myokardinfarkt, Herzinsuffizienz und Kardiomyopathie sind bei Patienten beobachtet worden, die Xeloda erhalten haben.","Cardiac arrhythmias, angina pectoris, myocardial infarction, heart failure and cardiomyopathy have been reported in patients receiving Xeloda.",17,16
"2729","de","en","Hexal Ag Industriestrasse 25 D-83607 Holzkirchen Deutschland","Hexal Ag Industriestrasse 25 D-83607 Holzkirchen Germany",7,7
"2730","de","en","HEXAVAC - Eine Einzeldosis in einer Fertigspritze ohne Kanüle - Packung mit 1 Dosis","HEXAVAC - single dose pre-filled syringe with attached needle - Pack of 10",13,14
"2731","de","en","Hierauf basierend sollte eine Begründung für den für das Produkt festgelegten Mindesttiter abgeleitet werden.","On the basis of this, a justification should be provided for the minimum potency specified for the product.",18,14
"2732","de","en","Hierzu gehören Standard-Anästhetika, Analgetika, Antipyretika, intravenös zu verabreichende Volumenersatzmittel, Antikoagulantien und Vasopressoren.","These include standard anaesthetic agents, analgesics, antipyretics, intravenous fluids, anticoagulants and vasopressor agents.",13,12
"2733","de","en","Hikma Farmacêutica (Portugal), Lda.","Hikma Farmacêutica (Portugal) Lda.",4,4
"2734","de","en","Hinweis, dass das Arzneimittel mit keiner anderen Person geteilt werden darf","changed her method of contraception",5,11
"2735","de","en","HINWEISE FÜR DEN GEBRAUCH INFORMATION IN BRAILLE-SCHRIFT ä n","INFORMATION IN BRAILLE lo no",5,9
"2736","de","en","HINWEISE FÜR DEN GEBRAUCH m ei","INSTRUCTIONS ON USE ng lo",5,6
"2737","de","en","HINWEISE FÜR DIE RICHTIGE ANWENDUNG","ADVICE ON CORRECT ADMINISTRATION",4,5
"2738","de","en","Hinweise für die Zubereitung von 99mTc-Depreotid:","Instructions for the preparation of 99mTc-depreotide:",6,6
"2739","de","en","HINWEISE ZUR UND ART DER ANWENDUNG","METHOD AND ROUTE OF ADMINISTRATION",5,6
"2740","de","en","HINWEISE ZUR UND ART(EN) DER ANWENDUNG","CONDITIONS OF THE MARKETING AUTHORISATION",5,6
"2741","de","en","Hinzu kommen noch die Gegenanzeigen von HCTZ.","They are extended with the contraindications of HCTZ.",8,7
"2742","de","en","HIV-RNA-Werte < 50 Kopien/ml **","HIV RNA < 50 copies/ ml",6,5
"2743","de","en","Hoechst Marion Roussel Broadwater Park Denham, Uxbridge Middlesex UB9 5HP Vereinigtes Königreich","Hoechst Marion Roussel Broadwater Park Denham, Uxbridge Middlesex UB9 5HP UK",11,12
"2744","de","en","Hoffsveien 1 D N- 0275 Oslo Tlf: + 47 24 12 65 00 Österreich JANSSEN-CILAG Pharma GmbH.","Hoffsveien 1 D N- 0275 Oslo Tlf: + 47 24 12 65 00 Österreich JANSSEN-CILAG Pharma GmbH.",17,17
"2745","de","en","Höhere Dosierungen als 300 mg Irbesartan/25 mg Hydrochlorothiazid ein Mal täglich werden nicht empfohlen.","Doses higher than 300 mg irbesartan/ 25 mg hydrochlorothiazide once daily are not recommended.",14,14
"2746","de","en","Höhere Strahlendosen können unter bestimmten klinischen Voraussetzungen gerechtfertigt sein.","Higher doses might be justified in some clinical circumstances.",9,9
"2747","de","en","Hörgatún 2 IS-210 Garðabær Sími: +354 535 7000","Hörgatún 2 IS-210 Garðabær Sími: +354 535 7000",8,8
"2748","de","en","Hörverlust Gefäßerkrankungen: hoher Blutdruck Erkrankungen der Atemwege: pfeifendes Atmen Erkrankungen des Magen-Darm-Trakts:","Wheezing Gastrointestinal disorders: gastrointestinal bleeding Liver disorders:",7,12
"2749","de","en","HR = 0,82 (95% CI:","HR = 0.82 (95% CI:",5,5
"2750","de","en","Humalog BASAL 100 E/ml KwikPen Injektionssuspension Insulin lispro Protamin Suspension Zur subkutanen Anwendung","Humalog BASAL 100 U/ ml KwikPen, suspension for injection Insulin lispro protamine suspension Subcutaneous use",15,13
"2751","de","en","HUMALOG HUMALOG NPL HUMALOG MIX","HUMALOG HUMALOG NPL HUMALOG MIX",5,5
"2752","de","en","Humalog Mix25 besteht zu 25% aus einer Insulin lispro Lösung und zu 75% aus einer Insulin lispro Protaminsuspension.","Humalog Mix25 consists of 25% insulin lispro solution and 75% insulin lispro protamine suspension.",14,18
"2753","de","en","Human tick-borne encephalitis immunoglobulin i.m.","Human tick-borne encephalitis immunoglobulin i. m.",6,5
"2754","de","en","Humira kann zu einer Reaktivierung von einer HBV-Infektion bei Personen führen, die dieses Virus tragen.","Humira can cause reactivation of HBV in people who carry this virus.",12,15
"2755","de","en","Hund (> 11-22 kg)","Dogs (> 11-22 kg)",4,4
"2756","de","en","Hunde wiesen eine tubuläre Degeneration in den Hoden sowie Oligospermie auf.","Dogs showed tubular degeneration in the testes and oligospermia.",9,11
"2757","de","en","Hunde: intravenöse oder subkutane Gabe.","Dogs: intravenous or subcutaneous use.",5,5
"2758","de","en","Huntercombe Lane South Taplow, Maidenhead","Huntercombe Lane South Taplow, Maidenhead",5,5
"2759","de","en","HYCAMTIN 1 mg Pulver zur Herstellung eines Infusionslösungskonzentrats Topotecan","HYCAMTIN 1 mg powder for concentrate for solution for infusion topotecan",11,9
"2760","de","en","Hypästhesie (herabgesetzte Berührungsempfindlichkeit); Durchfall (weicher oder wässriger Stuhl).","Hypesthesia (i. e. decrease of your sense of touch); diarrhoea (loose or watery stools).",14,8
"2761","de","en","Hyperkaliämie, Erhöhung der ALT","Hyperkalaemia, elevation of ALT",4,4
"2762","de","en","Hyperkalzämie > 12 mg/dl (2,99 mmol/l).","Hypercalcaemia > 12 mg/ dl (2.99 mmol/ l).",8,6
"2763","de","en","Hypophosphatämie Wie andere Nicotinsäurepräparate wurde Trevaclyn mit einer geringen Reduktion des Phosphatspiegels in Verbindung gebracht.","Hypophosphatemia As with other nicotinic acid medicinal products, Trevaclyn was associated with small decreases in phosphorus levels.",17,15
"2764","de","en","Hypophysen-Gonaden-(HPG-)Achse während der Geschlechtsreifung von jungen männlichen und weiblichen CD-Ratten, denen Fluoxetin verabreicht wurde.","axis during sexual maturation of juvenile CD male and female rats administered fluoxetine.",13,14
"2765","de","en","Hypotonie wurde auch gelegentlich (< 1%) während einer Kombinationstherapie mit anderen Antihypertensiva beobachtet.","Hypotension was also uncommon (< 1%) during combination therapy with other antihypertensive agents.",13,13
"2766","de","en","Hypromellose 2208, mikrokristalline Cellulose, Povidon K30, Siliciumdioxid und Magnesiumstearat (Ph.","- Inactive ingredients in the white, sustained-release layer: hypromellose 2208, microcrystalline",11,10
"2767","de","en","Hypromellose Hypromelloseacetatsuccinat Sucrose Zucker-Stärke-Pellets Talkum Titandioxid (E 171) Triethylcitrat","Hypromellose Acetate Succinate Sucrose Sugar spheres Talc Titanium dioxide (E171) Triethyl citrate.",12,9
"2768","de","en","Hypromellose Titandioxid (E171) Lactose Triacetin Indigocarmin-Aluminiumsalz (E132)","Hypromellose titanium dioxide (E171) lactose triacetin indigo carmine aluminium lake (E132)",11,7
"2769","de","en","Hypromellose, Hypromelloseacetatsuccinat, Sucrose, Zucker-Stärke-Pellets, Talkum, Titandioxid (E 171), Triethylcitrat.","Capsule content: hypromellose, hydroxypropyl methylcellulose acetate succinate, sucrose, sugar spheres, talc, titanium dioxide (E171), triethyl citrate.",16,9
"2770","de","en","I-04010 Campoverde di Aprilia (Latina) Tel: + 39 06 928921","I-04010 Campoverde di Aprilia (Latina) Tel: + 39 06 928921",10,10
"2771","de","en","I.E./0,8 ml Injektions- oder Infusionslösung","Tevagrastim 48 MIU/ 0.8 ml solution for injection or infusion",10,5
"2772","de","en","Ibaflin 150 mg Tabletten","EU/ 2/ 00/ 022/ 007 Ibaflin tablets",7,4
"2773","de","en","Ibaflin 7,5% Gel zur oralen Eingabe sollte nicht bei Katzen angewandt werden.","Ibaflin 7.5% Oral Gel should not be used in cats.",10,12
"2774","de","en","Ibandronsäure wurde 60 Minuten vor der ersten Nahrungs- oder Flüssigkeitsaufnahme des jeweiligen Tages eingenommen (Nüchternperiode nach der Einnahme).","Ibandronic acid was taken 60 minutes before the first food or drink of the day (post-dose fasting period).",18,18
"2775","de","en","Icandra 50 mg/850 mg Filmtabletten Icandra 50 mg/1000 mg Filmtabletten","Icandra 50 mg/850 mg film-coated tablets Icandra 50 mg/1000 mg film-coated tablets",12,10
"2776","de","en","ICN Polfa Rzeszów S.A. ul.","ICN Polfa Rzeszów S. A. ul.",6,5
"2777","de","en","IDflu enthält nicht mehr als 0,05 Mikrogramm Ovalbumin je Dosis.","IDflu does not contain more than 0.05 microgram ovalbumin per dose.",11,10
"2778","de","en","Ihr Arzt hat Ihnen Nespo (ein Antianämikum) zur Behandlung Ihrer Anämie verordnet.","Your doctor has given you Nespo (an anti-anaemic) to treat your anaemia.",12,12
"2779","de","en","Ihr Arzt hat Ihnen nun Januvia als zusätzliches Arzneimittel verordnet, um Ihren Blutzucker zu kontrollieren.","Your doctor is now prescribing Januvia as an additional medicine to help control your blood sugar.",16,15
"2780","de","en","Ihr Arzt kann eine kurzzeitige Unterbrechung der Humira- Behandlung empfehlen.","Your doctor may recommend temporary discontinuation.",6,10
"2781","de","en","Ihr Arzt kann Ihnen außer Liprolog Mix50 Pen auch noch ein länger wirkendes Insulin verschreiben.","Your doctor may tell you to use Liprolog Mix50 Pen as well as a longer-acting insulin.",16,15
"2782","de","en","Ihr Arzt kann Ihnen vorschlagen, die Dosis schrittweise zu reduzieren, bevor Sie die Behandlung beenden.","Your doctor may suggest you to reduce the dose gradually before stopping treatment.",13,15
"2783","de","en","Ihr Arzt kann zur Abschätzung des Blutungsrisikos einen Bluttest durchführen.","Your doctor can perform a blood test to assess the risk of bleeding.",13,10
"2784","de","en","Ihr Arzt möchte jetzt überprüfen, ob die Behandlung erfolgreich war.","Your doctor now wishes to find out if the treatment has been successful.",13,10
"2785","de","en","Ihr Arzt oder das medizinische Fachpersonal wird darauf achten, dass STAMARIL nicht in ein Blutgefäß verabreicht wird.","Your doctor or nurse will take care that STAMARIL is not injected into a blood vessel.",16,17
"2786","de","en","Ihr Arzt oder eine Krankenschwester wird Ihnen Faslodex langsam als intramuskuläre Injektion in Ihr Gesäß verabreichen.","Your doctor or nurse will give you Faslodex as a slow intramuscular injection into your buttock.",16,16
"2787","de","en","Ihr Arzt sollte entscheiden, ob Sie XERISTAR zusammen mit anderen Arzneimitteln einnehmen dürfen.","Your doctor should decide whether you can take XERISTAR with other medicines.",12,13
"2788","de","en","Ihr Arzt wird abklären, ob irgendwelche Symptome mit einer Überempfindlichkeitsreaktion in Zusammenhang stehen.","Your doctor will check whether any symptoms you had may be related to this hypersensitivity reaction.",16,13
"2789","de","en","Ihr Arzt wird auch auf andere Zeichen achten.","Your doctor will be mindful of other signs as well.",10,8
"2790","de","en","Ihr Arzt wird aufgrund der Körperoberfläche (Größe und Gewicht) entscheiden, welche Dosis die geeignetste ist.","Your doctor will decide the most appropriate dose based on body surface area (height and weight).",16,15
"2791","de","en","Ihr Arzt wird die neue Dosis festlegen.","The new dose will be determined by your doctor.",9,7
"2792","de","en","Ihr Arzt wird die niedrigste Dosierung von Viani","The doctor will prescribe the lowest strength of Viani Diskus that will best control your symptoms.",16,8
"2793","de","en","Ihr Arzt wird dies mit Ihnen besprechen.","Your doctor will discuss this with you.",7,7
"2794","de","en","Ihr Arzt wird entscheiden, wie oft Sie die Infusionen erhalten müssen.","Your doctor will decide how often you should receive the infusions.",11,11
"2795","de","en","Ihr Arzt wird festlegen, wann Ihnen Zometa gegeben wird.","When Zometa is given Your doctor will determine when you will be given Zometa.",14,9
"2796","de","en","Ihr Arzt wird Ihnen diese Karte geben, bevor Sie mit der Einnahme von Tracleer beginnen.","Your doctor will give this card to you before you start taking Tracleer.",13,15
"2797","de","en","Ihr Arzt wird Ihnen mitteilen, warum Sie mit Biograstim behandelt werden.","Your doctor will tell you why you are being treated with Biograstim.",12,11
"2798","de","en","Ihr Arzt wird Ihnen mitteilen, wenn sich Ihre Dosis ändert.","Your doctor will inform you if your dose changes.",9,10
"2799","de","en","Ihr Arzt wird Ihnen sagen, ob dies auf Sie zutrifft.","Your doctor will tell you if this applies to you.",10,10
"2800","de","en","Ihr Arzt wird Ihnen zeigen, in welchen Hautbereich Sie Apidra spritzen sollen.","Your doctor will show you in which area of the skin you should inject Apidra.",15,12
"2801","de","en","Ihr Arzt wird Ihnen zur Weiterbehandlung < Phantasiebezeichnung > Kapseln verordnen.","Your doctor will then prescribe< Invented name > capsules for you instead.",12,11
"2802","de","en","Ihr Arzt wird Ihr Blut kontrollieren, um den besten Zeitpunkt für die Gewinnung der Stammzellen zu bestimmen.","Your doctor will monitor your blood to determine the best time to collect the stem cells.",16,17
"2803","de","en","Ihr Arzt wird Ihre Blutgerinnungswerte überwachen.","Your doctor may need to monitor your blood coagulation.",9,6
"2804","de","en","Ihr Arzt wird Ihre individuelle Omnitrope-Dosierung und das Behandlungsschema mit Ihnen besprechen.","Your doctor will advise you about your individualised dose of Omnitrope and treatment schedule.",14,12
"2805","de","en","Ihr Arzt wird Ihre Temodal-Dosis berechnen.","Your doctor will work out your dose of Temodal.",9,6
"2806","de","en","Ihr Arzt wird in regelmäßigen Abständen geeignete Labortests durchführen, um sicherzustellen, dass Sie ausreichende Faktor-VIII-Spiegel haben.","Your doctor will perform appropriate laboratory tests to make sure that you have adequate Factor VIII levels.",17,16
"2807","de","en","Ihr Arzt wird möglicherweise entscheiden, die Behandlung zu beenden. eim","ge decide to stop treatment.",5,10
"2808","de","en","Ihr Arzt wird Sie beraten, wann Sie gefahrlos geimpft werden können.","Your doctor will advise you when it is safe for you to be vaccinated.",14,11
"2809","de","en","Ihr Arzt wird Sie genau darüber informieren, wann Sie aufhören sollen, Nespo anzuwenden. el","Your doctor will tell you exactly when to stop taking Nespo.",11,14
"2810","de","en","Ihr Auge enthält eine klare, wässrige Flüssigkeit, die das Augeninnere mit Nährstoffen versorgt.","Your eye contains a clear, watery liquid that feeds the inside of the eye.",14,13
"2811","de","en","Ihr Insulinbedarf kann sich ändern, wenn Sie zusätzlich Folgendes nehmen:","ed octreotide and lanreotide.",4,10
"2812","de","en","Ihre andere Hand ist somit frei, um den Kolben zu bewegen.","Your other hand will be free to move the plunger.",10,11
"2813","de","en","Ihre Behandlung wird bis ca.","end of your chemotherapy.",4,5
"2814","de","en","Ihre Wirkung resultiert aus der Hemmung der bakteriellen DNA-Gyrase.","Its action results from inhibition of bacterial DNA gyrase.",9,9
"2815","de","en","II.E.2 Identifikation und Nachweis der wirksamen Bestandteile","II. E.2 Identification and assay of active ingredients",8,7
"2816","de","en","Im Einzelfall können jeweils nur einzelne dieser Symptome und/oder Befunde auffällig sein.","In individual cases, only some of these symptoms and/ or findings may be evident.",14,12
"2817","de","en","Im Falle des Auftretens von Überdosierungserscheinungen erfolgt die Behandlung symptomatisch.","If symptoms of overdose appear, treatment is to be symptomatic.",10,10
"2818","de","en","Im Falle einer klinisch relevanten Hypokalzämie müssen Kalziumgluconat-Infusionen wie klinisch angezeigt verabreicht werden.","In the event of hypocalcaemia, calcium gluconate infusions should be administered as clinically indicated.",14,13
"2819","de","en","Im Falle einer Polyglobulie sollte Nespo vorübergehend abgesetzt werden (siehe Abschnitt 4.2).","In the event of polycythaemia, Nespo should be temporarily withheld (see section 4.2).",13,12
"2820","de","en","Im Falle einer Überdosierung sollte eine symptomatische Behandlung eingeleitet werden.","In the case of overdosage symptomatic treatment should be initiated.",10,10
"2821","de","en","Im Falle einer Überdosierung sollte Sebivo abgesetzt werden, und es sollte bedarfsorientiert eine allgemeine supportive Therapie erfolgen.","In the event of an overdose, Sebivo should be discontinued and appropriate general supportive treatment applied as necessary.",18,17
"2822","de","en","Im Falle einer Überdosierung sollten geeignete symptomatische und unterstützende Behandlungen der Vitalfunktionen eingeleitet werden.","Cases of overdose should receive appropriate symptomatic and supportive therapy for vital functions.",13,14
"2823","de","en","Im Falle von schweren allergischen Reaktionen sollte eine alternative Therapie in Erwägung gezogen werden.","In case of severe allergic reactions, alternative therapy should be considered.",11,14
"2824","de","en","Im Folgenden ist eine allgemeine Beschreibung zur Anwendung aufgeführt.","The following is a general description of the administration process.",10,9
"2825","de","en","Im Folgenden werden weitere Gründe angegeben, warum Tadalafil Lilly für Sie nicht geeignet sein könnte.","The following are reasons why Tadalafil Lilly may also not be suitable for you.",14,15
"2826","de","en","Im folgenden werden zusätzliche pharmakokinetische Daten nach der oralen Verabreichung von Olanzapin beschrieben.","Additional pharmacokinetic data following administration of oral olanzapine are described below.",11,13
"2827","de","en","Im Jahr 1993 wurde er Direktor für Informationssysteme und Informationstechnologie bei Astra AB in Griechenland.","In 1993 he became Director of Information Systems/ Information Technology at Astra AB in Greece.",15,15
"2828","de","en","Im Jahre 1998 wurden 22 neue Anträge abschließend bearbeitet und 4 in Angriff genommen.","During 1998 there were 22 new applications finalised with four in progress.",12,14
"2829","de","en","Im Kühlschrank lagern Das Behältnis im Umkarton aufbewahren, um den Inhalt vor Licht zu schützen","Store in a refrigerator Keep the container in the outer carton, in order to protect from light",17,15
"2830","de","en","Im Laufe der Behandlung kann Ihr Arzt die Dosis noch Ihren persönlichen Bedürfnissen entsprechend anpassen.","During the course of the treatment your doctor may adjust the dose to suit your individual needs.",17,15
"2831","de","en","Im Original-Umkarton aufbewahren, um den Inhalt vor Licht zu schützen.","Store in the original carton in order to protect from light.",11,10
"2832","de","en","Im peripheren Blut ist Dexmedetomidin vorwiegend an Plasmaproteine gebunden (> 90%).","In the circulation, dexmedetomidine is largely bound to plasma proteins (> 90%).",12,11
"2833","de","en","Im Rahmen einer Differentialdiagnose des Hustens sollte an einen Husten gedacht werden, der durch ACE-Hemmer induziert wurde.","ACE inhibitor-induced cough should be considered as part of the differential diagnosis of cough.",14,17
"2834","de","en","Im sauren pH-Bereich der Optisulin Injektionslösung (pH 4) ist es vollständig löslich.","It is completely soluble at the acidic pH of the Optisulin injection solution (pH 4).",15,12
"2835","de","en","Im September 1998 faßte der CVMP den von der Industrie rückhaltlos befürworteten Beschluß, diesen Plan öffentlich bekanntzumachen.","In September 1998, with the full agreement of industry, the CVMP agreed to make this plan publicly available.",18,17
"2836","de","en","Im September 2001 wurde er zum Pressebeauftragten ernannt.","He was nominated as press officer in September 2001.",9,8
"2837","de","en","Im Tiermodell an normalgewichtig heranwachsenden und adipösen Ratten reduziert Sibutramin die Gewichtszunahme.","In animal models using lean growing and obese rats, sibutramine produces a reduction in bodyweight gain.",16,12
"2838","de","en","Im Tierversuch konnte gezeigt werden, dass Ciprofloxacin an den gewichttragenden Gelenken von Jungtieren Arthropathien verursacht.","191 Ciprofloxacin has been shown to cause arthropathy in weight-bearing joints of immature animals.",14,15
"2839","de","en","Im umgekehrten Falle beeinflussen diese Arzneimittel die Pharmakokinetik von Nateglinid nicht.","Conversely, these medicinal products had no effect on the pharmacokinetics of nateglinide.",12,11
"2840","de","en","Im Vergleich zu Amlodipin ergab sich eine 23%ige relative Risikoreduktion.","There was a 23% relative risk reduction compared with amlodipine.",10,10
"2841","de","en","Im Vergleich zu historischen Kontrollgruppen waren die Plasmaspiegel unverändert.","Stavudine and VIRAMUNE can be co-administered without dose adjustments.",9,9
"2842","de","en","Im Wundheilungsprozess induziert Becaplermin die Zellproliferation.","In the process of healing the wound, becaplermin induces cell proliferation.",11,6
"2843","de","en","Im Zusammenhang mit TNF-blockierenden Substanzen wurde in seltenen Fällen über das Auftreten von Panzytopenie einschließlich aplastischer Anämie berichtet.","Rare reports of pancytopenia including aplastic anaemia have been reported with TNF blocking agents.",14,18
"2844","de","en","Im Zweifelsfall fragen Sie Ihren Arzt.","If you are unsure about this, ask your doctor.",9,6
"2845","de","en","Imiquimod Creme sollte bei Patienten mit Autoimmunerkrankungen (siehe 4.5) mit Vorsicht angewendet werden.","Imiquimod cream should be used with caution in patients with autoimmune conditions (refer to section 4.5).",16,13
"2846","de","en","Immunglobulin darf nicht mit CELVAPAN verabreicht werden.","Immunoglobulin is not to be given with CELVAPAN.",8,7
"2847","de","en","Immunglobulin vom Menschen, wovon mindestens 97% IgG sind.","human normal immunoglobulin, of which at least 97% is IgG.",10,8
"2848","de","en","Immunsuppressiva (Ciclosporin, Tacrolimus, Sirolimus):","Immunosuppressants (cyclosporin, tacrolimus, sirolimus):",4,4
"2849","de","en","Impetiginöse Läsionen, > 10 an der Zahl und von einer Gesamtfläche größer als 100 cm2.","• Impetiginous lesions > 10 in number and exceeding 100 cm2 in total surface area.",15,15
"2850","de","en","Impfstoff gegen die Europäische Schweinepest.","Vaccine against Classical Swine Fever gA",6,5
"2851","de","en","Imprida enthält zwei Wirkstoffe, Amlodipin und Valsartan.","Imprida contains two active substances, amlodipine and valsartan.",8,7
"2852","de","en","In allen diesen Studien wurde Dicural bei Kälbern mit Enrofloxacin verglichen.","All seven studies compared Dicural with enrofloxacin in calves.",9,11
"2853","de","en","In allen Studien war die Änderung des Gewichts der Hauptindikator für die Wirksamkeit.","In all of the studies, the main measure of effectiveness was the change in weight.",15,13
"2854","de","en","In anderen Fällen wurde Exelon abgesetzt (siehe Abschnitt 4.8).","In other cases, Exelon has been discontinued (see section 4.8).",10,9
"2855","de","en","In beiden Fällen wird die zweite Dosis ein bis drei Monate nach der ersten Dosis gegeben.","The second dose in both cases is given between one and three months after the first one.",17,16
"2856","de","en","In beiden Studien führte die Behandlung mit Volibris in beiden Dosierungsstufen zu einer signifikanten Besserung des 6MWD-Ergebnisses.","In both studies, treatment with Volibris resulted in a significant improvement in 6MWD for each dose of Volibris.",18,17
"2857","de","en","In Blisterpackungen sind Remeron 30 mg Filmtabletten in den folgenden Packungsgrößen erhältlich:","For Remeron 30 mg film-coated tablets in blisters the following pack sizes are available:",14,12
"2858","de","en","In den betroffenen Betrieben zeigte ein Drittel der behandelten Schweine Nebenwirkungen, die Mortalität betrug 1%.","On affected farms, one third of the pigs treated were affected, with a mortality of 1%.",16,15
"2859","de","en","In den meisten Fällen wurde eine Injektionsrate von 4 ml pro Minute verwendet.","In most of the cases, an infusion rate of up to 4 ml per minute has been used.",18,13
"2860","de","en","In der dritten Studie betrug die durchschnittliche Abnahme 0,71 mmol/l über 44 Wochen.","In the third, there was an average fall of 0.71 mmol/ l over 44 weeks.",15,13
"2861","de","en","In der folgenden Graphik wird das pharmakodynamische Profil von Humalog Mix25 und BASAL dargestellt:","In the figure below the pharmacodynamics of Humalog Mix25 and BASAL are illustrated.",13,14
"2862","de","en","In der folgenden Tabelle sind die Daten von drei nicht kontrollierten Studien mit B-CLL-Patienten zusammengefasst:","Data available from three uncontrolled B-CLL studies are summarised in the following table:",13,15
"2863","de","en","In der gepoolten Patientenkohorte lagen für 335 Vigabatrin-Patienten über 14 Jahren verwertbare Daten der Gesichtsfelduntersuchungen vor.","From the pooled patient cohort 335 vigabatrin patients above 14 years of age had usable visual field results.",18,16
"2864","de","en","In der klinischen Praxis könnte Neutropenie allerdings bereits im ersten Zyklus auftreten.","41 However, in clinical practice neutropenia could occur earlier.",9,12
"2865","de","en","In der klinischen Studie 1 waren 31% der mit TORISEL behandelten Patienten 65 Jahre oder älter.","In Study 1, 31% of patients treated with TORISEL were 65 or older.",13,16
"2866","de","en","In der LIPID-Studie wurde außerdem eine Analyse von Schlaganfällen und nicht-hämorrhagischen Schlaganfällen als sekundäre Kriterien durchgeführt.","In the LIPID study, an analysis of strokes and non-haemorrhagic strokes was also performed as secondary criteria.",17,16
"2867","de","en","In der Originalverpackung aufbewahren, um den Inhalt vor Feuchtigkeit zu schützen.","Store in the original package in order to protect from moisture.",11,11
"2868","de","en","In der Originalverpackung aufbewahren, um den Inhalt vor Licht und Feuchtigkeit zu schützen.","Store in the original package in order to protect from light and moisture.",13,13
"2869","de","en","In der Originalverpackung aufbewahren, um den Inhalt vor Licht zu schützen.","Store in the original package in order to protect from light.",11,11
"2870","de","en","In der Originalverpackung aufbewahren.","Store in the original package.",5,4
"2871","de","en","In der Originalverpackung und an einem trockenen Ort aufbewahren, um den Inhalt vor Feuchtigkeit zu schützen.","Store in the original package and in a dry place in order to protect from moisture.",16,16
"2872","de","en","In der Regel alle 5 bis 6 Monate.","Generally speaking this means every 5 to 6 months.",9,8
"2873","de","en","In der Regel ist 24 Stunden nach der Applikation der Calciumspiegel im Serum wieder auf seinen Ausgangswert abgesunken.","In general, serum calcium levels return to baseline levels 24 hours after dosing.",13,18
"2874","de","en","In der Regel kommt es zu keinen wesentlichen Veränderungen des renalen Plasmaflusses und der glomerulären Filtrationsrate.","Generally, there are no major changes in renal plasma flow and glomerular filtration rate.",14,16
"2875","de","en","In der Regel verschwinden sie nach Beendigung der Erbituxtherapie mit der Zeit wieder.","They usually disappear over time after the end of Erbitux therapy.",11,13
"2876","de","en","In der terminalen Halbwertszeit gab es keine Unterschiede.","There were no differences in terminal half-lives.",7,8
"2877","de","en","In der überwiegenden Anzahl sprechen die Patienten auf 1-mal täglich {HANDELSNAME} 10 mg ausreichend gut an.","The majority of patients are controlled with {PRODUCT NAME} 10 mg once a day.",14,16
"2878","de","en","In der zweiten Studie erwies sich Kiovig bei der Erhöhung der Zahl der Blutplättchen als wirksam.","In the second study, Kiovig was shown to be effective in increasing the platelet count.",15,16
"2879","de","en","In der Zwischenzeit sollten Sie eine andere Methode der Schwangerschaftsverhütung anwenden.","In the meantime, you should use another method of contraception.",10,11
"2880","de","en","In diesem Fall beenden Sie sofort die Anwendung des Arzneimittels und holen Sie ärztlichen Rat ein.","If this occurs, stop administering the product immediately and seek medical advice.",12,16
"2881","de","en","In diesem Fall ist eine umfassende medizinische Untersuchung einschließlich der Leberfunktion in Erwägung zu","- if you experience progressive anorexia, asthenia (weakness, exhaustion) and weight decrease",12,14
"2882","de","en","In diesem Fall sollte die Eingangsdosis von 60 mg von einer 5-mg-Tagesdosis gefolgt werden.","The active substance in Efient, prasugrel, is an inhibitor of platelet aggregation.",12,14
"2883","de","en","In diesem Fall sollte es wie gewohnt die nächste Dosis einnehmen.","In that case carry on with the next dose as normal.",11,11
"2884","de","en","In diesem Tierarzneimittel ist Emodepsid verantwortlich für die Wirksamkeit gegen Toxocara cati, Toxascaris leonina und Ancylostoma tubaeforme.","In this product, emodepside is responsible for the efficacy against Toxocara cati, Toxascaris leonina, and Ancylostoma tubaeforme.",17,17
"2885","de","en","In diesen Fällen sollte die Behandlung sofort abgebrochen und der Patient einer fachärztlichen Untersuchung unterzogen werden.","In view of this rare but serious risk, it must be emphasised that:",13,16
"2886","de","en","In diesen Fällen sollte überdacht werden, ob das Autofahren ratsam ist.","The advisability of driving should be considered in these circumstances.",10,11
"2887","de","en","In diesen Fällen wird die intravenöse Gabe eines Normalinsulins empfohlen.","Instead, regular insulin administered intravenously is recommended in such cases.",10,10
"2888","de","en","In diesen Studien war bei den Patienten die Diagnose primäre (psychophysiologische) Schlaflosigkeit gestellt worden.","In these studies, patients were diagnosed with primary (psychophysiological) insomnia.",10,14
"2889","de","en","In dieser Altersgruppe wird Ihr Arzt über den möglichen Nutzen der Anwendung entscheiden.","In this age group your doctor will decide on the potential benefit of its use.",15,13
"2890","de","en","In dieser Untergruppe gab es eine dauerhafte virologische Ansprechrate von 92% (89/97).","In this subgroup, there was a 92% (89/ 97) sustained virological response rate.",13,12
"2891","de","en","In einem solchen Fall muss die Dosis den Vorgaben entsprechend angepasst werden.","If it occurs, appropriate dose adjustment should be made as provided.",11,12
"2892","de","en","In einer dieser Studien wurde Insuman in einer Insulinpumpe angewendet.","In one of the studies, Insuman was used in an insulin pump.",12,10
"2893","de","en","In einer klinischen Studie wurde bei 27% der Patienten über Hyperlipidämie als unerwünschtes Ereignis berichtet.","In a clinical trial, hyperlipaemia was reported as an adverse event in 27% of patients.",15,15
"2894","de","en","In einer Toxizitätsstudie mit einmaliger Verabreichung erhielten Mäuse eine Dosis von 125 mg pro kg intravenös.","In a single dose toxicity study a dose of 125 mg/ kg rod",13,16
"2895","de","en","In einer weiteren Studie wurde die Wirkung von Prandin in Kombination mit Metformin untersucht.","Another study looked at the effect of adding Prandin to metformin.",11,14
"2896","de","en","In einigen Fällen kann eine Gewichtszunahme Symptom einer Herzinsuffizienz sein; deshalb ist das Gewicht engmaschig zu kontrollieren.","In some cases weight increase may be a symptom of cardiac failure, therefore weight should be closely monitored.",18,17
"2897","de","en","In folgenden Situationen kann die Behandlung Ihrer Zuckerkrankheit viel Sorgfalt erfordern:","In the following situations, the management of your diabetes may require a lot of care:",15,11
"2898","de","en","In Gegenwart von Brinzolamid bindet sich der Metabolit überwiegend an CA-I.","This metabolite binds mainly to CA-I in the presence of brinzolamide.",11,11
"2899","de","en","In In-vitro-Studien wurden keine mutagenen Effekte, aber schwache klastogene Effekte beobachtet.","No mutagenic but a weak clastogenic activity was observed in in vitro studies.",13,11
"2900","de","en","In klinischen Pharmakologiestudien zeigte sich unter Lumiracoxib eine dosisabhängige Hemmung der COX-2 im Plasma ohne Hemmung der COX-1.","Across clinical pharmacology studies, lumiracoxib produced dose-dependent inhibition of COX-2 in plasma without inhibition of COX-1.",16,18
"2901","de","en","In klinischen Prüfungen wurde jedoch keine inadequate Uteruskontraktion post partum beobachtet.","However, inadequate uterus contraction postpartum was not observed during the clinical trials.",12,11
"2902","de","en","In klinischen Studien an Kindern wurden häufig Manien und Hypomanien berichtet (siehe Abschnitt 4.8).","In paediatric trials, mania and hypomania were commonly reported (see section 4.8).",12,14
"2903","de","en","In klinischen Studien entwickelten etwa 5% der Patienten unter Abacavir-Behandlung eine Überempfindlichkeitsreaktion.","In clinical studies, approximately 5% of subjects receiving abacavir developed a hypersensitivity reaction.",13,12
"2904","de","en","In klinischen Studien führte Bivalirudin nachweislich zu einer adäquaten Antikoagulation während der PCI.","In clinical studies bivalirudin has been shown to provide adequate anticoagulation during PCI procedures.",14,13
"2905","de","en","In klinischen Studien hat Aripiprazol nicht zu einer klinisch relevanten Gewichtszunahme geführt (siehe Abschnitt 5.1).","In clinical trials aripiprazole has not been shown to induce clinically relevant weight gain (see section 5.1).",17,15
"2906","de","en","In klinischen Studien hat sich gezeigt, dass Cubicin bei der Behandlung von Pneumonie nicht wirksam ist.","It has been demonstrated in clinical studies that Cubicin is not effective in the treatment of pneumonia.",17,16
"2907","de","en","In klinischen Studien schieden jedoch nur 1,6% der Patienten aufgrund dieser Nebenwirkungen aus.","No serious ophthalmic or systemic undesirable effects related to OPATANOL were reported in clinical studies.",15,13
"2908","de","en","In klinischen Studien war das Auftreten von Hypoxämie häufig, speziell innerhalb der ersten 15 Minuten der Dexmedetomidin-Ketamin-Anästhesie.","In clinical trials the incidence of hypoxaemia was common, especially within the 15 first minutes into dexmedetomidine-ketamine anaesthesia.",18,17
"2909","de","en","In klinischen Studien wurde Etoricoxib ohne Rücksicht auf die Nahrungsaufnahme verabreicht.","In clinical trials, etoricoxib was administered without regard to food intake.",11,11
"2910","de","en","In klinischen Studien wurde ZIMULTI 20 mg morgens meist vor dem Frühstück verabreicht.","clinical studies, ZIMULTI 20 mg was taken in the morning usually before breakfast. lp",14,13
"2911","de","en","In klinischen Studien wurden 541 Krebs-Patienten und 188 gesunde Probanden mit Filgrastim ratiopharm exponiert.","During clinical studies 541 cancer patients and 188 healthy volunteers were exposed to Filgrastim ratiopharm.",15,14
"2912","de","en","In klinischen Studien wurden außerdem keine klinisch relevanten Nierenveränderungen festgestellt.","Furthermore, no clinically significant renal abnormalities were noted in clinical trials.",11,10
"2913","de","en","In klinischen Studien wurden die unten genannten Nebenwirkungen beobachtet, die möglicherweise auf die Visudyne-Behandlung zurückzuführen sind:","In clinical trials, the following adverse reactions were considered potentially related to Visudyne therapy.",14,16
"2914","de","en","In Kombination mit Metformin kann die bisherige Metformin-Dosis mit Beginn der Actos-Behandlung beibehalten werden.","In combination with metformin, the current metformin dose can be continued when starting Actos treatment.",15,14
"2915","de","en","In Langzeitstudien an Mäusen und Ratten gab es keine Hinweise auf Kanzerogenität.","There was no evidence of any carcinogenicity in life long studies in mice and rats.",15,12
"2916","de","en","In sehr seltenen Fällen (< 1:100 000) können Hypersensibilitätsreaktionen beobachtet werden.","In very rare cases (< 1/ 100000), hypersensitivity can be observed.",11,11
"2917","de","en","In sehr seltenen Fällen kann ein Hoden in den Leistenring aszendieren.","In very rare cases, a testicle may be able to ascend the inguinal ring.",14,11
"2918","de","en","In seltenen Fällen können Reaktionen an der Injektionsstelle das Absetzen von Levemir erforderlich machen.","On rare occasions, injection site reactions may require discontinuation of Levemir.",11,14
"2919","de","en","In seltenen Fällen können Schmerzen an der Injektionsstelle auftreten, die zu vorübergehenden funktionalen Beschwerden (Steifheit) führen können.","Pain at the injection site can occur in rare cases, which may result in temporary functional discomfort (stiffness).",18,17
"2920","de","en","In seltenen Fällen können Überempfindlichkeitsreaktionen (allergische Reaktionen) auftreten, die der Behandlung bedürfen.","Rarely, a hypersensitivity (allergic) reaction may occur, which requires treatment.",10,12
"2921","de","en","In seltenen Fällen wurden thromboembolische Prozesse mit einer Puregon/hCG-Therapie in Verbindung gebracht.","In rare instances, thromboembolism has been associated with Puregon/ hCG therapy as with other gonadotrophins.",15,12
"2922","de","en","In seltenen Fällen wurden vaginale Blutungen beobachtet.","In rare cases vaginal bleeding occurred.",6,7
"2923","de","en","In solchen Fällen ist unverzüglich ein Arzt zu Rate zu ziehen und die Packungsbeilage oder das Etikett vorzuzeigen.","In these cases take immediate contact to a doctor.",9,18
"2924","de","en","In solchen Fällen muss eine neue Patrone genommen werden, die eine homogene Suspension zeigt.","In such cases, a new cartridge yielding a uniform suspension must be used.",13,14
"2925","de","en","In Studien an weiblichen Ratten zeigte sich eine verminderte Fertilität sowie eine erhöhte embryonale Mortalität.","Studies with female rats revealed reduced fertility and enhanced embryo mortality.",11,15
"2926","de","en","In Tierversuchen wurde gezeigt, dass P-gp eine wesentliche Einflussgröße für die Bioverfügbarkeit von Sprimeo ist.","In experimental animals, it has been shown that P-gp is a major determinant of Sprimeo bioavailability.",16,15
"2927","de","en","In Übereinstimmung mit den nationalen Anforderungen entsorgen.","Dispose of in accordance with local requirements",7,7
"2928","de","en","In Verwendung befindliche Pens nicht im Kühlschrank aufbewahren.","The pen in use must not be stored in a refrigerator.",11,8
"2929","de","en","In vitro hemmt Bexaroten das Wachstum von Tumorzelllinien, die von hämatopoetischen oder von Plattenepithelzellen abstammen.","In vitro, bexarotene inhibits the growth of tumour cell lines of haematopoietic and squamous cell origin.",16,15
"2930","de","en","In vivo- und in vitro- Studien haben gezeigt, dass das S(+)-Isomer für die klinische Wirkung verantwortlich ist.","In vivo and in vitro studies indicate that the S(+) isomer is responsible for the clinical activity.",17,17
"2931","de","en","In zwei Studien wurden Patienten eingeschlossen, die eine Chemotherapie erhielten.","Two of the studies recruited patients who were being treated with chemotherapy.",12,10
"2932","de","en","In-vitro-Plasmaproteinbindungsstudien zur Wechselwirkung mit Warfarin bei klinisch relevanten Konzentrationen ergaben keine Wechselwirkung.","In vitro plasma protein binding interaction studies with warfarin at clinically relevant concentrations, however, showed no interaction.",17,12
"2933","de","en","In-vitro-Studien haben gezeigt, dass Celecoxib den über CYP 2C19 katalysierten Metabolismus hemmen kann.","In vitro studies have shown some potential for celecoxib to inhibit CYP2C19 catalysed metabolism.",14,13
"2934","de","en","INCRELEX erhöhte die Wachstumsgeschwindigkeit beträchtlich.","INCRELEX caused the speed of growth to increase significantly.",9,5
"2935","de","en","Incurin wurde in drei groß angelegten Feldversuchen an Hündinnen untersucht.","Incurin has been studied in bitches in three large field trials.",11,10
"2936","de","en","Indigocarmin (E132) Titandioxid (E171) Gelatine Unterteil:","Indigo carmine (E132) Titanium dioxide (E171) Gelatin Body:",8,6
"2937","de","en","Indinavir AUC: ↓ 20% Indinavir Cmin: ↑ 29% (Im Vergleich zu Indinavir 800 mg TID allein)","Indinavir AUC: ↓ 20% Indinavir Cmin: ↑ 29% (Relative to Indinavir 800 mg TID alone)",15,16
"2938","de","en","Indinavir Cmin: ↑ 10-fach (Im Vergleich zu Indinavir 800 mg TID allein*) Ritonavir AUC24Std:","68% Indinavir Cmin: ↑ 10-fold (Relative to Indinavir 800 mg TID alone*) Ritonavir AUC24hr:",14,14
"2939","de","en","Indinavir/Ritonavir/Efavirenz (800 mg zweimal täglich/100 mg zweimal täglich/600 mg einmal täglich)","152 Medicinal product by therapeutic",5,11
"2940","de","en","InductOs wird zusätzlich zu der Standardbehandlung und Versorgung von Schienbeinbrüchen angewendet.","InductOs is used in addition to standard treatment and care of shin bone fractures.",14,11
"2941","de","en","Induktion und Synchronisation der Ovulation zur Produktion von Fischeiern im Augenstadium und Fischbrut.","Induction and synchronisation of ovulation for the production of eyed-eggs and fry.",12,13
"2942","de","en","Industriepark 30 B-2220 Heist-op-den-Berg Belgien.","Industriepark 30 B-2220 Heist-op-den-Berg Belgium.",5,5
"2943","de","en","Infanrix hexa darf nicht angewendet werden,","Infanrix hexa should not be given:",6,6
"2944","de","en","Infektionen der Haut und des","Daily dose in mL",4,5
"2945","de","en","Infektionen der oberen Atemwege, Harnwegsinfektionen einschließlich Cystitis","Upper respiratory tract infection, urinary tract infection including cystitis",9,7
"2946","de","en","Infektionen durch Viren, zu bekämpfen.","body ’ s defence system, works).",6,5
"2947","de","en","Infektionen und parasitäre Erkrankungen Häufig:","6 Infections and Infestations Common:",5,5
"2948","de","en","Infektionen und parasitäre Erkrankungen Meningitis","Infections and infestations Meningitis",4,5
"2949","de","en","Infektionen und parasitäre Erkrankungen Sehr häufig:","Infections and infestations Very common:",5,6
"2950","de","en","Influenzapandemie-Impfstoff (Oberflächenantigen, inaktiviert, adjuvantiert) i.m.-Injektion in den Deltamuskel","Focetria injection Pandemic Influenza Vaccine (surface antigen, inactivated, adjuvanted) I. M. injection into the deltoid muscle",16,8
"2951","de","en","Infolgedessen sollten Neugeborene sorgfältig überwacht werden.","Consequently newborns should be monitored carefully.",6,6
"2952","de","en","Infolgedessen verlieren die Patienten die Fähigkeit zur kontrollierten und zuverlässigen Steuerung ihrer Bewegungen.","The patients then lose their ability to control their movements reliably.",11,13
"2953","de","en","INFORMATION FÜR DEN ANWENDER","INFORMATION FOR THE USER",4,4
"2954","de","en","INFORMATION FÜR DEN ANWENDER (Pulver in Durchstechfl + Lösungsm. in Ampullen)","INFORMATION FOR THE USER Solvent in ampoules",7,11
"2955","de","en","INFORMATION FÜR DEN ANWENDER Karvea 150 mg Tabletten Irbesartan","INFORMATION FOR THE USER Karvea 150 mg tablets irbesartan",9,9
"2956","de","en","Informationen über den Verschreibungsstatus dieses Arzneimittels finden Sie auf dem Etikett bzw. der Faltschachtel.","Information on the prescription status of this product may be found on the label/ outer package.",16,14
"2957","de","en","Informationen zum Pharmakokinetik-/Pharmakodynamik (PK/PD)-Profil von Cinacalcet sind in Abschnitt 5.1 zu finden.","Information regarding the pharmacokinetic/ pharmacodynamic (PK/ PD) profile of cinacalcet is given in section 5.1",15,12
"2958","de","en","Informieren Sie bitte Ihren Arzt oder Apotheker, wenn Sie Nebenwirkungen bemerken, die nicht in dieser Gebrauchsinformation angegeben sind.","If you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.",17,18
"2959","de","en","Informieren Sie bitte Ihren Arzt, wenn Sie unter Nierenproblemen leiden, da Ihre Dosis gegebenenfalls angepasst werden muss.","Tell your doctor if you suffer from kidney problems because your dose may need to be adjusted.",17,17
"2960","de","en","Informieren Sie Ihren Apotheker, wenn Sie eine Veränderung des Aussehens der Aerius Lyophilisat zum Einnehmen bemerken.","Tell your pharmacist if you notice any change in the appearance of Aerius oral lyophilisate.",15,16
"2961","de","en","Informieren Sie Ihren Arzt oder Apotheker sofort und folgen Sie seinen Anweisungen.","Tell your doctor or pharmacist immediately and follow his/ her instructions.",11,12
"2962","de","en","Informieren Sie Ihren Arzt umgehend, wenn eines der folgenden Ereignisse während der Anwendung von Ciprofloxacin Bayer eintritt.","Tell your doctor immediately, if any of the following occurs during treatment with Ciprofloxacin Bayer.",15,17
"2963","de","en","Informieren Sie Ihren Arzt unverzüglich, wenn Sie schwanger sind oder vorhaben schwanger zu werden.","Tell your doctor immediately if you are pregnant or intend to become pregnant.",13,14
"2964","de","en","Informieren Sie Ihren Arzt, wenn Sie diese Arzneimittel anwenden.","Inform your doctor if you are using these medicines.",9,9
"2965","de","en","Informieren Sie Ihren Arzt, wenn Sie in Ihrer Diät den Natriumgehalt begrenzen sollen.","Talk to your doctor if you have been told to limit the amount of sodium in your diet.",18,13
"2966","de","en","Informieren Sie Ihren Arzt, wenn Sie jemals eine Krebserkrankung hatten.","Tell your doctor if you have ever had any type of cancer.",12,10
"2967","de","en","Infusionsbeutel 60 ml pro Beutel","Infusion bag 60 ml per bag (polyolefin)",7,5
"2968","de","en","Infusionslösung Klare, farblose Lösung pH-Wert der Lösung:","Solution for infusion Clear, colourless solution pH of the solution:",10,7
"2969","de","en","Ingelvac CircoFLEX enthält kleine Mengen eines Proteins von PCV2.","Ingelvac CircoFLEX contains small amounts of a protein from PCV2.",10,9
"2970","de","en","Inhaber der Genehmigung für das Inverkehrbringen Anschrift","Marketing Authorisation Holder Sapporobogen 6-8 D-80809 München",7,7
"2971","de","en","Inhaber der Genehmigung für das Inverkehrbringen ist das Unternehmen Eisai Ltd.","The marketing authorisation holder is Eisai Ltd.",7,11
"2972","de","en","Inhaber der Genehmigung für das Inverkehrbringen/Antragsteller","Marketing Authorisation Holders/ Applicants",4,6
"2973","de","en","Inhaber der Herstellungserlaubnis werden weiterhin jährliche PSURs einreichen.","The Marketing Authorisation Holder will continue to submit the PSUR on a yearly basis.",14,8
"2974","de","en","INHABER DER HERSTELLUNGSERLAUBNIS, DIE FÜR DIE CHARGENFREIGABE VERANTWORTLICH SIND","32 A MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE",9,9
"2975","de","en","INHALT NACH GEWICHT VOLUMEN ODER EINHEITEN","CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT",8,6
"2976","de","en","INHALT NACH GEWICHT, VOLUMEN ODER EINHEITEN än 0,3 ml (10.000 IE/ml)","CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT ct",9,11
"2977","de","en","INHALT NACH GEWICHT, VOLUMEN ODER STÜCKZAHL","CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES",10,6
"2978","de","en","Inhibitoren wurden bei vorbehandelten Patienten, die Faktor VIII-Produkte, einschließlich ReFacto AF, erhielten, beobachtet.","Inhibitors have been observed in previously treated patients receiving factor VIII products, including ReFacto AF.",15,13
"2979","de","en","Initialdosen von 60 E/kg Körpergewicht","Initial doses of 60 U/ kg of body weight once every 2 weeks have shown",15,5
"2980","de","en","Injektionslösung 1 x 10 ml 5 x 10 ml","Solution for injection 1 x 10 ml 5 x 10 ml",11,9
"2981","de","en","Injektionslösung Die Lösung ist klar und farblos.","Solution for injection Solution is clear and colourless.",8,7
"2982","de","en","Injektionslösung in einem Fertigpen (0,6 ml) zum Einmalgebrauch Packungsgröße:","Solution for injection in a single use pre-filled pen (0.6 ml).",11,9
"2983","de","en","Injektionslösung Klare, farblose bis leicht gefärbte Flüssigkeit (pink).","Clear, colourless to slightly coloured (pink) liquid",7,8
"2984","de","en","Injektionslösung Klare, farblose, wässrige Lösung.","Solution for injection Clear, colourless, aqueous solution.",7,5
"2985","de","en","Injektionslösung Mehrfachdosierungs-Pen Interferon alfa-2b Subkutane Anwendung.","IntronA 18 million IU solution for injection multidose pen interferon alfa-2b Subcutaneous use",13,6
"2986","de","en","Injektionssuspension 5 x 3 ml 10 x 3 ml","Suspension for injection 5 x 3 ml 10 x 3 ml",11,9
"2987","de","en","Injektionssuspension in einer Fertigspritze","Suspension for injection in pre-filled syringe.",6,4
"2988","de","en","Injizieren Sie die Mischung sofort.","Inject the mixture immediately.",4,5
"2989","de","en","Injizieren Sie Ihr Insulin niemals direkt in eine Vene oder einen Muskel.","Never inject your insulin directly into a vein or muscle.",10,12
"2990","de","en","Injizieren Sie nicht an Stellen, an denen Ihre Haut empfindlich, verletzt, gerötet oder verhärtet ist.","Do not inject into areas where the skin is tender, bruised, red, or hard.",14,15
"2991","de","en","Innerhalb der Gruppe der Chinolone wurde eine Kreuzresistenz beobachtet.","Within the class of quinolones cross-resistance has been observed.",9,9
"2992","de","en","Innerhalb jeder Häufigkeitsgruppierung sind die Nebenwirkungen nach abnehmendem Schweregrad dargestellt.","Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.",13,10
"2993","de","en","Innerhalb von 2 Wochen wurden wieder Normalwerte erreicht.","These changes returned to normal within two weeks.",8,8
"2994","de","en","Innerhalb von 30 Minuten nach der Injektion sollte eine kohlenhydrathaltige Mahlzeit oder Zwischenmahlzeit eingenommen werden.","An injection should be followed within 30 minutes by a meal or snack containing carbohydrates.",15,15
"2995","de","en","Innerhalb von einer Stunde aufbrauchen.","Use within one hour",4,5
"2996","de","en","InnoLet gibt zwischen 1 und 50 Einheiten in Schritten von 1 Einheitt ab.","InnoLet delivers 1-50 units in increments of 1 unit.",9,13
"2997","de","en","Inovelon 100 mg Filmtabletten","Inovelon 100 mg film-coated tablets",5,4
"2998","de","en","Inovelon darf nicht eingenommen werden,","Do not take Inovelon",4,5
"2999","de","en","Inovelon in dieser Gruppe gibt und die Dosis Ihres Arzneimittels möglicherweise langsamer gesteigert werden muss.","this group and the dose of your medicine may need to be increased more slowly.",15,15
"3000","de","en","Insbesondere dient es der Erkennung des Verlusts von Nervenzellen, die den chemischen Botenstoff Dopamin freisetzen.","It specifically helps to detect the loss of nerve cells that release dopamine, a chemical messenger.",16,15
"3001","de","en","Insgesamt 573 Patienten wurden randomisiert und erhielten entweder TMZ + RT (n=287) oder nur RT (n=286).","A total of 573 patients were randomised to receive either TMZ + RT (n=287) or RT alone (n=286).",18,16
"3002","de","en","Insgesamt hatten 90% der Patienten einen vorangegangenen Myokardinfarkt und/oder eine vorhergehende koronare Revaskularisation.","Overall, 90% of the patients had a previous myocardial infarction and/ or a previous coronary revascularisation.",16,13
"3003","de","en","Insgesamt war das Verträglichkeits- und Wirksamkeitsprofil bei 2-mal und bei 3-mal täglicher Gabe ähnlich.","Overall, the safety and efficacy profiles for BID and TID dosing regimens were similar.",14,14
"3004","de","en","Insgesamt wurden 16 jährliche Neubewertungen von Arzneimitteln in Ausnahmefällen bearbeitet.","A total of 16 annual reassessments of medicinal products",9,10
"3005","de","en","Insgesamt wurden 17 Fälle des zoster- und varizellenartigen Exanthems, das nicht an der Injektionsstelle auftrat, berichtet.","Of the 17 reported noninjection-site zosteriform and varicella-like rashes, 10 specimens were available and adequate for PCR testing.",18,16
"3006","de","en","Instillieren Sie den Inhalt eines Euterinjektors (50 mg Pirlimycin) in jedes infizierte Euterviertel.","Treatment consists of eight infusions of one syringe every 24 hours.",11,13
"3007","de","en","Insulatard 40 I.E./ml Injektionssuspension in einer Durchstechflasche Insulin human (r-DNS)","Insulatard 40 IU/ ml suspension for injection in a vial Insulin human (rDNA)",13,10
"3008","de","en","Insulatard Durchstechflaschen sind zur Verwendung mit Insulinspritzen mit der entsprechenden Einheitenskala vorgesehen.","Insulatard vials are for use with insulin syringes with the corresponding unit scale.",13,12
"3009","de","en","Insulatard wird im Allgemeinen subkutan (unter die Haut) in den Oberschenkel injiziert.","Insulatard is given subcutaneously (under the skin) by injection, usually in the thigh.",13,12
"3010","de","en","Insulin glargin wird mittels gentechnologischer Methoden unter Verwendung von Escherichia coli hergestellt.","Insulin glargine is produced by recombinant DNA technology in Escherichia coli.",11,12
"3011","de","en","Insulin human (entsprechend 1,4 mg).","Each ml contains 40 IU insulin human (equivalent to 1.4 mg) of the active substance.",15,5
"3012","de","en","Insulin Human Winthrop Basal 100 I.E./ml Injektionssuspension in einer Patrone Insulin human","Insulin Human Winthrop Basal 100 IU/ml suspension for injection in a cartridge Insulin human",14,12
"3013","de","en","Insulin Human Winthrop Basal gibt es in Fertigpens, OptiSet, mit 3 ml Suspension (300 I.E.).","534 Insulin Human Winthrop Basal is supplied in pre-filled pens, OptiSet, containing 3 ml suspension (300 IU).",17,15
"3014","de","en","Insulin Human Winthrop Basal wird zur Senkung eines zu hohen Blutzuckerspiegels bei Patienten mit Diabetes mellitus eingesetzt.","Insulin Human Winthrop Basal is used to reduce high blood sugar in patients with diabetes mellitus.",16,17
"3015","de","en","Insulin Human Winthrop Comb 15 100 I.E./ml Injektionssuspension in einem Fertigpen Insulin human","Insulin Human Winthrop Comb 15 100 IU/ml suspension for injection in a pre-filled pen Insulin human",16,13
"3016","de","en","Insulin Human Winthrop Comb 15 darf nicht mit anderen Insulinen oder mit Insulinanaloga gemischt werden.","Insulin Human Winthrop Comb 15 must not be mixed with any other insulin or with insulin analogues.",17,15
"3017","de","en","Insulin Human Winthrop Comb 25 kann während der Stillzeit verwendet werden.","Insulin Human Winthrop Comb 25 can be used during breastfeeding.",10,11
"3018","de","en","Insulin Human Winthrop Comb 50 100 I.E./ml","Insulin Human Winthrop Comb 50",5,7
"3019","de","en","Insulin Human Winthrop Comb 50 in Patronen wurde für die Anwendung in einem OptiPen entwickelt.","Insulin Human Winthrop Comb 50 in cartridges has been developed for use in the OptiPen series.",16,15
"3020","de","en","Insulin Human Winthrop Infusat kann während der Stillzeit verwendet werden.","Insulin Human Winthrop Infusat can be used during breastfeeding.",9,10
"3021","de","en","Insulin Human Winthrop Rapid 40 I.E./ml","Insulin Human Winthrop Rapid",4,6
"3022","de","en","Insulin Human Winthrop SoloStar ist weiß mit einem farbigen Injektionsknopf.","Insulin Human Winthrop SoloStar is white with a colour on the injection button.",13,10
"3023","de","en","Insulin lispro Protaminsuspension Humalog Mix25:","Humalog: insulin lispro solution Humalog NPL: insulin lispro protamine suspension Humalog Mix25:",12,5
"3024","de","en","Insulin pro ml Lösung.","Insulin Human Winthrop Rapid contains 40 IU of insulin per ml solution.",12,4
"3025","de","en","Insuline und Analoga, lang wirkend.","Insulins and analogues for injection, long-acting.",6,5
"3026","de","en","Insulinsuspensionen sollten nicht mit Infusionslösungen gemischt werden.","Insulin suspensions should not be added to infusion fluids.",9,7
"3027","de","en","Insuman Basal 40 I.E./ml Injektionssuspension in einer Durchstechflasche","Insuman Basal 40 IU/ ml suspension for injection in a vial",11,8
"3028","de","en","Insuman Basal darf niemals intravenös injiziert werden.","Insuman Basal must never be injected intravenously.",7,7
"3029","de","en","Insuman Comb 25 100 I.E./ml Injektionssuspension in einer Patrone","Insuman Comb 25 100 IU/ ml suspension for injection in a cartridge",12,9
"3030","de","en","Insuman Comb 25 in Patronen wurde für die Anwendung in einem OptiPen entwickelt.","Insuman Comb 25 in cartridges has been developed for use in the OptiPen series.",14,13
"3031","de","en","Insuman Comb 50 100 I.E./ml Injektionssuspension in einem Fertigpen","Insuman Comb 50 100 IU/ ml suspension for injection in a pre-filled pen.",13,9
"3032","de","en","Insuman Comb 50 wird 20 bis 30 Minuten vor einer Mahlzeit subkutan injiziert.","Insuman Comb 50 is injected subcutaneously 20 to 30 minutes before a meal.",13,13
"3033","de","en","Insuman Infusat wurde für die Anwendung mit einem Hoechst Infusor und H -Tron entwickelt.","Insuman Infusat has been developed for use in Hoechst Infusor and H-Tron.",12,14
"3034","de","en","Insuman Rapid 100 I.E./ml Injektionslösung in einem Fertigpen","Insuman Rapid 100 IU/ ml solution for injection in a pre-filled pen",12,8
"3035","de","en","Insuman Rapid ist eine neutrale Insulin-Lösung (Normalinsulin).","Insuman Rapid is a neutral insulin solution (regular insulin).",9,7
"3036","de","en","Insuman SoloStar ist weiß mit einem farbigen Injektionsknopf.","Insuman SoloStar is white with a colour on the injection button.",11,8
"3037","de","en","INTANZA kann zeitgleich mit anderen Impfstoffen in unterschiedliche Extremitäten verabreicht werden.","Immunisation should be carried out on separate limbs.",8,11
"3038","de","en","INTELENCE sollte bei diesen Patienten mit Vorsicht angewendet werden (siehe auch Abschnitte 4.4 und 5.2).","INTELENCE should be used with caution in these patients (see also sections 4.4 and 5.2).",15,15
"3039","de","en","INTELENCE und Atazanavir/Ritonavir können ohne Dosisanpassungen angewendet werden.","INTELENCE and atazanavir/ ritonavir can be used without dose adjustment.",10,8
"3040","de","en","Interferon beta wird von verschiedenen Zelltypen, u.a. den Fibroblasten und Makrophagen produziert.","Interferon beta is produced by various cell types including fibroblasts and macrophages.",12,12
"3041","de","en","Intervall zwischen der ersten Infusion und dem Fortschreiten der Erkrankung.","6 Time to Disease Progression: interval from the first infusion to disease progression.",13,10
"3042","de","en","Intervet de Bilt Ambachtstraat 2, De Bilt Niederlande","Intervet de Bilt Ambachtstraat 2, De Bilt The Netherlands",9,8
"3043","de","en","Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer Niederlande","Wim de Körverstraat 35 5831AN Boxmeer The Netherlands",8,11
"3044","de","en","Intervet International Podruznica Krizna 10 SI-1000 Ljubljana Slowenien Tel: +386 (15) 417 567 Fax: +386 (15) 233 567","Intervet International Podruznica Krizna 10 SI-1000 Ljubljana Slovenija Tel: +386 (15) 417 567 Fax: +386 (15) 233 567",18,18
"3045","de","en","IntonA 3 MIO Pulver","IntronA 3 MIU powder",4,4
"3046","de","en","Intramuskuläre Anwendung Vor Gebrauch schütteln","Read the package leaflet before use intramuscular use Shake before use",11,5
"3047","de","en","Intravenös gegebenes Fentanyl kann Bradykardien hervorrufen.","Intravenous fentanyl has been shown to cause bradycardia.",8,6
"3048","de","en","Intravenöse Anwendung (Hunde) Intramuskuläre Anwendung (Hunde und Katzen)","Intravenous use (dogs) Vial (glass) Intramuscular use (dogs and cats)",10,8
"3049","de","en","Intravenöse Anwendung, nur zum einmaligen Gebrauch Vor der Anwendung verdünnen – Packungsbeilage beachten","Intravenous use, single use only Must be diluted before use – Read the package leaflet before use",17,13
"3050","de","en","Intravenöse Dosis (mg Ciprofloxacin)","Dose intravenous (mg ciprofloxacin) 200-400 mg twice daily 200-400mg twice daily",11,4
"3051","de","en","intravenöse oder orale Anfangsdosis wird nicht empfohlen","No oral or intravenous loading dose is recommended",8,7
"3052","de","en","IntronA ist bei fertilen Männern mit Vorsicht einzusetzen.","IntronA must be used with caution in fertile men.",9,8
"3053","de","en","IntronA kann innerhalb dieses 7- Tage-Zeitraumes jederzeit in den Kühlschrank zurückgelegt werden.","IntronA can be put back in the refrigerator at any time during this seven- day period.",16,12
"3054","de","en","INVANZ muss aufgelöst und vor der Anwendung verdünnt werden.","INVANZ must be reconstituted and then diluted prior to administration.",10,9
"3055","de","en","INVEGA wurde bei älteren Patienten mit Demenz nicht untersucht.","INVEGA has not been studied in elderly patients with dementia.",10,9
"3056","de","en","Invirase 200 mg Hartkapseln sind hellbraun und grün.","Invirase 200 mg hard capsules are light brown and green.",10,8
"3057","de","en","Invirase/Ritonavir ist bei Patienten mit dekompensierter Lebererkrankung kontraindiziert (siehe Abschnitt 4.4).","Invirase/ ritonavir is contraindicated in decompensated liver disease (see section 4.4).",11,11
"3058","de","en","IONSYS gibt über jeden 10-minütigen Dosierungszeitraum eine Nominaldosis von 40 Mikrogramm Fentanyl ab.","IONSYS delivers a nominal dose of 40 micrograms fentanyl over each 10-minute dosing period.",14,13
"3059","de","en","IPSEN Ltd., 190 Bath Road, Slough, Berkshire, SL1 3XE, Vereinigtes Königreich","IPSEN Ltd, 190 Bath Road, Slough, Berkshire, SL1 3XE, UK",10,11
"3060","de","en","Irbesartan BMS 300 mg","Irbesartan BMS 300 mg",4,4
"3061","de","en","Irbesartan BMS enthält Lactose.","Important information about some of the ingredients of Irbesartan BMS Irbesartan BMS contains lactose.",14,4
"3062","de","en","Irbesartan Hydrochlorothiazide BMS ist ein Arzneimittel, das zwei Wirkstoffe, Irbesartan und Hydrochlorothiazid, enthält.","Irbesartan Hydrochlorothiazide BMS is a medicine that contains two active substances, irbesartan and hydrochlorothiazide.",14,13
"3063","de","en","Irbesartan Hydrochlorothiazide Winthrop kann ein Mal täglich unabhängig von den Mahlzeiten eingenommen werden.","Irbesartan Hydrochlorothiazide Winthrop can be taken once daily, with or without food.",12,13
"3064","de","en","Irbesartan ist ohne vorhergehende metabolische Umwandlung wirksam.","Irbesartan does not require metabolic activation for its activity.",9,7
"3065","de","en","Irbesartan Winthrop wird mit oder ohne Nahrung oral eingenommen.","Irbesartan Winthrop is taken by mouth, with or without food.",10,9
"3066","de","en","Irbesartan wird durch die Leber mittels Glukuronidkonjugation und Oxidation metabolisiert.","Irbesartan is metabolised by the liver via glucuronide conjugation and oxidation.",11,10
"3067","de","en","Ireland Baxter Healthcare Ltd Unit 7 Deansgrange Industrial Estate IRL-Blackrock, Dublin Tel: +353 1 2065500","Ireland Baxter Healthcare Ltd Unit 7 Deansgrange Industrial Estate IRL-Blackrock, Dublin Tel: +353 1 2065500",15,15
"3068","de","en","Ireland C & M Veterinary Distributors Limited IE-Limerick Tel:","Ireland C & M Veterinary Distributors Limited IE-Limerick Tel:",9,9
"3069","de","en","Ireland GlaxoSmithKline (Ireland) Limited Tel: + 353 (0)1 4955000","Ireland GlaxoSmithKline (Ireland) Limited Tel: + 353 (0)1 4955000",9,9
"3070","de","en","Ireland Malta United Kingdom Alcon Laboratories (UK) Ltd. + 44 (0) 1442 34 1234 (United Kingdom)","Ireland Malta United Kingdom Alcon Laboratories (UK) Ltd. + 44 (0) 1442 34 1234 (United Kingdom)",16,16
"3071","de","en","Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck.com","38 Ireland Merck Sharp and Dohme Ireland (Human Health) Limited Tel: +353 (0)1 2998700 medinfo_ireland@merck. com",16,14
"3072","de","en","Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636","49 Ireland Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636",15,14
"3073","de","en","Ireland UCB (Pharma) Ireland Ltd.","Ireland UCB (Pharma) Ireland Ltd.",5,5
"3074","de","en","Ischämische Kolitis, ulzerative Kolitis","Ischaemic colitis, ulcerative colitis",4,4
"3075","de","en","ISENTRESS oder Tenofovirdisoproxilfumarat erforderlich.","(mechanism of interaction unknown)",4,4
"3076","de","en","ISENTRESS stoppt die Wirkung des Enzyms.","ISENTRESS stops this enzyme working.",5,6
"3077","de","en","Ísland Gilead Sciences Sweden AB Sími: + 46 (0) 8 5057 1849","Ísland Gilead Sciences Sweden AB Sími: + 46 (0) 8 5057 1849",12,12
"3078","de","en","Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00","86 Ísland Hörgatún 2 IS-210 Garðabær Sími: + 354 535 70 00",12,11
"3079","de","en","Ísland Icepharma Lynghálsi 13 IS-110 Reykjavik Sími: + 354 540 8000","Ísland Icepharma Lynghálsi 13 IS-110 Reykjavik Sími: + 354 540 8000",11,11
"3080","de","en","Ísland Merck Sharp & Dohme Ísland ehf.","29 Ísland Merck Sharp & Dohme Ísland ehf.",8,7
"3081","de","en","Ísland Norton Healthcare Ltd t/a IVAX Pharmaceuticals UK Tel.: +44 8705 02 03 04","Ísland Norton Healthcare Ltd t/a IVAX Pharmaceuticals UK Tel.: +44 8705 02 03 04",14,14
"3082","de","en","Ísland Swedish Orphan A/S Sími: +45 32 96 68 69","Ísland Swedish Orphan A/S Sími: +45 32 96 68 69",10,10
"3083","de","en","Isolate 226 44 52 34","Isolates 226 44 52 34",5,5
"3084","de","en","Ist die Behandlung erfolgreich, die Dosierung auf eine halbe Tablette pro Tag vermindern.","If treatment is successful lower the dose to half a tablet a day.",13,13
"3085","de","en","Ist die Verträglichkeit bei einem Patienten gesichert, kann die Infusionsrate bei den nachfolgenden Infusionen allmählich erhöht werden.","After patient tolerance is established, the infusion rate may be increased gradually with subsequent infusions.",15,17
"3086","de","en","Ist dies nicht möglich, können Sie diese beiden Arzneimittel jedoch auch zur selben Zeit einnehmen.","If this is not possible, it is acceptable to take the two medicines at the same time.",17,15
"3087","de","en","Ist Ihre Injektion beendet, entsorgen Sie unverzüglich die gebrauchten Spritzen, vorzugsweise in einem für spitze Gegenstände vorgesehenen Behälter.","Once you have finished your injection, immediately discard the syringes used safely, preferably in a sharp container.",17,18
"3088","de","en","Istituto Farmaceutico S.p.A Via Umberto Boccioni, 1 21040 Origgio, Varese Italien","Istituto Farmaceutico S. p. A Via Umberto Boccioni, 1 21040 Origgio, Varese Italy",13,11
"3089","de","en","It is forwarded to the European Parliament, Council, Commission and Member States.","It is forwarded to the European Parliament, Council, Commission and Member States.",12,12
"3090","de","en","Italia Abbott Srl I-0401 1 Campoverde di Aprilia (Latina) Tel: + 39 06 928921","Italia Abbott Srl I-0401 1 Campoverde di Aprilia (Latina) Tel: + 39 06 928921",14,14
"3091","de","en","Italia Boehringer Ingelheim Italia S.p.A.","Italia Boehringer Ingelheim Italia S. p. A.",7,5
"3092","de","en","Italia GE Healthcare Srl Via Galeno 36 I-20126 Milano Tel: + 39 02 26001 111","Italia GE Healthcare Srl Via Galeno 36 I-20126 Milano Tel: + 39 02 26001 111",15,15
"3093","de","en","Italia Lundbeck Italia S.p.A.","Italia Lundbeck Italia S. p. A.",6,4
"3094","de","en","Italia Novo Nordisk Farmaceutici S.p.A.","Italia Novo Nordisk Farmaceutici S. p. A.",7,5
"3095","de","en","Italia Via fratelli Cervi snc, Centro Direzionale Milano Due Palazzo Borromini I-20090 Segrate (Milano) Tel: + 39-02 21018.1","Italia Via fratalli Cervi snc, Centro Direzionale Milano Due Palazzo Borromini I-20090 Segrate (Milano) Tel: + 39-02 21018.1",18,18
"3096","de","en","J05 AX0 Antivirales Arzneimittel","J05 AX0 Antiviral agent",4,4
"3097","de","en","Jährliche Berichte werden als Teil der jährlichen Überprüfung der Zulassung, die unter außergewöhnlichen Umständen erteilt wurde, eingereicht.","Annual reports will be submitted as part of annual reassessment of the Marketing Authorisation issued under exceptional circumstances.",18,17
"3098","de","en","Janssen Farmacêutica Portugal Lda.","Janssen Farmacêutica Portugal Risperdal Consta Lda.",6,4
"3099","de","en","Janssen-Cilag AS Hoffsveien 1D 0275 Oslo Norwegen","Janssen-Cilag AS Hoffsveien 1D 0275 Oslo Norway",7,7
"3100","de","en","Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Belgien.","Janssen-Cilag International NV, Turnhoutseweg 30, B-2340 Beerse, Belgium.",8,8
"3101","de","en","Janssen-Cilag SpA Via C.","Janssen-Cilag SpA Via C.",4,4
"3102","de","en","Januar 1999 Datum der letzten Verlängerung:","Date of last renewal:",4,6
"3103","de","en","Janumet sollte zu den Mahlzeiten eingenommen werden, um den mit Metformin einhergehenden Magenproblemen vorzubeugen.","Janumet should be taken with food to avoid any stomach problems caused by metformin.",14,14
"3104","de","en","Jean-Louis ROBERT Frau Jacqueline GENOUX-HAMES","Luxembourg Dr Jean-Louis ROBERT Ms Jacqueline GENOUX-HAMES",7,5
"3105","de","en","Jean-René BRUNETIÈRE Directeur-Général Agence du Médicament 143-147, blvd Anatole France F-93200 Saint-Denis CEDEX Tel:","Jean-René BRUNETIÈRE Directeur-Général Agence du Médicament 143-147, blvd Anatole France F-93200 Saint-Denis CEDEX Tel:",14,14
"3106","de","en","Jede < Cozaar > 50 mg Tablette enthält 50 mg Losartan (als Kaliumsalz).","Each Cozaar 50 mg Tablet contains 50 mg of losartan (as potassium salt).",13,13
"3107","de","en","Jede 0,4 ml Pipette enthält:","Each 0.4 ml pipette contains:",5,5
"3108","de","en","Jede 0,5 ml-Fertigspritze enthält 30 Mikrogramm (6 Millionen I.E.) Interferon beta-1a.","Each 0.5 ml pre-filled syringe contains 30 micrograms (6 million IU) of interferon beta-1a.",14,11
"3109","de","en","Jede 1.0 ml Pipette enthält:","Each 1 ml pipette contains:",5,5
"3110","de","en","Jede 15 ml-Durchstechflasche mit Konzentrat enthält 300 mg Natalizumab (20 mg/ml);","Each 15 ml vial of concentrate contains 300 mg natalizumab (20 mg/ ml);",13,11
"3111","de","en","Jede 4,0 ml Pipette enthält:","Each 4 ml pipette contains:",5,5
"3112","de","en","Jede 80 mg Durchstechflasche enthält 0,10 mmol (2,21 mg) Natrium.","Each 80 mg vial contains 0.10 mmol (2.21 mg) sodium.",10,10
"3113","de","en","Jede BIO-SET Durchstechflasche enthält 30 Mikrogramm (6 Millionen I.E.) Interferon beta-1a.","Each BIO-SET vial contains 30 micrograms (6 million IU) of interferon beta-1a.",12,11
"3114","de","en","Jede Dosierungseinheit (Pipette) von ProMeris Duo enthält:","Each unit dose (pipette) of ProMeris Duo delivers:",8,7
"3115","de","en","Jede Dosis enthält 10 Mikrogramm Exenatide.","Each dose contains 10 micrograms exenatide.",6,6
"3116","de","en","Jede Durchstechflasche Aldurazyme ist nur zum Einmalgebrauch vorgesehen.","Each vial of Aldurazyme is intended for single use only.",10,8
"3117","de","en","Jede Durchstechflasche BeneFIX enthält nominell 1.000 I.E.","contains nominally 1000 IU of nonacog alfa.",7,7
"3118","de","en","Jede Durchstechflasche enthält 1 mg Trabectedin.","Each vial contains 1 mg of trabectedin.",7,6
"3119","de","en","Jede Durchstechflasche enthält 100 mg Infliximab.","Each vial contains 100 mg of infliximab",7,6
"3120","de","en","Jede Durchstechflasche enthält 15 mg Pegvisomant.","Each vial contains 15 mg of pegvisomant.",7,6
"3121","de","en","Jede Durchstechflasche enthält 20 mg Pegvisomant.","Each vial contains 20 mg of pegvisomant.",7,6
"3122","de","en","Jede Durchstechflasche enthält 250 µg Romiplostim.","Each vial contains 250 µg of romiplostim.",7,6
"3123","de","en","Jede Durchstechflasche enthält 400 mg Panitumumab.","Each vial contains 400 mg panitumumab.",6,6
"3124","de","en","Jede Durchstechflasche enthält 90 mg Ustekinumab in 1 ml Injektionslösung.","Each vial contains 90 mg ustekinumab in 1 ml of solution for injection.",13,10
"3125","de","en","Jede Durchstechflasche enthält nominell 250 I.E.* Moroctocog alfa**.","Each vial contains nominally 250 IU* moroctocog alfa**.",8,8
"3126","de","en","Jede Durchstechflasche hat einen Schnappdeckel aus Plastik, der vor Manipulationen schützt.","Each vial has a protective, tamper-proof plastic cap.",8,11
"3127","de","en","Jede Durchstechflasche Soliris enthält 300 mg Wirkstoff in 30 ml Arzneimittellösung.","Each vial of Soliris contains 300 mg of active ingredient in 30 ml of product solution.",16,11
"3128","de","en","Jede Einzeldosis à 0,8 ml des vorgefüllten Pens enthält 40 mg Adalimumab.","ed Each 0.8 ml single dose pre-filled pen contains 40 mg of adalimumab.",13,12
"3129","de","en","Jede Einzeldosis von Viani enthält:","Each single dose of Viani provides:",6,5
"3130","de","en","Jede Fertigspritze (0,5 ml) enthält 44 Mikrogramm (12 M.I.E.) Interferon beta-1a.","Eachpre-filled syringe (0.5 ml) contains 44 micrograms (12 MIU) of interferon beta-1a.",12,11
"3131","de","en","Jede Fertigspritze enthält 0,5 ml oder 0,8 ml Lösung.","Each pre-filled syringe contains 0.5 ml or 0.8 ml of solution.",11,9
"3132","de","en","Jede Fertigspritze enthält 3 ml Lösung.","Each pre-filled syringe contains 3 ml of solution.",8,6
"3133","de","en","Jede Fertigspritze enthält 6 mg Pegfilgrastim* in 0,6 ml Injektionslösung.","Each pre-filled syringe contains 6 mg of pegfilgrastim* in 0.6 ml solution for injection.",14,10
"3134","de","en","Jede Filmtablette enthält 10 mg Memantinhydrochlorid (entsprechend 8,31 mg Memantin).","Each film-coated tablet contains 10 mg memantine hydrochloride (equivalent to 8.31 mg memantine).",13,10
"3135","de","en","Jede Filmtablette enthält 150 mg Irbesartan und 12,5 mg Hydrochlorothiazid.","Each film-coated tablet contains 150 mg of irbesartan and 12.5 mg of hydrochlorothiazide.",13,10
"3136","de","en","Jede Filmtablette enthält 200 mg Lacosamid.","Each film-coated tablet contains 200 mg lacosamide.",7,6
"3137","de","en","Jede Filmtablette enthält 300 mg Irbesartan als Irbesartan-Hydrochlorid.","Each film-coated tablet contains 300 mg irbesartan (as",8,8
"3138","de","en","Jede Filmtablette enthält 600 mg Efavirenz.","Each film-coated tablet contains 600 mg of efavirenz.",8,6
"3139","de","en","Jede Filmtablette enthält 7,5 mg Olanzapin","Each tablet contains 7.5 mg olanzapine.",6,6
"3140","de","en","Jede Flasche ist etwa zur Hälfte gefüllt, und enthält drei Milliliter Lösung.","Each bottle is about half full and contains 3 millilitres of solution.",12,12
"3141","de","en","Jede FORSTEO-Packung enthält eine Bedienungsanleitung, die ausführlich den Gebrauch des Injektors beschreibt.","Each FORSTEO pack is provided with a user manual that fully describes the use of the pen.",17,12
"3142","de","en","Jede Hartkapsel enthält 132,8 mg wasserfreie Lactose.","Each hard capsule contains 132.8 mg of anhydrous lactose.",9,7
"3143","de","en","Jede INVEGA 9 mg Retardtablette enthält 9 mg Paliperidon.","Each INVEGA 9 mg prolonged-release tablet contains 9 mg of paliperidone.",11,9
"3144","de","en","Jede Kapsel enthält 10 mg Lenalidomid. • Die sonstigen Bestandteile sind:","Each capsule contains 10 mg of lenalidomide. • The other ingredients are:",12,11
"3145","de","en","Jede Kapsel enthält 150 mg Atazanavir (als Sulfat).","Each capsule contains 150 mg of atazanavir (as sulphate).",9,8
"3146","de","en","Jede Kapsel enthält 250 mg Mycophenolatmofetil.","Each capsule contains 250 mg mycophenolate",6,6
"3147","de","en","Jede Kapsel enthält 80 mg Valsartan.","Each capsule contains 80 mg valsartan.",6,6
"3148","de","en","Jede Kapsel REYATAZ 300 mg enthält 300 mg Atazanavir.","Each capsule of REYATAZ 300 mg contains 300 mg atazanavir.",10,9
"3149","de","en","Jede Markierung (0,1, 0,2, 0,3 usw.) stellt ein Zehntel eines Milliliters (0,1 ml) dar.","Each mark (0.1, 0.2, 0.3, etc) represents one-tenth of a millilitre (0.1 ml).",13,14
"3150","de","en","Jede Olanzapin Teva 2,5 mg Filmtablette enthält 2,5 mg des Wirkstoffs.","Each Olanzapine Teva 2. 5 mg film-coated tablet contains 2. 5 mg of the active substance.",16,11
"3151","de","en","Jede Packung beinhaltet des Weiteren ein Gerät zur Rekonstitution (BAXJECTII).","Each pack also contains a device for reconstitution (BAXJECT II).",10,10
"3152","de","en","Jede Packung enthält 10 Ampullen.","Each pack contains 10 ampoules.",5,5
"3153","de","en","Jede Packung enthält 14 Tabletten, also 2 Tabletten pro Tag für 7 Tage.","Each package has 14 tablets, corresponding to 2 tablets per day for 7 days.",14,13
"3154","de","en","Jede Packung enthält Blisterpackungen mit 30, 56 oder 100 Tabletten.","Each pack contains blisters of 30, 56 or 100 tablets.",10,10
"3155","de","en","Jede Pipette Prac-tic enthält folgende Bestandteile Einzeldosis 2,2 ml","Each pipette of Prac-tic delivers the following:",7,9
"3156","de","en","Jede Rebetol Kapsel enthält 40 mg Lactose.","Each Rebetol capsule contains 40 mg of lactose.",8,7
"3157","de","en","Jede Remeron 45 mg Filmtablette enthält 45 mg Mirtazapin.","SN027512) and sodium hydrogen carbonate.",5,9
"3158","de","en","Jede Retardtablette enthält 12 mg Paliperidon.","Each prolonged-release tablet contains 12 mg paliperidone",7,6
"3159","de","en","Jede Stalevo-Tablette enthält eine komplette Dosis Levodopa, Carbidopa und Entacapon.","Each Stalevo tablet contains one complete dose of levodopa, carbidopa and entacapone.",12,10
"3160","de","en","Jede Tablette AMMONAPS enthält 500 mg","Each tablet of AMMONAPS contains 500 mg",7,6
"3161","de","en","Jede Tablette enthält 0,5 mg Estradiol (als Hemihydrat) und 0,1 mg Norethisteronacetat. • Die sonstigen Bestandteile sind:","Each tablet contains 0.5 mg estradiol (as hemihydrate) and 0.1 mg norethisterone acetate. • Other ingredients are:",17,17
"3162","de","en","Jede Tablette enthält 50 mg Losartan-Kalium.","Each tablet contains 50 mg losartan potassium.",7,6
"3163","de","en","Jede Tablette enthält 500 mg Ranolazin.","Each tablet contains 500 mg of ranolazine.",7,6
"3164","de","en","Jede Tablette enthält 80 mg Telmisartan und 12,5 mg Hydrochlorothiazid.","Each tablet contains 80 mg telmisartan and 12.5 mg hydrochlorothiazide.",10,10
"3165","de","en","Jede Tablette Karvezide 150 mg/12,5 mg enthält 150 mg Irbesartan und 12,5 mg Hydrochlorothiazid.","Each tablet of Karvezide 150 mg/ 12.5 mg contains 150 mg irbesartan and 12.5 mg hydrochlorothiazide.",16,14
"3166","de","en","Jede überzogene Tablette enthält 321 mg Lactose-Monohydrat.","Each coated tablet contains 312 mg lactose monohydrate.",8,7
"3167","de","en","Jede ungeklärte Vaginalblutung bedarf der Abklärung, die sich nach der klinischen Indikation richtet.","Any unexplained vaginal bleeding should be investigated as clinically indicated.",10,13
"3168","de","en","Jede Woche vom Tag -7 bis 3 Monate nach der Transplantation","every week from day -7 up to 3 months after transplantation",11,11
"3169","de","en","jede zweite Woche n=814 n (%)","40 mg eow N=814 n (%)",6,6
"3170","de","en","Jeder Humalog KwikPen enthält 300 Einheiten in den vorliegenden 3 ml.","Each Humalog KwikPen contains 300 units (3 millilitres).",8,11
"3171","de","en","Jeder Karton enthält eine Tube Gel.","Each carton contains one tube of gel.",7,6
"3172","de","en","Jeder ml Infusionslösung enthält 2,99 mg Natrium.","Each ml of solution for infusion contains includes 2.99 mg sodium.",11,7
"3173","de","en","Jeder Pen enthält 60 Dosen der sterilen, konservierten Lösung (etwa 1,2 ml).","Each pre-filled pen contains 60 doses of sterile preserved solution (approximately 1.2ml)",12,12
"3174","de","en","Jeder Pen enthält genügend Insulin für mehrfache Dosierungen.","Each pen contains multiple doses.",5,8
"3175","de","en","Jedes 20 cm2-Pflaster enthält 9,0 mg Rotigotin.","Each patch of 20 cm2 contains 9.0 mg of rotigotine.",10,7
"3176","de","en","Jedes dieser Anzeichen und/oder Umstände kann bei Ihnen auftreten.","You might have any of these symptoms and/ or conditions.",10,9
"3177","de","en","Jedes Entzündungssymptom ist zu bewerten; falls notwendig ist eine Behandlung einzuleiten.","Any inflammatory symptoms should be evaluated and treatment instituted when necessary.",11,11
"3178","de","en","Jedes Pflaster gibt 1 mg Rotigotin über 24 Stunden ab.","Each patch releases 1 mg of rotigotine per 24 hours.",10,10
"3179","de","en","Jedes Pflaster gibt 8 mg Rotigotin über 24 Stunden ab.","Each patch releases 8 mg of rotigotine per 24 hours.",10,10
"3180","de","en","Jedoch scheint der Wirkstoff keinem signifikanten enterohepatischen Kreislauf zu unterliegen.","However, the medicinal product does not appear to undergo significant enterohepatic recirculation.",12,10
"3181","de","en","Jedoch stehen derzeit keine Tiermodelle für die Untersuchung von SUD zur Verfügung.","However, there was currently no animal model available to investigate SUDs.",11,12
"3182","de","en","Jedoch war bei Rauchern die Erlotinib-Clearance erhöht.","However, smokers had an increased rate of erlotinib clearance.",9,7
"3183","de","en","Jedoch werden niedrigere Spitzen-Serumwerte (Cmax) erreicht.","However, lower peak serum levels (Cmax) are achieved.",8,6
"3184","de","en","Jedoch wird eine Überwachung der Kreatinkinase empfohlen.","However monitoring of creatine kinase is recommended.",7,7
"3185","de","en","Jedoch wurden keine behandlungsbedingten äußerlichen oder skelettalen Missbildungen bei den Feten beobachtet.","24 malformations were observed.",4,12
"3186","de","en","Jedoch wurden Müdigkeit, Mundtrockenheit und Kopfschmerzen öfter berichtet als mit Placebo.","However, fatigue, dry mouth and headache were reported more often than with a dummy tablet.",15,11
"3187","de","en","Jetzt haben Sie 26 Einheiten eingestellt (Abbildung F).","There, you’ ve set 26 units (picture F).",8,8
"3188","de","en","Jetzt können Sie die Injektion vornehmen.","You are now ready to inject the dose. lp",9,6
"3189","de","en","JO5 AX In Kombination mit Zidovudine - zur Behandlung von Patienten fortgeschrittener HIV-1-Infektion","JO5 AX Combined treatment of advanced HIV",7,13
"3190","de","en","John Wyeth & Brother Ltd.","John Wyeth & Brother Ltd.",5,5
"3191","de","en","Johnson & Johnson D.O.O.","Johnson & Johnson D. O. O.",6,4
"3192","de","en","Jones zur pharmazeutischen Industrie, wo er im Sektor Tiergesundheit arbeitete.","Kingdom and Canada, Dr Jones joined the pharmaceutical industry in the animal health sector.",14,10
"3193","de","en","Jonna SUNELL-HUET Durchwahl (44-20) 74 18 84 65 E-Mail: certificate@emea.eu.int","Jonna SUNELL-HUET Direct telephone (44-20) 74 18 84 65 E-mail: certificate@emea. eu. int",13,10
"3194","de","en","Juli 2001 als Arzneimittel für seltene Leiden zur Behandlung von Morbus Wilson ausgewiesen.","Wilzin was designated an orphan medicinal product on 31 July 2001 for the treatment of Wilson’ s disease.",18,13
"3195","de","en","Juli 2002 im Amt) Ad-hoc-Arbeitsgruppe der GMP-Inspektionsdienste Ad-hoc-Arbeitsgruppe der GCP-Inspektionsdienste","Three separate referrals for arbitration under Article 33 of Directive 82/2001/EC were made to CVMP in 2002.",17,10
"3196","de","en","Juli 2006 erteilte die Europäische Kommission eine Genehmigung für das Inverkehrbringen von ATryn in der gesamten Europäischen Union.","The European Commission granted a marketing authorisation valid throughout the European Union for ATryn on 28 July 2006.",18,18
"3197","de","en","Juli 2006 mit der Annahme einer Liste von Fragen.","The arbitration procedure started on 27 July 2006 with the adoption of a list of questions.",16,9
"3198","de","en","Juni 2001) sowie mehrere Tagungen von Sachverständigengruppen der VICH aus.","A successful joint EMEA- 28 EMEA Annual Report 2001",9,10
"3199","de","en","Juni 2003 durch die Agence nationale du médicament vétérinaire, Frankreich, erteilt.","Manufacturing Authorisation issued on 23/ 06/ 2003 by the National Agency for Veterinary Medicinal Products, France.",16,11
"3200","de","en","Juni 2008 wurde mehrheitlich ein befürwortendes Gutachten angenommen.","The scientific conclusions are provided in Annex II, together with the Summary of Product Characteristics in Annex III.",18,8
"3201","de","en","Jupiterstraat 250 NL-2132 HK Hoofddorp Tel: +31 23 566 8777 infonl@nycomed.com","Jupiterstraat 250 NL-2132 HK Hoofddorp Tel: +31 23 566 8777 infonl@nycomed. com",12,11
"3202","de","en","Juvenile idiopathische Arthritis (ab 4 Jahren)","Juvenile idiopathic arthritis (age 4 years and above)",8,6
"3203","de","en","Kaletra 200 mg/50 mg Filmtabletten Lopinavir/Ritonavir","Kaletra 133.3 mg/ 33.3 mg soft capsules lopinavir/ ritonavir",9,6
"3204","de","en","Kaletra sollte von Ärzten verschrieben werden, die in der Behandlung von HIV-Infektionen Erfahrung haben.","Kaletra should be prescribed by physicians who are experienced in the treatment of HIV infection.",15,14
"3205","de","en","Kaliumsparende Diuretika, Kaliumergänzungsmittel oder kaliumhaltige Kochsalzersatzprodukte:","Potassium sparing diuretics, potassium supplements or potassium-containing salt substitutes:",9,6
"3206","de","en","Kalt-gepresste Aluminium/Aluminium-Blisterpackungen in Faltschachteln mit 28, 35, 56 und 70 Filmtabletten pro Packung.","Cold-formed aluminium/ aluminium blister in cartons of 28, 35, 56 & 70 film-coated tablets per carton.",16,13
"3207","de","en","kann anderen Menschen schaden, auch wenn diese dieselben Beschwerden haben wie Sie.","if their symptoms are the same as yours.",8,12
"3208","de","en","kann Docetaxel Winthrop in Kombination mit Doxorubicin und Cyclophosphamid verabreicht werden.","administered in combination with doxorubicin and cyclophosphamide.",7,11
"3209","de","en","kann Hydroxocobalamin bei Schwangeren jedoch angewendet werden.","hydroxocobalamin may be given to a pregnant woman.",8,7
"3210","de","en","Kann während der Trächtigkeit angewendet werden.","Can be used during pregnancy.",5,6
"3211","de","en","Kapitel 2 Hauptziele der Verwaltung.......................................................15","Chapter 2 Key objectives for administration.......................................... ..15",7,5
"3212","de","en","Kaplan Meier Kurven der Überlebenszeit nach Histologie","32 Kaplan Meier Plots of Overall Survival by Histology",9,7
"3213","de","en","Kapsel durch Folie drücken","Push product through foil",4,4
"3214","de","en","Kapselförmige rosa Filmtablette mit der Prägung „ 515“ auf einer Seite.","Capsule-shaped, pink film-coated tablet with “ 515 ” debossed on one side.",12,11
"3215","de","en","Karl FEIDEN (2) Hermann PABEL ΕΛΛΑ∆Α/Greece","Karl FEIDEN (2) Hermann PABEL ΕΛΛΑ∆Α/Greece",6,6
"3216","de","en","Karton für Flasche mit 8,8 ml, 17,5 ml oder 35,1 ml.","Bottle containing 8.8, 17.5 or 35.1 ml.",7,11
"3217","de","en","Karvea gehört zu einer Klasse von Arzneimitteln, die als Angiotensin-II-Rezeptorantagonisten bekannt sind.","Karvea belongs to a group of medicines known as angiotensin-II receptor antagonists.",12,12
"3218","de","en","Karvezide 300 mg/25 mg Tabletten Irbesartan/Hydrochlorothiazid","Karvezide 300 mg/ 25 mg tablets irbesartan/ hydrochlorothiazide",8,6
"3219","de","en","Katze mit einem Körpergewicht von 2,6 bis 7,5 kg.","Cats weighing 2.6 – 7.5 kg.",6,9
"3220","de","en","Kauen Sie die Kapsel nicht.","Do not chew the capsule.",5,5
"3221","de","en","KEIN ANDERES ARZNEIMITTEL DARF GLEICHZEITIG MIT INTRONA INFUNDIERT WERDEN.","NO OTHER MEDICINAL PRODUCT CAN BE INFUSED CONCOMITANTLY WITH INTRONA.",10,9
"3222","de","en","Kein Studienteilnehmer erhielt zuvor nicht- nukleosidische Reverse-Transkriptase-Hemmer.","All patients were non-nucleoside reverse transcriptase inhibitor naïve.",8,7
"3223","de","en","Keine Glukoselösung verwenden (siehe 6.2).","Do not use with glucose-containing solutions (see 6.2).",8,5
"3224","de","en","Keine klinisch relevante pharmakokinetische Wechselwirkung.","No clinically significant pharmacokinetic interaction.",5,5
"3225","de","en","Keiner der Patienten wurde während der Studie HBsAg- oder HBeAg-negativ.","No patients became HBsAg- or HBeAg-negative during the study.",9,10
"3226","de","en","Keiner dieser Befunde ist von klinischer Relevanz.","Neither of these findings is of clinical relevance.",8,7
"3227","de","en","Keiner dieser Fälle war mit einer Blutung oder anderen unerwünschten Ereignissen verbunden.","None of these cases were associated with bleeding or other adverse events.",12,12
"3228","de","en","KENNZEICHNUNG DER FOLIE, 15 mg (ALLE PACKUNGSGRÖSSEN)","FOIL LABEL, 15 mg (ALL PACK SIZES)",7,7
"3229","de","en","Kentera 3,9 mg / 24 Stunden transdermales Pflaster","Kentera 3.9 mg / 24 h transdermal patch",8,8
"3230","de","en","Kepivance sollte mit 1,2 ml Wasser für Injektionszwecke rekonstituiert werden.","Kepivance should be reconstituted with 1.2 ml water for injections.",10,10
"3231","de","en","Keppra 500 mg Filmtabletten Levetiracetam","Keppra 500 mg film-coated tablets.",5,5
"3232","de","en","Képviselet Tel: +36 1 310 7440","Képviselet Tel: +36 1 310 7440",6,6
"3233","de","en","Ketoconazol (400 mg täglich) erhöhte die AUC von Tadalafil (20 mg) um das 4-fache und cmax um 22%.","Ketoconazole (400 mg daily) increased tadalafil (20 mg) exposure (AUC) 4-fold and Cmax by 22%.",15,18
"3234","de","en","Ketoconazol Cmax ↓ 0,56 (0,42-0,73) Nevirapin Plasmaspiegel ↑ 1,15-1,28 verglichen mit historischen Kontrollen.","Nevirapine: plasma levels: ↑ 1.15- 1.28 compared to historical controls.",10,13
"3235","de","en","Ketoconazol, Ritonavir), da sich möglicherweise eine Erhöhung der Plasmaspiegel von Fluticason-17-propionat ergeben kann.","Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) guidelines).",15,13
"3236","de","en","keuchende Atmung, Nesselausschlag) entwickeln, während Sie dieses Arzneimittel erhalten, suchen Sie unverzüglich Ihren Arzt auf.","hives) while on this medication, seek medical help immediately.",9,15
"3237","de","en","KG Benzstraße 1 D-61352 Bad Homburg v.d.H.","KG Benzstraße 1 D-61352 Bad Homburg v. d. H.",9,7
"3238","de","en","KG Gieselweg 1 D-38110 Braunschweig Tel: + 49 5307 9300","KG Gieselweg 1 D-38110 Braunschweig Tel: + 49 5307 9300",10,10
"3239","de","en","Kind er neigen besonders dazu, während der Behandlung mit Viraferon und Ribavirin, Depressionen zu entwickeln.","Children are particularly prone to develop depression when being treated with Viraferon and ribavirin.",14,15
"3240","de","en","Kinder (3 Monate - 12 Jahre):","Children (3 months to 12 years of age):",8,6
"3241","de","en","Kinder mit AIDS Immunmodulation:","Children with AIDS Immunomodulation:",4,4
"3242","de","en","Kinder und Jugendliche ei","is of about 2-5 hours.",5,4
"3243","de","en","Kinder und Jugendliche Olanzapin ist nicht angezeigt für die Behandlung von Kindern und Jugendlichen unter 18 Jahren.","23 Olanzapine is not indicated for the treatment of children and adolescent patients below 18 years.",16,17
"3244","de","en","Kinder und Jugendliche von 2 bis 12 Jahren","Children and adolescents aged 2 to 12 years",8,8
"3245","de","en","Kinder von 6 bis 12 Jahren:","Children aged from 6 to 12 years:",7,6
"3246","de","en","Kinder, die Combivir einnehmen, müssen sorgfältig auf Nebenwirkungen überwacht werden.","Children taking Combivir should be closely monitored for side effects.",10,10
"3247","de","en","KINDERWARNHINWEIS ""AUSSER REICH- UND SICHTWEITE VON KINDERN AUFBEWAHREN""","THE WORDS “ KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”",12,8
"3248","de","en","KINDERWARNHINWEIS, DASS DAS ARZNEIMITTEL FÜR KINDER UNERREICHBAR UND NICHT SICHTBAR AUFZUBEWAHREN IST","SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN",17,12
"3249","de","en","Kindheit oder seit dem Erwachsenenalter an einem Wachstumshormonmangel leiden.","either childhood or adult-onset etiology.",5,9
"3250","de","en","Kiovig bewirkt eine Normalisierung krankheitsbedingt erniedrigter IgG-Spiegel im Blut.","At higher doses, it can help to adjust an abnormal immune system and modulate the immune response.",17,9
"3251","de","en","KIOVIG gehört zur Gruppe der sogenannten Immunglobuline.","KIOVIG belongs to a class of medications called immunoglobulins.",9,7
"3252","de","en","Kit für ein radioaktives Arzneimittel zur Infusion","Kit for radiopharmaceutical preparation for infusion",6,7
"3253","de","en","Kivexa, Trizivir), nie wieder eingenommen werden.","Kivexa, Trizivir) must not be restarted.",6,6
"3254","de","en","Kleben Sie diese Aufkleber in Ihren Kalender als Erinnerung, wann Sie das Pflaster wechseln müssen.","Use these stickers on your calendar to help you remember when to change your patch",15,15
"3255","de","en","Kleine Mengen dieses Arzneimittels können in die","Small amounts of this medicine may pass into",8,7
"3256","de","en","Klinische Daten zur Anwendung von VELCADE während der Schwangerschaft liegen nicht vor.","For VELCADE no clinical data with regard to exposure during pregnancy are available.",13,12
"3257","de","en","Klinische Erfahrungen mit massiver Überdosierung liegen nicht vor.","There is no clinical experience with massive overdosage.",8,8
"3258","de","en","Klinische Erfahrungen Therapieerfolge werden in diesem Abschnitt als vollständige oder partielle Remission definiert.","Successful outcome in this section is defined as complete or partial response.",12,13
"3259","de","en","Klinische Studie 1, 6 Indexläsionen; Klinische Studie 2, bis zu 8 Indexläsionen 2.","Study 1, 6 index lesions; Study 2, up to 8 index lesions 2.",13,13
"3260","de","en","Klinische Studien bei Morbus Parkinson","Clinical trials in Parkinson’ s disease",6,5
"3261","de","en","Klinische Symptome waren Sedierung, Ataxie, Tremor, erhöhte Pulszahl, erschwerte Atmung, Miosis und Appetitmangel.","Clinical signs included sedation, ataxia, tremors, increased heart rate,",9,13
"3262","de","en","Klinische Untersuchungen am Menschen ergaben keine klinisch relevanten Veränderungen der Schilddrüsenfunktionstests.","Clinical investigation in humans has revealed no clinically significant alteration in thyroid function tests.",14,11
"3263","de","en","Klopfen Sie vorsichtig mit dem Finger gegen den durchsichtigen Patronenhalter, damit sich eventuell vor- handene Luftbläschen oben sammeln.","Tap the clear cartridge holder gently with your finger so any air bubbles collect near the top.",17,18
"3264","de","en","KO (m2) = √ (Größe (cm) X Gewicht (kg) / 3600)","BSA (m2) = √ (Height (cm) X Weight (kg) / 3600)",11,11
"3265","de","en","Koadministration empfohlen bei gleichzeitiger Gabe von Loratidin mit Indinavir/Ritonavir.","Careful monitoring of therapeutic and adverse effects is recommended when loratidine is concomitantly administered with indinavir/ ritonavir.",17,9
"3266","de","en","Kombinationen oraler Antidiabetika; ATC-Code:","Combinations of oral blood glucose lowering drugs; ATC code:",9,4
"3267","de","en","Kombinationstherapie ViraferonPeg 1,5 Mikrogramm/kg/Woche in Kombination mit Ribavirin-Kapseln.","94 Combination therapy ViraferonPeg 1.5 micrograms/kg/week in combination with ribavirin capsules.",11,8
"3268","de","en","Kommission a) An die Kommission geschickt am b) Datum der Verordnung c) OJ Nr.","Commission a) Sent to Commission b) Date of regulation c) Official Journal",12,14
"3269","de","en","Komplette Ansprechrate pro Tag in den kombinierten TIH-Studien","Proportion of complete responders by day in the combined TIH studies",11,8
"3270","de","en","KOMPLETTE ZUSAMMENFASSUNG DER WISSENSCHAFTLICHEN BEURTEILUNG VON Ciprofloxacin Nycomed und damit verbundenen Bezeichnungen (siehe Anhang I)","OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF Ciprofloxacin Nycomed and associated names (see Annex I)",15,15
"3271","de","en","KOMPLETTE ZUSAMMENFASSUNG DER WISSENSCHAFTLICHEN BEURTEILUNG VON ORACEA","OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF ORACEA",8,7
"3272","de","en","KOMPLETTE ZUSAMMENFASSUNG DER WISSENSCHAFTLICHEN BEURTEILUNG VON VIANI EVOHALER UND DAMIT VERBUNDENEN BEZEICHNUNGEN (SIEHE ANHANG I)","OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF VIANI EVOHALER AND ASSOCIATED NAMES (SEE ANNEX I)",15,15
"3273","de","en","Konferenzdienste Sylvie BÉNÉFICE Bereichsleiter","Head of Sector Conference services Sylvie BÉNÉFICE Head of Sector Information technology",12,4
"3274","de","en","konjugiert an Tetanustoxoid als Trägerprotein 1 2 adsorbiert an Aluminiumhydroxid","conjugated to tetanus toxoid as a carrier 1",8,10
"3275","de","en","könnte, die ein optimales Ansprechen auf Somatropin verhindern kann.","Hypothyroidism may reduce the optimal response to somatropin.",8,9
"3276","de","en","Kontrolle zu halten) einnehmen","- ritonavir or other CYP3A4 inhibitors (medicines that help control HIV infection)",12,4
"3277","de","en","Kontrollieren Sie Ihr Gewicht in regelmäßigen Abständen; falls Ihr Gewicht zunimmt, informieren Sie bitte Ihren Arzt.","Your weight should be checked at regular intervals; if your weight increases, inform your doctor.",15,16
"3278","de","en","Konzentrat zur Herstellung einer Infusionslösung","Concentrate for solution for infusion",5,5
"3279","de","en","Konzentrates für eine Injektions- oder Infusionslösung EU/1/04/289/002","EU/ 1/ 04/ 289/ 002",5,7
"3280","de","en","Konzentrationen von Insulin-Antikörpern in Verbindung gebracht.","and 2 diabetes mellitus. ic",5,6
"3281","de","en","Kopfschmerzen Schwindel, Schläfrigkeit, Parästhesie, Synkope","Headache Dizziness, somnolence, paraesthesia, syncope",5,5
"3282","de","en","Kopfschmerzen, Parästhesie, Dysgeusie Schwindel, Hypästhesie, Tremor","Headache, paraesthesia, dysgeusia Dizziness, hypoaesthesia, tremor",6,6
"3283","de","en","Kopfschmerzen, Schwindel, Verstopfung und Durchfall.","The most common side effects are: headache, dizziness, constipation and diarrhoea.",11,5
"3284","de","en","Kopfschmerzen, Verstopfung, geschwollene Hände, Knöchel oder Füße (Ödeme) Gelenkschmerzen, niedriger Blutzucker  Sehr selten:","Headache, constipation, swollen hands, ankle or feet (oedema), joint pain, low blood glucose  Very rare:",16,14
"3285","de","en","Koronis Dilou 9 Peristeri 12134 Griechenland","Koronis Dilou 9 Peristeri 12134 Greece",6,6
"3286","de","en","Körpergewicht < 30 kg ≥ 30 kg","Patient weight < 30 kg ≥ 30 kg",8,7
"3287","de","en","Körpergewicht in kg Anfangsdosis","Body weight in kg Initial dose",6,4
"3288","de","en","Krampfanfälle Gelegentlich wurde über das Auftreten von Krampfanfällen berichtet, ohne dass eine Anamnese von Krampfanfällen oder Epilepsie bestand.","5 Seizures Seizures have been uncommonly reported in patients without previous history of seizures or epilepsy.",16,18
"3289","de","en","Krampfanfälle, wobei in den meisten dieser Fälle Krampfanfälle in der Anamnese oder Risikofaktoren für Krampfanfälle berichtet wurden. malignes","seizures or risk factors",4,18
"3290","de","en","Kreatinin-Clearance (ml/min) > 50 30 - < 50","≥ 50 30- < 50",5,8
"3291","de","en","Kreuzresistenzen mit anderen Makrolid-Antibiotika können nicht ausgeschlossen werden.","Cross-resistance to other macrolide antibiotics cannot be excluded.",8,8
"3292","de","en","Kriterien für die hämatologische Remission (Remission bestätigt nach ≥ 4 Wochen):","Haematological response criteria (all responses to be confirmed after ≥ 4 weeks):",12,11
"3293","de","en","KRKA, d.d., Novo mesto, Š marješ cesta 6, 8501 Novo mesto, Slovenia ka","KRKA, d. d., Novo mesto, Š marješ cesta 6, 8501 Novo mesto, Slovenia ka",14,13
"3294","de","en","Kruczkowskiego, 8 00 - 380 Warschau Polen","Kruczkowskiego, 8 00 - 380 Warszawa Poland",7,7
"3295","de","en","KS innerhalb des Körpers wird von Panretin nicht beeinflusst.","It does not treat KS that is inside the body.",10,9
"3296","de","en","Kühe mit tastbaren Euterveränderungen aufgrund von chronischer subklinischer Mastitis sollten nicht behandelt werden.","Do not treat cows with palpable udder changes due to chronic subclinical mastitis.",13,13
"3297","de","en","Kühl lagern und transportieren (2 ºC bis 8 ºC).","Store and transport refrigerated (2 C – 8 C).",9,9
"3298","de","en","Kühl lagern und transportieren (2°C – 8°C).","Store and transport refrigerated (2°C – 8°C).",7,7
"3299","de","en","Kutane Vaskulitis (einschließlich leukozytoklastische Vaskulitis), Stevens- Johnson-Syndrom, Erythema multiforme","Cutaneous vasculitis (including leukocytoclastic vasculitis), Stevens-Johnson syndrome, erythema multiforme",9,9
"3300","de","en","L 045 vom 15.02.97","L 045 of 15.02.97",4,4
"3301","de","en","L 272 vom 25.10.1996, S.","1 OJ No L272 of 25.10.1996, p.",7,5
"3302","de","en","L 272 vom 25.10.96 7/16 ANHANG III","L 272 of 25.10.96",4,7
"3303","de","en","L03AA11 Treatment of multiple","L03AA11 a) Treatment of b) multiple",6,4
"3304","de","en","La- gern Sie es nicht nahe einer Heizung oder in der Sonne.","Do not put it near heat or in the sun.",10,12
"3305","de","en","Laboratoire Rpg - Ranbaxy Pharmacie Generiques 4, Place Louis Armand, 75012 Paris","Laboratoire Rpg - Ranbaxy Pharmacie Generiques 4, Place Louis Armand, 75012 Paris France",13,12
"3306","de","en","Laboratório Medinfar - Produtos Farmacêuticos, S.A.","Laboratório Medinfar - Produtos Farmacêuticos, S. A.",7,6
"3307","de","en","Lacer SA Sardenya 346 - 350 E - 08025 Barcelona Spanien","Lacer SA Sardenya 346 - 350 E - 08025 Barcelona Spain",11,11
"3308","de","en","Lachs-Calcitonin besitzt weder ein embryotoxisches, teratogenes noch mutagenes Potenzial.","Salmon calcitonin is devoid of embryotoxic, teratogenic and mutagenic potential.",10,9
"3309","de","en","Lactatdehydrogenase im Blut erhöht","blood lactate dehydrogenase increased",4,4
"3310","de","en","Lactose (wasserfrei), Mikrokristalline Cellulose, Povidon, Natriumstärkeglykolat, Talkum, Magnesiumstearat.","22 Lactose (anhydrous), Microcrystalline cellulose, Povidone, Sodium starch glycollate, Talc, Magnesium stearate.",12,8
"3311","de","en","Lactose OLANZAPIN MYLAN Tabletten enthalten Lactose.","5 Olanzapine tablets contain lactose monohydrate.",6,6
"3312","de","en","Lactose-Monohydrat Mikrokristalline Cellulose Croscarmellose-Natrium Hyprolose Magnesiumstearat","Lactose monohydrate Cellulose, microcrystalline Croscarmellose sodium Hydroxypropyl cellulose Magnesium stearate",10,6
"3313","de","en","Lactose-Monohydrat Mikrokristalline Cellulose Croscarmellose-Natrium Prägelatinierte Maisstärke Siliciumdioxid Magnesiumstearat (Ph.Eur.) Eisen(III)-oxid und Eisen(III)-hydroxid-oxid x H2O","Lactose monohydrate Microcrystalline cellulose Croscarmellose sodium Pregelatinized starch Silicon dioxide Magnesium stearate Red and yellow ferric oxides",17,14
"3314","de","en","Lactose-Monohydrat Natriumdodecylsulfat Povidon K30 Croscarmellose-Natrium Magnesiumstearat","Capsules contain: lactose monohydrate sodium lauryl sulphate povidone K30 croscarmellose sodium",11,6
"3315","de","en","Lactose-Monohydrat, Citronensäure und Natriumhydroxid.","- The other ingredients are lactose monohydrate, citric acid anhydrous and sodium hydroxide.",13,4
"3316","de","en","LAGERN SIE DIE DURCHSTECHFLASCHE NACH DER HERSTELLUNG DER SUSPENSION NICHT, SONST KANN SICH DIE SUSPENSION ABSETZEN.","DO NOT STORE THE VIAL AFTER RECONSTITUTION OR THE SUSPENSION MAY SETTLE",12,16
"3317","de","en","Lagern Sie Humalog BASAL KwikPen vor dem ersten Gebrauch im Kühlschrank (2°C - 8°C).","Before the first use store your Humalog BASAL KwikPen in a refrigerator (2°C – 8°C).",15,14
"3318","de","en","Lagerungsbedingungen des rekonstituierten Arzneimittels siehe Abschnitt 6.3.","For storage conditions of the reconstituted medicinal product, see section 6.3.",11,7
"3319","de","en","Lagerungsbedingungen des rekonstituierten und verdünnten Arzneimittels siehe Abschnitt 6.3.","For storage conditions of the reconstituted and diluted medicinal product, see section 6.3.",13,9
"3320","de","en","Laktatazidosen treten im Allgemeinen nach wenigen oder mehreren Monaten Behandlung auf.","Lactic acidosis generally occurred after a few or several months of treatment.",12,11
"3321","de","en","Laktose, Thiomersal (als Konservierungsmittel),","- The other ingredients in the vaccine are: lactose, thiomersal (preservative), sodium chloride and",14,4
"3322","de","en","Lamivudin und Zidovudin werden gut aus dem Magen-Darm-Trakt absorbiert.","Lamivudine and zidovudine are well absorbed from the gastrointestinal tract.",10,9
"3323","de","en","Lamivudin wird in unveränderter Form vor allem renal ausgeschieden.","Lamivudine is predominately cleared unchanged by renal excretion.",8,9
"3324","de","en","Lamivudin) < 0,01 (stratifizierter Cochran-Mantel-Haenszel-Test)","# p-value (vs. lamivudine) < 0.01 (stratified Cochran-Mantel-Haenszel test)",9,5
"3325","de","en","Langzeitansprechen bei PegIntron + Ribavirin (abhängig von Ribavirin-Dosis, Genotyp und Viruslast)","Sustained response rates with PegIntron + ribavirin (by ribavirin dose, genotype and viral load)",14,11
"3326","de","en","Lansoprazol setzt den Säuregehalt im Magen herab.","Lansoprazole reduces the acid content of the stomach.",8,7
"3327","de","en","Lantus 100 Einheiten/ml Injektionslösung in einer Durchstechflasche Insulin glargin","Lantus 100 Units/ ml Solution for injection in a vial Insulin glargine",12,9
"3328","de","en","Lapatinib hemmt das ErbB-abhängige Wachstum von Tumorzellen in vitro und in verschiedenen Tiermodellen.","Lapatinib inhibits ErbB-driven tumour cell growth in vitro and in various animal models.",13,13
"3329","de","en","Largo Umberto Boccioni, 1 I-21040 Origgio / VA Tel: +39 02 96541","Largo Umberto Boccioni, 1 I-21040 Origgio / VA Tel: +39 02 96541",12,12
"3330","de","en","las 73, rue de Stalle B-1180 Bruxelles Belgien","SP Europe 73, rue de Stalle B-1180 Bruxelles Belgium",9,8
"3331","de","en","las Anwendung Zur subkutanen Anwendung.","Administration For subcutaneous use.",4,5
"3332","de","en","las einer erhöhten Clearance und einer verminderten Wirksamkeit von Adalimumab (siehe Abschnitt 5.1).","increased clearance and reduced efficacy of adalimumab (see section 5.1).",10,13
"3333","de","en","las In klinischen Studien wurden bei subkutaner Verabreichung von Trudexa keine schwerwiegenden allergischen unerwünschten Reaktionen beobachtet.","Serious allergic adverse reactions have not been reported with subcutaneous administration of Trudexa during clinical trials.",16,16
"3334","de","en","las Koyanagi-Harada (VKH)-Syndromen berichtet.","Cases of Vogt-Koyanagi-Harada (VKH) syndrome have been reported in patients with chronic hepatitis C treated with interferon.",17,4
"3335","de","en","las LV-1004 Riia Läti Tel: + 371 7605580","LV-1004 Riia Läti Tel: + 371 7605580 na",8,8
"3336","de","en","las Novo Nordisk A/S DK-2880 Bagsværd Dänemark","au Novo Nordisk A/ S DK-2880 Bagsværd Denmark",8,7
"3337","de","en","las Queenborough Kent ME11 5EL Vereinigtes Königreich","ris Kent ME11 5EL United Kingdom",6,7
"3338","de","en","las SP Europe, 73, rue de Stalle, B-1180 Bruxelles, Belgien","s SP Europe, 73, rue de Stalle, B-1180 Bruxelles, Belgium",10,10
"3339","de","en","las Οδός Αγίου Νικολάου, 8 CY-1055 Λευκωσία Τηλ: +357-22 757188","405 Κύπρος Οδός Αγίου Νικολάου, 8 CY-1055 Λευκωσία Τηλ: + 357-22 757188",12,10
"3340","de","en","Lassen Sie die Haut trocknen.","Let the skin dry.",4,5
"3341","de","en","Lassen Sie sich auf jeden Fall vom Arzt Ihres Kindes informieren, welche Dosierung für Ihr Kind richtig ist.","Be sure that your child's doctor clearly informs you what the correct dosage for your child should be.",18,18
"3342","de","en","Latvija Abbott Laboratories Baltics Vienī bas 87h LV-1004 Rī ga Tel: + 371 67605580","Latvija Abbott Laboratories Baltics Vienības 87h LV-1004 Rīga Tel: + 371 67605580",12,14
"3343","de","en","Latvija Bauskas 58a -401 Rīga, LV-1004 Tel: + 371-7 21 38 25 zn","ed Rīga, LV-1004 Tel: + 371-7 21 38 25",9,13
"3344","de","en","Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000","Latvija Eli Lilly Holdings Limited pārstāvniecība Latvijā Tel: +371 7364000",10,10
"3345","de","en","Latvija GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com","Latvija GlaxoSmithKline Latvia SIA Tel: + 371 67312687 lv-epasts@gsk.com",9,9
"3346","de","en","Latvija SIA “ Merck Sharp & Dohme Latvija”.","Latvija SIA “Merck Sharp & Dohme Latvija”.",7,8
"3347","de","en","LDPE ist die produktberührende Oberfläche.","LDPE is the product contact surface.",6,5
"3348","de","en","Lebendimpfstoffe sollten nicht gleichzeitig mit Enbrel verabreicht werden.","Live vaccines should not be given concurrently with Enbrel.",9,8
"3349","de","en","Lebensbedrohliche Überempfindlichkeit (anaphylaktische Reaktion) gegenüber dem arzneilich wirksamen Bestandteil oder einem der sonstigen Bestandteile.","Life threatening hypersensitivity (anaphylactic reaction) to the active substance or any of the excipients.",14,14
"3350","de","en","Lebererkrankungen wie schwere Hepatomegalie mit Steatose","Common: raised blood levels of liver enzymes and bilirubin Rare: liver disorders such as severe hepatomegaly with steatosis,",18,6
"3351","de","en","Leberfunktionsstörungen Patienten mit Leberfunktionsstörungen sollten eine reduzierte Dosis erhalten.","Hepatic impairment In patients with hepatic impairment a reduced dose should be used.",13,9
"3352","de","en","Leberfunktionsstörungen Toremifen sollte jedoch bei Patienten mit Leberfunktionsstörungen (siehe Abschnitt 5.2) vorsichtig eingesetzt werden.","Hepatic impairment Toremifene should be used cautiously in patients with liver impairment (see section 5.2).",15,14
"3353","de","en","Leberversagen, Gallengangsentzündung, Fettleber Erkrankungen der Knochen und Muskeln:","Liver failure, bile duct inflammation, fatty liver Musculoskeletal disorders:",9,8
"3354","de","en","Leere Pens dürfen nicht wieder verwendet werden und müssen vorschriftsgemäß entsorgt werden.","Empty pens must never be reused and must be properly discarded.",11,12
"3355","de","en","Legen Sie Apidra nicht in die Nähe des Gefrierfachs oder eines Kühlelements.","Do not put Apidra next to the freezer compartment or a freezer pack.",13,12
"3356","de","en","Legen Sie das Infusionsset unter aseptischen Be- dingungen an.","Use aseptic technique when inserting the infusion set.",8,9
"3357","de","en","Legen Sie den bereits in Gebrauch befindlichen Fertigpen nicht in den Kühl- schrank.","Do not keep the pre -filled pen that you are using in the fridge.",14,13
"3358","de","en","Legen Sie den Fertigpen nicht in die Nähe des Gefrierfachs oder eines Kühlelements.","Do not put the pre-filled pen next to the freezer compartment or a freezer pack.",15,13
"3359","de","en","Leicht Mittelstark Stark Sehr stark","Adjustment guidelines for treatment-limiting toxicity",5,5
"3360","de","en","Leichte bis schwere Reaktionen an der Injektionsstelle (Schmerzen, Rötung, Bluterguss, Schwellung und/oder Reizung der Injektionsstelle)","Mild to severe injection site reaction (pain, redness, bruising, swelling and/ or irritation at the site of injection)",18,15
"3361","de","en","Leichte oder mittelschwere infusionsbedingte Nebenwirkungen (siehe Abschnitt 4.8) sprechen normalerweise auf eine Reduktion der Infusionsgeschwindigkeit an.","Mild or moderate infusion-related reactions (section 4.8) usually respond to a reduction in the rate of infusion.",17,16
"3362","de","en","Leichtes Mineralöl Sonstige Bestandteile:","Light Mineral Oil Excipients",4,4
"3363","de","en","leiden, dürfen Sie nicht mit ORENCIA ____________________ behandelt werden.","ORENCIA increases the risk of getting ____________________ infections.",8,9
"3364","de","en","Leitende EMEA-Mitarbeiter im Porträt","EMEA/ MB/ 049/ 01-EN-Final Work progamme for 2002 Annex 1 EMEA establishment plan 2000 – 2002",16,4
"3365","de","en","Leiter der Agenturen für Humanarzneimittel EMEA-/MRFG-Sekretariat (E-Mail) Europäischer Produktindex","Significant support was also provided to the ICH process.",9,9
"3366","de","en","Lenalidomid besitzt ein asymmetrisches Kohlenstoffatom und kann daher in den optisch aktiven Formen S(-) und R(+) vorliegen.","Lenalidomide has an asymmetric carbon atom and can therefore exist as the optically active forms S(-) and R(+).",18,17
"3367","de","en","Les Isnes Rue Louis Genonceau, 13 BE-5023 Gembloux Belgien","Les Isnes Rue Louis Genonceau, 13 BE-5023 Gembloux Belgium",9,9
"3368","de","en","Lesen Sie alle Angaben sorgfältig durch, bevor Sie die Fertigspritze benutzen.","Read all instructions thoroughly before using the pre-filled syringe.",9,11
"3369","de","en","Lesen Sie dann Abschnitt 2 “Vorbereitung des Pens”","Then, move on to Section 2 – Getting Started.",9,8
"3370","de","en","Lesen Sie die folgenden Hinweise sorgfältig durch, bevor Sie Ihren OptiSet benutzen.","Read these instructions carefully before using your OptiSet.",8,12
"3371","de","en","Lesen Sie die gesamte Packungsbeilage sorgfältig durch, bevor Ihr Kind diesen Impfstoff erhält.","Read all of this leaflet carefully before your child receives this vaccine.",12,13
"3372","de","en","Lesen Sie die gesamte Packungsbeilage sorgfältig durch, bevor Sie mit der Anwendung dieses Arzneimittels beginnen.","Read all of this leaflet carefully before you start using this medicine.",12,15
"3373","de","en","Lesen Sie die gesamte Packungsbeilage sorgfältig durch, bevor Sie mit der Einnahme dieses Arzneimittels beginnen","Read all of this leaflet carefully before you start taking this medicine.",12,15
"3374","de","en","Lesen Sie vor der Anwendung die Packungsbeilage.","Read the package leaflet before use.",6,7
"3375","de","en","Lettland Pfizer Luxembourg SARL Filiā le Latvijā Tel: + 371 670 35 775","Latvija Pfizer Luxembourg SARL Filiā le Latvijā Tel: + 371 670 35 775",13,13
"3376","de","en","LeukoScan wird mit 0,5 ml isotonischer Kochsalzlösung für Injektionszwecke rekonstituiert.","10 LeukoScan is reconstituted with 0.5 ml isotonic sodium chloride injection.",11,10
"3377","de","en","Leukose sowie alle drei Jahre gegen Panleukopenie.","components, and every three years for the panleucopenia component.",9,7
"3378","de","en","Leukotriene verursachen Verengungen und Schwellungen der Atemwege der Lungen.","Leukotrienes cause narrowing and swelling of airways in the lungs.",10,9
"3379","de","en","Levemir sollte nicht mit Infusionslösungen gemischt werden.","Levemir should not be added to infusion fluids.",8,7
"3380","de","en","Levitra vardenafil Part B","• Levitra • vardenafil • Part B",7,4
"3381","de","en","Levodopa, Carbidopa und Entacapon.","Stalevo is a medicine that contains three active substances: levodopa, carbidopa and entacapone.",13,4
"3382","de","en","Lippen, Scheide, Penisspitze, Rektum oder Anus auftragen.","vagina, tip of the penis, rectum, or anus.",8,7
"3383","de","en","Liprolog 100 E/ml Injektionslösung in Durchstechflasche Insulin lispro (über rDNA hergestellt)","Liprolog 100 U/ ml solution for injection in vial Insulin lispro (rDNA origin)",13,11
"3384","de","en","Liprolog BASAL Pen dient zur Behandlung des Diabetes mellitus.","Liprolog Basal Pen is used to treat diabetes.",8,9
"3385","de","en","Liprolog KwikPen darf nicht angewendet werden,","Do not use Liprolog KwikPen",5,6
"3386","de","en","Liprolog Mix ist eine Mischung dieser beiden Formulierungen.","Liprolog Mix is a mixture of these two formulations.",9,8
"3387","de","en","Liprolog Mix50 Patronen sind nicht zum Mischen mit anderen Insulinen in der Patrone ausgelegt.","Liprolog Mix50 cartridges are not designed to allow any other insulin to be mixed in the cartridge.",17,14
"3388","de","en","Liste A Liste B","List A List B",4,4
"3389","de","en","Liste der sonstigen Bestandteile","6.1 List of excipients",4,4
"3390","de","en","LITAK ist eine Injektionslösung.","LITAK is a solution for injection.",6,4
"3391","de","en","Livezeni, Nr 7A Târgu Mureş 540472 – - RO Tel: + 40 265 208 120","Livezeni, Nr 7A Târgu Mureş 540472 – RO Tel: + 40 265 208 120",14,15
"3392","de","en","LOCF ITT (NC = F)","LOCF ITT (NC = F) carried forward",7,5
"3393","de","en","Lokale Allergie tritt häufig auf (≥ 1/100 bis 1/10).","Local allergy is common (≥ 1/ 100 to < 1/ 10).",11,9
"3394","de","en","Lokale allergische Reaktionen kommen bei Patienten häufig vor (1/100 bis 1/10).","72 Local allergy in patients is common (1/ 100 to < 1/ 10).",13,11
"3395","de","en","Lokale Hautreizungen, wie z.B.","Local skin reactions such as erythema, erosion, excoriation, flaking and oedema are common.",13,4
"3396","de","en","London, Juni 2008 EMEA/532160/2007 – Rev.1","London, June 2008 EMEA/ 532160/ 2007 – Rev.1",8,6
"3397","de","en","Lonza Biologics, plc 228 Bath Road","Lonza Biologics, plc 228 Bath Road Slough Berkshire SL1 4DX United Kingdom",12,6
"3398","de","en","Lopinavir wird in hohem Maße durch das hepatische Cytochrom P450-System, in erster Linie durch das Isoenzym CYP3A metabolisiert.","Lopinavir is extensively metabolised by the hepatic cytochrome P450 system, almost exclusively by isozyme CYP3A.",15,18
"3399","de","en","Loratadin arcana 10 mg- Filmtabletten","Loratadin arcana 10 mg- Filmtabletten",5,5
"3400","de","en","Loratadine 10 mg/pseud oephedrin e sulph 240 mg","Loratadine 10 mg/ pseudoephedrin e sulph 240 mg",8,8
"3401","de","en","Lorazepam/Efavirenz (2 mg Einmalgabe/600 mg einmal täglich)","Lorazepam/ Efavirenz (2 mg single dose/ 600 mg once daily) ANTICONVULSANTS",11,7
"3402","de","en","Losartan ist für die Behandlung der Hypertonie angezeigt.","Losartan is indicated for the treatment of hypertension.",8,8
"3403","de","en","Lösungsmittel für PegIntron Wasser für Injektionszwecke","Solvent for PegIntron Water for injections",6,6
"3404","de","en","Lösungsmittel Histidin Salzsäure (zur Einstellung des pH-Wertes) Natriumhydroxid (zur Einstellung des pH-Wertes) Wasser für Injektionszwecke","Solvent Histidine Hydrochloric acid (for pH-adjustment) Sodium hydroxide (for pH-adjustment) Water for injections",13,15
"3405","de","en","Lösungsmittel Wasser für Injektionszwecke","Solvent Water for injections.",4,4
"3406","de","en","Lösungsmittel zur Herstellung eines Konzentrats zur Herstellung einer Infusionslösung von ECALTA Zur intravenösen Anwendung","Solvent for concentrate for solution for infusion for ECALTA Intravenous use",11,14
"3407","de","en","Lot 20/32 ANGABEN AUF DEM BEÄLTNIS","18/ 28 PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE",9,6
"3408","de","en","Lovett House Lovett Road, Staines Middlesex TW18 3AZ – UK Tel: + 44 (0) 1784 419615","Lovett House Lovett Road, Staines Middlesex TW18 3AZ – UK Tel: + 44 (0) 1784 419615",16,16
"3409","de","en","Loxicom 0,5 mg/ml Suspension zum Eingeben für Hunde","Loxicom 0.5 mg/ ml oral suspension for dogs",8,8
"3410","de","en","LT-08124 Vilnius Tel. + 370 52 101868 Ar","uth Tel. + 370 52 101868",6,8
"3411","de","en","Ltd Tel: +356 21232175","Ltd Tel: +356 21232175",4,4
"3412","de","en","Lucentis darf nicht bei Ihnen angewendet werden,","You must not receive Lucentis",5,7
"3413","de","en","Luft in die Durchstechflasche injizieren","Inject air into vial",4,5
"3414","de","en","Luftblasen in der Patrone sind vor der Injektion zu entfernen (siehe Bedienungsanleitung des Pens).","Air bubbles must be removed from the cartridge before injection (see instruction for using pen).",15,14
"3415","de","en","Luftblasen steigen so nach oben.","This will cause any air bubbles to rise to the top.",11,5
"3416","de","en","LUMIGAN 0,3 mg/ml Augentropfen Bimatoprost Anwendung am Auge.","LUMIGAN 0.3 mg/ ml, eye drops, solution Bimatoprost Ocular use",10,8
"3417","de","en","Luminity wird ausschließlich als Diagnostikum angewendet.","Luminity is for diagnostic use only.",6,6
"3418","de","en","Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung Das Lyophilisat ist weiß.","Powder and solvent for solution for injection The powder is white.",11,11
"3419","de","en","Lyophilisat und Lösungsmittel zur Herstellung einer Suspension zur intranasalen Applikation.","Lyophilisate and solvent for suspension for nasal administration.",8,10
"3420","de","en","LYRICA 75 mg Hartkapseln Pregabalin","LYRICA 75 mg hard capsules Pregabalin",6,5
"3421","de","en","Lysodren darf nicht eingenommen werden,","Do not take Lysodren",4,5
"3422","de","en","Lysodren kann die Wirkung verschiedener anderer Arzneimittel beeinflussen.","Lysodren may interfere with several medicines.",6,8
"3423","de","en","M irapexin pramipexole Teil B","Mirapexin pramipexole Part B",4,5
"3424","de","en","M01AH Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis.Treatment of primary dysmenorrhoea","M01AH Symptomatic relief in the treatment of osteoarthritis or",9,14
"3425","de","en","MabCampath ist ein Konzentrat zur Herstellung einer Infusionslösung und wird in Durchstechflaschen aus Glas geliefert.","MabCampath is a concentrate for solution for infusion that comes in a glass vial.",14,15
"3426","de","en","MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung","MabThera 500 mg concentrate for solution for infusion",8,8
"3427","de","en","Machen Sie dies jedes Mal auf die gleiche Weise.","Do the same thing every time.",6,9
"3428","de","en","Macugen ist als Packung mit einer Einzeldosis erhältlich.","Macugen is supplied in a single dose pack.",8,8
"3429","de","en","Magen-Darm-*, Atemwegs-* und Hirnblutungen*) Hypertonie","haemorrhage (inc. gastrointestinal*, respiratory tract* and cerebral haemorrhage*) hypertension",9,5
"3430","de","en","Magensaftresistente Hartkapseln (Magensaftresistente Kapsel) Undurchsichtiges gelbes Ober- und Unterteil.","Opaque yellow cap and body.",5,9
"3431","de","en","Magisterabschluss in Politikwissenschaft, Geschichte und Englisch an der Universität Hamburg.","Masters Degree in political science, history and English from the University of Hamburg.",13,10
"3432","de","en","Maisstärke Povidon (E 1201) Crospovidon (E 1202) hochdisperses Siliciumdioxid Magnesiumstearat (E 470b) Lactose-Monohydrat","Maize starch povidone (E1201) crospovidone (E1202) silica colloidal anhydrous magnesium stearate (E470b) lactose monohydrate",14,13
"3433","de","en","maligne Hautveränderungen (Tumore) oder wenn Sie aus irgendeinem Grunde ein geschwächtes (immunkomprimiertes) Immunsystem haben.","if you have a weakened immune system (immuno-compromised) whatever the cause.",11,14
"3434","de","en","malignes neuroleptisches Syndrom, diabetisches Koma, zerebrovaskuläre Erkrankung, zerebrale Ischämie, Bewegungsstörung","Neuroleptic malignant syndrome, Diabetic coma, Cerebrovascular disorder, Cerebral ischaemia, Movement disorder",11,10
"3435","de","en","Malta Agrimed Limited Tel: +356 21 465 797","Malta Agrimed Limited Tel: +356 21 465 797",8,8
"3436","de","en","Malta BioMarin Europe Limited biomarinen@bmrn.com","Malta BioMarin Europe Limited biomarinen@bmrn. com",6,5
"3437","de","en","Malta Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820","Malta Gilead Sciences International Ltd Tel: + 44 (0) 20 7136 8820",12,12
"3438","de","en","Malta Nicobrand Limited A Subsidiary of Watson Pharmaceuticals, Inc.","Malta Nicobrand Limited A Subsidiary of Watson Pharmaceuticals, Inc.",9,9
"3439","de","en","Malta Vivian Corporation Ltd.","Malta Vivian Corporation Ltd.",4,4
"3440","de","en","Man nimmt an, dass die Pharmakokinetik der Metforminresorption nicht linear ist.","It is assumed that the pharmacokinetics of metformin absorption is non-linear.",11,11
"3441","de","en","Management of adverse event reports VICH:","Management of adverse event reports VICH:",6,6
"3442","de","en","Manche Menschen verspüren nach der Injektion von Avonex grippeartige Symptome.","Some people find that after injecting Avonex, they feel like they have flu.",13,10
"3443","de","en","Manche Patienten sprechen möglicherweise auf geringere Dosen an.","Some patients may respond to lower doses.",7,8
"3444","de","en","Manchmal kann eine paradoxe Erhöhung des Cholesterins (gesamt und LDL) bei Patienten mit einer Hypertriglyceridämie auftreten.","Sometimes a paradoxical increase of (total and LDL) cholesterol can occur in patients with hypertriglyceridaemia.",15,16
"3445","de","en","Männer und Frauen im fortpflanzungsfähigen Alter müssen während einer Behandlung mit TRISENOX wirksame Schwangerschaftsverhütungsmaßnahmen anwenden.","Men, and women of childbearing potential must use effective contraception during treatment with TRISENOX.",14,15
"3446","de","en","Männer und Frauen, die mit Alimta behandelt werden, müssen darauf hingewiesen werden, dass Alimta die Fruchtbarkeit beeinträchtigt.","Alimta affects fertility, so both men and women who receive it need to be made aware of this.",18,17
"3447","de","en","Mannitol (Ph.Eur.) (E421) Mikrokristalline Cellulose / hochdisperses Siliciumdioxid Croscarmellose-Natrium Magnesiumstearat (Ph.","Mannitol (E421) Silicified microcrystalline cellulose Croscarmellose sodium",7,11
"3448","de","en","Mannitol Natriumcitrat Wasser für Injektionszwecke","Mannitol Sodium citrate Water for injections",6,5
"3449","de","en","Maraviroc AUC12: ↑ 2,53 (1,71, 3,15) Maraviroc Cmax: ↑ 1,25 (0,87, 2,82) Die Konzentration von Efavirenz,","Tipranavir/ ritonavir 500 mg/ 200 mg BID (maraviroc 150 mg BID) NNRTI + PI",14,16
"3450","de","en","Maraviroc ein Kombinationsmedikament, das Efavirenz, Emtricitabin und Tenofovir enthält und unter dem Namen ATRIPLA geführt wird.","maraviroc a combination medicine containing efavirenz, emtricitabine and tenofovir, which is currently known as ATRIPLA.",15,16
"3451","de","en","Mare de Deu de Montserrat, 221 08041 Barcelona España Tel: +34 93 4466000 Email: veterinaria@esteve.es","Mare de Deu de Montserrat, 221 08041 Barcelona España Tel: +34 93 4466000 Email: veterinaria@esteve.es",15,15
"3452","de","en","Marios MARSELOS Frau Julia YOTAKI","Marios MARSELOS Mrs Julia YOTAKI",5,5
"3453","de","en","Maropitant hat eine hohe Plasma-Proteinbindung und kann mit anderen Stoffen mit ebenfalls hoher Bindung konkurrieren.","Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.",15,15
"3454","de","en","Maropitant wird bei Hunden zu über 99% an Plasmaproteine gebunden.","Plasma protein binding of maropitant in dogs is more than 99%.",11,10
"3455","de","en","März 2000 Datum der Verlängerung:","9 March 2000 t uc",5,5
"3456","de","en","März 2006 die EMEA mit den Gründen für die unterschiedlichen Auffassungen.","The Denmark referred the reasons for disagreement to the EMEA on 31 March 2006.",14,11
"3457","de","en","MASIVET 150 mg Filmtabletten für Hunde.","MASIVET 150 mg film-coated tablets for dogs.",7,6
"3458","de","en","Massieren Sie die Einstichstelle nicht.","Do not rub the area you have just injected.",9,5
"3459","de","en","Maximale Plasmakonzentrationen von Vareniclin werden typischerweise innerhalb von 3 bis 4 Stunden nach Einnahme erreicht.","Following administration of multiple oral doses to healthy volunteers, steady- state conditions were reached within 4 days.",17,15
"3460","de","en","Mayne Pharma (Benelux) N.V.","Mayne Pharma (Benelux) N.V.",4,4
"3461","de","en","Mechanismen, die für die Abweichung von der Linearität verantwortlich sind, wurden nicht identifiziert.","Mechanisms responsible for deviation from linearity have not been identified.",10,13
"3462","de","en","Median (Monate) Hazard Ratio","Median (months) Hazard ratio",4,4
"3463","de","en","Mediane prozentuale (%) Veränderung (95% CI)","Median percent (%) change (95% IC)",6,6
"3464","de","en","Mediane Zeit bis zur Progression (Wochen)","Median time to progression (weeks)",5,6
"3465","de","en","Medikamente zur Behandlung der Epilepsie (wie Phenytoin).","their removal from the body, for example medicines used to treat epilepsy (such as phenytoin).",15,7
"3466","de","en","Medikiertes Futter, das nicht innerhalb von 24 Stunden verzehrt wird, ist zu ersetzen.","Feed to which the oral powder has been added should be replaced if not consumed within 24 hours.",18,13
"3467","de","en","Medis-Danmark A/S Havelse Molle 14 DK-3600 Frederikssund Danmark","Medis-Danmark A/ S Havelse Molle 14 DK-3600 Frederikssund Danmark",9,8
"3468","de","en","Mefloquin, Halofantrin, Pentamidin, Cisaprid, Erythromycin i.v.)","mefloquine, halofantrine, pentamidine, cisapride, erythromycin IV).",6,6
"3469","de","en","Mehrfachpackung, bestehend aus 10 Teilpackungen mit jeweils 1 Fertigspritze mit 1 ml Injektionslösung.","Multipack comprising 10 intermediate packs, each containing 1 pre-filled syringe of 1 ml solution for injection.",16,13
"3470","de","en","Meloxivet 1,5 mg/ml Suspension zum Eingeben für Hunde","Meloxivet 1.5 mg/ ml oral suspension for dogs",8,8
"3471","de","en","Menschen mit bekannter Überempfindlichkeit gegenüber Makrolidantibiotika sollten den Kontakt mit dem Tierarzneimittel vermeiden.","People with known hypersensitivity to the macrolide class should avoid contact with the product.",14,13
"3472","de","en","Menschen, die überempfindlich (allergisch) gegen nichtsteroidale Antiphlogistika sind, sollten den Kontakt mit Metacam vermeiden.","People who are hypersensitive (allergic) to NSAIDs should avoid contact with Metacam.",12,14
"3473","de","en","menschlicher Blutgerinnungsfaktor IX sind","- if you are hypersensitive (allergic) to the active substance, human coagulation factor IX.",14,4
"3474","de","en","Merck – Paroxetine 20 mg","Merck – Paroxetine 20 mg",5,5
"3475","de","en","Merial Laboratoire Lyon Gerland 254, rue Marcel Mérieux F-69007 Lyon Frankreich","Mérial Laboratoire Lyon Gerland, 254 rue Marcel Merieux 69007 Lyon France",11,11
"3476","de","en","MERIAL, 4 Chemin du Calquet, F-31300 Toulouse, Frankreich","MERIAL, 4 chemin du Calquet, FR-31300 Toulouse, France.",8,8
"3477","de","en","Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Deutschland","100 D-60318 Frankfurt/Main Germany.",4,9
"3478","de","en","Messen Sie 94 ml gereinigtes Wasser in einen Messzylinder ab.","Measure 94 ml of purified water in a graduated cylinder.",10,10
"3479","de","en","Metabolische Azidose, Diabetes mellitus, Hyponatriämie, Hyperkalzämie, Hyperurikämie, Hypalbuminämie, Kachexie, Gedeihstörung, Gicht, Hypophosphatämie, Hyperphosphatämie, Appetitzunahme","Metabolic acidosis, diabetes mellitus, hyponatraemia, hypercalcaemia, hyperuricaemia, hypoalbuminaemia, cachexia, failure to thrive, gout, hypophosphataemia, hyperphosphataemia, increased appetite",17,14
"3480","de","en","Metabolisierung Rosiglitazon wird umfangreich metabolisiert und es wird keine Muttersubstanz unverändert ausgeschieden.","Metabolism Metabolism of rosiglitazone is extensive with no parent compound being excreted unchanged.",13,12
"3481","de","en","Metabolisierung Rotigotin wird zu einem großen Teil metabolisiert.","Metabolism Rotigotine is metabolised to a great extent.",8,8
"3482","de","en","Metabolismus und Elimination Die Metabolisierung von Lansoprazol wird überwiegend über das Enzym CYP2C19 katalysiert.","The metabolism of lansoprazole is mainly catalysed by the enzyme CYP2C19.",11,14
"3483","de","en","Metacam 0,5 mg/ml Suspension zum Eingeben für Hunde","Metacam 0.5 mg/ ml oral suspension for dogs",8,8
"3484","de","en","Metacam 20 mg/ml Injektionslösung für Rinder, Schweine und Pferde Meloxicam","Metacam 20 mg/ ml solution for injection for cattle, pigs and horses Meloxicam",13,10
"3485","de","en","Metacresol, Natriumchlorid, Trometamol, Polysorbat 20, Salz- säure 36%, Natriumhydroxid, Wasser für Injektionszwecke.","- The other ingredients are: metacresol, sodium chloride, trometamol, polysorbate 20,",11,12
"3486","de","en","Metaflumizon 799,5 mg und Amitraz 799,5 mg","Metaflumizone 799.5 mg and amitraz 799.5 mg",7,7
"3487","de","en","Metalyse löst die Blutgerinnsel auf und unterstützt die Wiederherstellung des normalen Blutflusses zum Herzen.","The effectiveness of Metalyse has been studied in a large trial (ASSENT II) in about 17,000 patients.",17,14
"3488","de","en","Metalyse sollte nur von einem mit der thrombolytischen Therapie erfahrenen Arzt verschrieben werden.","Metalyse should be prescribed by doctors who have experience in the use of thrombolytic treatment.",15,13
"3489","de","en","Metformin erhöht die Transportkapazität von spezifischen membranständigen Glukosetransportern (GLUT-1 und GLUT-4).","Metformin increases the transport capacity of specific types of membrane glucose transporters (GLUT-1 and GLUT-4).",15,11
"3490","de","en","Metformin wirkt hauptsächlich durch Hemmung der Glukosebildung und Verminderung der Resorption (Aufnahme) von Glukose im Darm.","Metformin works mainly by inhibiting glucose production and reducing its absorption in the gut.",14,16
"3491","de","en","Methicillin-sensible Staphylokokken (einschließlich Staphylococcus aureus)* Streptococcus agalactiae* Streptococcus pneumoniae*† Streptococcus pyogenes* Gramnegative Aerobier:","Methicillin-susceptible-staphylococci (including Staphylococcus aureus)* Streptococcus agalactiae* Streptococcus pneumoniae*† Streptococcus pyogenes Gram-negative aerobes:",12,13
"3492","de","en","METHODE ART(EN) DER ANWENDUNG","METHOD AND ROUTE(S) OF ADMINISTRATION",5,4
"3493","de","en","METHOTREXAT BEI PATIENTEN MIT RHEUMATOIDER ARTHRITIS VON < 3-JÄHRIGER ERKRANKUNGSDAUER Veränderung gegenüber dem Ausgangswert","COMPARISON OF ENBREL vs METHOTREXATE IN PATIENTS WITH RA OF < 3 YEARS DURATION",14,14
"3494","de","en","Methyl-4-hydroxybenzoat und Propyl-4-hydroxybenzoat können allergische Reaktionen (möglicherweise Spätreaktionen) hervorrufen.","Methyl parahydroxybenzoate and propyl parahydroxybenzoate may cause allergic reactions (possibly delayed).",11,9
"3495","de","en","Metoclopramid, können die Resorption von Paliperidon beeinflussen.","Medicinal products affecting gastrointestinal transit time may affect the absorption of paliperidone, e. g., metoclopramide.",15,7
"3496","de","en","mg/m2) mg/m2) mg/m2) mg/m2)","mg/ m2) mg/ m2) mg/ m2) mg/ m2)",8,4
"3497","de","en","Micardis ist ein Arzneimittel, das den Wirkstoff Telmisartan enthält.","Micardis is a medicine that contains the active substance telmisartan.",10,9
"3498","de","en","MicardisPlus ist eine Kombination der beiden Wirkstoffe Telmisartan und Hydrochlorothiazid in einer Tablette.","MicardisPlus is a combination of two active substances, telmisartan and hydrochlorothiazide in one tablet.",14,13
"3499","de","en","Michael RUTTER Herr John O'BRIEN","Jan LUTHMAN United Kingdom Dr Michael RUTTER Mr John O'BRIEN",10,5
"3500","de","en","Midazolam wird in großem Umfang über CYP3A4 metabolisiert.","Midazolam is extensively metabolized by CYP3A4.",6,8
"3501","de","en","Mikrogramm (Placebo) n=124 (n=123)","250 microgram (Placebo) n=124 (n=123)",5,4
"3502","de","en","Mikrokristalline Cellulose Crospovidon Hypromellose Magnesiumstearat hochdisperses Siliciumdioxid","Cellulose microcrystalline Crospovidone Hypromellose Magnesium stearate Silica, colloidal anhydrous",9,7
"3503","de","en","Mikrokristalline Cellulose Hydriertes pflanzliches Öl Natriumdodecylsulfat","Microcrystalline cellulose Hydrogenated vegetable oil Sodium laurilsulfate.",7,6
"3504","de","en","Mikrosphären beeinträchtigen und den Effekt des Kontrastmittels herabsetzen könnte.","microspheres and loss of contrast effect.",6,9
"3505","de","en","MINDESTANGABEN AUF BLISTERPACKUNGEN ODER FOLIENSTREIFEN","111 MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS",9,5
"3506","de","en","Mindestens 61% der oralen Dosis werden innerhalb von 24 Stunden unverändert ausgeschieden.","At least 61% of the oral dose is eliminated unchanged within 24 hours.",13,12
"3507","de","en","Minervum 7061 NL-4817 ZK Breda Niederlande","Minervum 7061 NL-4817 ZK Breda The Netherlands",7,6
"3508","de","en","Minimum von Minimum von 10 1","minimum of minimum of 10 1",6,6
"3509","de","en","MIRAPEXIN 0,088 mg Tabletten Pramipexol","MIRAPEXIN 0.088 mg tablets Pramipexole",5,5
"3510","de","en","MIRCERA 250 µg/0,3 ml Injektionslösung Methoxy-Polyethylenglycol-Epoetin beta s.c./i.v.","MIRCERA 250 µg/0.3 ml injection methoxy polyethylene glycol-epoetin beta SC/IV",10,8
"3511","de","en","MIRCERA 60 Mikrogramm /0,3 ml Injektionslösung in einer Fertigspritze Methoxy-Polyethylenglycol-Epoetin beta","MIRCERA 60 micrograms/0.3 ml solution for injection in pre-filled syringe methoxy polyethylene glycol-epoetin beta",14,11
"3512","de","en","MIRCERA stimuliert die Erythropoese durch Interaktion mit dem Erythropoietin-Rezeptor auf den Vorläuferzellen im Knochenmark.","MIRCERA stimulates erythropoiesis by interaction with the erythropoietin receptor on progenitor cells in the bone marrow.",16,14
"3513","de","en","Mischen Sie dann das Pulver mit etwa einem halben Glas (100 ml) Wasser und trinken Sie es sofort.","Then mix the powder in about half a glass (100 ml) of water and drink immediately.",16,18
"3514","de","en","Mischen Sie die Lösung nicht mit anderen injizierbaren Arzneimitteln.","Do not mix the solution with other injectable medicines.",9,9
"3515","de","en","Mischen Sie Insulin mit keinem anderen Arzneimittel.","Do not mix insulin with any other medicines.",8,7
"3516","de","en","Mit Ausnahme zur Behandlung infantiler Spasmen darf < HANDELSNAME > nicht zur Monotherapie eingesetzt werden.","Except for the treatment of infantile spasms ,< TRADENAME > should not be initiated as monotherapy.",16,15
"3517","de","en","Mit dem wachsendem Arbeitsumfang wird es notwendig sein, 1997 die Bearbeitung von Änderungsanträgen zu überprüfen.","With the increasing workload it will be necessary to review the processing of variation applications in 1997.",17,15
"3518","de","en","Mit der beabsichtigten Erhaltungsdosis sollte ohne Initialdosis begonnen werden.","The intended maintenance dose should be started with no loading dose.",11,9
"3519","de","en","Mit der in Competact enthaltenen Kombination an Stoffen wurden keine tierexperimentellen Studien durchgeführt.","No animal studies have been conducted with the combined products in Competact.",12,13
"3520","de","en","Mit der Wirkstoffkombination in Zomarist wurden tierexperimentelle Studien mit einer Dauer von bis zu 13 Wochen durchgeführt.","Animal studies of up to 13-week duration have been conducted with the combined substances in Zomarist.",16,17
"3521","de","en","Mit Fuzeon ist keine Heilung der HIV-Infektion zu erzielen.","Fuzeon is not a cure for HIV infection.",8,9
"3522","de","en","Mit Olanzapinpamoat 1 H2O wurden präklinische Sicherheitsstudien durchgeführt.","Preclinical safety studies were performed using olanzapine pamoate monohydrate.",9,8
"3523","de","en","Mit SoloStar kann die Dosis in 1er-Schritten von 1 bis 80 Einheiten eingestellt werden.","SoloStar delivers insulin in doses from 1 to 80 units in steps of 1 unit.",15,14
"3524","de","en","Mit zunehmender Erfahrung werden Sie den für Sie angenehmsten Winkel finden.","With experience, you will find the angle that is most comfortable for you.",13,11
"3525","de","en","Mittlere relative Veränderungen vom Ausgangswert in% (95% Konfidenzintervall)","from baseline% [95% CI]",4,8
"3526","de","en","Mittlere Veränderung nach 24 Wochen ± SD Adjustierter Behandlungs-","Mean baseline ± SD Mean change at 24 weeks ± SD Adjusted treatment",13,9
"3527","de","en","MIXTARD 10 MIXTARD 20 MIXTARD 30 MIXTARD 40 MIXTARD 50","MIXTARD 10 MIXTARD 20 MIXTARD 30 MIXTARD 40 MIXTARD 50",10,10
"3528","de","en","Mixtard 30 FlexPen 100 I.E./ml Injektionssuspension in einem Fertigpen Insulin human (r-DNS)","Mixtard 30 FlexPen 100 IU/ ml suspension for injection in a pre-filled pen Insulin human (rDNA)",16,12
"3529","de","en","Mixtard 40 Penfill 100 I.E./ml Injektionssuspension in einer Patrone.","Mixtard 40 Penfill 100 IU/ ml suspension for injection in a cartridge.",12,9
"3530","de","en","MO DI MI DO FR SA SO","MON TUE WED THU FRI SAT SUN",7,7
"3531","de","en","Mögliche oder wahrscheinliche Nebenwirkungen von Cidofovir aus klinischen Studien und von Meldungen nach der Markteinführung","Adverse reactions possibly or probably related to cidofovir based on clinical trial experience and post-marketing surveillance",16,15
"3532","de","en","Möglicherweise entscheidet Ihr Arzt, dass es zweckmäßiger für Sie ist, wenn Sie sich Kineret selbst spritzen.","Your doctor may decide that it would be m ore convenient for you to inject Kineret yourself.",17,16
"3533","de","en","Möglicherweise kann eine zusätzliche Behandlung erforderlich werden, wie z.B. die Einnahme eines Antiallergikums oder von Paracetamol.","You may require additional treatment such as an antihistamine or paracetamol.",11,16
"3534","de","en","Möglicherweise müssen Ihre Insulindosis, der Zeitpunkt der Anwendung, Ihre Ernährung oder Ihre körperliche Bewegung angepasst werden.","The amount or timing of insulin, food or exercise may need to be adjusted.",14,16
"3535","de","en","Möglicherweise müssen sie die Einnahme von alli beenden.","It may be necessary to discontinue treatment.",7,8
"3536","de","en","Möglicherweise ordnet Ihr Arzt während Ihrer Behandlung auch Blutuntersuchungen zur Überwachung Ihrer Nieren an.","Your doctor may also order blood tests during treatment to monitor your kidneys.",13,14
"3537","de","en","Möglicherweise sind nicht alle Packungsgrößen in Ihrem Land erhältlich.","Not all pack sizes may be marketed",7,9
"3538","de","en","Möglicherweise sind nur ein paar Anwendungen von ABILIFY Injektionslösung notwendig.","Only a few doses of ABILIFY solution for injection may be needed.",12,10
"3539","de","en","Mometasonfuroat ist ein Kortikosteroid mit starker topischer, aber geringer systemischer Wirkung.","Mometasone furoate is a corticosteroid with high topical potency but little systemic effect.",13,11
"3540","de","en","Monat * SRH-Bereich ≥ 25 mm² ** MN-Titer ≥ 20","Seroneutralisation rate** Month 6 * SRH area > 25 mm² ** MN titre > 20",15,10
"3541","de","en","Monotard insulin human, rDNA Part A","• Monotard • insulin human, rDNA • Part A",9,6
"3542","de","en","Montevideo utca 3/B H-1037 Budapest, Tel: +36 1 4369980","Montevideo utca 3/B H-1037 Budapest Tel: +36 1 4369980",9,9
"3543","de","en","Mosquito Way Hatfield Hertfordshire AL10 9SN RENJU UNIT Tel: +44 (0)020 8600 1400","Mosquito Way Hatfield Hertfordshire AL10 9SN RENJU UNIT Tel: +44 (0)20 8600 1400",13,13
"3544","de","en","Moxidectin, 23-(O-methyloxim)-F28249-alfa, ist ein makrozyklisches Lakton der zweiten Generation aus der Gruppe der Milbemycine.","Moxidectin, 23-(O-methyloxime)-F28249 alpha is a second-generation macrocyclic lactone of the milbemycin family.",12,14
"3545","de","en","Moxifloxacin bei Patienten mit ZNS-Erkrankungen, die zu Krampfanfällen prädisponieren oder bei denen die Krampfschwelle herabgesetzt ist.","disorders which may predispose to seizures or lower the seizure threshold.",11,16
"3546","de","en","Mr Merrick, Hedrich Blessing)","Mr Merrick, Hedrich Blessing)",4,4
"3547","de","en","MSD Magyarország Kft, Tel.: + 36.1.888.5300 Malta:","MSD Magyarország Kft, Tel.: + 36.1.888.5300 Malta:",7,7
"3548","de","en","Müdigkeit Brustschmerzen, Schwäche, Schüttelfrost, Unwohlsein, Fieber Asthenie, Schmerzen, grippeähnliches Syndrom","Fatigue Chest pain, weakness, chills, malaise, fever Asthenia, pain, flu-like syndrome",11,10
"3549","de","en","Mukositis Mittelschwere bis schwere Mukositis tritt bei den empfohlenen Paxene-Dosen und dem empfohlenen Therapieplan gelegentlich auf.","Moderate to severe mucositis is uncommon with the recommended dose and schedule of Paxene.",14,16
"3550","de","en","multiplem Myelom, die nicht vorbehandelt sind, und die nicht für eine Hochdosis-Chemotherapie mit Knochenmarktransplantation geeignet sind","have not been previously treated for multiple myeloma and are unsuitable for high-dose chemotherapy with bone marrow transplant.",18,16
"3551","de","en","Muskulo- skeletale Schmerzen Muskelsteifig- keit Muskel- krämpfe","Musculo- skeletal pain Muscle tightness Muscle spasm",7,7
"3552","de","en","Myalgie, Arthralgie, Skelettmuskelschmerzen Arthritis","Myalgia, arthralgia, musculoskeletal pain",4,4
"3553","de","en","Mycamine ist indiziert bei:","Mycamine is indicated for:",4,4
"3554","de","en","Mycophenolatmofetil Teva 500 mg Filmtabletten Mycophenolatmofetil","Mycophenolate mofetil Teva 500mg film-coated tablets Mycophenolate mofetil",8,6
"3555","de","en","Mylan BV Dieselweg 25, 3752 LB, Bunschoten Niederlande","Mylan BV Dieselweg 25, 3752 LB, Bunschoten The Netherlands",9,8
"3556","de","en","Myocet kann Schwindel verursachen.","Myocet has been reported to cause dizziness.",7,4
"3557","de","en","Myopathie, Rückenschmerzen, Muskel- /Skelettschmerzen, Myalgie","Myopathy, back pain, musculoskeletal pain, myalgia",6,5
"3558","de","en","n • eine verkürzte Gesamtüberlebenszeit und erhöhte Zahl an Todesfällen, zurückzuführen auf","au In controlled clinical studies, use of Nespo and other erythropoiesis-stimulating agents (ESAs) have shown:",15,12
"3559","de","en","n = 331 69%","n = 331 69%",4,4
"3560","de","en","n 1% Hydrokortison-Acetat auf Gesicht und Nacken §§ Höhere Werte = größere Verbesserung","hydrocortisone acetate on face and neck §§ higher values = greater improvement",12,13
"3561","de","en","n 6.4 Besondere Vorsichtsmaβ nahmen für die Aufbewahrung","6.4 Special precautions for storage",5,8
"3562","de","en","n Blisterpackung für die Packungsgrößen 30, 70 x 1 und 90 Filmtablette/n","d Blisters of the presentations of 30, 70 x 1 and 90 film-coated tablets",14,12
"3563","de","en","n Dynepo 5.000 IE/0,5 ml Injektionslösung in einer Fertigspritze","Dynepo 5,000 IU/ 0.5 ml solution for injection in a prefilled syringe Epoetin delta",14,9
"3564","de","en","n Nespo 15 µg","Nespo 15 µg Darbepoetin alfa IV/ SC",7,4
"3565","de","en","n Nespo 30 Mikrogramm Injektionslösung in einer Fertigspritze Darbepoetin alfa","Nespo 30 micrograms solution for injection in a pre-filled syringe Darbepoetin alfa",12,10
"3566","de","en","n Viraferon 25 Millionen I.E./2,5 ml Injektionslösung","ed Viraferon 25 million IU/ 2.5 ml solution for injection interferon alfa-2b",12,7
"3567","de","en","n Wirkung auf das Einstellen des Rauchens sowie auf Rückfälle im darauf folgenden Jahr gemessen.","ise of the studies) on smoking cessation, and on relapses in the following year.",14,15
"3568","de","en","N-Dealkylbuprenorphin ist ein (mü)-Opioid-Agonist mit einer schwachen intrinsischen Aktivität.","N-dealkylbuprenorphine is a μ (mu)-opioid agonist with weak intrinsic activity.",10,9
"3569","de","en","Nach 14-tägiger Behandlung hatten beide Medikamente bei etwa 92% der Patienten die Erkrankung erfolgreich geheilt oder gebessert.","After 14 days of treatment, both medicines had been successful in curing or improving about 92% of patients.",18,17
"3570","de","en","Nach 28 Tagen betrug die Mortalitätsrate in der Studie der Phase 3b 25,3%.","At 28 days, the mortality rate in the Phase 3b study was 25.3%.",13,13
"3571","de","en","Nach 48 Stunden wurde dieselbe Dosis noch einmal verabreicht.","The dosage was repeated 48 hours later.",7,9
"3572","de","en","Nach 5 Monaten sollte eine Wiederholungsimpfung erfolgen, danach jährliche Auffrischungsimpfungen.","This should be followed by revaccination 5 months later, and afterwards by yearly booster vaccinations.",15,10
"3573","de","en","Nach 6-monatiger Behandlung kann eine Dosisanpassung erforderlich sein (siehe Abschnitt 4.4).","A dose correction may be needed after six months of treatment (see section 4.4).",14,11
"3574","de","en","nach Abgave des Gutachtens der EMEA in der Beurteilungsphase","EMEA post-opinion phase Assessment phase",5,9
"3575","de","en","Nach Ablauf einer maximalen Lagerfrist von 9 Monaten bei Raumtemperatur ist das Produkt zu verwenden oder zu verwerfen.","After a maximum storage period of 9 months at room temperature, the product must be used or discarded.",18,18
"3576","de","en","Nach achtwöchiger Behandlung bei einmal wöchentlicher Anwendung kommt es zu keinem weiteren Serumkonzentrationsanstieg.","There is no further accumulation after 8 weeks of once weekly dosing.",12,13
"3577","de","en","Nach Anbruch der Durchstechflasche ist Atriance bis zu 8 Stunden bei bis zu 30°C haltbar.","Atriance is stable for up to 8 hours at up to 30ºC once the vial is opened.",17,15
"3578","de","en","Nach Anbruch kann eine Patrone bis zu 4 Wochen aufbewahrt werden.","Once in-use, cartridges may be kept for up to 4 weeks.",11,11
"3579","de","en","Nach Anbruch können Sie Ihren Humalog Mix50 Pen bis zu 28 Tage bei Raumtemperatur (unter 30°C) aufbewahren.","Keep your Humalog Mix50 Pen in use at room temperature (below 30°C) for up to 28 days.",17,17
"3580","de","en","Nach Anbruch können Sie Liprolog Mix25 bis zu 28 Tage bei Raumtemperatur (unter 30°C) aufbewahren.","Keep the product in use at room temperature (below 30°C) for up to 28 days.",15,15
"3581","de","en","Nach Anwendung der individuellen Korrekturformel lag kein Wert außerhalb der Grenzen.","When using the individual correction formulae, none of the values were out of the limit.",15,11
"3582","de","en","Nach Berücksichtigung aller zur Verfügung stehenden Daten nahm der CHMP am 23.","The list of product names concerned is given in Annex I.",11,12
"3583","de","en","Nach dem Aufziehen in die Injektionsspritze:","After withdrawl in the injection syringe:",6,6
"3584","de","en","Nach dem ersten Öffnen des Behältnisses:","After first opening the container:",5,6
"3585","de","en","Nach dem ersten Öffnen kann Rebetol Lösung zum Einnehmen 1 Monat lang verwendet werden.","Once the bottle has been opened, the oral solution can be used for 1 month.",15,14
"3586","de","en","Nach dem Öffnen innerhalb von 3 Monaten aufbrauchen.","When opened, use within 3 months.",6,8
"3587","de","en","Nach dem Sicherheitstest muss im Dosisfenster „ 0“ angezeigt werden.","The dose window must show “ 0” following the safety test.",11,10
"3588","de","en","Nach der Anwendung gründlich Hände waschen.","Wash hands thoroughly after use.",5,6
"3589","de","en","Nach der Anwendung Hände waschen.","Wash hands after use of the product.",7,5
"3590","de","en","Nach der Anwendung sind der vorgefüllte PegIntron-Injektor sowie etwaige nicht verwendete Lösung zu verwerfen.","After administering the dose, discard the PegIntron pre-filled pen and any unused solution contained in it.",16,14
"3591","de","en","Nach der Markteinführung sind bei schwangeren Frauen, die mit Herceptin behandelt wurden, Fälle von Oligohydramnie berichtet worden.","In the postmarketing setting, cases of oligohydramnios have been reported in pregnant women receiving Herceptin.",15,17
"3592","de","en","Nach der Rekonstitution enthält jeder ml der Suspension 5 mg Paclitaxel.","After reconstitution, each ml of suspension contains 5 mg of paclitaxel.",11,11
"3593","de","en","Nach der Rekonstitution enthalten 0,5 ml entnehmbares Volumen der Injektionslösung 250 Mikrogramm Romiplostim (500 Mikrogramm/ml).","After reconstitution, a deliverable volume of 0.5 ml solution contains 250 micrograms of romiplostim (500 micrograms/ ml).",17,15
"3594","de","en","Nach der Rekonstitution ist STAMARIL eine beige bis rosa-beige Injektionssuspension.","After reconstitution STAMARIL is a beige to pink beige suspension for injection.",12,10
"3595","de","en","Nach der Verabreichung von Dexmedetomidin können eine verminderte- Herzfrequenz und ein temporärer AV-Block beobachtet werden.","Reduced heart rate and temporary AV-block can be seen after administration of dexmedetomidine.",13,15
"3596","de","en","Nach der Verdünnung (siehe Abschnitt 6.6) enthält die Infusionslösung etwa 2,6 mg/ml Natalizumab.","When diluted (see section 6.6), the solution for infusion contains approximately 2.6 mg/ ml of natalizumab.",16,13
"3597","de","en","Nach der zweiten Impfung traten im Vergleich zur ersten Applikation weniger Reaktionen auf.","There were fewer reactions after the second vaccination compared with the first.",12,13
"3598","de","en","Nach einem Jahr Behandlung wurde ebenfalls eine Verbesserung der Leberfunktion beobachtet.","Improvement in liver function was also seen after one year of therapy",12,11
"3599","de","en","Nach einem Jahr hatten alle Patienten, die ZIMULTI erhielten, mehr Gewicht verloren als die Patienten,","After one year, all patients who received ZIMULTI lost more weight than those who received placebo:",16,15
"3600","de","en","Nach einem Untersuchungsgang verbleibendes Gadograf ist zu verwerfen.","Contrast medium not used in one examination must be discarded.",10,8
"3601","de","en","Nach einer Überdosierung birgt die Exposition gegenüber dem Umgebungslicht ein erhöhtes Risiko für das Auftreten von Photosensitivitäts-Reaktionen.","Exposure to ambient light after overdose carries an increased risk of photosensitivity reactions.",13,17
"3602","de","en","Nach einer vollständigen Grundimmunisierung sollte eine Auffrischimpfung vorzugsweise vor","After the completion of the primary series, a booster should be administered preferably before the",15,9
"3603","de","en","Nach einjähriger Therapie fanden sich folgende Ergebnisse:","One year of therapy, showed the following results:",8,7
"3604","de","en","Nach Einnahme der Tabletten sollte noch mindestens 30 Minuten nüchtern geblieben werden.","Fasting should be continued for at least 30 minutes after taking the tablet.",13,12
"3605","de","en","Nach Entfernen des Pflasters nehmen die T estosteron-Serumspiegel schnell ab (siehe Abschnitt 5.2).","Removal of the patch results in a rapid decrease in serum testosterone levels (see section 5.2).",16,13
"3606","de","en","Nach Entnahme aus der Verpackung sollte Foscan unverzüglich angewendet werden.","Once removed from its packaging it should be administered immediately.",10,10
"3607","de","en","Nach Ergebnissen aus In-vitro-Studien hemmt Gemfibrozil die Atorvastatin-Glucuronidierung.","According to results of in vitro studies the metabolic pathway of atorvastatin via glucuronidation is inhibited by Gemfibrozil.",18,8
"3608","de","en","Nach HBeAg-Serokonversion blieben serologisches Ansprechen und klinische Remission nach Absetzen von Lamivudin im Allgemeinen erhalten.","Following HBeAg seroconversion, serologic response and clinical remission are generally durable after stopping lamivudine.",14,15
"3609","de","en","Nach intravenöser Infusion des aktiven Metaboliten beträgt das mittlere Verteilungsvolumen im Steady-State 169 l.","The mean steady-state volume of distribution following intravenous infusion of the active metabolite is 169 l.",16,14
"3610","de","en","Nach jedem Gebrauch das Dosierspray reinigen und die Verschlusskappe wieder aufsetzen.","The device should be cleaned after each use and the cap replaced.",12,11
"3611","de","en","Nach jeder Dosis- oder Behandlungsplananpassung ist der Hämoglobinwert wöchentlich bzw. alle zwei Wochen zu bestimmen.","After any dose or schedule adjustment the haemoglobin should be monitored every one or two weeks.",16,15
"3612","de","en","Nach Markteinführung wurden auch Fälle von Verlust des Bewusstseins, Verwirrtheit und geistigen Beeinträchtigungen berichtet.","There have also been post marketing reports of loss of consciousness, confusion and mental impairment.",15,14
"3613","de","en","Nach mehrfacher Gabe von 20 mg ein Mal täglich an Probanden im Nüchternzustand wurden maximale Plasmakonzentrationen","Following multiple once-daily doses of 20 mg",7,16
"3614","de","en","Nach Öffnen ist der Inhalt der Flasche innerhalb von 3 Monaten aufzubrauchen.","Once opened, the contents of the bottle should be used within 3 months.",13,12
"3615","de","en","Nach oraler Gabe wird Adefovirdipivoxil rasch in Adefovir umgewandelt.","Following oral administration, adefovir dipivoxil is rapidly converted to adefovir.",10,9
"3616","de","en","Nach oraler Verabreichung der Tabletten lag die terminale Halbwertszeit bei 1,2 Std.","After oral administration of the tablets, the terminal half-life in blood was 1.2 h.",14,12
"3617","de","en","Nach Rekonstitution enthält die Lösung 100 IE Follitropin beta pro ml.","After reconstitution, the solution contains 100 IU of follitropin beta per ml.",12,11
"3618","de","en","Nach Rekonstitution sollte der Impfstoff umgehend angewendet werden.","After reconstitution, the vaccine should be used immediately.",8,8
"3619","de","en","Nach Resuspension: gleichmäßig milchig weiße Suspension.","After re-suspension, milky white suspension.",5,6
"3620","de","en","Nach subkutaner Anwendung wird Fondaparinux vollständig und schnell resorbiert","After subcutaneous dosing, fondaparinux is completely and rapidly absorbed (absolute bioavailability",11,9
"3621","de","en","Nach subkutaner und intravenöser Anwendung war auch die Halbwertszeit bei erwachsenen und pädiatrischen Patienten mit chronischer Niereninsuffizienz ähnlich.","Half-life was also similar between adult and paediatric patients with CRF following both intravenous and subcutaneous administration.",17,18
"3622","de","en","Nach Tag 28 beginnt der nächste Zyklus.","After Day 28, the next cycle will begin.",8,7
"3623","de","en","Nach Verabreichung der Dosis den Injektor in einem geeigneten Behälter entsorgen.","After injection of the dose, discard the pen in an appropriate container.",12,11
"3624","de","en","Nach Verdünnung sollte das Arzneimittel sofort innerhalb von 24 Stunden verwendet werden.","After dilution, the product should be used immediately within 24 hours.",11,12
"3625","de","en","Nach Vermischen enthält eine Dosis (0,5 ml) 3,75 Mikrogramm Hämagglutinin des folgenden Influenzavirus-Stamms:","After mixing, one dose (0.5 ml) contains 3.75 micrograms of haemagglutinin from the following influenza virus strain:",17,13
"3626","de","en","Nachdem der Impfstoff vermischt wurde:","After the vaccine is mixed:",5,5
"3627","de","en","Nachfolgend sind Nebenwirkungen nach Systemorganklassen und absoluter Häufigkeit (alle berichteten Ereignisse) aufgelistet.","Adverse reactions are listed below, by system organ class and absolute frequency (all reported events).",15,12
"3628","de","en","Nadeln dürfen nicht wieder verwendet werden.","Needles must not be reused.",5,6
"3629","de","en","Naglazyme ist eine Infusionslösung (Tropf in eine Vene), die den Wirkstoff Galsulfase enthält.","It contains the active substance galsulfase.",6,13
"3630","de","en","NAME DES PHARMAZEUTISCHEN UNTERNEHMERS","NAME OF THE MARKETING AUTHORISATION HOLDER",6,4
"3631","de","en","Name und Anschrift der Hersteller der Wirkstoffe biologischen Ursprungs","Name and address of the manufacturers of the biological active substances",11,9
"3632","de","en","Name und Anschrift der Hersteller, die für die Chargenfreigabe im EWR verantwortlich sind","Name and address of the manufacturers responsible for batch release in the EEA",13,13
"3633","de","en","Name und Anschrift der Hersteller, die für die Chargenfreigabe verantwortlich sind","Name and address of the manufacturer responsible for batch release",10,11
"3634","de","en","Name und Anschrift der Herstellers, die für die Chargenfreigabe verantwortlich sind","Name and address of the manufacturers responsible for batch release",10,11
"3635","de","en","Name und Anschrift des für die Chargenfreigabe verantwortlichen Herstellers Laboratorios Hipra, S.A.","Name and address of the manufacturer responsible for batch release Laboratorios Hipra S. A.",14,12
"3636","de","en","Name und Anschrift des Herstellers des arzneilich wirksamen Bestandteils biologischen Ursprungs","Name and address of the manufacturer of the biological active substance",11,11
"3637","de","en","NAME UND ANSCHRIFT DES PHARAMZEUTISCHEN UNTERNEHMERS","NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER",8,6
"3638","de","en","Name und Anschrift des/der für die Chargenfreigabe verantwortlich(en) Hersteller(s)","Name and address of the manufacturer(s) responsible for batch release",10,9
"3639","de","en","Name und Anschrift des/der Hersteller(s) des (der) arzneilich wirksamen Bestandteils (Bestandteile) biologischen Ursprungs","Name and address of the manufacturer(s) of the biological active substance(s)",11,13
"3640","de","en","Nateglinid war nicht teratogen bei Ratten.","Nateglinide was not teratogenic in rats.",6,6
"3641","de","en","Natriumchlorid Chlorwasserstoffsäure (Spuren) Natriumacetat, Trihydrat Stickstoff","Sodium Chloride Hydrochloric Acid (Trace) Sodium Acetate, Trihydrate Nitrogen",9,6
"3642","de","en","Natriumchlorid und Wasser für Injektionszwecke.","0.9% sodium chloride solution",4,5
"3643","de","en","Natriumchlorid Wasser für Injektionszwecke","Sodium chloride Water for injections",5,4
"3644","de","en","Natriumchlorid, Salzsäure, Wasser für Injektionszwecke.","Excipients: sodium chloride, hydrochloric acid, water for injection.",8,5
"3645","de","en","Natriumchlorid, Schwefelsäure, Natriumhydroxid, Wasser für Injektionszwecke","Sodium chloride, sulphuric acid, sodium hydroxide, water for injections",9,6
"3646","de","en","Natriumdihydrogenphosphat Monohydrat, Dinatriumhydrogenphosphat Heptahydrat,","au Excipients: sodium phosphate monobasic monohydrate, sodium phosphate dibasic heptahydrate,",10,4
"3647","de","en","Natriumhydroxid 0.2 M, Natrium Chlorid, D-Sorbitol, gereinigtes Gelatin porciner Herkunft.","Sodium hydroxide 0.2 M, sodium chloride, D-Sorbitol, purified gelatin of porcine origin.",12,10
"3648","de","en","Natriumphenylbutyrat ist ein Prodrug und wird im Körper schnell zu Phenylacetat verstoffwechselt.","Sodium phenylbutyrate is a pro-drug and is rapidly metabolised to phenylacetate.",11,12
"3649","de","en","ND: nicht untersucht 1.Basierend auf einer Vergleichsstudie mit Atazanavir 400 mg einmal täglich.","Based on cross-study comparison to 400 mg atazanavir once daily alone.",11,13
"3650","de","en","Nebenschilddrüsenkarzinom und primärer Hyperparathyreoidismus","Parathyroid carcinoma and Primary Hyperparathyroidism",5,4
"3651","de","en","Nebenwirkungen ≥ 1 bis < 10% der Patienten","Uncommon adverse reactions ≥ 0.1 to < 1% of patients",10,8
"3652","de","en","Nebenwirkungen ≥ 10% der Patienten Alopezie; Nagelveränderungen (schwer:","Alopecia; Nail disorders (severe:",4,8
"3653","de","en","Nebenwirkungen auf, die nicht schon in kürzeren und/oder früheren Studien berichtet worden wären. ni","No adverse events previously unreported in shorter duration and/ or previous studies were observed in this long-term study.",18,14
"3654","de","en","Nebenwirkungen aus anderer klinischer Anwendung:","During other clinical experience:",4,5
"3655","de","en","Nebenwirkungen aus klinischen Studien mit Nelfinavir","Adverse reactions from clinical trials with nelfinavir",7,6
"3656","de","en","Nebenwirkungen bemerken, die nicht in dieser Gebrauchsinformation angegeben sind, informieren Sie bitte den Arzt Ihres Babys.","please tell your baby ’ s doctor.",7,16
"3657","de","en","Nebenwirkungen bemerken, die nicht in dieser Gebrauchsinformation angegeben sind, informieren Sie bitte Ihren Arzt oder Ihr Pflegepersonal.","please tell your doctor or nurse.",6,17
"3658","de","en","Nebenwirkungen mit Gemzar® können sein:","Side effects with Gemzar may include:",6,5
"3659","de","en","Nebenwirkungen vom NCI-CTC Grad 3 - 5","Very Common and Common Adverse Drug Reactions",7,7
"3660","de","en","Nebenwirkungen, die die Haut betreffen","Side effects concerning the skin",5,5
"3661","de","en","Nebenwirkungen, die nach Markteinführung berichtet wurden:","Side effects that have been reported during marketed use include:",10,6
"3662","de","en","Nebenwirkungen, über die gelegentlich berichtet wurde (bei weniger als 1 von 100 Patienten)","219 Side effects reported uncommonly (in less than 1 patient in 100)",12,13
"3663","de","en","Nederland Abbott BV Siriusdreef 51 NL-2132 WT Hoofddorp","Nederland Abbott BV Siriusdreef 51 NL-2132 WT Hoofddorp",8,8
"3664","de","en","Nederland Abbott BV Siriusdreef 51 NL-2132 WT Hoofddorp Tel: + 31 (0) 888 222 688","Siriusdreef 51 NL-2132 WT Hoofddorp Tel: + 31 (0) 888 222 688",12,15
"3665","de","en","Nederland Genzyme Europe BV, Tel: +31 35 6991200","Nederland Genzyme Europe BV, Tel: +31 35 699 1200",9,8
"3666","de","en","Nederland Maarssenbroeksedijk 4 NL-3542 DN Utrecht","Nederland Maarssenbroeksedijk 4 NL-3542 DN Utrecht",6,6
"3667","de","en","Nederland Novartis Pharma B.V.","Nederland Novartis Pharma B.V.",4,4
"3668","de","en","Nederland ratiopharm Nederland bv Tel: +31 75 653 00 00","Nederland ratiopharm Nederland bv Tel: +31 75 653 00 00",10,10
"3669","de","en","Nederland Takeda Global Research and Development Centre (Europe) Ltd., Verenigd Koninkrijk Tel: + 44 (0)203 116 8000","Nederland Takeda Global Research and Development Centre (Europe) Ltd., Verenigd Koninkrijk Tel: + 44 (0)203 116 8000",17,17
"3670","de","en","Nehmen Sie {HANDELSNAME} 80 mg immer genau nach Anweisung Ihres Arztes ein.","Always take {PRODUCT NAME} 80 mg exactly as your doctor has told you.",13,12
"3671","de","en","Nehmen Sie bitte immer 52 ml Wasser, unabhängig von der Ihnen verschriebenen Dosis.","You should always use 52 ml of water, irrespective of the recommended dose you are taking.",16,13
"3672","de","en","Nehmen Sie CellCept immer genau nach Anweisung des Arztes ein.","Always take CellCept exactly as your doctor has told you.",10,10
"3673","de","en","Nehmen Sie den Strohhalm und einen Atembeutel mit der Aufschrift ""Probenzeit:","The straw and one breath bag labelled “sampling time:",9,11
"3674","de","en","Nehmen Sie die Tablette im Ganzen mit etwas Wasser ein.","Swallow it whole with some water.",6,10
"3675","de","en","Nehmen Sie die Tabletten unzerkaut mit einem Glas Wasser ein. ich","Swallow the tablets whole with a glass of water.",9,11
"3676","de","en","Nehmen Sie die verordnete Dosis nicht zweimal an einem Tag.","Do not take two doses in one day.",8,10
"3677","de","en","Nehmen Sie die Verschlusskappe ab (wie durch den Pfeil gezeigt wird).","Take off the pen cap (as shown by the arrow).",10,11
"3678","de","en","Nehmen Sie die Verschlusskappe ab.","Take off the pen cap.",5,5
"3679","de","en","Nehmen Sie Emselex immer genau nach Anweisung des Arztes ein.","Always take Emselex exactly as your doctor has told you.",10,10
"3680","de","en","Nehmen Sie Glivec täglich ein, bis Ihr Arzt Ihnen die Beendigung der Behandlung empfiehlt.","How long to take Glivec Take Glivec daily until your doctor tells you to stop.",15,14
"3681","de","en","Nehmen Sie Ihre erste Dosis morgens ein.","Take your first dose in the morning.",7,7
"3682","de","en","Nehmen Sie Ihre Packung Zarzio aus dem Kühlschrank.","Take your Zarzio pack out of the refrigerator.",8,8
"3683","de","en","Nehmen Sie INVEGA immer genau nach Anweisung des Arztes ein.","Always take INVEGA exactly as your doctor has told you.",10,10
"3684","de","en","Nehmen Sie keinerlei Arzneimittel zur Behandlung des Durchfalls ein, ohne dies zuvor mit Ihrem Arzt abzusprechen.","Do not take any medicine to treat diarrhoea without first checking with your doctor.",14,16
"3685","de","en","Nehmen Sie Levitra immer genau nach Anweisung des Arztes ein.","Always take Levitra exactly as your doctor has told you.",10,10
"3686","de","en","Nehmen Sie nach Möglichkeit die Packung des Arzneimittels und diese Gebrauchsinformation mit.","If possible, take the medicine pack and this leaflet with you.",11,12
"3687","de","en","Nehmen Sie nicht die doppelte Dosis ein, um die vergessene Einnahme der Tablette nachzuholen.","Do not take a double dose to make up for the forgotten individual doses.",14,14
"3688","de","en","Nehmen Sie nicht die doppelte Dosis ein, wenn Sie die vorherige Einnahme vergessen haben.","Do not take a double dose to make up for a forgotten capsule.",13,14
"3689","de","en","Nehmen Sie nicht mehr als die empfohlene Dosis ein.","Do not take more than the recommended dose.",8,9
"3690","de","en","Nehmen Sie OSSEOR immer genau nach Anweisung des Arztes ein.","Always take OSSEOR exactly as your doctor has told you.",10,10
"3691","de","en","Nehmen Sie Remeron immer genau nach Anweisung Ihres Arztes oder Apothekers ein.","87 Always take Remeron exactly as your doctor or pharmacist tells you to.",13,12
"3692","de","en","Nehmen Sie Revlimid und Dexamethason immer genau nach Anweisung des Arztes ein.","Always take Revlimid and dexamethasone exactly as your doctor has told you.",12,12
"3693","de","en","Nehmen Sie Thalidomide Celgene immer genau nach Anweisung des Arztes ein.","Always take Thalidomide Celgene exactly as your doctor has told you to.",12,11
"3694","de","en","Nehmen Sie Vivanza nicht häufiger als einmal am Tag ein.","53 Tell the doctor if you think Vivanza is too strong or too weak.",14,10
"3695","de","en","Nehmen Sie Zavesca immer genau nach Anweisung des Arztes ein.","Always take Zavesca exactly as your doctor has told you.",10,10
"3696","de","en","Nekrose an der Injektionsstelle*","27 System Organ Class",4,4
"3697","de","en","Nelfinavir: siehe Empfehlungen unter „ gleichzeitige Einnahme von Kaletra Tabletten und Efavirenz“.","Nelfinavir: see recommendations described for Kaletra tablets co-administration with efavirenz.",10,12
"3698","de","en","Neoclarityn 5 mg Lyophilisat zum Einnehmen Desloratadin","Neoclarityn 5 mg oral lyophilisate desloratadine",6,7
"3699","de","en","Neoclarityn Schmelztablette ist ein antiallergisches Arzneimittel, welches Sie nicht schläfrig macht.","Neoclarityn orodispersible tablet is an antiallergy medicine that does not make you drowsy.",13,11
"3700","de","en","NeoRecormon in Patronen soll nur mit dem Reco-Pen verabreicht werden.","NeoRecormon cartridge should only be used with Reco-Pen.",8,10
"3701","de","en","Nespo 10 Mikrogramm Injektionslösung in einer Fertigspritze.","Nespo 10 micrograms solution for injection in a pre-filled syringe.",10,7
"3702","de","en","Nespo 50 Mikrogramm Injektionslösung in einem vorgefüllten Injektor.","Nespo 50 micrograms solution for injection in a pre-filled pen.",10,8
"3703","de","en","Nespo 80 Mikrogramm Injektionslösung in einem vorgefüllten Injektor","Nespo 80 micrograms solution for injection in a pre-filled pen Darbepoetin alfa",12,8
"3704","de","en","Neugeborene weisen eine verringerte MetHb-Reduktaseaktivität auf und könnten daher einem größeren Methämoglobinämierisiko ausgesetzt sein.","Neonates have diminished MetHb reductase activity and could therefore be at greater risk of developing methaemoglobinaemia.",16,14
"3705","de","en","Neulasta, das länger als 72 Stunden bei Raumtemperatur gelagert wurde, muss verworfen werden.","Neulasta left at room temperature for more than 72 hours should be discarded.",13,13
"3706","de","en","Neupopeg, das länger als 72 Stunden bei Raumtemperatur gelagert wurde, ei","Neupopeg left at room temperature for more than 72 hours should be discarded.",13,11
"3707","de","en","Neupro 4 mg/24 h transdermales Pflaster Rotigotin","Neupro 4 mg/24 h transdermal patch Rotigotine",7,7
"3708","de","en","Neupro ist in folgenden Packungsgrößen erhältlich:","Neupro is available in the following pack-sizes:",7,6
"3709","de","en","Neupro könnte dazu führen, dass Sie sich extrem schläfrig fühlen und dass Sie ganz plötzlich einschlafen.","173 Neupro may make you feel very drowsy, and you may fall asleep very suddenly.",15,16
"3710","de","en","NeuroBloc 5000 E/ml Injektionslösung Clostridium botulinum Toxin Typ B","NeuroBloc 5000 U/ ml Solution for injection Botulinum Toxin Type B",11,9
"3711","de","en","Neutropenie / Agranulozytose / Thrombozytopenie / Anämie:","13  EMEA 2005 Neutropenia/ Agranulocytosis/ Thrombocytopenia/ Anaemia:",8,7
"3712","de","en","Neutropenie / Agranulozytose Bei Patienten, die ACE-Hemmer erhielten, ist über Neutropenie/Agranulozytose, Thrombozytopenie und Anämie berichtet worden.","Neutropenia/ Agranulocytosis Neutropenia/ Agranulocytosis, thrombocytopenia and anaemia have been reported in patients receiving ACE inhibitors.",15,16
"3713","de","en","NEVANAC war hinsichtlich der Reduzierung der Entzündungsanzeichen wirksamer als Placebo und genauso wirksam wie Ketorolac.","NEVANAC was more effective than placebo and as effective as ketorolac in reducing signs of inflammation.",16,15
"3714","de","en","Nexavar könnte die Wundheilung","Nexavar might affect the",4,4
"3715","de","en","Nicht angebrochene Durchstechflaschen Im Kühlschrank lagern (2 °C – 8 °C).","Unopened vials Store in a refrigerator (2°C - 8°C).",9,11
"3716","de","en","Nicht anwenden bei bekannter Resistenz gegenüber Amoxicillin.","Do not use in case of known resistance to amoxicillin.",10,7
"3717","de","en","Nicht anwenden bei bekannter Überempfindlichkeit gegenüber dem Wirkstoff oder einem der sonstigen Bestandteile.","Do not use in case of hypersensitivity to the active substance or to any of the excipients.",17,13
"3718","de","en","Nicht anwenden bei Hunden mit großflächigen Läsionen.","9/ 15 Do not use in dogs with extensive lesions.",10,7
"3719","de","en","Nicht anwenden bei Hunden mit Neutropenie, definiert als absolute Neutrophilenzahl < 2000/µl.","Do not use in dogs with neutropenia defined as absolute neutrophil count < 2000 / mm3.",16,12
"3720","de","en","Nicht anwenden bei Hunden, die an Hypoadrenocorticismus, Hyperkaliämie oder Hyponatriämie leiden.","Do not use the product in dogs suffering from hypoadrenocorticism, hyperkalaemia or hyponatraemia.",13,11
"3721","de","en","Nicht anwenden bei Hunden, die jünger als 6 Wochen sind.","Do not use in dogs less than 6 weeks of age.",11,10
"3722","de","en","Nicht anwenden bei Tieren mit einem geschädigten hämatopoetischen System.","Do not use in animals with impaired haematopoietic systems.",9,9
"3723","de","en","Nicht anwenden bei trächtigen oder laktierenden Tieren.","Do not use in pregnant or lactating animals.",8,7
"3724","de","en","Nicht anwenden bei Zuchtrüden.","Do not use in male breeding dogs.",7,4
"3725","de","en","Nicht bekannt Allgemeine Erkrankungen und Beschwerden am Verabreichungsort","Not known General disorders and administration site Uncommon Investigations",9,8
"3726","de","en","Nicht bekannt* Infektion der Injektionsstelle, einschließlich Cellulitis","*Not known Injection site infections, including cellulitis",7,7
"3727","de","en","Nicht direkt in eine Vene spritzen.","Do not inject directly into a vein.",7,6
"3728","de","en","Nicht einfrieren, um eine Beschädigung der Lösungsmittel-Fertigspritze zu vermeiden.","Do not freeze, in order to prevent damage to the pre-filled solvent syringe.",13,9
"3729","de","en","Nicht im Kühlschrank lagern oder einfrieren.","Do not refrigerate or freeze.",5,6
"3730","de","en","Nicht intramuskulär injizieren. ich","Do not administer intramuscularly. lo There is limited experience from treatment with fondaparinux in haemodynamically unstable patients no",18,4
"3731","de","en","Nicht mit einem anderen Impfstoff oder immunologischen Produkt mischen","nd Do not mix with any other vaccine or immunological product.",11,9
"3732","de","en","Nicht mit einem anderen Impfstoff oder immunologischen Produkt mischen.","Do not mix with any other vaccine or immunological product.",10,9
"3733","de","en","Nicht nukleosidische Reverse-Transkriptase-Inhibitoren (NNRTIs):","22 Non-nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs):",7,4
"3734","de","en","Nicht schütteln (Schütteln bewirkt Schaumbildung in der Raptiva-Lösung).","Do not shake (Shaking will cause foaming of the Raptiva solution).",11,8
"3735","de","en","NICHT SCHÜTTELN, UM SCHAUMBILDUNG ZU VERMEIDEN.","AVOID SHAKING TO PREVENT FOAM FORMATION.",6,6
"3736","de","en","Nicht über 25 °C lagern.","Do not store above 25°C",5,5
"3737","de","en","Nicht über 25° C lagern.","Do not store above 25°C.",5,5
"3738","de","en","Nicht über 25°C lagern.","Do not store above 25 °C 99 10.",8,4
"3739","de","en","Nicht über 30 °C lagern.","Do not store above 30 °C.",6,5
"3740","de","en","Nicht über 30°C lagern","26 Do not store above 30°C",6,4
"3741","de","en","Nicht über 30°C lagern.","Do not store above 30°C",5,4
"3742","de","en","Nicht über 30º C lagern.","Do not store above 30ºC.",5,5
"3743","de","en","Nicht über 30ºC lagern.","Do not store above 30°C.",5,4
"3744","de","en","Nicht unter 5 mg einmal täglich dosieren.","Do not dose below 5 mg once daily.",8,7
"3745","de","en","Nicht verbrauchte Lösung ist zu verwerfen.","Any unused solution should be discarded.",6,6
"3746","de","en","Nicht verbrauchtes Arzneimittel oder Abfallmaterial ist entsprechend den nationalen Anforderungen zu entsorgen.","7 Any unused product or waste material should be disposed of in accordance with local requirements.",16,12
"3747","de","en","Nicht verwendete Injektionslösung muss nach der Entnahme der Dosis verworfen werden. ln","s Any unused product must be discarded after withdrawal of the dose.",12,12
"3748","de","en","Nicht verwendete Suspension ist zu verwerfen.","Discard any unused portion.",4,6
"3749","de","en","Nicht verwendeter Impfstoff oder Abfallmaterial ist entsprechend den nationalen Anforderungen zu entsorgen.","Any unused product or waste material should be disposed of in accordance with local requirements.",15,12
"3750","de","en","Nicht verwendeter Impfstoff oder davon stammende Abfallmaterialien sind entsprechend den nationalen Anforderungen zu entsorgen.","Any unused vaccine or waste material should be disposed of in accordance with local requirements.",15,14
"3751","de","en","Nicht verwendetes Arzneimittel oder Abfallmaterial ist entsprechend den nationalen Anforderungen zu entsorgen.","117 Any unused product or waste material should be disposed of in accordance with local requirements.",16,12
"3752","de","en","Nicht vorhanden Vorhanden Nicht auswertbar RT-PCR für PML / RARα","Absent Present Not evaluable",4,10
"3753","de","en","Nicht zerbeißen, zerbrechen oder kauen.","Do not crush, break or chew.",6,5
"3754","de","en","Nicht zuletzt müssen wir uns auf die Erweiterung der Europäischen Union einstellen.","Last but not least, we have to absorb the accession of new members of the European Union.",17,12
"3755","de","en","Nicht zutreffend Nicht zutreffend","Not Applicable Not Applicable",4,4
"3756","de","en","Nichtauffinden und die Nichtentfernung von Gonazon haben keine ernsthaften Auswirkungen auf den Gesundheitsstatus der Hündin.","Inability to locate and remove Gonazon will not have serious effects on the general health of the dog.",18,15
"3757","de","en","Nichtsteroidale Antirheumatika oder Estrogene reduzieren die antihypertensive Wirkung von Doxazosin.","Non- steroidal antirheumatics or estrogens may reduce the antihypertensive effect of doxazosin.",12,10
"3758","de","en","Nicotinsäure Bei einer Überdosierung mit Nicotinsäure sollten supportive Maßnahmen ergriffen werden.","Nicotinic acid For an overdose of nicotinic acid, supportive measures should be employed.",13,11
"3759","de","en","Niedrigere Konzentrationen von Lopinavir/Ritonavir verursachten keine signifikante Blockade des (HERG-) Kaliumstroms.","Lower concentrations of lopinavir/ ritonavir did not produce significant potassium (HERG) current blockade.",13,11
"3760","de","en","Nierenfunktion und Kaliumgehalt des Serums sollten überwacht werden (siehe Abschnitt 4.4).","Renal function and serum potassium should be monitored (see section 4.4).",11,11
"3761","de","en","Nierenfunktionsstörungen (leicht, mittel und schwer) führten zu keiner signifikanten Veränderung der Pharmakokinetik von Nevirapin.","Renal impairment (mild, moderate and severe) resulted in no significant change in the pharmacokinetics of nevirapine.",16,14
"3762","de","en","Nifedipine Pharmamatch retard 30 mg Retardtabletten enthalten 30","Nifedipine Pharmamatch retard 30 mg, prolonged-release",6,8
"3763","de","en","Nilotinib ist in Studien zur Sicherheitspharmakologie, Toxizität bei wiederholter Gabe, Genotoxizität, Reproduktionstoxizität und Phototoxizität untersucht worden.","Nilotinib has been evaluated in safety pharmacology, repeated dose toxicity, genotoxicity, reproductive toxicity and phototoxicity studies.",16,16
"3764","de","en","Nitisinon zeigte embryofetale Toxizität bei Maus und Kaninchen unter klinisch relevanten Dosierungen.","Nitisinone has shown embryo-foetal toxicity in the mouse and rabbit at clinically relevant dose levels.",15,12
"3765","de","en","NL-2132 WT Hoofddorp Tel: + 31 (0) 23 5544400","Abbott BV Siriusdreef 51 NL-2132 WT Hoofddorp Tel: + 31 (0) 23 5544400",13,9
"3766","de","en","NNRTIs Delavirdin 400 mg TID (Indinavir 600 mg TID) Delavirdin 400 mg TID","NNRTIs Delavirdine 400 mg TID (Indinavir 600 mg TID)",9,13
"3767","de","en","NO5AX Tre atment of Schizophrenia","NO5AX Treatment of Schizophrenia",4,5
"3768","de","en","Nobilis Influenza H7N1 wurde unter „ außergewöhnlichen Umständen“ zugelassen.","Nobilis Influenza H7N1 has been authorised under “ Exceptional Circumstances”.",10,9
"3769","de","en","Noël WATHION Durchwahl (44-20) 74 18 85 92 E-Mail: noel.wathion@emea.eu.int","Noël WATHION Direct telephone (44-20) 74 18 85 92 E-mail: noel. wathion@emea. eu. int",14,10
"3770","de","en","Nonafact 100 IE/ml Pulver und Lösungsmittel zur Herstellung einer Injektionslösung.","Nonafact 100 IU/ ml powder and solvent for solution for injection.",11,10
"3771","de","en","Norbuprenorphi ↑ 2.05 ↑ 1.61 ↑ 2.01 n Der Interaktionsmechanismus ist CYP3A4 und UGT1A1Hemmung.","norbuprenorphine ↑ 2.05 ↑ 1.61 ↑ 2.01 The mechanism of interaction is CYP3A4 and UGT1A1 inhibition.",16,14
"3772","de","en","Norfloxacine Merck 400 mg","Norfloxacine Merck 400 mg",4,4
"3773","de","en","Norge Bayer AS Tlf:+47 24 11 18 00","Norge Bayer AS Tlf: +47 24 11 18 00",9,8
"3774","de","en","Norge GE Healthcare AS Nycoveien 1-2 NO-0401 Oslo Tlf: + 47 23 18 50 50","Norge GE Healthcare AS Nycoveien 1-2 NO-0401 Oslo Tlf: + 47 23 18 50 50",15,15
"3775","de","en","Norge Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Tyskland Tlf: +49 (0)69 1503 – 1","Norge Merz Pharmaceuticals GmbH Eckenheimer Landstraße 100 D-60318 Frankfurt Tyskland Tlf: +49 (0)69 1503 – 1",16,16
"3776","de","en","Norge Nycomed Pharma AS Drammensveien 852 NO-1372 Asker Tlf: +47 6676 3030","Norge Nycomed Pharma AS Drammensveien 852 NO-1372 Asker Tlf: +47 6676 3030",12,12
"3777","de","en","Norge Sandoz AS Jernbaneveien 4 N-1400 Ski Tlf: +47 64 91 30 00","Norge Sandoz AS Jernbaneveien 4 N-1400 Ski Tlf: + 47 64 91 30 00",14,13
"3778","de","en","Norge Teva Sweden AB Tlf: +46 42 12 11 00","Norge Teva Sweden AB Tlf: +46 42 12 11 00",10,10
"3779","de","en","Normalerweise ist eine Behandlungsdauer von 16 – 24 Wochen ausreichend, um eine Remission zu erreichen.","A treatment course of 16-24 weeks is normally sufficient to achieve remission.",12,15
"3780","de","en","Normalerweise ist hierzu eine Behandlungsdauer von 7 bis 14 Tagen ausreichend.","Usually, 7 to 14 days of treatment is sufficient to reach this state.",13,11
"3781","de","en","Normales Immunglobulin vom Menschen zur intravenösen Anwendung, ATC-Code:","Pharmacotherapeutic group: immune sera and immunoglobulins: immunoglobulins, normal human, for intravascular administration, ATC code:",14,8
"3782","de","en","Norvir ist ein Arzneimittel, das den Wirkstoff Ritonavir enthält.","Norvir is medicine containing the active substance ritonavir.",8,9
"3783","de","en","Note for guidance on co-ordinating investigator signature of clinical study reports","Note for guidance on co-ordinating investigator signature of clinical study reports",11,11
"3784","de","en","Novartis Animal Health d.o.o., Tel: + 386 1 580 2884","Novartis Animal Health d. o. o., Tel: + 386 1 580 2884",12,10
"3785","de","en","Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB Vereinigtes Königreich 8.","Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom",12,13
"3786","de","en","Novartis Healthcare A/S, Tel: +45-39 16 84 00","Novartis Healthcare A/ S, Tel: +45-39 16 84 00",9,8
"3787","de","en","Novartis Pharma GmbH Roonstraße 25 D-90429 Nürnberg Deutschland","Novartis Pharma GmbH Roonstraße 25 D-90429 Nürnberg Germany",8,8
"3788","de","en","Novartis Sante Animale S.A.S Usine de Huningue 26, rue de la Chapelle F-68330 Huningue Cedex France","Novartis Santé Animale S. A. S Usine de Huningue 26, rue de la Chapelle F-68332 Huningue Cedex France",18,16
"3789","de","en","Novartis Vaccines and Diagnostics S.r.l. - Via Fiorentina, 1 – Siena, Italien.","Novartis Vaccines and Diagnostics S. r. l. - Via Fiorentina, 1 – Siena, Italy.",14,12
"3790","de","en","November 2002 Datum der letzten Verlängerung der Zulassung:","12 November 2002 Date of last renewal:",7,8
"3791","de","en","November 2003 ein Gutachten ab mit der Empfehlung,","The list of product names concerned is given in the Annex I.",12,8
"3792","de","en","Novo mesto, Š marješ ka cesta 6, 8501 Novo mesto, Slowenien","Novo mesto, Š marješ ka cesta 6, 8501 Novo mesto, Slovenia",11,11
"3793","de","en","Novo Nordisk A/S Novo Allé DK-2880 Bagsværd Dänemark","Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd Denmark",9,8
"3794","de","en","Novo Nordisk A/S Novo Allé DK-2880-Bagsværd, Dänemark","Novo Nordisk A/ S Novo Allé DK-2880 Bagsværd, Denmark",9,7
"3795","de","en","NovoFine Injektionsnadeln sind zum Gebrauch mit NovoRapid NovoLet vorgesehen.","NovoFine needles are designed to be used with NovoRapid NovoLet.",10,9
"3796","de","en","NovoMix 30 kann diesen Bedarf ganz oder teilweise decken.","NovoMix 30 may fully or partially meet this requirement.",9,9
"3797","de","en","NovoMix 50 ist eine weiße Suspension.","NovoMix 50 is a white suspension.",6,6
"3798","de","en","NovoMix 70 FlexPen Verschlusskappe","NovoMix 70 FlexPen Pen cap",5,4
"3799","de","en","NovoMix wird subkutan (unter die Haut) in die Bauchdecke oder in den Oberschenkel gespritzt.","NovoMix is administered subcutaneously (under the skin) by injection in the abdominal wall (tummy), or the thigh.",17,14
"3800","de","en","NovoRapid FlexPen 100 E/ml Injektionslösung in einem Fertigpen Insulinaspart","NovoRapid FlexPen 100 U/ ml solution for injection in a pre-filled pen insulin aspart",14,9
"3801","de","en","NovoRapid InnoLet darf nicht wieder aufgefüllt werden.","Do not refill NovoRapid InnoLet.",5,7
"3802","de","en","NovoRapid Penfill darf nur von einer Person verwendet werden","NovoRapid Penfill is for use by one person only",9,9
"3803","de","en","NovoRapid wird daher schneller als lösliches Humaninsulin aus der Subkutanschicht resorbiert.","NovoRapid is therefore more rapidly absorbed from the subcutaneous layer compared to soluble human insulin.",15,11
"3804","de","en","NovoSeven 4,8 mg (240 kIE) Pulver und Lösungsmittel zur Herstellung einer Injektionslösung eptacog alfa (aktiviert)","NovoSeven 4.8 mg (240 KIU) Powder and solvent for solution for injection eptacog alfa (activated)",15,15
"3805","de","en","Noxafil 40 mg/ml Suspension zum Einnehmen Posaconazol","Noxafil 40 mg/ ml oral suspension posaconazole",7,7
"3806","de","en","Nplate sollte ein Mal pro Woche injiziert werden, um Ihre Blutplättchenzahl hoch zu halten.","Nplate should be injected once per week in order to keep your platelet counts up.",15,14
"3807","de","en","Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase, ATC-Code:","Nucleoside and nucleotide reverse transcriptase inhibitors, ATC code:",8,8
"3808","de","en","NUMMER(N) IM ARZNEIMITTELREGISTER DER EUROPÄISCHEN GEMEINSCHAFT","8 MARKETING AUTHORISATION NUMBER",4,6
"3809","de","en","Nur 12 der 492 Patienten mit Langzeitansprechen erlitten während dieser Studie einen Rückfall.","of long-term follow-up and only 12 sustained responders' out of 492 relapsed during this study.",15,13
"3810","de","en","Nur äußerlich auf gesunde Haut auftragen.","Apply only to the skin surface and on intact skin.",10,6
"3811","de","en","Nur gesunde Tiere impfen.","Only healthy animals should be vaccinated.",6,4
"3812","de","en","Nur nach Anweisung des Arztes anwenden.","Use only as directed by a doctor.",7,6
"3813","de","en","Nur zum einmaligen Gebrauch, vor der Anwendung verdünnen – Packungsbeilage beachten","Single use only, must be diluted – see leaflet",9,11
"3814","de","en","Nur zum einmaligen Gebrauch.","For single use only.",4,4
"3815","de","en","Nur zur äußerlichen Anwendung.","For external use only.",4,4
"3816","de","en","Nur zur einmaligen Anwendung.","For single-use only, any unused solution should be discarded.",9,4
"3817","de","en","Nur zur intravenösen Anwendung","For intravenous use only",4,4
"3818","de","en","NV AstraZeneca SA Egide Van Ophemstraat 110 B-1180 Brussel","NV AstraZeneca SA Egide Van Ophemstraat 110 B-1180 Brussel",9,9
"3819","de","en","o Anzeichen von Hautausschlag.","any signs of skin rash.",5,4
"3820","de","en","Ob Abatacept beim Menschen in die Muttermilch übergeht, ist nicht bekannt.","It is not known whether abatacept is excreted in human milk.",11,11
"3821","de","en","Obstipation, Bauchschmerzen, Flatulenz, Dyspepsie, Diarrhö, Übelkeit, Erbrechen, Pankreatitis","Rare: constipation, abdominal pain, flatulence, dyspepsia, diarrhoea, nausea, vomiting, pancreatitis",10,8
"3822","de","en","Obwohl die klinische Erfahrung darauf","SPC Section 4.3 Contraindications",4,5
"3823","de","en","Öffnen Sie den Folienbeutel an der vorgestanzten Kerbstelle und entnehmen Sie die sterile Injektionshilfe.","Open the foil pouch using the pre-cut incision to remove the sterile injection device.",14,14
"3824","de","en","Ohrinfektionen bei Hunden können durch Bakterien oder Pilze verursacht werden.","Ear infections in dogs can be caused by bacteria or fungi.",11,10
"3825","de","en","Ohrs und des Labyrinths","Hypertension Dyspnoea, Dysphonia, Cough, Rhinorrhoea, Throat tightness Salivary hypersecretion,,",9,4
"3826","de","en","OJ C 243, 31.08.2001, p.","• OJ C 243, 31.08.2001, p.",6,5
"3827","de","en","OJ No.C 226/6 of 25.07.97","OJ No.C 226/6 of 25.07.97",5,5
"3828","de","en","Oktober 2003 Datum der letzten Verlängerung:","24 October 2003 Date of last renewal:",7,6
"3829","de","en","Oktober 2007 in eine Entscheidung umgewandelt.","The final opinion was converted into a Decision by the European Commission on 24 October 2007.",16,6
"3830","de","en","OLANZAPIN MYLAN 2,5 mg Filmtabletten Olanzapin","Olanzapine Mylan 2.5 mg film-coated tablets Olanzapine",7,6
"3831","de","en","Olanzapin Neopharma 2,5 mg","Olanzapine Neopharma 2.5 mg",4,4
"3832","de","en","Olanzapin Teva 20 mg Schmelztabletten","Olanzapine Teva 20 mg orodispersible tablet",6,5
"3833","de","en","Olanzapin Teva Tabletten zerbrechen leicht, daher sollten Sie die Tabletten vorsichtig handhaben.","Olanzapine Teva tablets break easily, so you should handle the tablets carefully.",12,12
"3834","de","en","Olanzapinpamoat 1 H2O entsprechend 300 mg Olanzapin.","Olanzapine pamoate monohydrate equivalent to 300 mg olanzapine.",8,7
"3835","de","en","Omeprazol (CYP2C19-Hemmer; CYP2C19- und CYP3A4-Substrat):","Omeprazole (CYP2C19 inhibitor; CYP2C19 and CYP3A4 substrate):",7,5
"3836","de","en","Omnitrope 1,3 mg/ml ist nur zum einmaligen Gebrauch bestimmt.","Omnitrope 1.3 mg/ ml is for single use only.",9,9
"3837","de","en","Omnitrope wird mit einer kurzen Injektionsnadel in das Fettgewebe unter der Haut gespritzt.","Omnitrope is given through a short injection needle into the fatty tissue just under your skin.",16,13
"3838","de","en","Onsenal kann zusammen mit niedrig dosierter Acetylsalicylsäure (Aspirin) eingenommen werden.","Onsenal can be taken with low dose acetylsalicylic acid (aspirin).",10,10
"3839","de","en","Onsior 40 mg Tabletten für Hunde Robenacoxib","Onsior 40 mg tablets for dogs Robenacoxib",7,7
"3840","de","en","Opacode S-1-8115 schwarz Opacode S-1-8114 schwarz Kommentar:","10 aluminium lake Opacode Black S-1-8115 Opacode Black S-1-8114",9,7
"3841","de","en","OPATANOL darf nicht angewendet werden....","BEFORE YOU USE OPATANOL",4,5
"3842","de","en","Opletalova 55 CZ-110 00 Praha 1 Tel.: +420 225774111","Opletalova 55 CZ-110 00 Praha 1 Tel.: +420 225774111",9,9
"3843","de","en","OPRYMEA wird angewendet zur Behandlung der Symptome bei idiopathischer Parkinson-Krankheit.","Oprymea is used to treat the symptoms of primary Parkinson's disease.",11,10
"3844","de","en","Optikusneuropathie (NAION) hatten, diese Erkrankung wird manchmal auch als ""Schlaganfall des Auges"" beschrieben.","(NAION), a condition described as “ stroke of the eye”.",10,13
"3845","de","en","Optimark 500 Mikromol/ml Injektionslösung in einer Fertigspritze","Optimark 500 micromol/ ml solution for injection in a pre-filled syringe",11,7
"3846","de","en","Optimark ist bei diesen Patienten mit Vorsicht anzuwenden.","Optimark should be used in these patients with caution.",9,8
"3847","de","en","OptiSet ist beschädigt, verwenden Sie einen neuen OptiSet.","OptiSet is damaged, use a new OptiSet.",7,8
"3848","de","en","OptiSet muss vor Staub und Schmutz geschützt werden.","You can clean the outside of your OptiSet by wiping it with a damp cloth.",15,8
"3849","de","en","Optisulin 100 Einheiten/ml Injektionslösung in einer Durchstechflasche","Optisulin 100 Units/ ml solution for injection in a vial",10,7
"3850","de","en","Orale Kontrazeptiva können bei Patienten unter Emend an Wirksamkeit verlieren.","Oral contraceptives may become less effective in patients taking Emend.",10,10
"3851","de","en","Orange-weiße, runde Filmtabletten, auf denen auf einer Seite „62,5“ eingeprägt ist.","Orange-white, round film-coated tablets with “62,5” on one side.",9,11
"3852","de","en","Orfadin wird zur Behandlung der angeborenen Tyrosinämie Typ 1 (HT-1), einer seltenen Kinderkrankheit, angewendet.","Orfadin is used to treat hereditary tyrosinemia type 1 (HT-1), a rare childhood disease.",14,14
"3853","de","en","Organigramm des Sekretariats der EMEA","Organigram of the EMEA Secretariat",5,5
"3854","de","en","Organon Laboratories Ltd Cambridge Science Park Milton Road Cambridge CB4 0FL Vereinigtes Königreich","Organon Laboratories Ltd Cambridge Science Park Milton Road Cambridge CB4 0FL United Kingdom",13,13
"3855","de","en","Organon, Kloosterstraat 6, P.O.","Aacifar Produtos Químicos e Farmacêuticos, Lda Av.",7,4
"3856","de","en","Organon, Kloosterstraat 6, Postbus 20, 5340 BH Oss, Niederlande Organon (Ireland) Ltd., P.O.","Organon, Kloosterstraat 6, Postbus 20, 5340 BH Oss, The Netherlands • Organon (Ireland) Ltd., P. O.",16,13
"3857","de","en","Organspezifische Toxizität trat nicht auf.","No target organ toxicity was observed.",6,5
"3858","de","en","Orgasmusstöru ngen (bei der Frau), Harnverhaltung","Abnormal orgasm (females), Urinary retention",5,6
"3859","de","en","Orion Corporation Orionintie 1 FI-02200 Espoo Finnland","Orion Corporation Orionintie 1 FI-02200 Espoo Finland",7,7
"3860","de","en","Orphan Europe SARL, Immeuble „ Le Wilson“, F- 92058 Paris La Défense, Frankreich.","Orphan Europe SARL, Immeuble “ Le Wilson”, F-92058 Paris La Défense, France",12,13
"3861","de","en","Orthostatische Hypotonie kann verstärkt werden;","57 Alcohol: potentiation of orthostatic hypotension may occur;",8,5
"3862","de","en","örtlichen Behandlungsrichtlinien und den für die Definition einer komplizierten Infektion verwendeten diagnostischen Kriterien).","policy and diagnostic criteria used for defining complicated infection).",9,13
"3863","de","en","Oseltamivirphosphat verhindert eine Infektion mit dem Influenzavirus und dessen Replikation in vitro.","Oseltamivir phosphate inhibits influenza virus infection and replication in vitro.",10,12
"3864","de","en","OSSEOR wurde in zwei großen Studien bei fast 7 000 älteren Frauen nach den Wechseljahren untersucht.","OSSEOR has been studied in almost 7,000 postmenopausal elderly women in two large studies.",14,16
"3865","de","en","Osteonekrose des Kiefers steht üblicherweise im Zusammenhang mit einer Zahnextraktion und/oder einer lokalen Infektion (einschließlich Osteomyelitis).","Osteonecrosis of the jaw is generally associated with tooth extraction and / or local infection (including osteomyelitis).",17,16
"3866","de","en","Österreich Alcon Ophthalmika GmbH + 43 (0)1 596 69 70","Österreich Alcon Ophthalmika GmbH + 43 (0)1 596 69 70",10,10
"3867","de","en","Österreich Amgen GmbH Tel: +43 (0) 1 50 217","Amgen GmbH Tel: +43 (0) 1 50 217",8,9
"3868","de","en","Österreich Bayer Austria Ges.m.b.H.","Österreich Bayer Austria Ges. m. b. H.",7,4
"3869","de","en","Österreich Deutschland Spanien Frankreich Niederlande Vereinigtes Königreich","Spain France The Netherlands United Kingdom",6,7
"3870","de","en","Österreich ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64","Österreich ESTEVE GmbH Max-Planck-Strasse 11 D-85716 Unterschleissheim, Deutschland HRB München 99927 Tel: +49-89-321419-64",13,13
"3871","de","en","Österreich JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300","Österreich JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300",13,13
"3872","de","en","Österreich Servier Austria GmbH Tel: +43 (1) 524 39 99","Tel: +43 (1) 524 39 99",6,10
"3873","de","en","Österreich TAD Pharma GmbH Tel: + 49 (0) 4721 6060","TAD Pharma GmbH Tel: + 49 (0) 4721 6060",9,10
"3874","de","en","Ovitrelle 250 Mikrogramm/0,5 ml Injektionslösung in einer Fertigspritze.","Ovitrelle 250 micrograms/ 0.5 ml solution for injection in a pre-filled syringe.",12,8
"3875","de","en","Oxaliplatin am Tag 1, alle 2 Wochen Leucovorin am Tag 1 und 2, alle 2","Oxaliplatin on Day 1, every 2 weeks",7,15
"3876","de","en","Oxyglobin ist für die einmalige Anwendung vorgesehen.","Oxyglobin is intended for single administration.",6,7
"3877","de","en","P a s t e u r M e r ieux MSD F","Pasteur Merieux MSD F",4,13
"3878","de","en","p atients with a type I Gaucher disease","patients with a type I Gaucher disease",7,8
"3879","de","en","P-1000 – 266 Lisboa Tel: +351 21 849 3979","P-1000 – 266 Lisboa Tel.: +351 21 849 3979",9,9
"3880","de","en","Pabianickie Zakł ady Farmaceutyczne Polfa S.A., ul.Marszał ka J.","Pabianickie Zakł ady Farmaceutyczne Polfa S. A., ul. Marszał ka J.",11,9
"3881","de","en","Packung mit 10 Flaschen Suspension (je 25 Dosen) + 10 Flaschen Emulsion (je 25 Dosen).","10 vials of suspension (25 dose size) + 10 vials of emulsion (25 dose size)",15,15
"3882","de","en","PACKUNG MIT 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 SCHMELZTABLETTEN","BOX OF 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 ORODISPERSIBLE TABLETS",16,15
"3883","de","en","Packung zu 10 Durchstechflaschen","Box of 10 vials",4,4
"3884","de","en","Packungen mit 1 oder 6 Spritzen.","Pack of 1 or 6 syringes.",6,6
"3885","de","en","Packungen mit 2 Patronen.","Pack size of 2 cartridges.",5,4
"3886","de","en","Packungen mit 30 x 1 Filmtabletten in perforierten Aluminium Blister zur Abgabe von Einzeldosen..","Packs of 30 x 1 film-coated tablets in aluminium perforated unit dose blisters.",13,14
"3887","de","en","Packungen mit Flaschen zu 60, 75, 100, 125, 150 oder 200 ml Lösung zum Einnehmen.","Pack with a bottle of 10, 15, 20, or 30 ml solution.",12,15
"3888","de","en","Packungsbeilage beachten. er ng 4.","See leaflet for further information. lon 4.",7,5
"3889","de","en","Packungsgrößen mit 1 (Einzelpackung), 2, 3 oder 6 Durchstechflaschen (Bündelpackungen).","Pack sizes of 1 (single unit pack), 2, 3 or 6 vials (multi-packs).",13,10
"3890","de","en","Packungsgrößen zu 1, 3 und 10.","Pack sizes of 1, 3 and 10.",7,6
"3891","de","en","Packungsgrößen zu 28, 56 und 98 Hartkapseln.","Packs of 28, 56 and 98 capsules.",7,7
"3892","de","en","Paclitaxel 6 mg/ml (150 mg/25 ml)","Active ingredient: paclitaxel 6 mg/ml (100 mg/16.7 ml)",8,6
"3893","de","en","Paclitaxel Paclitaxel/Avastin (n = 354) (n = 368)","Paclitaxel/ Avastin Paclitaxel (n=368) (n=354)",5,8
"3894","de","en","Pädiatrische Patienten Über die Anwendung von Bonviva in diesen Altersgruppen liegen keine Daten vor.","Paediatric Population There are no data on the use of Bonviva in these age groups.",15,14
"3895","de","en","Paliperidon soll nicht bei Patienten mit einer Kreatinin-Clearance von weniger als 10 ml/min angewendet werden.","Paliperidone should not be used in patients with creatinine clearance below 10 ml/ min.",14,15
"3896","de","en","Pandemrix, Suspension zur Herstellung einer Emulsion zur Injektion Pandemischer Influenza-Impfstoff (H5N1)","Pandemrix suspension for emulsion for injection Pandemic influenza vaccine (H5N1)",10,11
"3897","de","en","Pankreatitis, Colitis ischaemica, Colitis ulcerosa, Zahnfleischbluten","Pancreatitis, ischaemic colitis, ulcerative colitis, gingival",6,6
"3898","de","en","Panzytopenie (möglicherweise aufgrund antiproliferativer Mechanismen), Leukopenie","Rare: pancytopenia (probably by antiproliferative mechanism), leucopenia (leucocytes < 2 G/ l), eosinophilia",13,6
"3899","de","en","Panzytopenie, Anämie (Grad 3-4), Leukopenie","Pancytopenia, anaemia (grade 3-4), leukopenia",5,5
"3900","de","en","Papillenödem (siehe Abschnitt 4.4), Störungen des Sehnervs (einschließlich optischer Neuritis, siehe Abschnitt 4.4), Nystagmus, Skleritis, Blepharitis","Papilloedema (see Section 4.4), optic nerve disorder (including optic neuritis, see Section 4.4), nystagmus, scleritis, blepharitis",16,16
"3901","de","en","Parareg 30 mg Filmtabletten Cinacalcet","Parareg 30 mg film-coated tablets Cinacalcet",6,5
"3902","de","en","Parästhesie; Kopfschmerzen; Dysgeusie; Hypoästhesie erhöhte Tränensekretion; Konjunktivitis","32%); Febrile neutropenia (includes neutropenia associated with fever and antibiotic use) or neutropenic sepsis",14,7
"3903","de","en","Parenterale Arzneimittel sind vor der Anwendung visuell auf Partikel und Verfärbungen zu überprüfen.","Parenteral medicinal products should be inspected visually for particulate matter and discolouration prior to administration.",15,13
"3904","de","en","Parenterale Arzneimittel sollten vor der Anwendung visuell auf Partikel und Verfärbungen überprüft werden.","53 Parenteral drug products should be inspected visually for particulate matter and discolouration prior to administration.",16,13
"3905","de","en","Parke Davis Lambert Court Chestnut Avenue Eastleigh, Hampshire SO53 3ZQ Vereinigtes Königreich","Lopid Parke Davis Lambert Court Chestnut Avenue Eastleigh, Hampshire SO53 3ZQ United Kingdom",13,12
"3906","de","en","Paroxat 20 mg – Filmtabletten","Paroxat 20 mg – Filmtabletten",5,5
"3907","de","en","Paroxetina Alpharma 20 mg Comprimidos","Paroxetina Alpharma 20 mg Comprimidos",5,5
"3908","de","en","Paroxetine Bexal 40 mg","Paroxetine Bexal 40 mg",4,4
"3909","de","en","Patienten ab 12 Jahren müssen den Inhalt eines Weithalsgefäßes mit 75 mg einnehmen.","Patients from the age of 12 must take the content of 1 jar with 75 mg.",16,13
"3910","de","en","Patienten mit anamnestisch bekannter Depression ist daher besondere Aufmerksamkeit zu widmen.","Abbott Scandinavia AB P. O. Box 509 16929 Solna, Sweden",10,11
"3911","de","en","Patienten mit der seltenen hereditären Fructose-Intoleranz dürfen Kinzalmono nicht einnehmen.","Patients with rare hereditary problems of fructose intolerance should not take Kinzalmono.",12,10
"3912","de","en","Patienten mit der seltenen hereditären Fructose-Intoleranz, Glucose-Galactose-Malabsorption oder Saccharase-Isomaltase- Mangel sollten VIRACEPT nicht einnehmen.","Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltese insufficiency should not take this medicine.",18,14
"3913","de","en","Patienten mit dieser Krankheit können sich außerdem depressiv, ängstlich oder angespannt fühlen.","People with this disease may also feel depressed, anxious or tense.",11,12
"3914","de","en","Patienten mit eingeschränkter Leberfunktion:","Patients with hepatic impairment:",4,4
"3915","de","en","Patienten mit eingeschränkter Nierenfunktion sollten diätetische Empfehlungen zur Reduktion der Natriumaufnahme in Betracht ziehen (siehe Abschnitt 4.4).","Patients with impaired renal function should consider a dietary recommendation to reduce sodium intake (see section 4.4).",17,17
"3916","de","en","Patienten mit Einschränkung der Leberfunktion Bei Patienten mit leichter oder mäßiger Einschränkung der Leberfunktion ist keine Dosisanpassung erforderlich.","Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment.",17,18
"3917","de","en","Patienten mit Hämophilie A können Antikörper (Inhibitoren) gegenüber Faktor VIII bilden.","Haemophilia A patients may develop antibodies (inhibitors) to factor VIII.",10,11
"3918","de","en","Patienten mit klinisch signifikantem Ansprechen (%)","Patients with clinically significant response (%)",6,6
"3919","de","en","Patienten mit Leber- oder Nierenfunktionsstörung","Patients with hepatic or renal impairment",6,5
"3920","de","en","Patienten mit myoklonischen Anfällen dürften dazu besonders neigen.","Patients with myoclonic seizures may be particularly CPMP/ 1357/ 99",10,8
"3921","de","en","Patienten mit Niereninsuffizienz können eine Hypokalzämie oder Hyperkalzämie entwickeln.","Patients with renal insufficiency may develop hypocalcaemia or hypercalcaemia.",9,9
"3922","de","en","Patienten mit Resistenzmutationen (%) Patientenpopulation Erwachsene und Jugendliche Kinder (1 – 12 Jahre)","No specific antidote is known.",5,13
"3923","de","en","Patienten mit schwerer Leberinsuffizienz wurden nicht untersucht (siehe Abschnitt 4.3).","Patients with severe liver impairment have not been studied (see section 4.3).",12,10
"3924","de","en","Patienten mit Tuberkulose oder anderen schweren Infektionen wie Sepsis, Abszessen und opportunistischen Infektionen (siehe Abschnitt 4.4).","Patients with tuberculosis or other severe infections such as sepsis, abscesses, and opportunistic infections (see section 4.4).",17,16
"3925","de","en","Patienten mit verminderter Leberfunktion","Patients with liver impairment",4,4
"3926","de","en","Patienten müssen auf die Bildung von Faktor IX-Hemmkörpern (Inhibitoren) hin überwacht werden.","Patients should be monitored for the development of factor IX inhibitors.",11,12
"3927","de","en","Patienten müssen im Hinblick auf Infektionen einschließlich Tuberkulose vor, während und nach Behandlung mit Trudexa engmaschig überwacht werden.","Patients must be monitored closely for infections, including tuberculosis, before, during and after treatment with Trudexa.",16,18
"3928","de","en","Patienten nötig, hauptsächlich wegen Anämie und Neutropenie.","commonly for anaemia and neutropaenia.",5,7
"3929","de","en","Patienten sprechen unterschiedlich auf die Behandlung mit Combivir an.","Response to treatment with Combivir varies between patients.",8,9
"3930","de","en","Patienten, bei denen im Verlauf der Behandlung Schwindelgefühle oder Sehschwierigkeiten auftreten, dürfen kein Fahrzeug führen oder Maschinen bedienen.","Patients who experience dizziness or visual difficulties during therapy must not drive or operate machinery.",15,18
"3931","de","en","Patienten, bei denen sich unter Behandlung mit Trudexa eine neue Infektion entwickelt, sollten engmaschig beobachtet werden.","Patients who develop a new infection while undergoing treatment with Trudexa should be monitored closely.",15,16
"3932","de","en","Patienten, die bereits Metformin mit oder ohne einen Sulfonylharnstoff einnehmen, sollten Janumet mit derselben Dosierung Metformin einnehmen.","Patients already taking metformin, with or without a sulphonylurea, should take Janumet containing the same dose of metformin.",18,17
"3933","de","en","Patienten, die das Therapieregime nach einem Ansprechen nach 48 Wochen beendet hatten, wurden zensiert.","Patients completing treatment while in response after 48 weeks were censored.",11,14
"3934","de","en","Patienten, die mit Bexaroten behandelt werden und Probleme mit den Augen bekommen, sollten einer angemessenen Augenuntersuchung unterzogen werden.","Any patient treated with bexarotene who experiences visual difficulties should have an appropriate ophthalmologic examination.",15,18
"3935","de","en","Patienten, die mit Pemetrexed behandelt werden, müssen zur Reduktion der Toxizität zusätzlich Vita- mine erhalten (siehe Abschnitt 4.4).","To reduce toxicity, patients treated with pemetrexed must also receive vitamin supplementation (see section 4.4).",15,18
"3936","de","en","Patienten, die mit RoActemra behandelt werden, sollten den Patientenpass erhalten.","Patients treated with RoActemra should be given the Patient Alert Card.",11,10
"3937","de","en","Patienten, die STELARA erhalten, können gleichzeitig Impfungen mit inaktivierten oder Totimpfstoffen erhalten.","Patients receiving STELARA may receive concurrent inactivated or non-live vaccinations.",10,12
"3938","de","en","Patienten, die während der Enbrel-Behandlung eine neue Infektion entwickeln, sollten engmaschig beobachtet werden.","185 Patients who develop a new infection while undergoing treatment with Enbrel should be monitored closely.",16,13
"3939","de","en","Patrick Le Courtois, Referatsleiter, geboren am 9.","Patrick Le Courtois, Head of Unit, b.",7,7
"3940","de","en","Patrone (Glas) in Fertigpen","cartridge (glass) in pre-filled pen",5,4
"3941","de","en","Paxene 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung (Paclitaxel)","Paxene 6 mg/ml concentrate for solution for infusion (paclitaxel)",9,9
"3942","de","en","Pedea soll als Kurzinfusion über 15 Minuten am besten unverdünnt gegeben werden.","Pedea should be administered as a short infusion over 15 minutes, preferably undiluted.",13,12
"3943","de","en","Pegasys 180 Mikrogramm + Ribavirin 1 000/1 200 mg, 24 Wochen:","Odds Ratio (95% CI) = 2.12 (1.30 to 3.46)",9,11
"3944","de","en","Pegasys 180 Mikrogramm + Ribavirin 800 mg, 48 Wochen:","Pegasys 180 mcg ribavirin 800 mg, 48 w:",8,9
"3945","de","en","PegIntron 100 Mikrogramm Pulver für eine Injektionszubereitung s.c.","PegIntron 100 micrograms powder for injection SC",7,8
"3946","de","en","PegIntron 50 Mikrogramm wird wie folgt angeboten:","PegIntron 50 micrograms is supplied as:",6,7
"3947","de","en","PegIntron 80 Mikrogramm wird in unterschiedlichen Packungsgrößen angeboten:","283 PegIntron 80 micrograms is available in different pack sizes:",10,8
"3948","de","en","PegIntron ist ein Arzneimittel, das den arzneilich wirksamen Bestandteil Peginterferon alfa-2b enthält.","PegIntron is a medicine containing the active substance peginterferon alfa-2b.",10,12
"3949","de","en","Pegintron peginterferon alfa-2b A","3 487 000 6.31%",4,4
"3950","de","en","Pegvisomant ist hoch-selektiv für den Wachstumshormon-Rezeptor, weshalb keine Kreuzreaktionen mit anderen Zytokin-Rezeptoren, einschließlich dem Prolaktin- Rezeptor auftreten.","Pegvisomant is highly selective for the GH receptor, and does not cross-react with other cytokine receptors, including prolactin.",18,17
"3951","de","en","Pemetrexed wird sowohl von dem reduzierten Folat-Carrier als auch membranständigen folatbindenden Proteintransportsystemen in die Zellen transportiert.","Pemetrexed is transported into cells by both the reduced folate carrier and membrane folate binding protein transport systems.",18,16
"3952","de","en","Penetration unter die Mukosa oder gleichzeitige schwere Blutungen) muss intranasales Calcitonin abgesetzt werden.","In case of mild ulceration, medication is to be interrupted temporarily until healing occurs.",14,13
"3953","de","en","Penfill Patronen sind zur Verwendung mit Insulininjektionssystemen von Novo Nordisk und NovoFine Injektionsnadeln vorgesehen.","Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine needles.",16,14
"3954","de","en","Pens für Kinder unzugänglich aufbewahren.","If you have any questions or problems with your KwikPen, contact your healthcare professional for assistance.",16,5
"3955","de","en","Pentagon Park Boundary Way Hemel Hempstead Herts HP2 7UD Vereinigtes Königreich","Pentagon Park Boundary Way Hemel Hempstead Herts., HP2 7UD United Kingdom",11,11
"3956","de","en","per se des Insulins aus dem Plasma (Insulin hat im Blutkreislauf eine t½ von nur wenigen Minuten).","ed insulin from plasma (insulin in the blood stream has a t½ of a few minutes).",16,17
"3957","de","en","Per Sjöberg geleitete Arbeitsgruppe Sicherheit (SWP) hielt 1998 zwei Sitzungen ab.","The Safety Working Party (SWP), chaired by Dr Per Sjöberg met twice in 1998.",14,11
"3958","de","en","Perfektastrasse 84A A-1230 Wien Tel: + 43 1 891-22","Perfektastrasse 84A A-1230 Wien Tel: + 43 1 891-22",9,9
"3959","de","en","Perikarderguss Lungenödem Aszites Pulmonaler Hochdruck Blutungen","Pericardial effusion Pulmonary oedema Ascites Pulmonary hypertension",7,6
"3960","de","en","periphere Ödeme, Palpitationen und Brustschmerzen","peripheral edema, palpitation and chest pain.",6,5
"3961","de","en","peripherer Neuropathie) Erkrankungen der Atemwege, des Brustraums und Mediastinums","peripheral neuropathy) Respiratory, thoracic and mediastinal disorders",7,9
"3962","de","en","Peristaltikhemmende Arzneimittel dürfen nicht gegeben werden.","Medicinal products that inhibit peristalsis should not be given.",9,6
"3963","de","en","Personen im Alter von 12 Monaten oder älter erhalten eine Dosis.","Individuals 12 months or older should receive one dose.",9,11
"3964","de","en","Personen mit bekannter Überempfindlichkeit gegenüber NSAID sollten den Kontakt mit dem Tierarzneimittel vermeiden.","Do not eat, drink, or smoke when handling the product.",10,13
"3965","de","en","Personen mit hohem Blutdruck merken oft","People with high blood pressure often do not notice any signs of this problem.",14,6
"3966","de","en","Pfizer 23-25 Avenue Du Dr.","Pfizer 23-25 Avenue Du Dr.",5,5
"3967","de","en","Pfizer Aps Lautrupvang 8 Dk 2750 Ballerup Dänemark","Pfizer Aps Lautrupvang 8 Dk 2750 Ballerup Denmark",8,8
"3968","de","en","Pfizer Corporation Austria Gesmbh Floridsdorfer Hauptstraße 1 1210 Wien Österreich","Pfizer Corporation Austria Gesmbh Floridsdorfer Hauptstraße 1 1210 Wien Austria",10,10
"3969","de","en","Pfizer Hellas Ae Mesogeion 243","Pfizer Hellas Ae Mesogeion 243",5,5
"3970","de","en","Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ Großbritannien","Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom",10,9
"3971","de","en","Pfizer Limited Ramsgate Road Sandwich, Kent CT13 9NJ, Vereinigtes Königreich","Ramsgate Road Sandwich, Kent CT13 9NJ, UK",7,10
"3972","de","en","Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, Vereinigtes Königreich.","Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom.",10,10
"3973","de","en","Pfizer Manufacturing Belgium NV.","Pfizer Manufacturing Belgium NV.",4,4
"3974","de","en","Pfizer Santé Grand Public (FR) 23-25 avenue du docteur Lannelongue 75668 Paris Cedex 14","Pfizer Santé Grand Public (FR) 23-25 avenue du docteur Lannelongue 75668 Paris cedex 14",14,14
"3975","de","en","Phantasiebezeichnung Thymanax Thymanax Thymanax Thymanax Thymanax Thymanax Thymanax Thymanax","Invented name Thymanax Thymanax Thymanax Thymanax Thymanax Thymanax Thymanax Thymanax",10,9
"3976","de","en","Pharmaceutical and biological aspects of combined","Pharmaceutical and biological aspects of combined",6,6
"3977","de","en","Pharmaceutical Laboratories 446 Irakliou Avenue 141 22 Iraklio CANA SA Athens Griechenland","Pharmaceutical Laboratories 446 Irakliou Avenue 141 22 Iraklio CANA SA Athens",11,12
"3978","de","en","Pharmacovigilance of veterinary medicinal products:","Pharmacovigilance of veterinary medicinal products:",5,5
"3979","de","en","Pharmakokinetik in speziellen Patientengruppen","Pharmacokinetics in special patient groups",5,4
"3980","de","en","Pharmakokinetische Parameter bei mit Caelyx behandelten AIDS-KS-Patienten","Pharmacokinetic Parameters in Caelyx-Treated AIDS-KS",5,7
"3981","de","en","Pharmakotherapeutische Gruppe (ATC Code):","Pharmaco-therapeutic group (ATC Code):",4,4
"3982","de","en","Pharmakotherapeutische Gruppe: andere Zytokine und Immunmodulatoren; ATC-Code:","Other cytokines and immunomodulators; ATC code:",6,7
"3983","de","en","Pharmakovigilanzinformationen und -daten im Anschluss an die Implementierung von EudraVigilance","Two informative meetings with non-EU regulatory authorities from the enlargement countries as foreseen within the PERF II initiative",18,10
"3984","de","en","Pharmazeutischer Unternehmer Baxter AG Industriestrasse 67 A-1221 Wien, Österreich","Marketing Authorisation Holder Baxter AG Industriestrasse 67 A-1221 Vienna",9,9
"3985","de","en","Pharmazeutischer Unternehmer Les Laboratoires Servier 22, rue Garnier 92200 Neuilly-sur-Seine Frankreich","Marketing Authorisation Holder Les Laboratoires Servier 22, rue Garnier 92200 Neuilly-sur-Seine France",12,11
"3986","de","en","Pharmazeutischer Unternehmer Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB Vereinigtes Königreich","Marketing Authorisation holder Novartis Europharm Limited Wimblehurst Road Horsham West Sussex, RH12 5AB United Kingdom",15,14
"3987","de","en","Pharmazeutischer Unternehmer und Hersteller","Marketing authorisation holder and manufacturer",5,4
"3988","de","en","Pharmazeutischer Unternehmer und Hersteller Amgen Europe B.V.","Marketing Authorisation Holder and Manufacturer Amgen Europe B. V.",9,7
"3989","de","en","Pharmazeutischer Unternehmer und Hersteller Merck KGaA, 64271 Darmstadt, Deutschland","Marketing Authorisation Holder and Manufacturer Merck KGaA, 64271 Darmstadt, Germany",10,9
"3990","de","en","Pharmvit Limited Unit 13, Metropolitan Centre Derby Road, Greenford Middlesex UB6 8UJ Vereinigtes Königreich","Pharmvit Limited Unit 13, Metropolitan Centre Derby Road, Greenford Middlesex UB6 8UJ United Kingdom",14,14
"3991","de","en","Pharyngitis, Niesen, Husten, postnasale Schleimbildung, Halsreizung","Uncommon: pharyngitis, sneezing, cough, postnasal drip, throat irritation.",8,6
"3992","de","en","Phenobarbital, Primidon, Phenytoin, Carbamazepin, Diazepam.","62 phenobarbital, primidone, phenytoin, carbamazepine, diazepam.",6,5
"3993","de","en","Phenprocoumon, Acenocoumarol (CYP2C9- / CYP3A4- Substrate):","28 Other oral anticoagulants e. g. phenprocoumon, acenocoumarol (CYP2C9, CYP3A4 substrates):",11,6
"3994","de","en","PhotoBarr 75 mg Pulver zur Herstellung einer Injektionslösung","PhotoBarr 75 mg powder for solution for injection.",8,8
"3995","de","en","Pierre Fabre Medicament 45, Place Abel Gance 92654 Boulogne Cedex Frankreich","Pierre Fabre Medicament 45, Place Abel Gance 92654 Boulogne Cedex France",11,11
"3996","de","en","Pimozid (Saquinavir/Ritonavir) Orale Kontrazeptiva","Pimozide (saquinavir/ ritonavir) Oral contraceptives",5,4
"3997","de","en","Pioglitazon und alle aktiven Metaboliten liegen überwiegend an Plasmaproteine gebunden vor (> 99%).","Pioglitazone and all active metabolites are extensively bound to plasma protein (> 99%).",13,13
"3998","de","en","Piro 10mg Abz 10231.00.00","Piro 10mg Abz 10231.00.00",4,4
"3999","de","en","Piroxicam 20 Heumann 12426.01.00","Piroxicam 20 Heumann 12426.01.00",4,4
"4000","de","en","Piroxicam Dispersible Tablets 20mg","Piroxicam Dispersible Tablets 20mg",4,4
"4001","de","en","Piroxicam Ivax 20 Mg, Gélule","Piroxicam Ivax 20 Mg, Gélule",5,5
"4002","de","en","Piroxicam Teva 10 Mg, Gélule","Piroxicam Teva 10 Mg, Gélule",5,5
"4003","de","en","Pirsue ist ein Antibiotikum, das Pirlimycin Hydrochlorid als arzneilich wirksamen Bestandteil enthält.","Pirsue is an antibiotic that contains pirlimycin hydrochloride as the active substance.",12,12
"4004","de","en","Placebo 44% 32% 51% 17% 76%","Placebo 44% 32% 51% 17% 76%",6,6
"4005","de","en","PLANUNG DER EINNAHME VON BONVIVA","PLANNING WHEN TO TAKE BONVIVA",5,5
"4006","de","en","Plavix darf nicht eingenommen werden,","Do not take Plavix:",4,5
"4007","de","en","Plazebokontrollierte Studien bei digitalen Ulzerationen","Placebo-controlled trials in digital ulcers",5,5
"4008","de","en","PLIVA Kraków Zakł ady Farmaceutyczne S.A. ul.","PLIVA Kraków Zakł ady Farmaceutyczne S. A. ul.",8,7
"4009","de","en","Pneumocystis-carinii - Pneumonie (PCP) Prophylaxe wurde während der RT und kombinierten TMZ-Therapie gefordert.","Pneumocystis carinii pneumonia (PCP) prophylaxis was required during RT and combined TMZ therapy.",13,13
"4010","de","en","Pod Nádražím 853 CZ-268 01 Hořovice Tel: + 420 311 545 011","Pod Nádraž ím 853 CZ-268 01 Hoř ovice Tel: + 420 311 545 011",14,12
"4011","de","en","Polska Alcon Polska Sp. z o.o. + 48 22 820 3450","Polska Alcon Polska Sp. z o.o. + 48 22 820 3450",11,11
"4012","de","en","Polska Bristol-Myers Squibb Polska Sp. z o.o.","Polska Bristol-Myers Squibb Polska Sp. z o. o.",8,7
"4013","de","en","Polska GSK Commercial Sp. z o.o.","Polska GSK Commercial Sp. z o.o.",6,6
"4014","de","en","Polska MSD Polska Sp.z o.o.","Polska MSD Polska Sp. z o. o.",7,5
"4015","de","en","Polska Orphan Europe GmbH Max-Planck Str.","Polska Orphan Europe GmbH Max-Planck Str.",6,6
"4016","de","en","Polska sanofi-aventis Sp. z o.o.","Polska sanofi-aventis Sp. z o.o.",5,5
"4017","de","en","Polska Wyeth Sp. z o.o.","Polska Wyeth Sp. z o.o.",5,5
"4018","de","en","Polyethylen (PEHD) Einmaldosis (Blister):","Polyethylene (PEHD) Unit dose (blister):",5,4
"4019","de","en","Polysorbat 20 und Wasser zur Injektion.","Polysorbate 20 and water for injections.",6,6
"4020","de","en","Polyvinylchlorid/Folien-Blisterpackungen mit 60 Filmtabletten.","Polyvinyl chloride/ foil blister packs containing 60 tablets.",8,4
"4021","de","en","Porcilis PCV enthält geringe Mengen eines Proteins von PCV2.","Porcilis PCV contains small amounts of a protein from PCV2.",10,9
"4022","de","en","Portugal Abbott Laboratórios, Lda.","Portugal Abbott Laboratórios, Lda.",4,4
"4023","de","en","Portugal Bayer Portugal S.A.","Portugal Bayer Portugal S. A.",5,4
"4024","de","en","Portugal EF-Eisai Farmacêutica, Unipessoal Lda Tel: + 351 21 421 7399","Portugal EF-Eisai Farmacêutica, Unipessoal Lda Tel: +351 21 421 7399",10,11
"4025","de","en","Portugal Laboratórios Pfizer, Lda.","Portugal Laboratórios Pfizer, Lda.",4,4
"4026","de","en","Portugal Merck Sharp & Dohme, Lda Tel: +351 21 4465700 informacao_doente@merck.com","Portugal Merck Sharp & Dohme, Lda Tel: +351 21 4465700 informacao_doente@merck.com",11,11
"4027","de","en","Portugal Rue Agualva dos Açores 16 PT-2735-557 Agualva Cacem Tel: +351 21 433 9300","Portugal Rue Agualva dos Açores 16 PT-2735-557 Agualva Cacem Tel: +351 21 433 9300",14,14
"4028","de","en","Portugal Smith Kline & French Portuguesa, Produtos Farmacêuticos, Lda.","Portugal GlaxoSmithKline, Produtos Farmacêuticos, Lda.",5,9
"4029","de","en","Portugal Tecnifar - Indústria Técnica Farmacêutica, S.A.","Portugal Tecnifar - Indústria Técnica Farmacêutica, S. A.",8,7
"4030","de","en","Posaconazol muss zusammen mit einer Mahlzeit oder mit einem Nahrungsergänzungsmittel angewendet werden (siehe Abschnitt 4.2).","Posaconazole should be administered with food or a nutritional supplement (see section 4.2).",13,15
"4031","de","en","Post-Baseline-Wert 80 80 78 80 79 79 79 77 77 57 71 76 78 28","80 78 80 79 79 79 77 77 57 71 76 78 28",13,15
"4032","de","en","Postbus 251 NL-2180 AG Hillegom, Niederlande","Postbus 251 NL-2180 AG Hillegom, Netherlands",6,6
"4033","de","en","Potency Test nach Ph.Eur.","Purified Saponin Cholesterol Phosphatidylcholine",4,4
"4034","de","en","Potential von Darbepoetin alfa wurde nicht in Langzeit-Tierstudien untersucht.","The carcinogenic potential of darbepoetin alfa has not been evaluated in long-term animal studies.",14,9
"4035","de","en","Potenzielle Beeinflussung von RISPERDAL CONSTA durch andere Arzneimittel","Potential for other medicinal products to affect RISPERDAL CONSTA",9,8
"4036","de","en","POULVAC FLUFEND H5N3 RG","POULVAC FLUFEND H5N3 RG",4,4
"4037","de","en","Powder for infusion 200 IU","a) Powder for infusion b) 200 IU",7,5
"4038","de","en","Pradaxa 110 mg Hartkapseln","Pradaxa 110 mg hard capsules",5,4
"4039","de","en","Prämedikation vor der Einleitung und zum Erhalt einer Vollnarkose bei Katzen mit Ketamin.","Premedication in cats before induction and maintenance of general anaesthesia with ketamine.",12,13
"4040","de","en","Prätherapeutische LDH-Spiegel (Median, U/l) Freies Hämoglobin zu Beginn der Studie (Median, mg/dl)","Pre-treatment LDH levels (median, U/L) Free Haemoglobin at baseline (median, mg/dL)",11,12
"4041","de","en","Pregabalin wird nicht an Plasmaproteine gebunden.","Pregabalin is not bound to plasma proteins.",7,6
"4042","de","en","Preotact enthält den Wirkstoff Parathormon.","Preotact contains the active substance parathyroid hormone.",7,5
"4043","de","en","Prepandrix ist ein Impfstoff, der bei Erwachsenen ab dem vollendeten 18.","Prepandrix is a vaccine for use in adults from 18 to 60 years old.",14,11
"4044","de","en","Present ation a) Form b) Dose c) Number of Presentations","Present ation a) Form b) Dose c) Number of Presentations",10,10
"4045","de","en","Previcox 8,2 mg/g Paste zum Eingeben bei Pferden.","Previcox 8.2 mg/ g oral paste for horses.",8,8
"4046","de","en","PREZISTA sollte bei Patienten mit bekannter Sulfonamidallergie mit Vorsicht angewendet werden.","PREZIST A should be used with caution in patients with a known sulphonamide allergy.",14,11
"4047","de","en","PREZISTA-Tabletten enthalten Gelborange S (E110), welches allergieähnliche Reaktionen hervorrufen kann.","PREZISTA tablets contain sunset yellow FCF (E110) which may cause an allergic reaction.",13,10
"4048","de","en","Prialt ist in Packungen mit einer einzelnen Durchstechflasche zu 1 ml, 2 ml oder 5 ml erhältlich.","Prialt is supplied in packs containing a single vial of either 1 ml, 2 ml or 5 ml.",18,17
"4049","de","en","Primäre kombinierte Endpunkte Kardiovaskulärer (CV) Tod, nicht tödlicher MI oder nicht tödlicher Schlaganfall Primäre einzelne Endpunkte","Primary Composite Outcome Events Cardiovascular (CV) death, non fatal MI, or non fatal stroke Primary Individual Outcome Events",18,16
"4050","de","en","Primärer Endpunkt der Zentralstudie war der Anteil von Patienten, die nach Ablauf der Studiendauer am Leben waren.","8 The primary endpoint of the pivotal trial was the proportion of patients who were alive.",16,17
"4051","de","en","PritorPlus senkte den diastolischen Blutdruck wirksamer als Placebo und Telmisartan allein.","PritorPlus was more effective than placebo and than telmisartan alone in reducing diastolic blood pressure.",15,11
"4052","de","en","Pro Dosis (1 ml):","Per dose of 1ml:",4,4
"4053","de","en","Pro Durchstechflasche darf nur eine Dosis angewendet werden.","Only one dose should be administered per vial.",8,8
"4054","de","en","Proben, in denen Emedastin quantifizierbar war, lieferten Werte im Bereich zwischen 0,30 und 0,49 ng/ml.","Samples in which emedastine was quantifiable ranged from 0.30 to 0.49 ng/ ml.",13,15
"4055","de","en","Probenecid-Tabletten werden gegeben, um das Risiko für eine Nierenschädigung gering zu halten.","Probenecid tablets are given to minimise the potential for kidney damage.",11,12
"4056","de","en","Procoralan soll nicht an Kindern und Jugendlichen unter 18 Jahren angewendet werden.","Procoralan is not intended for use in children and adolescents younger than 18 years.",14,12
"4057","de","en","Produktinformation Arztinformation zu Exjade (Broschüre und Kurzinformation) Informationspaket für Patienten","Product information Physician information about Exjade (brochure and pocket card) Patient information pack",13,10
"4058","de","en","Profender 150 mg/30 mg Tabletten mit veränderter Wirkstofffreisetzung für große Hunde","Profender 150 mg / 30 mg modified-release Tablets for Large Dogs",11,11
"4059","de","en","Profender Lösung zum Auftropfen für Katzen","Profender spot-on solution for cats",5,6
"4060","de","en","ProMeris Duo 199,5 mg + 199,5 mg Lösung zum Auftropfen für mittelgroße Hunde {5,1-10,0 kg}","ProMeris Duo 199.5 mg + 199.5 mg Spot-on for medium sized dogs {5.1-10.0 kg}",14,15
"4061","de","en","Prometax 2 mg/ml [nur auf der Faltschachtel]","Prometax 2 mg/ ml [folding box only]",7,7
"4062","de","en","Promotion auf dem Gebiet der öffentlichen Gesundheit an der Universität Bordeaux.","PhD in public health from the University of Bordeaux.",9,11
"4063","de","en","Proposal for a core-SPC for Valerianae radix","Proposal for a core-SPC for Valerianae radix",7,7
"4064","de","en","Prospel 5 mg loratadine","Prospel 5 mg loratadine (+ Pseudo-",6,4
"4065","de","en","Protaphane InnoLet 100 I.E./ml Injektionssuspension in einem Fertigpen.","Protaphane InnoLet 100 IU/ ml suspension for injection in a pre-filled pen.",12,8
"4066","de","en","Protaphane muss vor übermäßiger Hitze und Sonnenlicht geschützt werden.","Protaphane must be protected from excessive heat and sunlight.",9,9
"4067","de","en","Protein dO (nicht toxisches Deletionsderivat des dermonekrotischen Toxins von Pasteurella multocida) Inaktivierte Bordetella bronchiseptica Zellen 1","- Protein dO (non-toxic deletion derivative of Pasteurella multocida",9,16
"4068","de","en","PROTELOS ist ein nichthormonelles Arzneimittel zur Behandlung von Osteoporose bei postmenopausalen Frauen.","PROTELOS is a non-hormonal medicine used to treat osteoporosis in postmenopausal women.",12,12
"4069","de","en","Protopy ist i n zwei Stärken erhältlich (Protopy 0,03% und Protopy 0,1% Salbe).","Protopy is available in two strengths (Protopy 0.03%",8,13
"4070","de","en","Prozentsatz der Prozentsatz der Patienten mit Patienten mit","Percent of Percent of",4,8
"4071","de","en","Prüfen Sie das Aussehen von Filgrastim HEXAL.","Check the appearance of Filgrastim HEXAL.",6,7
"4072","de","en","Prüfen Sie den Träger auf Vollständigkeit:","Check the blister tray contains:",5,6
"4073","de","en","Prüfen Sie, ob an der Nadelspitze Insulin austritt.","Check if insulin comes out of the needle tip.",9,8
"4074","de","en","Pruritus Angioödem, Urtikaria, Hautausschlag, psoriasisartiger Hautausschlag, Psoriasis (einschließlich Erstmanifestationen und pustulöse Formen, primär Handflächen und Fußsohlen)","Pruritus Angioedema, urticaria, rash, psoriasiform rash, psoriasis (including new onset and pustular, primarily palms & soles)",16,16
"4075","de","en","Psoriasis (neu oder verschlimmert) §, makulopapulöser Hautausschlag, erythematöser Hautausschlag, Ekzem,","Stevens Johnson syndrome, toxic epidermal necrolysis, erythema multiforme",8,10
"4076","de","en","PSUR-Vorlagen, wenn Prepandrix während der Influenza-Pandemie angewendet wird:","PSUR submission when Prepandrix is used during the influenza pandemic:",10,8
"4077","de","en","Psychiatrische Erkrankungen Erkrankungen des Nervensystems","Psychiatric disorders Nervous system disorders",5,5
"4078","de","en","Psychomoto- rische Hyperaktivität / Agitiertheit","Psychomotor hyperactivity / agitation",4,5
"4079","de","en","Public Statement on Lactose prepared using Calf Rennet:","Public Statement on Lactose prepared using Calf Rennet:",8,8
"4080","de","en","Puh/Tel: +358 (0) 9 525 331","Puh/Tel: +358 (0) 9 525 331",6,6
"4081","de","en","Pulver Saccharose Dextran Sorbitol Aminosäuren Dulbecco`s modifiziertes Eagle-Medium (DMEM)","Powder Sucrose Dextran Sorbitol Amino acids Dulbecco’s Modified Eagle Medium (DMEM)",11,9
"4082","de","en","Pulver und Beimischungen für ein Konzentrat zur Herstellung einer liposomalen Infusionsdispersion.","Powder and pre-admixtures for concentrate for liposomal dispersion for infusion",10,11
"4083","de","en","Pulver und Lösungsmittel zur Herstellung einer","Powder and solvent for solution for injection",7,6
"4084","de","en","Pulver und Lösungsmittel zur Herstellung einer Injektionslösung","ADVATE 1500 IU powder and solvent for solution for injection.",10,7
"4085","de","en","Pulver und Lösungsmittel zur Herstellung einer Injektionslösung Nonacog alfa (rekombinanter Blutgerinnungsfaktor IX)","BeneFIX 250 IU powder and solvent for solution for injection Nonacog alfa (recombinant coagulation factor IX)",16,12
"4086","de","en","Pulver und Lösungsmittel zur Herstellung einer Injektionslösung.","Helixate NexGen 500 IU Powder and solvent for solution for injection.",11,7
"4087","de","en","Pulver und Suspension zur","Powder and suspension for",4,4
"4088","de","en","Pulver zur Herstellung einer Injektionslösung","Powder for solution for injection",5,5
"4089","de","en","Pulver zur Herstellung einer Injektionslösung:","Powder for solution for injection:",5,5
"4090","de","en","Pulver zur Herstellung einer Injektionssuspension.","Powder for suspension for injection.",5,5
"4091","de","en","Pulver zur Herstellung einer Loesung zur Infusion und intravesikalen Instillation","Powder for solution for infusion and intravesical instillation",8,10
"4092","de","en","Pulver zur Herstellung einer Lösung zum Einnehmen","powder for oral solution",4,7
"4093","de","en","Pulver zur Herstellung einer Suspension zum Einnehmen.","Powder for oral suspension.",4,7
"4094","de","en","Pulver zur Herstellung eines Infusionslösungskonzentrats:","Powder for concentrate for solution for infusion:",7,5
"4095","de","en","Pulver zur Injektion Lutropin alfa Subkutane Anwendung","Lutropin alfa Subcutaneous use.",4,7
"4096","de","en","Punktschätzung und Konfidenzintervalle wurden bezüglich des personenbezogenen Nachbeobachtungszeitraums adjustiert.","Note: point estimates and confidence intervals are adjusted for person-time of follow-up.",12,9
"4097","de","en","Puregon 100 IE/0,5 ml Injektionslösung Follitropin beta","Puregon 100 IU/ 0.5 ml solution for injection follitropin beta",10,7
"4098","de","en","Puregon 250 IE/0,5 ml Injektionslösung Follitropin beta","Puregon 250 IU/ 0.5 ml solution for injection follitropin beta",10,7
"4099","de","en","Puregon 75 IE/0,5 ml Injektionslösung","Puregon 75 IU/ 0.5 ml solution for injection",8,5
"4100","de","en","Puregon darf nicht angewendet werden,","Do not use Puregon",4,5
"4101","de","en","Puregon Injektionslösung enthält Follitropin beta, ein Hormon, das die Bezeichnung follikelstimulierendes Hormon (FSH) trägt.","Puregon solution for injection contains follitropin beta, a hormone known as follicle-stimulating hormone (FSH).",14,14
"4102","de","en","Purevax RCP FeLV Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension.","Purevax RCP FeLV Lyophilisate and solvent for suspension for injection.",10,10
"4103","de","en","PVC / Aluminium-Blister in Packungen mit 2, 10, 14, 20, 28, 30, 50, 56 und 100 Tabletten.","PVC / Aluminium blister in cartons of 2, 10, 14, 20, 28, 30, 50, 56 and 100.",17,17
"4104","de","en","Pylobactell, 100 mg Tablette zur Herstellung einer Lösung zum Einnehmen.","Pylobactell 100 mg soluble tablet",5,10
"4105","de","en","Pyrexie, Brustschmerz, peripheres Ödem, allgemeines Unwohlsein, Schüttelfrost, anomales Gefühl, Hitzegefühl, Reizbarkeit, Schmerz, Trockenheit","pyrexia, chest pain, peripheral oedema, malaise, chills, abnormal feeling, feeling hot, irritability, pain, xerosis",14,13
"4106","de","en","QUADRAMET darf vor Gebrauch nicht verdünnt werden.","QUADRAMET should not be diluted before use.",7,7
"4107","de","en","QUALITATIVE UND QUANTITATIVE ZUSAMMENSETZUNG","2 QUALITATIVE AND QUANTITATIVE COMPOSITION",5,4
"4108","de","en","Quixidar 1,5 mg/0,3 ml Injektionslösung Fondaparinux-Natrium","Quixidar 1.5 mg/ 0.3 ml solution for injection fondaparinux sodium",10,6
"4109","de","en","Quixidar 7,5 mg/0,6 ml Injektionslösung","d Quixidar 7.5 mg/ 0.6 ml solution for injection",9,5
"4110","de","en","Radiologische Untersuchungen Die strukturelle Gelenkschädigung wurde in Studie II radiologisch über einen Zeitraum von zwei Jahren beurteilt.","Radiographic response Structural joint damage was assessed radiographically over a two-year period in Study II.",15,17
"4111","de","en","Raloxifen zeigte keine Genotoxizität in irgendeinem der umfassenden Testsysteme, die angewandt wurden.","10 Raloxifene was not genotoxic in any of the extensive battery of test systems applied.",15,12
"4112","de","en","Rapamune ist ein Arzneimittel, das den Wirkstoff Sirolimus enthält.","Rapamune is a medicine that contains the active substance sirolimus.",10,9
"4113","de","en","Rapinyl kann manche Menschen benommen machen.","Rapinyl can make some people feel drowsy.",7,6
"4114","de","en","Raptiva gibt es in folgenden Packungsgrößen:","Raptiva is available in:",4,6
"4115","de","en","Rasilez bewirkte einen additiven blutdrucksenkenden Effekt, wenn es zusammen mit Hydrochlorothiazid oder Ramipril gegeben wurde.","Rasilez induced an additive blood-pressure-lowering effect when added to hydrochlorothiazide and to ramipril.",13,15
"4116","de","en","Ratiograstim enthält keine Konservierungsmittel.","Ratiograstim does not contain any preservative.",6,4
"4117","de","en","ratiopharm Arzneimittel Vertriebs- GmbH Albert-Schweitzer-","ratiopharm Arzneimittel Vertriebs- GmbH Albert-Schweitzer- Gasse 3, 1140 WIEN, Austria",10,5
"4118","de","en","ratiopharm Arzneimittel Vertriebs- GmbH Albert-Schweitzer- Gasse 3, 1140 WIEN, Österreich","Albert-Schweitzer- Gasse 3, 1140 WIEN, Austria",6,10
"4119","de","en","ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm Deutschland info@ratiopharm.de","ratiopharm GmbH Graf-Arco-Straße 3 D-89079 Ulm Germany info@ratiopharm. de",9,8
"4120","de","en","Reaktionen an der Einstichstelle Bei der intravenösen Anwendung von Ciprofloxacin wurde über venöse Irritationen berichtet.","Injection Site Reaction Local intravenous site reactions have been reported with the intravenous administration of ciprofloxacin.",16,15
"4121","de","en","Reaktionen an der Injektionsstelle (1) Einzelne AEs wurden nicht berücksichtigt, außer sie wurden als medizinisch relevant betrachtet.","(1) Isolated AEs have not been considered except if they were medically relevant.",13,17
"4122","de","en","Reaktionen an der Injektionsstelle und lokale Überempfindlichkeitsreaktionen.","Skin and subcutaneous tissue disorders Common: injection site reactions and local hypersensitivity reactions.",13,7
"4123","de","en","Rebetol 40 mg/ml Lösung zum Einnehmen Ribavirin","Rebetol 40 mg/ml oral solution ribavirin",6,7
"4124","de","en","Rebif 44 Mikrogramm/0,5 ml Injektionslösung in einer Patrone","Rebif 44 micrograms/ 0.5ml solution for injection in cartridge",9,8
"4125","de","en","Rebound-Phänomene (Verschlimmerung von Symptomen nach abruptem Absetzen der Behandlung) können nicht ausgeschlossen werden.","Rebound (worsening of symptoms after abrupt discontinuation of treatment) can not be excluded.",13,13
"4126","de","en","Reckitt Benckiser Healthcare (UK) Ltd Dansom Lane Hull, East Yorkshire HU8 7DS Vereinigtes Königreich","Reckitt Benckiser Healthcare (UK) Ltd Dansom Lane Hull, East Yorkshire HU8 7DS United Kingdom",14,14
"4127","de","en","Reconcile 32 mg Kautabletten für Hunde Fluoxetin (als Hydrochlorid)","Reconcile 32 mg chewable tablets for dogs Fluoxetine (as hydrochloride)",10,9
"4128","de","en","Reduktion auf 0,5 Mio.E./kg/Tag (5 μ g/kg/Tag) Filgrastim absetzen","Filgrastim dose adjustment Reduce to 0.5 MU/ kg/ day (5 μ g/ kg/ day) Discontinue filgrastim",16,9
"4129","de","en","Reduktion der Docetaxel-Dosis um 20%.","Third episode: reduce docetaxel dose by 20%.",7,5
"4130","de","en","Referat Kommunikation und Netzwerke","together with the replacement of the Agency’s local area",9,4
"4131","de","en","Referatsleiter-Team Bereich Personal und Haushalt Bereich Zentrale Beschaffung Bereich Rechnungsführung Reservestellen","Head of Unit team Sector for Personnel and budget Sector for Infrastructure services Sector for Accounting Reserve posts",18,11
"4132","de","en","regelmäßig auf ein erneutes Auftreten der Tumorerkrankung untersucht werden.","recurrence of the malignancy.",4,9
"4133","de","en","Regelmäßige Blutbildkontrollen werden empfohlen (siehe oben).","Regular monitoring of blood counts is recommended (see above).",9,6
"4134","de","en","REGRANEX 0,01% Gel Becaplermin","REGRANEX 0.01% gel becaplermin",4,4
"4135","de","en","Reiben Sie die Injektionsstelle nicht.","If needed, you may cover the injection site with a plaster.",11,5
"4136","de","en","Reinhard Kroker, Vorsitzender des CVMP, geboren am 21.","Reinhard Kroker, Chairman of the CVMP, b.",7,8
"4137","de","en","Rekombinantes Hepatitis-B-Oberflächenantigen (S-Protein*), adsorbiert 20 Mikrogramm pro 1 ml","Hepatitis B virus surface antigen recombinant (S protein)* adsorbed 20 micrograms per 1 ml",14,9
"4138","de","en","Rekombinantes Interferon alfa-2b hemmt sowohl in vitro als auch in vivo die Virusreplikation.","Recombinant interferon alfa-2b also inhibits viral replication in vitro and in vivo.",12,13
"4139","de","en","Rekonstituierte Lösung und Infusionslösung:","Reconstituted solution and infusion solution:",5,4
"4140","de","en","Rekonstitution und Verdünnung sind gemäß den Richtlinien der guten Praxis durchzuführen, insbesondere im Hinblick auf aseptische Bedingungen.","Reconstitution and dilution should be performed in accordance with good practices rules, particularly with respect to asepsis.",17,17
"4141","de","en","Relatives Risiko (95% KI)","25.1 33.0 (21.1, 33.0) (29.1, 42.4) 1.31) 0.88 (0.7, 14.8 18.3 (5.3, 24.3) (12.2, 24.4)",15,4
"4142","de","en","RELISTOR darf nicht angewendet werden,","Do not use RELISTOR",4,5
"4143","de","en","RELISTOR kann ohne Rücksicht auf Nahrungsmittel injiziert werden.","RELISTOR can be injected without regard to food.",8,8
"4144","de","en","Remicade wurde nicht bei Patienten unter 6 Jahren mit Morbus Crohn untersucht.","Remicade has not been studied in patients with Crohn’ s disease below the age of 6 years.",17,12
"4145","de","en","Renagel Tabletten sind weißliche, ovale Filmtabletten mit der aufgedruckten Bezeichnung „ Renagel 400“ auf einer Seite.","Renagel tablets are film coated, off white, oval tablets with Renagel 400 imprinted on one side.",16,16
"4146","de","en","Repaglinid zeigt beim Menschen eine hohe Plasmaproteinbindung (über 98%).","Repaglinide is highly bound to plasma proteins in humans (greater than 98%).",12,9
"4147","de","en","Reperfusionsarrhythmien können zu Herzstillstand führen, lebensbedrohlich sein und die Anwendung konventioneller antiarrhythmischer Therapien erforderlich machen.","14 arrest, can be life threatening and may require the use of conventional antiarrhythmic therapies.",15,15
"4148","de","en","Replagal ist zur Langzeitanwendung bestimmt.","Replagal is intended for long-term use.",6,5
"4149","de","en","Reprezentanţă Tel: + 40 (21) 300 29 04","Reprezentanţă Tel: + 40 (21) 300 29 04",8,8
"4150","de","en","Reproduction is authorised provided the source is acknowledged Wie wirkt Atripla?","Reproduction is authorised provided the source is acknowledged. tenofovir in the body.",12,11
"4151","de","en","Reproduction is authorised provided the source is acknowledged.","Reproduction is authorised provided the source is acknowledged.",8,8
"4152","de","en","resistent ≥ 4 mg/l","Resistant ≥ 4 mg/ l ≤ 14 mm",8,4
"4153","de","en","Resorption Die absolute Bioverfügbarkeit von Rivaroxaban ist hoch (80% - 100%), bezogen auf die 10 mg-Dosis.","Absorption The absolute bioavailability of rivaroxaban is high (80% - 100%) for the 10 mg dose.",16,16
"4154","de","en","Resorption Nach der Applikation wird Rotigotin kontinuierlich aus dem transdermalen Pflaster abgegeben und über die Haut resorbiert.","Absorption Following application, rotigotine is continuously released from the transdermal patch and absorbed through the skin.",16,17
"4155","de","en","Resultat* rein / fast rein","Outcome* Clear / almost clear Marked improvement Improved No improvement / worse",12,5
"4156","de","en","Retacrit 20000 I.E./0,5 ml Injektionslösung in Fertigspritze","Retacrit 20000 IU/ 0.5ml solution for injection in pre-filled syringe",10,7
"4157","de","en","Retacrit darf nicht geschüttelt und nicht mit anderen Lösungen vermischt werden.","Retacrit must not be shaken or mixed with any other liquid.",11,11
"4158","de","en","Retikulozytenzahl-Anstieg < 40.000/µl und Hb-Anstieg < 1 g/dl","The recommended dosing regimen is described in the following diagram:",10,8
"4159","de","en","Revlimid 10 mg Hartkapseln","Revlimid 10 mg hard capsules",5,4
"4160","de","en","Revlimid DARF NICHT EINGENOMMEN WERDEN","DO NOT TAKE Revlimid",4,5
"4161","de","en","Rexetine 30 mg filmtabletta","Rexetine 30 mg filmtabletta",4,4
"4162","de","en","REYATAZ 50 mg/1,5 g Pulver zum Einnehmen Atazanavir","REYATAZ 50 mg/ 1.5 g oral powder atazanavir",8,8
"4163","de","en","Rheumatoide Arthritis er ng Trudexa ist in Kombination mit Methotrexat indiziert zur t lä","Rheumatoid arthritis lon Trudexa in combination with methotrexate, is indicated for:",11,14
"4164","de","en","Ribavirin 200 mg. − Die sonstigen Bestandteile sind:","- The active substance is ribavirin 200 mg.",8,8
"4165","de","en","Ribavirin Teva ist mit der Nahrung einzunehmen.","Ribavirin Teva must be taken with food",7,7
"4166","de","en","Rifabutin 150 mg einmal täglich","Rifabutin 150 mg QD",4,5
"4167","de","en","Rifampicin 600 mg qd (Saquinavir/Ritonavir 1000/100 mg bid)","Rifampicin 600 mg qd (saquinavir/ritonavir 1000/100 mg bid)",8,8
"4168","de","en","Rifampicin, Phenytoin, Phenobarbital, Carbamazepin, Johanniskraut) sollte keine Behandlung mit Ranexa eingeleitet werden (siehe Abschnitt 4.4).","John’ s Wort) (see section 4.4).",6,15
"4169","de","en","Rifampicin) sollte Pioglitazon mit Vorsicht angewendet werden.","Glycaemic control should be monitored closely.",6,7
"4170","de","en","Rīgas raj., LV-2167 Tel.: +371 67619365","Rīgas raj., LV-2167 Tel: +371 67619365",6,6
"4171","de","en","Rinder, Schweine und Pferde","Cattle, pigs and horses",4,4
"4172","de","en","Riprazo 150 mg Filmtabletten Aliskiren","Riprazo 150 mg film-coated tablets Aliskiren",6,5
"4173","de","en","Risiko in Bezug auf Epilepsie und antiepileptische Arzneimittel im Allgemeinen","Risk related to epilepsy and antiepileptic medicinal products in general",10,10
"4174","de","en","RISPERDAL CONSTA soll alle zwei Wochen tief intramuskulär unter Verwendung der beigefügten Spezialnadel in den Glutealmuskel verabreicht werden.","RISPERDAL CONSTA should be administered every two weeks by deep intramuscular gluteal injection using the enclosed safety needle.",18,18
"4175","de","en","Risperdal Quicklet 4 mg","Risperdal Quicklet 4 mg",4,4
"4176","de","en","RISPERDAL Schmelztabletten sowie RISPERDAL Lösung zum Einnehmen sind bioäquivalent gegenüber RISPERDAL Filmtabletten.","RISPERDAL orodispersible tablets and oral solution are bio-equivalent to RISPERDAL film-coated tablets.",12,12
"4177","de","en","RISPERDAL und zugehörige Namen (siehe Anhang I) 0,25 mg Filmtabletten Risperidon","RISPERDAL and associated names (see Annex I) 0.25 mg film-coated tablets",11,11
"4178","de","en","Risperidon-Janssen 1 mg Loesung 1 mg/ml","Risperidon-Janssen 1 mg Loesung 1 mg/ ml",7,6
"4179","de","en","Rispolept Quicklet 4 mg","Rispolept Quicklet 4 mg",4,4
"4180","de","en","Ritonavir erhöht die Serumspiegel von Nelfinavir infolge der CYP3A4 Hemmung.","Ritonavir increases the serum levels of nelfinavir as a result of CYP3A4 inhibition.",13,10
"4181","de","en","Ritonavir kann die Plasmakonzentration von Fluticasonpropionat erheblich erhöhen.","Patients who have required high dose emergency corticosteroid therapy in the past may also be at risk.",17,8
"4182","de","en","Ritonavir wird nicht empfohlen (siehe","REYATAZ/ ritonavir is not recommended (see",6,5
"4183","de","en","Ritonavir zur Verbesserung der Pharmakokinetik","Ritonavir dosed as a pharmacokinetic enhancer",6,5
"4184","de","en","Ritonavir-Spiegel können sich erhöhen, wenn die Einnahme von Johanniskraut beendet wird.","Ritonavir levels may increase on stopping St John’ s wort.",10,11
"4185","de","en","Ritonavir/Efavirenz (500 mg zweimal täglich/600 mg einmal täglich)","Ritonavir/ Efavirenz (500 mg twice daily/ 600 mg once daily)",10,8
"4186","de","en","Rivastigmin geht mit seinen Zielenzymen eine kovalente Bindung ein, wodurch die Enzyme vorübergehend inaktiviert werden.","Rivastigmine interacts with its target enzymes by forming a covalently bound complex that temporarily inactivates the enzymes.",17,15
"4187","de","en","Rotarix enthält geringe Mengen Rotavirus, ein Virus, das eine Gastroenteritis verursacht.","Rotarix contains small amounts of rotavirus, a virus that causes gastroenteritis.",11,11
"4188","de","en","Rotaviren werden fäkal-oral (durch Hand-zu-Mund-Kontakt) übertragen, wenn man mit dem Stuhl infizierter Personen in Berührung gekommen ist.","Rotavirus is easily spread from hand-to-mouth due to contact with stools from an infected person.",15,17
"4189","de","en","Roxac 20 mg Filmtabletten","Roxac 20 mg Filmtabletten",4,4
"4190","de","en","Rua General Ferreira Martins, 8 - 7º Miraflores 1495-137 Algés Portugal","Rua General Ferreira Martins, 8 - 7º Miraflores 1495-137 Algés Portugal",11,11
"4191","de","en","Rückenschmerzen Muskelkrämpfe Arthralgie Myalgie","Muscle spasms Arthralgia Myalgia",4,4
"4192","de","en","Rue de l'Institut 89 1330 Rixensart Belgien","Rue de l’Institut 89 1330 Rixensart Belgium",7,7
"4193","de","en","Rue de l'Institut 89 B-1330 Rixensart, Belgien","Rue de l'Institut 89 B-1330 Rixensart, Belgium",7,7
"4194","de","en","Rue du Bosquet, 2 B-1348 Ottignies/Louvain-la-Neuve Belgique/Belgien","Rue du Bosquet, 2 B-1348 Ottignies/Louvain-la-Neuve Belgique/Belgien",7,7
"4195","de","en","rz 1 Durchstechflasche zum Einmalgebrauch 4 Durchstechflaschen zum Einmalgebrauch 5.","er 4 single use vials 5.",6,10
"4196","de","en","rz 4.10 Überdosierung (Symptome, Notfallmassnahmen, Gegenmittel), falls erforderlich","or 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary",9,8
"4197","de","en","rz des Hämatokritwertes, der Erythrozytenzahl und der Retikulozyten, welche mit den erwarteten pharmakologischen Wirkungen korrespondierten.","347 effect (decreased tissue perfusion due to increased blood viscosity).",10,15
"4198","de","en","rz Nahrungsmittel und Getränke haben keinen Einfluss auf Nespo.","Food and drink do not affect Nespo.",7,9
"4199","de","en","rz vor der Injektion entfernen.","solution with the air bubble is harmless.",7,5
"4200","de","en","S ≤ 0,03 mg/l S ≤ 0,03 mg/l S ≤ 0,5 mg/l","S ≤ 0.03 mg/L S ≤ 0.03 mg/L S ≤ 0.5 mg/L",12,12
"4201","de","en","s DNS-Technologie bzw. tierisches Insulin) kann eine Veränderung der Dosierung nach sich ziehen.","Changes in strength, brand (manufacturer), type (fast-, dual-, long-acting insulin etc.), Me",12,13
"4202","de","en","s las Es ist nicht bekannt, ob die Substanz beim Menschen in die Muttermilch übertritt.","3 ed It is not known if the substance is excreted in human milk.",14,15
"4203","de","en","s las Welchen Nutzen hat Advasure in diesen Studien gezeigt?","What benefit has Advasure shown during the studies?",8,10
"4204","de","en","Š marješ ka cesta 6 8501 Novo mesto Slowenien","Š marješ ka cesta 6 8501 Novo mesto Slovenia",9,9
"4205","de","en","S steht für „ short cap“ (= verkürzte innere Hülle der Injektionsnadel).","The S stands for short cap.",6,12
"4206","de","en","S-P Veterinary Ltd Breakspear Road South Harefield Uxbridge UB9 6LS Vereinigtes Königreich","S-P Veterinary Ltd Breakspear Road South Harefield Uxbridge UB9 6LS United Kingdom",12,12
"4207","de","en","Sabril poudre pour solution orale","Sabril poudre pour solution orale",5,5
"4208","de","en","Sagen Sie Ihrem Arzt, wenn Sie stillen.","Tell your doctor if you are breast-feeding.",7,7
"4209","de","en","Salbutamol Sandoz 100 µg/Dosis","100 μ g/ dose",4,4
"4210","de","en","Salzsäure 30%, Wasser für Injektionszwecke.","Hydrochloric acid 30%, water for injections.",6,5
"4211","de","en","Saquinavir hemmt selektiv die HIV-Protease und verhindert dadurch die Bildung reifer, infektiöser Viruspartikel.","Saquinavir selectively inhibits the HIV protease, thereby preventing the creation of mature infectious virus particles.",15,13
"4212","de","en","Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom Tel: +44 1 494 567 567","Saunderton High Wycombe Buckinghamshire HP14 4HJ United Kingdom Tel: +44 1 494 567 567",14,14
"4213","de","en","SBA-MenC- Ergebnisse sind für 177 Probanden verfügbar, Anti-PRP-Ergebnisse für 178 Probanden.","SBA-MenC results are available for 177 subjects, anti-PRP results for 178 subjects.",12,11
"4214","de","en","Schachtel mit 1 Mehrdosenbehältnis (der Inhalt beträgt 10 ml für 10 Dosen).","Box containing 1 multidose container (the content of 10 ml is equivalent to 10 doses).",15,12
"4215","de","en","Schaumbildung kann nicht vermieden werden, sollte aber unbedingt auf ein Min- destmaß eingeschränkt werden.","Although the concentrate will foam, every effort should be made to minimise the amount of foam generated.",17,14
"4216","de","en","Schefferlie und der Mitberichterstatter Prof.","Schefferlie and the co-rapporteur was Prof.",6,5
"4217","de","en","Schellack Propylenglycol Ammoniumhydroxid Indigocarmin (E132)","Shellac Propylene glycol Ammonium hydroxide Indigocarmin (E132)",7,5
"4218","de","en","Schellack, Propylenglycol, gereinigtes Wasser, Ammoniak-Lösung, Kaliumhydroxid, Eisen(II,III)-oxid (E 172).","Printing ink: shellac, propylene glycol, purified water, ammonium hydroxide, potassium hydroxide, black iron oxide (E 172).",16,9
"4219","de","en","Schering Hellas SA 466 Irakliou Ave. & 12-14","Schering Hellas SA 466 Irakliou Ave. & 12-14",8,8
"4220","de","en","Schering-Plough Europe, 73, Rue De Stalle, B-1180 Brussels, Belgien","Schering-Plough Europe, 73, Rue De Stalle, B-1180 Brussels, Belgium",9,9
"4221","de","en","Schieben Sie den Spritzenkolben langsam bis zur korrekten Dosis vor.","Push the plunger up slowly to the correct dose.",9,10
"4222","de","en","Schiefhals (Torticollis spasmodicus) Folgende Nebenwirkungen wurden bei der Anwendung von Xeomin beobachtet:","Twisted neck (spasmodic torticollis) The following side effects were reported with Xeomin:",12,12
"4223","de","en","Schienbeinen (Erythema nodosum), Herzklopfen","53 and/ or rash (Churg-Strauss syndrome) have been reported.",9,4
"4224","de","en","Schlafen zu verhelfen und/oder Ängste zu nehmen)","- cisapride (to treat some stomach conditions)",7,7
"4225","de","en","Schläfrigkeit, Benommenheit), Euphorie, vorübergehende anomale Bewegungen (z.","Very rare cases of idiosyncratic hepatitis.",6,7
"4226","de","en","Schläfrigkeit, peripheres Ödem und Asthenie können vor allem bei älteren Patienten auftreten.","Somnolence, peripheral oedema and asthenia may be more frequent in the elderly.",12,12
"4227","de","en","Schlafstörun- gen Apathie Verwirrtheit Zähneknir- schen","Sleep disorder Apathy Disorientation",4,6
"4228","de","en","Schlafstörungen, Kopfschmerzen, Übelkeit, Durchfall, Grippesymptome, Nervosität, Depressionen, Schmerzen, Schwitzen und Benommenheit.","The following events have been mentioned: insomnia, headache, nausea, diarrhoea, flu syndrome, nervousness, depression, pain, sweating and dizziness.",18,11
"4229","de","en","Schleimhäute, Zunge, Glottis und/ oder Larynx beschrieben.","blister strip in carton box PVC/ aluminium",7,7
"4230","de","en","Schleimhautentzündung Erythem am Verabreichungsort Lokalisiertes Ödem Ödem am Verabreichungsort Unwohlsein","Mucosal inflammation Infusion site erythema Localised oedema Infusion site oedema Malaise",11,10
"4231","de","en","Schließen Sie das Weithalsgefäß und schütteln Sie vorsichtig, bis sich das Pulver ganz gelöst hat.","The jar is closed and carefully shaken until all the powder has dissolved completely.",14,15
"4232","de","en","Schließen Sie den Pen durch Aufsetzen der Verschlußkappe.","Replace the cap on the pen.",6,8
"4233","de","en","Schlüsselelemente, die enthalten sein müssen","Key elements to be included",5,5
"4234","de","en","Schmerzen im Brustkorb, periphere Ödeme, Malaise, Schmerzen an der Injektionsstelle, Gesichtsödeme*","Chest pain, peripheral oedema, malaise, injection site pain, face oedema*",10,11
"4235","de","en","Schmerzen in den Extremitäten, Knochenschmerzen, Sklelettmuskulatur-, Bindegewebs- und","Nail disorder, pruritus, dry skin, erythema, nail discolouration, skin hyperpigmentation, onycholysis Skin and subcutaneous tissue disorders:",16,8
"4236","de","en","Schmerzen, Schüttelfrost, Komplikationen an der Infusionsvene.","Very common: fever Common: pain, chills, infused-vein complications",8,6
"4237","de","en","schnellstmöglichen Wechsels auf orale Behandlung) Infektionen der unteren Atemwege","Infections of the lower respiratory tract",6,9
"4238","de","en","Schrauben Sie die Injektionsnadel gerade und fest auf Ihren FlexPen.","Screw the needle straight and tightly onto your FlexPen.",9,10
"4239","de","en","Schrauben Sie die Spritze von der Entnahmevorrichtung ab.","Unscrew the syringe from the vial access device.",8,8
"4240","de","en","Schreiben Sie das Öffnungsdatum auf das Tablettenbehältnis.","Write the date of opening on the tablet container.",9,7
"4241","de","en","SCHRITT 1 Überprüfung des Pens","STEP 1 Check the Pen",5,5
"4242","de","en","SCHÜTTELN SIE DIE DURCHSTECHFLASCHE NICHT.","DO NOT SHAKE THE VIAL.",5,5
"4243","de","en","Schutzwirkung der flüssigen Formulierung:","Protective efficacy of the liquid formulation:",6,4
"4244","de","en","Schwangere und stillende Mütter sollten PREZISTA nicht einnehmen, es sei denn, der Arzt hat es ausdrücklich verordnet.","Pregnant or breast-feeding mothers should not take PREZISTA unless specifically directed by the doctor.",14,17
"4245","de","en","Schwangerschaft (siehe auch Abschnitte 4.4 und 4.6).","Pregnancy (see also sections 4.4 and 4.6).",7,7
"4246","de","en","Schwangerschaft Die Anwendung während der Schwangerschaft ist kontraindiziert.","Pregnancy Use during pregnancy is contraindicated.",6,8
"4247","de","en","Schwangerschaft Die bis heute vorliegenden Informationen zeigen kein erhöhtes Risiko, wenn (Phantasiebezeichnung) während der Schwangerschaft eingenommen wird.","Information collected to date does not indicate a increased risk when used during pregnancy.",14,17
"4248","de","en","Schwangerschaft Es liegen keine hinreichenden Daten für die Verwendung von Brinzolamid bei Schwangeren vor.","Pregnancy There are no adequate data from the use of brinzolamide in pregnant women.",14,14
"4249","de","en","Schwangerschaft Für Porfimer-Natrium liegen keine Daten über exponierte Schwangere vor.","Pregnancy There are no clinical data on exposed pregnancies available for porfimer sodium.",13,10
"4250","de","en","Schwangerschaft und Stillzeit Dieses Produkt sollte während Schwangerschaft und Stillzeit nicht eingenommen werden.","45 Pregnancy and breast-feeding It is preferable not to use this product during pregnancy and breast-feeding.",16,13
"4251","de","en","Schwangerschaft und Stillzeit Enviage darf während der Schwangerschaft nicht eingenommen werden.","Pregnancy and breast-feeding Do not take Enviage if you are pregnant.",11,11
"4252","de","en","Schwangerschaft und Stillzeit Es liegen keine Daten zur Anwendung von Daronrix in der Schwangerschaft vor.","38 Pregnancy and breast-feeding There is no information on the use of Daronrix in pregnant women.",16,15
"4253","de","en","Schwangerschaft und Stillzeit Fragen Sie vor der Einnahme/Anwendung von allen Arzneimitteln Ihren Arzt oder Apotheker um Rat.","Pregnancy and breast-feeding Ask your doctor or pharmacist for advice before taking any medicine.",14,17
"4254","de","en","Schwangerschaft und Stillzeit Naglazyme sollte nicht während der Schwangerschaft angewendet werden, es sei denn, es ist eindeutig erforderlich.","Pregnancy Naglazyme should not be used during pregnancy unless clearly necessary.",11,18
"4255","de","en","Schwangerschaft und Stillzeit Wenden Sie Protopy nicht an, wenn Sie schwanger sind oder stillen.","Don’ t use Protopy if you are pregnant or breast-feeding.",10,14
"4256","de","en","Schwangerschaftswoche) (siehe Abschnitt 4.4)","Apnoea in very premature infants (≤ 28 weeks of gestation) (see section 4.4)",13,4
"4257","de","en","Schweine (Sauen und Jungsauen).","Pigs (sows and gilts).",4,4
"4258","de","en","Schwenken Sie das Fläschchen vorsichtig, bis das Pulver vollständig gelöst ist.","Gently swirl each vial until the powder is completely dissolved.",10,11
"4259","de","en","Schwere allergische Reaktionen erfordern ein Absetzen der Behandlung und eine sorgfältige Überwachung.","Allergic reactions Anaphylactic reactions have been rarely reported, in some cases after previous topical exposure to retinoids.",17,12
"4260","de","en","Schwere Hypoglykämien, insbesondere wenn sie wiederholt auftreten, können zu neurologischen Schäden führen.","138 Severe hypoglycaemic attacks, especially if recurrent, may lead to neurological damage.",12,12
"4261","de","en","Schwere Nierenfunktionseinschränkung (Kreatinin-Clearance < 30 ml/min) (siehe Abschnitt 4.4).","Severe renal impairment (creatinine clearance < 30 ml/ min) (see section 4.4).",12,9
"4262","de","en","Schweres OHSS (siehe Abschnitt 4.4)","Severe OHSS (see section 4.4) Ovarian torsion, a complication of OHSS",11,5
"4263","de","en","Schwerwiegende Nebenwirkungen, einschließlich allergische und anaphylaktische Reaktionen wurden berichtet.","Severe effects have been reported, including allergic and anaphylactic reactions.",10,9
"4264","de","en","Schwerwiegende Überempfindlichkeitsreaktionen (Anaphylaxie und Angioödem) wurden bei Patienten berichtet, die Celecoxib erhielten (siehe Abschnitt 4.8).","Serious hypersensitivity reactions (anaphylaxis and angioedema) have been reported in patients receiving celecoxib (see section 4.8).",16,15
"4265","de","en","Schwerwiegender Muskelschaden und Schmerzen","Serious muscle damage and pain.",5,4
"4266","de","en","Schwindel Akathisie6 Parkinsonismus6 Dyskinesie6","Dizziness Akathisia6 Parkinsonism6 Dyskinesia6",4,4
"4267","de","en","Schwindel Parästhesien Kopfschmerzen Angstgefühle","CPMP/ 4514/ 02/ Final 1 TRADE NAME OF THE MEDICINAL PRODUCT",11,4
"4268","de","en","Schwindel, Kopfschmerzen, Konzentrationsstörungen, Mundtrockenheit","Dizziness, headache, concentration impaired, mouth dry",6,4
"4269","de","en","Schwindel, Tinnitus Hörverlust, Hörstörung","Vertigo, tinnitus Hearing loss, hearing disorder",6,4
"4270","de","en","se 5.3 Präklinische Daten zur Sicherheit","47 5.3 Preclinical safety data",5,6
"4271","de","en","se behandelten Patienten kann es zu einer Blutdruckerhöhung oder einer Verschlechterung einer bereits bestehenden Hypertonie kommen.","Patients on Dynepo therapy",4,16
"4272","de","en","se Genotyp 1 (n=92)","172 Genotype 1 (n=92)",4,4
"4273","de","en","se Obwohl Interferon im Allgemeinen als speziesspezifisch betrachtet wird, wurden Toxizitätstudien am Tier durchgeführt.","Although interferon is generally recognised as being species specific, toxicity studies in animals were lon conducted.",16,14
"4274","de","en","se örtlichen Vertreter des Pharmazeutischen Unternehmers in Verbindung.","If you want more information about this medicine, please contact the local representative of the Marketing Authorisation Holder.",18,8
"4275","de","en","se Zahnabszess, Herpes simplex, Harnwegsinfektion, Vaginitis, Gastroenteritis Gutartige, bösartige und","ge vaginitis, gastroenteritis Neoplasms benign, malignant and unspecified (including lon cysts and polyps) Common:",14,10
"4276","de","en","Sebivo Filmtabletten sind in Packungen mit 28 oder 98 Tabletten verfügbar.","Sebivo film-coated tablets are supplied in packs of 28 or 98 tablets.",12,11
"4277","de","en","Sehr häufig (bei mehr als einem Anwender von 10)","Very common (affects more than 1 user in 10) Headache Flushing",11,9
"4278","de","en","Sehr häufig • Übelkeit • Erbrechen","Very common • Vomiting • Nausea",6,6
"4279","de","en","sehr häufig häufig gelegentlich selten sehr selten","happening in more than 1 in 10 patients happening in 1 in 100 to 1 in 10 patients",18,7
"4280","de","en","Sehr häufig Nicht kontrollierbare Bewegungen (Dyskinesien), Übelkeit, unbedenkliche rotbraune Verfärbung des Urins.","Very common Uncontrollable movements (dyskinesias), feeling sick (nausea) and harmless reddish-brown discoloration of urine.",14,12
"4281","de","en","Sehr häufig: • Infektionen des Halses oder der Luftwege.","Very common: • Infection of the throat or airways.",9,9
"4282","de","en","Sehr häufige Nebenwirkungen (Nebenwirkungen, die bei 10 von 100 Patienten auftreten können, die Hepsera einnehmen)","Very common side effects (These can affect more than 10 in every 100 people taking Hepsera)",16,15
"4283","de","en","Sehr selten (< 1/10.000)","Very rare (< 1/ 10,000) i dic",7,4
"4284","de","en","Sehr selten (≤ 1/10 000)","Common (≥ 1/ 100, < 1/ 10)",7,5
"4285","de","en","Sehr selten (≤ 1/10 000) Störungen des Nervensystems:","Rare (≥ 1/ 10 000, < 1/ 1000) Very Rare (≤ 1/ 10 000) Nervous system disorders:",17,8
"4286","de","en","Sehr selten (≤ 1/10.000):","Very rare (≤ 1/ 10,000):",5,4
"4287","de","en","Sehr selten auftretende Nebenwirkungen (die bei weniger als einem von 10000 Patienten vorkommen):","The following side effects are very rare (occur in less than 1 in 10000 patients):",15,13
"4288","de","en","Sehr selten Sehr selten","Very rare Very rare",4,4
"4289","de","en","Sehr selten: § Psychiatrische Erkrankungen","Very rarely: § Psychiatric disorders",5,5
"4290","de","en","Sehr selten*: neurosensorischer Hörverlust, Vertigo","Very rare*: sensorineural hearing loss, vertigo",6,5
"4291","de","en","Sehstörungen, Photopsie, verschwommenes Sehen","visual disturbance, photopsia, blurred vision",5,4
"4292","de","en","Seine Sicherheit und Wirksamkeit wurde bei Frauen im Alter von 18 bis 45 Jahren untersucht.","Its safety and effectiveness have been studied in women aged 18 to 45 years.",14,15
"4293","de","en","Seit September 1997 ist sie bei der EMEA beschäftigt.","She joined the EMEA in September 1997.",7,9
"4294","de","en","Seite 2/2 ©EMEA 2007","Page 2/ 2 ©EMEA 2007",5,4
"4295","de","en","Seite 2/3 ©EMEA 2008 Warum wurde Equilis Prequenza zugelassen?","Why has Equilis Prequenza been approved?",6,9
"4296","de","en","Seite 3/3 ©EMEA 2007","Page 3/ 3 ©EMEA 2007",5,4
"4297","de","en","Selbst Versuchstiere in schlechtem Allgemeinzustand hatten sich innerhalb von 1– 2 Wochen weitgehend erholt.","Even experimental animals in a poor general state had largely recovered within 1– 2 weeks.",15,14
"4298","de","en","Selbsttötungsgedanken und entsprechendes Verhalten wurden während der Behandlung mit Aripiprazol berichtet.","Suicidal thoughts and behaviours have been reported during aripiprazole treatment.",10,11
"4299","de","en","Selten (bei mehr als 1 von 10000 Patienten beobachtet)","Rare (seen in more than 1 in 10,000 people)",9,9
"4300","de","en","Seltene, als MNS berichtete Fälle wurden auch im Zusammenhang mit Olanzapin erhalten.","Rare cases reported as NMS have also been received in association with olanzapine.",13,12
"4301","de","en","Separate leere sterile behältnisse","Separate empty sterile containers",4,4
"4302","de","en","September 2004 wurde ein Verfahren zur gegenseitigen Anerkennung eingeleitet.","A Mutual Recognition Procedure was started on 16 September 2004.",10,9
"4303","de","en","Seretide Diskus und zugehörige Namen (siehe Annex I) 50/500 mikrogramm einzeldosiertes Pulver zur Inhalation.","Seretide Diskus and associated names (see Annex I) 50/ 500 microgram/ dose inhalation powder, pre- dispensed.",16,14
"4304","de","en","Serono Europe Limited, 56 Marsh Wall, London E14 9TP, Vereinigtes Königreich","Serono Europe Limited, 56 Marsh Wall, London E14 9TP, United Kingdom.",11,11
"4305","de","en","Seroxat Suspensie 2 mg / ml","Seroxat Suspensie 2 mg / ml",6,6
"4306","de","en","Serum-Kalium- und -Phosphat-Spiegel sollten während der Behandlung mit NeoRecormon regelmäßig überprüft werden.","Serum potassium and phosphate levels should be monitored regularly during therapy with NeoRecormon.",13,12
"4307","de","en","Setzen Sie die Pen-Kappe wieder auf den Pen.","The pen cap should be replaced on the pen.",9,8
"4308","de","en","Setzen Sie sich an einen bequemen und hellen Platz, wo Sie die Dynepo Fertigspritze leicht erreichen können. ni","Find a comfortable, well-lit place and put the Dynepo pre-filled syringe where you can reach it. ct",17,18
"4309","de","en","Sevofluran hat eine dämpfende Wirkung auf die Atmung, die sich in einer Abnahme der Ventilationshäufigkeit äußert.","Sevoflurane has a depressive effect on respiration characterised by a fall in ventilation frequency.",14,16
"4310","de","en","Shire Park Welwyn Garden City Hertfordshire AL7 1TW - UK","Hertfordshire AL7 1TW - UK",5,10
"4311","de","en","Shire Park Welwyn Garden City Hertfordshire AL7 1TW Tel: +44-(0)1 707 363 636","Shire Park Welwyn Garden City Hertfordshire AL7 1TW i dic",10,13
"4312","de","en","SIA Merck Sharp & Dohme Latvija, Skanstes 13 Riga, LV-1013 Lettland","SIA Merck Sharp & Dohme Latvija Skanstes 13 Riga, LV-1013 Latvia",11,11
"4313","de","en","SICHERHEIT Das Sicherheitsprofil von Arzneimitteln, die Paroxetin enthalten wurde vom CHMP geprüft.","SAFETY The overall safety profile of paroxetine containing medicinal products was reviewed by the CHMP.",15,12
"4314","de","en","Sie anhand der Beschriftung Ihres SoloStar sicher, dass Sie das richtige Insulin","Check the label on your SoloStar to make sure you have the correct insulin.",14,12
"4315","de","en","Sie binden sich an den Rezeptor und verhindern die für ein weiteres Wachstum der Peptidkette notwendige Translokation.","They bind to the donor site and prevent the translocation necessary for keeping the peptide chain growing.",17,17
"4316","de","en","Sie diese senkrecht auf den Tubenverschluss wie in der Abbildung gezeigt.","Turn the cap upside-down and replace the cap vertically over the tip seal as shown in the diagram.",18,11
"4317","de","en","Sie dürfen {HANDELSNAME} 10 mg nicht verwenden, wenn Sie sichtbare Zeichen für eine Qualitätsminderung bemerken.","91 Do not use {PRODUCT NAME} 10 mg if you notice visible signs of deterioration.",15,15
"4318","de","en","Sie dürfen Busilvex nach dem auf dem Umkarton angegebenen Verfalldatum nicht mehr verwenden.","Do not use Busilvex after the expiry date which is stated on the carton.",14,13
"4319","de","en","Sie dürfen das Arzneimittel nach dem auf dem Etikett und Umkarton angegebenen Verfalldatum nicht mehr anwenden.","Do not use NovoRapid after the expiry date which is stated on the label and carton.",16,16
"4320","de","en","Sie dürfen das Arzneimittel nach dem auf dem Karton und dem Behältnis angegebenen Verfalldatum nicht mehr anwenden.","Do not use after the expiry date stated on the carton and the bottle.",14,17
"4321","de","en","Sie dürfen das Arzneimittel nach dem auf dem Umkarton angegebenen Verfalldatum nicht mehr anwenden.","Do not use Circadin after the expiry date which is stated on the carton.",14,14
"4322","de","en","Sie dürfen das Arzneimittel nach dem auf dem Umkarton und dem Flaschenetikett angegebenen Verfalldatum nicht mehr anwenden.","Do not use Sebivo after the expiry date which is stated on the carton and bottle label.",17,17
"4323","de","en","Sie dürfen das Arzneimittel nach dem auf den Durchstechflaschen nach ""verw. bis"" angegebenen Verfalldatum nicht mehr anwenden.","Do not use GONAL-f after the expiry date which is stated on the vial after the EXP.",17,17
"4324","de","en","Sie dürfen das Arzneimittel nach dem auf der Faltschachtel und der Blisterpackung angegebenen Verfalldatum nicht mehr verwenden.","Do not use Aerius after the expiry date which is stated on the carton and blister.",16,17
"4325","de","en","Sie dürfen das Arzneimittel nach dem auf der Verpackung angegebenen Verfallsdatum nicht mehr verwenden.","Do not use Ziagen after the expiry date which is stated on the package.",14,14
"4326","de","en","Sie dürfen den Impfstoff nach dem auf dem Umkarton und dem Etikett angegebenen Verfallsdatum nicht mehr anwenden.","Do not use Prevenar after the expiry date stated on the carton and label.",14,17
"4327","de","en","Sie dürfen die Behandlung nicht abbrechen, bevor Sie Ihren Arzt konsultiert haben.","You should not discontinue the treatment without first contacting your doctor.",11,12
"4328","de","en","Sie dürfen EXUBERA nur durch den Mund und über Ihr Insulin-Inhalationsgerät einatmen.","The blister will be punctured inside the inhaler when al",10,12
"4329","de","en","Sie dürfen Humalog KwikPen nicht anwenden, wenn die Lösung verfärbt ist oder feste Bestandteile enthält.","Do not use Humalog KwikPen, if the solution is coloured or it has solid pieces in it.",17,15
"4330","de","en","Sie dürfen ihn nicht einweichen, waschen oder mit einem Schmiermittel behandeln.","Do not soak it, wash or lubricate it.",8,11
"4331","de","en","Sie dürfen Inovelon nicht mehr anwenden, wenn Sie eine Veränderung der Färbung der Tabletten bemerken.","Do not use Inovelon if you notice a change in colour of the tablets.",14,15
"4332","de","en","Sie dürfen Kivexa nach dem auf der Verpackung angegebenen Verfallsdatum nicht mehr verwenden.","Do not use Kivexa after the expiry date stated on the packaging.",12,13
"4333","de","en","Sie dürfen nicht stillen wenn Sie TYSABRI erhalten.","Do not breast-feed whilst using TYSABRI.",6,8
"4334","de","en","Sie dürfen Optaflu nach dem auf dem Etikett und dem Umkarton angegebenen Verfalldatum nicht mehr anwenden.","Do not use Optaflu after the expiry date which is stated on the label and carton.",16,16
"4335","de","en","Sie dürfen Velmetia nach dem auf der Blisterpackung und dem Umkarton angegebenen Verfalldatum nicht mehr verwenden.","Do not use Velmetia after the expiry date which is stated on the blister and the carton.",17,16
"4336","de","en","Sie dürfen Viraf eron nicht verwenden, wenn Sie Veränderungen im Aussehen von Viraferon bemerken.","uth Do not use Viraferon if you notice changes in the appearance of Viraferon",14,14
"4337","de","en","Sie dürfen Zonegran während der Schwangerschaft nur einnehmen, wenn Ihr Arzt Sie dazu anweist.","You must only take Zonegran during your pregnancy if your doctor tells you to.",14,14
"4338","de","en","Sie erhalten Ihr Arzneimittel in Form einer Tablette mit verzögerter Wirkstofffreisetzung (Retardtablette).","Your medicine is in the form of prolonged-release tablets.",9,12
"4339","de","en","Sie erschien insbesondere bei Frauen und Patienten mit schwarzer Hautfarbe weniger günstig (siehe Abschnitt 5.1).","In particular, they appeared less favourable in women and non-white subjects (see section 5.1).",14,15
"4340","de","en","Sie hören keine Klickge- räusche beim Injizieren.","You don’t hear clicking while injecting.",6,7
"4341","de","en","Sie ist eine überwiegend atherogene Mischung erhöhter Werte von LDL- und VLDL-Cholesterin.","It is a particularly atherogenic mixture of elevated LDL-cholesterol and VLDL- cholesterol.",12,12
"4342","de","en","Sie kann auch mit einem geeigneten Autoinjektor verabreicht werden.","It may also be administered with a suitable auto-injector.",9,9
"4343","de","en","Sie können auch weiterhin Infektionen oder andere Erkrankungen entwickeln, die mit der HIV-Infektion einhergehen.","You may continue to develop infections or other illnesses linked to HIV infection.",13,14
"4344","de","en","Sie können die Suspension zusammen mit einer Mahlzeit oder zwischen den Mahlzeiten einnehmen.","You can take the suspension at mealtimes or in between meals.",11,13
"4345","de","en","Sie können Dosen zwischen 2 und 78 Einheiten in Schritten von jeweils 2 Einheiten einstellen.","You can dial doses from 2 to 78 units in increments of 2 units.",14,15
"4346","de","en","Sie können einen Wattebausch oder Mull auf die Injektionsstelle drücken.","You can press a cotton ball or gauze over the injection site.",12,10
"4347","de","en","Sie können Karvezide unabhängig von den Mahlzeiten einnehmen.","You can take Karvezide with or without food.",8,8
"4348","de","en","Sie können maximal 4 Wochen lang bei einer Temperatur von nicht über 25 °C aufbewahrt werden.","After first use: the product may be stored for a maximum of 4 weeks not above 25°C.",17,16
"4349","de","en","Sie können niemanden damit anstecken.","You can’ t pass it on to anyone else.",9,5
"4350","de","en","Sie können sich nach der Einnahme von PROTELOS sofort hinlegen, wenn Sie möchten.","You may lie down immediately after taking PROTELOS if you wish.",11,13
"4351","de","en","Sie könnten dann empfindlicher auf die Nebenwirkungen von","Remeron is used to treat depressive illness.",7,8
"4352","de","en","Sie müssen den Grund für Ihre Unterzuckerung herausfinden, um weitere Unterzuckerungen zu","If you do not respond to glucagon treatment, you will have to be treated lp",15,12
"4353","de","en","Sie müssen diese Diät sorgfältig einhalten.","through the kidney and liver.",5,6
"4354","de","en","Sie müssen Ihrem Arzt mitteilen, wenn Sie vermuten schwanger zu sein (oder schwanger werden könnten).","You must tell your doctor if you think that you are (or might become) pregnant.",15,15
"4355","de","en","Sie müssen Plavix so lange einnehmen, wie es Ihnen Ihr Arzt verordnet.","You should take Plavix for as long as your doctor continues to prescribe it.",14,12
"4356","de","en","Sie müssen regelmäßigen Kontakt zu Ihrem Arzt halten.","You must keep in regular contact with your doctor.",9,8
"4357","de","en","Sie müssen sich selbst eine LITAK-Injektion direkt unter die Haut geben.","You will need to give yourself an injection into the tissue just under the skin.",15,11
"4358","de","en","Sie müssen weiterhin entsprechende Vorsichtsmaßnahmen einhalten.","They must continue to use appropriate precautions.",7,6
"4359","de","en","Sie Nebenwirkungen bemerken, die nicht in dieser Gebrauchsinformation angegeben sind, informieren Sie bitte Ihren Arzt oder Apotheker.","please tell your doctor or pharmacist.",6,17
"4360","de","en","Sie sehen darauf einen blauen Strich.","You will see a blue line on it.",8,6
"4361","de","en","Sie sind in Flaschen abgepackt.","They are packed in bottles.",5,5
"4362","de","en","Sie sollten daher auch während der Therapie mit VIRACEPT in ärztlicher Behandlung bleiben.","You should, therefore, remain under the care of your doctor while taking VIRACEPT.",13,13
"4363","de","en","Sie sollten es Ihrem Arzt mitteilen, wenn dies bei Ihnen auftritt.","You should tell your doctor if this happens to you.",10,11
"4364","de","en","Sie sollten Ihre Zähne zweimal täglich gründlich putzen und regelmäßige zahnärztliche Untersuchungen durchführen lassen.","You should brush your teeth thoroughly twice daily and have regular dental examinations.",13,14
"4365","de","en","Sie sollten Ihrem Arzt berichten, wenn Sie neue oder ungewöhnliche Symptome und Begebenheiten beobachten.","You should report any new and exceptional symptoms and circumstances whenever you see your doctor.",15,14
"4366","de","en","Sie sollten nicht zu einem anderen Vernebler wechseln, ohne vorher Ihren Arzt um Rat gefragt zu haben.","You should not switch to another nebuliser without consulting your treating doctor.",12,17
"4367","de","en","Sie sollten Rasilez nicht zusammen mit Grapefruitsaft einnehmen.","You should not take Rasilez together with grapefruit juice.",9,8
"4368","de","en","Sie sollten Tadalafil Lilly nicht zusammen mit irgendeiner anderen Behandlung der erektilen Dysfunktion anwenden.","You should not use Tadalafil Lilly together with any other treatments for erectile dysfunction.",14,14
"4369","de","en","Sie sollten über frühe Anzeichen einer solchen","These symptoms can constitute an early",6,7
"4370","de","en","Sie sollten vor der Testdurchführung 6 Stunden gefastet haben, vorzugsweise über Nacht.","The test should be carried out after having fasted 6 hours before application, preferably overnight.",15,12
"4371","de","en","Sie sollten Zyrtec nicht während der Stillzeit einnehmen, da Cetirizin in die Muttermilch übergeht.","You should not take Zyrtec during breast feeding because cetirizine passes into breast milk.",14,14
"4372","de","en","Sie war zuständig für 33 Leitlinien, von denen 12 neu erarbeitet und 5 veröffentlicht wurden.","Two workshops were organised in 2001, with patient representative organisations and with sponsors and pharmaceutical industry organisations.",17,15
"4373","de","en","Sie werden einen leichten Widerstand spüren, wenn die Nadel den Stopfen durchstößt.","You will feel a slight resistance as the needle passes through the stopper.",13,12
"4374","de","en","Sie werden gebeten, sich auf die MRT-Untersuchungsliege zu legen.","You will be asked to lie down on the MRI scanning bed.",12,9
"4375","de","en","Sie werden nur 2 Dosen von Simulect erhalten.","You will only be given two doses of Simulect.",9,8
"4376","de","en","Sie wird subkutan injiziert (unter die Haut gespritzt).","It is given by subcutaneous injection (under the skin).",9,8
"4377","de","en","Sie wirken beide auf ähnliche Weise gegen zu hohen Blutdruck, indem Sie die Blutgefäße entspannen.","They act in similar ways to reduce blood pressure by allowing the blood vessels to relax.",16,15
"4378","de","en","Siehe 3 Wie ist Mixtard anzuwenden?","See 3 How to use Mixtard.",6,6
"4379","de","en","Siehe Abschnitt 4.4 „ Warnhinweise und Vorsichtsmaßnahmen für die Anwendung“ und 5.2 „ Pharmakokinetische Eigenschaften“.","See 4.4 Special warning and precautions for use and 5.2 Pharmacokinetic properties.",12,15
"4380","de","en","Siehe Abschnitt 4.4 Flache Narkose.","See section 4.4 light anaesthesia.",5,5
"4381","de","en","Siehe Abschnitt 6.5 für die Anzahl der Dosen je Glasfläschchen.","See section 6.5 for the number of doses per vial.",10,10
"4382","de","en","Simulect kann Ihr Kind schädigen.","Simulect may harm your baby.",5,5
"4383","de","en","SINGULAIR 4 mg Granulat","SINGULAIR 4 mg granules",4,4
"4384","de","en","Sint Lenaartseweg 48/4 B-2320 Hoogstraten Belgien","Sint Lenaartseweg 48/ 4 B-2320 Hoogstraten Belgium",7,6
"4385","de","en","Sitagliptin 50 mg + Metformin 1000 mg (n=178)","Sitagliptin 50 mg + metformin 1000 mg (N=178)",8,8
"4386","de","en","Sitzungen des CPMP im Jahr 1998","CPMP meetings in 1998",4,6
"4387","de","en","Sitzungen des Verwaltungsrates 2003","3.10 Veterinary mutual recognition facilitation group 2 EMEA Work Programme 2003",11,4
"4388","de","en","Skelettmuskula-tur-, Bindegewebs- und Knochen-erkrankungen","Musculoskeletal and connective tissue disorders",5,4
"4389","de","en","Skelettmuskulatur- und Bindegewebserkrankungen Häufig:","Musculoskeletal system and connective tissue disorders Common: back pain, arthralgia",10,4
"4390","de","en","Skelettmuskulatur-, Bindegewebs- und Knochenerkrankungen Arthralgien, Myalgien","Musculoskeletal and connective tissue disorders: arthralgia, myalgia.",7,6
"4391","de","en","Skelettmuskulatur-, Bindegewebs- und Knochenerkrankungen Selten:","Musculoskeletal and connective tissue disorders Rare: muscle cramp",8,5
"4392","de","en","Skelettmuskulatur-, Bindegewebs- und Knochenerkrankungen:","49 Musculoskeletal, connective tissue and bone disorders:",7,4
"4393","de","en","Slovakofarma As Nitrianská 100 92027 Hlomovec Ungarn","Slovakofarma As Nitrianská 100 92027 Hlomovec Hungary",7,7
"4394","de","en","Smithkline Beecham Pharmaceuticals New Horizont Court, TW8 9EP Brentford, Middlesex UK","Smithkline Beecham Pharmaceuticals New Horizont Court, TW8 9EP Brentford, Middlesex UK",11,11
"4395","de","en","So viele Unterlagen wie möglich und zumindest die Zusammenfassungen der Merkmale des Arzneimittels sollten auf Englisch vorgelegt werden.","As many documents as possible, and at least the SPCs, should be presented in English.",15,18
"4396","de","en","Sobald Sie die Flüssigkeit eingespritzt haben, entfernen Sie die Injektionsnadel und l assen die Haut los.","Remove the needle and let go of your skin.",9,16
"4397","de","en","Sofern eine Lymphopenie auftritt, ist die Prophylaxe fortzusetzen bis sich die Lymphopenie bis zum Grad ≤ 1 bessert.","If lymphopenia occurs, they are to continue the prophylaxis until recovery of lymphopenia to grade ≤ 1.",17,18
"4398","de","en","Sofern keine anderen klinischen Indikationen vorliegen, sollte die Leberfunktion alle 6 Monate untersucht werden.","Unless otherwise clinically indicated, liver function should be checked every 6 months.",12,14
"4399","de","en","Sofort oder innerhalb von 3 Stunden nach Auflösen verwenden.","Use immediately or within 3 hours of reconstitution.",8,9
"4400","de","en","Software für die Verwaltung des Help- Desk ist im Hause entwickelt worden und wird regelmäßig aktualisiert.","Software for the management of the Help Desk has been developed in-house and is regularly updated.",16,16
"4401","de","en","Solange hohe Ciclosporinspiegel vorliegen, darf < Phantasiebezeichnung > nicht verabreicht werden.","In practice ,< Invented name > therapy has been",9,11
"4402","de","en","Solange nicht unbedingt notwendig sollte Zeritnicht während der Schwangerschaft verwendet werden.","Zerit should not be used during pregnancy unless clearly necessary.",10,11
"4403","de","en","Solchen Hautveränderungen können Sie vorbeugen, indem Sie bei","Changing the site with each injection may help to prevent such skin changes.",13,8
"4404","de","en","Soliris 300 mg Konzentrat zur Herstellung einer Infusionslösung Eculizumab","NAME OF THE MEDICINAL PRODUCT Soliris 300 mg concentrate for solution for infusion Eculizumab",14,9
"4405","de","en","Sollte dies bei Ihnen der Fall sein, sollten Sie nicht am Straßenverkehr teilnehmen oder Maschinen bedienen.","If you feel dizzy or tired, do not drive or operate machinery.",12,16
"4406","de","en","Sollte eine anaphylaktoide Reaktion auftreten, ist die Injektion sofort","If an anaphylactoid reaction occurs, the injection should be discontinued immediately and appropriate therapy should be initiated.",17,9
"4407","de","en","Sollte eine Anwendung nicht vermieden werden können, sind ein sorgfältiges Monitoring und eine Flüssigkeitstherapie erforderlich.","If use cannot be avoided, these animals require careful monitoring and fluid therapy.",13,15
"4408","de","en","Sollte eine Hündin nach einer induzierten Läufigkeit trächtig werden, könnten Resorption der Embryonen oder Abort auftreten.","If a bitch becomes pregnant following induced heat, embryonic resorption or abortion may occur.",14,16
"4409","de","en","sollte mit Valproat unabhängig von weiterer Begleitmedikation","should be used with valproate regardless of any",8,7
"4410","de","en","Sollten die geschilderten Symptome auftreten, ist so schnell wie möglich eine sorgfältige ärztliche Untersuchung angezeigt.","Should the above mentioned symptoms occur, a careful medical examination is indicated as soon as possible.",16,15
"4411","de","en","Sollten Sie die Anwendung der Pflaster einmal mehrere Tage lang unterbrochen haben, müssen Sie","If you have not applied a patch for several days, talk to your doctor before applying another one.",18,14
"4412","de","en","Sollten Sie oder jemand in Ihrer Familie an dieser Erkrankung leiden, sollten Sie Ihren Arzt aufsuchen.","If you or someone in your family suffers from this disease, you should consult your doctor.",16,16
"4413","de","en","Somatropin erhöht zudem die Herzleistung; der Mechanismus ist aber noch unklar.","Somatropin also increases cardiac output, but the mechanism has yet to be clarified.",13,11
"4414","de","en","SOMAVERT 10 mg Pulver und Lösungsmittel zur Herstellung einer Injektionslösung","SOMAVERT 10 mg powder and solvent for solution for injection.",10,10
"4415","de","en","Somit sind die Patienten normalerweise fahrtüchtig und können auch Aufgaben, die Konzentration erfordern, ausführen.","This means that patients usually may drive or perform tasks requiring concentration.",12,14
"4416","de","en","SonoVue wurde in sechs Hauptstudien an insgesamt 895 Patienten untersucht.","SonoVue has been studied in a total of 895 patients in six main studies.",14,10
"4417","de","en","Sonstige Bestandteile siehe unter 6.1.","For excipients, see 6.1.",4,5
"4418","de","en","Sorbitanoleat, 2-Ethylhexylacrylat - 1-Vinyl-2-Pyrrolidon-Copolymer, E110, E180, Ciaftalan-Kupfer, Polyethylen, silikonisierter Polyester.","Sorbitan oleate, 2-Ethylhexylacrylate – 1-Vinyl-2-pyrrolidone copolymer, E110, E180, copper phthalocyanine blue pigment, polyethylene, siliconised polyester.",15,10
"4419","de","en","Sowohl in klinischen Studien als auch in Anwendungsbeobachtungen wurde gelegentlich über Überempfindlichkeitsreaktionen berichtet.","5 Manifestations of hypersensitivity have been reported uncommonly in both clinical and post-marketing settings.",14,13
"4420","de","en","SP Europe Rue de Stalle, 73 B-1180 Bruxelles, Belgien","SP Europe Rue de Stalle, 73 B-1180 Bruxelles, Belgium",9,9
"4421","de","en","sp Pro Dosis von 2 ml:","e sp Per dose of 2 ml:",7,6
"4422","de","en","Spätkomplikationen bei Erwachsenen und Kindern im Alter über 12 Jahren.","adults and children above 12 years of age.",8,10
"4423","de","en","Specifar Abee 28th October Street No 1 Agia Barbara 12351 Griechenland","Specifar Abee 28th October Street No 1 Agia Barbara 12351 Greece",11,11
"4424","de","en","Spezielle Studien zur Beurteilung der Verringerung des Risikos von Komplikationen wurden nicht durchgeführt.","Specific studies have not been conducted to assess of the reduction in the risk of complications.",16,13
"4425","de","en","SPEZIFISCHE AUFLAGEN, DIE VOM INHABER DER GENEHMIGUNG FÜR DAS INVERKEHRBRINGEN ERFÜLLT WERDEN MÜSSEN","SPECIFIC OBLIGATIONS TO BE FULFILLED BY THE MARKETING AUTHORISATION HOLDER",10,13
"4426","de","en","Spezifisches Bibliotheks-, Dokumentations- und Vervielfältigungsmaterial","Special library, documentation and reproduction equipment",6,5
"4427","de","en","Spielsucht (pathologisches Spielen), zwanghaftes Einkaufen, sowie","increased sexual desire), binge eating.",5,6
"4428","de","en","Spironolacton nicht in Verbindung mit NSAIDs bei Hunden mit Niereninsuffizienz anwenden.","Do not administer spironolactone in conjunction with NSAIDs to dogs with renal insufficiency.",13,11
"4429","de","en","Sprechen Sie mit Ihrem Arzt, bevor Sie mit der Einnahme von Exforge beginnen.","If any of these apply to you, tell your doctor before taking Exforge.",13,13
"4430","de","en","Sprechen Sie mit Ihrem Arzt, falls Sie eine der folgenden Erkrankungen haben oder schon einmal hatten:","Consult your doctor if you have or have ever had:",10,16
"4431","de","en","Sprimeo sollte einmal täglich mit einer leichten Mahlzeit und vorzugsweise jeden Tag zur selben Zeit eingenommen werden.","Sprimeo should be taken with a light meal once a day, preferably at the same time each day.",18,17
"4432","de","en","Spritzen im Umkarton lagern, um sie vor Licht zu schützen. ei","Keep the syringes in the outer carton to protect from du",11,11
"4433","de","en","Spülen Sie sie nicht die Toilette hinunter und werfen Sie sie nicht in das Abwassersystem.","Do not flush them down the toilet, nor place them in liquid waste disposal systems.",15,15
"4434","de","en","Spuren von Heparin) enthalten.","The injection syringes must not contain any other medicinal product or residue (e. g. traces of heparin).",17,4
"4435","de","en","Stabilisieren Sie die Haut, indem Sie sie spannen oder eine größere Fläche zusammendrücken.","Stabilise the skin by spreading it or pinching up a large area.",12,13
"4436","de","en","Stada Arzneimittel AG Stadastraße 2-18 D-61118 Bad Vibel Deutschland","Stada Arzneimittel AG Stadastraße 2-18 D-61118 Bad Vibel Germany",9,9
"4437","de","en","STAMARIL (oder anderer nationaler Handelsname) Pulver in Fläschchen zur Herstellung einer Injektionssuspension Gelbfieber-Lebendimpfstoff","Yellow fever vaccine (Live).",4,13
"4438","de","en","Stamm (IVR-116) 15 Mikrogramm HA**","A/ New Caledonia/ 20/ 99 (H1N1) like strain (IVR-116) 15 micrograms HA**",12,5
"4439","de","en","Stamm (NYMC X-161) 9 Mikrogramm HA**","A/ Wisconsin/ 67/ 2005 (H3N2) like strain (NYMC X-161) 9 micrograms HA**",12,6
"4440","de","en","Stand Zur Stellungnahme herausgegeben im Januar 2001","Released for consultation January 2001",5,7
"4441","de","en","Standard- Doxorubicin-HCl zeigt eine ausgeprägte Gewebeverteilung (Verteilungsvolumen:","Standard doxorubicin hydrochloride displays extensive tissue distribution (volume of distribution:",10,7
"4442","de","en","Standard- Vorlagefristen für PSURs.","LABELLING AND PACKAGE LEAFLET",4,4
"4443","de","en","Stark eingeschränkte Leberfunktion (Child-Pugh C Stadium), besonders schwere hepatobiliäre Obstruktion.","Severely reduced liver function (Child - Pugh class C), especially severe obstructive hepatobiliary disease.",14,10
"4444","de","en","Stärke 300 mg 600 mg 400 mg","Strength 300 mg 600 mg 400 mg",7,7
"4445","de","en","Starkes Schütteln kann zur Aggregation von Pegfilgrastim führen, so dass es biologisch inaktiv wird.","Excessive shaking may aggregate pegfilgrastim, rendering it biologically inactive. od",10,14
"4446","de","en","STARTVAC ist eine elfenbeinfarbene, homogene Emulsion zur Injektion.","STARTVAC is an ivory-coloured homogeneous emulsion for injection.",8,8
"4447","de","en","Statut der Beamten der Europäischen Gemeinschaften, insbesondere Artikel 14 des Anhangs VII.","Staff Regulations of officials of the European Communities, and in particular Article 14 of Annex VII thereto.",17,12
"4448","de","en","Stechen Sie die Nadel schnell und kräftig in die Hautfalte.","Insert the needle into the skin fold with a quick, firm action.",12,10
"4449","de","en","Stechen Sie mit der Injektionsnadel unter die Hautoberfläche, wie es Ihnen Ihr Arzt oder Apotheker gezeigt hat.","Put the needle fully into the skin as shown by your nurse or doctor.",14,17
"4450","de","en","Stechen Sie nun die Injektionsnadel in die Durchstechflasche mit dem lang wirkenden Insulin 6.","Now push the needle into the vial of long-acting insulin 6.",11,14
"4451","de","en","Stecken Sie die Spitze der Pipette in die Öffnung des weißen Stopfens.","Insert nozzle of syringe into opening of white stopper.",9,12
"4452","de","en","Steht keine Sicherheitsbox zur Verfügung, sollte die Ausstattung um eine Maske und Sicherheitsgläser ergänzt werden.","If no safety box is available, the equipment should be supplemented with a mask and protective glasses.",17,15
"4453","de","en","STELARA 45 mg Injektionslösung","STELARA 45 mg solution for injection",6,4
"4454","de","en","Stellen Sie die offene Ampulle behutsam aufrecht auf Ihre Arbeitsfläche.","Carefully place the open ampoule upright on the work surface.",10,10
"4455","de","en","Stellen Sie Flasche und Spritze auf den Kopf.","Turn the vial and syringe upside down.",7,8
"4456","de","en","Stellen Sie sicher, dass sich die Spitze der Nadel in der Lösung befindet.","Ensure that the tip of the needle is in the solution.",11,13
"4457","de","en","Stellen Sie sicher, dass Sie Glivec so lange einnehmen, wie es Ihnen verschrieben wird.","Make sure you take Glivec for as long as it is prescribed.",12,14
"4458","de","en","Steriles, weißes bis weißliches Pulver.","Sterile white to off-white powder.",5,5
"4459","de","en","Stevens-Johnson-Syndrom†, toxische epidermale Nekrolyse†","Stevens-Johnson syndrome, toxic epidermal necrolysis",5,4
"4460","de","en","Stillzeit Die Ergebnisse von Untersuchungen am Menschen haben gezeigt, dass Tacrolimus in die Muttermilch ausgeschieden wird.","Lactation Human data demonstrate that tacrolimus is excreted into breast milk.",11,16
"4461","de","en","Stillzeit Geringe Mengen Paroxetin gehen in die Muttermilch über.","Lactation Small amounts of paroxetine are excreted into breast milk.",10,9
"4462","de","en","Stillzeit Ob Nilotinib in die Muttermilch übertritt, ist nicht bekannt.","Lactation It is not known whether nilotinib is excreted in human milk.",12,10
"4463","de","en","Stillzeit Optaflu erhalten sollten.","Therefore your doctor will decide whether you should receive Optaflu if you are pregnant or breast- feeding.",17,4
"4464","de","en","Stillzeit Teilen Sie Ihrem Arzt unverzüglich mit, ob Sie stillen.","Breast-feeding Tell your doctor at once if you are breast-feeding.",10,10
"4465","de","en","Stillzeit Wenn Sie stillen, dürfen Sie {HANDELSNAME} nicht einnehmen.","Breast-feeding Do not take {PRODUCT NAME} if you are breast-feeding.",10,9
"4466","de","en","STOCRIN 50 mg Filmtabletten Efavirenz","STOCRIN 50 mg film-coated tablets efavirenz",6,5
"4467","de","en","STOCRIN muss in Kombination mit anderen antiretroviralen Arzneimitteln angewendet werden (siehe Abschnitt 4.5).","STOCRIN must be given in combination with other antiretroviral medicines (see section 4.5).",13,13
"4468","de","en","Stoffwechsel- und Ernährungsstörungen Häufig","Metabolism and nutrition disorders common",5,4
"4469","de","en","Stoffwechsel- und Ernährungsstörungen Häufig Gelegentlich Selten","Blood and lymphatic system disorders Rare Neutropenia Metabolism and nutrition disorders Common Uncommon Rare Psychiatric disorders",16,6
"4470","de","en","Stoffwechsel- und Ernährungsstörungen U","Metabolism and nutritional disorders Uncommon:",5,4
"4471","de","en","Stomatitis, Glossitis, Anorexie, Nausea, Emesis, abdominelle Schmerzen, weicher Stuhlgang oder Diarrhö.","Stomatitis, glossitis, anorexia, nausea, emesis, abdominal pain, loose stool or diarrhoea.",11,11
"4472","de","en","Störung der Geschmacks- empfindung","Metabolism and nutrition disorders",4,4
"4473","de","en","Strada Statale No 17, km 22 I-67019 Scoppito (L'Aquila), Italien Ar","Strada Statale No 17, km 22 I-67019 Scoppito (L’ Aquila), Italy",11,11
"4474","de","en","STRONGHOLD 45 mg Lösung zum Auftropfen","STRONGHOLD 45 mg spot-on solution",5,6
"4475","de","en","Studien an Ratten ergaben, dass Atazanavir in die Milch ausgeschieden wird.","Studies in rats have demonstrated that atazanavir is excreted in the milk.",12,11
"4476","de","en","Studien zur Karzinogenität von Nelarabin wurden nicht durchgeführt.","Carcinogenicity testing of nelarabine has not been performed.",8,8
"4477","de","en","Studien zur Reproduktionstoxizität an Ratten, Kaninchen und Affen ergaben keine teratogenen Eigenschaften.","Reproduction toxicology studies in the rat, rabbit and monkey did not disclose any teratogenic properties.",15,12
"4478","de","en","Studienabschluss in Betriebswirtschaftslehre am Institut Supérieur de Gestion in Paris.","He is a graduate in business administration from the Institut Supérieur de Gestion in Paris.",15,10
"4479","de","en","Studienabschluß in Pharmazie an der Universität Straßburg.","Qualified pharmacist from the University of Strasbourg.",7,7
"4480","de","en","Stunden vor der Transplantation zu verabreichen.","The active substance in Zenapax, daclizumab, is a monoclonal antibody.",10,6
"4481","de","en","Su verursachen, die bis zu vier Wochen anhält.","Su Porcilis Pesti contains mineral oil.",6,8
"4482","de","en","Subkutane oder intramuskuläre Anwendung.","Subcutaneous or Intramuscular use.",4,4
"4483","de","en","Subkutane oder intravenöse Anwendung","Subcutaneous or intravenous use",4,4
"4484","de","en","Subkutane und intramuskuläre Anwendung von Rebif sind bezüglich der Verfügbarkeit von Interferon beta äquivalent.","Subcutaneous and intramuscular administrations of Rebif produce equivalent exposure to interferon beta.",12,14
"4485","de","en","Suboxone 2 mg/0,5 mg Sublingualtabletten Buprenorphin / Naloxon","Suboxone 2 mg/ 0.5 mg sublingual tablets buprenorphine / naloxone",10,8
"4486","de","en","Succursale belge/Belgisch bijhuis Tél/Tel: +32 (0) 2 373 42 11 MSDBelgium_info@merck.com","Succursale belge/ Belgisch bijhuis Tél/ Tel: +32 (0) 2 373 42 11 MSDBelgium_info@merck. com",14,11
"4487","de","en","Sucralfat/Antazida können die Bioverfügbarkeit von Lansoprazol reduzieren.","Sucralfate/Antacids may decrease the bioavailability of lansoprazole.",7,7
"4488","de","en","Sucrose Natriumcitrat Methionin Polysorbat 20 Benzylalkohol Wasser für Injektionszwecke.","43 benzyl alcohol water for injections.",6,9
"4489","de","en","Sucrose Natriumdihydrogenphosphat-Monohydrat Dinatriumhydrogenphosphat-Dihydrat Methionin Polysorbat 20 konzentrierte Phosphorsäure Natriumhydroxid","Sucrose Sodium dihydrogen phosphate monohydrate Disodium phosphate dihydrate",8,9
"4490","de","en","Sucrosemonopalmitat, eine Esterverbindung, entsprechen theoretisch, wenn vollständig aufgelöst, maximal 5,9 mg Sucrose (Saccharose).","which is an ester, theoretically corresponds to maximally 5.9 mg of sucrose when fully hydrolysed.",15,13
"4491","de","en","Suizidgedanken und Verschlechterung Ihrer Depression oder Angststörung","Thoughts of suicide and worsening of your depression or anxiety disorder",11,7
"4492","de","en","Summen, Klingeln oder Pfeifen;","Cases of diabetes mellitus or increased blood sugars have been reported in patients receiving Kaletra.",15,4
"4493","de","en","Supra- ventrikuläre Arrhythmien, überwiegend Vorhof- flimmern","Nervous System Disorders Headache (15.3%) Somnolence (10.9%) Dizziness (10.3%)",9,6
"4494","de","en","Supraventrikuläre Arrhythmien, überwiegend Vorhofflimmern","Supra-ventricular arrhythmia, mainly atrial fibrillation",5,4
"4495","de","en","suspensie 100 microgram per dosis","aërosol, suspensie 100 microgram per dosis",6,5
"4496","de","en","Symptome einer Überdosierung können Schwindel und Kopfschmerzen sein.","Symptoms of overdose may be dizziness and headache.",8,8
"4497","de","en","Symptome können bis zu 24 Stunden nach Einnahme ausbleiben.","Symptoms may not be present for up to 24 hours after ingestion.",12,9
"4498","de","en","Synthon B V Microweg 22 6545 GN Nijmegen The Netherlands","Synthon B V Microweg 22 6545 GN Nijmegen The Netherlands",10,10
"4499","de","en","systemischer Lupus erythematodes, Muskelschwäche, Arthritis","systemic lupus erythematosus, muscle weakness, arthritis",6,5
"4500","de","en","Systemorganklasse Infektionen und parasitäre Erkrankungen","System Organ Class Infections and infestations",6,5
"4501","de","en","T IBOTEC, eine Division von JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300","T IBOTEC, eine Division von JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300",17,17
"4502","de","en","Tabelle 1 zeigt eine Zusammenfassung der Nebenwirkungen in klinischen Psoriasis-Studien.","Table 1 provides a summary of adverse reactions from psoriasis clinical studies.",12,10
"4503","de","en","Tabelle 12 Aufrechterhaltung der klinischen Remission und des Ansprechens (Prozent der Patienten)","23 Table 12 Maintenance of Clinical Remission and Response (Percent of Patients)",12,12
"4504","de","en","Tabelle 14 Psoriasis-Studie II (CHAMPION) Wirksamkeitsergebnisse nach 16 Wochen","Table 14 Ps Study II (CHAMPION) Efficacy Results at 16 Weeks",11,9
"4505","de","en","Tabelle 3a Richtlinien für die Dosierungsänderung für die PegIntron- Monotherapie Laborwerte","Table 3a Dose modification guidelines for PegIntron monotherapy",8,11
"4506","de","en","Tablette in den Fang des Hundes legen.","Place the tablet in the dog’ s mouth.",8,7
"4507","de","en","Tablette Tablette Tablette Tablette Tablette","Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet Tablet",15,5
"4508","de","en","Tablettenbruchstücke sollten in der Original-Blisterpackung aufbewahrt werden.","Partially used tablets should be stored in the original blister pack.",11,7
"4509","de","en","Tablettenkern Lactose-Monohydrat HyproloseCrospovidon mikrokristalline Cellulose Magnesiumstearat","Tablet core Lactose monohydrate Hyprolose Crospovidone Microcrystalline cellulose Magnesium stearate",10,6
"4510","de","en","TachoSil darf nur von erfahrenen Chirurgen unter sterilen Bedingungen angewendet werden.","TachoSil should only be used by an experienced surgeon under sterile conditions.",12,11
"4511","de","en","Tadalafil Lilly wird zur Behandlung von Männern mit erektiler Dysfunktion angewendet.","Tadalafil Lilly is a treatment for men with erectile dysfunction.",10,11
"4512","de","en","Tag nach der Transplantation (8 - 15 ng/ml) und nach 6 Monaten (5 - 10 ng/ml) entsprechend eingestellt.","40 15 ng/ ml by Day 5 and 5 to 10 ng/ mL after Month 6.",16,18
"4513","de","en","TAM-Mutationen könnten selektiert werden, wenn Thymidinanaloga mit Abacavir assoziiert sind.","TAMs might be selected when thymidine analogs are associated with abacavir.",11,10
"4514","de","en","Tamiflu 75 mg Hartkapseln Oseltamivir","Tamiflu 75 mg hard capsules Oseltamivir",6,5
"4515","de","en","Tarceva 51% 31% 51% 17% 77%","Tarceva 51% 31% 51% 17% 77%",6,6
"4516","de","en","Targretin Kapseln sollten bei Patienten mit einer bekannten Überempfindlichkeit auf Retinoide mit Vorsicht eingesetzt werden.","Targretin capsules should be used with caution in patients with a known hypersensitivity to retinoids.",15,15
"4517","de","en","Tasigna ist eine Langzeittherapie.","This is a long-term treatment.",5,4
"4518","de","en","Tasmar 100 mg Tabletten:","Tasmar 100 mg tablets:",4,4
"4519","de","en","Tasmar wurde zunächst in zwei 13-wöchigen Studien und einer sechswöchigen Studie an insgesamt 594 Patienten untersucht.","Tasmar was originally studied in a total of 594 patients, in two 13-week studies and one six-week study.",18,16
"4520","de","en","Taśmowa 7 PL-02-677 Warszawa Tel.: + 48-(0)22 478 41 50","PL-02-677 Warszawa Tel.: + 48-(0)22 478 41 50",8,10
"4521","de","en","Tatoiou Street, Nea Erythrea, 146 71, Greece","Tatoiou Street, Nea Erythrea, 146 71, Greece",7,7
"4522","de","en","TAXOTERE wird Ihnen von medizinischem Fachpersonal verabreicht.","TAXOTERE will be administered to you by a healthcare professional.",10,7
"4523","de","en","Teil einer Bündelpackung mit 2 Packungen mit je 98 Tabletten mit veränderter Wirkstofffreisetzung","Component of a multi-pack comprising 2 packs, each containing 98 modified-release tablets.",12,13
"4524","de","en","Teil IV Präklinische und klinische Daten.","Part IV Preclinical and clinical information.",6,6
"4525","de","en","Teilen Sie daher Ihrem Arzt bitte unbedingt mit, wenn Sie schwanger sind oder planen, schwanger zu werden.","It is therefore important to tell your doctor if you are pregnant or planning to become pregnant.",17,17
"4526","de","en","Teilen Sie Ihrem Arzt jede frühere oder derzeitige schwerwiegende Erkrankung mit.","- if you have a serious problem with your liver other than chronic hepatitis C.",15,11
"4527","de","en","Teilen Sie Ihrem Arzt mit, wenn Sie schwanger sind, eine Schwangerschaft vermuten oder planen.","Tell your doctor if you are pregnant, think you may be pregnant, or are planning to become pregnant.",18,14
"4528","de","en","Teilen Sie Verwandten, Freunden und nahestehenden Kollegen Folgendes mit:","488 Tell your relatives, friends and close colleagues the following:",10,9
"4529","de","en","Tekturna beeinflusste nicht die Serum-Kreatinin- Konzentration, war aber mit einer Zunahme der Häufigkeit (4,2% gegenüber.","Tekturna did not affect the serum concentration of creatinine but was associated with an increased frequency (4.2% vs.",18,15
"4530","de","en","Tekturna sollte deshalb nicht zusammen mit Grapefruitsaft eingenommen werden.","Grapefruit juice should not be taken together with Tekturna.",9,9
"4531","de","en","Telmisartan wird über eine Konjugation zu einem pharmakologisch inaktiven Acylglucuronid metabolisiert.","Telmisartan is metabolised by conjugation to form a pharmacologically inactive acylglucuronide.",11,11
"4532","de","en","Telmisartan zeigt am AT1-Rezeptor keine partielle Wirkung als Agonist.","Telmisartan does not exhibit any partial agonist activity at the AT1 receptor.",12,9
"4533","de","en","Temodal 180 mg Hartkapseln Temozolomid Zum Einnehmen","Temodal 180 mg hard capsules Temozolomide Oral use",8,7
"4534","de","en","Temodal Hartkapseln sind angezeigt zur Behandlung von:","Temodal hard capsules is indicated for the treatment of:",9,7
"4535","de","en","Tenofovir 300 mg 1x tgl.","Tenofovir 300 mg q. d.",5,5
"4536","de","en","Teratologie-Studien wurden bei Kaninchen und Ratten durchgeführt.","Teratology studies were conducted in rabbits and rats.",8,7
"4537","de","en","Terfenadin oder Astemizol (zur Behandlung von Allergien)","- if you have kidney problems (severely impaired renal function) and/ or liver problems (severely",15,7
"4538","de","en","Terfenadine YM 200 suspensie","Terfenadine YM 200 suspensie",4,4
"4539","de","en","TESAVEL 25 mg Filmtabletten Sitagliptin","TESAVEL 25 mg film-coated tablets Sitagliptin",6,5
"4540","de","en","TESAVEL darf nicht eingenommen werden,","Do not take TESAVEL",4,5
"4541","de","en","TESLASCAN ist bei Kaninchen nicht teratogen.","3 Lactation The degree of excretion into human breast milk is not known.",13,6
"4542","de","en","TESLASCAN kann auch in der MRT zur Untersuchung von Läsionen der Bauchspeicheldrüse eingesetzt werden.","TESLASCAN can also be used with MRI to investigate lesions of the pancreas.",13,14
"4543","de","en","Tests in 5 wichtigen Cytochrom-P450-Isoenzymen ergaben:","When tested in five major cytochrome P450 isoenzymes:",8,6
"4544","de","en","TEVA Pharmaceuticals Works Private Limited Company H-2100 Gödöllő, Táncsics Mihály út 82 Ungarn","Teva Pharmaceuticals Works Private Limited Company H-2100 Gödöll ő, Táncsics Mihály ut 82 Hungary",14,13
"4545","de","en","TEXT {ART/TYP} (2 Durchstechflaschen)","OUTER CARTON TEXT( 2 VIALS)",5,4
"4546","de","en","TEXT FALTSCHACHTEL Puregon 200 IE/0,5 ml 1 Durchstechflasche","OUTER CARTON TEXT Puregon 200 IU/ 0.5 ml 1 vial",10,8
"4547","de","en","Text für die äußere Umhüllung von 10-ml-, 15-ml-, 20-ml- und 30-ml-Fertigspritzen","Text for the outer packaging of 10 ml, 15 ml, 20 ml and 30 ml pre-filled syringes",17,11
"4548","de","en","TEXT UMKARTON Fertavid 200 IE/0,5 ml 5 Durchstechflaschen","OUTER CARTON TEXT Fertavid 200 IU/ 0.5 ml 5 vials",10,8
"4549","de","en","Thalidomid hat ein chirales Zentrum und wird in Form des Razemats aus (+)-(R)- und (-)-(S)-Thalidomid verwendet.","Thalidomide has a chiral centre and is used clinically as a racemate of (+)-(R)- and (-)-(S)- thalidomide.",17,16
"4550","de","en","The European Agency for the Evaluation of Medicinal Products","The European Agency for the Evaluation of Medicinal Products",9,9
"4551","de","en","The introduction of nucleic acid amplification technology (NAT) for the","Guidelines The introduction of nucleic acid amplif ication technology (NAT) for the",12,10
"4552","de","en","The Wellcome Foundation Limited Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 0NN Vereinigtes Königreich","The Wellcome Foundation Limited Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 0NN United Kingdom",15,15
"4553","de","en","Therapie und Vorbeugung von Erbrechen aus anderer Ursache als Reisekrankheit","Treatment and prevention of vomiting (except motion sickness)",8,10
"4554","de","en","Therapieabbruchrate aufgrund von unerwünschten Ereignissen lag bei 7% bei Patienten, die mit Zerit behandelt wurden.","Discontinuation due to undesirable events was 7% for the patients treated with Zerit.",13,15
"4555","de","en","Theryttrex yttrium(Y-90) chloride Part B","• Theryttrex • yttrium(Y-90) chloride",5,5
"4556","de","en","Thiazid-Diuretika können durch eine verminderte Ausscheidung die Serumkalziumspiegel erhöhen.","Thiazide diuretics may increase serum calcium levels due to the decreased excretion.",12,9
"4557","de","en","Thiazide sollten vor der Durchführung von Funktionstests der Nebenschilddrüse abgesetzt werden.","Thiazides should be discontinued before carrying out tests for parathyroid function.",11,11
"4558","de","en","Thrombin spielt im Blutgerinnungsprozess eine zentrale Rolle.","By using Angiox during ACS or PCI, the risk of a blood clot forming is greatly reduced.",17,7
"4559","de","en","Thromboembolien Sehr selten (< 0,01%) wurde ein zeitlicher Zusammenhang zwischen einer Olanzapin-Behandlung und venösen Thromboembolien (VTE) berichtet.","Thromboembolism Temporal association of olanzapine treatment and venous thromboembolism has very rarely (< 0.01%) been reported.",16,17
"4560","de","en","thromboembolischer Ereignisse um (54% - 95% CI:","In a pooled analysis of these studies, the recommended dose regimen of fondaparinux versus",14,7
"4561","de","en","Thrombose der Leberarterie, mit Venenverschluss einhergehende Lebererkrankung","and function abnormalities, cholestasis and",5,7
"4562","de","en","Thrombozyten, Blutungen und Blutgerinnung","Platelets, bleeding and clotting",4,4
"4563","de","en","Thrombozytopenie Erkrankungen des Gastrointestinaltrakts Sehr selten:","Blood and lymphatic system disorders Very rare: thrombocytopenia Gastrointestinal disorders Very rare:",12,6
"4564","de","en","Thrombozytopenie Es gibt keine klinischen Daten darüber, ob die Impfung mit ProQuad eine Thrombozytopenie auslösen oder verschlimmern kann.","Thrombocytopenia No clinical data are available regarding the development or worsening of thrombocytopenia in individuals vaccinated with ProQuad.",18,18
"4565","de","en","Thrombozytopenie, Lymphadenopathie, Lymphopenie Aplastische Anämie Erythrozytenaplasie, idiopathische thrombozytopenische","Leukopaenia Thrombocytopaenia, lymphadenopathy, lymphopenia Aplastic anaemia",6,8
"4566","de","en","Thymusdrüse aus irgendeinem Grund operativ entfernt wurde.","removed for any reason",4,7
"4567","de","en","Thyrotropin alfa Intramuskuläre Anwendung","Thyrogen 0.9 mg powder for solution for injection. thyrotropin alfa Intramuscular use.",12,4
"4568","de","en","TIBOTEC, eine Division von JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300","TIBOTEC, eine Division von JANSSEN-CILAG Pharma GmbH Pfarrgasse 75 A-1232 Wien Tel: +43 1 610 300",16,16
"4569","de","en","Tierarzneimittel dürfen nicht mit dem Abwasser bzw. über die Kanalisation entsorgt werden.","These measures should help to protect the environment.",8,12
"4570","de","en","Tierexperimentelle Studien an Mäusen haben eine Reproduktionstoxizität gezeigt (siehe Abschnitt 5.3).","Studies in mice have shown reproductive toxicity (see section 5.3).",10,11
"4571","de","en","Tierexperimentelle Studien haben eine Reproduktionstoxizität der einzelnen Wirkstoffe gezeigt (siehe Abschnitt 5.3).","Studies in animals have shown reproductive toxicity of the separate compounds (see section 5.3).",14,12
"4572","de","en","Tierexperimentelle Studien haben eine Reproduktionstoxizität gezeigt (siehe Abschnitt 5.3).","Studies in animals have shown reproductive toxicity (see section 5.3).",10,9
"4573","de","en","Tierexperimentelle Studien zeigten, dass sowohl Vildagliptin als auch Metformin in die Muttermilch ausgeschieden werden.","Studies in animals have shown excretion of both metformin and vildagliptin in milk.",13,14
"4574","de","en","Tierexperimentelle Untersuchungen zeigten keine Beeinträchtigung der Fertilität durch Lamotrigin.","Animal experiments did not reveal impairment of fertility by lamotrigine.",10,9
"4575","de","en","Tierstudien ergaben eine Verminderung der Überlebenswahrscheinlichkeit der Feten unter hohen Dosen (siehe Abschnitt 5.3).","Animal studies have shown reduced foetal survival at high doses (see section 5.3).",13,14
"4576","de","en","Tierstudien sind unzureichend im Hinblick auf die Reproduktionstoxizität (siehe Abschnitt 5.3).","Animal studies are insufficient with respect to reproductive toxicity (see section 5.3).",12,11
"4577","de","en","Tierstudien zeigten, dass Entecavir in die Muttermilch ausgeschieden wird.","Animal studies have shown excretion of entecavir in breast milk.",10,9
"4578","de","en","Tierversuche zu Embryotoxizität und Teratogenität wurden nicht durchgeführt.","Animal reproduction studies have not been conducted.",7,8
"4579","de","en","Tinnitus Hörschwäche Neurosensorische Taubheit","vision blurred, photophobia, eye disorders cataract blindness",7,4
"4580","de","en","Tinnitus Hörschwäche Neurosensorische Taubheit Eingeschränktes Hörvermögen","tinnitus hypoacusis deafness neurosensory hearing impaired",6,6
"4581","de","en","Tinnitus Sehr selten: verminderte Hörleistung","Cardiac disorders Uncommon: myocardial infarction*, heart failure, palpitations",8,5
"4582","de","en","Titandioxid (E 171), Schellack, Soja-Lecithin, Polydimethylsiloxan.","Titanium dioxide (E 171), Shellac, Soya lecithin, Polydimethylsiloxane.",8,6
"4583","de","en","Tlf: + 47 22 88 18 00","Tlf: + 47 22 88 18 00",7,7
"4584","de","en","TMZ ist ein embryotoxisches, teratogenes und gentoxisches Alkylanz.","TMZ is an embryotoxic, teratogenic and genotoxic alkylating agent.",9,8
"4585","de","en","Todesfälle (%)bei Placebo -Patienten 183/322 (56.8) 61/144 (42.4) 122/849 (14.4)","164/ 335 (49.0) 183/ 322 (56.8) 49/ 161 (30.4) 61/ 144 (42.4) 137/ 870 (15.7) 122/ 849 (14.4)",18,10
"4586","de","en","Tony Humphreys, Stellvertretender Leiter des Bereichs Neue chemische Substanzen, geboren am 12.","Tony Humphreys, Deputy Head of Sector, New chemical substances, b.",10,12
"4587","de","en","Topotecan hemmt die menschlichen P450-Enzyme nicht (siehe Abschnitt 5.2).","Topotecan does not inhibit human P450 enzymes (see Section 5.2).",10,9
"4588","de","en","Toremifen wird für Patientinnen nach der Menopause empfohlen.","Toremifene is recommended for postmenopausal patients.",6,8
"4589","de","en","Toxizität wurde bei Affen gezeigt, die 100 x 106 I.E./kg/Tag über 3 Monate erhielten.","Toxicity was demonstrated in monkeys given 100 x 106 IU/kg/day for 3 months.",13,14
"4590","de","en","Tracleer 125 mg Tabletten","Tracleer 125 mg tablets",4,4
"4591","de","en","TRACTOCILE 7,5 mg/ml Konzentrat zur Herstellung einer Infusionslösung Atosiban","TRACTOCILE 7.5 mg/ ml concentrate for solution for infusion atosiban",10,9
"4592","de","en","TRACTOCILE darf nicht angewendet werden:","Do not use TRACTOCILE:",4,5
"4593","de","en","Tragen Sie dunkle, fest gewebte Kleidungsstücke.","Wear dark, closely woven clothing.",5,6
"4594","de","en","Tramadol, Triptane) kann das Risiko eines Serotoninsyndroms erhöhen.","Co-administration with serotonergic drugs (e. g. tramadol, triptans) may increase the risk of serotonin syndrome.",15,8
"4595","de","en","Transaminasen störung Bilirubinanstieg Gallestauung Hepatitis","Photosensitivity reactions (see section 4.4)",5,5
"4596","de","en","Transparente PVC/PVdC-Aluminium-Blisterpackungen in Packungsgrößen zu 100 oder 300 Kapseln pro Faltschachtel.","Transparent PVC/ PVdC – aluminium blisters in pack sizes of 100 or 300 capsules per carton.",16,11
"4597","de","en","Trauminhalte, Libidoabnahme, Schwindelgefühl, erhöhte Muskelspannung (Hypertonus), Schlaflosigkeit, Nervosität, Parästhesien, Sedierung, Zittern, Verwirrtheit, Depersonalisation","Abnormal dreams, Decreased libido, Dizziness, Increased muscle tonus (hypertonia), Insomnia, Nervousness, Paresthesia, Sedation, Tremor, Confusion, Depersonalisation",16,13
"4598","de","en","TRAVATAN wurde in drei zwischen 6 und 12 Monaten dauernden Hauptstudien an 1.989 Patienten untersucht.","TRAVATAN has been studied in 1,989 patients in three main studies, lasting between 6 and 12 months.",17,15
"4599","de","en","Trazec 60 mg Filmtabletten Trazec 120 mg Filmtabletten Trazec 180 mg Filmtabletten","Trazec 60 mgfilm-coated tablets Trazec 120 mg film-coated tablets Trazec 180 mg film-coated tablets Nateglinide",15,12
"4600","de","en","Treatment of amyotrophic lateral sclerosis","• Treatment of amyotrophic lateral sclerosis",6,5
"4601","de","en","Treatment of inborn errors of primary bile acid synthesis","Treatment of inborn errors of primary bile acid synthesis",9,9
"4602","de","en","Treatment of myelodysplastic syndromes","Treatment of myelodysplastic syndromes",4,4
"4603","de","en","Treatment of patent ductus arteriosus","Treatment of patent ductus arteriosus",5,5
"4604","de","en","Treatment of renal cell carcinoma","• Treatment of renal cell carcinoma",6,5
"4605","de","en","Tredaptive-Tabletten enthalten Laropiprant in der einer Schicht und Nicotinsäure in der anderen Schicht.","In Tredaptive tablets, laropiprant is in one of the layers, and the other layer contains nicotinic acid.",17,13
"4606","de","en","Trennen Sie die beiliegende Warnhinweiskarte ab, diese enthält wichtige Sicherheitsinformationen.","Detach enclosed Alert Card, it contains important safety information",9,10
"4607","de","en","Treten solche Hemkörpern auf, ist dies an einer unzureichenden klinischen Reaktion zu erkennen.","If such inhibitors occur, the condition will manifest itself as an insufficient clinical response.",14,13
"4608","de","en","Trevilor retard 37,5 mg Trevilor retard 75 mg Trevilor retard 150 mg","Trevilor retard 37,5 mg Trevilor retard 75 mg Trevilor retard 150 mg",12,12
"4609","de","en","Triatec faible 1,25 mg, gélule Triatec 2.5 mg, gélule Triatec 5 mg, gélule","Triatec faible 1,25 mg, gélule Triatec 2.5 mg, gélule",9,13
"4610","de","en","Trimethoprim 28,89% Gew./Ge w.","Trimethoprim 5.78%w/ w Sulfadiazine 28.89% w/ w",7,4
"4611","de","en","TRISENOX ist ein Konzentrat zur Herstellung einer Infusionslösung, das den arzneilich wirksamen Bestandteil Arsentrioxid (1 mg/ml) enthält.","TRISENOX is a concentrate for solution for infusion containing the active substance arsenic trioxide (1 mg/ ml).",17,17
"4612","de","en","TRITACE enthält den Wirkstoff Ramipril.","TRITACE contains a medicine called ramipril.",6,5
"4613","de","en","TRITANRIX HepB DARF UNTER KEINEN UMSTÄNDEN INTRAVENÖS INJIZIERT WERDEN.","TRITANRIX HepB SHOULD UNDER NO CIRCUMSTANCES BE ADMINISTERED INTRAVENOUSLY.",9,9
"4614","de","en","Tritazide tablets 2.5 mg/12.5 g","Tritazide tablets 2.5 mg/12.5 g",5,5
"4615","de","en","Tritt keine klinische Besserung ein, sollte die Behandlung spätestens 10 Tage nach Therapiebeginn abgebrochen werden.","Treatment should be discontinued after 10 days at the latest if no clinical improvement is apparent.",16,15
"4616","de","en","Trizivir soll nicht zusammen mit Stavudin, Zalcitabin, Injektionen von Ganciclovir oder Foscarnet eingenommen werden.","Trizivir should not be taken with stavudine, zalcitabine, injections of ganciclovir or foscarnet.",13,14
"4617","de","en","Tropfen Sie nicht die doppelte Dosis ein, um die versäumte Dosis nachzuholen","Do not use a double dose to make up.",9,12
"4618","de","en","Tropfen zum Einnehmen, Lösung","bottle (glass) bottle (glass) bottle (glass) blister (alu/ PP) blister (alu/ PP) blister (alu/ PP) blister (alu/ PP)",18,4
"4619","de","en","Trotz Antibiotikabehandlung können manchmal einige Bakterien überleben und weiterwachsen.","351 Despite antibiotics, some bacteria may survive or grow.",9,9
"4620","de","en","Trübe Lösungen oder Lösungen mit Niederschlag nicht verwenden.","Do not use solutions which are cloudy or contain particles.",10,8
"4621","de","en","Trudexa 40 mg Injektionslösung","Trudexa 40 mg solution for injection.",6,4
"4622","de","en","Trudexa so lange abgesetzt werden, bis die Infektionen unter Kontrolle sind.","predispose patients to infections, including the use of concomitant immunosuppressive medications.",11,11
"4623","de","en","Truvada kann zu Schwindelgefühl führen.","Truvada can cause dizziness.",4,5
"4624","de","en","Tub erkulose und andere opportunistische Infektionen (Infektionen, die bei einer verringerten","Other side effects that have been observed in patients taking Trudexa:",11,11
"4625","de","en","Tulathromycin kann bei Hautkontakt zur Überempfindlichkeit führen.","Tulathromycin may cause sensitisation by skin contact.",7,7
"4626","de","en","Tumorpatienten, die eine Chemotherapie erhalten","Cancer patients receiving chemotherapy in",5,5
"4627","de","en","Turnhoutseweg 30 B-2340 Beerse, Belgium Tel: +32(0)14.60.21.11 Fax: +32 (0)14.60.21.00","Turnhoutseweg 30 B-2340 Beerse, Belgium Tel: +32(0)14.60.21.11 Fax: +32(0)14.60.21.00",9,10
"4628","de","en","Twinrix Erwachsene darf nicht angewendet werden,","Twinrix Adult should not be given:",6,6
"4629","de","en","Tygacil kann zu einer Verlängerung bestimmter Tests zur Messung der Blutgerinnung führen.","Tygacil may prolong certain tests that measure how well your blood is clotting.",13,12
"4630","de","en","Typ-2- Diabetes wird auch als nicht insulinabhängiger Diabetes mellitus Typ 2 bezeichnet.","Type 2 diabetes is also called non-insulin-dependent diabetes mellitus, or NIDDM.",11,12
"4631","de","en","Typhus Durch Gram-negative Bakterien verursachte intraabdominale Infektionen","Typhoid fever Intra-abdominal infections due to Gram-negative bacteria",8,7
"4632","de","en","Typischerweise ist der Husten nicht produktiv, persistierend und klingt nach Beendigung der Therapie ab.","Characteristically, the cough is non- productive, persistent and resolves after discontinuation of therapy.",13,14
"4633","de","en","Typischerweise wurden solche Reaktionen innerhalb der ersten Wochen oder Monate nach Beginn einer CART beobachtet.","Typically, such reactions have been observed within the first weeks or months of initiation of CART.",16,15
"4634","de","en","Tyverb wurde „ unter Auflagen“ zugelassen.","Tyverb has been given ‘ Conditional Approval’.",7,6
"4635","de","en","Übelkeit / Erbrechen sind seltener, wenn die Injek- tionen am Abend oder nach einer Mahlzeit gegeben werden.","Nausea/ vomiting are less frequent when the injection is done in the evening and after meals.",16,17
"4636","de","en","Übelkeit, gastroösophagealer Reflux, Divertikel, Erbrechen*, Dysphagie, Reizkolon","Nausea, gastroesophageal reflux disease, diverticulum, vomiting, * dysphagia, irritable bowel syndrome",11,7
"4637","de","en","Über Atemwegsinfekte, Otitis media, Krämpfe und Bronchitis wurde nur in klinischen Studien bei Kindern berichtet.","Respiratory tract infections, otitis media, convulsions and bronchitis were reported only in clinical studies in children.",16,15
"4638","de","en","Über Brady- und Tachyarrhythmien wurde berichtet.","Brady- and tachyarrhythmias have been reported.",6,6
"4639","de","en","Über die Tätigkeit der Arbeitsgruppen zur Erleichterung der gegenseitigen Anerkennung wird in den Kapiteln 2 und 3 berichtet.","Details of the activities of the mutual recognition facilitation groups are given in Chapters 2 and 3.",17,18
"4640","de","en","Über Durchfälle einschließlich schwerer Diarrhö, die eine Hospitalisierung erforderlich machte, wurde unter der Behandlung mit oralem Topotecan berichtet.","Diarrhoea, including severe diarrhoea requiring hospitalization, has been reported during treatment with oral topotecan.",14,18
"4641","de","en","Über Dysphagie wurde auch nach Injektionen berichtet, die nicht in die zervikale Muskulatur erfolgten.","Dysphagia has been reported following injection to sites other than the cervical musculature.",13,14
"4642","de","en","Über ein ovarielles Überstimulationssyndrom wurde bei weniger als 6% der mit Luveris behandelten Patientinnen berichtet.","Ovarian hyperstimulation syndrome was observed in less than 6% of patients treated with Luveris.",14,15
"4643","de","en","Über einige spät auftretende neurologische Störungen (Hypertonie, Konvulsionen, Verhaltenänderungen) wurde berichtet.","Some late-onset neurological disorders have been reported (hypertonia, convulsion, abnormal behaviour).",11,11
"4644","de","en","Über Erythrozytenaplasie, eine Erkrankung, bei der der Körper gar keine oder vermindert rote Blutkörperchen produziert, wurde berichtet.","302 of red blood cells, has been reported.",8,17
"4645","de","en","Über folgende Nebenwirkungen wurde seit Markteinführung berichtet.","Following side effects have been reported in post marketing experience.",10,7
"4646","de","en","Über Spielzwang, verstärkte Libido und Hypersexualität wurde bei Patienten berichtet, die mit Dopaminagonisten, einschließlich Rotigotin, behandelt wurden.","52 Pathologic gambling, increased libido and hypersexuality have been reported in patients treated with dopamine agonists, including rotigotine.",18,17
"4647","de","en","Überblick über das EMEA-Arbeitsprogramm 2006 EMEA/145874/2006","Summary of the EMEA work programme 2006 EMEA/ 62913/ 2006",10,6
"4648","de","en","Überempfindlichkeit gegen den arzneilich wirksamen Bestandteil oder einem der sonstige Bestndteile.","Hypersensitivity to the active substance or to any of the excipients.",11,11
"4649","de","en","Überempfindlichkeit gegen den Wirkstoff oder einen der sonstigen Bestandteile (siehe Abschnitt 6.1).","Hypersensitivity to the active substance or to any of the excipients (see section 6.1).",14,12
"4650","de","en","Überempfindlichkeit gegen den Wirkstoff, andere Cephalosporine oder einen der sonstigen Bestandteile.","Hypersensitivity to cefuroxime, other cephalosporins or to any of the excipients.",11,11
"4651","de","en","Überempfindlichkeit gegen die Wirkstoffe oder gegen einen der sonstigen Bestandteile.","Hypersensitivity to the active substances or to any of the excipients.",11,10
"4652","de","en","Überempfindlichkeit gegen Insulin lispro oder einen sonstigen Bestandteil.","Hypersensitivity to insulin lispro or to any of the excipients.",10,8
"4653","de","en","Überempfindlichkeit gegen Sunitinibmalat oder einen der sonstigen Bestandteile.","Hypersensitivity to sunitinib malate or to any of the excipients.",10,8
"4654","de","en","Überempfindlichkeitsreaktion (siehe auch Abschnitt 4.8)","Hypersensitivity Reaction (see also section 4.8)",6,5
"4655","de","en","Überempfindlichkeitsreaktionen Nach Markteinführung wurde bei Patienten unter Januvia über schwerwiegende Überempfindlichkeitsreaktionen berichtet.","Hypersensitivity Reactions Postmarketing reports of serious hypersensitivity reactions in patients treated with Januvia have been reported.",16,12
"4656","de","en","Überleben (%; Kaplan-Meier-Methode) Progressionsfrei","Survival (%; Kaplan-Meier Estimates) Progression-Free",5,4
"4657","de","en","Überlebensrate bei Hunden mit Zyanidvergiftung","7 Survival of cyanide-poisoned dogs",5,5
"4658","de","en","Überprüfen Sie anhand des Etiketts, ob Protaphane InnoLet den richtigen Insulintyp enthält.","Check the label to make sure that your Protaphane InnoLet contains the correct type of insulin.",16,12
"4659","de","en","Überprüfen Sie Ihren Blutzucker.","Check your blood sugar",4,4
"4660","de","en","Überprüfen Sie vor Gebrauch alle neuen Zylinderampullen.","Inspect all new cartridges prior to use.",7,7
"4661","de","en","Überwachung der Atemfunktion während der Erholung:","Monitoring respiratory function during recovery:",5,6
"4662","de","en","Überwiegend handelt es sich um oberflächliche Blutungen an der Injektionsstelle.","The type of haemorrhage is predominantly superficial at the injection site.",11,10
"4663","de","en","Üblicherweise sollten Sie Liprolog Mix25 innerhalb von 15 Minuten vor oder nach einer Mahlzeit anwenden.","You should normally use Liprolog Mix25 within 15 minutes of a meal.",12,15
"4664","de","en","UCB Magyarország Kft Árpád fejedelem útja 26-28 1023 Budapest Ungarn","UCB Magyarország Kft Árpád fejedelem útja 26-28 1023 Budapest Hungary",10,10
"4665","de","en","UCB Pharma GmbH Tel: +43 / (0) 129180-0","Österreich UCB Pharma GmbH Tel: +43 / (0) 129180-0",9,8
"4666","de","en","ug Arzneimittel- A gentur (EMEA) http://www.emea.europa.eu/ verfügbar.","Detailed information on this medicinal product is available on the website of the European Medicines ed",16,7
"4667","de","en","ug die Haut während der Injektion aufrecht.","th the skin during the injection",6,7
"4668","de","en","ug was auf geringe Relevanz für die klinische Anwendung hindeutet.","ed 6.1 List of excipients",5,10
"4669","de","en","UK - Vereinigtes Königreich","UK - United Kingdom",4,4
"4670","de","en","Ultratard ist ein sehr lang wirkendes Insulin.","Ultratard is a very long-acting insulin.",6,7
"4671","de","en","Um den Beutel zu öffnen, halten Sie ihn an beiden Seiten fest.","To open the sachet, hold the two sides of the sachet.",11,12
"4672","de","en","Um den zunehmenden Arbeitsumfang zu bewältigen, wurden parallel dazu viele kleinere Sitzungen organisiert.","In order to better cope with the increased workload, many parallel breakout sessions were also organised.",16,13
"4673","de","en","Um die erforderliche Dosis einzustellen, halten Sie den Pen waagerecht mit einer Hand am Schaft.","394 To set the required dose, hold the pen horizontally by the barrel with one hand.",16,15
"4674","de","en","Um die Resuspension zu erleichtern, befinden sich in der Patrone 3 kleine Metallkügelchen.","Each cartridge contains three small metal balls to facilitate quick and thorough mixing of the contents.",16,13
"4675","de","en","Um einen bestmöglichen Behandlungserfolg zu erzielen, muss Zyrtec jedoch vorschriftsgemäß eingenommen werden.","However, you still need to use Zyrtec carefully to get the best results from it.",15,12
"4676","de","en","Um sich selbst eine subkutane Injektion zu geben, brauchen Sie: m","To give yourself a subcutaneous injection you will need:",9,11
"4677","de","en","UMKARTON 100 mg/ml SUSPENSION ZUM EINNEHMEN (enthält die Flasche(n) mit dem Granulat und die Flasche(n) mit dem Lösungsmittel)","OUTER CARTON 100 mg/mL ORAL SUSPENSION (containing the bottle(s) for the granules and the bottle(s) for the solvent)",18,18
"4678","de","en","UMKARTON FÜR BÜNDELPACKUNGEN (EINSCHLIESSLICH BLUE BOX)","OUTER CARTON OF MULTIPACKS (INCLUDING BLUE BOX)",7,6
"4679","de","en","Umstellung auf Insulin Human Winthrop Comb 50","Transfer to Insulin Human Winthrop Comb 50",7,7
"4680","de","en","Umstellung von derzeit nicht mit Entacapon behandelten Patienten auf Stalevo","How to transfer patients not currently treated with entacapone to Stalevo",11,10
"4681","de","en","Unbehandelt kann dieser Zustand zu diabetischem Koma oder zum Tod führen.","If you don’ t treat it, this could lead to diabetic coma and death.",14,11
"4682","de","en","und 1.500 g, die vor der 34.","gestational age of less than 34 weeks.",7,7
"4683","de","en","und Protokollunterstützung) Sitzungstage insgesamt","protocol assistance) Total meeting days",5,4
"4684","de","en","UNERREICHBAR UND NICHT SICHTBAR AUFZUBEWAHREN IST","OF THE REACH AND SIGHT OF CHILDREN",7,6
"4685","de","en","Unerwünschte Ereignisse bei internistischen Patienten","Undesirable effects in medical patients",5,5
"4686","de","en","Unerwünschte Wirkungen in klinischen Studien bei Erwachsenen Infektionen, Infestationen","73 Undesirable effects in clinical studies in adult patients Infections and infestations",12,9
"4687","de","en","Ungefähr 20% der Dosis werden als Metaboliten im Urin ausgeschieden.","About 20% of the dose has been accounted for in urine as metabolite.",13,10
"4688","de","en","Ungefähr 97% des verabreichten Meloxicams sind an Plasmaproteine gebunden.","Approximately 97% of meloxicam is bound to plasma proteins.",9,9
"4689","de","en","United Drug House Magna Drive Dublin 24 Irland","United Drug House Magna Drive Dublin 24 Ireland.",8,8
"4690","de","en","Unmittelbar vor der Injektion muss der Inhalt der zu verwendenden Spritze resuspendiert werden.","The contents of the dosing syringe must be re-suspended immediately prior to administration.",13,13
"4691","de","en","Unruhe, Schlafstörungen, Benommenheit und Schwindelanfälle,","the most common adverse reactions which have been described are: depression, confusion, agitation, sleep disorders, dizziness and vertigo.",18,5
"4692","de","en","Unter der Behandlung mit Venlafaxin können Krampfanfälle auftreten.","Convulsions may occur with venlafaxine therapy.",6,8
"4693","de","en","Unter diesen Umständen wird die maximale Serumkonzentration nach 2-3 Stunden erreicht.","Under these circumstances maximum serum concentration is achieved after 2-3 hours.",11,11
"4694","de","en","Unter keinen Umständen darf Humalog BASAL Pen in die Vene verabreicht (intrave- nös appliziert) werden.","Under no circumstances should Humalog BASAL be given intravenously.",9,15
"4695","de","en","Unter keinen Umständen darf Liprolog BASAL intravenös appliziert werden.","Under no circumstances should Liprolog Basal be given intravenously.",9,9
"4696","de","en","Unter Xolair-Therapie soll nicht gestillt werden.","Nursing mothers should not breast-feed during Xolair therapy.",8,6
"4697","de","en","Unterhautzellgewebes 24%); Alopezie (G3/4:","24%); Alopecia (G3/ 4:",4,4
"4698","de","en","Unterleibsschmerzen, abdominale Distension, gravierende Vergrößerung der Ovarien, Gewichtszunahme, Dyspnoe, Oligurie und gastrointestinale Symptome einschließlich Übelkeit, Erbrechen und Durchfall.","Clinical evaluation may reveal hypovolaemia,",5,18
"4699","de","en","Unternehmen a) Name b) Sitz","Company a) Name b) Origin",5,5
"4700","de","en","Unterschiede zu den Erwachsenen und andere besondere Gesichtspunkte werden in den folgenden Abschnitten beschrieben.","Differences from adults and other special considerations are discussed in the following paragraphs.",13,14
"4701","de","en","Untersuchung der Auswirkungen von Anagrelid und Hydroxyharnstoff auf die Inzidenz mit der Erkrankung zusammenhängender thrombotischer und hämorrhagischer Ereignisse.","To investigate the effects of anagrelide and hydroxyurea on incidence of disease related thrombotic and haemorrhagic events.",17,18
"4702","de","en","Untersuchungen können außerdem eine Abnahme der Kaliumkonzentration im Blut ergeben.","Tests may also show decreases in potassium in the blood.",10,10
"4703","de","en","Urtikaria, Hautausschlag, Pruritus, Alopezie Muskel- schmerzen, Hypertonie","Urticaria, Rash, Pruritus, Alopecia",4,7
"4704","de","en","Urtikaria, Juckreiz, Hautausschlag) 5","angioedema skin reactions (e. g. urticaria, pruritis, rash) 5",9,4
"4705","de","en","Usine de Huningue 26, rue de la Chapelle BP 224 68332 Huningue cedex Frankreich","Usine de Huningue 26, rue de la Chapelle BP 224 68332 Huningue cedex France",14,14
"4706","de","en","V32I+I47V, I50V, I54L/M und I84V.","V32I+I47V, I50V, I54L/ M and I84V.",6,5
"4707","de","en","Valdoxan ist zum Einnehmen bestimmt.","Valdoxan is for oral use.",5,5
"4708","de","en","Valtropin liegt als Pulver (Lyophilisat) und Lösungsmittel zur Herstellung einer Injektionslösung vor.","Valtropin is presented as a powder and solvent for solution for injection.",12,12
"4709","de","en","Vaniqa verlangsamt erwiesenermaßen das Haarwachstum.","Vaniqa has been shown to reduce the rate of hair growth.",11,5
"4710","de","en","Varicella-Zoster-Virus1, Stamm Oka/Merck (lebend, abgeschwächt), mind.","Varicella-zoster virus1, Oka/ Merck strain, (live, attenuated) not less than 19400 PFU (plaque-forming units).",14,6
"4711","de","en","VASOVIST ist eine Injektionslösung mit dem Wirkstoff Gadofosveset Trinatriumsalz.","VASOVIST is a solution for injection containing the active substance gadofosveset trisodium.",12,9
"4712","de","en","Vectibix ist zur Anwendung bei Erwachsenen (18 Jahre und älter) bestimmt.","Vectibix is for use in adults 18 years and over.",10,11
"4713","de","en","VELCADE wird für die Behandlung des multiplen Myeloms (Krebsform des Knochenmarks) bei Erwachsenen angewendet:","VELCADE is used for the treatment multiple myeloma (a cancer of the bone marrow) in adults:",16,14
"4714","de","en","Velmetia wird zweimal täglich angewendet.","Velmetia is taken twice a day.",6,5
"4715","de","en","Velosulin ist ein Ersatzinsulin, das mit dem von der Bauchspeicheldrüse gebildeten Insulin identisch ist.","substance in Velosulin, insulin human (rDNA), is produced by a method known as ‘ recombinant DNA ic",17,14
"4716","de","en","Venöse thromboembolische Ereignisse Sehr selten:","Rash Reproductive system and breast disorders Very rare:",8,5
"4717","de","en","Ventavis und bestimmte andere Arzneimittel können sich in ihrer Wirkung in Ihrem Körper gegenseitig beeinflussen.","Ventavis and certain other medicines may influence each other in the way they work in your body.",17,15
"4718","de","en","Ventrikuläre Tachykardie / Fibrillation, plötzlicher Tod (siehe Abschnitt","Ventricular tachycardia/ fibrillation, sudden death (see section 4.4)",8,8
"4719","de","en","Verabreichung von DepoCyte 4.","How DepoCyte is given 4.",5,4
"4720","de","en","Verabschiedet im Dezember 1997","Adopted in December 1997",4,4
"4721","de","en","Verabschiedet im Juli 1998","Adopted in July 1998",4,4
"4722","de","en","Verabschiedet im September 1997","Adopted in September 1997",4,4
"4723","de","en","Veranschlagt sind ferner Mittel für den Kauf von Fernsprechbüchern.","It also covers the purchase of directories.",7,9
"4724","de","en","Veranschlagt sind Mittel für die Pauschalzulagen für die jeweiligen Mitarbeiter.","This appropriation covers the fixed allowances of relevant staff.",9,10
"4725","de","en","VERBOT DES VERKAUFS, DER ABGABE UND ANWENDUNG","CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO SAFE AND EFFECTIVE USE",14,7
"4726","de","en","VERBOT DES VERKAUFS, DER ABGABE UND/ODER DER ANWENDUNG","PROHIBITION OF SALE, SUPPLY AND/ OR USE",7,8
"4727","de","en","VERBOT DES VERKAUFS; DER ABGABE UND/ODER DER ANWENDUG","PROHIBITION OF SALE, SUPPLY AND/OR USE",6,8
"4728","de","en","Verfügbare Daten deuten darauf hin, dass bei Patienten mit leichter bis mittelschwerer Nierenfunktionsstörung keine Dosisanpassung notwendig ist.","Available data suggest that no dose adjustment is necessary in patients with mild to moderate renal impairment.",17,17
"4729","de","en","Verfügung gestellt werden, in denen Bicalutamid 150 mg zugelassen ist.","bicalutamide 150 mg is authorised.",5,10
"4730","de","en","Vergewissern Sie sich, dass Sie das von Ihrem Arzt ver- schriebene Humalog Mix25 erhalten.","Make sure you get the Humalog Mix25 that your doctor has told you to use.",15,14
"4731","de","en","Verhalten im Notfall 5.","What to do in an emergency 5.",7,4
"4732","de","en","Verkehrstüchtigkeit und das Bedienen von Maschinen","170 Driving and using machines",5,6
"4733","de","en","Verkehrstüchtigkeit und das Bedienen von Maschinen ► wenn Sie ein Fahrzeug führen oder Werkzeuge oder Maschinen bedienen:","Your ability to concentrate or to react will be less during a hypo.",13,17
"4734","de","en","Verkehrstüchtigkeit und das Bedienen von Maschinen Ciprofloxacin Kabi kann Ihre Aufmerksamkeit reduzieren.","Driving and using machines Ciprofloxacin Kabi can reduce your attention.",10,12
"4735","de","en","Verkehrstüchtigkeit und das Bedienen von Maschinen:","Driving and using machines Toremifene has no influence on the ability to drive and use machines.",16,6
"4736","de","en","Verkürzte Infusionen mit Dosierungen > 6 mg/kg wurden nicht untersucht.","Shortened infusions at doses > 6 mg/ kg have not been studied.",12,10
"4737","de","en","Verlangsamt die Aufnahme von Amoxicillin","lansoprazole + clarithromycin +",4,5
"4738","de","en","Vermehrt treten diese bei Patienten in der akzelerierten Phase der CML auf.","Occurrence is more frequent in patients with accelerated-phase CML.",9,12
"4739","de","en","Vermeiden Sie e s, die desinfizierte Stelle vor der Injektion noch einmal zu berühren.","ris area again before injecting.",5,14
"4740","de","en","Vermeiden Sie es, die desinfizierte Stelle vor der Injektion noch einmal zu berühren.","Do not touch the area again before injecting.",8,13
"4741","de","en","Vermeidung einer Kontamination des Inhaltes, mit äußerster Vorsicht erfolgen.","au strict aseptic conditions and precautions taken to avoid contamination of the contents.",13,9
"4742","de","en","Verschließen Sie die Flasche fest mit der kindergesicherten Verschlusskappe.","Close bottle with child-resistant cap tightly.",6,9
"4743","de","en","Verschlimmerung von Asthma, Schwindelgefühl, Ohrgeräusche, erhöhte PSA-Werte (PSA = Prostata-spezifisches Antigen).","Effects in the body worsening of asthma, dizziness, ringing in ears, increased prostate antigen.",14,11
"4744","de","en","Verstopfung, Blähungen, Übelkeit, Abdominalschmerzen, Diarrhoe","Constipation, flatulence, nausea, abdominal pain, and diarrhoea.",7,5
"4745","de","en","Versuchen Sie, Actos 45 mg Tabletten täglich - entsprechend den Anweisungen Ihres Arztes - einzunehmen.","Try to take Actos 45mg tablets daily as prescribed.",9,15
"4746","de","en","Versuchen Sie, die Tabletten immer zur gleichen Tageszeit einzunehmen.","Try to take your tablets at the same time each day.",11,9
"4747","de","en","verträglichen Dosen eines Sulfonylharnstoffs unzureichend eingestellt ist und bei denen Metformin wegen Kontraindikationen oder Unverträglichkeit ungeeignet ist,","of a sulphonylurea and for whom metformin is inappropriate due to contraindications or intolerance,",14,17
"4748","de","en","Verw. bis {Monat/Jahr} Haltbarkeit nach Auflösung oder Rekonstitution::","EXP {month/ year} Shelf life after reconstitution:",7,8
"4749","de","en","Verwendbar bis Monat/Jahr Nach dem Anbrechen unmittelbar verwenden.","EXP month/ year Once opened, use immediately",7,8
"4750","de","en","Verwenden Sie das gesamte Lösungsmittel in der Spritze, um das Betaferonpulver in der Durchstechflasche aufzulösen.","Use all the solvent in the syringe to dissolve the Betaferon powder in the vial.",15,15
"4751","de","en","Verwenden Sie die Injektionslösung nicht, wenn sie nicht klar ist oder Schwebstoffe enthält.","Do not use if you notice that the solution is not clear or contains particles.",15,13
"4752","de","en","Verwenden Sie diesen OptiSet nicht, wenn die Lösung trüb oder verfärbt ist oder Partikel enthält.","Do not use this OptiSet if insulin is cloudy, coloured or has particles.",13,15
"4753","de","en","Verwenden Sie für jede Injektion eine neue Injektionsnadel.","Use a new needle for each injection.",7,8
"4754","de","en","Verwenden Sie ihn nicht, wenn der letzte Tag des angegebenen Monats bereits abgelaufen ist.","Do not use it if the date has passed the last day of the month shown",16,14
"4755","de","en","Verwenden Sie immer einen neuen SoloStar, wenn Sie bemerken, dass Ihre Blutzuckereinstellung un - erwartet schlechter wird.","Always use a new pen if you notice that your blood sugar control is unexpectedly getting worse.",17,17
"4756","de","en","Verwenden Sie jede Spritze nur für eine Injektion.","Use each syringe only for one injection.",7,8
"4757","de","en","Verwenden Sie KEINE andere Spritze.","DO NOT use any other syringe.",6,5
"4758","de","en","Verwenden Sie keine Lösungen, die Niederschläge oder andere Partikel aufweisen.","Do not use material that shows evidence of precipitation or any other particulate matter.",14,10
"4759","de","en","Verwenden Sie nur die aufgeführten Gegenstände.","Use only the items listed.",5,6
"4760","de","en","Verwenden Sie nur Ihren eigenen Pen!","Do not share your Pen.",5,6
"4761","de","en","Verwenden Sie nur Injektionsnadeln, die für SoloStar geeignet sind.","Only use injection needles that have been approved for use with SoloStar.",12,9
"4762","de","en","Verwerfen Sie nach Gebrauch die Spritze und Nadel.","Discard syringe and needle after use.",6,8
"4763","de","en","Verwirrtheit, Panikattacken, gedrückte Stimmung, verminderte Libido","Confusional state, Panic attack, Depressed mood, Libido decreased",8,6
"4764","de","en","Verzögerte Reaktionen (nach Stunden oder Tagen) können auftreten.","Delayed reactions (after hours to days) may occur.",8,8
"4765","de","en","VFEND darf nicht an Kinder unter 2 Jahren verabreicht werden.","VFEND should not be given to children younger than 2 years of age.",13,10
"4766","de","en","VFEND ist eine nicht konservierte, sterile, lyophilisierte Einzeldosis.","VFEND is a single dose unpreserved sterile lyophile.",8,8
"4767","de","en","Via Complutense 140 28805 Alcala de Henares Spanien","Via Compultense 140 28805 Alcala de Henares Spain",8,8
"4768","de","en","Via Egadi, 7 20144 Milano Italien","Via Egadi, 7 20144 Milano Italy",6,6
"4769","de","en","Via Luigi Einaudi 11 00012 Guidonia Montecelio/Rom Italien","Via Luigi Einaudi 11 00012 Guidonia Montecelio/ Rome Italy",9,8
"4770","de","en","Via Privata Maria Teresa, 11 20123 Milano Italien","Via Privata Maria Teresa, 11 20123 Milano Italy",8,8
"4771","de","en","Via San Martino 12 I-20122 Mailand Italien","Via San Martino 12 I-20122 Milan Italy",7,7
"4772","de","en","VIAGRA Filmtabletten sind blaue, gerundete, rautenförmige Tabletten.","VIAGRA film-coated tablets are blue, with a rounded-diamond shape.",9,7
"4773","de","en","Viale Tiziano, 25 I-00196 Roma Tel: +39 06 324911","Viale Tiziano, 25 I-00196 Roma Tel: +39 06 324911",9,9
"4774","de","en","Vianex S.A Tatoiou Street 18 Km Athen-Lamia National Road 14671 Nea Erythrea Athen Griechenland","Vianex S. A Tatoiou Street 18 Km Athens-Lamia National Road 14671 Nea Erythrea Athens Greece",15,14
"4775","de","en","Viani Evohaler ist ausschließlich für die Inhalation durch den Mund vorgesehen.","Viani Evohaler is for inhalation by mouth only.",8,11
"4776","de","en","Vidaza war hinsichtlich der Verlängerung der Überlebensdauer wirksamer als die herkömmliche Versorgung.","Vidaza was more effective than conventional care in extending survival.",10,12
"4777","de","en","Viele dieser Wechselwirkungen wurden teilweise durch in vitro Studien und in klinischen Versuchen bestätigt.","Many of these interactions have been partially confirmed by in vitro studies and in clinical trials.",16,14
"4778","de","en","Viele Nebenwirkungen von Aldara Creme sind auf ihre lokale Wirkung auf ihrer Haut zurückzuführen.","28 Many of the undesirable effects of Aldara cream are due to its local action on your skin.",18,14
"4779","de","en","Vielleicht möchten Sie diese später nochmals lesen.","Read all of this leaflet carefully before you start taking this medicine. − Keep this leaflet.",16,7
"4780","de","en","Vier Wochen nach Beendung dieser ersten Behandlung wird Ihr Arzt Ihre Haut beurteilen.","Four weeks after finishing this first treatment, your doctor will assess your skin.",13,13
"4781","de","en","Vimpat 150 mg 1 Filmtablette enthält 150 mg Lacosamid.","Vimpat 150 mg 1 film-coated tablet contains 150 mg lacosamide.",10,9
"4782","de","en","Vimpat muss zweimal täglich eingenommen werden.","Vimpat must be taken twice a day.",7,6
"4783","de","en","Viracept bewirkte bei zweimal und bei dreimal täglicher Einnahme eine ähnliche Senkung der Viruslast.","Viracept brought about similar reductions in viral load whether it was taken twice or three times a day.",18,14
"4784","de","en","Viraferon 18 Millionen I.E./3 ml Injektionslösung","Viraferon 18 million IU/ 3 ml solution for injection",9,6
"4785","de","en","Viraferon 18 Millionen I.E./3 ml Injektionslösung Interferon alfa-2b","Viraferon, 18 million IU/3 ml solution for injection Interferon alfa-2b",10,8
"4786","de","en","Viraferon in Kombination mit Ribavirin:","Viraferon in combination with ribavirin:",5,5
"4787","de","en","Viraferon ist als Pulver in den Stärken 5 Millionen I.E./ml für den Gebrauch als Einzeldosis erhältlich.","Viraferon is supplied as a powder at strengths of 5 million IU/ ml for single-dose use.",16,16
"4788","de","en","Viraferon wird dreimal in der itte","Interferon s may cause unusual tiredness; if you are injecting this",11,6
"4789","de","en","ViraferonPeg 120 Mikrogramm – Durchstechflasche mit Pulver","ViraferonPeg 120 micrograms - vial of powder",7,7
"4790","de","en","ViraferonPeg 50 Mikrogramm wird in unterschiedlichen Packungsgrößen angeboten:","ViraferonPeg 50 micrograms is available in different pack sizes:",9,8
"4791","de","en","ViraferonPeg hat die Fähigkeit zu freiem Interferon alfa-2b zu depegylieren.","ViraferonPeg has a potential to depegylate to free interferon alfa-2b.",10,10
"4792","de","en","Virale Infektionen Infektionen der oberen Atemwege","Viral infection Upper respiratory infection",5,6
"4793","de","en","VIRAMUNE bekämpft die HIV-1 Infektion durch Verringerung der Virusmenge im Blut.","Viramune fights HIV-1 infection by reducing the amount of the virus in the blood.",14,11
"4794","de","en","Virbagen Omega feline interferon Part A","• Virbagen Omega • feline interferon",6,6
"4795","de","en","Viread wird auch zur Behandlung der chronischen Hepatitis B, einer Infektion mit dem Hepatitis-B-Virus (HBV), bei Erwachsenen angewendet.","Viread is also used to treat chronic hepatitis B, an infection with hepatitis B virus (HBV), in adults.",18,18
"4796","de","en","Virlix, Zyrtec, Cetirizine-UCB Norwegen:","Reactine, Zyrtec, Cetirizine-UCB Malta:",4,4
"4797","de","en","Virologisches Ansprechen auf Saquinavir/Ritonavir, stratifiziert nach der Zahl der Saquinavir-assoziierten Resistenzmutationen vor Behandlungsbeginn","Virological response to saquinavir/ritonavir stratified by the number of baseline saquinavir- associated resistance mutations",14,13
"4798","de","en","VISTIDE muss vor der Verabreichung in 100 Millilitern einer 0,9%igen (physiologischen) Kochsalzlösung verdünnt werden.","VISTIDE must be diluted in 100 millilitres 0.9% (normal) saline prior to administration.",13,14
"4799","de","en","Vivanza darf nicht zusammen mit Nitraten (Arzneimittel zur Behandlung von Angina pectoris) eingenommen werden.","Vivanza should not be taken with nitrates (medicines used to treat angina).",12,14
"4800","de","en","Volibris wird zur Behandlung der pulmonal arteriellen Hypertonie (PAH) angewendet.","Volibris is used to treat pulmonary arterial hypertension (PAH).",9,10
"4801","de","en","Vollständige Angaben dazu sind der Zusammenfassung der Merkmale des Arzneimittels zu entnehmen (ebenfalls Bestandteil des EPAR).","For full details, see the Summary of Product Characteristics (also part of the EPAR).",14,16
"4802","de","en","Von 1971 bis 1974 absolvierte Gerard O’ Malley ein Praktikum in Dublin.","From 1971 to 1974, Mr O’Malley completed articles in Dublin.",10,12
"4803","de","en","Von 1987 bis 1994 war Frau Ashley-Smith in der","From 1987 to 1994, Dr Ashley-Smith was employed in the",10,9
"4804","de","en","Von 1992 bis 1998 hatte er das Amt des Direktors der AIDES Fédération Nationale inne.","He served as Director-General of AIDES Fédération Nationale from 1992 to 1998.",12,15
"4805","de","en","von 48 Stunden nach der Impfung","Collapse or shock-like state (hypotonic-hyporesponsiveness episode) within 48 hours of vaccination.",11,6
"4806","de","en","von Aerius Schmelztablette oder gegen Loratadin sind.","orodispersible tablet, or to loratadine.",5,7
"4807","de","en","Von der Glykosilierung anderer Proteine ist bekannt, dass diese deren Stabilität, Aktivität, Gewebeverteilung und Halbwertszeit im Blut beeinflusst.","Glycosylation of other proteins is known to affect their stability, activity, biodistribution, and half-life in blood.",16,18
"4808","de","en","Von einer Anwendung von Aerius in der Schwangerschaft und Stillzeit wird abgeraten.","If you are pregnant or nursing a baby, taking Aerius syrup is not recommended.",14,12
"4809","de","en","Von milden vorübergehenden Diarrhoen, weicher Fäzes oder Erbrechen wurde häufig berichtet.","Mild and transient diarrhoea, soft faeces or vomiting were commonly reported.",11,11
"4810","de","en","Von verminderter Milchproduktion bei stillenden Müttern wurde im Zusammenhang mit Pseudoephedrin, einem Bestandteil von Aerinaze, berichtet.","Decreased milk production in nursing mothers has been reported with pseudoephedrine, a component of Aerinaze.",15,16
"4811","de","en","Vor Anwendung bitte Gebrauchsinformation beachten.","Read the package leaflet before use",6,5
"4812","de","en","Vor Beginn der Avastin Behandlung wird eine Untersuchung auf Proteinurie empfohlen.","Testing for proteinuria is recommended prior to start of Avastin therapy.",11,11
"4813","de","en","Vor Beginn der Behandlung sollte die Empfindlichkeit der zu bekämpfenden Erreger überprüft werden.","Susceptibility testing of the target bacteria should be carried out prior to treatment.",13,13
"4814","de","en","Vor dem Gebrauch gut schütteln.","Shake well before use.",4,5
"4815","de","en","Vor der Anwendung von Rebif müssen Sie mit Ihrem Arzt Folgendes besprechen:","Before using Rebif, you should tell your doctor if any of the following applies to you:",16,12
"4816","de","en","Vor der ersten Entnahme von Insulin wird die Sicherheits-Plastikkappe der Durchstechflasche entfernt.","Before the first withdrawal of insulin you must remove the safety tear-off capon the vial.",15,12
"4817","de","en","Vor der jeweils nächsten Instillation ist so viel wie möglich von dem applizierten Volumen zu entfernen.","Remove as much as possible of the amount administered before the next instillation.",13,16
"4818","de","en","Vor der Rekonstitution ist das Pulver beige bis orange-beige; das Lösungsmittel ist klar und farblos.","Before reconstitution, the powder is beige to orange beige; the solvent is clear and colourless.",15,15
"4819","de","en","Vor der Verabreichung von OPTISON lesen Sie bitte Punkt 6.6 Hinweise für die Handhabung.","Before administering OPTISON, please see section 6.6 for instructions for use/ handling.",12,14
"4820","de","en","Vor der Verwendung muss Insuman Infusat 1 bis 2 Stunden bei Raumtemperatur aufbewahrt werden.","Before use, Insuman Infusat must be kept at room temperature for 1 to 2 hours.",15,14
"4821","de","en","Vor der Zubereitung die Gebrauchsanweisung gründlich lesen.","Read directions for use thoroughly before starting the preparation procedure.",10,7
"4822","de","en","Vor einer Hyposensibilisierung sollte ein vorübergehendes Absetzen von TRITAZIDE erwogen werden.","A temporary discontinuation of TRITAZIDE should be considered prior to desensitization.",11,11
"4823","de","en","Vor extremer Hitze schützen.","Avoid exposure to excessive heat.",5,4
"4824","de","en","Vor Gebrauch gut schütteln.","24 Shake well before use.",5,4
"4825","de","en","Vor Gebrauch kräftig schütteln","intramuscular use Shake well before use",6,4
"4826","de","en","Vor Gebrauch verdünnen Vor der Anwendung Packungsbeilage lesen","Dilute before use Read the package leaflet before use",9,8
"4827","de","en","Vor jedem Gebrauch gut schütteln.","Shake well before each use.",5,5
"4828","de","en","Vor jeder Anwendung ist die Durchstechflasche zu schütteln.","The vial should be shaken prior to each administration.",9,8
"4829","de","en","Vorabkontrolle von Haushaltstransaktionen 2000-2002","a priori control of budgetary transactions 2000-2002",7,4
"4830","de","en","Vorbereitung des Produkts vor dem Gebrauch:","Preparation of the product before use:",6,6
"4831","de","en","Vorbeugung und Behandlung von Calcium-Mangelzuständen Erwachsene:","Prevention and treatment of calcium deficiency Adults:",7,6
"4832","de","en","Vorkommen von Infektionen, Status der","- Assessment of long term pulmonary morbidity (e. g., incidence of infections, pulmonary function",14,5
"4833","de","en","Vorläufige Daten weisen darauf hin, dass Irbesartan die AUC und Cmax von Riprazo reduziert.","3 Preliminary data suggest that irbesartan may decrease Riprazo AUC and Cmax.",12,14
"4834","de","en","Vorsicht ist außerdem geboten, wenn Atripla gleichzeitig mit anderen Arzneimitteln eingenommen wird.","Caution is also needed when Atripla is taken at the same time as other medicines.",15,12
"4835","de","en","Vorsicht, nicht in die Augen des Tieres sprühen.","Care should be taken to avoid spraying into the eyes of the animal.",13,8
"4836","de","en","Vorteile einer Injektion anderer Substanzen in den Ort der Paravasation sind nicht bekannt.","There is no known benefit from injecting the extravasation site with another substance.",13,13
"4837","de","en","Vorübergehend kann ein kardialer elektrischer Schrittmacher bei Bedarf verwendet werden.","Temporary cardiac electrical pacing may be instituted if required.",9,10
"4838","de","en","Vorübergehende erektile Impotenz, verminderte Libido","Transient erectile impotence, libido decreased",5,5
"4839","de","en","w.7 bis w.9 w.13 bis w.15 16 400 IE/kg IL-2 und danach 0,5 ml Ceplene.","w.13 to w.15 IL-2 16 400 IU/ kg followed by 0.5 ml Ceplene.",13,15
"4840","de","en","Waarderweg 39 P.O Box 581 2031 BN Haarlem Niederlande","Waarderweg 39, P. O Box 581 NL-2031 BN Haarlem The Netherlands",11,9
"4841","de","en","Während der Anwendung von LUMIGAN sollten Sie daher nicht stillen.","Breast-feeding LUMIGAN may get into breast milk so you should not breast-feed while you are taking LUMIGAN.",17,10
"4842","de","en","Wohin soll ich mich spritzen?","After use (needle safety cover down)",6,5
"4843","de","en","Wurde ein adäquates Ansprechen erreicht, sollte die ausgewählte Dosierung bzw. das Dosierungsintervall fortgeführt werden.","If adequate response is achieved, patients should be continued on the selected dose or dose frequency.",16,14
"4844","de","en","Wurde eine Dosis aufgrund einer Toxizität reduziert, wird eine Dosiseskalation in den nachfolgenden Zyklen nicht empfohlen.","Once a dose has been reduced because of toxicity, dose escalation in the subsequent cycles is not recommended.",18,16
"4845","de","en","wurden häufig beobachtet und sind manchmal schwerwiegend.","frequently, and are sometimes severe.",5,7
"4846","de","en","Wut Aggression Suizidgedanken Suizidversuch","Anger Aggression Suicidal ideation Suicide attempt",6,4
"4847","de","en","Wyeth AB, Dalvägen 12, B.O.BOX 1822, 17124 Solna Sweden","Wyeth AB, Dalvägen 12, B. O. BOX 1822, 17124 Solna Sweden",11,9
"4848","de","en","Wyeth Medica Ireland Little Connell Newbridge, Co.","Wyeth Medica Ireland Little Connell Newbridge, Co.",7,7
"4849","de","en","Wyeth-Lederle Pharma GmbH Storchengasse 1 A-1150 Vienna Austria","Wyeth-Lederle Pharma GmbH Storchengasse 1 A-1150 Vienna Austria",8,8
"4850","de","en","x Obergrenze des Normbereichs","4.5 2.4 5.7 5.5 4.9 3.8",6,4
"4851","de","en","Xarelto 10 mg Filmtabletten","Xarelto 10 mg film-coated tablets",5,4
"4852","de","en","Xeloda 150 mg Filmtabletten Capecitabin","Xeloda 150 mg film-coated tablets Capecitabine",6,5
"4853","de","en","XERISTAR 30 mg magensaftresistente Hartkapseln XERISTAR 60 mg magensaftresistente Hartkapseln Duloxetin (als Hydrochlorid)","XERISTAR 30 mg hard gastro-resistant capsules XERISTAR 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)",15,13
"4854","de","en","Xigris erhöht das Blutungsrisiko.","Xigris increases the risk of bleeding.",6,4
"4855","de","en","Xolair kann über Ihre Muttermilch an Ihr Baby abgegeben werden.","Xolair may be passed in your breast milk to your baby.",11,10
"4856","de","en","Xyrem 4,5 - 9","Xyrem 4.5 - 9",4,4
"4857","de","en","Xyrem darf nicht eingenommen werden,","Do not take Xyrem",4,5
"4858","de","en","Yarvitan 5 mg/ml Lösung zum Eingeben für Hunde Mitratapid","Yarvitan 5 mg/ ml oral solution for dogs Mitratapide",9,9
"4859","de","en","Yentreve darf nicht bei Patientinnen mit bestimmten Lebererkrankungen oder schwerer Nierenerkrankung angewendet werden.","Yentreve should not be used in patients with certain types of liver disease or with severe kidney disease.",18,13
"4860","de","en","Yondelis war bei einmaliger Gabe alle drei Wochen wirksamer als mit dem alternativen Dosierungsschema.","Yondelis was more effective when it was given once every three weeks than the alternative dosing schedule.",17,14
"4861","de","en","Yttriga darf einem Patienten nicht direkt verabreicht werden.","Yttriga must not be given directly to any patient.",9,8
"4862","de","en","Zahlungen für administrative Unterstützung von den Institutionen der Gemeinschaft","Payment for administrative assistance from the Community institutions",8,9
"4863","de","en","Zalasta 10 mg Schmelztabletten","Zalasta 10 mg orodispersible tablets",5,4
"4864","de","en","Zalasta 5 mg Tabletten","Zalasta 5 mg tablets",4,4
"4865","de","en","Zamenhof, 36 E-28027 Madrid Tel: +34 (91) 301 93 00","Zamenhof, 36 E-28027 Madrid Tel: +34 (91) 301 93 00",10,10
"4866","de","en","Zavesca 100 mg Hartkapseln Miglustat","Zavesca 100 mg hard capsules",5,5
"4867","de","en","Zeckensaison verabreicht werden, oder der Behandlungsplan kann an die örtliche epidemiologische Situation angepasst werden.","For treatment of biting lice a single dose should be sufficient.",11,14
"4868","de","en","Zeffix ist angezeigt zur Behandlung der chronischen Hepatitis B bei Erwachsenen mit:","Zeffix is indicated for the treatment of chronic hepatitis B in adults with:",13,12
"4869","de","en","Zeichen von antiandrogenen Wirkungen, auftreten könnte.","Thus, the spontaneous reporting provides minor reassurance regarding the safety of loratadine use in pregnancy.",15,6
"4870","de","en","Zeigen Sie dem Arzt die Packungsbeilage oder das Etikett.","Show the package leaflet or the label to the physician.",10,9
"4871","de","en","zen an der Injektionsstelle, Flüssigkeitsansammlung im Körper","fluid in your body",4,7
"4872","de","en","Zerebrovaskuläre Hämorrhagie, zerebrovaskuläre Ischämie, Krampfanfälle, Bewusstseinsstörung, Enzephalopathie, Neuropathie, Polyneuropathie","Cerebrovascular haemorrhage, cerbrovascular ischaemia, seizure, impaired consciousness, encephalopathy, neuropathy, polyneuropathy",10,9
"4873","de","en","Zerene 10 mg Hartkapseln (Zaleplon)","Zerene 10 mg hard capsules zaleplon",6,5
"4874","de","en","Zerit 200 mg Pulver zur Herstellung einer Lösung zum Einnehmen Stavudin","Zerit 200 mg powder for oral solution Stavudine",8,11
"4875","de","en","Zevalin darf nicht bei Kindern und Jugendlichen angewendet werden.","Children and adolescents should not be given Zevalin.",8,9
"4876","de","en","ZIAGEN 300 mg FILMTABLETTEN Abacavir","Ziagen 300 mg Film-Coated Tablets abacavir",6,5
"4877","de","en","Ziagen-Tabletten sollten im Idealfall unzerkleinert geschluckt werden.","Ziagen tablets should ideally be swallowed without crushing.",8,7
"4878","de","en","Zidovudin zeigte bei beiden Tierspezies eine ähnliche Wirkung, aber nur bei sehr hoher systemischer Exposition.","Zidovudine had a similar effect in both species, but only at very high systemic exposures.",15,15
"4879","de","en","Ziehen Sie vorsichtig am Kolben, um sicherzustellen, dass Sie nicht in ein Blutgefäß gestochen haben.","Pull slightly on the plunger to check that a blood vessel has not been punctured.",15,15
"4880","de","en","Zimbagasse 5 A-1147 Wien Tel: + 43 1 57600-0","Zimbagasse 5 A-1147 Wien Tel: + 43 1 57600-0",9,9
"4881","de","en","Zink wird über die Muttermilch ausgeschieden; beim gestillten Säugling kann dadurch ein durch Zink induzierter Kupfermangel auftreten.","Zinc is excreted in human breast milk and zinc-induced copper deficiency in the breast-fed baby may occur.",17,17
"4882","de","en","Zinkchlorid, Glycerol, Metacresol, Natriumhydroxid, Salzsäure und Wasser für Injektionszwecke.","– The other ingredients are zinc chloride, glycerol, metacresol, sodium hydroxide, hydrochloric acid and water for injections.",17,9
"4883","de","en","Zinn(II)-chlorid, Dihydrat Essigsäure, Eisessig (Spuren) Kaliumnatriumtartrat, Tetrahydrat Saccharose","Stannous Chloride, Dihydrate Acetic Acid, Glacial (Trace) Sodium Potassium Tartrate, Tetrahydrate Sucrose",12,8
"4884","de","en","Zittern, Kopfschmerzen, Schwindel, Schwächegefühl, niedriger Blutzucker  Gelegentlich:","Trembling, headache, dizziness, weakness, low blood glucose  Uncommon:",9,8
"4885","de","en","Zoledronsäure wird nicht metabolisiert, ihre Ausscheidung erfolgt in unveränderter Form über die Nieren.","Zoledronic acid is not metabolised and is excreted unchanged via the kidney.",12,13
"4886","de","en","Zometa (Zoledronsäure) gehört zu dieser Arzneimittelgruppe.","This category of drugs includes Zometa (zoledronic acid).",8,6
"4887","de","en","Zometa 4 mg/5 ml Konzentrat zur Herstellung einer Infusionslösung","Zometa 4 mg/ 5 ml concentrate for solution for infusion",10,9
"4888","de","en","Zonegran 25 mg Hartkapseln Zonisamid","Zonegran 25 mg hard capsules zonisamide",6,5
"4889","de","en","Zonisamid hat eine lange Eliminations- Halbwertszeit, daher können seine Wirkungen anhalten.","Zonisamide has a long elimination half-life so its effects may be persistent.",12,11
"4890","de","en","zu 2 Jahre lang kontinuierlich mit Macugen behandelt (128 mit 0,3 mg, 126","Injury, poisoning and procedural complications",5,13
"4891","de","en","Zu Beginn einer Insulintherapie können Refraktionsanomalien auftreten, die aber in der Regel wieder abklingen.","Refraction anomalies may occur upon initiation of insulin therapy.",9,14
"4892","de","en","Zu den Arzneimitteln, die den Posaconazol-Blutspiegel absenken können, gehören: • Rifabutin und Rifampicin (zur Behandlung von bestimmten Infektionen).","Medicines that can decrease blood levels of posaconazole include: • Rifabutin and rifampicin (used to treat certain infections).",18,18
"4893","de","en","Zu den Beobachtungen an der Anwendungsstelle zählten Erythem, Verdickung der Epidermis, Schuppenbildung und Loslösen des Stratum corneum.","Observed effects at the application site included erythema, epidermal thickening, scaling and loosening of the stratum corneum.",17,17
"4894","de","en","Zu den sonstigen Bestandteilen siehe Abschnitt 6.1.","For inactive ingredients see section 6.1",6,7
"4895","de","en","Zu den weiteren häufigen Nebenwirkungen zählen Hautrötungen (Gesicht oder Oberkörper).","Other common side effects are skin flushes (face or upper body).",11,10
"4896","de","en","Zu diesem Zeitpunkt wertete der CHMP die anfänglich vom Unternehmen eingereichten Unterlagen aus.","The CHMP was evaluating the initial documentation provided by the company.",11,13
"4897","de","en","zu eine langsamere und weniger variable Resorption.","If convenient, the abdominal wall, the gluteal region or the deltoid region may also be used.",16,7
"4898","de","en","Zu einer akuten Überdosierung von PREZISTA zusammen mit Ritonavir 100 mg beim Menschen liegen nur begrenzte Erfahrungswerte vor.","Human experience of acute overdose with PREZISTA co-administered with 100 mg ritonavir is limited.",14,18
"4899","de","en","zu Für dieses Arzneimittel sind keine besonderen Lagerungsbedingungen erforderlich.","This medicinal product does not require any special storage conditions dic",11,9
"4900","de","en","zu Hautinfektion (einschließlich Weichteilinfektion und Impetigo), oberflächliche Pilzinfektionen (einschließlich Haut, Nagel, Fuß)","(including cellulitis and impetigo), superficial fungal infections (including skin, nail and foot) Me",13,12
"4901","de","en","zu Nicht verwendete Injektionslösung muss nach Entnahme der Dosis verworfen werden.","Any unused product must be discarded after withdrawal of the dose.",11,11
"4902","de","en","Zu Patienten mit schwerer Leberfunktionsstörung liegen keine","No pharmacokinetic data are available in patients with severe hepatic impairment.",11,7
"4903","de","en","zu Rīga, LV-1004 Tel: + 371-7 21 38 25","ed Bauskas 58a -401 Rīga, LV-1004 Tel: + 371-7 21 38 25",12,9
"4904","de","en","zu Tel: + 44-(0)1 707 363 636","ori Tel: + 44-(0)1 707 363 636",7,7
"4905","de","en","Zu welchen Schlussfolgerungen gelangte der CHMP?","What are the conclusions of the CHMP?",7,6
"4906","de","en","zu wenig Ultratard kann eine Hypo- bzw. eine Hyperglykämie verursachen.","Taking too much or too little Ultratard may cause respectively hypo or hyperglycaemia.",13,10
"4907","de","en","Zubereitungen zur intravenösen Infusion:","Preparation for intravenous infusion:",4,4
"4908","de","en","Zubrin 200 mg Lyophilisate zum Eingeben für Hunde","Zubrin 200 mg oral lyophilisates for dogs",7,8
"4909","de","en","Zucker (Sucrose) und Konservierungsmittel Methyl(4-hydroxybenzoat) (E218) und Propyl(4- hydroxybenzoat) (E216)","Sugar (sucrose) and preservatives: methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216)",11,10
"4910","de","en","Zuckerkrankheit, zusammen mit Efficib einnehmen, da Ihre Blutzuckerspiegel stark erniedrigt werden können (Hypoglykämie).","experience low blood sugar levels (hypoglycaemia).",6,13
"4911","de","en","Zudem gibt es bisher keine biologische Erklärung, die einen Kausalzusammenhang bestätigen würde.","Additionally, there is no biologic explanation so far to support a causal link.",13,12
"4912","de","en","Zugangsstelle zur Femoralarterie CABG-bedingt Urogenital Gastrointestinal Oral/oropharyngeal Hämoglobin-/Hämatokrit-Abnahme Gelegentlich","Femoral Artery Access CABG-related Genitourinary Gastrointestinal Oral/ Oropharyngeal Haemoglobin/ Haematocrit decrease Uncommon",12,9
"4913","de","en","Zugelassener Lebensmittelzusatz (E 524), CR No 2034/96","Approved food additive (E 524), CR No 2034/ 96 CR No 1442/ 95",13,7
"4914","de","en","Zulassungsinhaber Fort Dodge Animal Health C.J. van Houtenlaan 36 1381 CP Weesp Niederlande","Marketing authorisation holder Fort Dodge Animal Health C. J. van Houtenlaan 36 1381 CP Weesp The Netherlands",17,13
"4915","de","en","Zulassungsinhaber ist Eli Lilly Nederland B.V., Grootslag 1-5, 3991 RA Houten, Niederlande.","Eli Lilly Nederland B.V., Grootslag 1-5, 3991 RA Houten, The Netherlands.",11,12
"4916","de","en","Zulassungsinhaber MERIAL 29 avenue Tony Garnier F-69007 LYON, FRANKREICH","MERIAL 29 avenue Tony Garnier 69007 Lyon, France",8,9
"4917","de","en","Zulassungsinhaber Novartis Sanidad Animal S.L.","Marketing authorisation holder Novartis Sanidad Animal S. L.",8,5
"4918","de","en","Zulassungsinhaber Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ Großbritannien","Marketing Authorisation Holder Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom",13,10
"4919","de","en","Zulassungsrechtliche Angelegenheiten und organisatorische Unterstützung","Committee for Proprietary Medicinal Products",5,5
"4920","de","en","Zum Eingeben entsprechend der folgenden Tabelle.","For oral use as per table below.",7,6
"4921","de","en","Zum Einnehmen Flasche (Glas)","Oral use Oral use Oral use Oral use Oral use Oral use Oral use",14,4
"4922","de","en","Zum Einnehmen Vor der Einnahme gut schütteln.","Oral use Shake well before use.",6,7
"4923","de","en","zum Einnehmen zum Einnehmen zum Einnehmen","oral use oral use oral use",6,6
"4924","de","en","Zum Einnehmen Zum Einnehmen Zum Einnehmen Zum Einnehmen","Oral use Oral use Oral use Oral use",8,8
"4925","de","en","Zum gegenwärtigen Zeitpunkt ist der genaue Verlauf und Charakter des Thalidomid-Metabolismus beim Menschen nicht bekannt.","At the present time, the exact metabolic route and fate of thalidomide is not completely known in humans.",18,15
"4926","de","en","Zum Zeitpunkt der Impfung waren 7% der Frauen infiziert (d.h.","Seven percent of women were infected at time of vaccination (i. e.",12,10
"4927","de","en","Zum Zeitpunkt dieser Analyse waren etwa 200 Patienten aus der Placebo-Gruppe zu Sorafenib übergewechselt.","At the time of this analysis, about 200 patients had crossed-over to sorafenib from the placebo group.",17,14
"4928","de","en","Zunächst entfernen Sie den Kunststoffdeckel von der Flasche.","First, remove the flip-off cap of the vial.",8,8
"4929","de","en","Zur Anwendung darf nur eine klare und Partikel-freie Lösung kommen.","Only clear solution free from particles and discoloration should be used.",11,10
"4930","de","en","Zur Anwendung von Circadin bei Personen mit Autoimmunerkrankungen liegen keine klinischen Daten vor.","2 No clinical data exist concerning the use of Circadin in individuals with autoimmune diseases.",15,13
"4931","de","en","Zur Behandlung akuter Schmerzen und Entzündungen in Zusammenhang mit muskuloskelettalen Störungen bei Katzen.","For the treatment of acute pain and inflammation associated with musculo-skeletal disorders in cats.",14,13
"4932","de","en","Zur Behandlung von Erbrechen in Kombination mit unterstützenden Maßnahmen.","For the treatment of vomiting, in combination with other supportive measures.",11,9
"4933","de","en","Zur Beurteilung eines neuen Antrags benötigt der CHMP in der Regel bis zu 210 Tage.","The CHMP normally takes up to 210 days to evaluate a new application.",13,15
"4934","de","en","Zur Capecitabin- Dosisberechnung nach Körperoberfläche siehe die Zusammenfassung der Produktmerkmale von Capecitabin.","For capecitabine dose calculation according to body surface area, see capecitabine summary of product characteristics.",15,12
"4935","de","en","Zur Eingabe ohne Futter oder mit einer kleinen Menge Futter.","Give either without food or with a small amount of food.",11,10
"4936","de","en","Zur Erhaltung einer ANC von > 2,0 x 109/l kann eine Langzeitanwendung erforderlich sein.","Long-term administration may be required to maintain the ANC > 2.0 x 109/ l.",14,14
"4937","de","en","Zur Haltbarkeit des zubereiteten Produktes lesen Sie die Packungsbeilage.","Read the leaflet for the shelf life of the reconstituted product",11,9
"4938","de","en","Zur Kombination von CellCept mit anderen Phosphatbindern als Sevelamer liegen keine Daten vor.","There is no data on CellCept with phosphate binders other than sevelamer.",12,13
"4939","de","en","Zur Linderung von Schmerzen und Entzündungen bei Osteoarthritis und zur Verringerung der damit verbundenen Lahmheit bei Pferden.","Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.",15,17
"4940","de","en","Zur Pharmakokinetik von Micafungin bei Patienten mit schwerer Leberinsuffizienz liegen keine aus- reichenden Daten vor (siehe Abschnitt 5.2).","There are insufficient data on the pharmacokinetics of micafungin in patients with severe hepatic impairment (see section 5.2).",18,18
"4941","de","en","Zur Sicherstellung der effizienten und nachhaltigen Verwendung der Finanzmittel werden dem Management zeitgerechte Berichte vorgelegt.","Timely reports will be presented to management to ensure effective and efficient use of financial resources.",16,15
"4942","de","en","Zur Sicherstellung einer korrekten Dosierung sollte das Körpergewicht so genau wie möglich ermittelt werden, um Unterdosierungen zu vermeiden.","To ensure a correct dosage, body weight should be accurately determined to avoid under-dosing.",14,18
"4943","de","en","Zur Stellungnahme freigegeben im Februar 2002","Released for consultation February 2002",5,6
"4944","de","en","Zur Stellungnahme freigegeben im Mai 2002","Released for consultation May 2002",5,6
"4945","de","en","Zur Stimulierung einer aktiven Immunität gegen Babesiose, hervorgerufen durch Babesia canis.","To stimulate active immunity against babesiosis caused by Babesia canis.",10,11
"4946","de","en","Zur subkutanen Injektion reinigen Sie die Haut an der Injektionsstelle mit einem Alkoholtupfer.","For subcutaneous injection, clean the skin at the site of injection using an alcohol wipe.",15,13
"4947","de","en","Zur Therapie einer Überdosierung von Bondenza stehen keine speziellen Informationen zur Verfügung.","No specific information is available on the treatment of over dosage with Bondenza.",13,12
"4948","de","en","Zur Therapie und Metaphylaxe von Atemwegserkrankungen beim Rind (BRD), hervorgerufen durch Mannheimia haemolytica, Pasteurella multocida und Histophilus somni.","Therapeutic and preventive treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni.",18,18
"4949","de","en","Zur Vermeidung einer möglichen Übertragung von Krankheiten darf jeder Pen nur von ausschließlich einem Patienten benutzt werden.","To prevent the possible transmission of disease, each pen must be used by one patient only.",16,17
"4950","de","en","Zur Vorbeugung von Erbrechen mit Ausnahme von Erbrechen bei Reisekrankheit.","For the prevention of vomiting except that induced by motion sickness.",11,10
"4951","de","en","Zusammen mit einem Ernährungs- und Bewegungsprogramm senkt dieses Arzneimittel Ihren Blutzucker.","Along with diet and exercise, this medicine helps lower your blood sugar.",12,11
"4952","de","en","Zusammenfassung der Krankheitsverläufe in Studien der Phasen II und III","Summary of Disease Outcomes from the Phase III and Phase II studies",12,10
"4953","de","en","ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS","SUMMARY OF PRODUCT CHARACTERISTICS",4,5
"4954","de","en","Zusammenfassung der Merkmale des Arzneimittels, Abschnitt 4.2).","Summary of Product Characteristics, section 4.2).",6,7
"4955","de","en","ZUSAMMENFASSUNG DER MERKMALE DES ARZNEIMITTELS, ETIKETTIERUNG UND PACKUNGSBEILAGE","SUMMARY OF PRODUCT CHARACTERISTICS, LABELLING AND PACKAGE LEAFLET",8,8
"4956","de","en","Zusammenfassung des EPAR für die Öffentlichkeit","EPAR summary for the public",5,6
"4957","de","en","Zusammengefasste Ergebnisse von plazebokontrollierten Studien","Integrated findings from placebo-controlled trials",5,5
"4958","de","en","Zusätzlich enthalten die Packungen für jede Durchstechflasche","Additionally, for each vial the packs contain",7,7
"4959","de","en","Zusätzlich ist Amprenavir auch ein Hemmstoff des CYP3A4-Enzyms, allerdings in geringerem Ausmaß als Ritonavir.","Amprenavir in addition is also an inhibitor of the CYP3A4 enzyme, although to a lesser extent than ritonavir.",18,14
"4960","de","en","Zusätzlich können einige Patienten an Erbrechen leiden.","In addition some patients may experience vomiting.",7,7
"4961","de","en","Zusätzlich sollte ein aktualisierter RMP vorgelegt werden:","In addition, an updated RMP should be submitted",8,7
"4962","de","en","Zusätzlich wurde eine signifikante Reduktion der Inzidenz von Hüftfrakturen (1,1% gegenüber 2,2%; Reduktion um 51%) festgestellt.","In this study alendronate daily reduced the incidence of ≥ 1 new",12,16
"4963","de","en","Zusätzliche unerwünschte Ereignisse nach Markteinführung oder aus klinischen Studien der Phase IV","The additional adverse reactions in Table 2 have been reported from postmarketing surveillance or no",15,12
"4964","de","en","Zwei Injektionen im Abstand von 21 Tagen.","Basic vaccination: two injections 21 days apart.",7,7
"4965","de","en","Zwei Wochen nach der Erstimpfung entwickelten die Pferde einen Schutz.","Horses developed protection two weeks after primary vaccination.",8,10
"4966","de","en","Zwischen Kreatinin-Clearance und Vardenafil- Exposition (AUC und Cmax) wurde keine statistisch signifikante Korrelation beobachtet (siehe Abschnitt 4.2).","No statistically significant correlation was observed between creatinine clearance and vardenafil exposure (AUC and Cmax) (see section 4.2).",18,17
"4967","de","en","ZWISCHENPACKUNGEN DER MEHRFACHPACKUNGEN (OHNE BLUE BOX) MIT PA/ALU/PVC-BLISTERPACKUNGEN","INTERMEDIATE CARTON OF MULTIPACKS (WITHOUT BLUE BOX) CONTAINING PA/ ALU/ PVC BLISTERS",12,8
